##GENOME_BUILD=GRCh38
##CALLING_DATE=2023-10-24
##SOURCE=freebayes v1.3.6
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 2023_04-163-g852d0cef
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous/hemizygous case count of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous allele count of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype allele count of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=AlphaMissense=AlphaMissense pathogenicity score. Deleterious threshold > 0.564.
##DESCRIPTION=MaxEntScan=MaxEntScan reference score and alternate score for (1) native splice site, (2) acceptor gain and (3) donor gain. Comma-separated list if there are different predictions for several transcripts.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction. These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_mosaic=Mosaic variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140549_01	GS140550_01	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	CADD	REVEL	AlphaMissense	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_mosaic	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	1022518	1022518	G	T	hom	hom	het	off-target	QUAL=3757;DP=64,45,56;AF=0.98,1.00,0.64;MQM=60;SAP=307;ABP=13;SAR=143;SAF=1	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+56G>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677944 [benign DISEASE=not provided];			rs2799064	0.34507	0.35944,0.25052,0.18907,0.35454,0.37174	9381,	33649	99475	-0.4950	2.94			/0.0>0.0/0.0>2.9	COSV65071508	AGRN|0.00|0.00|0.00|0.00|14|-1|-2|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1022587	1022587	-	TGTAGTCTGACCTGTGGTCTGAC	wt	het	het	off-target	QUAL=126;DP=15,9,8;AF=0.00,0.44,0.88;MQM=60;SAP=27;ABP=6;SAR=11;SAF=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+128_463+129insAGTCTGACCTGTGGTCTGACTGT::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+128_49+129insAGTCTGACCTGTGGTCTGACTGT::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs6143083	0.91311	0.71741,0.96451,0.92169,0.99732,0.98798	64471,	9777	13201		7.54			/0.0>0.8/0.6>0.6		AGRN|0.10|0.00|0.00|0.00|46|-18|46|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035170	1035171	GG	-	n/a	het	het	off-target	QUAL=260;DP=1,14,8;AF=0.00,0.57,0.50;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.464-96_464-95del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.50-96_50-95del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs56001364	0.32655	0.34155,0.34916,0.23832,0.31683,0.36933	2279,	16597	43629	-0.2380	1.09			/0.0>0.0/3.0>3.0		AGRN|0.00|0.00|0.00|0.00|-3|48|12|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035170	1035172	GGG	-	n/a	het	het	off-target	QUAL=260;DP=1,14,8;AF=0.00,0.21,0.13;MQM=60;SAP=12;ABP=22;SAR=0;SAF=4	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.464-97_464-95del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.50-97_50-95del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs56001364	0.02181	0.06218,0.01233,0.00384,0.00878,0.00326	15,	1370	62796	-0.2380	1.06			/0.0>0.0/3.0>3.0		AGRN|0.00|0.00|0.00|0.00|-3|48|-46|-2		48	345	0	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035385	1035385	C	T	wt	het	wt	off-target	QUAL=3175;DP=51,254,388;AF=0.00,0.54,0.00;MQM=60;SAP=3;ABP=6;SAR=66;SAF=71	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron3/35:c.511+61C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron3/38:c.97+61C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs377303595	0.00103	0.00058,0.00039,0.00000,0.00179,0.00000	0,	156	152034	-2.2080	1.16			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|21|31|-2|8		0	49	0	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035498	1035498	C	T	het	wt	het	off-target	QUAL=2261;DP=68,125,185;AF=0.53,0.00,0.43;MQM=60;SAP=253;ABP=8;SAR=115;SAF=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron3/35:c.511+174C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron3/38:c.97+174C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs151122070	0.00016	0.00002,0.00013,0.00019,0.00022,0.00000	0,	24	152118	-0.9310	1.12			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|10|-8|-20|25		0	4	0	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041823	1041823	G	C	hom	hom	hom	off-target;low_conf_region	QUAL=825;DP=9,9,14;AF=1.00,1.00,1.00;MQM=55;SAP=13;ABP=0;SAR=22;SAF=10	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron6/35:c.1177+121G>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron6/38:c.763+121G>C::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677945 [benign DISEASE=not provided];			rs3121552	0.41896	0.38085,0.47936,0.69231,0.44891,0.50000	1045,	1498	4976	-2.5600	0.55			/0.0>0.0/0.0>0.0	COSV65071601	AGRN|0.00|0.00|0.00|0.00|-4|8|20|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041950	1041950	T	C	hom	hom	hom		QUAL=1742;DP=13,20,26;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0;SAR=6;SAF=53	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron6/38:c.764-6T>C::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128292 [benign DISEASE=not specified,Congenital myasthenic syndrome 8];			rs2799066	0.87314	0.71715,0.92165,0.99981,0.92181,0.95732	58337,	15313	19177	-0.8440	0.67			6.8>6.9/6.8>6.9/0.0>0.0		AGRN|0.00|0.12|0.00|0.00|-7|11|11|39	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1042190	1042190	G	A	hom	hom	hom	off-target	QUAL=1524;DP=18,15,21;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0;SAR=52;SAF=2	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.970+28G>A::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263159 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided];			rs2710876	0.78799	0.44149,0.88328,0.96800,0.91755,0.94663	50662,	18508	32242	-1.7260	0.18			/0.0>0.0/2.0>4.4		AGRN|0.00|0.00|0.02|0.00|2|-2|2|-28	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1043224	1043225	CT	-	wt	wt	het	off-target	QUAL=1480;DP=59,167,187;AF=0.00,0.00,0.46;MQM=60;SAP=134;ABP=6;SAR=7;SAF=79	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron7/35:c.1385-15_1385-14del::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron7/38:c.971-15_971-14del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263160 [benign DISEASE=not provided,Congenital myasthenic syndrome 8,not specified];			rs35881187	0.44317	0.10988,0.62210,0.78569,0.54851,0.55523	18381,	30472	84478	-0.1120	4.43			/9.0>8.1/0.0>0.0		AGRN|0.11|0.04|0.00|0.00|48|16|21|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045080	1045080	G	A	hom	hom	hom	off-target	QUAL=785;DP=4,9,14;AF=1.00,1.00,1.00;MQM=60;SAP=26;ABP=0;SAR=5;SAF=22	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron12/35:c.2255-81G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron12/38:c.1841-81G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677948 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs3128097	0.89863	0.79466,0.93300,0.99981,0.92932,0.96248	61714,	13154	15408	2.3760	8.34			/0.0>0.0/6.6>3.3		AGRN|0.00|0.00|0.03|0.43|30|-33|30|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045707	1045707	A	G	hom	hom	hom	off-target	QUAL=5759;DP=68,51,65;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=92;SAF=92	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron14/38:c.2123-26A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263172 [benign DISEASE=Congenital myasthenic syndrome 8,not specified,not provided];			rs3128098	0.85383	0.64399,0.91033,0.99981,0.92778,0.96175	56727,	16419	22233	-0.8630	1.44			/0.0>0.0/0.0>0.0		AGRN|0.11|0.00|0.00|0.00|33|26|-12|33	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1046551	1046551	A	G	hom	hom	hom		QUAL=6222;DP=51,71,96;AF=1.00,1.00,1.00;MQM=60;SAP=6;ABP=0;SAR=101;SAF=117	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon18/39:c.2652A>G:p.Ser884=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128297 [benign DISEASE=not specified,Congenital myasthenic syndrome 8];			rs2465128	0.80155	0.51414,0.88107,0.96182,0.90993,0.89182	51078,	19390	30092	-1.0320	0.11			/0.0>0.0/0.0>0.0	COSV65068047	AGRN|0.00|0.01|0.00|0.00|-36|21|38|-38	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047064	1047064	A	G	hom	hom	hom	off-target	QUAL=9374;DP=69,114,155;AF=1.00,0.99,1.00;MQM=60;SAP=692;ABP=0;SAR=332;SAF=5	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+107A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+107A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677950 [benign DISEASE=not provided];			rs3128099	0.81732	0.54361,0.89284,0.96790,0.91814,0.94766	52914,	18385	27763	1.1180	7.41			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.03|0.00|-21|-27|-28|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047082	1047082	T	C	hom	hom	hom	off-target	QUAL=9022;DP=76,105,139;AF=1.00,1.00,1.00;MQM=60;SAP=655;ABP=0;SAR=315;SAF=5	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+125T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+125T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677951 [benign DISEASE=not provided];			rs3128100	0.98587	0.95382,0.99090,0.99981,0.99906,0.99896	73957,	2057	2149	-4.5630	0.01			/0.0>0.2/5.1>7.4		AGRN|0.01|0.00|0.00|0.01|47|-48|0|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047133	1047133	T	C	hom	hom	hom	off-target	QUAL=5690;DP=44,70,77;AF=1.00,1.00,1.00;MQM=60;SAP=320;ABP=0;SAR=179;SAF=12	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+176T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+176T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677952 [benign DISEASE=not provided];			rs3128101	0.91287	0.84513,0.93674,0.99981,0.92928,0.96319	63556,	11765	13255	-0.0520	10.24			/0.0>0.0/5.0>0.0		AGRN|0.13|0.00|0.11|0.00|-4|19|29|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047561	1047561	T	C	hom	hom	hom	off-target	QUAL=9183;DP=47,105,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0;SAR=107;SAF=194	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron20/35:c.3517-12T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron20/38:c.3103-12T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263181 [benign DISEASE=not specified,Congenital myasthenic syndrome 8];			rs3128102	0.79386	0.46401,0.88334,0.96779,0.91710,0.94704	51078,	18612	31360	-0.1470	2.44			6.8>6.3/6.8>6.3/0.0>0.0		AGRN|0.04|0.01|0.00|0.00|37|12|37|13	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047614	1047614	T	C	hom	hom	hom		QUAL=15508;DP=140,143,208;AF=0.99,1.00,1.00;MQM=60;SAP=11;ABP=0;SAR=223;SAF=266	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon21/39:c.3144T>C:p.Phe1048=:PF01390 [SEA domain]		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128302 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs10267	0.81960	0.53817,0.89590,0.99923,0.92000,0.95659	53403,	17888	27446	2.1470	7.24			/0.0>0.0/0.0>0.0	COSV65071416	AGRN|0.01|0.00|0.00|0.00|-16|-8|39|6	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1048922	1048922	T	C	het	wt	hom		QUAL=588;DP=9,17,19;AF=0.67,0.00,1.00;MQM=60;SAP=7;ABP=5;SAR=16;SAF=9	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon24/39:c.3747T>C:p.Thr1249=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128307 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs9442391	0.50415	0.29246,0.64656,0.81845,0.56201,0.56682	20786,	34643	74961	-1.2460	0.61			/0.0>0.1/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|-26|18|0|-2	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1049886	1049886	C	T	het	wt	hom	off-target	QUAL=584;DP=8,11,20;AF=0.50,0.00,1.00;MQM=60;SAP=3;ABP=3;SAR=13;SAF=11	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron26/35:c.4745-17C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron26/38:c.4331-17C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263188 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs2275813	0.45216	0.16071,0.62439,0.80891,0.53730,0.54871	18221,	31986	82908	-1.7470	1.60			11.5>11.3/11.5>11.3/0.0>0.0		AGRN|0.14|0.00|0.00|0.00|17|-4|25|-11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050064	1050064	G	-	hom	hom	wt	off-target;low_conf_region	QUAL=322;DP=4,9,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=9	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+41del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292619 [benign DISEASE=not provided];			rs71576592	0.54716	0.73060,0.49611,0.64914,0.45344,0.48649	19472,	34173	60513	0.0280	0.38			/4.7>4.7/0.0>0.0		AGRN|0.00|0.00|0.01|0.00|-26|2|-50|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050066	1050066	G	T	wt	wt	het	off-target;low_conf_region	QUAL=322;DP=4,9,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+29G>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263191 [benign DISEASE=not specified,not provided];			rs2275812	0.35173	0.10981,0.44888,0.16812,0.45312,0.46930	9412,	30480	90870	-1.2390	0.55			/4.7>6.7/0.0>6.9	COSV65067816	AGRN|0.00|0.00|0.00|0.01|-47|-28|-2|-29	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050069	1050069	G	A	wt	wt	hom	off-target;low_conf_region	QUAL=322;DP=4,9,6;AF=0.75,1.00,0.00;MQM=60;SAP=4;ABP=3;SAR=1;SAF=2	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+32G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263192 [benign DISEASE=not provided,not specified];			rs2799067	0.56125	0.33449,0.60514,0.55427,0.62369,0.62895	13928,	32696	47336	0.1660	1.25			/0.0>0.0/0.0>0.0	COSV65067820	AGRN|0.00|0.00|0.00|0.00|-32|32|-32|-23	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050070	1050070	G	A	hom	hom	wt	off-target;low_conf_region	QUAL=322;DP=4,9,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=9	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+33G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1232566 [benign DISEASE=not provided];			rs397834473	0.50284	0.68309,0.46944,0.58323,0.41206,0.43162	19437,	34644	72688	-0.3950	0.59			/0.0>0.0/0.0>0.0	COSV65068887	AGRN|0.00|0.00|0.00|0.00|42|31|-33|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051063	1051063	C	T	hom	hom	hom	off-target	QUAL=1097;DP=18,12,7;AF=1.00,1.00,1.00;MQM=59;SAP=13;ABP=0;SAR=25;SAF=12	AGRN	intron,splice_region&intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron30/35:c.5254-190C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron31/38:c.4851+20C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677954 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710887	0.78242	0.43384,0.88253,0.99496,0.91038,0.90224	50077,	18720	33058	-0.0930	0.84			/0.0>0.0/0.0>0.0		AGRN|0.01|0.00|0.02|0.00|-31|-48|31|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051820	1051820	C	T	hom	hom	hom		QUAL=10531;DP=63,134,150;AF=0.97,1.00,0.99;MQM=60;SAP=113;ABP=0;SAR=238;SAF=106	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron34/38:c.5249+5C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128317 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs9803031	0.78729	0.45252,0.88553,0.99458,0.91069,0.88702	50443,	18847	32349	-1.1710	0.73			9.6>8.7/0.0>0.0/9.6>8.7		AGRN|0.00|0.00|0.00|0.00|-27|-5|-5|-29	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1053552	1053552	G	C	hom	het	hom	off-target	QUAL=496;DP=11,4,7;AF=1.00,0.50,1.00;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron33/35:c.5652-201G>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron36/38:c.5306+59G>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677955 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710871	0.75121	0.43012,0.86767,0.99458,0.85924,0.89133	45926,	22286	37800	-0.5450	0.04			/1.4>1.7/0.0>0.0	COSV65071518	AGRN|0.00|0.00|0.00|0.00|24|1|8|32	33589840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1054900	1054900	C	T	wt	het	het		QUAL=4766;DP=101,174,207;AF=0.00,0.51,0.59;MQM=60;SAP=309;ABP=12;SAR=19;SAF=191	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon39/39:c.5712C>T:p.Asp1904=:PF00054 [Laminin G domain]		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128319 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs4275402	0.59132	0.32267,0.71957,0.81190,0.69607,0.60717	28830,	32220	62120	-0.7120	0.31			/0.0>0.0/2.6>1.8	COSV65070964	AGRN|0.00|0.00|0.00|0.00|37|2|-23|-4	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055000	1055000	C	T	hom	het	het		QUAL=12361;DP=162,333,432;AF=0.97,0.44,0.49;MQM=60;SAP=130;ABP=9;SAR=171;SAF=345	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263157 [benign DISEASE=not specified];			rs3121561	0.35128	0.50720,0.25380,0.18294,0.29457,0.31897	10237,	32927	98619	-0.4130	0.50			/0.0>0.0/0.0>0.0	COSV65069616	AGRN|0.00|0.00|0.00|0.00|7|-7|7|26	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055037	1055037	T	C	hom	het	het		QUAL=16508;DP=186,389,502;AF=0.99,0.46,0.49;MQM=60;SAP=15;ABP=8;SAR=276;SAF=333	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292868 [benign DISEASE=not provided];			rs2465136	0.38562	0.60149,0.27051,0.18793,0.30300,0.36827	12824,	32989	93421	0.2810	13.13			/0.0>0.1/0.0>0.0	COSV65069776	AGRN|0.00|0.00|0.00|0.00|-44|29|8|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055137	1055137	C	T	hom	het	hom		QUAL=18365;DP=120,285,372;AF=0.99,0.48,1.00;MQM=60;SAP=201;ABP=4;SAR=433;SAF=194	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1185529 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710872	0.87995	0.84077,0.92207,0.99962,0.87540,0.94518	59057,	15807	18271	0.1560	6.08			/0.0>0.0/0.0>0.0		AGRN|0.00|0.05|0.00|0.00|14|-28|-5|18	32314116	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055393	1055393	C	T	hom	het	hom		QUAL=22447;DP=183,297,404;AF=1.00,0.54,1.00;MQM=60;SAP=88;ABP=7;SAR=288;SAF=459	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799072	0.81718	0.64442,0.89847,0.99481,0.86697,0.89859	51702,	20907	27811	-1.0550	5.67			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|-4|-16|-29|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055426	1055426	G	A	hom	het	hom		QUAL=24703;DP=229,312,451;AF=0.97,0.54,1.00;MQM=60;SAP=59;ABP=8;SAR=347;SAF=494	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799073	0.81727	0.64467,0.89861,0.99480,0.86696,0.89897	51712,	20902	27798	-0.1780	2.88			/3.7>2.5/0.0>0.0		AGRN|0.01|0.00|0.00|0.00|-49|50|28|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055604	1055604	G	A	hom	het	hom		QUAL=15901;DP=148,190,273;AF=1.00,0.59,1.00;MQM=60;SAP=268;ABP=16;SAR=394;SAF=139	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs8014	0.88383	0.85302,0.92406,0.99961,0.87588,0.94642	59543,	15418	17680	-1.8980	0.15			/0.0>0.0/0.1>0.0		AGRN|0.00|0.00|0.00|0.00|5|-25|-42|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1056279	1056279	C	-	hom	het	hom	off-target	QUAL=3776;DP=10,67,98;AF=1.00,0.52,1.00;MQM=60;SAP=296;ABP=3;SAR=141;SAF=2	AGRN	downstream_gene	AGRN:ENST00000379370.7:downstream_gene_variant:MODIFIER::::,AGRN:ENST00000620552.4:downstream_gene_variant:MODIFIER::::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs60286592	0.88398	0.85352,0.92409,0.99961,0.87585,0.94677	59496,	15396	17638	0.3350	1.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	2024923	2024923	G	A	hom	het	het	off-target	QUAL=6566;DP=82,172,170;AF=1.00,0.49,0.48;MQM=60;SAP=84;ABP=4;SAR=76;SAF=172	GABRD	splice_region&intron	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000638771.1:splice_region_variant&intron_variant:LOW:intron1/7:c.69-19G>A::,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256824 [benign DISEASE=not specified,Idiopathic generalized epilepsy];			rs2376805	0.81274	0.79510,0.76767,0.71929,0.83045,0.78132	50293,	23074	28492	-0.2210	4.09			7.7>6.2/7.7>6.2/0.0>0.0	COSV66080160	GABRD|0.02|0.00|0.00|0.00|2|19|2|43	25741868,20561060,33887383,34160285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025598	2025598	T	C	het	wt	het		QUAL=6809;DP=161,341,399;AF=0.54,0.00,0.49;MQM=60;SAP=73;ABP=3;SAR=190;SAF=94	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon4/8:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256823 [benign DISEASE=not specified,not provided,Idiopathic generalized epilepsy];			rs2229110	0.65458	0.72927,0.59982,0.33971,0.65556,0.46640	33171,	33152	52502	-1.2170	12.60			/1.9>0.7/0.0>0.0	COSV66080001	GABRD|0.00|0.01|0.00|0.00|-50|9|48|-2	25741868,33887383,34160285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025781	2025781	G	-	het	wt	het	off-target	QUAL=1301;DP=54,54,75;AF=0.46,0.00,0.52;MQM=60;SAP=142;ABP=3;SAR=64;SAF=0	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron4/7:c.470+45del::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron4/8:c.470+45del::	regulatory_region_variant:promoter	137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs3831907	0.12878	0.20600,0.08052,0.03353,0.11532,0.07240	1489,	16610	132514	-3.0860	0.76			/0.0>0.0/0.0>0.0		GABRD|0.00|0.00|0.00|0.01|-47|48|31|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2027822	2027822	A	G	hom	het	het	off-target	QUAL=6011;DP=70,136,180;AF=0.97,0.55,0.55;MQM=60;SAP=503;ABP=10;SAR=239;SAF=3	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron5/7:c.553+163A>G::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28574670	0.86481	0.96350,0.79459,0.79737,0.83275,0.82226	57226,	17084	20562	-0.0360	4.86			/0.0>0.0/0.0>0.0	COSV66080172	GABRD|0.00|0.00|0.00|0.00|-27|-30|19|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2028422	2028422	-	C	n/a	het	het	off-target	QUAL=189;DP=0,6,11;AF=,0.67,0.55;MQM=60;SAP=25;ABP=4;SAR=10;SAF=0	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron6/8:c.691+131dup::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron6/8:c.775+131dup::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron6/7:c.691+131dup::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron6/8:c.691+131dup::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs138736063	0.23327	0.21770,0.21540,0.48776,0.21695,0.39171	4472,	26251	115681		5.48			/0.0>1.7/0.0>0.0		GABRD|0.00|0.00|0.00|0.00|-4|1|-37|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029235	2029235	C	T	het	het	wt		QUAL=4943;DP=121,267,387;AF=0.49,0.56,0.01;MQM=60;SAP=20;ABP=8;SAR=126;SAF=85	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon7/9:c.900C>T:p.Ser300=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon7/8:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256825 [benign DISEASE=not specified,not provided,Idiopathic generalized epilepsy];			rs28408173	0.12627	0.03160,0.15829,0.43257,0.13589,0.26654	1790,	15636	132968	-0.4760	3.35			/3.7>4.4/0.0>0.0	COSV66080067	GABRD|0.00|0.01|0.00|0.00|21|0|-18|31	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029487	2029487	T	C	hom	het	het	off-target	QUAL=4898;DP=52,118,191;AF=1.00,0.37,0.52;MQM=60;SAP=233;ABP=6;SAR=26;SAF=170	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron7/8:c.848-64T>C::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron7/8:c.932-64T>C::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron7/7:c.848-64T>C::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron7/8:c.848-133T>C::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28581504	0.83739	0.86804,0.78501,0.79817,0.83225,0.82181	53391,	20553	24727	-1.4640	0.88			/0.0>0.0/0.0>0.1	COSV66081616	GABRD|0.00|0.00|0.00|0.00|16|-3|-48|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029969	2029969	C	T	het	het	wt	off-target	QUAL=1625;DP=68,64,74;AF=0.57,0.50,0.01;MQM=60;SAP=42;ABP=5;SAR=54;SAF=18	GABRD	splice_region&intron,synonymous	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron8/8:c.1060-14C>T::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1144-14C>T::,GABRD:ENST00000638771.1:synonymous_variant:LOW:exon8/8:c.1266C>T:p.Thr422=:,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron8/8:c.991-14C>T::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256822 [benign DISEASE=Idiopathic generalized epilepsy,not specified];			rs28431879	0.12621	0.03159,0.15766,0.45444,0.13495,0.25889	1826,	15558	132994	-0.9510	0.64			7.6>6.9/7.6>6.9/0.0>0.0,/7.6>6.9/0.0>0.0	COSV66079834	GABRD|0.00|0.01|0.00|0.00|14|-44|24|19	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2405838	2405838	C	T	het	n/a	n/a		QUAL=108;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=5;SAR=8;SAF=0	PEX10	splice_region&intron	PEX10:ENST00000288774.8:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513.7:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596.5:splice_region_variant&intron_variant:LOW:intron5/5:c.913-10G>A::		602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	262791 [benign DISEASE=not provided,not specified,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B];			rs11586985	0.08782	0.02219,0.08014,0.11635,0.11756,0.10079	808,	11752	138850	-1.5970	0.04			13.7>13.5/13.7>13.5/0.0>0.0,0.0>0.0/13.7>13.5/0.0>0.0	COSV56580725	PEX10|0.00|0.01|0.00|0.00|-4|26|-24|-3	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2406687	2406687	C	A	wt	het	het	off-target	QUAL=1048;DP=46,45,55;AF=0.00,0.49,0.49;MQM=60;SAP=31;ABP=3;SAR=12;SAF=37	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron4/5:c.776+33G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1180486 [benign DISEASE=Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B,not provided];			rs3795269	0.38775	0.28817,0.42484,0.27259,0.43295,0.36718	12033,	34868	93054	0.5960	3.45			/0.0>0.0/0.0>0.0	COSV56579855	PEX10|0.00|0.00|0.00|0.00|-31|-41|31|33	35213538	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2407130	2407130	T	C	het	het	hom	off-target	QUAL=272;DP=12,5,4;AF=0.58,0.60,1.00;MQM=60;SAP=33;ABP=4;SAR=14;SAF=0	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron3/5:c.601-175A>G::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron3/5:c.601-235A>G::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron3/5:c.601-235A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1259297 [benign DISEASE=not provided];			rs2494427	0.81278	0.63653,0.81954,0.83051,0.89438,0.82422	51211,	21209	28477	-1.9020	0.52			/0.0>0.0/5.7>1.9		PEX10|0.00|0.00|0.00|0.02|30|-44|-44|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2408761	2408761	T	C	wt	het	het		QUAL=985;DP=43,39,48;AF=0.02,0.44,0.54;MQM=60;SAP=47;ABP=3;SAR=37;SAF=7	PEX10	synonymous	PEX10:ENST00000288774.8:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.7:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.5:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	129884 [benign DISEASE=Zellweger spectrum disorders,not specified,not provided,Peroxisome biogenesis disorder, complementation group 7,Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B];			rs2494598	0.74313	0.59900,0.77023,0.72594,0.81196,0.73249	42746,	27445	39037	-6.5220	0.15			/0.0>0.0/0.8>2.9	COSV56581176	PEX10|0.00|0.00|0.00|0.00|6|-34|-33|6	25741868,15542397	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5862774	5862774	C	A	het	wt	hom	off-target	QUAL=1524;DP=54,26,42;AF=0.35,0.00,1.00;MQM=60;SAP=127;ABP=13;SAR=1;SAF=60	MIR4689,NPHP4	upstream_gene,downstream_gene	MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::,NPHP4:ENST00000378156.9:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]				rs12133533	0.12683	0.03437,0.11895,0.08301,0.17768,0.14268	1586,	16125	132849	-0.3670	0.69							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5863728	5863728	T	G	hom	het	hom	off-target	QUAL=832;DP=15,9,11;AF=1.00,0.56,1.00;MQM=60;SAP=70;ABP=3;SAR=0;SAF=31	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron29/29:c.4140+162A>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1290771 [benign DISEASE=not provided];			rs11121648	0.56633	0.59768,0.51024,0.28508,0.57918,0.54655	24692,	36685	65907	-1.7180	0.22			/4.7>6.1/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-8|-49|14|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5864686	5864686	T	C	het	wt	hom	off-target	QUAL=233;DP=10,3,4;AF=0.90,0.00,1.00;MQM=60;SAP=31;ABP=17;SAR=13;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron27/29:c.3817-169A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287643 [benign DISEASE=not provided];			rs1287635	0.36421	0.24492,0.37390,0.27341,0.41937,0.43260	10585,	34184	96632	-2.0590	0.62			/0.5>0.0/0.0>0.0	COSV65394658	NPHP4|0.00|0.00|0.00|0.00|-42|-24|-24|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866447	5866447	T	C	het	wt	hom		QUAL=8931;DP=277,155,183;AF=0.50,0.00,0.99;MQM=60;SAP=29;ABP=3;SAR=191;SAF=129	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95683 [benign DISEASE=Nephronophthisis,not specified,not provided,Nephronophthisis 4,Senior-Loken syndrome 4];			rs555164	0.35378	0.20828,0.36936,0.27113,0.41970,0.43006	10237,	33267	98163	0.3050	2.05			/0.0>0.0/0.0>1.0	COSV65394708	NPHP4|0.00|0.01|0.00|0.00|11|-22|20|-22	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866971	5866971	A	G	het	wt	hom	off-target	QUAL=3780;DP=81,66,97;AF=0.48,0.00,1.00;MQM=60;SAP=150;ABP=3;SAR=20;SAF=116	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233249 [benign DISEASE=not provided];			rs12122135	0.12870	0.04056,0.12217,0.08343,0.17734,0.14840	1581,	16413	132519	-0.2330	1.83			/3.2>3.3/0.0>0.0	COSV65397177	NPHP4|0.00|0.00|0.00|0.01|-41|-14|-14|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867678	5867678	G	A	het	wt	hom	off-target	QUAL=7249;DP=127,156,193;AF=0.50,0.01,1.00;MQM=60;SAP=396;ABP=3;SAR=21;SAF=237	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron24/29:c.3472+62C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1289471 [benign DISEASE=not provided];			rs2297791	0.13418	0.05370,0.13416,0.10281,0.17696,0.15172	1629,	17154	131716	0.0360	2.09			/0.0>0.0/0.0>0.0	COSV65397184	NPHP4|0.00|0.00|0.00|0.00|-16|23|9|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867883	5867883	G	A	wt	wt	het		QUAL=3644;DP=133,269,360;AF=0.00,0.00,0.48;MQM=60;SAP=47;ABP=4;SAR=116;SAF=57	NPHP4	missense	NPHP4:ENST00000378156.9:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95682 [likely benign(replaced by megSAP based on classifications:1x1,6x2,1x3) DISEASE=not provided,Kidney disorder,Nephronophthisis,Senior-Loken syndrome 4,Nephronophthisis 4,not specified];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.00362	0.00138,0.00294,0.00000,0.00614,0.00062	2,	547	151633	0.0440	0.12	0.32	0.09	/0.0>0.0/0.7>8.5	COSV65394401	NPHP4|0.01|0.00|0.01|0.00|13|29|2|29	23757202	3	267	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874430	5874430	A	G	hom	het	hom	off-target	QUAL=5948;DP=74,68,112;AF=0.99,0.49,1.00;MQM=60;SAP=476;ABP=3;SAR=0;SAF=218	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260554 [benign DISEASE=not provided,not specified,Nephronophthisis 4];			rs868163	0.64014	0.70558,0.56208,0.28851,0.64495,0.61423	31634,	33692	54506	-4.9310	0.03			/0.0>0.0/0.0>0.0	COSV65397189	NPHP4|0.00|0.00|0.00|0.01|40|-39|-37|-4	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874777	5874777	C	T	hom	het	hom	off-target	QUAL=10957;DP=95,169,191;AF=0.98,0.50,1.00;MQM=60;SAP=3;ABP=3;SAR=187;SAF=182	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron21/29:c.3044+97G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1294884 [benign DISEASE=not provided];			rs1287638	0.51242	0.59498,0.37585,0.08505,0.52760,0.43191	20800,	36074	73910	-1.6980	0.09			/0.0>0.0/0.0>0.0	COSV65398749	NPHP4|0.00|0.00|0.00|0.00|-2|4|-2|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875102	5875102	T	A	het	wt	het		QUAL=2674;DP=89,87,127;AF=0.62,0.00,0.47;MQM=60;SAP=227;ABP=5;SAR=112;SAF=3	NPHP4	splice_acceptor	NPHP4:ENST00000378156.9:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T:p.?:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]		CS057899 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=NPHP4];		rs1287637	0.15434	0.10909,0.18735,0.18280,0.17735,0.16556	1975,	19525	128629	5.3340	24.40			9.3>0.9/9.3>4.3/0.0>0.0		NPHP4|0.91|1.00|0.00|0.00|-8|-2|-44|-43	20844548,26578562,23402433	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875162	5875162	T	C	hom	hom	hom	off-target	QUAL=5335;DP=48,66,69;AF=1.00,1.00,1.00;MQM=60;SAP=392;ABP=0;SAR=182;SAF=1	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron20/29:c.2818-62A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1269681 [benign DISEASE=not provided];			rs963030	0.43644	0.39197,0.38900,0.25029,0.49506,0.36594	14816,	36660	85602	-1.5800	0.18			/0.0>0.0/0.0>0.0	COSV65393027	NPHP4|0.00|0.00|0.00|0.00|-1|-16|41|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5877331	5877331	C	T	n/a	n/a	hom	off-target	QUAL=158;DP=1,0,4;AF=1.00,,1.00;MQM=60;SAP=7;ABP=0;SAR=4;SAF=1	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::	regulatory_region_variant:CTCF_binding_site	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260547 [benign DISEASE=not provided,not specified,Nephronophthisis 4];			rs3747989	0.83144	0.93292,0.77222,0.83507,0.79842,0.73780	52841,	20832	25648	-2.4900	0.18			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-33|9|-40|-43	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887157	5887157	G	C	wt	wt	het	off-target	QUAL=707;DP=16,54,77;AF=0.00,0.00,0.45;MQM=60;SAP=79;ABP=4;SAR=0;SAF=35	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+129C>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+129C>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1239115 [benign DISEASE=not provided];			rs41280812	0.11812	0.03322,0.11302,0.07532,0.16528,0.11883	1359,	15247	134123	-0.3970	0.20			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-1|22|-36|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887248	5887248	G	A	wt	wt	het	off-target	QUAL=1781;DP=131,147,187;AF=0.00,0.01,0.42;MQM=60;SAP=88;ABP=13;SAR=12;SAF=68	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+38C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260546 [benign DISEASE=not provided,not specified,Nephronophthisis 4];			rs41280814	0.11822	0.03334,0.11276,0.07562,0.16530,0.11973	1363,	15262	134166	-2.0980	0.01			/3.1>3.8/0.0>0.0	COSV65397198	NPHP4|0.00|0.00|0.00|0.00|42|-40|38|-14	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5904931	5904931	T	C	hom	hom	hom	off-target	QUAL=7808;DP=61,91,122;AF=1.00,1.00,1.00;MQM=60;SAP=564;ABP=0;SAR=270;SAF=4	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1956-127A>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1953-127A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1277940 [benign DISEASE=not provided];			rs3737234	0.83534	0.93465,0.76526,0.82973,0.80455,0.74907	53310,	20405	25039	-0.1200	2.79			/1.3>0.7/0.0>0.0		NPHP4|0.00|0.09|0.00|0.01|-33|-26|-49|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905119	5905119	A	G	het	het	het	off-target	QUAL=2280;DP=109,26,28;AF=0.53,0.58,0.64;MQM=60;SAP=130;ABP=8;SAR=9;SAF=82	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1955+173T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1952+173T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252595 [benign DISEASE=not provided];			rs11122125	0.40377	0.31212,0.47022,0.74634,0.40778,0.48217	12981,	35383	90585	0.0030	2.08			/0.6>0.0/0.0>0.0	COSV65393924	NPHP4|0.00|0.00|0.00|0.00|22|-11|-47|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905321	5905321	C	T	wt	wt	het		QUAL=2693;DP=208,206,262;AF=0.00,0.00,0.43;MQM=60;SAP=34;ABP=15;SAR=36;SAF=76	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:ENST00000622020.4:synonymous_variant:LOW:exon15/20:c.1923G>A:p.Glu641=:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95673 [benign DISEASE=Nephronophthisis,not specified,not provided,Nephronophthisis 4,Senior-Loken syndrome 4];			rs12120967	0.11797	0.03278,0.11363,0.07429,0.16567,0.11853	1357,	15233	134185	-0.7400	1.57			/0.0>0.0/0.0>0.0	COSV65395162	NPHP4|0.00|0.00|0.00|0.00|-13|32|-3|-29	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5907004	5907004	G	T	het	het	wt	off-target	QUAL=1029;DP=45,68,69;AF=0.53,0.38,0.00;MQM=60;SAP=112;ABP=6;SAR=0;SAF=50	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron13/29:c.1611+111C>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron13/19:c.1611+111C>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1242867 [benign DISEASE=not provided];			rs9628990	0.14301	0.05909,0.12161,0.00829,0.20319,0.11564	1862,	18020	130300	-2.2950	0.00			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-2|20|46|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927636	5927636	T	C	wt	wt	het	off-target	QUAL=2465;DP=135,152,186;AF=0.00,0.02,0.54;MQM=60;SAP=33;ABP=6;SAR=33;SAF=71	NPHP4	splice_region&intron	NPHP4:ENST00000378156.9:splice_region_variant&intron_variant:LOW:intron11/29:c.1441+13A>G::,NPHP4:ENST00000622020.4:splice_region_variant&intron_variant:LOW:intron11/19:c.1441+13A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95671 [benign DISEASE=not specified,not provided,Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4];			rs7520105	0.17091	0.21458,0.13374,0.07513,0.16702,0.12153	2301,	21383	126057	0.5400	12.77			/0.0>0.0/0.0>0.5	COSV65395165	NPHP4|0.00|0.00|0.00|0.00|35|13|9|13	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927918	5927918	A	G	wt	wt	het	off-target	QUAL=1019;DP=183,57,68;AF=0.00,0.00,0.62;MQM=60;SAP=94;ABP=11;SAR=42;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron10/29:c.1303-131T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron10/19:c.1303-131T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1241872 [benign DISEASE=not provided];			rs17432975	0.04065	0.01139,0.04470,0.00038,0.05994,0.02420	178,	5829	145977	-1.8320	0.03			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-1|-44|-44|-49		17	430	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947386	5947386	C	T	hom	hom	hom	off-target	QUAL=924;DP=19,9,7;AF=1.00,1.00,1.00;MQM=60;SAP=79;ABP=0;SAR=35;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-156G>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-156G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1235266 [benign DISEASE=not provided];			rs551207	0.84983	0.84458,0.80092,0.75087,0.86816,0.82065	55034,	19227	22847	-1.1100	0.22			/0.0>0.2/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|28|-39|-20|-39	17903299	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947414	5947414	G	A	het	het	hom	off-target	QUAL=156;DP=13,7,4;AF=0.38,0.29,1.00;MQM=60;SAP=27;ABP=7;SAR=11;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-184C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-184C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287789 [benign DISEASE=not provided];			rs10779677	0.52716	0.66413,0.50517,0.97710,0.42564,0.50496	22619,	34932	71908	-0.8700	0.15			/2.2>1.8/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-40|0|28|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967107	5967107	C	A	hom	hom	het	off-target	QUAL=843;DP=20,7,7;AF=1.00,1.00,0.71;MQM=60;SAP=64;ABP=6;SAR=1;SAF=31	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+192G>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+192G>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1249471 [benign DISEASE=not provided];			rs875574	0.66087	0.69860,0.63821,0.75895,0.63700,0.62893	33155,	34168	51562	0.4750	4.76			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-8|-1|22|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967192	5967192	A	G	hom	hom	het	off-target	QUAL=1972;DP=28,25,29;AF=1.00,1.00,0.55;MQM=60;SAP=113;ABP=4;SAR=5;SAF=64	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+107T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+107T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1250302 [benign DISEASE=not provided];			rs875573	0.64060	0.62864,0.63140,0.75915,0.63660,0.62873	31109,	35168	54638	-1.2340	0.07			/3.3>2.3/0.0>0.0	COSV65394014	NPHP4|0.00|0.00|0.00|0.00|36|-21|6|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967533	5967533	G	A	het	wt	het	off-target	QUAL=294;DP=21,12,27;AF=0.43,0.00,0.30;MQM=60;SAP=40;ABP=12;SAR=17;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.453-170C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.453-170C>T::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233320 [benign DISEASE=not provided];			rs75504751	0.04518	0.01206,0.04775,0.00038,0.06880,0.02026	242,	6393	145353	-0.1060	1.01			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-47|-49|35|-49		19	464	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5969027	5969027	A	-	het	het	het	off-target;low_conf_region	QUAL=2727;DP=87,31,37;AF=0.62,0.58,0.51;MQM=60;SAP=192;ABP=13;SAR=1;SAF=90	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.452+60del::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.452+60del::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1273587 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs34702999	0.65173	0.64044,0.64726,0.76491,0.64947,0.64737	26914,	34368	47130	-0.3090	0.57			/4.7>9.4/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-7|-3|50|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5969027	5969028	AA	-	het	het	wt	off-target;low_conf_region	QUAL=2727;DP=87,31,37;AF=0.16,0.29,0.08;MQM=60;SAP=51;ABP=152;SAR=1;SAF=25	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.452+59_452+60del::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.452+59_452+60del::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs34702999	0.00751	0.02049,0.00529,0.00043,0.00159,0.00048	8,	1000	134332	0.1920	0.57			/4.7>10.9/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-27|-7|-27|33		4	1133	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5978523	5978523	G	C	hom	hom	hom	off-target	QUAL=10141;DP=77,118,157;AF=1.00,1.00,1.00;MQM=60;SAP=767;ABP=0;SAR=352;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron2/29:c.136-110C>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron2/19:c.136-110C>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1244964 [benign DISEASE=not provided];			rs4908639	0.83939	0.93771,0.77908,0.83585,0.80691,0.75668	53729,	19934	24376	-0.7120	0.72			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|0|37|25|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5986372	5986372	C	G	wt	wt	het	off-target	QUAL=795;DP=54,46,52;AF=0.00,0.02,0.63;MQM=60;SAP=40;ABP=11;SAR=29;SAF=5	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron1/19:c.-38-45G>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1263812 [benign DISEASE=not provided];			rs1295111	0.41160	0.49023,0.39253,0.24575,0.38903,0.39809	13024,	36420	89300	-0.1890	2.27			/5.2>5.0/0.0>0.0		NPHP4|0.02|0.00|0.00|0.00|-45|-32|-45|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5992511	5992511	G	A	wt	wt	het	off-target	QUAL=398;DP=3,29,39;AF=0.00,0.00,0.51;MQM=60;SAP=46;ABP=3;SAR=20;SAF=0	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::	regulatory_region_variant:promoter	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1258554 [benign DISEASE=not provided];			rs61760765	0.04059	0.01233,0.04852,0.00039,0.06162,0.02297	183,	5811	145999	-0.1670	10.42			/0.0>0.0/0.0>0.0		KCNAB2|0.00|0.00|0.00|0.00|28|-25|-25|34		1	24	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	5992521	5992521	G	A	n/a	het	hom	off-target	QUAL=1351;DP=2,28,34;AF=1.00,0.68,1.00;MQM=60;SAP=122;ABP=11;SAR=55;SAF=0	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252161 [benign DISEASE=not provided];			rs806109	0.83599	0.94514,0.85872,0.99129,0.76181,0.86388	53596,	19943	24943	-0.3260	7.55			/0.0>0.0/0.0>0.0		KCNAB2|0.00|0.00|0.00|0.00|12|-35|24|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6465948	6465948	A	G	het	wt	het	off-target	QUAL=100;DP=8,5,7;AF=0.50,0.00,0.43;MQM=60;SAP=18;ABP=3;SAR=0;SAF=7	TNFRSF25	intron	TNFRSF25:ENST00000356876.8:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000377782.7:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000351959.9:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000348333.7:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000351748.7:intron_variant:MODIFIER:intron1/4:c.39+121T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]				rs3007416	0.18962	0.49690,0.10479,0.00078,0.06861,0.08676	5488,	17817	123055	0.1330	9.03			/7.2>7.2/0.0>0.0		TNFRSF25|0.00|0.00|0.00|0.00|-50|-18|-30|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466123	6466123	G	A	het	wt	het		QUAL=376;DP=14,5,20;AF=0.43,0.00,0.70;MQM=60;SAP=7;ABP=5;SAR=13;SAF=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297904 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];			rs3007417	0.18858	0.49413,0.10427,0.00077,0.06858,0.08616	5413,	17773	123059	-0.6470	9.16			/0.0>0.0/0.0>0.0	COSV61068166	PLEKHG5|0.00|0.00|0.00|0.00|2|46|2|-13,TNFRSF25|0.00|0.00|0.00|0.00|-25|46|2|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466143	6466150	CGTGCTCT	-	het	wt	het		QUAL=352;DP=12,6,20;AF=0.58,0.00,0.65;MQM=60;SAP=7;ABP=7;SAR=13;SAF=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.18894	0.49454,0.10446,0.00078,0.06931,0.08669	5410,	17842	123038	0.5380	8.04			/0.0>0.0/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|0|27|13|6,TNFRSF25|0.00|0.00|0.00|0.00|0|27|13|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466181	6466184	CGCC	-	hom	wt	het		QUAL=332;DP=5,3,15;AF=1.00,0.00,0.73;MQM=60;SAP=4;ABP=10;SAR=7;SAF=9	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.18842	0.49422,0.10428,0.00077,0.06843,0.08626	5413,	17771	123179	1.5390	11.15					PLEKHG5|0.00|0.00|0.00|0.00|40|-11|-43|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466259	6466259	C	T	het	wt	het		QUAL=303;DP=31,30,33;AF=0.35,0.00,0.39;MQM=60;SAP=55;ABP=12;SAR=0;SAF=24	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297910 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];			rs45604837	0.08831	0.17576,0.06592,0.00058,0.05906,0.07527	827,	11777	138663	-1.4900	3.58					PLEKHG5|0.01|0.00|0.00|0.00|-39|2|10|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466405	6466405	C	G	het	wt	het		QUAL=3444;DP=82,150,199;AF=0.49,0.00,0.54;MQM=60;SAP=110;ABP=4;SAR=31;SAF=116	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297912 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];		MIR3 (SINE/MIR)	rs2986754	0.18808	0.50421,0.10676,0.00077,0.06813,0.08626	5643,	17316	123472	-0.5600	3.06					PLEKHG5|0.00|0.00|0.00|0.00|23|-49|-5|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466798	6466798	A	-	het	het	het		QUAL=265;DP=45,6,7;AF=0.24,0.50,0.14;MQM=60;SAP=7;ABP=32;SAR=5;SAF=10	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062	0.07033	0.20939,0.03182,0.00232,0.01187,0.02936	880,	7980	128752	-2.9370	0.44					PLEKHG5|0.00|0.00|0.01|0.00|-27|19|47|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467273	6467273	A	G	het	wt	het		QUAL=1569;DP=76,53,59;AF=0.50,0.00,0.47;MQM=60;SAP=3;ABP=3;SAR=33;SAF=33	PLEKHG5	3'UTR	PLEKHG5:ENST00000535355.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400913.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000340850.10:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377728.8:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377748.6:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377732.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.8:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000673471.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000675694.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000675123.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*290T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297928 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,not provided];			rs14708	0.26133	0.57968,0.15898,0.00482,0.14263,0.16066	8164,	23413	112333	2.4130	12.38			/0.9>0.8/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|-1|50|40|-23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467685	6467685	C	T	het	wt	het	off-target	QUAL=3202;DP=84,136,170;AF=0.45,0.00,0.56;MQM=60;SAP=8;ABP=4;SAR=58;SAF=75	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron20/20:c.3219-113G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron21/21:c.*19-113G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron21/21:c.3186-113G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron20/20:c.3123-113G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron21/21:c.3309-113G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron21/21:c.3012-113G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron19/19:c.2319-113G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667940 [benign DISEASE=not provided];			rs9435269	0.19373	0.52501,0.10901,0.00077,0.06688,0.09595	6102,	17265	122647	-3.0990	0.02			/0.0>0.0/2.6>4.9		PLEKHG5|0.00|0.00|0.00|0.00|-2|6|-2|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469123	6469125	TCC	-	het	wt	het		QUAL=1340;DP=49,63,106;AF=0.41,0.05,0.45;MQM=60;SAP=36;ABP=8;SAR=19;SAF=52	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000535355.6:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000400913.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.5:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000340850.10:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.8:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377748.6:inframe_deletion:MODERATE:exon20/22:c.2340_2342del:p.Glu781del:,PLEKHG5:ENST00000377732.5:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000400915.8:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000673471.2:inframe_deletion:MODERATE:exon20/22:c.2463_2465del:p.Glu822del:,PLEKHG5:ENST00000377740.5:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675694.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675123.1:inframe_deletion:MODERATE:exon18/20:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000537245.6:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy,Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not specified,not provided];		(TCC)n (Simple_repeat)	rs113541584	0.08755	0.18152,0.06907,0.00406,0.05978,0.08569	707,	11301	132517	0.9800	10.16			/0.0>0.0/1.4>0.0		PLEKHG5|0.00|0.00|0.00|0.00|11|-23|6|-1	28993730	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469383	6469383	A	G	het	wt	het		QUAL=9713;DP=318,391,488;AF=0.48,0.00,0.48;MQM=60;SAP=14;ABP=6;SAR=171;SAF=216	PLEKHG5	synonymous	PLEKHG5:ENST00000535355.6:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000400913.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.5:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000340850.10:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.8:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377748.6:synonymous_variant:LOW:exon19/22:c.2175T>C:p.Ser725=:,PLEKHG5:ENST00000377732.5:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000400915.8:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000673471.2:synonymous_variant:LOW:exon19/22:c.2298T>C:p.Ser766=:,PLEKHG5:ENST00000377740.5:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675694.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675123.1:synonymous_variant:LOW:exon17/20:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000537245.6:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194881 [benign DISEASE=Charcot-Marie-Tooth disease recessive intermediate C,Autosomal recessive lower motor neuron disease with childhood onset,not specified,not provided];			rs730600	0.26235	0.58087,0.15846,0.00501,0.14315,0.17791	8213,	23479	112199	-0.1930	5.83			/0.0>0.0/1.2>0.0		PLEKHG5|0.02|0.02|0.00|0.00|30|38|-48|6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469747	6469747	C	T	het	wt	het	off-target	QUAL=2443;DP=136,59,88;AF=0.53,0.00,0.47;MQM=60;SAP=231;ABP=3;SAR=111;SAF=2	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-71G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-71G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-71G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-71G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-71G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-71G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-71G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1233170 [benign DISEASE=not provided];			rs77492523	0.06908	0.10822,0.05930,0.00058,0.05921,0.07374	429,	9651	141625	0.6490	6.32			/0.0>0.0/2.4>3.4		PLEKHG5|0.02|0.00|0.00|0.00|46|2|-2|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469763	6469763	G	C	het	wt	het	off-target	QUAL=2456;DP=132,42,70;AF=0.58,0.00,0.47;MQM=60;SAP=231;ABP=6;SAR=108;SAF=1	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-87C>G::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-87C>G::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-87C>G::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-87C>G::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-87C>G::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-87C>G::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-87C>G::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1180014 [benign DISEASE=not provided];			rs3007420	0.06961	0.10871,0.05923,0.00058,0.05924,0.08609	429,	9732	141538	0.8840	6.34			/0.0>0.0/0.0>0.6		PLEKHG5|0.00|0.00|0.00|0.00|41|30|1|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470129	6470129	G	A	het	wt	het	off-target	QUAL=244;DP=22,5,10;AF=0.41,0.00,0.50;MQM=60;SAP=33;ABP=4;SAR=0;SAF=14	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2007+107C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1800+107C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1974+107C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1911+107C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2097+107C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1800+107C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1800+107C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667938 [benign DISEASE=not provided];			rs3007421	0.17632	0.31775,0.12618,0.00482,0.13170,0.15499	2961,	20890	125252	0.9560	6.98			/1.2>1.1/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|2|31|16|-16	19136949,21537399,21537453,28628558,24076602	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470375	6470375	A	G	het	wt	het	off-target	QUAL=1086;DP=40,49,55;AF=0.45,0.00,0.53;MQM=60;SAP=3;ABP=3;SAR=25;SAF=22	PLEKHG5	splice_region&intron	PLEKHG5:ENST00000535355.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000400913.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.5:splice_region_variant&intron_variant:LOW:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000340850.10:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377728.8:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377748.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1855-20T>C::,PLEKHG5:ENST00000377732.5:splice_region_variant&intron_variant:LOW:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000400915.8:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000673471.2:splice_region_variant&intron_variant:LOW:intron16/21:c.1978-20T>C::,PLEKHG5:ENST00000377740.5:splice_region_variant&intron_variant:LOW:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000675694.1:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000675123.1:splice_region_variant&intron_variant:LOW:intron14/19:c.1681-20T>C::,PLEKHG5:ENST00000537245.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1260549 [benign DISEASE=Charcot-Marie-Tooth disease recessive intermediate C,Autosomal recessive lower motor neuron disease with childhood onset,not provided];			rs2986753	0.18176	0.33677,0.12729,0.00444,0.13194,0.15450	3225,	21169	124335	-0.3690	0.44			7.8>7.8/7.8>7.8/0.0>0.0		PLEKHG5|0.02|0.00|0.00|0.00|-29|34|-29|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470905	6470905	-	G	hom	hom	hom	off-target	QUAL=6173;DP=42,92,125;AF=0.98,0.98,0.99;MQM=60;SAP=29;ABP=0;SAR=155;SAF=100	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron14/21:c.1567-22dup::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron14/21:c.1690-22dup::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron12/19:c.1393-22dup::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron14/21:c.1504-22dup::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670557 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not provided];			rs111312565	0.99997	1.00000,1.00000,1.00000,0.99994,1.00000	75882,	4	4		2.28			/0.0>0.0/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|-18|-21|26|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471529	6471529	C	T	het	wt	het		QUAL=1652;DP=36,115,114;AF=0.67,0.00,0.45;MQM=60;SAP=52;ABP=3;SAR=17;SAF=58	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon13/22:c.1414G>A:p.Ala472Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon13/22:c.1537G>A:p.Ala513Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon11/20:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain]	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297959 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not provided];			rs74809741	0.06104	0.08380,0.05504,0.00058,0.05874,0.05521	308,	8674	142914	0.9380	18.48	0.04	0.07	/0.0>1.8/0.0>0.0	COSV61699881	PLEKHG5|0.00|0.00|0.00|0.00|-12|15|-41|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471906	6471906	C	T	het	wt	het	off-target	QUAL=2809;DP=83,120,185;AF=0.49,0.00,0.47;MQM=60;SAP=180;ABP=4;SAR=115;SAF=13	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron10/20:c.1288-98G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron10/21:c.1081-98G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron11/21:c.1255-98G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron10/20:c.1192-98G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron11/21:c.1378-98G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron11/21:c.1081-98G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron9/19:c.1081-98G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1253676 [benign DISEASE=not provided];			rs75682285	0.04700	0.05601,0.04397,0.00038,0.05003,0.05045	181,	6791	145033	-0.2320	3.14			/0.0>0.0/2.5>0.0		PLEKHG5|0.00|0.00|0.00|0.03|-2|45|-36|45		13	417	0	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6473333	6473333	G	C	het	wt	het		QUAL=479;DP=25,19,25;AF=0.44,0.00,0.56;MQM=60;SAP=57;ABP=3;SAR=25;SAF=0	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon9/22:c.887C>G:p.Thr296Ser:,PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon9/22:c.1010C>G:p.Thr337Ser:,PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon7/20:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	198895 [benign DISEASE=not specified,Charcot-Marie-Tooth disease recessive intermediate C,Autosomal recessive lower motor neuron disease with childhood onset,not provided];			rs61741379	0.27648	0.63112,0.16364,0.00730,0.14309,0.16770	9529,	23016	110106	0.8540	4.56	0.07	0.06	/0.0>0.0/0.0>0.0	COSV61700195	PLEKHG5|0.01|0.00|0.00|0.00|23|-10|1|-25	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6474721	6474721	G	A	het	wt	het	off-target	QUAL=72;DP=5,6,6;AF=0.40,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=2;SAF=3	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron5/20:c.510-134C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron5/21:c.303-134C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron6/21:c.477-134C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron5/20:c.414-134C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron6/21:c.414-134C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron6/21:c.600-134C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron6/21:c.303-134C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron4/19:c.303-134C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron6/21:c.414-134C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667937 [benign DISEASE=not provided];			rs2986751	0.16429	0.37391,0.13581,0.00119,0.07189,0.08586	2588,	15529	105321	-1.6160	0.65			/2.3>2.2/0.0>0.7	COSV100556630	PLEKHG5|0.00|0.00|0.25|0.16|-25|29|2|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6475695	6475695	C	T	wt	het	wt	off-target	QUAL=585;DP=170,61,77;AF=0.00,0.48,0.00;MQM=60;SAP=66;ABP=3;SAR=29;SAF=0	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron3/20:c.357-173G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron3/21:c.150-173G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron4/21:c.324-173G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron3/20:c.261-173G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron4/21:c.261-173G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron4/21:c.447-173G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron4/21:c.150-173G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron2/19:c.150-173G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron4/21:c.261-173G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]				rs147010314	0.00190	0.00055,0.00170,0.00000,0.00304,0.00000	0,	289	151921	-1.6440	0.16			/5.4>4.4/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.01|-14|26|-1|22		0	65	0	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6519461	6519461	G	C	het	het	het		QUAL=3422;DP=122,77,91;AF=0.52,0.45,0.52;MQM=60;SAP=320;ABP=3;SAR=0;SAF=146	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670484 [likely benign DISEASE=not provided];			rs17438786	0.02202	0.00563,0.01966,0.00000,0.03237,0.01661	48,	3253	148755	0.1090	6.88	0.09		/3.6>2.4/0.0>0.0				30	1146	0	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519547	6519547	C	T	hom	hom	hom		QUAL=20096;DP=180,205,270;AF=1.00,1.00,1.00;MQM=60;SAP=745;ABP=0;SAR=91;SAF=564	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	380860 [benign DISEASE=Charcot-Marie-Tooth disease recessive intermediate C,not specified,Autosomal recessive lower motor neuron disease with childhood onset];			rs1556035	0.78330	0.52874,0.86448,0.80895,0.88426,0.86698	48522,	22035	32943	0.6350	7.22			/0.0>0.0/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519783	6519783	C	T	hom	hom	hom		QUAL=42007;DP=293,456,586;AF=0.99,1.00,1.00;MQM=60;SAP=142;ABP=0;SAR=812;SAF=520	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667919 [benign DISEASE=not provided];			rs1010584	0.77310	0.52449,0.84873,0.78811,0.87343,0.85250	47329,	22983	34527	-0.5550	1.89			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520176	6520176	G	C	hom	hom	hom	off-target	QUAL=790;DP=19,4,6;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=29;SAF=0	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679849 [benign DISEASE=not provided];			rs4908903	0.97507	0.91719,0.99320,0.96445,0.99965,0.99690	72502,	3477	3797	0.0970	3.44							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520190	6520190	C	T	hom	hom	n/a	off-target	QUAL=387;DP=12,3,2;AF=0.92,1.00,1.00;MQM=60;SAP=38;ABP=0;SAR=16;SAF=0	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679848 [benign DISEASE=not provided];			rs4908904	0.77312	0.52433,0.84872,0.78783,0.87367,0.85280	47334,	22976	34524	0.6950	6.44							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10258594	10258594	C	G	wt	het	wt		QUAL=2875;DP=316,229,251;AF=0.00,0.50,0.00;MQM=60;SAP=5;ABP=3;SAR=52;SAF=62	KIF1B	synonymous	KIF1B:ENST00000377093.9:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696501.1:synonymous_variant:LOW:exon4/6:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696502.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696503.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696504.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083.5:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon3/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129399 [benign DISEASE=Charcot-Marie-Tooth disease,Hereditary cancer-predisposing syndrome,Charcot-Marie-Tooth disease type 2,not specified,not provided,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Pheochromocytoma];			rs12402052	0.23721	0.09220,0.30965,0.28346,0.29364,0.23974	4955,	26135	115909	0.0670	10.86			/5.4>5.1/0.0>1.0	COSV55805367	KIF1B|0.00|0.04|0.00|0.00|-47|10|40|10	25741868,24033266,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10261996	10261996	G	A	wt	het	wt	off-target	QUAL=2023;DP=317,179,272;AF=0.00,0.46,0.00;MQM=60;SAP=10;ABP=5;SAR=50;SAF=34	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000696501.1:intron_variant:MODIFIER:intron5/5:c.429+26G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+26G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+26G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1266483 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome];			rs4846209	0.34765	0.33692,0.38150,0.35841,0.34480,0.26859	9287,	34204	99036	0.2760	1.71			/0.0>0.0/5.9>0.0	COSV55815439	KIF1B|0.00|0.00|0.02|0.01|-26|-27|-14|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10262095	10262095	A	G	wt	het	wt	off-target	QUAL=860;DP=182,87,156;AF=0.00,0.46,0.00;MQM=60;SAP=40;ABP=4;SAR=33;SAF=7	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+125A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+125A>G::,KIF1B:ENST00000696501.1:intron_variant:MODIFIER:intron5/5:c.429+125A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+125A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+125A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+125A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+125A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+125A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+125A>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1178036 [benign DISEASE=not provided];			rs4846210	0.23757	0.09256,0.30937,0.28530,0.29390,0.24015	4961,	26155	115783	1.8680	8.82			/10.2>3.6/0.0>0.0	COSV55805380	KIF1B|0.00|0.00|0.00|0.00|33|2|-40|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10267349	10267349	A	T	wt	het	wt	off-target	QUAL=1116;DP=257,100,131;AF=0.00,0.50,0.00;MQM=60;SAP=55;ABP=3;SAR=8;SAF=43	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.430-31A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.430-31A>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1181451 [benign DISEASE=not provided];			rs12141246	0.37171	0.41314,0.38800,0.39702,0.34570,0.27381	10656,	35078	95316	-1.5780	0.98			/0.7>1.9/0.0>0.0	COSV55808764	KIF1B|0.00|0.00|0.00|0.00|32|31|-19|30	17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10268280	10268280	C	T	wt	het	wt	off-target	QUAL=2383;DP=242,186,187;AF=0.00,0.52,0.00;MQM=60;SAP=46;ABP=4;SAR=71;SAF=27	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron7/20:c.720+17C>T::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron7/48:c.720+17C>T::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron7/46:c.720+17C>T::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron7/48:c.720+17C>T::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron7/20:c.720+17C>T::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron6/47:c.720+17C>T::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron6/46:c.720+17C>T::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron6/47:c.720+17C>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	260542 [benign DISEASE=Charcot-Marie-Tooth disease,Pheochromocytoma,not specified,Charcot-Marie-Tooth disease type 2A1,Hereditary cancer-predisposing syndrome,Charcot-Marie-Tooth disease type 2,not provided];			rs1339458	0.25667	0.15791,0.31980,0.28483,0.29409,0.24048	5356,	28278	112918	-1.5610	2.36			/0.0>0.0/0.0>0.0	COSV55802811	KIF1B|0.00|0.00|0.00|0.00|-1|-17|-17|14	25741868,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10275257	10275257	G	A	hom	hom	hom	off-target	QUAL=5032;DP=132,16,16;AF=0.99,1.00,1.00;MQM=60;SAP=357;ABP=0;SAR=0;SAF=163	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron9/46:c.865-171G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron9/47:c.883-171G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron9/46:c.883-171G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron9/47:c.883-171G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1226716 [benign DISEASE=not provided];			rs6685773	0.99244	0.99776,0.99385,1.00000,0.98783,0.99628	74972,	1133	1151	-0.2060	0.23			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|4|-36|4|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282294	10282294	C	T	wt	het	wt	off-target	QUAL=962;DP=137,88,110;AF=0.00,0.49,0.00;MQM=60;SAP=96;ABP=3;SAR=0;SAF=43	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron12/20:c.1163-106C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron14/48:c.1223-28C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron12/46:c.1163-106C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron14/48:c.1223-28C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron12/20:c.1163-106C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron13/47:c.1223-28C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron12/46:c.1181-28C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron13/47:c.1223-106C>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917113 [benign DISEASE=not provided,Charcot-Marie-Tooth disease];			rs3748575	0.54429	0.71361,0.51022,0.36444,0.47727,0.44741	23479,	35745	69245	0.4840	10.03			/0.2>0.8/0.0>0.0		KIF1B|0.01|0.00|0.00|0.00|28|-4|28|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282571	10282571	G	A	wt	het	het	off-target	QUAL=5608;DP=180,218,224;AF=0.01,0.50,0.50;MQM=60;SAP=99;ABP=3;SAR=160;SAF=61	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron13/46:c.1392+38G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron14/47:c.1356+38G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292705 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs3748576	0.70407	0.92633,0.68915,0.52253,0.60171,0.62148	39359,	28328	44992	-0.5210	0.35			/1.7>2.2/0.0>0.0	COSV55814192	KIF1B|0.00|0.00|0.00|0.00|-38|4|-10|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10295776	10295776	C	T	wt	het	wt		QUAL=1539;DP=135,128,158;AF=0.01,0.48,0.00;MQM=60;SAP=11;ABP=3;SAR=39;SAF=24	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron17/20:c.1639+10C>T::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron19/48:c.1777+10C>T::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron17/46:c.1639+10C>T::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron17/47:c.1639+10C>T::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron18/47:c.1702+10C>T::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron18/47:c.1702+10C>T::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron18/47:c.1777+10C>T::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron17/46:c.1735+10C>T::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron18/47:c.1699+10C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	177960 [benign DISEASE=Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,Hereditary cancer-predisposing syndrome,not specified,not provided,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Pheochromocytoma];			rs3753037	0.26594	0.18950,0.32317,0.28450,0.29443,0.23933	5574,	29250	111510	0.2620	6.71			/0.0>0.0/0.0>0.0	COSV55805392	KIF1B|0.00|0.00|0.00|0.00|-23|-32|-10|-34	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10296504	10296504	C	A	wt	het	wt	off-target	QUAL=1191;DP=215,115,156;AF=0.00,0.45,0.00;MQM=60;SAP=70;ABP=5;SAR=6;SAF=46	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron17/20:c.1640-78C>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron19/48:c.1778-78C>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron17/46:c.1640-78C>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron17/47:c.1640-78C>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron18/47:c.1703-78C>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron18/47:c.1703-78C>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron19/48:c.1778-78C>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron17/20:c.1640-78C>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron18/47:c.1778-78C>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron17/46:c.1736-78C>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron18/47:c.1700-78C>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292717 [benign DISEASE=not provided];			rs2275424	0.23736	0.09248,0.30889,0.28335,0.29381,0.23944	4957,	26142	115850	-0.0170	2.97			/0.0>0.0/0.0>0.0	COSV55818663	KIF1B|0.00|0.00|0.00|0.00|39|-24|3|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10296790	10296790	A	G	wt	het	wt	off-target	QUAL=799;DP=257,65,99;AF=0.00,0.54,0.00;MQM=60;SAP=42;ABP=4;SAR=30;SAF=5	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron18/20:c.1724-107A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron20/48:c.1862-107A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron18/46:c.1724-107A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron18/47:c.1724-107A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron19/47:c.1787-107A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron19/47:c.1787-107A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron20/48:c.1862-107A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron18/20:c.1724-107A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron19/47:c.1862-107A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron18/46:c.1820-107A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron19/47:c.1784-107A>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1182225 [benign DISEASE=not provided];			rs912961	0.31833	0.29776,0.36212,0.35750,0.31635,0.26557	7810,	32734	103546	-0.4830	1.22			/2.2>3.7/0.0>0.0	COSV55805404	KIF1B|0.00|0.00|0.00|0.00|1|4|-34|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297149	10297149	T	-	het	het	het	off-target;low_conf_region	QUAL=3797;DP=180,166,234;AF=0.34,0.29,0.32;MQM=60;SAP=3;ABP=174;SAR=89;SAF=94	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron19/20:c.1905-9del::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron21/48:c.2043-9del::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron19/46:c.1905-9del::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron19/47:c.1905-9del::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron20/47:c.1968-9del::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron20/47:c.1968-9del::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron21/48:c.2043-9del::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron19/20:c.1905-9del::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron20/47:c.2043-9del::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron19/46:c.2001-9del::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron20/47:c.1965-9del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917114 [benign DISEASE=Charcot-Marie-Tooth disease];		(T)n (Simple_repeat)	rs58344165	0.00686	0.00222,0.00652,0.00243,0.00858,0.00177	1,	982	142408	0.1110	0.09			/2.3>1.3/0.0>0.0		KIF1B|0.00|0.01|0.00|0.00|-9|33|-23|33		8	3059	26	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297348	10297348	A	G	wt	het	wt	off-target	QUAL=1824;DP=194,133,186;AF=0.00,0.56,0.00;MQM=60;SAP=84;ABP=8;SAR=64;SAF=11	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron20/20:c.1977+102A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+102A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+102A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+102A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+102A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+102A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+102A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron20/20:c.1977+102A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+102A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+102A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+102A>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248254 [benign DISEASE=not provided];			rs3748577	0.31843	0.29786,0.36211,0.35866,0.31633,0.26672	7806,	32715	103441	-1.5910	0.02			/0.0>4.6/0.0>0.0	COSV55805274	KIF1B|0.00|0.00|0.00|0.00|-31|38|-1|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306429	10306429	T	G	wt	het	wt		QUAL=2589;DP=249,230,227;AF=0.00,0.45,0.00;MQM=60;SAP=4;ABP=8;SAR=56;SAF=49	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+9183T>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+9183T>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+9183T>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9183T>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9183T>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs8019	0.39316	0.46952,0.40360,0.35913,0.35789,0.28033	11978,	35760	92170	0.5490	7.79			/5.0>7.4/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|41|20|1|41	22363396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306634	10306634	C	G	wt	het	wt		QUAL=2901;DP=291,253,280;AF=0.00,0.47,0.00;MQM=60;SAP=84;ABP=4;SAR=94;SAF=27	KIF1B,RN7SL731P	3'UTR,intron,non_coding_transcript_exon	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+9388C>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+9388C>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+9388C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9388C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9388C>G::,RN7SL731P:ENST00000584329.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			7SLRNA (srpRNA)	rs4623	0.33983	0.30895,0.37905,0.35787,0.34483,0.27436	8848,	33550	99552	-0.5050	2.10			/2.3>1.3/1.6>0.0		KIF1B|0.00|0.00|0.00|0.00|1|-23|-42|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307366	10307366	G	A	wt	het	wt		QUAL=343;DP=114,43,46;AF=0.01,0.42,0.00;MQM=60;SAP=29;ABP=5;SAR=17;SAF=2	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+10120G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+10120G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+10120G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10120G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10120G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs2004034	0.23794	0.09197,0.31177,0.28415,0.29421,0.24648	5002,	26178	115880	0.6790	3.12			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-11|1|-11|-37	23032637	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307533	10307533	T	C	wt	het	wt		QUAL=1164;DP=190,88,99;AF=0.00,0.59,0.01;MQM=60;SAP=118;ABP=9;SAR=0;SAF=53	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+10287T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+10287T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+10287T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10287T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10287T>C::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs1065828	0.33966	0.30882,0.37942,0.35823,0.34468,0.27331	8901,	33744	100212	-0.5710	2.54			/6.3>5.8/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-41|13|-41|12	31477794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10324118	10324118	-	TTGAAA	het	het	het	off-target;low_conf_region	QUAL=4484;DP=229,138,185;AF=0.43,0.42,0.38;MQM=60;SAP=443;ABP=42;SAR=220;SAF=6	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron23/47:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2495+57_2495+58insTGAAAT::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2459+57_2459+58insTGAAAT::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241982 [benign DISEASE=not provided];			rs3831405	0.23935	0.09284,0.31098,0.27959,0.29630,0.25042	4994,	26340	115448		3.98			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.10|0.00|4|-17|4|-29	32986753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10324654	10324654	T	-	het	het	wt	off-target	QUAL=41;DP=101,25,36;AF=0.13,0.16,0.06;MQM=59;SAP=44;ABP=149;SAR=0;SAF=19	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2538-92del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2400-92del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron23/47:c.2400-92del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron24/47:c.2463-92del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron24/47:c.2463-92del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2538-92del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2538-92del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2496-92del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2460-92del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs201407650	0.00179	0.00066,0.00160,0.00020,0.00187,0.00088	0,	257	143595	0.2880	0.60			/8.1>7.5/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-12|18|-12|18		1	252	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10334478	10334478	C	G	het	het	het	off-target	QUAL=8208;DP=248,152,219;AF=0.53,0.48,0.53;MQM=60;SAP=434;ABP=5;SAR=34;SAF=286	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron25/47:c.2787-42C>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron25/46:c.2883-42C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron26/47:c.2847-42C>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1179832 [benign DISEASE=not provided];			rs2276100	0.32796	0.31998,0.36799,0.35750,0.32039,0.27817	8308,	33236	102156	-0.1170	3.79			/0.1>0.0/0.0>0.0	COSV55805280	KIF1B|0.00|0.00|0.00|0.00|42|35|50|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10337022	10337022	A	G	wt	wt	het	off-target	QUAL=1131;DP=203,79,101;AF=0.00,0.00,0.47;MQM=60;SAP=47;ABP=4;SAR=8;SAF=39	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron27/47:c.2992-52A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron28/47:c.3055-52A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron28/47:c.3055-52A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron27/46:c.3088-52A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron28/47:c.3052-52A>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs71643087	0.02095	0.00543,0.00818,0.00038,0.03195,0.02134	51,	3087	148999	0.3500	0.68			/0.0>0.0/0.0>1.3		KIF1B|0.00|0.00|0.00|0.00|-27|14|26|-18		13	1029	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10341952	10341952	A	-	het	het	het	off-target;low_conf_region	QUAL=1556;DP=56,43,54;AF=0.41,0.33,0.54;MQM=59;SAP=146;ABP=9;SAR=0;SAF=66	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron30/46:c.3376-82del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron30/47:c.3376-82del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron31/47:c.3514-82del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron30/46:c.3472-82del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron31/47:c.3436-82del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1251637 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs33942183	0.50988	0.52913,0.53081,0.43555,0.49595,0.52200	12740,	36235	59323	1.0050	0.81			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-15|-50|-50|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10343424	10343424	G	A	het	het	het	off-target	QUAL=4704;DP=182,99,125;AF=0.51,0.46,0.48;MQM=60;SAP=433;ABP=4;SAR=198;SAF=0	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron32/46:c.3550+137G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron32/47:c.3550+137G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron33/47:c.3688+137G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron32/46:c.3646+137G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron33/47:c.3610+137G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1233883 [benign DISEASE=not provided];			rs1556916	0.34711	0.32505,0.38255,0.35813,0.34871,0.27828	9303,	34096	99128	0.1300	1.33			/5.0>4.3/4.0>0.0	COSV55805410	KIF1B|0.00|0.00|0.00|0.00|0|8|6|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10348780	10348780	T	-	het	het	het	off-target;low_conf_region	QUAL=313;DP=137,134,144;AF=0.19,0.17,0.10;MQM=60;SAP=63;ABP=434;SAR=53;SAF=11	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron35/46:c.3811+60del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron36/47:c.4012+60del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron36/47:c.3874+60del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron36/47:c.3874+60del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron36/47:c.3949+60del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron35/46:c.3907+60del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron36/47:c.3871+60del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs35253111	0.01040	0.02869,0.00748,0.00421,0.00207,0.00108	11,	1491	143965	0.2760	0.70			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.02|22|-50|-50|-46		7	365	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360860	10360860	G	A	het	het	het	off-target	QUAL=10099;DP=218,259,308;AF=0.55,0.50,0.49;MQM=60;SAP=458;ABP=3;SAR=55;SAF=344	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-69G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-69G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-69G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-69G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-69G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292713 [benign DISEASE=not provided];			rs3748578	0.29207	0.27080,0.33619,0.27615,0.29829,0.25083	6576,	31218	107544	-0.6940	1.39			/0.0>0.0/0.0>0.0	COSV55805417	KIF1B|0.00|0.00|0.00|0.00|-11|-40|-26|1	23028799,27122668,31475028	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360879	10360879	C	T	het	het	het	off-target	QUAL=11885;DP=258,298,373;AF=0.52,0.51,0.50;MQM=60;SAP=369;ABP=3;SAR=94;SAF=375	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-50C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-50C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-50C>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248757 [benign DISEASE=not provided];			rs3748579	0.32791	0.32006,0.36887,0.35734,0.32012,0.27778	8292,	33211	102063	-0.6290	1.47			/1.1>1.3/3.7>3.2	COSV55805298	KIF1B|0.00|0.00|0.00|0.00|50|-30|-45|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365005	10365005	-	A	wt	wt	het	off-target;low_conf_region	QUAL=398;DP=51,18,27;AF=0.24,0.11,0.07;MQM=56;SAP=44;ABP=79;SAR=0;SAF=19	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-79dup::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-79dup::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-79dup::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-79dup::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-79dup::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-79dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-79dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-79dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-79dup::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241038 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs57088720	0.36609	0.65783,0.29400,0.33397,0.22581,0.34195	9260,	23912	73474		2.20			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|18|11|4|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365006	10365006	A	-	het	het	wt	off-target;low_conf_region	QUAL=398;DP=51,18,27;AF=0.16,0.11,0.33;MQM=59;SAP=38;ABP=96;SAR=0;SAF=16	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-79del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-79del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-79del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-79del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-79del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-79del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-79del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-79del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-79del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluY (SINE/Alu)	rs57088720	0.00120	0.00031,0.00145,0.00027,0.00098,0.00116	0,	139	115977	-0.0900	1.86			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|12|-15|6|5		9	269	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365060	10365060	T	-	het	het	het	off-target	QUAL=3199;DP=98,90,112;AF=0.46,0.46,0.53;MQM=60;SAP=156;ABP=4;SAR=22;SAF=123	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-33del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-33del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-33del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1260773 [benign DISEASE=not provided];			rs34161257	0.52759	0.65915,0.50590,0.36300,0.47527,0.46099	21584,	36162	71034	1.3520	2.77			/0.0>0.0/0.0>0.0		KIF1B|0.01|0.00|0.00|0.00|49|48|50|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365808	10365808	C	T	wt	wt	het	off-target	QUAL=201;DP=62,36,39;AF=0.00,0.00,0.33;MQM=60;SAP=31;ABP=12;SAR=13;SAF=0	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron43/48:c.4752+160C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron41/46:c.4614+160C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron42/47:c.4815+160C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron42/47:c.4677+160C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron42/47:c.4677+160C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron43/48:c.4752+160C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron42/47:c.4752+160C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron41/46:c.4710+160C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron42/47:c.4674+160C>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292731 [benign DISEASE=not provided];		L2c (LINE/L2)	rs11121549	0.08639	0.02106,0.14733,0.15730,0.09589,0.15499	756,	11627	138957	0.0260	1.54			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|7|-33|7|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10368394	10368394	G	A	het	het	het	off-target	QUAL=8659;DP=186,253,307;AF=0.52,0.46,0.49;MQM=60;SAP=368;ABP=4;SAR=58;SAF=305	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron41/46:c.4615-73G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron42/47:c.4816-73G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron42/47:c.4753-73G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron41/46:c.4711-73G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron42/47:c.4675-73G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292718 [benign DISEASE=not provided];		MER21B (LTR/ERVL)	rs12130563	0.32795	0.32003,0.36850,0.35687,0.32020,0.27826	8310,	33210	102112	-0.1800	0.68			/0.0>0.0/1.8>4.0	COSV55805423	KIF1B|0.01|0.00|0.02|0.00|47|-10|2|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10371100	10371100	T	C	het	het	het	off-target	QUAL=7054;DP=220,156,224;AF=0.45,0.47,0.53;MQM=60;SAP=388;ABP=4;SAR=32;SAF=259	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron43/47:c.4888-41T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron42/46:c.4783-41T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron43/47:c.4747-41T>C::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1228335 [benign DISEASE=not provided];			rs17411502	0.25777	0.15319,0.32073,0.27635,0.29786,0.25093	5473,	28257	112885	-0.5520	5.68			/0.0>0.0/0.0>0.0	COSV55805429	KIF1B|0.01|0.03|0.00|0.00|-10|23|47|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375112	10375112	T	C	het	het	het	off-target	QUAL=7801;DP=274,183,218;AF=0.47,0.50,0.45;MQM=60;SAP=403;ABP=8;SAR=280;SAF=38	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron45/46:c.5151+66T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron46/47:c.5352+66T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron46/47:c.5289+66T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron45/46:c.5247+66T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron46/47:c.5211+66T>C::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1239662 [benign DISEASE=not provided];			rs11121551	0.34700	0.32416,0.38266,0.35847,0.34881,0.27893	9311,	34089	99193	0.5700	6.62			/0.6>0.9/0.0>0.0	COSV55805435	KIF1B|0.00|0.00|0.00|0.00|16|-31|10|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375266	10375266	C	A	het	het	het		QUAL=7267;DP=295,115,148;AF=0.45,0.57,0.52;MQM=60;SAP=4;ABP=3;SAR=143;SAF=134	KIF1B	synonymous	KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000696502.1:synonymous_variant:LOW:exon47/48:c.5364C>A:p.Thr1788=:PF00169 [PH domain],KIF1B:ENST00000696503.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000696504.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon46/47:c.5259C>A:p.Thr1753=:PF00169 [PH domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon47/48:c.5223C>A:p.Thr1741=:PF00169 [PH domain]		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129401 [benign DISEASE=Charcot-Marie-Tooth disease,Hereditary cancer-predisposing syndrome,Charcot-Marie-Tooth disease type 2,not specified,not provided,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Pheochromocytoma];			rs11121552	0.24017	0.09291,0.31183,0.27669,0.29757,0.25041	5097,	26330	115552	-0.5900	5.52			/4.3>3.2/0.0>0.0	COSV55805449	KIF1B|0.01|0.00|0.00|0.00|40|-11|-7|22	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376834	10376834	-	AC	het	het	wt		QUAL=4764;DP=130,109,127;AF=0.38,0.32,0.01;MQM=59;SAP=23;ABP=226;SAR=29;SAF=57	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473_5367-1472dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473_5331-1472dup::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291586 [uncertain significance DISEASE=Pheochromocytoma,Charcot-Marie-Tooth disease type 2,Neuroblastoma];			rs111663673	0.05434	0.05992,0.04432,0.04705,0.05536,0.02273	195,	7430	136094		2.16			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-36|41|32|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376866	10376866	C	T	het	wt	het		QUAL=4764;DP=130,109,127;AF=0.38,0.32,0.01;MQM=60;SAP=16;ABP=8;SAR=45;SAF=71	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291594 [benign DISEASE=Neuroblastoma];		(AC)n (Simple_repeat)	rs78490707	0.00791	0.00113,0.00170,0.11895,0.00324,0.03494	49,	1006	138404	-1.7410	0.41			/1.2>1.4/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|9|1|-2|38		3	107	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10377948	10377948	A	T	het	het	wt		QUAL=1163;DP=76,54,72;AF=0.41,0.48,0.00;MQM=60;SAP=80;ABP=7;SAR=6;SAF=51	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-391A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-391A>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291610 [benign DISEASE=Neuroblastoma];		AluSg (SINE/Alu)	rs2847347	0.03801	0.01103,0.03544,0.00597,0.06001,0.01118	153,	5477	146357	0.2090	2.28			/0.0>0.4/0.0>0.0				1	27	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378629	10378629	C	T	het	het	het		QUAL=12165;DP=255,281,354;AF=0.56,0.51,0.51;MQM=60;SAP=4;ABP=7;SAR=241;SAF=225	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*227C>T::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291618 [benign DISEASE=Neuroblastoma];			rs1536262	0.55183	0.73792,0.51527,0.36437,0.47664,0.45820	24286,	35278	68098	-1.2380	0.55			/6.3>7.2/0.0>0.0			27980619,31477794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378834	10378834	G	A	het	het	het		QUAL=8782;DP=282,160,193;AF=0.52,0.57,0.52;MQM=60;SAP=72;ABP=10;SAR=222;SAF=118	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*432G>A::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291619 [benign DISEASE=Neuroblastoma];			rs1002076	0.32784	0.31975,0.36840,0.35767,0.32018,0.27817	8298,	33216	102130	0.4980	2.91			/1.4>0.4/0.0>0.0			25854172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10380498	10380498	A	G	het	het	het		QUAL=9074;DP=328,182,225;AF=0.51,0.49,0.48;MQM=51;SAP=11;ABP=3;SAR=200;SAF=163	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2096A>G::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291652 [benign DISEASE=Neuroblastoma];		AluSx (SINE/Alu)	rs1138791	0.35711	0.35867,0.38701,0.35869,0.34903,0.27893	9821,	34607	97663	-1.5530	2.62			/0.0>0.0/5.2>4.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10381606	10381606	T	C	het	het	het		QUAL=13655;DP=454,272,349;AF=0.53,0.44,0.50;MQM=60;SAP=304;ABP=3;SAR=403;SAF=131	KIF1B	downstream_gene	KIF1B:ENST00000676179.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000620295.2:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000622724.3:downstream_gene_variant:MODIFIER::::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	368794 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Pheochromocytoma,Neuroblastoma];			rs3748581	0.53213	0.66976,0.50860,0.36436,0.47581,0.46298	22184,	36444	71054	0.4330	9.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11012522	11012522	T	C	hom	hom	hom	off-target	QUAL=805;DP=5,10,11;AF=1.00,1.00,1.00;MQM=60;SAP=59;ABP=0;SAR=0;SAF=26	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+42T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs968545	0.95016	0.98850,0.96387,0.99962,0.93230,0.95039	68833,	6940	7586	-0.9450	7.05			/4.5>3.9/0.0>0.0		TARDBP|0.00|0.00|0.00|0.00|-23|-3|-8|-42	18068872,18802454,34002018	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11012828	11012828	C	T	het	het	hom	off-target	QUAL=366;DP=14,4,12;AF=0.29,0.50,1.00;MQM=60;SAP=42;ABP=7;SAR=18;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+348C>T::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron1/6:c.-13+85C>T::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron1/5:c.-13+85C>T::	regulatory_region_variant:promoter	605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs4133584	0.63898	0.25717,0.72625,0.65267,0.81195,0.69371	35456,	26280	54912	0.3350	11.79			/0.0>0.0/0.0>0.0		TARDBP|0.00|0.00|0.00|0.01|-33|-48|-49|24	18802454,21832997,17434264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11017202	11017202	C	T	het	n/a	wt	off-target	QUAL=90;DP=40,0,3;AF=0.28,,0.00;MQM=57;SAP=27;ABP=21;SAR=11;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron3/5:c.402+195C>T::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron3/6:c.402+195C>T::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron3/5:c.402+195C>T::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron2/5:c.402+195C>T::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs1002487715	0.00004	0.00004,0.00000,0.00000,0.00002,0.00000	0,	4	105870	-2.1360	1.43			/3.7>3.8/0.0>0.0	COSV53570701	TARDBP|0.00|0.00|0.00|0.00|29|23|1|-10		1	3	0	0 / 0					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11019020	11019020	A	G	het	het	hom	off-target	QUAL=3368;DP=102,39,52;AF=0.54,0.51,1.00;MQM=60;SAP=279;ABP=4;SAR=127;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron4/6:c.543+147A>G::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1293144 [benign DISEASE=not provided];			rs2273348	0.63981	0.25888,0.72684,0.65728,0.81215,0.69320	35491,	26279	54755	0.1640	3.71			/0.0>0.0/0.0>1.2		TARDBP|0.00|0.00|0.00|0.00|-17|-50|-5|3	19005574,21937999,18545701,17614162,17434264,22550220,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11020666	11020666	-	G	het	het	hom	off-target	QUAL=4287;DP=95,61,95;AF=0.45,0.62,1.00;MQM=59;SAP=385;ABP=4;SAR=176;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.714+69dup::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	522225 [benign DISEASE=not specified,Amyotrophic lateral sclerosis type 10,not provided];		AluSc (SINE/Alu)	rs143130606	0.88007	0.96810,0.89899,0.92439,0.83453,0.86843	58908,	15406	18154		0.94			/0.0>0.0/0.0>0.0		TARDBP|0.00|0.00|0.00|0.00|5|26|-48|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11020751	11020751	A	-	het	het	het	off-target	QUAL=138;DP=41,8,12;AF=0.32,0.13,0.25;MQM=56;SAP=40;ABP=29;SAR=17;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.714+166del::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.714+166del::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.714+166del::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.714+166del::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1283048 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs57781131	0.09805	0.20674,0.05827,0.23767,0.03403,0.11590	926,	10590	114448	0.4500	1.20			/0.0>0.0/0.0>0.0		TARDBP|0.00|0.00|0.00|0.00|2|19|7|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11021998	11021998	G	-	het	het	hom	off-target	QUAL=3632;DP=126,47,64;AF=0.51,0.49,1.00;MQM=60;SAP=331;ABP=3;SAR=0;SAF=151	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.715-126del::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.715-126del::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1221094 [benign DISEASE=not provided];			rs3835416	0.63892	0.25722,0.72665,0.65527,0.81175,0.69167	35414,	26291	54885	0.1340	1.10			/0.0>0.0/0.0>0.0		TARDBP|0.00|0.00|0.00|0.00|33|2|-15|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11024947	11024947	-	TGTTT	het	het	hom		QUAL=16243;DP=374,257,269;AF=0.49,0.51,1.00;MQM=60;SAP=33;ABP=3;SAR=335;SAF=246	TARDBP,MASP2	3'UTR,intron	TARDBP:ENST00000240185.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::,MASP2:ENST00000700088.1:intron_variant:MODIFIER:intron11/11:c.1396+1802_1396+1803insAAACA::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	291763 [benign DISEASE=Amyotrophic Lateral Sclerosis, Dominant,Frontotemporal dementia,Immunodeficiency due to MASP-2 deficiency];			rs3059695	0.88020	0.96974,0.89841,0.92523,0.83405,0.86966	59078,	15398	18178		4.86			/0.1>1.0/0.0>0.0,/0.0>0.0/2.7>5.4		TARDBP|0.00|0.00|0.00|0.00|-21|-4|-22|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11786035	11786035	-	T	het	hom	het		QUAL=4376;DP=117,37,51;AF=0.74,0.89,0.90;MQM=60;SAP=252;ABP=127;SAR=14;SAF=152	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+757dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4644dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775	0.98402	0.96193,0.99423,0.99690,0.99313,0.99937	72488,	2333	2393		1.54			/1.8>3.3/0.0>0.0,/0.0>0.0/0.0>0.0		C1orf167|0.00|0.00|0.01|0.00|-25|-24|-25|23,MTHFR|0.00|0.00|0.00|0.00|11|9|17|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786195	11786195	G	A	hom	het	het		QUAL=15081;DP=332,159,181;AF=1.00,0.50,0.54;MQM=60;SAP=44;ABP=5;SAR=206;SAF=304	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+906G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4485C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.67797	0.54491,0.77602,0.89550,0.70612,0.66839	35684,	31653	48935	0.4760	3.52			/0.0>0.0/0.0>0.4,/4.6>5.6/0.0>0.0		C1orf167|0.00|0.00|0.00|0.00|2|-41|2|12,MTHFR|0.00|0.00|0.00|0.00|-14|21|-6|-2	31637880,21273288,19493349,19593234,20056627,22747749,26046315,28963520,20692813,24853127,25566964,32117640,18221821,24687778,28969008,29299150,29340069,31694048,32073761,18180959,31601265,31750632,31737664,31671528,25165408,26770518,23430981,23166529,25349462,23848401,34126931,34163215,33223666,35987633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786390	11786390	G	A	hom	hom	hom		QUAL=25345;DP=383,181,217;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0;SAR=439;SAF=342	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-998G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4290C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs4845884	0.93945	0.79063,0.97448,1.00000,0.99934,0.99959	67802,	7342	9214	-0.8090	0.77			/0.0>0.0/0.0>0.0		C1orf167|0.00|0.00|0.00|0.01|4|-17|1|32,MTHFR|0.00|0.00|0.00|0.00|-27|14|-27|0	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786606	TTTT	-	het	het	het		QUAL=2152;DP=77,23,31;AF=0.64,0.52,0.65;MQM=57;SAP=36;ABP=19;SAR=58;SAF=23	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-770_3082-767del::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4074_*4077del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.54156	0.38651,0.68939,0.75866,0.57524,0.45378	21344,	34207	65093	0.3080	0.58			/10.7>9.9/0.0>0.0,/0.0>0.0/0.0>0.0		C1orf167|0.00|0.02|0.00|0.00|49|24|-40|24,MTHFR|0.00|0.00|0.00|0.00|-44|-4|-43|38	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786607	TTTTT	-	het	het	het		QUAL=2152;DP=77,23,31;AF=0.21,0.35,0.10;MQM=59;SAP=3;ABP=101;SAR=14;SAF=13	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-771_3082-767del::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-771_3568-767del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4073_*4077del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs55780505	0.00170	0.00054,0.00258,0.00167,0.00139,0.00023	0,	241	141893	0.3080	0.57			/10.7>8.9/0.0>0.0,/0.0>0.0/0.0>0.0		C1orf167|0.00|0.02|0.00|0.00|49|24|19|-24,MTHFR|0.00|0.00|0.00|0.00|18|-4|-44|38	26046315	2	58	0	0 / 0					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787277	11787277	-	GAA	hom	het	het		QUAL=9572;DP=232,133,223;AF=0.97,0.58,0.41;MQM=60;SAP=76;ABP=5;SAR=139;SAF=254	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-108_3082-106dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*3400_*3402dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs35134728	0.56554	0.39893,0.70458,0.76993,0.60826,0.47326	25339,	35163	65945		0.59			/0.0>0.0/0.0>0.0,/1.6>1.6/0.0>0.0		C1orf167|0.02|0.00|0.00|0.00|-18|5|-18|-27,MTHFR|0.00|0.00|0.00|0.00|26|-40|-14|-40	26046315,21478897,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787702	11787702	C	T	hom	het	het		QUAL=12020;DP=194,243,292;AF=0.98,0.51,0.52;MQM=60;SAP=43;ABP=4;SAR=186;SAF=279	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron17/20:c.3188-171C>T::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2978G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs3737966	0.55248	0.37386,0.69378,0.77360,0.59992,0.45004	24365,	35269	68041	0.6820	4.70			/4.6>5.4/0.0>0.0,/3.4>2.6/0.0>0.0	COSV57172225	C1orf167|0.00|0.00|0.00|0.00|6|10|-17|18,MTHFR|0.00|0.01|0.00|0.00|-8|27|-8|27	26046315,30339177,32117640,21478897,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788082	11788082	G	A	wt	het	het		QUAL=2673;DP=123,85,122;AF=0.01,0.55,0.48;MQM=60;SAP=3;ABP=3;SAR=55;SAF=51	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron18/20:c.3362+35G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2598C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs11559040	0.13539	0.03919,0.11110,0.10154,0.18183,0.24193	1758,	17084	131552	-1.3250	2.70			/0.0>1.2/1.3>1.6,/2.9>2.5/0.0>0.0	COSV57171817	C1orf167|0.00|0.01|0.00|0.00|3|48|-9|-35,MTHFR|0.00|0.00|0.00|0.00|-40|47|31|-35	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788822	11788822	A	G	hom	hom	hom		QUAL=19177;DP=248,151,218;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0;SAR=333;SAF=283	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron20/20:c.3672+76A>G::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs2077360	0.93708	0.78216,0.97396,1.00000,0.99931,0.99979	67508,	7562	9574	-0.5450	0.76			/0.0>0.1/0.0>0.0,/1.1>0.6/10.2>8.7		C1orf167|0.00|0.00|0.00|0.00|-29|30|-29|-16,MTHFR|0.00|0.00|0.00|0.00|40|-14|40|6	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11789390	11789390	A	G	hom	hom	hom		QUAL=17775;DP=150,188,226;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0;SAR=302;SAF=261	C1orf167,MTHFR	missense,3'UTR	C1orf167:ENST00000433342.6:missense_variant:MODERATE:exon21/21:c.3793A>G:p.Arg1265Gly:,C1orf167:ENST00000688073.1:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs868014	0.93958	0.79090,0.97468,1.00000,0.99934,0.99979	67781,	7318	9188	-5.2110	0.01	0.03	0.04	/0.0>0.0/0.0>0.0	COSV57171235	C1orf167|0.00|0.00|0.00|0.00|1|31|12|2,MTHFR|0.00|0.00|0.00|0.00|50|38|-50|7	28171870,26046315,31671528,23292069,30182779,34298760,33239899,34953598	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790308	11790308	T	G	hom	het	het		QUAL=19144;DP=316,351,385;AF=1.00,0.49,0.49;MQM=60;SAP=231;ABP=4;SAR=470;SAF=204	MTHFR	3'UTR	MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000423400.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292223 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs4846049	0.63195	0.49376,0.75089,0.77531,0.67413,0.54474	31075,	33888	55934	-0.8740	1.52			/0.0>0.0/0.0>0.0		MTHFR|0.00|0.00|0.00|0.00|-8|-22|-15|36	22100073,31637880,20556870,24991086,31469255,19683694,21448238,19593234,20056627,20962791,26046315,28657672,28722783,28963520,24391914,23227261,25723397,32117640,24315498,31601265,21515602,22647417,25882505,26690224,27454313,29379315,31737664,27106592,28855605,29657307,30781868,29434917,29666641,24006081,29534533,23303660,27980618,28587112,29871275,33223666,34707639,34885097,35987633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790946	11790946	G	C	wt	het	het	off-target	QUAL=3878;DP=208,168,180;AF=0.00,0.48,0.43;MQM=60;SAP=43;ABP=9;SAR=106;SAF=52	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1753-230C>G::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1018-48C>G::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1224887 [benign DISEASE=not provided,Homocystinuria due to MTHFR deficiency];			rs3818762	0.23504	0.14750,0.17322,0.22282,0.27820,0.41636	4602,	26511	116241	-2.2640	0.05			/2.4>1.9/0.3>1.3	COSV100453746	MTHFR|0.00|0.04|0.00|0.00|30|-48|1|-3	22100073,21273288,22241680,31502714,23874907	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11791061	11791061	A	G	hom	hom	hom	off-target	QUAL=13743;DP=179,126,128;AF=0.99,1.00,1.00;MQM=60;SAP=79;ABP=0;SAR=154;SAF=277	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1875+146T>C::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1875+146T>C::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1872+146T>C::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1752+146T>C::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1017+146T>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177028 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs7518348	0.90920	0.68821,0.96153,0.99865,0.99850,0.99876	64264,	9749	13809	0.0820	6.51			/4.1>3.3/0.0>0.0		MTHFR|0.00|0.00|0.00|0.00|-24|-5|-25|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11792243	11792243	C	T	wt	het	het	off-target	QUAL=4658;DP=171,198,209;AF=0.01,0.47,0.48;MQM=60;SAP=14;ABP=5;SAR=82;SAF=113	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron6/7:c.897+35G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1170841 [benign DISEASE=not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs1476413	0.23442	0.16054,0.17293,0.23117,0.26996,0.41238	4505,	26634	116410	-1.1200	1.21			/0.0>0.0/0.0>0.0	COSV57171175	MTHFR|0.00|0.00|0.00|0.00|34|35|35|0	21273288,27437086,19493349,19048631,21254358,21254359,19593234,20056627,20962791,22039442,22155867,22241680,22747749,22903727,23893618,26646537,20692813,22495907,28266606,30339177,29421402,29732742,31502714,19064567,24314549,23430981,23166529,19075497,20356773,34126931,32993083,33195260,32825595,25084201,28361099,34734498,35700037,36160803	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794400	11794400	G	A	hom	hom	hom		QUAL=18598;DP=121,205,265;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0;SAR=230;SAF=360	MTHFR	synonymous	MTHFR:ENST00000376592.6:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376590.9:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376583.7:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.6:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000423400.7:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:ENST00000641407.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:,MTHFR:ENST00000641820.1:synonymous_variant:LOW:exon4/8:c.570C>T:p.Phe190=:		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	167306 [benign DISEASE=not specified,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Homocystinuria due to MTHFR deficiency];			rs4846051	0.90942	0.68881,0.96124,0.99864,0.99850,0.99855	64232,	9718	13764	0.6480	4.72			/3.6>3.6/0.0>0.0		MTHFR|0.01|0.00|0.00|0.00|-20|47|26|-42	28871186,19591822,19493349,25110414,29193749,22241680,31208817,16439441,18483346,23300409,25982422,19144510,34126931,34169999,32993083,36160803	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794419	11794419	T	G	wt	het	het		QUAL=7188;DP=167,229,287;AF=0.01,0.54,0.54;MQM=60;SAP=7;ABP=11;SAR=129;SAF=152	MTHFR	missense	MTHFR:ENST00000376592.6:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376590.9:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376583.7:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.6:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000423400.7:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:ENST00000641407.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000641820.1:missense_variant:MODERATE:exon4/8:c.551A>C:p.Glu184Ala:		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	3521 [conflicting interpretations of pathogenicity,other DISEASE=not specified,not provided,Gastrointestinal stromal tumor,Neural tube defects, folate-sensitive,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Homocystinuria due to MTHFR deficiency,MTHFR THERMOLABILE POLYMORPHISM,Schizophrenia, susceptibility to,Stroke];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.26339	0.16705,0.20701,0.22052,0.31589,0.40677	5754,	28495	111877	3.7560	20.90	0.20	0.08	/0.0>0.0/1.6>2.1	COSV57171183	MTHFR|0.00|0.00|0.00|0.00|-39|-4|2|3	21467728,18603647,21146954,21533139,21919968,22100073,23205182,27348238,29972410,30409984,30571812,20078877,26446360,26451011,22281051,18992148,16642433,21273288,24944790,21514219,23946381,25928231,25294155,18936436,19538716,19591822,20417488,20556870,21857382,21935354,22540831,22707612,22992668,23776350,25266489,26091847,27018927,27233804,28086795,31646966,25214541,28827732,30337837,30793520,31361092,19493349,23736036,24167597,24590654,25110414,25691056,29193749,21658613,22486600,12970910,28253266,19048631,26884752,30877365,21254358,21254359,22927710,26843965,22496743,30235667,28927418,27369588,22022476,18191955,21204206,19442614,29694444,19064578,22655231,23175176,27583843,26870349,30203425,19683694,21274745,27808252,24340057,27217270,20718043,28822116,19593234,20056627,20962791,22155867,22241680,22747749,22903727,22792358,24130171,21748308,19062539,24048206,18182569,30139066,19700502,25980667,23049672,9545395,10677336,10958762,11590551,11742092,11752418,11781870,11938441,12560871,14724163,15103709,15951337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794614	11794614	C	A	wt	het	het	off-target	QUAL=2497;DP=60,100,109;AF=0.02,0.51,0.52;MQM=60;SAP=214;ABP=4;SAR=106;SAF=3	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1290-76G>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1290-76G>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1287-76G>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1167-76G>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.432-76G>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177041 [benign/likely benign DISEASE=not specified,not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs12121543	0.21339	0.14344,0.15631,0.20764,0.24862,0.33610	3726,	24967	119503	-0.1370	5.40			/0.0>0.0/1.8>0.0	COSV64877122	MTHFR|0.02|0.01|0.00|0.00|-41|0|2|1	21273288,20056627,22039442,22241680,22933837,24853127,25566964,22103680,22649255,25165408,24006081,35700037	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794698	11794698	G	A	hom	het	het	off-target	QUAL=3045;DP=70,57,54;AF=1.00,0.46,0.39;MQM=60;SAP=192;ABP=9;SAR=109;SAF=8	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.431+31C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177042 [benign DISEASE=not specified,not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs1994798	0.56202	0.43617,0.68789,0.75960,0.58551,0.48359	24771,	35822	66524	-4.4220	0.05			/0.0>0.4/0.0>0.0	COSV64877997	MTHFR|0.00|0.00|0.04|0.00|2|-48|2|-45	20718043,20056627,22241680,11781870,18538037,32073761,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800063	11800063	T	C	hom	het	het	off-target	QUAL=4634;DP=74,102,134;AF=0.99,0.55,0.46;MQM=60;SAP=416;ABP=3;SAR=0;SAF=190	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron4/11:c.709+149A>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron5/12:c.709+149A>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron4/11:c.706+149A>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron3/10:c.586+149A>G::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1295234 [benign DISEASE=not provided];			rs11121832	0.74673	0.69174,0.81504,0.89437,0.75243,0.69518	42537,	28256	38438	-0.9060	0.52			/0.0>0.5/0.0>0.0		MTHFR|0.00|0.00|0.00|0.00|23|13|-16|13	20056627,22039442,20692813,28266606,22252258	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800401	11800401	C	T	wt	het	het	off-target	QUAL=7116;DP=176,242,317;AF=0.00,0.54,0.49;MQM=60;SAP=266;ABP=4;SAR=236;SAF=50	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron3/11:c.599-79G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron4/12:c.599-79G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron3/11:c.596-79G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron2/10:c.476-79G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1180162 [benign DISEASE=not provided];			rs2066471	0.12264	0.03034,0.10223,0.09769,0.16598,0.20444	1446,	15753	133391	0.2400	5.22			/6.6>2.4/0.0>0.0	COSV64701666	MTHFR|0.00|0.06|0.00|0.00|-2|21|6|-7	18778477,21085059,20692813,30339177,31671528,23292069	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11806034	11806034	T	G	hom	n/a	n/a		QUAL=13;DP=3,0,1;AF=1.00,,1.00;MQM=60;SAP=12;ABP=0;SAR=0;SAF=4	MTHFR,CLCN6	upstream_gene	MTHFR:ENST00000376592.6:upstream_gene_variant:MODIFIER::::,MTHFR:ENST00000376590.9:upstream_gene_variant:MODIFIER::::,MTHFR:ENST00000376583.7:upstream_gene_variant:MODIFIER::::,MTHFR:ENST00000376585.6:upstream_gene_variant:MODIFIER::::,MTHFR:ENST00000423400.7:upstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:upstream_gene_variant:MODIFIER::::,CLCN6:ENST00000312413.10:upstream_gene_variant:MODIFIER::::,CLCN6:ENST00000346436.11:upstream_gene_variant:MODIFIER::::,CLCN6:ENST00000376496.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]&602726_[GENE=CLCN6_PHENOS=Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities, 619173 (3), Autosomal dominant]				rs937886850						-2.2640	2.90							0	0	0	0 / 0					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), CLCN6 (inh=AD oe_syn=1.08 oe_mis=0.81 oe_lof=0.42)
chr1	11949898	11949898	C	T	het	het	het		QUAL=6858;DP=126,190,248;AF=0.46,0.53,0.49;MQM=60;SAP=58;ABP=3;SAR=182;SAF=98	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255803 [benign DISEASE=not specified,Ehlers-Danlos syndrome, kyphoscoliotic type 1,Familial thoracic aortic aneurysm and aortic dissection];			rs7529452	0.25399	0.06369,0.28890,0.37766,0.31470,0.43156	6298,	25999	113363	1.0800	13.23			/10.7>10.9/0.0>0.0	COSV52144592	PLOD1|0.00|0.00|0.00|0.05|5|-32|-12|12	25741868,20357209,20072119,19442614,21527992,35140610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11949899	11949899	G	A	wt	het	wt		QUAL=2014;DP=151,188,243;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=4;SAR=43;SAF=46	PLOD1	missense	PLOD1:ENST00000196061.5:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	196247 [benign/likely benign DISEASE=Ehlers-Danlos syndrome,not specified,Familial thoracic aortic aneurysm and aortic dissection,Ehlers-Danlos syndrome, kyphoscoliotic type 1];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.25902	0.54023,0.14210,0.25483,0.14989,0.21414	7475,	24404	112578	1.2640	15.53	0.15	0.05	/10.7>10.1/0.0>0.0	COSV52140857	PLOD1|0.00|0.00|0.00|0.05|4|8|3|11	25741868,19442614,21527992,34707639	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11950721	11950721	A	G	het	hom	het	off-target	QUAL=726;DP=36,8,13;AF=0.50,1.00,0.46;MQM=60;SAP=72;ABP=3;SAR=32;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron4/18:c.466+201A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1265885 [benign DISEASE=not provided];		L2 (LINE/L2)	rs60895266	0.55621	0.70139,0.45179,0.70658,0.48209,0.66736	24567,	35306	67372	0.1120	4.78			/0.0>0.0/0.0>0.0		PLOD1|0.04|0.00|0.00|0.00|-33|2|-48|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11952923	11952923	G	A	het	het	het	off-target	QUAL=805;DP=45,15,18;AF=0.53,0.40,0.44;MQM=60;SAP=86;ABP=3;SAR=38;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron5/18:c.579+188G>A::	regulatory_region_variant:open_chromatin_region	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1290288 [benign DISEASE=not provided];		MLT1A0 (LTR/ERVL-MaLR)	rs58495963	0.28144	0.12284,0.30483,0.40955,0.33150,0.44440	7070,	28619	109173	0.3250	4.51			/0.0>0.0/0.0>0.0		PLOD1|0.00|0.00|0.00|0.00|2|5|5|45	35501403	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11955097	11955097	G	A	het	het	het	off-target	QUAL=2555;DP=86,54,74;AF=0.60,0.44,0.54;MQM=60;SAP=255;ABP=6;SAR=116;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.643+204G>A::	regulatory_region_variant:enhancer	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1250242 [benign DISEASE=not provided];			rs2273288	0.28209	0.12591,0.30491,0.40736,0.33134,0.44389	7084,	28739	109195	-0.9050	1.65			/0.0>0.0/6.4>7.5		PLOD1|0.00|0.00|0.01|0.00|-3|41|-3|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956715	11956715	T	C	wt	het	wt	off-target	QUAL=381;DP=51,48,51;AF=0.02,0.44,0.00;MQM=60;SAP=51;ABP=5;SAR=0;SAF=22	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.644-202T>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1273224 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs6665648	0.26415	0.55668,0.14393,0.26856,0.14954,0.21586	7868,	24382	111760	0.3040	5.80			/0.0>0.0/0.0>0.0		PLOD1|0.00|0.00|0.00|0.00|33|-19|33|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956900	11956900	T	G	wt	het	wt	off-target	QUAL=3761;DP=109,311,392;AF=0.00,0.50,0.00;MQM=60;SAP=70;ABP=3;SAR=43;SAF=112	PLOD1	splice_region&intron	PLOD1:ENST00000196061.5:splice_region_variant&intron_variant:LOW:intron6/18:c.644-17T>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	384719 [benign DISEASE=not specified,Ehlers-Danlos syndrome, kyphoscoliotic type 1];			rs41307745	0.04716	0.01239,0.02770,0.14749,0.05602,0.13320	271,	6630	144896	1.9980	17.56			10.5>8.8/10.5>8.8/0.0>0.0	COSV52140829	PLOD1|0.01|0.02|0.00|0.00|9|17|-10|-2		41	994	0	0 / 0					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11958321	11958321	C	G	het	het	het	off-target	QUAL=406;DP=17,10,11;AF=0.41,0.50,0.73;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron8/18:c.844-195C>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1231062 [benign DISEASE=not provided];			rs2273290	0.28104	0.12265,0.30448,0.40263,0.33137,0.44251	7048,	28578	109172	-0.5240	1.52			/4.1>2.6/0.0>0.0		PLOD1|0.02|0.00|0.00|0.00|-18|6|39|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11964178	11964178	C	T	het	het	het		QUAL=1161;DP=18,36,53;AF=0.56,0.39,0.53;MQM=60;SAP=3;ABP=3;SAR=26;SAF=26	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255799 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,not specified,Familial thoracic aortic aneurysm and aortic dissection];			rs1130529	0.33120	0.29513,0.31954,0.39516,0.32521,0.45046	8715,	32864	101562	-0.7380	6.42			/0.0>0.0/2.5>1.6	COSV52140468	PLOD1|0.00|0.01|0.00|0.00|-20|-42|-21|-4	25741868,20357209,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11965296	11965296	T	C	het	hom	het	off-target	QUAL=1309;DP=36,21,26;AF=0.53,1.00,0.46;MQM=60;SAP=116;ABP=3;SAR=0;SAF=52	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron13/18:c.1471-184T>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1263662 [benign DISEASE=not provided];		L2b (LINE/L2)	rs2273291	0.57746	0.80823,0.46531,0.68168,0.46881,0.65771	27325,	32973	64117	-2.0320	0.15			/5.8>6.0/0.0>0.0		PLOD1|0.02|0.00|0.00|0.00|-31|9|36|-3	20357209,19442614,21527992,29273593	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967147	11967147	C	T	het	hom	het	off-target	QUAL=9543;DP=42,205,211;AF=0.48,1.00,0.52;MQM=60;SAP=128;ABP=3;SAR=237;SAF=98	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1297286 [benign DISEASE=not provided];			rs2273293	0.50399	0.57525,0.43485,0.63795,0.46128,0.62966	19900,	36738	75326	-3.2240	0.01			/0.0>0.0/0.0>0.0	COSV52142788	PLOD1|0.00|0.00|0.00|0.00|28|-23|-5|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967251	11967251	G	A	het	hom	het	off-target	QUAL=5768;DP=151,82,82;AF=0.58,1.00,0.61;MQM=60;SAP=479;ABP=19;SAR=219;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+160G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1285712 [benign DISEASE=not provided];			rs3818157	0.50586	0.57631,0.43513,0.63551,0.46452,0.62968	20004,	36690	74920	0.7040	3.71			/0.0>0.0/0.0>0.0		PLOD1|0.01|0.00|0.00|0.00|-16|-13|-16|-13	19005574,21937999,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11970938	11970938	A	G	het	hom	het	off-target;low_conf_region	QUAL=911;DP=29,23,31;AF=0.45,0.96,0.29;MQM=59;SAP=99;ABP=12;SAR=44;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron17/18:c.1902+122A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1257523 [benign DISEASE=not provided];			rs59235751	0.42466	0.62495,0.40865,0.66095,0.35428,0.64736	2948,	6516	16816	0.3120	0.84			/0.0>0.0/2.4>0.7		PLOD1|0.00|0.00|0.00|0.00|-2|2|-45|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973056	11973056	A	G	het	hom	het	off-target	QUAL=11282;DP=134,209,264;AF=0.51,1.00,0.48;MQM=60;SAP=391;ABP=3;SAR=337;SAF=68	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1278494 [benign DISEASE=not provided];			rs3737961	0.56703	0.77619,0.46249,0.67974,0.46719,0.65877	26077,	33653	65519	-0.1100	3.69			/0.0>0.0/0.2>0.0	COSV52144992	PLOD1|0.00|0.00|0.00|0.00|39|14|-9|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973063	11973063	G	C	het	hom	het	off-target	QUAL=10118;DP=115,199,252;AF=0.56,0.99,0.48;MQM=60;SAP=438;ABP=3;SAR=330;SAF=53	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+66G>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1280245 [benign DISEASE=not provided];			rs3820190	0.57483	0.80373,0.46460,0.67934,0.46716,0.65939	26988,	33017	64343	0.8350	2.81			/0.0>0.0/0.2>0.5	COSV52151982	PLOD1|0.00|0.00|0.00|0.00|31|17|31|-16	32221480	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11980146	11980146	A	G	het	hom	het	off-target	QUAL=876;DP=24,20,24;AF=0.42,1.00,0.46;MQM=60;SAP=84;ABP=5;SAR=1;SAF=40	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.5:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675053.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675298.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674548.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1290963 [benign DISEASE=not provided];			rs2236053	0.50152	0.59081,0.42785,0.63995,0.44820,0.62495	19724,	36612	75598	-0.8990	3.38							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980267	11980267	A	G	het	hom	het		QUAL=4117;DP=30,101,123;AF=0.47,1.00,0.36;MQM=60;SAP=111;ABP=22;SAR=35;SAF=124	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-270A>G::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-367A>G::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-367A>G::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-312A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Hereditary motor and sensory neuropathy with optic atrophy,not provided,Charcot-Marie-Tooth disease type 2,Ehlers-Danlos syndrome, kyphoscoliotic type 1];			rs2236054	0.50663	0.61077,0.42965,0.64003,0.44739,0.62396	20255,	36400	74898	-0.9010	3.28			/0.0>0.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.04|31|44|-1|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980422	11980422	T	C	het	hom	het		QUAL=5098;DP=54,113,128;AF=0.43,1.00,0.43;MQM=60;SAP=138;ABP=11;SAR=150;SAF=41	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-115T>C::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-212T>C::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-157T>C::,MFN2:ENST00000674658.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-310T>C::,MFN2:ENST00000674910.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-189T>C::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Hereditary motor and sensory neuropathy with optic atrophy,Ehlers-Danlos syndrome, kyphoscoliotic type 1,Charcot-Marie-Tooth disease type 2,not provided];			rs2180183	0.53254	0.69323,0.44127,0.68210,0.44797,0.63459	22800,	35289	71003	-0.2290	9.63			/4.1>3.4/0.0>0.0		MFN2|0.00|0.00|0.01|0.00|26|48|24|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTT	het	het	wt	off-target	QUAL=275;DP=87,34,137;AF=0.06,0.26,0.11;MQM=59;SAP=49;ABP=367;SAR=1;SAF=24	MFN2	intron,5'UTR	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-140_-52-135dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-43_-149-38dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1443_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-43_-247-38dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1443_-127+1448dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-43_-211-38dup::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-43_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-43_-271-38dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1251375 [benign DISEASE=not provided];			rs34602102	0.02588	0.08402,0.01018,0.00127,0.00504,0.00157	202,	3166	134388		3.98			/2.6>4.2/0.0>0.0		MFN2|0.00|0.01|0.00|0.00|28|-1|14|48		2	26	0	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTTT	wt	het	het	off-target	QUAL=275;DP=87,34,137;AF=0.08,0.21,0.08;MQM=58;SAP=58;ABP=340;SAR=1;SAF=28	MFN2	intron,5'UTR	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-141_-52-135dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-44_-149-38dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1442_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-44_-247-38dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1442_-127+1448dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-44_-211-38dup::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-44_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-44_-271-38dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1238604 [benign DISEASE=not provided];			rs34602102	0.32587	0.34703,0.31125,0.41164,0.30800,0.37083	8015,	28707	92547		3.93			/2.6>5.0/0.0>0.0		MFN2|0.01|0.01|0.00|0.00|50|-1|14|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11982204	11982204	A	G	het	hom	het	off-target	QUAL=7703;DP=208,102,154;AF=0.53,1.00,0.49;MQM=60;SAP=584;ABP=3;SAR=282;SAF=5	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron2/19:c.-5+90A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1720A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron2/17:c.-103+90A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1720A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron2/19:c.-73+90A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron2/19:c.-67+90A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron2/19:c.-95+90A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron2/19:c.-127+90A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1279097 [benign DISEASE=not provided];			rs2236055	0.57117	0.78308,0.46316,0.67934,0.47036,0.60980	26525,	33694	65128	1.7780	11.88			/0.0>0.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|29|21|14|-13	20940517,26816493,28513770,30940795,32782719,34469753,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11992348	11992348	G	A	hom	hom	hom	off-target	QUAL=5799;DP=127,38,31;AF=1.00,1.00,1.00;MQM=60;SAP=429;ABP=0;SAR=0;SAF=196	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron3/19:c.176-207G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron3/17:c.-34-3808G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683180 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs6675934	0.88575	0.97040,0.88006,0.99962,0.83087,0.97185	60097,	14585	17385	0.7390	3.93			/0.0>0.0/0.0>0.0		MFN2|0.00|0.02|0.00|0.00|7|-28|-17|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11996383	11996383	C	T	hom	hom	hom	off-target	QUAL=14891;DP=164,177,169;AF=1.00,0.99,1.00;MQM=60;SAP=941;ABP=0;SAR=489;SAF=20	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron5/19:c.474+65C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron4/17:c.129+65C>T::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1180064 [benign DISEASE=not provided];			rs2236056	0.64961	0.68622,0.54460,0.63763,0.64778,0.68123	32482,	33802	53274	-1.0310	0.07			/8.5>8.2/0.0>0.0	COSV52421940	MFN2|0.00|0.00|0.00|0.01|23|19|-21|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12001293	12001293	G	A	het	wt	het	off-target	QUAL=1819;DP=95,44,75;AF=0.48,0.00,0.49;MQM=58;SAP=183;ABP=3;SAR=0;SAF=83	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron8/19:c.817-108G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron7/17:c.472-108G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1200078 [likely benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs139807696	0.02422	0.00844,0.01473,0.00000,0.04058,0.00290	62,	3563	148525	-0.2120	0.53			/0.0>0.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|18|47|-3|-1		8	236	0	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002148	12002148	A	G	hom	hom	hom	off-target	QUAL=14620;DP=179,139,190;AF=0.98,0.99,0.99;MQM=60;SAP=1069;ABP=0;SAR=500;SAF=3	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+45A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+45A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]				rs2236057	0.64888	0.64723,0.55314,0.68106,0.66293,0.70790	32381,	33932	53404	-2.3750	0.13			/0.0>0.0/0.0>0.0	COSV52420984	MFN2|0.00|0.00|0.00|0.01|50|3|26|3	26816493,26916081,30940795,32782719	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002304	12002304	C	G	hom	hom	hom	off-target	QUAL=3712;DP=56,31,48;AF=1.00,1.00,0.98;MQM=60;SAP=294;ABP=0;SAR=134;SAF=0	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+201C>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+201C>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683181 [benign DISEASE=not provided];			rs2236058	0.57394	0.52807,0.49863,0.55476,0.60566,0.63256	25486,	36294	64782	0.0370	5.11			/6.6>6.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|16|36|5|-32	26816493,22778543,30940795,34163214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12006987	12006987	T	G	hom	hom	hom	off-target	QUAL=6053;DP=104,38,66;AF=1.00,1.00,0.98;MQM=60;SAP=386;ABP=0;SAR=8;SAF=199	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron17/19:c.2005-66T>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron15/17:c.1528-66T>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	676150 [benign DISEASE=not provided];			rs7550536	0.54454	0.44192,0.48899,0.55504,0.59656,0.62059	23202,	36340	69208	-0.1560	1.88			/0.0>0.7/0.7>6.4	COSV52424175	MFN2|0.02|0.00|0.04|0.00|46|13|-5|-2	20031578	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011376	12011376	C	G	wt	het	wt	off-target	QUAL=1454;DP=220,157,168;AF=0.00,0.43,0.00;MQM=60;SAP=144;ABP=9;SAR=1;SAF=68	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron17/17:c.2205-120C>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron17/17:c.2205-120C>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron19/19:c.2337-120C>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1650C>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron17/17:c.1860-120C>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::	regulatory_region_variant:open_chromatin_region	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1284248 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs3766741	0.08012	0.11035,0.04103,0.14412,0.06436,0.14756	590,	11007	139921	-0.8280	0.13			/0.0>0.0/0.0>0.0	COSV52422123	MFN2|0.00|0.00|0.00|0.00|23|-9|23|17	26816493,22778543,30940795	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011623	12011623	A	G	hom	hom	hom		QUAL=29544;DP=257,325,425;AF=0.99,0.99,1.00;MQM=60;SAP=124;ABP=0;SAR=619;SAF=383	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1897A>G::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292381 [benign DISEASE=Charcot-Marie-Tooth disease type 2,not provided,Hereditary motor and sensory neuropathy with optic atrophy,not specified];			rs1042842	0.70823	0.84895,0.58268,0.69214,0.66384,0.70439	39029,	29587	44347	-0.7360	1.04			/7.2>7.6/0.7>0.0	COSV52422477	MFN2|0.00|0.00|0.00|0.00|16|-26|-1|1	29352517,17940179,21686698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012461	12012461	G	C	hom	hom	hom		QUAL=12758;DP=106,143,172;AF=0.99,1.00,1.00;MQM=60;SAP=77;ABP=0;SAR=150;SAF=270	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1796G>C::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292393 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs3088064	0.55462	0.46631,0.49403,0.59249,0.59962,0.62588	23926,	36315	67589	0.1930	4.22			/2.1>3.7/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|11|-8|-9|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012477	12012477	C	T	wt	het	wt		QUAL=1667;DP=102,145,189;AF=0.00,0.50,0.00;MQM=60;SAP=4;ABP=3;SAR=33;SAF=39	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1780C>T::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292394 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs14305	0.05350	0.01882,0.03181,0.14633,0.06635,0.14547	318,	7500	143932	0.1590	6.51			/0.0>0.0/0.0>0.8		MFN2|0.00|0.00|0.00|0.00|-50|-5|-2|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16043933	16043937	GGGGG	-	n/a	n/a	hom	off-target	QUAL=51;DP=0,0,3;AF=,,1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+61_-8+65del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-545_-7-541del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+61_-8+65del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs140434107	0.48179	0.42124,0.48511,0.73224,0.48284,0.48922	10009,	28607	52301	0.2600	0.91			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-6|50|50|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM131C2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16043984	16043984	T	C	n/a	n/a	hom	off-target	QUAL=84;DP=0,1,3;AF=,0.00,1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+104T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-502T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-502T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+104T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-502T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+104T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs945393	0.50638	0.45262,0.47567,0.71772,0.53222,0.46419	18423,	35980	70992	-2.5450	0.03			/0.0>0.0/3.3>0.0	COSV65160122	CLCNKB|0.00|0.00|0.00|0.00|3|-2|-37|-2	22578033	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM131C2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044404	16044404	G	A	het	n/a	n/a	off-target	QUAL=74;DP=6,1,2;AF=0.67,0.00,1.00;MQM=53;SAP=16;ABP=4;SAR=0;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-7-82G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-82G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-7-82G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277450 [benign DISEASE=not provided];			rs945394	0.53385	0.27676,0.65834,0.71170,0.62318,0.67157	22476,	33894	68848	-1.2310	0.73			/0.0>0.4/0.8>6.7	COSV65160124	CLCNKB|0.02|0.00|0.02|0.00|2|47|-4|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM131C2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044572	16044572	G	T	het	n/a	hom		QUAL=235;DP=4,1,5;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5;SAR=5;SAF=4	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon5/23:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon3/21:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon4/22:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447107 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];			rs2015352	0.54824	0.30076,0.66684,0.66415,0.64110,0.68165	24634,	33907	68537	0.0080	18.63	0.30	0.12	/1.6>2.6/0.0>0.0	COSV65159885	CLCNKB|0.00|0.00|0.00|0.00|-19|-22|11|31	23550235,16109321,32327693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM131C2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045377	16045377	C	G	het	het	hom	off-target	QUAL=2492;DP=70,36,40;AF=0.56,0.50,1.00;MQM=60;SAP=214;ABP=4;SAR=0;SAF=97	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-181C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-181C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-181C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-181C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1287171 [benign DISEASE=not provided];			rs6604908	0.54535	0.27992,0.66529,0.70444,0.64171,0.71058	24671,	33483	69051	-0.8840	0.47			/1.9>0.0/0.0>0.0	COSV65160125	CLCNKB|0.00|0.00|0.00|0.00|-41|35|25|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045437	16045437	A	C	hom	hom	hom	off-target	QUAL=5741;DP=55,76,76;AF=1.00,1.00,1.00;MQM=60;SAP=453;ABP=0;SAR=0;SAF=207	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-121A>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-121A>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-121A>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-121A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1183407 [benign DISEASE=not provided];			rs6604909	0.82729	0.54427,0.90277,0.99961,0.94149,0.93794	54456,	16882	26262	-1.9550	0.55			/0.0>0.0/0.0>0.0		CLCNKB|0.05|0.00|0.00|0.00|30|50|30|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045508	16045508	G	C	het	het	hom	off-target	QUAL=6450;DP=55,129,149;AF=0.42,0.48,1.00;MQM=60;SAP=360;ABP=5;SAR=19;SAF=215	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-50G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-50G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-50G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-50G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209775 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs6604910	0.54516	0.27997,0.66571,0.70287,0.64158,0.70930	24662,	33514	69114	-0.4740	4.26			/0.0>0.0/0.0>0.0	COSV65160072	CLCNKB|0.00|0.04|0.00|0.00|50|-41|50|49	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045788	16045788	T	-	het	het	wt	off-target	QUAL=3386;DP=22,52,73;AF=0.59,0.50,0.90;MQM=60;SAP=86;ABP=3;SAR=41;SAF=1	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.229+102del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.229+102del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.229+102del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.229+102del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.229+102del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.229+102del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1238992 [benign DISEASE=not provided];			rs67016480	0.28070	0.26111,0.23767,0.29467,0.30005,0.22567	6012,	30115	107985	0.0300	1.52			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.01|-15|8|-11|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045788	16045788	T	G	het	het	hom	off-target	QUAL=3386;DP=22,52,73;AF=0.59,0.50,0.90;MQM=60;SAP=167;ABP=3;SAR=97;SAF=8	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.229+102T>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.229+102T>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.229+102T>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.229+102T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1281750 [benign DISEASE=not provided];			rs6604911	0.65618	0.40623,0.73724,0.76930,0.72883,0.77006	24051,	33253	42627	0.0300	4.17			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.01|0.00|-16|-23|-23|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046416	16046416	G	A	hom	hom	hom	off-target	QUAL=7913;DP=100,88,92;AF=0.98,1.00,1.00;MQM=59;SAP=607;ABP=0;SAR=0;SAF=278	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-119G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-119G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-119G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-119G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279049 [benign DISEASE=not provided];			rs2014848	0.70237	0.38883,0.82888,0.98798,0.80905,0.89100	40482,	25634	45172	0.3310	3.75			/0.0>0.0/0.0>1.7		CLCNKB|0.01|0.00|0.00|0.01|43|-42|-3|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046476	16046476	G	A	hom	hom	hom	off-target	QUAL=12429;DP=81,142,182;AF=1.00,1.00,1.00;MQM=60;SAP=445;ABP=0;SAR=59;SAF=346	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-59G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-59G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-59G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-59G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209776 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs2014841	0.70252	0.38894,0.82908,0.98802,0.80919,0.89136	40551,	25638	45198	0.0580	1.12			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.01|0.00|0.00|-1|-17|-23|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046629	16046629	A	G	hom	hom	hom		QUAL=23226;DP=184,248,314;AF=0.98,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=382;SAF=360	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon7/23:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon5/21:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon6/22:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447104 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];			rs5257	0.70271	0.38942,0.82897,0.98781,0.80911,0.89136	40534,	25628	45140	-3.8900	0.63			/11.2>8.2/0.0>0.0		CLCNKB|0.23|0.88|0.00|0.05|13|2|-49|34	23550235,26045835	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046705	16046707	CTT	-	hom	het	hom	off-target;low_conf_region	QUAL=9732;DP=117,147,211;AF=1.00,0.50,1.00;MQM=60;SAP=378;ABP=3;SAR=332;SAF=69	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+44_358+46del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+44_358+46del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+44_358+46del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1280604 [benign DISEASE=not provided];			rs35820664	0.67611	0.36740,0.81072,0.98780,0.78017,0.86972	37662,	27213	49121	1.7440	8.18			/5.6>3.2/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-41|9|-41|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046787	16046787	A	G	hom	hom	hom	off-target	QUAL=8087;DP=113,78,91;AF=0.97,1.00,1.00;MQM=60;SAP=609;ABP=0;SAR=279;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+124A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+124A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+124A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+124A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1230357 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2095540	0.70193	0.38904,0.82836,0.98783,0.80821,0.89114	40508,	25698	45316	-2.1740	0.02			/4.9>5.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-33|4|37|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16047835	16047835	A	G	hom	hom	hom	off-target;low_conf_region	QUAL=610;DP=11,4,5;AF=1.00,1.00,1.00;MQM=60;SAP=38;ABP=0;SAR=1;SAF=19	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.359-70A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.359-70A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.359-70A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.359-70A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209691 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs945403	0.84467	0.60368,0.91175,0.99962,0.94167,0.93799	56038,	16338	23614	-3.8870	0.18			/2.7>2.3/0.0>0.0		CLCNKB|0.00|0.04|0.03|0.00|-41|6|5|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048038	16048038	G	C	hom	hom	hom		QUAL=383;DP=5,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=12;SAF=1	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon8/23:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon6/21:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon7/22:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447105 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];			rs2014562	0.89056	0.76363,0.92782,0.99961,0.94221,0.93838	60802,	13717	16629	-0.5020	7.47			/1.8>2.0/2.6>0.0		CLCNKB|0.00|0.00|0.08|0.12|-15|6|18|-48	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048127	16048127	C	G	hom	n/a	n/a	off-target	QUAL=383;DP=11,1,1;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=6;SAF=7	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron8/22:c.498+83C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron5/19:c.498+83C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron6/20:c.498+83C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron7/21:c.498+83C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron5/19:c.498+83C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron5/19:c.498+83C>G::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1183733 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B];			rs2863440	0.70283	0.39021,0.82923,0.98805,0.80905,0.89117	40588,	25645	45165	-0.4220	1.67			/0.0>0.0/1.2>1.9		CLCNKB|0.00|0.00|0.01|0.00|8|36|0|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048161	16048161	A	G	hom	n/a	hom	off-target	QUAL=618;DP=13,2,5;AF=1.00,1.00,1.00;MQM=60;SAP=14;ABP=0;SAR=5;SAF=15	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron8/22:c.498+117A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron6/20:c.498+117A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron7/21:c.498+117A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron5/19:c.498+117A>G::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1265585 [benign DISEASE=not provided];		L2c (LINE/L2)	rs2902490	0.70293	0.39007,0.82925,0.98804,0.80921,0.89133	40586,	25629	45137	-0.2570	2.10			/8.4>1.1/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|22|2|-38|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048499	16048499	C	T	hom	hom	hom		QUAL=18018;DP=158,204,245;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0;SAR=293;SAF=313	CLCNKB	splice_region&intron	CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron9/22:c.577-5C>T::,CLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron7/20:c.577-5C>T::,CLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron8/21:c.577-5C>T::,CLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	381050 [benign DISEASE=not specified,Bartter disease type 4B,Bartter disease type 3,not provided];			rs1889788	0.70059	0.38656,0.82669,0.98777,0.80754,0.88889	40322,	25719	45457	-0.3220	5.31			4.3>4.2/4.3>4.2/0.0>0.0	COSV65161773	CLCNKB|0.00|0.01|0.00|0.00|-16|5|11|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048568	16048568	C	G	hom	hom	hom		QUAL=16997;DP=185,174,217;AF=0.98,1.00,1.00;MQM=52;SAP=216;ABP=0;SAR=405;SAF=168	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon10/23:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon8/21:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon9/22:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504916 [benign DISEASE=not provided,not specified,Bartter disease type 4B,Bartter disease type 3];			rs1889789	0.82564	0.57053,0.89586,0.99922,0.92408,0.93592	53660,	17877	26439	-0.2280	5.97	0.22	0.06	/2.5>1.6/0.0>0.0	COSV65159497	CLCNKB|0.00|0.00|0.00|0.00|-30|-6|14|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048569	16048569	A	C	hom	hom	hom		QUAL=16997;DP=185,174,217;AF=0.98,1.00,1.00;MQM=52;SAP=216;ABP=0;SAR=405;SAF=168	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon10/23:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon8/21:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon9/22:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504915 [benign DISEASE=not specified,not provided,Bartter disease type 4B,Bartter disease type 3];			rs1889790	0.82567	0.57065,0.89579,0.99922,0.92408,0.93595	53659,	17878	26434	-2.9260	2.40			/2.5>8.8/0.0>0.0	COSV65161020	CLCNKB|0.00|0.00|0.00|0.02|12|-31|12|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048715	16048715	G	A	het	wt	hom	off-target	QUAL=4177;DP=96,103,100;AF=0.48,0.00,0.99;MQM=60;SAP=11;ABP=3;SAR=61;SAF=84	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.655+133G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.655+133G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.655+133G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1290690 [benign DISEASE=not provided];			rs9633514	0.29871	0.10591,0.36280,0.70449,0.36121,0.37448	8204,	28923	106427	0.0370	7.21			/2.2>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-10|7|38|-39	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048859	16048859	C	T	hom	hom	hom		QUAL=18729;DP=169,201,238;AF=1.00,1.00,1.00;MQM=60;SAP=28;ABP=0;SAR=262;SAF=346	CLCNKB	intron,5'UTR	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.656-261C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.656-261C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.656-261C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375667.7:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1259614 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs9442227	0.69114	0.37129,0.81408,0.98804,0.79919,0.88868	39478,	26091	46943	0.4180	8.65			/0.6>1.5/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|18|1|-40|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049343	16049343	C	G	hom	hom	hom	off-target	QUAL=1470;DP=22,14,17;AF=1.00,1.00,1.00;MQM=60;SAP=110;ABP=0;SAR=1;SAF=52	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron11/22:c.781+98C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron9/20:c.781+98C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron10/21:c.781+98C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron1/12:c.274+98C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279349 [benign DISEASE=not provided];			rs7545067	0.71223	0.39526,0.83353,0.98801,0.82259,0.89290	41697,	24864	43740	-2.2830	0.26			/0.0>2.5/0.0>0.0	COSV65162067	CLCNKB|0.00|0.00|0.00|0.00|1|49|-1|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049696	16049696	C	T	hom	hom	hom		QUAL=25540;DP=180,313,405;AF=0.99,1.00,1.00;MQM=45;SAP=277;ABP=0;SAR=280;SAF=616	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon12/23:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon10/21:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon11/22:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447108 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];			rs7367494	0.83477	0.56923,0.90653,0.99783,0.94111,0.93626	54670,	16546	24918	-0.1040	0.08	0.22	0.06	/0.0>0.3/0.0>0.0	COSV65159503	CLCNKB|0.00|0.01|0.01|0.01|-16|-50|-2|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049735	16049735	-	T	hom	hom	hom	off-target	QUAL=26382;DP=85,345,451;AF=0.98,1.00,1.00;MQM=51;SAP=34;ABP=0;SAR=383;SAF=495	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+33_866+34insT::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+33_866+34insT::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+33_866+34insT::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277184 [benign DISEASE=not provided];			rs59006537	0.83464	0.56852,0.90678,0.99902,0.94120,0.93726	54700,	16575	24959		1.60			/0.3>0.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|4|18|-29|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049737	16049737	A	T	hom	hom	hom	off-target	QUAL=26382;DP=85,345,451;AF=0.98,1.00,1.00;MQM=51;SAP=34;ABP=0;SAR=383;SAF=495	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+35A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+35A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+35A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+35A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209692 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs59924562	0.83463	0.56854,0.90685,0.99902,0.94122,0.93726	54726,	16582	24972	-2.4980	0.10			/0.3>3.2/0.0>0.0	COSV65161540	CLCNKB|0.01|0.00|0.00|0.00|16|2|-31|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049744	16049744	C	-	hom	hom	hom	off-target	QUAL=24275;DP=82,336,442;AF=0.95,0.99,0.99;MQM=52;SAP=12;ABP=0;SAR=395;SAF=453	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+47del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+47del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+47del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+47del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209750 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs34589727	0.83503	0.56947,0.90714,0.99922,0.94123,0.93726	54759,	16533	24903	-0.1770	1.35			/0.3>0.7/0.0>0.0		CLCNKB|0.00|0.01|0.00|0.00|49|10|-37|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049783	16049783	G	A	hom	hom	hom	off-target	QUAL=30561;DP=140,364,503;AF=0.99,1.00,1.00;MQM=57;SAP=41;ABP=0;SAR=569;SAF=436	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.867-32G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.867-32G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.867-32G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.360-32G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209751 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs7365182	0.83294	0.56305,0.90632,0.99961,0.94132,0.93656	54745,	16712	25312	0.7450	5.09			/0.0>1.2/0.0>0.4		CLCNKB|0.02|0.00|0.00|0.00|2|32|-4|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049824	16049824	T	C	hom	hom	hom		QUAL=32746;DP=180,361,484;AF=1.00,1.00,1.00;MQM=60;SAP=175;ABP=0;SAR=654;SAF=369	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon13/23:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon11/21:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon12/22:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	377683 [benign DISEASE=not provided,not specified,Bartter disease type 3,Bartter disease type 4B];			rs7368151	0.83474	0.56969,0.90648,0.99942,0.94123,0.93688	54977,	16636	25062	-4.6600	0.08			/5.7>5.8/0.0>0.0	COSV65161411	CLCNKB|0.02|0.07|0.00|0.00|-9|15|28|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049963	16049963	T	C	hom	hom	hom	off-target	QUAL=17645;DP=127,192,274;AF=0.99,1.00,1.00;MQM=59;SAP=232;ABP=0;SAR=421;SAF=171	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+47T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+47T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+47T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+47T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209752 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs7368166	0.83260	0.56549,0.90351,0.99805,0.93886,0.93244	54369,	16889	25259	-3.1490	1.04			/0.0>0.0/0.0>0.0	COSV65161797	CLCNKB|0.00|0.00|0.00|0.00|-47|25|-47|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049999	16049999	C	G	het	het	wt	off-target	QUAL=2733;DP=122,123,186;AF=0.46,0.56,0.00;MQM=57;SAP=166;ABP=3;SAR=111;SAF=14	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+83C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+83C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+83C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+83C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1288632 [benign DISEASE=not provided];			rs72651918	0.35903	0.14947,0.47010,0.58306,0.47279,0.50759	1921,	18744	40322	-1.0310	0.56			/0.0>0.0/0.0>0.0	COSV65161943	CLCNKB|0.00|0.00|0.00|0.00|-11|30|43|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16050336	16050336	C	T	hom	hom	hom	off-target	QUAL=3574;DP=36,40,44;AF=1.00,1.00,1.00;MQM=60;SAP=264;ABP=0;SAR=0;SAF=120	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.969-180C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.969-180C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.969-180C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.462-180C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1249220 [benign DISEASE=not provided];			rs10803412	0.71313	0.39271,0.83438,0.98819,0.82446,0.89262	41831,	24670	43578	-0.3660	2.89			/2.3>2.6/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-35|17|37|1	20975947,33398198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052154	16052154	C	G	het	het	wt	off-target	QUAL=483;DP=19,19,11;AF=0.58,0.68,0.00;MQM=60;SAP=39;ABP=9;SAR=2;SAF=22	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron17/22:c.1409-44C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron15/20:c.1409-44C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron16/21:c.1409-44C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1232843 [benign DISEASE=not provided];			rs2297726	0.14538	0.06970,0.15711,0.27907,0.16725,0.18116	1846,	18427	130027	0.0340	8.76			/0.0>0.0/0.0>0.0	COSV65160804	CLCNKB|0.00|0.00|0.00|0.00|17|-40|-35|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052244	16052244	G	A	wt	het	wt		QUAL=108;DP=27,22,16;AF=0.00,0.36,0.00;MQM=60;SAP=4;ABP=7;SAR=5;SAF=3	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon18/23:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon16/21:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon17/22:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	585703 [benign DISEASE=not specified,not provided];			rs34652156	0.03656	0.05882,0.02146,0.00019,0.02867,0.02090	145,	5274	146618	-4.4550	0.08			/2.3>1.2/0.0>0.0	COSV65160149	CLCNKB|0.01|0.01|0.00|0.00|16|-37|-3|15	21631963	36	1572	0	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052513	16052513	C	T	hom	hom	hom	off-target	QUAL=632;DP=11,4,8;AF=1.00,1.00,1.00;MQM=59;SAP=53;ABP=0;SAR=23;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1622+102C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1622+102C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1622+102C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1115+102C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1252498 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2050522	0.72032	0.41586,0.83986,0.98822,0.82444,0.89262	42290,	24875	42499	-2.4820	0.01			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|23|50|50|24	23550235,17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052520	16052520	-	GGGGCTGGGA	wt	hom	wt	off-target	QUAL=55;DP=6,4,7;AF=0.17,1.00,0.00;MQM=56;SAP=14;ABP=0;SAR=5;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1115+116_1115+117insGGAGGGGCTG::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1269731 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs199907733	0.17073	0.09052,0.17181,0.27934,0.19587,0.20295	2475,	20988	125986		8.61			/0.4>0.0/0.0>0.0		CLCNKB|0.04|0.00|0.00|0.00|43|16|-19|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16053538	16053538	C	T	wt	het	wt	off-target	QUAL=998;DP=119,80,121;AF=0.00,0.58,0.00;MQM=60;SAP=103;ABP=7;SAR=0;SAF=46	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1623-101C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1623-101C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1623-101C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1116-101C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1188481 [likely benign DISEASE=not provided];			rs34119714	0.01937	0.00510,0.01420,0.00019,0.02788,0.02030	49,	2849	149157	1.0120	6.65			/2.2>2.8/1.9>0.7		CLCNKB|0.00|0.03|0.00|0.00|34|-48|0|11		18	689	0	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053701	16053701	T	C	hom	hom	hom		QUAL=28482;DP=299,251,371;AF=1.00,1.00,1.00;MQM=51;SAP=169;ABP=0;SAR=328;SAF=593	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447094 [benign DISEASE=not specified,Bartter disease type 3,not provided,Bartter disease type 4B];			rs5253	0.88794	0.69610,0.92853,0.81955,0.98493,0.91912	61122,	12747	17037	-1.3380	0.03	0.28	0.06	/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.04|0.00|-23|11|22|-2	25919862,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053748	16053748	A	G	hom	het	hom		QUAL=15684;DP=139,232,314;AF=1.00,0.42,0.99;MQM=49;SAP=9;ABP=15;SAR=293;SAF=254	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447096 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.69481	0.79858,0.57670,0.80604,0.66108,0.58219	37116,	31137	46283	1.0120	7.04	0.16	0.05	/0.0>0.0/0.5>0.0		CLCNKB|0.00|0.00|0.01|0.16|-8|1|24|1	25919862,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053757	16053757	C	T	hom	het	hom		QUAL=14566;DP=125,218,303;AF=1.00,0.43,1.00;MQM=49;SAP=19;ABP=12;SAR=291;SAF=230	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon19/23:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon17/21:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon18/22:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447097 [benign DISEASE=not specified,not provided,Bartter disease type 3,Bartter disease type 4B];			rs2275167	0.62073	0.58519,0.53453,0.79957,0.64559,0.53160	29518,	35073	57501	0.5150	8.01			/0.0>0.0/0.0>0.0	COSV65152867	CLCNKB|0.00|0.00|0.31|0.02|-8|-17|-8|47	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053908	16053908	A	T	hom	het	hom	off-target	QUAL=5493;DP=63,108,96;AF=1.00,0.47,1.00;MQM=52;SAP=459;ABP=4;SAR=210;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1756+136A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1756+136A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1756+136A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1249+136A>T::	regulatory_region_variant:TF_binding_site	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1231115 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2275168	0.55363	0.34939,0.49403,0.80863,0.65174,0.52085	24850,	34236	67674	-0.1600	5.86			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-30|28|-10|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055227	16055227	C	T	hom	het	hom	off-target	QUAL=2087;DP=45,23,23;AF=1.00,0.39,1.00;MQM=60;SAP=170;ABP=5;SAR=0;SAF=77	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-208C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-208C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-208C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-208C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1251205 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12691552	0.40599	0.22889,0.41560,0.80394,0.46712,0.44364	13712,	34231	90207	0.2610	8.59			/0.0>0.0/0.0>0.0	COSV65153247	CLCNKB|0.00|0.00|0.00|0.00|-17|-50|-49|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055297	16055297	T	A	hom	het	hom	off-target	QUAL=2414;DP=29,43,46;AF=1.00,0.33,1.00;MQM=60;SAP=196;ABP=14;SAR=0;SAF=89	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-138T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-138T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-138T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-138T>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295187 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12047858	0.42539	0.29631,0.42054,0.80417,0.46773,0.44382	14488,	35589	87213	-0.4460	1.84			/2.8>0.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|12|32|-9|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055321	16055321	C	T	hom	het	hom	off-target	QUAL=3250;DP=40,43,57;AF=1.00,0.35,1.00;MQM=60;SAP=221;ABP=12;SAR=3;SAF=109	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-114C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-114C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-114C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-114C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1297841 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12029508	0.42552	0.29657,0.42057,0.80444,0.46768,0.44359	14503,	35595	87215	-0.6690	2.35			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-1|40|-12|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055591	16055591	C	T	hom	het	hom	off-target	QUAL=4844;DP=46,59,94;AF=0.98,0.51,1.00;MQM=60;SAP=71;ABP=3;SAR=48;SAF=121	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron20/22:c.1845+68C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron18/20:c.1845+68C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron19/21:c.1845+68C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron10/12:c.1338+68C>T::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1229089 [benign DISEASE=not provided];			rs2297727	0.42558	0.29789,0.42014,0.80497,0.46735,0.44218	14479,	35520	87030	-1.2050	0.05			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|29|9|20|4	19058262	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056223	16056223	T	C	hom	het	hom	off-target	QUAL=2809;DP=25,42,55;AF=1.00,0.48,1.00;MQM=60;SAP=156;ABP=3;SAR=8;SAF=92	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-199T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-199T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-199T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-199T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277187 [benign DISEASE=not provided];			rs12048851	0.43773	0.34520,0.42603,0.80261,0.46689,0.44267	14975,	36388	85212	-0.0840	6.09			/4.3>3.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-8|-23|19|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056235	16056235	C	T	hom	het	hom	off-target	QUAL=3334;DP=31,46,66;AF=1.00,0.48,1.00;MQM=60;SAP=204;ABP=3;SAR=7;SAF=112	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-187C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-187C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-187C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-187C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1241174 [benign DISEASE=not provided];			rs12030469	0.41860	0.28374,0.42031,0.80202,0.46360,0.44204	14039,	35363	88113	-2.4240	0.55			/4.3>5.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-20|-21|-20|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056296	16056296	G	C	hom	het	hom	off-target	QUAL=5270;DP=49,77,102;AF=1.00,0.51,1.00;MQM=60;SAP=416;ABP=3;SAR=0;SAF=190	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-126G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-126G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-126G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-126G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295162 [benign DISEASE=not provided];			rs12023153	0.42203	0.28467,0.42262,0.80409,0.46724,0.44216	14300,	35375	87613	-1.7360	0.09			/2.1>3.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|27|-37|8|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056333	16056335	TCT	-	hom	het	hom	off-target	QUAL=6556;DP=54,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=237;ABP=3;SAR=37;SAF=195	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-87_1930-85del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-87_1927-85del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-87_1930-85del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-87_1420-85del::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1180108 [benign DISEASE=not provided];			rs77508204	0.37166	0.11645,0.40033,0.80268,0.46468,0.43550	12645,	31077	95297	0.3780	4.85			/6.9>6.7/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-9|-40|21|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056336	16056336	T	A	hom	het	hom	off-target	QUAL=6556;DP=54,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=237;ABP=3;SAR=37;SAF=195	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-86T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-86T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-86T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-86T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295221 [benign DISEASE=not provided];			rs61769890	0.37182	0.11654,0.40063,0.80268,0.46469,0.43586	12645,	31082	95238	-0.0050	6.71			/6.9>4.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|13|11|12|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056339	16056339	T	A	hom	het	hom	off-target	QUAL=6556;DP=54,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=237;ABP=3;SAR=37;SAF=195	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-83T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-83T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-83T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-83T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1266107 [benign DISEASE=not provided];			rs61769891	0.37173	0.11640,0.40055,0.80206,0.46472,0.43591	12644,	31089	95285	-0.3090	2.07			/6.9>7.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|2|-16|31|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056382	16056382	A	G	hom	hom	hom	off-target	QUAL=11604;DP=50,147,203;AF=1.00,0.99,1.00;MQM=60;SAP=31;ABP=0;SAR=163;SAF=235	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-40A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-40A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-40A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209753 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs7517792	0.76858	0.70774,0.84667,0.81526,0.78584,0.83700	45030,	26537	35107	-2.2960	0.23			/4.5>5.6/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|44|40|39|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056582	16056582	T	G	wt	het	het	off-target	QUAL=10;DP=15,26,43;AF=0.07,0.38,0.26;MQM=55;SAP=42;ABP=26;SAR=21;SAF=1	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2016+74T>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2016+74T>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2013+74T>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2016+74T>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2016+74T>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2016+74T>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1506+74T>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1230713969	0.01518	0.01656,0.01478,0.00872,0.01507,0.01746	0,	1047	67913	-1.3770	4.07			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|15|3|-43|-7		0	1307	0	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056834	16056834	-	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,23,6;AF=0.00,0.17,0.67;MQM=45;SAP=7;ABP=24;SAR=2;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-29dup::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-29dup::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-29dup::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-29dup::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1246688 [benign DISEASE=not provided];			rs138507185	0.66015	0.43874,0.77633,0.80450,0.73356,0.79402	29214,	27005	43981		0.54			/0.9>1.7/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|11|35|35|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056841	16056841	G	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,23,6;AF=0.00,0.17,0.67;MQM=45;SAP=7;ABP=24;SAR=2;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-28G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-28G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-28G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209827 [benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs12746138	0.72123	0.57815,0.81519,0.81227,0.76346,0.82061	32995,	27312	36064	-2.2870	0.07			/0.9>0.0/0.0>0.0		CLCNKB|0.02|0.00|0.00|0.00|28|34|-6|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056907	16056907	C	T	het	wt	wt		QUAL=716;DP=259,140,144;AF=0.26,0.00,0.07;MQM=35;SAP=172;ABP=130;SAR=0;SAF=78	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon23/23:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon21/21:c.2052C>T:p.Ala684=:,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon22/22:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	785932 [benign/likely benign DISEASE=Bartter disease type 3,Bartter disease type 4B,not provided];			rs6698427	0.07141	0.12996,0.04777,0.20813,0.04086,0.08811	1,	6814	88636	-0.0040	4.92			/0.8>1.8/0.0>0.0	COSV65152730	CLCNKB|0.01|0.00|0.00|0.00|-38|-32|50|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056953	16056953	A	C	het	hom	hom	low_conf_region	QUAL=15876;DP=221,241,289;AF=0.70,1.00,0.89;MQM=40;SAP=913;ABP=77;SAR=65;SAF=588	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*37A>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*37A>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*37A>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209828 [benign DISEASE=not provided,Bartter disease type 4B,Bartter disease type 3];			rs10803415	0.72697	0.64755,0.77854,0.53303,0.77371,0.69214	29942,	34903	35599	-1.8020	0.48			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.01|0.00|-41|4|-41|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057052	16057052	T	C	wt	wt	het		QUAL=534;DP=235,398,596;AF=0.05,0.00,0.19;MQM=31;SAP=272;ABP=513;SAR=0;SAF=124	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*136T>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*136T>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*136T>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057839	0.22248	0.32653,0.15812,0.40072,0.17946,0.24460	8,	22599	79035	0.2550	5.43			/0.0>0.0/0.0>0.0	COSV65152725	CLCNKB|0.02|0.01|0.00|0.00|-6|9|-6|33	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057079	16057079	A	T	het	wt	het		QUAL=888;DP=247,380,616;AF=0.13,0.00,0.20;MQM=33;SAP=344;ABP=761;SAR=0;SAF=157	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*163A>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*163A>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*163A>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057841	0.25586	0.34822,0.19172,0.42576,0.21997,0.27481	0,	26706	77672	0.6160	6.28			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.02|0.00|0.00|-18|-33|-34|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057086	16057086	G	T	het	het	het		QUAL=19954;DP=249,383,619;AF=0.85,0.51,0.80;MQM=37;SAP=79;ABP=530;SAR=362;SAF=539	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*170G>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*170G>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*170G>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057844	0.51510	0.40739,0.61234,0.50511,0.55168,0.56405	10449,	55380	71806	-1.4160	0.21			/0.0>0.0/0.7>0.7		CLCNKB|0.05|0.00|0.00|0.00|-40|49|49|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057110	16057110	A	G	het	het	het		QUAL=19812;DP=197,404,646;AF=0.74,0.53,0.77;MQM=38;SAP=4;ABP=376;SAR=420;SAF=435	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*194A>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*194A>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*194A>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057845	0.50665	0.40267,0.60054,0.49724,0.54161,0.55288	9210,	56591	73041	-0.6030	1.45			/2.2>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-49|25|-25|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057173	16057173	T	G	hom	hom	hom		QUAL=32899;DP=175,360,660;AF=0.99,1.00,1.00;MQM=41;SAP=398;ABP=0;SAR=830;SAF=364	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*257T>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*257T>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*257T>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6660218	0.99999	1.00000,1.00000,1.00000,0.99997,1.00000	76104,	2	2	0.3150	3.77			/0.0>0.0/0.0>3.6		CLCNKB|0.00|0.00|0.00|0.00|-1|-38|-1|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057187	16057187	G	C	het	wt	het		QUAL=4440;DP=223,322,649;AF=0.20,0.00,0.36;MQM=41;SAP=38;ABP=261;SAR=171;SAF=104	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*271G>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*271G>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*271G>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	402540 [benign DISEASE=not specified];			rs1057854	0.32863	0.40731,0.25864,0.43845,0.30207,0.29170	223,	46374	95650	-3.2250	0.15	0.01		/0.0>0.0/0.0>0.0	COSV65152876	CLCNKB|0.00|0.00|0.00|0.00|46|5|-26|-45	24033266,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057247	16057247	C	G	het	hom	het		QUAL=18438;DP=346,224,516;AF=0.55,1.00,0.53;MQM=58;SAP=750;ABP=15;SAR=588;SAF=101	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*331C>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*331C>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*331C>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057857	0.62938	0.58525,0.66809,0.49365,0.65273,0.60118	19811,	55386	55948	-0.3610	3.09	0.02		/0.0>0.0/0.0>0.0	COSV65153970	CLCNKB|0.00|0.00|0.00|0.00|25|-3|-42|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057359	16057359	A	G	het	wt	het	off-target	QUAL=699;DP=107,56,110;AF=0.37,0.00,0.17;MQM=38;SAP=131;ABP=101;SAR=59;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs749928769	0.02714	0.02839,0.03450,0.00019,0.02715,0.01849	9,	4101	147625	-0.5220	2.21							0	305	0	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057419	16057419	C	T	het	het	het	off-target	QUAL=1580;DP=39,24,50;AF=0.85,0.46,0.66;MQM=47;SAP=170;ABP=35;SAR=77;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs10927896	0.31153	0.15999,0.33679,0.48567,0.36929,0.35458	1667,	43091	102597	-2.0060	0.42							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057479	16057479	G	T	wt	het	wt	off-target	QUAL=46;DP=47,6,18;AF=0.00,0.67,0.00;MQM=54;SAP=12;ABP=4;SAR=4;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs12144211	0.20659	0.25156,0.12770,0.00115,0.21473,0.09887	1960,	26727	117697	1.4340	9.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057491	16057491	G	A	het	wt	het	off-target	QUAL=146;DP=36,5,13;AF=0.25,0.00,0.31;MQM=60;SAP=31;ABP=26;SAR=13;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6604912	0.36926	0.43036,0.31946,0.46829,0.34753,0.38104	1,	55397	94629	1.0980	9.86							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057529	16057529	T	A	het	wt	het	off-target	QUAL=134;DP=24,3,3;AF=0.38,0.00,0.33;MQM=60;SAP=25;ABP=7;SAR=10;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6604913	0.36956	0.43084,0.31891,0.46911,0.34784,0.38185	1,	55490	94666	-0.4280	4.37							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16986248	16986248	C	T	het	hom	het		QUAL=706;DP=18,19,25;AF=0.39,0.95,0.44;MQM=60;SAP=12;ABP=5;SAR=12;SAF=24	ATP13A2	missense,synonymous	ATP13A2:ENST00000341676.9:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128475 [benign DISEASE=Autosomal recessive spastic paraplegia type 78,Kufor-Rakeb syndrome,Inborn genetic diseases,not specified,not provided];			rs3170740	0.41100	0.19854,0.44605,0.27616,0.52656,0.43387	14373,	33576	89314	-2.7740	0.29	0.24		/1.3>0.0/0.0>0.0	COSV58697923	ATP13A2|0.00|0.00|0.00|0.00|-23|8|40|-23	25741868,18414213,19085912,22743658,31562340,30232368,28170284,32327693,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986662	16986662	G	A	het	hom	het	off-target	QUAL=9714;DP=85,219,298;AF=0.39,1.00,0.50;MQM=60;SAP=42;ABP=5;SAR=243;SAF=158	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	559000 [benign DISEASE=Autosomal recessive spastic paraplegia type 78,not provided,Kufor-Rakeb syndrome];			rs2076605	0.41751	0.21856,0.44678,0.28148,0.52709,0.45292	14617,	34089	88347	2.1340	9.24			/0.0>0.0/0.0>0.0	COSV58702203	ATP13A2|0.00|0.01|0.00|0.00|-14|-30|22|-12	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986750	16986761	CCCAGGGCTCCT	-	het	wt	het	off-target	QUAL=2091;DP=49,167,210;AF=0.27,0.00,0.50;MQM=60;SAP=11;ABP=7;SAR=49;SAF=70	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1174788 [benign DISEASE=not specified,not provided];			rs143483351	0.24093	0.15641,0.33762,0.56075,0.23094,0.24585	4929,	26724	115258	1.8490	4.15			/0.0>0.0/0.6>0.6		ATP13A2|0.00|0.00|0.01|0.00|-44|-15|-25|1	33246661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986848	16986848	G	A	het	hom	het		QUAL=10680;DP=92,200,282;AF=0.48,1.00,0.50;MQM=60;SAP=17;ABP=3;SAR=217;SAF=167	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128473 [benign DISEASE=Inborn genetic diseases,Autosomal recessive spastic paraplegia type 78,Kufor-Rakeb syndrome,not specified,not provided];			rs9435659	0.41198	0.19423,0.44771,0.28236,0.52929,0.45245	14510,	33570	89334	-0.3600	0.47			/5.6>6.4/0.0>0.0	COSV58700662	ATP13A2|0.00|0.02|0.01|0.00|1|27|0|-43	25741868,18414213,19085912,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986959	16986959	G	A	het	wt	het		QUAL=2312;DP=59,138,178;AF=0.47,0.00,0.44;MQM=60;SAP=33;ABP=9;SAR=72;SAF=34	ATP13A2	splice_region&intron	ATP13A2:ENST00000341676.9:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:ENST00000326735.13:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000452699.5:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128471 [benign DISEASE=Inborn genetic diseases,Autosomal recessive spastic paraplegia type 78,Kufor-Rakeb syndrome,not specified,not provided];			rs7531163	0.24273	0.16537,0.33800,0.55768,0.23039,0.24363	4944,	26893	114749	0.7470	8.06			9.3>9.9/9.3>9.9/8.0>4.2	COSV104399909	ATP13A2|0.00|0.00|0.00|0.00|-21|-26|-50|-2	25741868,18414213,19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16987159	16987159	C	T	het	hom	het		QUAL=10662;DP=66,246,282;AF=0.52,1.00,0.47;MQM=60;SAP=150;ABP=4;SAR=123;SAF=290	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128470 [benign DISEASE=Autosomal recessive spastic paraplegia type 78,Kufor-Rakeb syndrome,Inborn genetic diseases,not specified,not provided];			rs761421	0.41780	0.22043,0.44714,0.27475,0.52714,0.45296	14645,	34185	88451	-0.8540	0.19			/0.0>0.0/6.5>8.9	COSV58699127	ATP13A2|0.00|0.03|0.01|0.00|-39|49|3|49	25741868,18414213,19085912,22743658,30232368,30034773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988207	16988207	C	T	het	wt	het		QUAL=11093;DP=281,493,584;AF=0.48,0.01,0.51;MQM=60;SAP=32;ABP=3;SAR=180;SAF=256	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128468 [benign DISEASE=Inborn genetic diseases,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not specified,not provided];			rs3738815	0.21171	0.14728,0.30499,0.56003,0.18759,0.23913	3993,	24198	119838	-2.3080	0.37			/5.1>5.6/0.0>0.0	COSV58700021	ATP13A2|0.05|0.00|0.00|0.00|-16|27|-14|6	25741868,18414213,19085912,22285144,22743658,30232368,34021172,35768426	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988447	16988447	G	A	het	hom	het		QUAL=14061;DP=300,262,322;AF=0.50,0.99,0.45;MQM=60;SAP=401;ABP=7;SAR=437;SAF=118	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128466 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,Inborn genetic diseases,not specified,not provided];			rs9435662	0.41084	0.19433,0.44498,0.28250,0.52743,0.45402	14422,	33573	89507	-5.0290	3.79			/0.0>0.0/0.0>1.2	COSV58700683	ATP13A2|0.00|0.00|0.00|0.00|-25|4|28|-33	25741868,18414213,19085912,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16991570	16991570	T	C	het	wt	het	off-target	QUAL=827;DP=47,24,20;AF=0.55,0.00,0.50;MQM=60;SAP=81;ABP=4;SAR=0;SAF=36	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron20/26:c.2236+164A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron20/28:c.2251+164A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron20/28:c.2236+164A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1281617 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2076604	0.21177	0.14645,0.30517,0.56573,0.18765,0.23955	4015,	24158	119808	-1.0580	5.70			/1.8>10.6/1.3>0.4		ATP13A2|0.94|0.09|0.00|0.00|-1|-28|0|-3	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16992516	16992516	G	A	het	hom	het		QUAL=6580;DP=81,128,152;AF=0.48,1.00,0.48;MQM=60;SAP=55;ABP=4;SAR=158;SAF=82	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase]		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128465 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,Inborn genetic diseases,not specified,not provided];			rs2076603	0.54767	0.44088,0.54036,0.28044,0.63515,0.49585	23512,	36216	68750	-0.0780	7.24			/0.0>0.0/0.0>0.0	COSV58700878	ATP13A2|0.00|0.00|0.01|0.00|20|-30|-24|21	25741868,18414213,19085912,22743658,30232368,30595370,30034773,33335927,33821002	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996703	16996703	A	T	het	n/a	het	off-target	QUAL=436;DP=33,1,7;AF=0.52,0.00,0.86;MQM=60;SAP=53;ABP=5;SAR=23;SAF=0	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1181-207T>A::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1196-207T>A::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1181-207T>A::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270970 [benign DISEASE=not provided];			rs2076602	0.21139	0.14598,0.30427,0.56347,0.18763,0.23913	3997,	24145	119895	0.1770	6.47			/0.7>0.0/0.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|17|-3|4|49	22285144	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996871	16996871	-	G	het	wt	het	off-target	QUAL=657;DP=30,26,46;AF=0.30,0.00,0.52;MQM=60;SAP=66;ABP=6;SAR=1;SAF=32	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+148dup::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+148dup::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+148dup::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1245001 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs55682704	0.21477	0.15947,0.30163,0.56325,0.18766,0.23891	4050,	24519	119257		0.25			/0.0>0.3/0.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|-34|-31|15|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996954	16996954	T	C	hom	hom	hom	off-target	QUAL=5631;DP=38,68,88;AF=0.97,1.00,1.00;MQM=60;SAP=348;ABP=0;SAR=9;SAF=184	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+66A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+66A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+66A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1192485 [benign DISEASE=Kufor-Rakeb syndrome,not provided,Autosomal recessive spastic paraplegia type 78];		MIR3 (SINE/MIR)	rs9435736	0.80678	0.74611,0.87230,0.84608,0.82418,0.73611	49690,	23262	29372	-1.1830	0.56			/0.0>0.0/1.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|9|-6|9|-6	19085912,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17004773	17004773	C	T	wt	het	wt		QUAL=643;DP=134,74,121;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=9;SAR=15;SAF=15	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	293803 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78];			rs140631323	0.00009	0.00002,0.00007,0.00000,0.00015,0.00000	0,	14	152166	-4.7190	0.12	0.00		/0.0>0.0/0.0>0.0	COSV58702839	ATP13A2|0.00|0.00|0.00|0.00|48|29|3|-12		1	15	0	0 / 0					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17005181	17005181	A	G	het	het	het	off-target	QUAL=3469;DP=124,83,126;AF=0.40,0.49,0.44;MQM=60;SAP=51;ABP=13;SAR=102;SAF=45	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron3/26:c.289-109T>C::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron3/28:c.289-109T>C::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron3/28:c.289-109T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270274 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs3738814	0.51789	0.64502,0.51174,0.71448,0.42852,0.57864	21041,	36569	73217	-0.0320	2.38			/0.8>0.3/0.0>0.0	COSV58699306	ATP13A2|0.00|0.00|0.00|0.00|-7|-29|24|-29	20189936,25429064,28448500,31217584,34021172,34594039,24067417,35831902	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	18871570	18871570	T	G	het	wt	het		QUAL=3439;DP=96,149,185;AF=0.52,0.00,0.47;MQM=60;SAP=9;ABP=3;SAR=78;SAF=59	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294333 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138333	0.24200	0.21565,0.23410,0.03496,0.27691,0.15934	4696,	27365	115129	0.9220	12.39			/0.0>0.0/0.2>0.0		ALDH4A1|0.00|0.00|0.00|0.00|3|-31|-30|25,RP13-279N23.2|0.00|0.00|0.00|0.00|-38|3|-30|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871606	18871606	C	G	het	wt	het		QUAL=3406;DP=97,144,166;AF=0.55,0.00,0.49;MQM=60;SAP=7;ABP=3;SAR=75;SAF=60	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294334 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138328	0.23491	0.20871,0.22914,0.00193,0.27285,0.12660	4485,	26750	116340	0.1220	4.21			/1.2>0.0/0.0>0.0	COSV51895732	ALDH4A1|0.00|0.00|0.00|0.00|17|-1|17|-11,RP13-279N23.2|0.00|0.00|0.00|0.00|-9|-1|17|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871647	18871647	T	C	het	wt	het		QUAL=3477;DP=123,139,146;AF=0.54,0.00,0.48;MQM=60;SAP=5;ABP=3;SAR=74;SAF=62	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294336 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7366541	0.24201	0.21573,0.23375,0.03490,0.27699,0.15935	4701,	27374	115184	-1.1350	1.41			/1.5>0.0/0.0>0.0	COSV51895747	ALDH4A1|0.00|0.00|0.00|0.00|45|-3|-24|16,RP13-279N23.2|0.00|0.00|0.02|0.00|45|-3|-24|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871920	18871920	G	A	het	wt	het		QUAL=4296;DP=168,168,196;AF=0.48,0.00,0.49;MQM=60;SAP=27;ABP=4;SAR=66;SAF=110	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294341 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1140477	0.25164	0.25168,0.23748,0.03463,0.27587,0.15935	4959,	28316	113706	0.5890	4.94			/2.4>3.8/0.7>0.8		ALDH4A1|0.00|0.00|0.00|0.00|-6|24|0|4,RP13-279N23.2|0.00|0.00|0.00|0.00|-6|24|0|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871924	18871924	C	T	het	wt	het		QUAL=4296;DP=168,168,196;AF=0.48,0.00,0.49;MQM=60;SAP=27;ABP=4;SAR=66;SAF=110	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294342 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138269	0.25161	0.25150,0.23761,0.03442,0.27591,0.15929	4960,	28309	113707	0.1370	5.45			/2.4>0.0/0.7>0.1		ALDH4A1|0.00|0.00|0.00|0.00|20|-10|-49|0,RP13-279N23.2|0.00|0.00|0.00|0.00|20|-10|-30|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872082	18872082	A	G	hom	hom	hom		QUAL=29667;DP=366,238,313;AF=1.00,1.00,0.99;MQM=60;SAP=9;ABP=0;SAR=482;SAF=431	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294344 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138267	0.65881	0.52346,0.76368,0.71520,0.70099,0.75539	33624,	32916	51874	-4.5340	0.12			/9.2>8.3/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-24|-11|-19|14,RP13-279N23.2|0.00|0.00|0.00|0.00|-24|-11|-19|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872133	18872133	G	A	het	wt	het		QUAL=6435;DP=295,205,264;AF=0.49,0.01,0.45;MQM=60;SAP=23;ABP=6;SAR=158;SAF=109	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294346 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs14311	0.25085	0.24628,0.23838,0.03476,0.27615,0.15921	4985,	28185	113947	-0.0090	1.70			/4.8>4.5/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-43|2|-37|9,RP13-279N23.2|0.00|0.00|0.00|0.00|-43|2|2|-37	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872143	18872143	G	A	het	hom	het		QUAL=12571;DP=243,206,259;AF=0.49,1.00,0.54;MQM=60;SAP=6;ABP=4;SAR=245;SAF=218	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294347 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs3202002	0.39844	0.24423,0.52140,0.67998,0.42475,0.59644	13009,	34573	91479	-0.2920	3.42			/4.8>4.6/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-34|-8|-9|-47,RP13-279N23.2|0.00|0.00|0.00|0.00|-24|-8|-8|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872188	18872188	C	-	het	hom	het		QUAL=7834;DP=106,169,187;AF=0.49,0.98,0.53;MQM=60;SAP=8;ABP=4;SAR=171;SAF=145	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839	0.40728	0.24954,0.52840,0.68554,0.43721,0.60236	13583,	34763	90125	-3.2790	0.02			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-21|-3|-21|29,RP13-279N23.2|0.00|0.00|0.00|0.00|-22|44|-21|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872401	18872401	A	G	het	wt	het		QUAL=5048;DP=193,194,248;AF=0.48,0.00,0.45;MQM=60;SAP=10;ABP=8;SAR=115;SAF=90	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294353 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs9117	0.18393	0.08535,0.19613,0.00193,0.24982,0.10810	3075,	21832	124152	0.2290	4.35			/2.1>2.4/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|27|-17|19|28,RP13-279N23.2|0.00|0.00|0.00|0.00|27|-17|-44|19	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872727	18872727	C	T	het	hom	het		QUAL=20788;DP=215,404,487;AF=0.43,1.00,0.47;MQM=60;SAP=58;ABP=16;SAR=293;SAF=428	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294359 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs11740	0.39940	0.24608,0.52346,0.67332,0.42582,0.59356	13035,	34563	91179	-0.7970	0.48			/0.1>5.5/0.0>0.0	COSV51892981	ALDH4A1|0.00|0.00|0.00|0.00|-2|-50|-1|-23,RP13-279N23.2|0.00|0.00|0.00|0.00|-2|-50|-1|-23	18843385,12970910,24686056	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872979	18872979	T	A	het	hom	het	off-target	QUAL=12558;DP=149,227,285;AF=0.47,0.99,0.52;MQM=60;SAP=126;ABP=3;SAR=300;SAF=142	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188868 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28700162	0.40014	0.24645,0.52383,0.67409,0.42667,0.59793	13110,	34605	91183	0.0000	7.70			/0.0>0.0/0.0>0.0	COSV51895558	ALDH4A1|0.01|0.05|0.00|0.00|-5|23|23|3,RP13-279N23.2|0.00|0.04|0.00|0.00|-5|23|2|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872993	18872993	A	G	het	wt	het	off-target	QUAL=4649;DP=105,202,254;AF=0.61,0.00,0.48;MQM=60;SAP=108;ABP=4;SAR=141;SAF=46	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35255325	0.18814	0.10003,0.19821,0.00173,0.24939,0.10886	3134,	22350	123496	0.0900	5.74			/6.6>6.0/0.0>0.0		ALDH4A1|0.02|0.03|0.00|0.00|9|-9|48|-9,RP13-279N23.2|0.01|0.02|0.00|0.00|9|-36|-36|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874401	18874401	C	T	het	wt	het	off-target	QUAL=2865;DP=116,112,143;AF=0.42,0.00,0.52;MQM=60;SAP=231;ABP=4;SAR=5;SAF=119	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+62G>A::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+62G>A::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+62G>A::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+62G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35657817	0.28622	0.37182,0.25534,0.00193,0.27657,0.12930	6711,	30076	108474	-1.0310	0.33			/0.0>0.0/1.4>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-25|37|22|6,RP13-279N23.2|0.00|0.00|0.00|0.00|-25|37|22|6	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874414	18874414	G	C	het	hom	het	off-target	QUAL=6916;DP=104,121,166;AF=0.55,1.00,0.46;MQM=60;SAP=368;ABP=3;SAR=24;SAF=231	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188869 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28529092	0.46233	0.42871,0.55489,0.67806,0.44209,0.62354	16498,	37225	81665	3.1040	11.59			/0.0>0.0/0.0>0.0	COSV51895606	ALDH4A1|0.00|0.00|0.00|0.00|-38|49|49|9,RP13-279N23.2|0.00|0.00|0.00|0.00|-47|49|49|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874690	18874690	G	C	hom	hom	hom	off-target	QUAL=9870;DP=98,111,134;AF=0.99,0.98,0.99;MQM=60;SAP=730;ABP=0;SAR=338;SAF=1	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-109C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-109C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-109C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-109C>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs6665917	0.64589	0.52689,0.74905,0.71935,0.68066,0.73612	32222,	33769	53845	-2.4860	0.14			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|47|-21|-21|-19,RP13-279N23.2|0.00|0.00|0.00|0.00|47|-21|-21|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874717	18874717	-	G	hom	hom	hom	off-target	QUAL=6214;DP=61,91,90;AF=0.92,0.98,0.99;MQM=60;SAP=511;ABP=0;SAR=234;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-137dup::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-137dup::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-137dup::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-137dup::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188871 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];		MIRb (SINE/MIR)	rs35163726	0.64133	0.52893,0.74575,0.67647,0.67690,0.70357	31698,	34074	54512		1.68			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.01|-44|-48|-48|36,RP13-279N23.2|0.00|0.00|0.00|0.01|-44|-48|-48|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18875462	18875462	A	G	hom	hom	hom		QUAL=18261;DP=312,131,138;AF=1.00,1.00,1.00;MQM=60;SAP=201;ABP=0;SAR=175;SAF=405	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family]	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294369 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified];			rs2230708	0.71452	0.68438,0.79181,0.72164,0.71548,0.76616	38866,	30784	43356	-1.3090	0.29			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|38|-36|-27|16,RP13-279N23.2|0.00|0.00|0.00|0.00|38|-36|-27|16	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876276	18876276	T	C	hom	hom	hom	off-target	QUAL=4035;DP=48,30,54;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0;SAR=19;SAF=113	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188872 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7550822	0.92170	0.77834,0.95660,0.99981,0.97878,0.98134	65159,	9867	11909	-0.0870	5.29			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-39|21|39|30,RP13-279N23.2|0.00|0.00|0.00|0.00|-39|21|39|30	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876402	18876402	G	A	hom	het	hom		QUAL=7441;DP=135,72,97;AF=0.99,0.33,0.99;MQM=60;SAP=27;ABP=20;SAR=100;SAF=153	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294374 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided];			rs2230707	0.47738	0.43578,0.60542,0.61547,0.46613,0.50104	17651,	37218	79394	-9.1790	1.01			/0.0>0.0/0.0>0.0	COSV51891838	ALDH4A1|0.00|0.01|0.00|0.00|1|47|-4|-10,RP13-279N23.2|0.00|0.01|0.00|0.00|1|47|-4|-10	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876423	18876423	T	C	hom	hom	hom		QUAL=7632;DP=100,74,88;AF=1.00,0.97,0.99;MQM=60;SAP=4;ABP=0;SAR=125;SAF=134	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294375 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided,not specified];			rs7550938	0.64280	0.48560,0.75033,0.72177,0.69460,0.74761	31974,	33395	54093	-6.0680	1.04			/3.9>3.7/0.0>0.0	COSV51894187	ALDH4A1|0.03|0.02|0.00|0.00|26|-6|-29|-31,RP13-279N23.2|0.03|0.02|0.00|0.00|26|-6|-29|-31	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876432	18876432	T	C	hom	hom	hom		QUAL=6356;DP=65,73,87;AF=1.00,0.96,0.99;MQM=60;SAP=5;ABP=0;SAR=104;SAF=117	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294376 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided,not specified];			rs2230706	0.64218	0.48532,0.74997,0.72019,0.69359,0.74782	31934,	33409	54203	0.1280	2.89			/3.9>5.0/0.0>0.0	COSV51893163	ALDH4A1|0.02|0.01|0.00|0.00|17|-15|-34|-40,RP13-279N23.2|0.02|0.01|0.00|0.00|17|-15|-34|-40	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877503	18877503	C	G	hom	hom	hom		QUAL=7567;DP=84,56,107;AF=0.98,1.00,1.00;MQM=60;SAP=133;ABP=0;SAR=183;SAF=62	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294382 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230705	0.70985	0.72157,0.71770,0.45481,0.71950,0.58089	38609,	30705	44113	1.5970	8.71			/2.7>3.2/0.0>0.0	COSV51892136	ALDH4A1|0.00|0.00|0.00|0.00|31|11|-15|25,RP13-279N23.2|0.00|0.00|0.00|0.00|31|11|-15|25	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877660	18877660	G	A	het	hom	wt	off-target	QUAL=269;DP=14,8,20;AF=0.43,1.00,0.00;MQM=60;SAP=33;ABP=4;SAR=14;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-48C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188873 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426813	0.72429	0.69957,0.82324,0.95562,0.69935,0.85617	40352,	29360	41898	-0.8390	0.54			/0.0>0.0/0.5>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-48|-50|30|49,RP13-279N23.2|0.00|0.00|0.00|0.00|-48|-50|30|49	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877679	18877679	A	G	hom	het	hom	off-target	QUAL=900;DP=14,7,20;AF=0.93,0.43,1.00;MQM=60;SAP=81;ABP=3;SAR=36;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-67T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-67T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-67T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-67T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188910 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426814	0.82122	0.87808,0.84127,0.87215,0.79009,0.74979	51430,	21983	27179	-1.3820	0.86			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-31|6|34|11,RP13-279N23.2|0.00|0.00|0.00|0.00|-31|6|34|11	35470798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877815	18877815	G	A	het	n/a	het	off-target	QUAL=256;DP=14,0,6;AF=0.57,,0.67;MQM=60;SAP=29;ABP=5;SAR=12;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-203C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-203C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-203C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-203C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			MIR3 (SINE/MIR)	rs41302007	0.31976	0.20760,0.26306,0.17389,0.38988,0.32544	8487,	31630	103396	-0.4680	0.17			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-14|3|-3|-33,RP13-279N23.2|0.00|0.00|0.00|0.00|-14|3|-3|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18879178	18879178	T	G	het	het	hom	off-target	QUAL=4351;DP=83,96,76;AF=0.48,0.55,0.99;MQM=60;SAP=368;ABP=4;SAR=0;SAF=168	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.940+122A>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.940+122A>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.940+122A>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.760+122A>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28497538	0.42704	0.48882,0.46694,0.36411,0.38366,0.42327	14310,	36256	87046	-3.6300	0.05			/1.4>1.9/0.1>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-46|2|21|3,RP13-279N23.2|0.00|0.00|0.00|0.00|-46|2|21|3	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18881651	18881651	-	GGTTGCCT	hom	hom	hom	off-target	QUAL=672;DP=7,7,14;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0;SAR=0;SAF=28	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs112548638	0.98441	0.94591,0.99431,1.00000,0.99975,0.99959	73707,	2254	2370		1.51			/0.0>0.0/0.0>0.9		ALDH4A1|0.00|0.00|0.01|0.00|-43|25|49|50,RP13-279N23.2|0.00|0.00|0.01|0.00|-43|25|49|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883049	18883049	A	G	hom	hom	hom	off-target	QUAL=11407;DP=85,156,145;AF=1.00,0.99,1.00;MQM=60;SAP=387;ABP=0;SAR=62;SAF=323	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron7/15:c.678+75T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron7/14:c.678+75T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron7/13:c.678+75T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron7/14:c.498+75T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188911 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426611	0.97018	0.89634,0.98960,0.99981,0.99959,0.99938	71804,	4085	4539	-1.8660	0.03			/3.6>2.4/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|17|-19|-44|-11,RP13-279N23.2|0.00|0.00|0.00|0.00|17|-19|-44|-11	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883524	18883524	G	A	het	wt	hom	off-target	QUAL=1109;DP=46,16,28;AF=0.41,0.00,1.00;MQM=60;SAP=97;ABP=6;SAR=46;SAF=1	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.454-96C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.454-96C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.454-96C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.274-96C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28508407	0.30465	0.45357,0.34093,0.24169,0.21986,0.23209	8031,	30249	105703	-3.5190	0.02			/2.0>2.6/0.0>0.0	COSV51893250	ALDH4A1|0.00|0.00|0.00|0.02|-26|4|-8|39,RP13-279N23.2|0.00|0.00|0.00|0.02|-26|4|-8|39	35470798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885436	18885436	A	C	wt	hom	wt	off-target;low_conf_region	QUAL=55;DP=4,7,5;AF=0.00,0.86,0.00;MQM=60;SAP=9;ABP=0;SAR=1;SAF=5	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+37T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+37T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs752213358	0.23644	0.25662,0.23958,0.19239,0.23115,0.25032	0,	12845	41481	-3.5210	0.04			/0.0>0.0/0.0>0.0	COSV51892118	ALDH4A1|0.00|0.00|0.00|0.00|-35|37|46|2,RP13-279N23.2|0.00|0.00|0.00|0.00|-35|37|46|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885441	18885441	G	C	n/a	het	wt	off-target;low_conf_region	QUAL=27;DP=2,9,6;AF=0.00,0.56,0.00;MQM=60;SAP=14;ABP=3;SAR=0;SAF=5	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+32C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+32C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs188233802	0.23422	0.26538,0.20837,0.22668,0.22727,0.26582	0,	9992	32668	-0.6210	0.57			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-43|41|41|-19,RP13-279N23.2|0.00|0.00|0.00|0.00|-43|41|41|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18889340	18889340	T	C	hom	hom	hom	off-target	QUAL=11027;DP=120,95,143;AF=1.00,1.00,1.00;MQM=60;SAP=178;ABP=0;SAR=94;SAF=264	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron3/14:c.69+22A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188912 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs941495	0.96893	0.99264,0.97055,0.99962,0.95429,0.99068	71460,	4553	4729	-0.5210	2.91			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.03|0.02|26|-43|26|9,RP13-279N23.2|0.00|0.00|0.03|0.02|26|-43|26|9	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18890554	18890554	A	C	het	het	wt	off-target	QUAL=1359;DP=84,37,50;AF=0.49,0.43,0.00;MQM=59;SAP=118;ABP=4;SAR=1;SAF=56	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron1/15:c.63-449T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron1/14:c.63-449T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron1/13:c.63-449T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron1/14:c.-119+140T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			AluSz (SINE/Alu)							0.4610	3.99			/3.0>2.2/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-35|16|32|16,RP13-279N23.2|0.00|0.00|0.00|0.00|-35|16|32|16		0	0	0	0 / 0					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21554325	21554325	-	ATAT	het	wt	het	off-target	QUAL=111;DP=25,9,13;AF=0.32,0.00,0.31;MQM=58;SAP=29;ABP=14;SAR=12;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron1/9:c.-54-6289_-54-6286dup::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron1/10:c.-104-6289_-104-6286dup::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1253752 [benign DISEASE=not provided];			rs61491376	0.63943	0.44038,0.66349,0.46437,0.75058,0.67768	31197,	31017	52673		0.15			/0.1>0.1/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|-27|29|-27|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563013	21563013	C	T	wt	wt	het	off-target	QUAL=665;DP=32,38,63;AF=0.00,0.00,0.51;MQM=60;SAP=72;ABP=3;SAR=0;SAF=32	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron4/11:c.298-97C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron2/9:c.67-97C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron3/10:c.133-97C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron4/11:c.298-97C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1177624 [benign DISEASE=not provided,Adult hypophosphatasia,Childhood hypophosphatasia,Infantile hypophosphatasia];			rs1256336	0.23645	0.31244,0.18049,0.01291,0.23677,0.10568	4605,	26714	116004	0.3480	3.29			/6.3>5.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|14|-2|23|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563142	21563142	T	C	hom	hom	het		QUAL=4790;DP=30,90,125;AF=0.97,1.00,0.52;MQM=60;SAP=33;ABP=3;SAR=67;SAF=117	ALPL	synonymous	ALPL:ENST00000374840.8:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.5:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.5:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374832.5:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase]		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	197678 [benign DISEASE=not specified,not provided,Hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,Infantile hypophosphatasia];			rs1780316	0.92595	0.86684,0.95262,0.98707,0.94388,0.95571	65340,	10226	11268	-0.8670	4.19			/0.9>1.2/0.0>0.0	COSV66379629	ALPL|0.00|0.00|0.00|0.00|-11|0|30|-12	25972531,27507156,30283886,23823483,25147783,34213743	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563893	21563893	G	A	hom	hom	het	off-target	QUAL=646;DP=16,6,5;AF=1.00,1.00,0.40;MQM=60;SAP=55;ABP=3;SAR=0;SAF=24	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-148G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-148G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-148G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-148G>A::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1188974 [benign DISEASE=not provided,Childhood hypophosphatasia];			rs1256335	0.80112	0.77344,0.85016,0.98375,0.78857,0.81182	48637,	23862	30072	-1.5660	0.09			/0.0>0.0/0.0>0.0	COSV66379633	ALPL|0.00|0.00|0.00|0.00|2|-16|50|49	30583557,19744961,19888898,25972531,23823483,25760040,32230794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563971	21563971	A	G	hom	hom	hom	off-target	QUAL=2585;DP=19,31,51;AF=1.00,1.00,1.00;MQM=60;SAP=222;ABP=0;SAR=0;SAF=101	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-70A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-70A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-70A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-70A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1177630 [benign DISEASE=not provided,Childhood hypophosphatasia,Infantile hypophosphatasia,Adult hypophosphatasia];		(GGGA)n (Simple_repeat)	rs1767428	0.98666	0.95397,0.99412,0.99980,0.99968,0.99979	72672,	1911	1991	-0.3600	1.78			/0.0>0.0/1.1>0.8		ALPL|0.00|0.00|0.00|0.00|44|2|-21|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21568455	21568455	G	A	het	wt	het	off-target	QUAL=665;DP=35,18,23;AF=0.54,0.06,0.57;MQM=60;SAP=75;ABP=4;SAR=33;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron7/11:c.792+208G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron5/9:c.561+208G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron6/10:c.627+208G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron7/11:c.792+208G>A::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1297879 [benign DISEASE=not provided];			rs35526713	0.07792	0.05455,0.07033,0.02655,0.08919,0.06954	475,	10897	140197	0.5610	5.19			/0.0>0.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|2|-18|2|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21570432	21570432	C	T	het	wt	het	off-target	QUAL=6287;DP=188,243,305;AF=0.49,0.00,0.55;MQM=60;SAP=191;ABP=6;SAR=205;SAF=55	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron8/11:c.862+58C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1177590 [benign DISEASE=not provided,Childhood hypophosphatasia,Infantile hypophosphatasia,Adult hypophosphatasia];			rs2275375	0.26083	0.30641,0.29356,0.47744,0.20002,0.30294	5477,	28651	112235	-1.1040	0.36			/0.0>1.1/0.1>1.3	COSV66376176	ALPL|0.00|0.00|0.00|0.00|46|48|-2|48	19500388,34213743	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573927	21573927	A	G	hom	hom	het	off-target	QUAL=5652;DP=76,78,97;AF=1.00,1.00,0.53;MQM=60;SAP=448;ABP=4;SAR=205;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+128A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+128A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+128A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+128A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1236467 [benign DISEASE=not provided];			rs2275370	0.76353	0.70676,0.79238,0.80255,0.78315,0.76853	44408,	27285	35957	-0.3860	4.29			/0.0>0.0/0.0>0.0	COSV66376031	ALPL|0.00|0.00|0.00|0.00|-6|-22|-37|1	19888898,25972531,19931660	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573966	21573966	A	C	het	het	wt	off-target	QUAL=1367;DP=69,49,64;AF=0.55,0.51,0.00;MQM=60;SAP=140;ABP=4;SAR=63;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+167A>C::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+167A>C::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+167A>C::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+167A>C::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1241664 [benign DISEASE=not provided];			rs35488260	0.21440	0.12617,0.18595,0.00019,0.28974,0.08209	3993,	24636	119530	0.5160	8.80			/0.0>1.4/0.0>0.0	COSV66376032	ALPL|0.00|0.00|0.00|0.00|11|33|39|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21575615	21575615	C	T	wt	wt	het	off-target	QUAL=1091;DP=120,68,99;AF=0.00,0.00,0.57;MQM=60;SAP=125;ABP=7;SAR=0;SAF=56	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.998-118C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.767-118C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.833-118C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.998-118C>T::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]				rs116835106	0.00849	0.00277,0.00543,0.00154,0.01273,0.02568	9,	1274	150902	-2.5310	0.12			/0.0>0.0/0.0>4.0		ALPL|0.02|0.00|0.00|0.03|23|45|-2|31		8	291	0	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21576457	21576457	C	A	wt	wt	het	off-target	QUAL=1844;DP=150,120,140;AF=0.01,0.00,0.54;MQM=60;SAP=69;ABP=5;SAR=14;SAF=62	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron10/11:c.1190-65C>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron8/9:c.959-65C>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron9/10:c.1025-65C>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron10/11:c.1190-65C>A::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1177605 [benign DISEASE=not provided,Childhood hypophosphatasia,Infantile hypophosphatasia,Adult hypophosphatasia];			rs1780329	0.24798	0.35028,0.27706,0.46884,0.16570,0.25810	5377,	26861	114073	-0.8730	0.94			/0.0>0.0/0.0>0.0	COSV66376181	ALPL|0.00|0.00|0.00|0.00|2|-50|-27|-50	25972531,17195227,18769922,25025693,29754330,31666285,23612078	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577713	21577713	C	T	wt	het	wt		QUAL=1739;DP=60,173,235;AF=0.00,0.46,0.00;MQM=60;SAP=12;ABP=6;SAR=31;SAF=49	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295558 [benign DISEASE=Hypophosphatasia,not provided];			rs1697405	0.35537	0.25747,0.38152,0.31000,0.40897,0.42375	10025,	33949	97951	1.5200	10.69			/1.7>2.0/0.0>0.0	COSV66376405	ALPL|0.00|0.00|0.00|0.00|-28|-6|16|43	27468225,31666285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577770	21577770	C	-	het	het	wt		QUAL=20516;DP=182,240,281;AF=0.53,0.45,1.00;MQM=60;SAP=13;ABP=3;SAR=90;SAF=122	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295560 [benign/likely benign DISEASE=Hypophosphatasia,not provided];			rs140511985	0.04581	0.01866,0.03880,0.00000,0.06809,0.02344	213,	6536	145012	0.9820	11.71			/0.0>0.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|-23|-39|-13|14		26	406	0	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577774	21577774	A	G	hom	hom	hom		QUAL=20516;DP=182,240,281;AF=0.53,0.45,1.00;MQM=60;SAP=13;ABP=3;SAR=90;SAF=122	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295561 [benign DISEASE=Hypophosphatasia,not provided];			rs1697406	0.87187	0.85193,0.87253,0.81204,0.88556,0.93076	57845,	16890	19484	0.1730	14.65			/0.0>0.0/0.0>0.5		ALPL|0.00|0.00|0.00|0.00|1|2|9|-8	27468225,28899360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577881	21577881	A	C	wt	wt	het		QUAL=2232;DP=128,191,197;AF=0.00,0.00,0.46;MQM=60;SAP=18;ABP=5;SAR=58;SAF=33	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295563 [benign DISEASE=Hypophosphatasia,not provided];			rs1772719	0.18693	0.19442,0.14263,0.01576,0.20204,0.20079	2714,	23018	123728	0.5140	15.42			/7.7>7.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|44|24|37|4	30583557,25972531,19931660,31959995,33574263	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21578514	21578514	G	A	wt	wt	het	off-target	QUAL=947;DP=149,53,84;AF=0.00,0.00,0.50;MQM=60;SAP=70;ABP=3;SAR=39;SAF=3	ALPL	downstream_gene	ALPL:ENST00000374840.8:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000539907.5:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000540617.5:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000374832.5:downstream_gene_variant:MODIFIER::::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]				rs1772720	0.08117	0.11316,0.04997,0.01253,0.07370,0.04459	554,	11227	139639	0.0150	4.82						30048462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21822690	21822690	G	C	het	wt	hom		QUAL=1349;DP=23,27,42;AF=0.43,0.00,1.00;MQM=60;SAP=91;ABP=4;SAR=3;SAF=49	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::,HSPG2:ENST00000374695.8:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295685 [benign DISEASE=Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs1049644	0.29940	0.40652,0.21960,0.16680,0.25471,0.40359	7246,	30857	106115	1.9690	10.28			/0.0>0.0/0.0>3.5,/7.8>6.0/0.0>0.0	COSV60827857	HSPG2|0.00|0.00|0.00|0.00|-37|-11|-41|26,LDLRAD2|0.00|0.00|0.00|0.00|-39|-18|28|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823442	21823442	T	C	hom	hom	hom		QUAL=15102;DP=111,143,233;AF=1.00,1.00,1.00;MQM=60;SAP=243;ABP=0;SAR=127;SAF=359	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295695 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs897467	0.79162	0.71753,0.76679,0.82279,0.82505,0.83002	47809,	24698	31672	-3.7920	0.96			/0.0>0.0/0.0>0.0,/1.0>3.3/0.0>0.0	COSV60827391	HSPG2|0.01|0.23|0.00|0.00|-11|-2|29|-27,LDLRAD2|0.00|0.00|0.00|0.00|4|24|18|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823625	21823625	C	T	wt	wt	het		QUAL=3360;DP=146,206,316;AF=0.00,0.00,0.44;MQM=60;SAP=11;ABP=12;SAR=81;SAF=59	LDLRAD2,HSPG2	3'UTR,intron,missense	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-285C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295699 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs1138469	0.05028	0.02965,0.03872,0.00019,0.05981,0.09718	257,	7136	144500	-2.5780	0.00	0.21	0.06	/2.6>3.7/0.0>0.0,/0.0>0.0/0.0>0.0	COSV60828274	HSPG2|0.00|0.00|0.00|0.00|1|17|-13|-9,LDLRAD2|0.01|0.00|0.00|0.00|-1|-27|-6|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823627	21823627	C	T	het	wt	het		QUAL=5826;DP=151,208,317;AF=0.46,0.01,0.55;MQM=60;SAP=8;ABP=5;SAR=134;SAF=111	LDLRAD2,HSPG2	3'UTR,intron,missense	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295700 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome];			rs3736360	0.15294	0.08273,0.13095,0.16622,0.17597,0.29693	1950,	19359	128821	0.0090	9.47	0.12	0.08	/0.0>0.0/0.0>0.0	COSV60827612	HSPG2|0.00|0.00|0.00|0.00|30|-1|-11|-17,LDLRAD2|0.00|0.00|0.00|0.00|12|-26|-8|-29	20072119,18559102,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823667	21823667	G	T	het	wt	het		QUAL=8062;DP=293,205,325;AF=0.48,0.01,0.55;MQM=60;SAP=4;ABP=5;SAR=167;SAF=158	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295701 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs3736358	0.14015	0.03718,0.12767,0.16712,0.17600,0.29677	1837,	17638	130754	3.7350	10.61			/0.0>0.8/0.0>0.0,/3.8>0.0/0.0>1.2	COSV60828118,COSV60829904	HSPG2|0.00|0.01|0.00|0.00|-2|40|21|-47,LDLRAD2|0.00|0.00|0.00|0.00|13|1|-20|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823764	21823764	C	T	het	hom	wt	off-target	QUAL=3648;DP=75,108,203;AF=0.51,0.99,0.00;MQM=60;SAP=116;ABP=3;SAR=116;SAF=29	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::,HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1225015 [benign DISEASE=not provided];			rs3736357	0.39124	0.14022,0.47544,0.64493,0.48652,0.33257	13591,	32255	92483	1.1280	8.82			/4.2>4.3/0.0>0.0,/0.0>0.0/1.7>1.1		HSPG2|0.02|0.00|0.00|0.00|-34|-49|-45|39,LDLRAD2|0.00|0.00|0.00|0.00|20|50|-16|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828352	21828352	A	G	het	wt	hom		QUAL=1306;DP=43,38,32;AF=0.37,0.00,0.97;MQM=60;SAP=7;ABP=9;SAR=19;SAF=28	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295707 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome];			rs2228347	0.25267	0.13632,0.21418,0.16602,0.30491,0.48096	5420,	27565	113591	1.3570	5.83			/0.6>1.5/0.0>0.0	COSV60827859	HSPG2|0.01|0.00|0.01|0.00|36|-22|-10|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828494	21828494	G	A	het	wt	hom	off-target	QUAL=584;DP=18,14,15;AF=0.44,0.00,1.00;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron88/96:c.12238-68C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267772 [benign DISEASE=not provided];			rs10917052	0.24166	0.13170,0.20267,0.16583,0.28834,0.47813	4924,	26823	115075	-0.3470	1.34			/3.8>2.9/0.0>0.0	COSV60827793	HSPG2|0.00|0.00|0.00|0.00|-33|-43|-7|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829230	21829230	T	C	hom	hom	hom	off-target	QUAL=2897;DP=42,17,33;AF=0.98,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=48;SAF=43	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11993-151A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439796 [benign DISEASE=not specified,not provided];		MIRb (SINE/MIR)	rs7518070	0.77238	0.70578,0.74742,0.81373,0.79856,0.82168	45520,	26435	34619	-1.9710	0.32			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-1|-8|5|49	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829348	21829348	T	C	het	wt	het	off-target	QUAL=1229;DP=38,67,75;AF=0.53,0.00,0.52;MQM=60;SAP=106;ABP=3;SAR=3;SAF=56	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618168 [benign DISEASE=not specified,not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs12042189	0.14054	0.03690,0.12894,0.16628,0.17597,0.29553	1839,	17699	130727	-0.9940	0.12			/0.0>0.0/0.0>0.0	COSV60828432	HSPG2|0.00|0.00|0.00|0.00|34|-32|35|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829360	21829360	C	T	het	wt	het	off-target	QUAL=1407;DP=59,71,83;AF=0.37,0.00,0.54;MQM=60;SAP=132;ABP=4;SAR=2;SAF=65	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618169 [benign DISEASE=not specified,not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs12023794	0.15307	0.08417,0.13146,0.17047,0.17562,0.28734	1944,	19395	128829	-1.2010	0.53			/0.0>0.0/0.0>0.0	COSV60829275	HSPG2|0.00|0.00|0.00|0.00|-2|44|23|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831196	21831196	G	A	hom	hom	hom	off-target	QUAL=16272;DP=95,206,257;AF=1.00,1.00,1.00;MQM=60;SAP=27;ABP=0;SAR=239;SAF=318	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron84/96:c.11562+19C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1174648 [benign DISEASE=not specified,not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs3736355	0.77025	0.70094,0.74653,0.81192,0.79763,0.81393	45249,	26569	34919	-2.8120	0.01			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|18|-1|19|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831627	21831627	G	T	het	wt	het	off-target	QUAL=2889;DP=81,101,143;AF=0.52,0.00,0.55;MQM=60;SAP=97;ABP=5;SAR=96;SAF=24	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1261831 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2270701	0.14658	0.05882,0.12985,0.16518,0.17560,0.30012	1894,	18499	129759	-3.4990	0.00			/4.4>3.4/0.0>0.0		HSPG2|0.10|0.00|0.00|0.00|-29|-47|43|25	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831870	21831870	G	A	het	hom	wt	off-target	QUAL=68;DP=10,4,5;AF=0.20,1.00,0.00;MQM=60;SAP=16;ABP=11;SAR=6;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron81/96:c.11208-74C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237413 [benign DISEASE=not provided];			rs4654771	0.35862	0.10172,0.39982,0.44137,0.48027,0.27490	11777,	30882	97356	0.0080	0.91			/4.2>4.4/0.0>0.0	COSV65932968	HSPG2|0.02|0.00|0.00|0.00|-17|34|4|29	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833281	21833281	G	A	het	wt	het		QUAL=4189;DP=139,207,237;AF=0.44,0.00,0.50;MQM=60;SAP=108;ABP=5;SAR=43;SAF=136	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF00054 [Laminin G domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295724 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome];			rs2229486	0.10064	0.17116,0.06799,0.00039,0.08046,0.10879	927,	13452	136778	-3.3340	0.71			/2.3>2.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-8|-10|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833550	21833550	C	T	het	wt	het		QUAL=5294;DP=187,223,284;AF=0.43,0.00,0.49;MQM=60;SAP=173;ABP=8;SAR=175;SAF=44	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295727 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2229493	0.10075	0.17147,0.06778,0.00039,0.08053,0.10936	924,	13460	136626	0.0570	11.56	0.05	0.06	/4.5>4.0/0.0>0.0	COSV105928417	HSPG2|0.05|0.02|0.00|0.02|3|38|-8|-14	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833655	21833655	C	T	het	hom	wt	off-target	QUAL=5311;DP=104,131,183;AF=0.61,1.00,0.00;MQM=60;SAP=290;ABP=13;SAR=177;SAF=17	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223305 [benign DISEASE=not provided];			rs7547731	0.39086	0.14162,0.47459,0.64456,0.48620,0.32919	13557,	32324	92632	-2.8300	0.11			/0.0>0.0/0.0>0.0		HSPG2|0.03|0.01|0.00|0.00|-24|-30|-24|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21835143	21835143	T	-	het	het	het	off-target	QUAL=162;DP=15,7,8;AF=0.40,0.29,0.50;MQM=60;SAP=29;ABP=6;SAR=12;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron76/96:c.10454-198del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1227252 [benign DISEASE=not provided];		FAM (SINE/Alu)	rs11338283	0.10535	0.17481,0.07219,0.00059,0.08384,0.11288	906,	13636	131186	-0.1600	0.58			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.03|10|-1|-44|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21835760	21835760	C	G	het	wt	het	off-target	QUAL=2653;DP=154,53,77;AF=0.50,0.00,0.49;MQM=51;SAP=244;ABP=3;SAR=114;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10356-123G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296079 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71636991	0.10047	0.17073,0.06782,0.00039,0.08057,0.10936	920,	13418	136604	-2.5810	0.14			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-13|-37|-38|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836660	21836660	A	C	het	hom	wt	off-target	QUAL=2039;DP=73,38,45;AF=0.58,1.00,0.00;MQM=60;SAP=177;ABP=7;SAR=0;SAF=80	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+142T>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245162 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs12567651	0.29073	0.08234,0.34045,0.33482,0.39018,0.22370	7722,	28752	107820	0.0320	9.68			/1.0>0.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-44|2|-13|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836717	21836717	C	A	het	wt	het	off-target	QUAL=2161;DP=112,72,93;AF=0.58,0.00,0.40;MQM=60;SAP=225;ABP=3;SAR=0;SAF=102	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+85G>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810881 [benign DISEASE=not specified,not provided];			rs35423650	0.04049	0.00948,0.03421,0.00019,0.05861,0.10266	177,	5809	146041	1.1510	4.66			/0.0>0.0/0.0>6.2		HSPG2|0.00|0.00|0.00|0.00|2|-49|2|31		14	493	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836897	21836897	G	A	het	wt	het		QUAL=5596;DP=183,226,354;AF=0.51,0.00,0.40;MQM=60;SAP=4;ABP=20;SAR=114;SAF=122	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295741 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome];			rs35444472	0.10022	0.17014,0.06769,0.00058,0.08038,0.10936	920,	13410	136914	2.2680	8.58			/6.1>5.7/0.0>0.0	COSV65932770	HSPG2|0.01|0.03|0.00|0.00|-15|50|12|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836909	21836909	G	A	wt	wt	het		QUAL=5292;DP=180,223,348;AF=0.01,0.00,0.60;MQM=60;SAP=3;ABP=35;SAR=108;SAF=103	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295743 [benign/likely benign DISEASE=Schwartz-Jampel syndrome,not provided,Connective tissue disorder,Lethal Kniest-like syndrome];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.05024	0.02982,0.03816,0.00019,0.06009,0.09238	257,	7130	144516	-2.2060	3.36			/0.0>0.0/2.0>0.4	COSV65933172	HSPG2|0.00|0.06|0.00|0.01|-27|38|6|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839408	21839408	A	G	het	wt	het		QUAL=2713;DP=83,39,87;AF=0.64,0.00,0.67;MQM=60;SAP=46;ABP=38;SAR=32;SAF=79	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295750 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs2291826	0.33509	0.53583,0.23614,0.16789,0.25942,0.39133	9706,	31500	101022	-3.3420	1.09			/0.0>0.0/0.0>0.6	COSV65933346	HSPG2|0.00|0.00|0.01|0.00|46|-37|-37|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839703	21839703	C	T	het	wt	het	off-target	QUAL=2066;DP=79,58,69;AF=0.54,0.00,0.58;MQM=60;SAP=19;ABP=8;SAR=29;SAF=54	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron72/96:c.9709+119G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1266053 [benign DISEASE=not provided];			rs35570238	0.09786	0.16196,0.06625,0.00154,0.08031,0.10913	856,	13165	137143	-0.5230	0.52			/0.5>0.1/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-20|22|-1|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841112	21841112	C	T	het	wt	het		QUAL=2082;DP=48,164,183;AF=0.46,0.00,0.42;MQM=60;SAP=94;ABP=15;SAR=17;SAF=81	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295758 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2228349	0.09804	0.16239,0.06630,0.00039,0.08044,0.10939	859,	13201	137253	0.9590	9.06	0.12	0.07	/3.4>3.6/0.0>1.5		HSPG2|0.00|0.00|0.01|0.00|-2|49|-2|-11	20072119,23049933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841723	21841723	C	T	het	hom	wt	off-target	QUAL=6351;DP=80,182,231;AF=0.48,1.00,0.00;MQM=60;SAP=60;ABP=3;SAR=148;SAF=72	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231634 [benign DISEASE=not provided];			rs7556412	0.61582	0.50513,0.59273,0.81876,0.65640,0.61268	29274,	34977	58347	-0.1040	1.72			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-12|-50|-12|-11	21146954,23593148,31970092,30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841783	21841783	G	T	het	wt	het	off-target	QUAL=3753;DP=141,115,148;AF=0.54,0.00,0.51;MQM=60;SAP=193;ABP=4;SAR=133;SAF=18	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-110C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1271902 [benign DISEASE=not provided];			rs34470509	0.04047	0.00948,0.03421,0.00019,0.05852,0.10344	177,	5805	146015	-0.2560	4.34			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|5|-24|-4|10		12	506	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841817	21841817	A	G	het	wt	het	off-target	QUAL=4003;DP=183,97,132;AF=0.51,0.00,0.52;MQM=60;SAP=183;ABP=4;SAR=139;SAF=23	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-144T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1226588 [benign DISEASE=not provided];			rs12043008	0.26213	0.30124,0.20200,0.17265,0.24998,0.39020	5270,	29291	112119	-0.2220	1.59			/0.0>0.0/0.0>0.0		HSPG2|0.06|0.00|0.00|0.00|36|-29|-38|-29	30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842308	21842308	T	C	het	wt	het		QUAL=1445;DP=63,76,87;AF=0.46,0.00,0.43;MQM=60;SAP=37;ABP=8;SAR=49;SAF=17	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295764 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs2229491	0.10253	0.17809,0.06815,0.00039,0.08043,0.10844	968,	13664	136558	-0.1830	3.31	0.04	0.05	/4.9>5.1/0.0>0.0		HSPG2|0.04|0.01|0.00|0.00|2|23|18|24	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842352	21842352	A	T	het	wt	het		QUAL=932;DP=42,44,57;AF=0.52,0.00,0.39;MQM=60;SAP=60;ABP=6;SAR=39;SAF=5	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295765 [benign DISEASE=Schwartz-Jampel syndrome,Connective tissue disorder,not provided,Lethal Kniest-like syndrome];			rs2229489	0.04055	0.00951,0.03426,0.00019,0.05860,0.10336	177,	5813	145935	3.3680	18.20	0.07	0.04	/2.0>1.6/0.0>0.0		HSPG2|0.00|0.03|0.00|0.00|28|-21|-24|-20	20452482,20072119	93	3216	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842489	21842489	T	C	het	wt	het	off-target	QUAL=628;DP=41,8,11;AF=0.51,0.00,0.64;MQM=60;SAP=3;ABP=4;SAR=14;SAF=14	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8911-109A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296076 [benign DISEASE=not provided];			rs7528408	0.10008	0.16944,0.06648,0.00039,0.08053,0.11139	912,	13394	136844	-0.1850	3.47			/0.0>0.0/0.9>0.0		HSPG2|0.00|0.00|0.01|0.00|38|22|-28|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842646	21842646	G	C	het	wt	het	off-target	QUAL=1605;DP=53,68,86;AF=0.36,0.00,0.58;MQM=60;SAP=120;ABP=3;SAR=4;SAF=65	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+124C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256741 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs7536441	0.09996	0.16925,0.06585,0.00039,0.08055,0.11070	907,	13387	136873	-0.1020	1.98			/0.0>0.0/0.4>0.0		HSPG2|0.00|0.01|0.00|0.00|5|17|10|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842693	21842693	A	G	het	wt	het	off-target	QUAL=2879;DP=65,122,157;AF=0.49,0.00,0.59;MQM=60;SAP=239;ABP=10;SAR=4;SAF=120	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+77T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1228779 [benign DISEASE=not provided];			rs75779078	0.04070	0.00984,0.03417,0.00019,0.05860,0.10531	179,	5828	145792	-2.2780	0.11			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.01|23|-12|47|37		14	493	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21844386	21844386	G	A	wt	wt	het	off-target	QUAL=2868;DP=82,180,236;AF=0.00,0.00,0.53;MQM=60;SAP=268;ABP=5;SAR=125;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron64/96:c.8465-87C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293477 [benign DISEASE=not provided];			rs75613822	0.05027	0.03061,0.03827,0.00019,0.05974,0.09151	253,	7144	144540	0.5770	8.57			/3.6>3.6/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-12|-4|-4|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21845965	21845965	T	C	hom	hom	hom	off-target	QUAL=2552;DP=12,37,42;AF=1.00,1.00,1.00;MQM=60;SAP=201;ABP=0;SAR=0;SAF=91	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron64/96:c.8464+143A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245045 [benign DISEASE=not provided];			rs7355045	0.77542	0.70033,0.70945,0.82111,0.81452,0.82119	45976,	25966	34152	-1.4080	0.84			/3.7>3.3/0.0>0.0	COSV65970143	HSPG2|0.06|0.00|0.07|0.00|19|-12|-30|-1	21146954,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21846651	21846651	C	T	het	wt	het	off-target	QUAL=8187;DP=107,377,509;AF=0.54,0.00,0.54;MQM=60;SAP=227;ABP=13;SAR=261;SAF=75	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1182109 [benign DISEASE=not provided];			rs34792235	0.04057	0.00953,0.03430,0.00019,0.05857,0.10497	180,	5815	146015	-0.3120	1.46			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-28|31|37|50		61	2191	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847184	21847184	T	C	het	wt	het	off-target	QUAL=1033;DP=54,55,60;AF=0.43,0.00,0.47;MQM=60;SAP=114;ABP=6;SAR=0;SAF=51	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+170A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296073 [benign DISEASE=not provided];		MER3 (DNA/hAT-Charlie)	rs12757119	0.04059	0.00953,0.03423,0.00019,0.05860,0.10510	180,	5818	146016	-4.5280	0.06			/5.4>3.2/0.0>0.0		HSPG2|0.00|0.02|0.00|0.00|-1|-4|-1|50		17	469	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847243	21847243	C	T	het	wt	het	off-target	QUAL=2878;DP=135,102,125;AF=0.53,0.00,0.46;MQM=60;SAP=285;ABP=3;SAR=0;SAF=130	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+111G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1250728 [benign DISEASE=not provided];			rs35921133	0.04065	0.00955,0.03436,0.00019,0.05870,0.10506	180,	5826	146008	-0.5830	1.38			/0.0>0.0/1.4>0.0		HSPG2|0.00|0.00|0.00|0.00|-2|-9|-2|43		16	522	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847497	21847497	A	G	het	wt	het		QUAL=7221;DP=162,326,425;AF=0.54,0.00,0.49;MQM=60;SAP=38;ABP=3;SAR=182;SAF=113	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295781 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,Connective tissue disorder];			rs35917892	0.04055	0.00953,0.03419,0.00019,0.05854,0.10489	179,	5811	145957	-2.0680	0.39			4.4>3.7/4.4>3.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-5|-5|-36		97	3203	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847933	21847933	T	G	het	wt	hom	off-target	QUAL=11604;DP=182,312,324;AF=0.46,0.01,0.99;MQM=60;SAP=3;ABP=5;SAR=200;SAF=208	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256801 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs2290501	0.36954	0.52536,0.26756,0.17317,0.31154,0.48194	11153,	33836	95784	-0.6650	5.02	0.03		/0.0>0.0/0.8>0.0	COSV65971017	HSPG2|0.00|0.00|0.00|0.00|25|43|26|25	23593148,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848025	21848025	G	T	het	wt	het		QUAL=7471;DP=271,358,363;AF=0.43,0.00,0.51;MQM=60;SAP=4;ABP=7;SAR=158;SAF=144	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295785 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,Connective tissue disorder];			rs12737091	0.04052	0.00953,0.03415,0.00019,0.05852,0.10513	177,	5812	146004	2.1420	13.41			/0.3>0.0/5.4>10.2		HSPG2|0.00|0.01|0.98|0.00|-14|38|3|-49		96	3204	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848107	21848107	A	G	hom	hom	hom	off-target	QUAL=17534;DP=86,235,247;AF=1.00,1.00,1.00;MQM=60;SAP=164;ABP=0;SAR=386;SAF=181	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron59/96:c.7738-14T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295787 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs3767138	0.77729	0.70740,0.70938,0.82027,0.81438,0.82072	46175,	25821	33859	0.2490	13.76			10.4>10.3/10.4>10.3/0.0>0.0	COSV65970146	HSPG2|0.02|0.00|0.00|0.00|-44|-14|-14|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848603	21848603	T	C	het	wt	het	off-target	QUAL=1823;DP=62,56,86;AF=0.48,0.00,0.58;MQM=60;SAP=144;ABP=5;SAR=4;SAF=76	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1236320 [benign DISEASE=not provided];			rs34726153	0.04083	0.00957,0.03440,0.00019,0.05905,0.10483	179,	5848	145780	-1.0900	0.26			/0.0>0.0/0.0>0.4		HSPG2|0.00|0.00|0.00|0.00|-34|25|25|40		61	2204	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21849969	21849969	C	T	het	wt	het	off-target	QUAL=1966;DP=45,76,131;AF=0.47,0.00,0.52;MQM=60;SAP=163;ABP=3;SAR=4;SAF=85	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron57/96:c.7446+72G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296070 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs71636993	0.04057	0.00965,0.03429,0.00019,0.05848,0.10513	179,	5817	146029	-2.0650	0.03			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-37|-43|27|-42		17	495	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850276	21850276	C	T	het	wt	het	off-target	QUAL=2816;DP=35,155,200;AF=0.49,0.00,0.50;MQM=60;SAP=10;ABP=3;SAR=68;SAF=49	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron56/96:c.7295-84G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1222260 [benign DISEASE=not provided];			rs34719083	0.04057	0.00950,0.03421,0.00019,0.05856,0.10506	181,	5812	146016	-1.4550	0.05			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-26|11|9|17		15	525	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850626	21850626	A	G	het	hom	wt	off-target	QUAL=582;DP=9,19,29;AF=0.56,1.00,0.00;MQM=58;SAP=55;ABP=3;SAR=24;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7159-128T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267282 [benign DISEASE=not provided];			rs61777200	0.36501	0.10666,0.40778,0.44220,0.48386,0.28388	12161,	31138	96482	-1.8450	0.12			/6.8>5.9/0.0>0.0	COSV65968900	HSPG2|0.00|0.00|0.00|0.00|-39|-12|-47|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851385	21851385	A	G	het	wt	het	off-target	QUAL=1341;DP=78,60,64;AF=0.42,0.00,0.48;MQM=60;SAP=142;ABP=6;SAR=0;SAF=64	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7158+161T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1247546 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12750012	0.04056	0.00950,0.03428,0.00019,0.05853,0.10522	180,	5814	146054	0.1220	6.09			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-34|-50|27		19	385	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851976	21851976	A	G	het	wt	het	off-target	QUAL=2497;DP=66,84,122;AF=0.61,0.02,0.53;MQM=60;SAP=8;ABP=9;SAR=46;SAF=61	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223987 [benign DISEASE=not provided];			rs34346159	0.04054	0.00949,0.03428,0.00019,0.05851,0.10514	180,	5807	145959	0.4620	6.02			/1.3>1.1/0.0>0.0		HSPG2|0.05|0.00|0.00|0.00|24|-18|-49|10		61	2201	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852498	21852498	C	T	het	wt	het	off-target	QUAL=2092;DP=72,62,79;AF=0.50,0.00,0.63;MQM=60;SAP=29;ABP=9;SAR=27;SAF=59	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+202G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296069 [benign DISEASE=not provided];			rs35337242	0.04055	0.00951,0.03428,0.00019,0.05856,0.10493	178,	5814	145988	-1.6520	0.13			/3.9>4.1/0.0>0.2		HSPG2|0.00|0.00|0.00|0.00|30|2|3|50		14	458	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852543	21852543	G	A	het	wt	het	off-target	QUAL=1526;DP=49,75,90;AF=0.43,0.00,0.56;MQM=60;SAP=76;ABP=3;SAR=11;SAF=60	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+157C>T::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296067 [benign DISEASE=not provided];			rs35999331	0.04051	0.00953,0.03427,0.00038,0.05851,0.10509	177,	5813	146057	0.1990	3.43			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.03|0.00|8|6|8|5		15	468	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852751	21852751	C	T	het	wt	het		QUAL=3486;DP=86,152,203;AF=0.43,0.00,0.51;MQM=60;SAP=20;ABP=3;SAR=87;SAF=54	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295807 [benign DISEASE=Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,Connective tissue disorder,not provided];			rs35669711	0.04057	0.00957,0.03423,0.00019,0.05852,0.10524	176,	5810	145722	0.0570	11.19	0.23	0.09	/4.1>2.2/0.0>0.0		HSPG2|0.00|0.00|0.02|0.00|-2|-10|33|-50		94	3202	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852958	21852958	C	T	het	wt	het		QUAL=5793;DP=76,272,434;AF=0.49,0.00,0.46;MQM=60;SAP=69;ABP=9;SAR=76;SAF=161	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF13927 [Immunoglobulin domain]	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295810 [benign DISEASE=Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,Connective tissue disorder,not provided];			rs34443576	0.04058	0.00973,0.03434,0.00019,0.05850,0.10464	179,	5815	145957	-8.1810	1.04			/0.0>0.0/3.3>2.2	COSV65974636	HSPG2|0.00|0.00|0.00|0.02|-21|17|-2|6		93	3199	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21853180	21853180	T	C	het	hom	wt	off-target	QUAL=4740;DP=54,146,193;AF=0.57,0.99,0.00;MQM=60;SAP=385;ABP=6;SAR=176;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6440-110A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237465 [benign DISEASE=not provided];			rs12049614	0.39908	0.14884,0.44361,0.63869,0.50316,0.33395	14042,	32565	91325	-0.3830	2.47			/0.0>0.0/0.0>0.0	COSV65970151	HSPG2|0.00|0.07|0.00|0.00|13|-22|26|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854055	21854055	T	C	hom	hom	hom	off-target	QUAL=4025;DP=83,20,32;AF=1.00,1.00,1.00;MQM=60;SAP=296;ABP=0;SAR=0;SAF=135	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6439+138A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293473 [benign DISEASE=not provided];			rs12117402	0.72913	0.61456,0.67236,0.62787,0.79512,0.76119	40950,	28868	41150	-0.1030	3.79			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|2|32|37|-5	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854230	21854230	C	T	het	wt	het		QUAL=3096;DP=86,143,196;AF=0.47,0.00,0.51;MQM=60;SAP=33;ABP=3;SAR=48;SAF=92	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285614 [benign DISEASE=Connective tissue disorder,not specified,not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs12742444	0.04036	0.00948,0.03409,0.00019,0.05831,0.10439	177,	5788	146030	0.0570	2.62			/2.0>1.5/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-27|41|7|-49		94	3190	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854829	21854829	A	G	het	wt	het	off-target	QUAL=1210;DP=44,63,74;AF=0.55,0.00,0.43;MQM=60;SAP=108;ABP=4;SAR=54;SAF=2	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron48/96:c.6133+19T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1242960 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs36080251	0.04065	0.00956,0.03425,0.00019,0.05871,0.10538	180,	5821	145881	-1.1260	0.01			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|18|-45|18|19		74	2548	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21855402	21855402	C	T	het	wt	het		QUAL=5633;DP=156,258,312;AF=0.49,0.00,0.54;MQM=60;SAP=117;ABP=5;SAR=65;SAF=178	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295823 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Connective tissue disorder,Schwartz-Jampel syndrome];			rs2229475	0.04041	0.00951,0.03416,0.00019,0.05839,0.10402	178,	5794	146024	1.9340	22.50	0.24	0.15	/0.0>0.0/0.0>0.0		HSPG2|0.01|0.01|0.00|0.00|28|-35|22|1	20072119	93	3197	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856978	21856978	A	C	hom	hom	hom	off-target	QUAL=1037;DP=18,7,13;AF=1.00,1.00,1.00;MQM=60;SAP=77;ABP=0;SAR=1;SAF=37	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293461 [benign DISEASE=not provided];			rs12024579	0.76186	0.66597,0.70448,0.81852,0.80812,0.80394	44462,	26810	36176	-0.9590	1.67			/2.8>0.9/0.0>0.0		HSPG2|0.00|0.01|0.00|0.00|37|-21|42|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856983	21856983	A	G	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13;SAR=0;SAF=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285244 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs200354565	0.05023	0.04103,0.03910,0.00019,0.05968,0.10563	206,	7228	144458	-3.0650	0.03			/2.8>2.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|32|-26|39|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856984	21856984	G	T	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13;SAR=0;SAF=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285245 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs12757277	0.05022	0.04102,0.03908,0.00019,0.05967,0.10589	206,	7229	144499	-2.1160	0.03			/2.8>1.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-2|-27|31|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21857246	21857246	A	G	hom	hom	het	off-target	QUAL=7827;DP=96,120,114;AF=1.00,1.00,0.48;MQM=60;SAP=69;ABP=3;SAR=90;SAF=181	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1220862 [benign DISEASE=not provided];			rs2305562	0.50007	0.42775,0.47993,0.45933,0.54810,0.37427	19217,	37482	75896	1.6720	9.86			/0.0>0.0/0.0>0.0	COSV65970004	HSPG2|0.00|0.00|0.01|0.00|-16|49|31|37	21146954,20072119,27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21859741	21859741	A	G	hom	hom	hom	off-target	QUAL=18263;DP=95,233,279;AF=1.00,1.00,1.00;MQM=60;SAP=596;ABP=0;SAR=507;SAF=100	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron41/96:c.5183-65T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293460 [benign DISEASE=not provided];			rs10917056	0.94147	0.81209,0.97658,0.95490,0.99799,0.99317	67917,	7413	8905	-0.1920	2.36			/0.6>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-24|-44|-14|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21862269	21862269	C	T	wt	wt	het	off-target	QUAL=836;DP=133,51,70;AF=0.00,0.00,0.53;MQM=60;SAP=83;ABP=4;SAR=37;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron37/96:c.4741-154G>A::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1239399 [benign DISEASE=not provided];		L1ME3G (LINE/L1)	rs74229164	0.17402	0.07138,0.16593,0.11710,0.21917,0.32409	2692,	21077	125599	-1.9940	0.04			/0.0>0.0/1.9>0.0		HSPG2|0.04|0.00|0.00|0.00|-49|-1|-48|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864333	21864333	-	C	wt	wt	het	off-target	QUAL=901;DP=61,74,80;AF=0.02,0.00,0.55;MQM=60;SAP=101;ABP=5;SAR=45;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron36/96:c.4627-121dup::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231660 [benign DISEASE=not provided];			rs3217649	0.17853	0.09854,0.16505,0.10401,0.21542,0.32441	2697,	21727	124793		0.09			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-21|6|39|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864961	21864961	G	A	het	hom	wt		QUAL=7173;DP=123,210,348;AF=0.40,1.00,0.00;MQM=60;SAP=4;ABP=14;SAR=125;SAF=133	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	291236 [benign DISEASE=Schwartz-Jampel syndrome,not provided,not specified,Lethal Kniest-like syndrome];			rs897471	0.70423	0.61298,0.77137,0.88633,0.73190,0.56752	38063,	30958	44974	4.3150	22.80	0.15	0.12	/1.1>1.7/0.0>0.0	COSV65969427	HSPG2|0.01|0.00|0.00|0.00|-7|-13|2|-28	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872462	21872462	G	A	wt	wt	het	off-target	QUAL=1649;DP=84,104,135;AF=0.00,0.00,0.52;MQM=60;SAP=130;ABP=3;SAR=67;SAF=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4030-85C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1222152 [benign DISEASE=not provided];			rs2290497	0.05667	0.04039,0.04438,0.02579,0.06343,0.12402	267,	8087	143505	0.1500	2.87			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|25|-10|50|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872588	21872588	A	T	hom	hom	hom	off-target	QUAL=5950;DP=55,82,80;AF=0.98,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=108;SAF=108	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1233017 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs2501266	0.98296	0.94128,0.99405,0.99981,0.99949,0.99959	73569,	2443	2593	-2.1080	0.15			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|10|29|33|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872752	21872752	C	T	het	hom	wt		QUAL=3071;DP=44,80,76;AF=0.64,1.00,0.01;MQM=60;SAP=22;ABP=10;SAR=70;SAF=39	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285755 [benign DISEASE=not specified,not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2229482	0.50746	0.28240,0.45593,0.42608,0.62801,0.50145	21449,	34134	74768	0.2560	7.98			/1.7>0.6/1.6>6.7	COSV65968754	HSPG2|0.01|0.04|0.00|0.00|-2|2|3|-46	28552196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873328	21873328	G	A	het	hom	wt	off-target	QUAL=1489;DP=44,32,39;AF=0.48,1.00,0.00;MQM=60;SAP=6;ABP=3;SAR=31;SAF=22	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1235752 [benign DISEASE=not provided];			rs2454290	0.75208	0.48611,0.84950,0.97421,0.85219,0.73395	45165,	24004	37690	0.0950	1.96			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-20|-23|47|-47	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873489	21873489	G	A	het	wt	het	off-target	QUAL=285;DP=18,7,14;AF=0.50,0.00,0.36;MQM=60;SAP=19;ABP=4;SAR=12;SAF=2	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-65C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810883 [benign/likely benign DISEASE=not specified,not provided];			rs34855688	0.03553	0.00832,0.03127,0.00019,0.05022,0.10137	153,	5101	146787	0.5720	4.88			/0.5>0.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-48|33|35|33		50	1880	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873574	21873574	A	G	hom	hom	het	off-target	QUAL=584;DP=17,3,5;AF=1.00,1.00,0.40;MQM=59;SAP=42;ABP=3;SAR=21;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-150T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1252344 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2247741	0.50856	0.22550,0.45969,0.20586,0.67712,0.54657	22905,	31514	74720	0.0600	6.33			/8.4>8.8/0.0>0.0	COSV65975718	HSPG2|0.00|0.00|0.00|0.00|-34|-9|30|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873589	21873589	T	C	hom	n/a	hom	off-target	QUAL=446;DP=9,2,5;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0;SAR=15;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-165A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248137 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2445136	0.98014	0.93166,0.99346,1.00000,0.99932,0.99814	73176,	2809	3023	-1.7210	0.38			/0.0>0.0/1.4>0.0		HSPG2|0.00|0.00|0.00|0.00|-49|-24|-39|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21874342	21874342	C	G	hom	hom	hom	off-target	QUAL=10481;DP=58,108,171;AF=1.00,1.00,1.00;MQM=60;SAP=323;ABP=0;SAR=57;SAF=280	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron28/96:c.3656+64G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293451 [benign DISEASE=not provided];			rs2445135	0.98225	0.93885,0.99372,1.00000,0.99946,0.99979	73476,	2537	2701	-0.8630	0.79			/6.5>8.1/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-11|-29|24|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21875616	21875616	C	T	hom	hom	hom	off-target	QUAL=26207;DP=207,283,401;AF=0.98,1.00,1.00;MQM=60;SAP=482;ABP=0;SAR=222;SAF=664	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron25/96:c.3302+13G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295864 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];		MIRb (SINE/MIR)	rs2501265	0.94933	0.82471,0.98071,1.00000,0.99894,0.99917	69043,	6415	7713	-6.5350	0.00			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.02|0.14|-2|26|-2|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21876766	21876766	A	G	wt	het	wt	off-target	QUAL=1698;DP=140,116,120;AF=0.00,0.60,0.00;MQM=60;SAP=155;ABP=14;SAR=70;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron21/96:c.2686-114T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1270927 [benign DISEASE=not provided];			rs2454295	0.54402	0.33175,0.49017,0.36888,0.66654,0.58178	24388,	33937	69327	0.2950	5.20			/5.7>4.2/0.0>0.0	COSV65972143	HSPG2|0.00|0.01|0.00|0.00|-43|-6|31|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878013	21878013	C	T	het	het	het	off-target	QUAL=2058;DP=48,71,60;AF=0.52,0.44,0.55;MQM=60;SAP=196;ABP=3;SAR=0;SAF=89	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron21/96:c.2685+173G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1260883 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs747546	0.14481	0.25795,0.12502,0.04098,0.09599,0.13255	2018,	17997	130115	-1.3340	0.25			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.04|8|-29|11|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878915	21878915	T	C	hom	hom	hom	off-target	QUAL=5311;DP=78,44,45;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=81;SAF=86	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+79A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293450 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2454294	0.97749	0.92174,0.99293,1.00000,0.99946,0.99979	72820,	3155	3427	-1.3790	1.30			/0.0>0.0/0.5>0.0		HSPG2|0.00|0.00|0.00|0.00|-46|-2|28|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878973	21878973	T	C	hom	hom	hom	off-target;low_conf_region	QUAL=3619;DP=35,49,36;AF=0.97,1.00,1.00;MQM=60;SAP=28;ABP=0;SAR=41;SAF=78	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1263480 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2454293	0.96531	0.87990,0.98836,0.99846,0.99919,0.99897	71099,	4693	5279	-0.5580	2.13			/0.0>0.0/4.0>0.0	COSV65975893	HSPG2|0.00|0.00|0.00|0.00|9|20|21|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21879262	21879262	C	A	het	het	het	off-target	QUAL=602;DP=29,19,17;AF=0.45,0.68,0.35;MQM=60;SAP=72;ABP=3;SAR=32;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron17/96:c.2344-141G>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1180925 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs55728940	0.06397	0.04624,0.08066,0.04043,0.06402,0.12143	343,	9044	142370	0.8450	4.47			/0.8>2.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-7|41|34|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880156	21880156	T	C	hom	hom	hom		QUAL=22060;DP=196,237,255;AF=1.00,1.00,1.00;MQM=60;SAP=41;ABP=0;SAR=289;SAF=399	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295881 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs989994	0.94022	0.79197,0.97828,0.99962,0.99928,0.99938	67938,	7274	9102	0.8000	15.51	0.14	0.06	/0.3>5.7/0.0>0.0		HSPG2|0.01|0.00|0.00|0.00|-1|-19|34|-49	26648445,20072119,22257501	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880449	21880449	G	A	hom	hom	hom		QUAL=7861;DP=122,61,73;AF=1.00,1.00,1.00;MQM=60;SAP=117;ABP=0;SAR=186;SAF=70	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295882 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1874793	0.94028	0.79216,0.97827,0.99942,0.99928,0.99938	67904,	7258	9086	1.5060	10.77			/0.0>0.0/0.0>0.0	COSV65974984	HSPG2|0.00|0.00|0.00|0.00|-3|23|19|-18	34946941	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880572	21880572	G	A	het	wt	het	off-target	QUAL=807;DP=36,41,52;AF=0.33,0.00,0.48;MQM=60;SAP=8;ABP=8;SAR=14;SAF=23	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron15/96:c.1999-13C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295886 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs77828146	0.01127	0.00270,0.00687,0.00000,0.01599,0.02234	20,	1675	150525	-1.8390	0.42			5.4>5.4/5.4>5.4/0.0>0.0		HSPG2|0.00|0.01|0.00|0.00|-13|-49|-25|-49		11	816	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880742	21880742	T	C	hom	hom	hom		QUAL=11010;DP=156,75,132;AF=1.00,1.00,1.00;MQM=60;SAP=21;ABP=0;SAR=154;SAF=209	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295887 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1874792	0.97769	0.92255,0.99294,0.99981,0.99944,0.99959	72826,	3131	3395	1.1480	7.39	0.07	0.05	/0.0>0.0/0.0>1.9		HSPG2|0.00|0.00|0.00|0.00|23|-31|1|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881312	21881324	CCCAGGGTGGCAG	-	hom	hom	hom	off-target	QUAL=6233;DP=49,71,113;AF=1.00,1.00,1.00;MQM=60;SAP=153;ABP=0;SAR=53;SAF=180	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron14/96:c.1818+15_1818+27del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267614 [benign DISEASE=not provided];			rs60267433	0.96542	0.87962,0.98868,1.00000,0.99935,0.99938	71087,	4667	5259	1.2990	4.37			/0.0>0.0/0.8>0.0		HSPG2|0.00|0.00|0.00|0.00|42|-38|15|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881537	21881537	C	T	het	hom	het	off-target	QUAL=4601;DP=69,94,124;AF=0.45,1.00,0.43;MQM=60;SAP=222;ABP=10;SAR=156;SAF=22	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439797 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs921847	0.93159	0.79867,0.97174,1.00000,0.98329,0.97638	66533,	8674	10408	-0.3390	1.18			/0.0>0.0/0.0>0.0		HSPG2|0.01|0.00|0.00|0.00|-14|0|-34|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21884729	21884729	T	C	het	het	het	off-target	QUAL=6831;DP=86,246,302;AF=0.51,0.43,0.47;MQM=60;SAP=63;ABP=12;SAR=101;SAF=191	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248089 [benign DISEASE=not provided,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome];			rs4654994	0.90562	0.85197,0.90912,0.96016,0.93304,0.90012	62475,	12818	14358	-1.0400	1.28			/2.3>0.0/0.0>0.0		HSPG2|0.01|0.00|0.03|0.00|-32|-2|38|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21885632	21885632	C	A	het	het	het	off-target	QUAL=2021;DP=40,69,61;AF=0.63,0.57,0.48;MQM=60;SAP=205;ABP=6;SAR=93;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron9/96:c.1079-181G>T::	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1238974 [benign DISEASE=not provided];			rs28653609	0.13834	0.23276,0.12161,0.04043,0.09799,0.11083	1766,	17497	130985	-0.6070	0.39			/1.3>2.5/0.0>0.0		HSPG2|0.01|0.00|0.01|0.00|-13|37|-35|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21887634	21887634	A	G	hom	het	hom		QUAL=12537;DP=116,181,213;AF=1.00,0.50,1.00;MQM=60;SAP=229;ABP=3;SAR=314;SAF=105	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295909 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs2229478	0.44902	0.63794,0.50950,0.63164,0.33636,0.39963	16869,	34419	83635	-1.8380	0.99	0.16		/2.4>1.9/0.0>0.0	COSV65929973	HSPG2|0.01|0.12|0.00|0.00|40|-7|-26|26	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21890615	21890615	G	A	hom	hom	hom		QUAL=26225;DP=236,277,333;AF=1.00,1.00,1.00;MQM=60;SAP=255;ABP=0;SAR=579;SAF=266	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295913 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome];			rs2501260	0.95657	0.84931,0.98317,1.00000,0.99943,0.99979	69966,	5594	6608	2.0910	13.31			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-6|33|-6|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22452666	22452666	T	C	hom	hom	hom		QUAL=28814;DP=267,256,396;AF=1.00,1.00,1.00;MQM=60;SAP=599;ABP=0;SAR=208;SAF=710	ZBTB40	intron,5'UTR	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000404138.5:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	regulatory_region_variant:promoter				MER58B (DNA/hAT-Charlie)	rs10737466	0.97763	0.92275,0.99143,1.00000,0.99954,0.99979	72832,	3131	3405	-1.5700	1.63			/0.0>0.0/0.0>0.0		ZBTB40|0.05|0.00|0.00|0.00|-7|26|-7|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22489769	22489769	T	C	hom	het	hom	off-target	QUAL=11365;DP=158,115,173;AF=1.00,0.45,1.00;MQM=60;SAP=800;ABP=5;SAR=4;SAF=379	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-69-111T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-69-111T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron2/18:c.-69-111T>C::	regulatory_region_variant:enhancer					rs1267005	0.72177	0.89072,0.78518,0.89649,0.61526,0.70033	40863,	27985	42291	0.8330	9.46			/0.0>0.0/0.0>0.0	COSV65144913	ZBTB40|0.00|0.00|0.00|0.00|-34|43|17|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22491224	22491224	A	G	hom	het	hom	off-target	QUAL=2374;DP=68,4,8;AF=1.00,0.75,1.00;MQM=60;SAP=175;ABP=5;SAR=0;SAF=79	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron2/17:c.698-176A>G::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron2/15:c.698-176A>G::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron3/18:c.698-176A>G::	regulatory_region_variant:enhancer					rs12566074	0.25636	0.07047,0.21372,0.31888,0.34615,0.37687	6339,	26310	113098	-1.7510	0.08			/0.0>0.0/0.0>0.0	COSV65144915	ZBTB40|0.00|0.00|0.00|0.01|-1|-7|-50|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22506250	22506250	A	T	hom	het	hom		QUAL=15641;DP=214,168,209;AF=1.00,0.55,0.99;MQM=60;SAP=486;ABP=7;SAR=426;SAF=88	ZBTB40	splice_region&intron	ZBTB40:ENST00000375647.5:splice_region_variant&intron_variant:LOW:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000374651.8:splice_region_variant&intron_variant:LOW:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000404138.5:splice_region_variant&intron_variant:LOW:intron7/18:c.1360+9A>T::						rs209732	0.72161	0.89105,0.78510,0.89830,0.61478,0.69983	40836,	27996	42308	0.9000	10.34			/0.0>0.0/0.0>0.0	COSV65144922	ZBTB40|0.00|0.00|0.00|0.00|-1|-34|-9|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22509184	22509184	A	G	hom	het	hom		QUAL=24928;DP=341,273,308;AF=1.00,0.53,1.00;MQM=60;SAP=4;ABP=5;SAR=406;SAF=388	ZBTB40	missense	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:			1260804 [benign DISEASE=not provided];			rs209729	0.78777	0.90723,0.83718,0.89771,0.71485,0.70582	47731,	24208	32240	0.2260	10.71	0.02	0.07	/0.0>0.0/0.0>0.0	COSV65144925	ZBTB40|0.00|0.00|0.00|0.00|20|-34|49|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511094	22511094	T	-	het	het	het	off-target	QUAL=2615;DP=99,32,33;AF=0.57,0.44,0.61;MQM=60;SAP=198;ABP=6;SAR=0;SAF=90	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron9/17:c.1834-69del::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron7/15:c.1498-69del::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron10/18:c.1834-69del::					(T)n (Simple_repeat)	rs34404742	0.29987	0.10997,0.27387,0.48358,0.37683,0.41903	6534,	27969	95813	-0.0480	6.16			/13.6>12.7/0.0>0.0		ZBTB40|0.00|0.17|0.00|0.00|-17|20|-6|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511094	22511095	TT	-	het	wt	het	off-target	QUAL=2615;DP=99,32,33;AF=0.23,0.09,0.15;MQM=59;SAP=70;ABP=141;SAR=0;SAF=31	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron9/17:c.1834-70_1834-69del::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron7/15:c.1498-70_1498-69del::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron10/18:c.1834-70_1834-69del::					(T)n (Simple_repeat)	rs34404742	0.00149	0.00060,0.00103,0.00270,0.00143,0.00023	0,	204	136732	-0.0480	6.07			/13.6>11.5/0.0>0.0		ZBTB40|0.00|0.29|0.00|0.00|0|20|-11|-44		2	378	3	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511451	22511451	T	C	hom	het	hom	off-target	QUAL=5376;DP=90,43,72;AF=0.99,0.49,1.00;MQM=60;SAP=279;ABP=3;SAR=167;SAF=15	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron10/17:c.2002+104T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron8/15:c.1666+104T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron11/18:c.2002+104T>C::						rs2073168	0.32291	0.19340,0.27175,0.45964,0.38511,0.41708	8747,	31577	102895	-0.7320	0.39			/0.0>0.0/2.2>0.0	COSV65144929	ZBTB40|0.00|0.00|0.00|0.00|3|-1|2|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22520216	22520216	G	A	hom	hom	hom		QUAL=12230;DP=172,94,136;AF=1.00,1.00,1.00;MQM=60;SAP=109;ABP=0;SAR=271;SAF=131	ZBTB40	missense	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type]						rs209720	0.99685	0.99891,0.99725,1.00000,0.99458,0.99959	75621,	478	480	1.8680	16.30	0.17	0.05	/0.0>0.0/2.5>2.5		ZBTB40|0.00|0.00|0.00|0.00|2|-33|2|-5	18840274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22521304	22521304	G	A	hom	het	hom	off-target	QUAL=3776;DP=124,31,17;AF=1.00,0.35,1.00;MQM=60;SAP=333;ABP=9;SAR=0;SAF=152	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron14/17:c.3049-192G>A::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron12/15:c.2713-192G>A::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron15/18:c.3049-192G>A::					MIRb (SINE/MIR)	rs12754103	0.28570	0.09119,0.25488,0.45771,0.37073,0.41397	7645,	28148	108602	-0.9840	0.10			/1.6>1.1/0.0>0.0	COSV65144938	ZBTB40|0.00|0.00|0.00|0.00|34|-12|5|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22522510	22522510	A	C	hom	het	hom	off-target	QUAL=15135;DP=172,199,257;AF=0.99,0.48,0.99;MQM=60;SAP=351;ABP=4;SAR=405;SAF=116	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::					MIR (SINE/MIR)	rs998978	0.30676	0.16031,0.26441,0.45762,0.37274,0.41497	8092,	30420	105318	-6.2610	0.01			/0.0>0.5/0.0>0.0	COSV65144854	ZBTB40|0.00|0.00|0.00|0.01|22|-18|-43|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22526222	22526222	G	C	hom	het	hom		QUAL=10762;DP=167,108,140;AF=0.99,0.46,0.99;MQM=60;SAP=172;ABP=4;SAR=94;SAF=260	ZBTB40	synonymous	ZBTB40:ENST00000375647.5:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000374651.8:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000404138.5:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:						rs881646	0.30638	0.16010,0.26454,0.45714,0.37226,0.41473	8078,	30406	105412	-1.1450	0.27			/2.1>2.8/0.0>0.0	COSV65144952	ZBTB40|0.00|0.00|0.00|0.01|-4|-20|-21|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22526648	22526648	G	A	hom	het	hom		QUAL=17272;DP=141,234,316;AF=1.00,0.50,1.00;MQM=60;SAP=18;ABP=3;SAR=318;SAF=255	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::						rs2281354	0.25636	0.06969,0.21619,0.31922,0.34546,0.37578	6335,	26300	113046	0.1690	1.44			/0.0>1.1/0.0>0.0	COSV65144954	ZBTB40|0.00|0.00|0.00|0.00|-35|-12|-13|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	T	het	het	het		QUAL=987;DP=36,33,40;AF=0.42,0.24,0.55;MQM=60;SAP=84;ABP=10;SAR=2;SAF=43	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::					AluJo (SINE/Alu)	rs35637563	0.34784	0.30578,0.27755,0.44603,0.37493,0.41155	8815,	31844	92758		0.68			/9.3>10.1/0.0>0.0		ZBTB40|0.00|0.00|0.00|0.00|1|20|-30|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	TT	wt	wt	het		QUAL=987;DP=36,33,40;AF=0.06,0.00,0.18;MQM=59;SAP=23;ABP=99;SAR=0;SAF=9	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::					AluJo (SINE/Alu)	rs35637563	0.00164	0.00300,0.00183,0.00103,0.00107,0.00224	1,	231	142133		0.65			/9.3>10.1/0.0>0.0		ZBTB40|0.01|0.00|0.00|0.00|20|26|-30|-13		0	23	0	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22530108	22530108	T	C	hom	het	hom		QUAL=18929;DP=224,216,281;AF=0.99,0.49,1.00;MQM=60;SAP=83;ABP=3;SAR=229;SAF=379	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	regulatory_region_variant:enhancer					rs1062663	0.31610	0.18831,0.26699,0.45735,0.37510,0.41618	8345,	31180	103572	-2.4240	0.05			/0.2>0.7/0.0>0.0	COSV65144958	ZBTB40|0.00|0.00|0.00|0.00|3|12|-4|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22638945	22638945	A	G	het	n/a	het		QUAL=333;DP=14,2,5;AF=0.64,1.00,0.60;MQM=60;SAP=13;ABP=6;SAR=11;SAF=3	C1QA	5'UTR,3'UTR,synonymous	C1QA:ENST00000695738.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695739.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000695740.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695741.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*563A>G::,C1QA:ENST00000695742.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*490A>G::,C1QA:ENST00000695743.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*820A>G::,C1QA:ENST00000695744.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695745.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695746.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000374642.8:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000438241.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)]		120550_[GENE=C1QA_PHENOS=C1q deficiency 1, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]	1167796 [benign DISEASE=not specified,C1Q deficiency,not provided];			rs172378	0.51180	0.73244,0.53176,0.58985,0.38497,0.60676	21690,	34402	74194	-0.7330	4.63	0.06		/0.0>0.0/0.0>0.0	COSV65889459	C1QA|0.00|0.00|0.00|0.00|26|-19|-33|34	25294155,19440201,19493541,20528885,25817358,20003265,20332777,21060334,25326229,26085599,26798662,29795138,31019999,26683148,22897949,25637052,32556499,22236909,33058021,29230368,35024943,35645665,36157263	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22639734	22639734	T	G	het	het	het	off-target	QUAL=7783;DP=142,222,257;AF=0.53,0.54,0.47;MQM=60;SAP=190;ABP=4;SAR=241;SAF=76	C1QA,C1QC	downstream_gene,upstream_gene	C1QA:ENST00000695738.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695739.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695740.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695741.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695742.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695743.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695744.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695745.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695746.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.8:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.2:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000438241.2:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695749.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	120550_[GENE=C1QA_PHENOS=C1q deficiency 1, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]			AluSq2 (SINE/Alu)	rs10917274	0.35759	0.42661,0.43471,0.44959,0.29895,0.45456	10137,	34034	97564	-2.9250	1.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647804	22647804	C	A	wt	het	wt		QUAL=578;DP=125,66,94;AF=0.02,0.50,0.00;MQM=60;SAP=79;ABP=3;SAR=35;SAF=0	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*731C>A::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*430C>A::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*21C>A::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]	1221376 [benign DISEASE=not provided];			rs9434	0.50460	0.79832,0.47968,0.57343,0.36816,0.42664	22004,	32351	74967	0.4160	3.88			/0.0>0.0/0.0>0.0	COSV65889466	C1QC|0.01|0.00|0.00|0.00|-20|49|50|44	19440201,19493541,19503741,19753309,31019999	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647887	22647903	CCACCAGATGGACTTCT	-	wt	het	wt		QUAL=68;DP=26,18,16;AF=0.00,0.50,0.00;MQM=60;SAP=23;ABP=3;SAR=9;SAF=0	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*816_*832del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*515_*531del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*106_*122del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]			L2d2 (LINE/L2)	rs60255495	0.34471	0.40628,0.36588,0.33138,0.32151,0.32358	9073,	32936	97108	2.1680	6.21			/5.5>7.0/0.0>0.0		C1QC|0.00|0.00|0.00|0.00|25|8|-32|-28	20147302	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648041	T	-	het	wt	het		QUAL=1422;DP=48,40,72;AF=0.40,0.20,0.47;MQM=60;SAP=88;ABP=23;SAR=6;SAF=55	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*983del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*682del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]			L2d2 (LINE/L2)	rs10601144	0.09280	0.09009,0.06180,0.07938,0.09436,0.19991	591,	11698	125920	0.1970	0.35			/7.7>7.6/0.0>0.0		C1QC|0.00|0.00|0.00|0.00|21|40|-12|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648042	TT	-	wt	het	wt		QUAL=1422;DP=48,40,72;AF=0.13,0.25,0.10;MQM=60;SAP=45;ABP=179;SAR=1;SAF=22	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*982_*983del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*681_*682del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*272_*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]	1257095 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs10601144	0.51211	0.79313,0.48810,0.58410,0.38045,0.43390	20079,	30895	67693	0.1970	0.35			/7.7>7.5/0.0>0.0		C1QC|0.00|0.00|0.00|0.00|21|40|-12|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648073	22648073	T	G	het	wt	wt		QUAL=64;DP=53,51,64;AF=0.38,0.12,0.11;MQM=59;SAP=75;ABP=10;SAR=0;SAF=33	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1000T>G::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*699T>G::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*290T>G::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]				rs1003478565	0.00289	0.00312,0.00535,0.00262,0.00237,0.00265	0,	383	131945	-0.6130	5.99			/0.0>0.0/0.0>0.0		C1QC|0.00|0.00|0.00|0.00|-45|-12|-45|-2		0	14	0	0 / 0					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648301	22648301	C	A	wt	het	wt	off-target	QUAL=97;DP=43,19,20;AF=0.00,0.37,0.00;MQM=60;SAP=18;ABP=6;SAR=7;SAF=0	C1QC,C1QB	downstream_gene,upstream_gene	C1QC:ENST00000695749.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:downstream_gene_variant:MODIFIER::::,C1QB:ENST00000695754.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695755.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695756.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695757.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695758.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695759.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695760.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695761.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695762.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::		120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3)]&120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]				rs294180	0.50775	0.79974,0.48088,0.57812,0.37238,0.42830	22262,	32489	74663	-1.0350	0.07						20528885	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653162	22653162	T	G	het	het	het	off-target	QUAL=528;DP=26,22,16;AF=0.62,0.41,0.31;MQM=60;SAP=68;ABP=4;SAR=0;SAF=30	C1QB	upstream_gene	C1QB:ENST00000695754.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695755.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695756.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695757.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695758.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695759.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695760.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695761.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695762.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]				rs291990	0.58348	0.84063,0.53590,0.64789,0.46270,0.61028	27958,	32717	63271	-1.0180	4.53				COSV59246057			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653406	22653406	T	C	het	het	het	off-target	QUAL=825;DP=46,17,21;AF=0.41,0.59,0.48;MQM=60;SAP=88;ABP=4;SAR=39;SAF=0	C1QB	intron,5'UTR	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+38T>C::,C1QB:ENST00000695755.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-88T>C::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+38T>C::,C1QB:ENST00000695757.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-44T>C::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::	regulatory_region_variant:promoter	120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]			MER5A (DNA/hAT-Charlie)	rs291989	0.58345	0.84055,0.53589,0.64902,0.46245,0.61003	27986,	32724	63324	-0.6110	6.67			/0.4>0.0/1.4>1.6		C1QB|0.00|0.00|0.00|0.00|16|21|20|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653494	22653494	C	A	het	het	het	off-target	QUAL=397;DP=23,6,16;AF=0.48,0.33,0.50;MQM=60;SAP=49;ABP=3;SAR=21;SAF=0	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+126C>A::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-24+24C>A::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+126C>A::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-24+68C>A::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::	regulatory_region_variant:promoter	120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]				rs913243	0.43012	0.45963,0.42973,0.43748,0.41622,0.51452	14168,	37028	86602	0.7930	6.53			/1.9>2.2/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|23|-47|-12|-24	21951915,29795138	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659292	22659292	-	GATGGATG	wt	het	wt	off-target;low_conf_region	QUAL=589;DP=28,22,42;AF=0.36,0.00,0.57;MQM=60;SAP=18;ABP=9;SAR=0;SAF=7	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-119_-23-112dup::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]	1269706 [benign DISEASE=not provided];		(GGAT)n (Simple_repeat)	rs56917855	0.21891	0.26075,0.23871,0.02703,0.21999,0.14067	3414,	21277	100281		2.96			/0.0>0.0/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|-14|-2|0|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659293	22659296	GATG	-	het	wt	het	off-target;low_conf_region	QUAL=589;DP=28,22,42;AF=0.36,0.00,0.57;MQM=59;SAP=77;ABP=3;SAR=0;SAF=34	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-115_-23-112del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]	1252299 [benign DISEASE=not provided];		(GGAT)n (Simple_repeat)	rs56917855	0.08384	0.06790,0.06075,0.07105,0.09107,0.18060	467,	9851	117849	2.2220	2.66			/0.0>0.0/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|-14|-2|5|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659347	22659350	GATG	-	het	het	het	off-target;low_conf_region	QUAL=1102;DP=29,50,60;AF=0.34,0.46,0.43;MQM=60;SAP=71;ABP=10;SAR=8;SAF=51	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-49_-23-46del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]			(GGAT)n (Simple_repeat)	rs140338008	0.48108	0.50080,0.57515,0.60224,0.45337,0.47551	13948,	35070	67918	0.5560	1.18			/0.0>0.0/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|-2|-14|8|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22661465	22661465	A	G	hom	hom	hom		QUAL=38300;DP=416,348,456;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=611;SAF=609	C1QB	3'UTR	C1QB:ENST00000695754.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695755.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695756.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::,C1QB:ENST00000695757.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695758.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695759.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695760.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695761.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695762.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000509305.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695763.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1004A>G::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3)]	1258616 [benign DISEASE=not provided];			rs10580	0.98407	0.99599,0.98973,1.00000,0.97598,0.99213	73653,	2388	2424	-1.0460	4.12			/0.0>1.3/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|1|14|12|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	23796496	23796496	C	T	het	het	wt	off-target;low_conf_region	QUAL=945;DP=81,50,54;AF=0.57,0.44,0.02;MQM=60;SAP=144;ABP=3;SAR=1;SAF=68	GALE	splice_region&intron	GALE:ENST00000617979.5:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::,GALE:ENST00000374497.7:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]	92889 [benign DISEASE=not provided,not specified,UDPglucose-4-epimerase deficiency];		G-rich (Low_complexity)	rs760941	0.67051	0.62090,0.69334,0.65308,0.68240,0.76486	19762,	33021	35649	-0.7980	0.86			/0.0>0.0/0.0>0.0	COSV100994767,COSV65720422,COSV65720626	GALE|0.00|0.00|0.00|0.00|39|-34|13|10	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	23798312	23798312	T	-	het	het	het	off-target	QUAL=55;DP=68,57,68;AF=0.13,0.19,0.09;MQM=59;SAP=30;ABP=227;SAR=22;SAF=4	GALE	intron	GALE:ENST00000617979.5:intron_variant:MODIFIER:intron4/11:c.238-82del::,GALE:ENST00000374497.7:intron_variant:MODIFIER:intron4/11:c.238-82del::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs372075997	0.00327	0.00205,0.00259,0.00360,0.00235,0.01323	0,	469	142805	-0.0470	0.87			/0.0>0.0/10.5>8.4		GALE|0.01|0.00|0.04|0.00|-49|-11|0|8		1	1497	0	0 / 0					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23801977	23801977	C	T	hom	het	hom		QUAL=30152;DP=375,347,431;AF=0.99,0.50,1.00;MQM=60;SAP=45;ABP=3;SAR=420;SAF=558	HMGCL	3'UTR	HMGCL:ENST00000374490.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	296841 [benign DISEASE=UDPglucose-4-epimerase deficiency,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs11714	0.91305	0.92883,0.87793,0.83089,0.91384,0.87324	63472,	12028	13234	-0.9180	7.69			/4.6>3.7/0.0>0.0		HMGCL|0.00|0.00|0.00|0.00|-15|44|-48|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23802636	23802636	A	G	het	wt	hom	off-target	QUAL=7925;DP=153,153,194;AF=0.51,0.00,0.99;MQM=60;SAP=351;ABP=3;SAR=239;SAF=31	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.877-72T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.664-72T>C::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177625 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase];			rs2076343	0.26904	0.13735,0.24676,0.26407,0.33792,0.15666	6126,	28661	111155	1.3650	11.77			/0.9>0.0/0.0>0.0	COSV52526949	HMGCL|0.05|0.00|0.00|0.00|15|7|-20|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23804204	23804204	G	A	het	het	wt	off-target	QUAL=1043;DP=75,30,25;AF=0.56,0.37,0.00;MQM=59;SAP=118;ABP=3;SAR=0;SAF=53	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.876+196C>T::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.663+196C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]			FRAM (SINE/Alu)	rs551491388	0.00175	0.00056,0.00079,0.00000,0.00307,0.00145	1,	264	151834	-0.5680	5.53			/0.0>0.0/0.0>0.0		HMGCL|0.00|0.00|0.00|0.00|-3|37|48|-17		0	57	0	0 / 0					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23807972	23807972	C	T	hom	het	hom	off-target	QUAL=3970;DP=88,38,40;AF=0.99,0.63,1.00;MQM=60;SAP=331;ABP=9;SAR=0;SAF=151	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron7/8:c.750+163G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron5/6:c.537+163G>A::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	684182 [benign DISEASE=not provided];		L2c (LINE/L2)	rs719399	0.92302	0.96625,0.88740,0.79068,0.91443,0.86656	64898,	10572	11706	-0.1450	1.46			/0.0>0.0/0.0>0.0		HMGCL|0.00|0.00|0.00|0.00|-20|-1|29|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23808231	23808231	T	C	hom	het	hom		QUAL=21788;DP=293,225,287;AF=1.00,0.53,1.00;MQM=60;SAP=18;ABP=5;SAR=384;SAF=315	HMGCL	synonymous	HMGCL:ENST00000374490.8:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.6:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	92602 [benign DISEASE=not specified,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs719400	0.92297	0.96582,0.88742,0.79097,0.91456,0.86652	64879,	10582	11712	1.2340	10.02	0.08		/8.3>8.7/0.0>0.0		HMGCL|0.00|0.01|0.00|0.00|-20|-16|1|35	25741868,17847002,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23814521	23814521	C	T	het	wt	hom	off-target	QUAL=2281;DP=97,32,44;AF=0.54,0.00,0.98;MQM=52;SAP=209;ABP=4;SAR=95;SAF=0	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron4/8:c.349-183G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron4/6:c.348+2154G>A::		613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	673763 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs11591205	0.26545	0.13224,0.23911,0.26053,0.33591,0.15299	5982,	28356	111574	0.2740	1.63			/1.1>1.4/2.6>0.0		HMGCL|0.01|0.00|0.00|0.00|-20|17|-36|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23817442	23817442	A	G	hom	het	hom	off-target	QUAL=12969;DP=187,117,181;AF=0.99,0.50,1.00;MQM=60;SAP=389;ABP=3;SAR=75;SAF=350	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	255488 [benign DISEASE=not specified,Deficiency of hydroxymethylglutaryl-CoA lyase,not provided];			rs2076344	0.92317	0.96585,0.88822,0.79138,0.91483,0.86652	64954,	10565	11691	-1.1720	1.30			/2.5>2.0/0.0>1.8		HMGCL|0.00|0.00|0.00|0.00|33|34|47|34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23825506	23825506	C	A	het	het	hom	off-target	QUAL=1462;DP=24,34,35;AF=0.29,0.47,1.00;MQM=60;SAP=97;ABP=8;SAR=54;SAF=4	HMGCL	upstream_gene	HMGCL:ENST00000374490.8:upstream_gene_variant:MODIFIER::::,HMGCL:ENST00000436439.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177626 [benign DISEASE=not provided,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs6697805	0.40495	0.38185,0.38564,0.46423,0.42131,0.28413	12241,	36415	89485	-2.8170	0.15							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23845053	23845053	C	G	het	het	hom	off-target	QUAL=2960;DP=103,48,45;AF=0.50,0.58,0.98;MQM=60;SAP=272;ABP=4;SAR=0;SAF=124	FUCA1	downstream_gene	FUCA1:ENST00000374479.4:downstream_gene_variant:MODIFIER::::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]				rs4649119	0.36537	0.22730,0.36038,0.47509,0.43138,0.28797	10647,	34137	96281	-0.2530	2.56						19442614	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23846275	23846275	-	T	wt	het	het	off-target	QUAL=136;DP=27,8,14;AF=0.11,0.38,0.57;MQM=57;SAP=33;ABP=23;SAR=14;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron6/7:c.1161-103dup::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1294438 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs11456086	0.36083	0.22222,0.35724,0.46967,0.43106,0.28232	9590,	31741	90201		0.65			/0.0>0.0/0.0>0.0		FUCA1|0.00|0.00|0.00|0.00|12|-29|4|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23846275	23846275	C	T	het	wt	het	off-target	QUAL=136;DP=27,8,14;AF=0.19,0.13,0.21;MQM=51;SAP=23;ABP=46;SAR=9;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron6/7:c.1161-102G>A::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs1329117558	0.00001	0.00000,0.00000,0.00000,0.00000,0.00000	0,	1	141191	-3.0710	0.08			/0.0>0.0/0.0>0.0		FUCA1|0.00|0.00|0.00|0.00|-6|-1|6|1		1	30	0	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854317	23854317	A	-	het	het	het	off-target	QUAL=589;DP=106,33,48;AF=0.12,0.61,0.15;MQM=59;SAP=66;ABP=136;SAR=3;SAF=37	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron5/7:c.969+43del::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1252223 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs55699941	0.09341	0.05410,0.12441,0.21828,0.10056,0.15303	644,	11841	127421	2.7730	8.02			/7.3>8.0/0.0>0.0	COSV65699151	FUCA1|0.00|0.00|0.00|0.00|-9|-38|43|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854472	23854472	T	C	het	wt	hom		QUAL=9724;DP=257,210,202;AF=0.50,0.00,1.00;MQM=60;SAP=12;ABP=3;SAR=146;SAF=183	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	regulatory_region_variant:CTCF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	691 [benign DISEASE=not provided,Fucosidosis,FU1/FU2 POLYMORPHISM];			rs13551	0.26839	0.14492,0.23850,0.26338,0.33515,0.14806	6032,	28741	111233	0.6870	17.84	0.06	0.08	/0.0>0.0/0.0>0.0	COSV65698861	FUCA1|0.00|0.00|0.00|0.00|33|4|22|-2	7815431,17427030,8504303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854687	23854687	C	T	het	wt	hom	off-target	QUAL=2493;DP=136,43,27;AF=0.51,0.00,1.00;MQM=60;SAP=211;ABP=3;SAR=96;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron4/7:c.769-127G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683990 [benign DISEASE=not provided];		MER20 (DNA/hAT-Charlie)	rs12748109	0.26525	0.13442,0.23668,0.26292,0.33514,0.14751	5939,	28411	111601	-0.3500	7.00			/1.3>0.9/0.0>0.0	COSV65698864	FUCA1|0.00|0.00|0.00|0.00|-15|32|-6|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23865710	23865710	A	G	het	het	hom	off-target	QUAL=8586;DP=224,100,138;AF=0.53,0.55,0.99;MQM=60;SAP=650;ABP=7;SAR=307;SAF=3	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron1/7:c.390-85T>C::	TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683925 [benign DISEASE=not provided];			rs34902309	0.37603	0.26332,0.36827,0.47262,0.43154,0.28835	11090,	34986	94858	0.9330	8.76			/0.9>0.0/0.0>0.0	COSV65692469	FUCA1|0.00|0.00|0.00|0.01|37|10|47|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868258	23868258	G	C	wt	het	wt		QUAL=1393;DP=158,112,123;AF=0.00,0.54,0.01;MQM=60;SAP=48;ABP=5;SAR=49;SAF=13	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	regulatory_region_variant:promoter	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193053 [benign DISEASE=not provided,not specified,Fucosidosis];			rs2070956	0.10691	0.11816,0.12754,0.20887,0.09593,0.14017	954,	14353	135845	0.7020	11.56	0.09	0.07	/0.0>0.0/0.1>0.0	COSV65692258	FUCA1|0.00|0.00|0.00|0.00|-42|30|35|-48	24033266,9039984,27346075,34425818,35055161	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868280	23868280	C	G	het	het	wt		QUAL=2487;DP=147,107,113;AF=0.46,0.45,0.00;MQM=60;SAP=153;ABP=8;SAR=102;SAF=13	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	296895 [benign/likely benign DISEASE=not provided,Fucosidosis];			rs61996282	0.00942	0.00227,0.04228,0.00000,0.00841,0.01593	21,	1392	150718	-2.1530	6.24	0.07	0.08	/0.0>0.0/0.0>0.0		FUCA1|0.00|0.00|0.00|0.00|8|-27|-13|16	25741868,34861174	3	347	0	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868283	23868283	G	A	wt	het	wt		QUAL=1196;DP=123,103,113;AF=0.00,0.52,0.01;MQM=60;SAP=63;ABP=4;SAR=47;SAF=8	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193052 [benign DISEASE=not specified,not provided,Fucosidosis];			rs2070955	0.10687	0.11793,0.12746,0.20919,0.09598,0.14037	952,	14345	135795	-0.7810	16.29	0.08	0.35	/0.0>0.0/0.0>0.0	COSV65692243	FUCA1|0.00|0.00|0.00|0.00|5|-3|2|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868298	23868298	A	G	wt	het	wt		QUAL=1137;DP=77,96,100;AF=0.01,0.52,0.01;MQM=60;SAP=57;ABP=3;SAR=44;SAF=8	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193051 [benign DISEASE=not specified,not provided,Fucosidosis];			rs2070954	0.10689	0.11801,0.12746,0.20931,0.09594,0.14061	953,	14338	135722	0.1300	10.33							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868372	23868372	A	C	wt	het	wt		QUAL=417;DP=27,49,33;AF=0.00,0.43,0.03;MQM=60;SAP=51;ABP=5;SAR=22;SAF=0	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	368872 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs2070953	0.10699	0.11816,0.12770,0.21000,0.09599,0.13960	962,	14351	135845	-0.5800	6.98							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868408	23868408	C	A	wt	het	wt	off-target	QUAL=319;DP=19,37,20;AF=0.00,0.46,0.00;MQM=60;SAP=40;ABP=4;SAR=17;SAF=0	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683915 [benign DISEASE=not provided];			rs2070952	0.10666	0.11843,0.12751,0.20948,0.09516,0.14070	961,	14298	135846	-0.5740	5.02							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	25800934	25800934	G	A	hom	hom	het	off-target	QUAL=6957;DP=91,93,127;AF=1.00,1.00,0.56;MQM=60;SAP=523;ABP=7;SAR=4;SAF=251	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron1/12:c.184-109G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron1/11:c.184-109G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron1/11:c.184-109G>A::	regulatory_region_variant:promoter	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669827 [benign DISEASE=not provided];			rs6659086	0.63175	0.77952,0.67447,0.64883,0.54866,0.73301	31155,	33495	55845	-0.9560	4.31			/0.0>0.0/0.0>0.0	COSV62525010	SEPN1|0.00|0.00|0.00|0.00|-23|1|12|-39	29777993	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25804968	25804968	G	A	het	hom	wt	off-target	QUAL=2266;DP=115,34,34;AF=0.53,1.00,0.00;MQM=60;SAP=209;ABP=4;SAR=0;SAF=95	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron3/12:c.404-174G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron2/11:c.302-174G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron2/11:c.302-174G>A::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669829 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs11247735	0.50840	0.49229,0.62911,0.61184,0.48248,0.68563	19881,	37373	74585	-0.0180	3.28			/0.4>8.3/0.0>0.0	COSV62524936	SEPN1|0.01|0.00|0.00|0.01|2|-24|43|-24	22615972,27186328,31027226,25330801,29793041	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25805163	25805163	G	A	hom	hom	het		QUAL=15930;DP=163,221,333;AF=0.99,1.00,0.52;MQM=60;SAP=255;ABP=4;SAR=151;SAF=405	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95963 [benign DISEASE=SEPN1-Related Disorders,not provided,not specified,Eichsfeld type congenital muscular dystrophy];			rs7349185	0.79513	0.78111,0.85301,0.93451,0.78069,0.88706	48208,	24310	31106	0.8690	13.21	0.04		/2.4>1.6/0.0>1.8	COSV62525203	SEPN1|0.00|0.00|0.00|0.00|-2|-48|-2|-21	25741868,24033266,18414213,23757202,23800289,26673400,32817544	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25809961	25809961	A	C	hom	hom	het	off-target	QUAL=5793;DP=63,88,141;AF=1.00,1.00,0.46;MQM=60;SAP=472;ABP=5;SAR=216;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron7/12:c.1010+141A>C::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron6/11:c.908+141A>C::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron6/11:c.839+141A>C::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669830 [benign DISEASE=not provided];			rs6686366	0.76796	0.67343,0.84026,0.97734,0.78231,0.89138	45241,	26167	35245	0.0430	4.83			/0.5>0.9/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|16|-29|15|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811645	25811645	C	A	hom	hom	het	off-target	QUAL=18775;DP=150,279,383;AF=1.00,1.00,0.53;MQM=60;SAP=41;ABP=6;SAR=368;SAF=263	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron7/11:c.922-46C>A::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	261271 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not provided,not specified];			rs760598	0.69907	0.46907,0.80435,0.96553,0.76568,0.88589	38885,	28477	45737	0.9110	4.70			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|16|46|-43|22	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811771	25811771	T	C	hom	hom	het		QUAL=24640;DP=211,353,489;AF=1.00,1.00,0.52;MQM=60;SAP=3;ABP=4;SAR=402;SAF=413	SELENON	synonymous	SELENON:ENST00000361547.7:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:,SELENON:ENST00000354177.9:synonymous_variant:LOW:exon8/12:c.1002T>C:p.Pro334=:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95956 [benign DISEASE=SEPN1-Related Disorders,not specified,not provided,Eichsfeld type congenital muscular dystrophy];			rs760597	0.74941	0.61675,0.82771,0.96604,0.78116,0.88783	43465,	27044	38112	0.3020	9.57			/4.1>4.6/0.0>0.0	COSV62525913	SEPN1|0.00|0.00|0.00|0.00|19|5|4|17	25741868,24033266,18414213,23757202,23800289	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811960	25811960	A	G	hom	hom	het	off-target	QUAL=7201;DP=60,127,194;AF=1.00,0.99,0.46;MQM=60;SAP=602;ABP=5;SAR=276;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1281+81A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1179+81A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1110+81A>G::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669832 [benign DISEASE=not provided];			rs11247744	0.74951	0.61661,0.82779,0.96627,0.78123,0.88772	43459,	27036	38084	0.0640	5.80			/4.3>4.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|-10|18|-1|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812480	25812480	-	ACAT	het	het	n/a	off-target;low_conf_region	QUAL=578;DP=22,7,1;AF=0.68,0.57,1.00;MQM=60;SAP=20;ABP=16;SAR=0;SAF=8	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-206_1282-205insCATA::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-206_1180-205insCATA::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-206_1111-205insCATA::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	1271278 [benign DISEASE=not provided];		(CA)n (Simple_repeat)	rs57085889	0.81877	0.85568,0.85655,0.97563,0.78149,0.88919	50973,	21925	27419		2.32			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|29|23|2|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812480	25812480	C	T	het	het	n/a	off-target;low_conf_region	QUAL=578;DP=22,7,1;AF=0.23,0.43,0.00;MQM=59;SAP=46;ABP=9;SAR=0;SAF=20	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-207C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-207C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-207C>T::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]			(CA)n (Simple_repeat)	rs116343724	0.00019	0.00010,0.00020,0.00000,0.00024,0.00021	1,	26	151308	-2.7320	0.06			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|31|23|-2|38		3000	5518	0	0 / 0					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812561	25812564	ACAA	-	n/a	hom	wt	off-target;low_conf_region	QUAL=170;DP=0,6,8;AF=,0.83,0.00;MQM=60;SAP=14;ABP=0;SAR=0;SAF=5	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-123_1282-120del::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-123_1180-120del::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-123_1111-120del::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]			(AC)n (Simple_repeat)	rs201110629	0.01724	0.00833,0.01558,0.00084,0.02302,0.01140	11,	1694	97834	0.1230	0.85			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|-27|43|24|20		7	404	0	0 / 0					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812564	25812564	-	AC	n/a	wt	hom	off-target;low_conf_region	QUAL=170;DP=0,6,8;AF=,0.83,0.00;MQM=60;SAP=10;ABP=0;SAR=0;SAF=3	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-82_1282-81dup::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-82_1180-81dup::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-82_1111-81dup::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	1233960 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs59333545	0.11240	0.11374,0.09321,0.02750,0.12600,0.09651	844,	12911	115285		2.66			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|-31|39|24|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812646	25812646	C	T	hom	hom	het	off-target	QUAL=2988;DP=19,54,70;AF=1.00,1.00,0.54;MQM=60;SAP=81;ABP=4;SAR=24;SAF=87	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-41C>T::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	261274 [benign DISEASE=not specified,not provided,Eichsfeld type congenital muscular dystrophy];			rs10902685	0.65845	0.29973,0.79259,0.96638,0.77991,0.88566	36507,	25883	51299	-0.0280	3.13			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.01|0.00|0.00|41|-24|-34|40	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812901	25812901	A	G	hom	hom	het	off-target	QUAL=2619;DP=34,40,56;AF=1.00,1.00,0.45;MQM=60;SAP=218;ABP=4;SAR=99;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+109A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+109A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+109A>G::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669834 [benign DISEASE=not provided];			rs3738451	0.75004	0.61868,0.82720,0.96564,0.78124,0.88734	43469,	26993	37969	-1.6750	0.11			/1.1>1.3/1.4>0.0		SEPN1|0.00|0.00|0.00|0.00|-15|13|-12|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812953	25812953	G	A	hom	hom	het	off-target	QUAL=1509;DP=20,25,25;AF=1.00,1.00,0.40;MQM=60;SAP=122;ABP=5;SAR=55;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+161G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+161G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+161G>A::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669835 [benign DISEASE=not provided];		MIRc (SINE/MIR)	rs10751726	0.65005	0.29880,0.78390,0.96587,0.76483,0.88500	35917,	26883	53143	0.3650	9.25			/0.0>2.2/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|3|-34|-39|49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25814082	25814082	C	A	hom	hom	het		QUAL=22129;DP=219,326,439;AF=1.00,1.00,0.50;MQM=60;SAP=130;ABP=3;SAR=489;SAF=277	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon11/12:c.1335C>A:p.Asn445Lys:		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95959 [benign DISEASE=SEPN1-Related Disorders,not provided,Eichsfeld type congenital muscular dystrophy,not specified];			rs2294228	0.65853	0.30132,0.79207,0.96587,0.77958,0.88652	36889,	26305	51897	0.1400	13.69	0.09		/0.0>0.0/0.0>0.0	COSV62525671	RP1-317E23.6|0.01|0.02|0.00|0.00|22|-5|-5|47,SEPN1|0.33|0.01|0.00|0.00|22|-27|25|47	25741868,24033266,18414213,23757202,22615972,25332755,23800289,26673400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25817213	25817213	-	TTTTG	hom	hom	het		QUAL=11772;DP=151,192,232;AF=0.96,1.00,0.43;MQM=59;SAP=216;ABP=13;SAR=115;SAF=322	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]				rs3033477	0.72264	0.52581,0.81648,0.96598,0.77958,0.88721	40659,	27525	41775		1.60			/0.0>0.6/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|23|47|17|-38,SEPN1|0.00|0.00|0.00|0.00|23|47|-8|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817330	25817330	T	C	hom	hom	het		QUAL=16585;DP=247,179,269;AF=1.00,0.98,0.45;MQM=55;SAP=20;ABP=8;SAR=239;SAF=305	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750	0.72078	0.51720,0.81660,0.96628,0.78052,0.88776	40881,	27687	42399	0.3080	2.99			/1.6>1.9/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|5|-20|-21|11,SEPN1|0.00|0.00|0.00|0.00|4|-20|27|-21	27586304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817440	25817440	T	C	hom	hom	het		QUAL=22347;DP=343,229,350;AF=1.00,1.00,0.45;MQM=54;SAP=96;ABP=10;SAR=276;SAF=453	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383	0.81016	0.82373,0.85009,0.97706,0.78253,0.89216	50114,	22945	28863	-1.2160	0.80			/5.5>4.8/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|-43|11|-43|10,SEPN1|0.00|0.00|0.00|0.00|-40|11|46|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817947	25817947	C	-	hom	hom	het		QUAL=4604;DP=81,80,108;AF=0.99,1.00,0.61;MQM=60;SAP=287;ABP=15;SAR=199;SAF=27	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs371383269	0.72536	0.52802,0.82135,0.96622,0.78257,0.88711	41194,	27583	41639	-0.8170	0.76			/7.8>8.0/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|19|25|24|13,SEPN1|0.02|0.00|0.00|0.00|25|38|24|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26177705	26177705	C	G	het	het	wt	off-target	QUAL=3171;DP=138,107,149;AF=0.60,0.48,0.00;MQM=60;SAP=285;ABP=8;SAR=133;SAF=1	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.52+106C>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.52+106C>G::	regulatory_region_variant:promoter				AluSx1 (SINE/Alu)	rs2783707	0.41039	0.59767,0.50144,0.65019,0.28721,0.48548	14603,	33157	89599	-0.9920	1.62			/0.0>0.0/4.4>3.5		CNKSR1|0.00|0.00|0.00|0.01|-5|39|-1|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180262	26180262	A	G	het	het	wt	off-target	QUAL=416;DP=49,5,6;AF=0.41,0.40,0.00;MQM=60;SAP=51;ABP=7;SAR=0;SAF=22	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-913A>G::					MER5A (DNA/hAT-Charlie)	rs1889737	0.25120	0.45425,0.36866,0.63863,0.09952,0.40050	7374,	23436	113824	0.0920	4.56			/0.6>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|-42|-36|-44|-36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180299	26180299	A	G	het	het	wt	off-target	QUAL=677;DP=59,16,18;AF=0.47,0.31,0.00;MQM=60;SAP=75;ABP=5;SAR=0;SAF=33	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-876A>G::					MIRb (SINE/MIR)	rs1889738	0.25101	0.45402,0.36837,0.63855,0.09961,0.40000	7351,	23409	113719	0.8660	7.19			/6.7>2.6/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|26|2|43|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181096	26181096	A	G	het	n/a	n/a	off-target	QUAL=85;DP=4,1,0;AF=0.75,1.00,;MQM=60;SAP=12;ABP=5;SAR=4;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.392+200A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.392+200A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-383+200A>G::					AluSz (SINE/Alu)	rs12044058	0.14568	0.09270,0.32199,0.64125,0.09706,0.39721	3022,	16068	129670	-0.4060	1.22			/0.0>0.0/0.6>0.0		CNKSR1|0.00|0.00|0.00|0.00|43|40|43|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181802	26181802	G	A	het	het	wt	off-target	QUAL=5043;DP=208,206,281;AF=0.50,0.51,0.00;MQM=60;SAP=293;ABP=3;SAR=21;SAF=188	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	regulatory_region_variant:open_chromatin_region				MIRb (SINE/MIR)	rs3819033	0.12499	0.02709,0.31345,0.59988,0.09629,0.39643	2675,	13651	133021	0.6040	7.55			/0.0>0.0/0.0>0.0	COSV64163468	CNKSR1|0.00|0.00|0.00|0.00|-44|-49|-23|-49	32450446,24560374	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181989	26181989	T	C	het	het	wt	off-target	QUAL=5568;DP=212,245,318;AF=0.46,0.53,0.00;MQM=60;SAP=249;ABP=3;SAR=193;SAF=33	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	regulatory_region_variant:open_chromatin_region					rs2275945	0.16434	0.15698,0.32807,0.64366,0.09719,0.39988	3415,	18164	127090	0.3060	11.55			/0.0>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|37|31|42|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26183948	26183948	G	A	het	het	hom	off-target;low_conf_region	QUAL=328;DP=12,3,8;AF=0.67,0.67,1.00;MQM=60;SAP=42;ABP=7;SAR=0;SAF=18	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron9/20:c.855+118G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron9/20:c.876+118G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron8/19:c.81+118G>A::						rs12733981	0.22748	0.06007,0.22916,0.22354,0.29945,0.12678	2623,	12766	61168	-0.1120	2.21	0.05		/8.2>6.5/0.0>0.0		CNKSR1|0.01|0.00|0.00|0.01|10|-17|10|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185209	26185209	A	G	hom	hom	hom	off-target	QUAL=20266;DP=160,212,265;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=340;SAF=296	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+23A>G::						rs2783680	0.59049	0.46783,0.69896,0.97181,0.58870,0.80651	27499,	34630	62158	-0.7820	0.29			/2.1>0.0/9.9>7.5		CNKSR1|0.00|0.00|0.00|0.02|9|1|-23|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185393	26185393	T	-	het	wt	het	off-target	QUAL=18;DP=15,10,14;AF=0.33,0.10,0.14;MQM=60;SAP=20;ABP=20;SAR=8;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+223del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+223del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+223del::					AluYj4 (SINE/Alu)	rs559527821	0.00314	0.00116,0.00332,0.00044,0.00320,0.00122	0,	410	130240	-1.7500	0.08			/3.7>3.1/0.0>0.0		CNKSR1|0.01|0.00|0.00|0.00|22|28|-27|-15		10	460	0	0 / 0					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26187620	26187620	C	T	het	wt	het	off-target	QUAL=114;DP=30,12,23;AF=0.23,0.00,0.09;MQM=43;SAP=23;ABP=53;SAR=9;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron16/20:c.1454+138C>T::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron16/20:c.1475+138C>T::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron15/19:c.680+138C>T::					AluSg (SINE/Alu)	rs1385309412	0.00001	0.00000,0.00000,0.00000,0.00002,0.00000	0,	1	119923	-1.7410	0.27			/0.0>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|30|28|-25|-29		1	6	0	0 / 0					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26187621	26187621	T	-	wt	het	wt	off-target	QUAL=114;DP=30,12,23;AF=0.20,0.50,0.17;MQM=50;SAP=38;ABP=39;SAR=16;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron16/20:c.1454+158del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron16/20:c.1475+158del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron15/19:c.680+158del::					AluSg (SINE/Alu)	rs35307485	0.24258	0.31813,0.35320,0.59419,0.16504,0.46527	3479,	22084	90680	0.3030	0.81			/0.0>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.01|0.00|28|-29|-29|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26189039	26189045	CCAGACT	-	hom	hom	hom	off-target	QUAL=1613;DP=16,20,32;AF=1.00,0.95,1.00;MQM=60;SAP=132;ABP=0;SAR=65;SAF=2	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron20/20:c.1872+101_1872+107del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron20/20:c.1893+101_1893+107del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron19/19:c.1098+101_1098+107del::						rs11278474	0.95319	0.83904,0.98051,0.99942,0.99882,0.99917	69337,	5973	7103	1.0370	5.72			/1.3>1.3/0.0>0.0		CNKSR1|0.01|0.01|0.00|0.00|12|5|-29|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26760698	26760698	T	A	het	het	wt	off-target	QUAL=486;DP=72,4,3;AF=0.43,0.50,0.00;MQM=59;SAP=75;ABP=6;SAR=0;SAF=33	ARID1A	intron	ARID1A:ENST00000430799.7:intron_variant:MODIFIER:intron4/19:c.772-158T>A::,ARID1A:ENST00000324856.13:intron_variant:MODIFIER:intron4/19:c.1921-158T>A::,ARID1A:ENST00000457599.6:intron_variant:MODIFIER:intron4/19:c.1921-158T>A::,ARID1A:ENST00000374152.7:intron_variant:MODIFIER:intron3/18:c.772-158T>A::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	1261600 [benign DISEASE=not provided];			rs191253395	0.08134	0.02735,0.07454,0.01995,0.11529,0.06301	590,	10840	135760	0.2220	0.45			/0.0>0.0/0.0>0.0	COSV61381440	ARID1A|0.00|0.00|0.00|0.00|-1|22|20|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26780484	26780484	C	T	wt	wt	het		QUAL=3133;DP=159,190,236;AF=0.00,0.00,0.52;MQM=60;SAP=11;ABP=4;SAR=72;SAF=51	ARID1A	synonymous	ARID1A:ENST00000430799.7:synonymous_variant:LOW:exon20/20:c.5434C>T:p.Leu1812=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000324856.13:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000457599.6:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000374152.7:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa]		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	210262 [benign/likely benign DISEASE=not specified,not provided,Intellectual disability, autosomal dominant 14];			rs149633292	0.00442	0.00043,0.00059,0.00000,0.00425,0.00083	10,	653	151541	0.6540	7.24	0.10		/4.6>4.6/0.0>0.0	COSV61385556	ARID1A|0.00|0.00|0.00|0.00|13|-26|-15|-19	25741868	1	246	0	0 / 0	2	"Prima Vista kein Anhalt für Splice-Defekt; 160727 [2] ahwalds1 28.07.2016"			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26781160	26781160	A	-	het	het	het	low_conf_region	QUAL=626;DP=88,16,27;AF=0.24,0.25,0.26;MQM=60;SAP=4;ABP=77;SAR=14;SAF=18	ARID1A	3'UTR	ARID1A:ENST00000430799.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:ENST00000324856.13:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs71007893	0.01836	0.02435,0.01419,0.00981,0.01706,0.00671	10,	2086	112576	0.0460	6.28			/0.0>0.0/4.8>4.8		ARID1A|0.00|0.00|0.00|0.00|-2|-1|-2|-15		18	349	0	0 / 0					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27369520	27369520	C	T	hom	hom	hom	off-target	QUAL=26188;DP=314,256,312;AF=1.00,1.00,1.00;MQM=60;SAP=1918;ABP=0;SAR=882;SAF=0	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	regulatory_region_variant:CTCF_binding_site	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs10218730	0.99255	0.97376,0.99791,1.00000,0.99997,0.99979	75011,	1104	1134	-0.5380	1.56			/0.0>0.0/0.0>2.2		FCN3|0.02|0.06|0.00|0.00|-43|9|3|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	27372958	27372958	A	T	hom	hom	hom	off-target	QUAL=1541;DP=31,16,9;AF=1.00,1.00,1.00;MQM=60;SAP=125;ABP=0;SAR=0;SAF=56	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron5/7:c.393+178T>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron4/6:c.360+178T>A::,FCN3:ENST00000699963.1:intron_variant:MODIFIER:intron5/6:c.393+178T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]	992482 [uncertain significance DISEASE=Rheumatic heart disease];			rs10794501	0.69460	0.54014,0.76449,0.90012,0.73943,0.79182	37450,	30491	46339	-0.1530	3.10			/0.0>0.0/4.0>1.4		FCN3|0.00|0.00|0.01|0.00|-31|6|-16|6	22471352,19220833,33591573,33499929	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	32780201	32780201	C	G	het	het	het		QUAL=9601;DP=261,187,254;AF=0.54,0.61,0.46;MQM=60;SAP=64;ABP=8;SAR=237;SAF=135	YARS1	synonymous	YARS1:ENST00000373477.9:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain],YARS1:ENST00000675785.2:synonymous_variant:LOW:exon10/12:c.1071G>C:p.Leu357=:PF01588 [Putative tRNA binding domain]		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297151 [benign DISEASE=Charcot-Marie-Tooth disease dominant intermediate C,not specified];			rs699005	0.10353	0.10047,0.16682,0.00173,0.10199,0.05919	905,	13934	136328	3.9130	9.05			/0.0>0.0/3.9>0.0		YARS|0.00|0.00|0.02|0.02|-7|49|12|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32780839	32780839	T	C	het	het	wt	off-target	QUAL=1327;DP=98,35,50;AF=0.42,0.54,0.00;MQM=60;SAP=133;ABP=6;SAR=0;SAF=60	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron10/12:c.1140+209A>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron9/11:c.993+209A>G::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1253354 [benign DISEASE=not provided];			rs2282293	0.13734	0.03411,0.12226,0.21005,0.18015,0.22938	1787,	17319	131233	-0.2280	1.76			/0.0>0.0/0.0>0.0	COSV65113845	YARS|0.00|0.00|0.00|0.00|13|-49|-12|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32782196	32782196	G	T	het	het	het	off-target	QUAL=1006;DP=40,30,23;AF=0.50,0.57,0.48;MQM=60;SAP=107;ABP=3;SAR=0;SAF=48	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron9/12:c.1042+208C>A::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron8/11:c.895+208C>A::	regulatory_region_variant:enhancer	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670891 [benign DISEASE=not provided];			rs699004	0.07914	0.01781,0.15574,0.00173,0.10109,0.05920	667,	10689	139891	-0.2010	1.30			/0.0>5.1/0.0>0.6		YARS|0.00|0.00|0.00|0.02|-2|23|40|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32786499	32786521	CACATGCATGACTATTCCTAGCC	-	het	het	wt	off-target	QUAL=3616;DP=117,227,316;AF=0.49,0.50,0.00;MQM=60;SAP=148;ABP=3;SAR=139;SAF=32	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron6/11:c.674-74_674-52del::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1175561 [benign DISEASE=not provided];		L2d (LINE/L2)	rs149745059	0.13695	0.03408,0.12159,0.20980,0.17962,0.22769	1779,	17256	131172	1.7760	4.89			/2.0>2.0/5.0>0.7		YARS|0.00|0.00|0.00|0.00|-50|-6|-20|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791044	32791044	G	C	het	het	het	off-target	QUAL=4780;DP=195,63,92;AF=0.57,0.52,0.57;MQM=60;SAP=429;ABP=14;SAR=0;SAF=196	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron6/12:c.684+118C>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron5/11:c.537+118C>G::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670889 [benign DISEASE=not provided];			rs881393	0.17338	0.26259,0.21426,0.00212,0.13844,0.06714	2659,	21023	125589	0.5200	4.34			/2.9>1.4/0.0>0.0		YARS|0.00|0.00|0.00|0.00|0|17|1|12	27903959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791283	32791283	C	A	hom	hom	het	off-target	QUAL=16382;DP=244,165,263;AF=0.99,0.99,0.52;MQM=60;SAP=277;ABP=4;SAR=403;SAF=141	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron4/11:c.445-29G>T::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670888 [benign DISEASE=not provided];			rs1765223	0.31176	0.30008,0.33703,0.21230,0.31849,0.29689	7496,	32348	104510	1.2110	7.15			/0.0>0.0/0.0>0.0	COSV65113032	YARS|0.00|0.00|0.00|0.00|-29|-32|-41|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32810823	32810823	G	A	hom	hom	hom	off-target	QUAL=21317;DP=292,158,212;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0;SAR=262;SAF=399	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron1/11:c.58-57C>T::	regulatory_region_variant:enhancer	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670335 [benign DISEASE=not provided];			rs4951787	0.98738	0.95632,0.99554,1.00000,0.99979,1.00000	74171,	1836	1920	-0.4320	0.48			/0.0>0.0/5.6>1.5		YARS|0.00|0.00|0.00|0.00|-34|-35|17|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32817174	32817174	C	A	het	het	het	off-target	QUAL=3106;DP=123,71,103;AF=0.48,0.51,0.44;MQM=60;SAP=48;ABP=5;SAR=43;SAF=97	YARS1	splice_region&intron	YARS1:ENST00000373477.9:splice_region_variant&intron_variant:LOW:intron1/12:c.57+14G>T::,YARS1:ENST00000675785.2:splice_region_variant&intron_variant:LOW:intron1/11:c.57+14G>T::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297163 [benign DISEASE=Charcot-Marie-Tooth disease dominant intermediate C,not specified];			rs72654020	0.10192	0.09490,0.16625,0.00173,0.10193,0.05830	890,	13727	136639	-0.2670	5.06			/0.0>0.0/0.0>0.0		YARS|0.00|0.00|0.01|0.01|13|34|-34|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	32817927	32817927	G	A	het	n/a	n/a		QUAL=31;DP=7,0,1;AF=0.57,,0.00;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	YARS1,S100PBP	5'UTR,intron	YARS1:ENST00000675785.2:5_prime_UTR_variant:MODIFIER:exon1/12:c.-683C>T::,S100PBP:ENST00000373476.5:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,S100PBP:ENST00000373475.10:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297175 [benign DISEASE=not provided,Charcot-Marie-Tooth disease dominant intermediate C];			rs72654022	0.07934	0.01835,0.15609,0.00173,0.10102,0.05919	676,	10724	140128	1.5060	14.83			/5.6>6.0/0.0>0.0,/0.0>0.0/2.6>2.0		S100PBP|0.00|0.00|0.00|0.00|-41|1|10|-43,YARS|0.00|0.00|0.02|0.00|-13|-49|-16|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33010464	33010464	G	A	het	het	wt		QUAL=861;DP=322,105,140;AF=0.22,0.13,0.07;MQM=34;SAP=4;ABP=339;SAR=50;SAF=45	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2717C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs143947377	0.49703	0.49364,0.49799,0.49768,0.49842,0.49777	0,	64367	65137	2.3890	18.09			/1.6>1.9/0.0>0.0	COSV61470449			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010473	33010473	A	T	het	het	wt		QUAL=970;DP=341,111,148;AF=0.23,0.13,0.07;MQM=34;SAP=6;ABP=353;SAR=56;SAF=45	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2708T>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs199780633	0.49688	0.49374,0.49784,0.49792,0.49816,0.49703	0,	64398	65206	0.7280	15.20			/3.0>1.1/0.0>0.0	COSV61467968			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010489	33010489	T	C	het	het	wt		QUAL=1341;DP=391,112,146;AF=0.24,0.11,0.08;MQM=35;SAP=7;ABP=369;SAR=66;SAF=51	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2692A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs140167370	0.49678	0.49358,0.49800,0.49656,0.49801,0.49779	0,	64433	65269	-2.4150	0.37			/0.0>0.0/0.0>0.0	COSV61470454			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010542	33010542	G	A	het	het	het		QUAL=70;DP=256,84,107;AF=0.14,0.12,0.11;MQM=38;SAP=5;ABP=535;SAR=33;SAF=25	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2639C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201412582	0.49678	0.49358,0.49798,0.49885,0.49798,0.49773	0,	63975	64805	0.4830	8.62			/0.0>0.0/0.5>0.0	COSV61467875			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010623	33010624	AC	-	het	het	het		QUAL=1726;DP=220,71,72;AF=0.29,0.27,0.33;MQM=46;SAP=3;ABP=139;SAR=52;SAF=54	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2557_*2558del::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs67829320	0.49924	0.49804,0.49967,0.49981,0.49973,0.50000	0,	74401	74629	-0.1030	4.34			/0.0>0.0/5.2>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010638	33010638	T	C	het	het	het		QUAL=2688;DP=269,72,79;AF=0.31,0.32,0.37;MQM=47;SAP=8;ABP=116;SAR=59;SAF=77	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2543A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066438	0.49940	0.49849,0.49967,0.49981,0.49979,0.50000	0,	75176	75358	0.0200	4.96			/0.0>0.0/6.9>3.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010691	33010691	A	G	het	het	het		QUAL=4597;DP=269,136,118;AF=0.30,0.49,0.46;MQM=50;SAP=131;ABP=64;SAR=46;SAF=155	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2490T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066439	0.49951	0.49871,0.49980,0.50000,0.49981,0.50000	0,	75861	76011	0.1500	6.12			/0.0>0.0/0.0>0.0	COSV61466645			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010752	33010752	C	T	het	het	het		QUAL=2565;DP=234,155,143;AF=0.18,0.41,0.33;MQM=47;SAP=26;ABP=208;SAR=57;SAF=97	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2429G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs66599471	0.49919	0.49806,0.49954,0.49981,0.49967,0.49979	4,	74888	75138	-0.2060	9.65			/0.0>0.0/1.5>2.9	COSV61466298			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010784	33010784	C	G	het	het	het	low_conf_region	QUAL=1867;DP=232,141,137;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=244;SAR=60;SAF=76	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2397G>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76881767	0.49710	0.49375,0.49818,0.49807,0.49849,0.49860	0,	67589	68379	0.0650	19.37			/7.6>8.8/0.0>0.0	COSV61466684			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010786	33010786	C	T	het	het	het	low_conf_region	QUAL=1867;DP=232,141,137;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=244;SAR=60;SAF=76	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2395G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201842558	0.49676	0.49305,0.49791,0.49757,0.49840,0.49736	0,	65619	66475	0.0390	16.02			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010795	33010795	G	A	het	het	het	low_conf_region	QUAL=1787;DP=233,132,137;AF=0.21,0.35,0.23;MQM=48;SAP=5;ABP=273;SAR=57;SAF=69	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2386C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs79824855	0.49511	0.49028,0.49671,0.49747,0.49706,0.49510	0,	58215	59365	1.6360	22.60			/0.0>0.0/0.0>0.0	COSV61466650			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010803	33010803	T	G	het	het	het	low_conf_region	QUAL=1361;DP=220,128,132;AF=0.20,0.32,0.23;MQM=48;SAP=5;ABP=286;SAR=52;SAF=63	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2378A>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76230073	0.48955	0.48085,0.49190,0.49206,0.49354,0.49040	0,	48571	50645	1.7520	20.60			/0.0>0.0/0.0>0.0	COSV61467923			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013330	33013330	G	C	het	wt	wt	low_conf_region	QUAL=529;DP=662,476,594;AF=0.18,0.04,0.02;MQM=36;SAP=23;ABP=610;SAR=93;SAF=56	AK2	missense,3'UTR	AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279	0.00310	0.00096,0.00179,0.00262,0.00511,0.00155	0,	450	144648	9.9640	25.30	0.78	0.84	/0.0>0.0/0.0>0.0	COSV61466144	AK2|0.00|0.00|0.00|0.00|41|-25|5|-25		0	1925	612	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013358	33013358	C	G	het	wt	wt	low_conf_region	QUAL=673;DP=636,424,555;AF=0.17,0.04,0.02;MQM=36;SAP=17;ABP=594;SAR=83;SAF=53	AK2	missense,3'UTR	AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	1599150 [benign DISEASE=Reticular dysgenesis];			rs72884305	0.00195	0.00056,0.00118,0.00184,0.00325,0.00135	0,	280	143274	-0.3850	21.60	0.19	0.18	/0.0>0.0/0.0>0.0	COSV61466156	AK2|0.00|0.00|0.00|0.00|44|-1|-23|45		0	1053	597	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	34781247	34781247	-	C	wt	wt	het		QUAL=151;DP=9,10,14;AF=0.00,0.00,0.57;MQM=60;SAP=20;ABP=4;SAR=0;SAF=8	GJB3	5'UTR	GJB3:ENST00000373366.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::	regulatory_region_variant:promoter,TF_binding_site_variant	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs3831969	0.25627	0.42280,0.15513,0.14523,0.19937,0.07694	5890,	27030	112632		8.32			/5.4>5.7/5.4>5.4		GJB3|0.00|0.00|0.00|0.00|14|-38|-16|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34782639	34782639	G	C	wt	het	het	off-target	QUAL=477;DP=96,22,36;AF=0.00,0.36,0.50;MQM=60;SAP=59;ABP=4;SAR=26;SAF=0	GJB3	intron	GJB3:ENST00000373366.3:intron_variant:MODIFIER:intron1/1:c.-26+861G>C::,GJB3:ENST00000373362.3:intron_variant:MODIFIER:intron1/1:c.-26+197G>C::	regulatory_region_variant:promoter	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs9426014	0.29420	0.52881,0.17490,0.14324,0.21039,0.09213	8280,	28103	107149	0.1660	6.28			/2.4>10.0/0.0>0.0		GJB3|0.01|0.00|0.00|0.00|3|-45|3|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34785628	34785628	G	A	wt	het	het		QUAL=9708;DP=262,358,377;AF=0.00,0.54,0.50;MQM=60;SAP=8;ABP=5;SAR=176;SAF=205	GJB3	3'UTR	GJB3:ENST00000373366.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::	regulatory_region_variant:CTCF_binding_site	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive; Deafness, autosomal dominant, with peripheral neuropathy (3)]	297196 [benign DISEASE=Erythrokeratodermia variabilis et progressiva 1,not provided];			rs476220	0.47810	0.61854,0.38712,0.17746,0.44121,0.26682	18250,	36058	79204	-0.1210	2.32			/1.7>0.0/3.3>1.3	COSV64904373	GJB3|0.00|0.00|0.00|0.00|2|10|9|-40	33126609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39026255	39026255	G	C	het	hom	het	off-target	QUAL=4559;DP=72,84,103;AF=0.46,1.00,0.50;MQM=60;SAP=165;ABP=4;SAR=28;SAF=140	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.8:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600	0.70356	0.49500,0.66394,0.42036,0.84903,0.50021	39640,	27435	44963	-0.2760	6.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39026408	39026408	G	T	het	hom	het		QUAL=4684;DP=93,91,115;AF=0.53,1.00,0.48;MQM=60;SAP=44;ABP=3;SAR=128;SAF=67	NDUFS5	splice_region&intron	NDUFS5:ENST00000372967.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.8:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1122472	0.70151	0.48777,0.66353,0.42145,0.84904,0.50000	39510,	27441	45299	-1.2850	5.35			/0.0>0.0/6.5>7.9		NDUFS5|0.00|0.00|0.74|0.01|-2|49|-6|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	-	T	het	wt	wt	off-target;low_conf_region	QUAL=383;DP=117,50,73;AF=0.10,0.36,0.22;MQM=59;SAP=101;ABP=207;SAR=45;SAF=0	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+69dup::						rs35464164	0.69573	0.48172,0.65869,0.42047,0.84371,0.49978	35867,	25994	42740		0.37			/3.8>3.9/0.0>0.0		NDUFS5|0.00|0.02|0.00|0.00|25|44|-37|-49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	C	T	wt	het	het	off-target;low_conf_region	QUAL=383;DP=117,50,73;AF=0.18,0.22,0.18;MQM=55;SAP=103;ABP=201;SAR=46;SAF=0	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+54C>T::						rs372159643	0.00006	0.00008,0.00000,0.00000,0.00008,0.00000	0,	9	140641	-1.1560	0.28			/3.8>4.0/0.0>0.0		NDUFS5|0.00|0.00|0.00|0.00|44|25|-41|-37		15	175	0	0 / 0					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029015	39029015	G	A	het	hom	het	off-target;low_conf_region	QUAL=5934;DP=201,98,124;AF=0.43,1.00,0.44;MQM=58;SAP=513;ABP=15;SAR=238;SAF=1	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+75G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+75G>A::					AluSq10 (SINE/Alu)	rs3768323	0.70395	0.49365,0.66492,0.41937,0.84939,0.50000	38539,	26575	43591	0.6170	3.13			/3.8>2.1/0.0>0.0		NDUFS5|0.00|0.00|0.00|0.00|23|-2|-8|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029088	39029088	G	A	het	hom	het	off-target	QUAL=2906;DP=121,43,65;AF=0.47,1.00,0.40;MQM=60;SAP=268;ABP=8;SAR=125;SAF=1	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+148G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+148G>A::					AluSq10 (SINE/Alu)	rs3768322	0.70369	0.49437,0.66419,0.41962,0.84912,0.50126	39414,	27250	44668	0.4830	4.37			/5.5>5.1/2.8>0.0		NDUFS5|0.05|0.00|0.00|0.00|-50|0|14|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40073404	40073404	C	T	hom	het	het		QUAL=18475;DP=390,208,252;AF=1.00,0.39,0.50;MQM=60;SAP=60;ABP=13;SAR=236;SAF=361	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657G>A::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*657G>A::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*788G>A::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297230 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126973	0.70174	0.62034,0.69663,0.65771,0.74149,0.66294	37586,	31457	45321	0.4510	7.40			/0.0>0.0/1.2>0.0		PPT1|0.00|0.00|0.00|0.00|49|-39|21|6	17145094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073531	40073531	-	TGAT	hom	het	het		QUAL=19438;DP=351,361,460;AF=0.99,0.44,0.47;MQM=60;SAP=63;ABP=16;SAR=291;SAF=432	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*526_*529dup::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*526_*529dup::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657_*660dup::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297233 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive,Neuronal ceroid lipofuscinosis 1,not provided];			rs397730033	0.66083	0.49631,0.66141,0.61871,0.73861,0.65637	33891,	32395	51415		4.99			/3.5>3.5/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|-40|40|40|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073556	40073556	G	C	hom	het	het		QUAL=29738;DP=537,424,540;AF=1.00,0.46,0.48;MQM=60;SAP=158;ABP=10;SAR=362;SAF=628	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*505C>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*505C>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*636C>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297234 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126972	0.69739	0.60586,0.69569,0.65712,0.74119,0.66245	37183,	31575	45969	-0.6230	3.29			/7.1>0.6/5.9>4.8		PPT1|0.00|0.00|0.00|0.00|15|-3|1|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073776	40073776	A	C	hom	het	het		QUAL=39447;DP=864,418,465;AF=0.99,0.53,0.45;MQM=60;SAP=66;ABP=4;SAR=742;SAF=548	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*285T>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*285T>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*416T>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297240 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs1126970	0.69757	0.60602,0.69531,0.65823,0.74145,0.66308	37211,	31579	45957	1.3970	10.22			/0.0>0.0/0.8>0.0		PPT1|0.00|0.00|0.00|0.00|0|30|0|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073900	40073900	A	G	het	wt	het		QUAL=7491;DP=343,237,267;AF=0.46,0.00,0.48;MQM=60;SAP=86;ABP=9;SAR=194;SAF=90	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*161T>C::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*161T>C::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*292T>C::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297242 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs11552578	0.11558	0.16564,0.09921,0.15456,0.07397,0.19888	1193,	15194	134524	2.4760	15.49			/0.0>0.0/0.0>0.0	COSV61222731	PPT1|0.00|0.00|0.00|0.00|17|2|-37|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080292	40080292	T	G	hom	het	het	off-target	QUAL=11292;DP=284,126,144;AF=1.00,0.45,0.47;MQM=60;SAP=846;ABP=6;SAR=5;SAF=403	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron7/9:c.714+105A>C::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron2/4:c.-31+105A>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron6/8:c.627+105A>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron6/8:c.624+105A>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron6/9:c.627+105A>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron6/7:c.627+105A>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron3/5:c.318+105A>C::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180456 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs3122428	0.73942	0.71146,0.70846,0.74488,0.74995,0.75797	41529,	29264	39584	-0.6460	0.98			/4.9>5.4/0.0>0.0	COSV65655125	PPT1|0.00|0.00|0.00|0.00|2|-33|-13|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080537	40080537	C	T	het	wt	het	off-target	QUAL=6273;DP=237,222,290;AF=0.49,0.00,0.49;MQM=60;SAP=191;ABP=4;SAR=203;SAF=54	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron6/9:c.624-50G>A::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron5/8:c.534-50G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron5/9:c.537-50G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron5/7:c.537-50G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron2/5:c.228-50G>A::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180457 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs77623018	0.05932	0.01622,0.06810,0.13531,0.05570,0.14617	442,	8128	142904	-2.3850	0.07			/4.0>3.5/0.0>0.0	COSV65655090	PPT1|0.00|0.00|0.00|0.00|-18|36|30|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40089649	40089649	C	T	het	het	wt	off-target;low_conf_region	QUAL=1706;DP=92,63,89;AF=0.49,0.46,0.01;MQM=60;SAP=166;ABP=4;SAR=75;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.521-137G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.434-137G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.431-137G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.434-137G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.434-137G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-137G>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668044 [benign DISEASE=not provided];			rs3131651	0.50650	0.29695,0.52508,0.44971,0.61695,0.46606	21019,	34898	74962	-2.7140	0.01			/2.0>1.1/0.0>0.0	COSV65655885	PPT1|0.00|0.00|0.00|0.00|-23|8|22|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091250	40091250	T	C	hom	hom	hom	off-target	QUAL=15679;DP=136,173,191;AF=1.00,1.00,1.00;MQM=60;SAP=547;ABP=0;SAR=73;SAF=427	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+79A>G::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+79A>G::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+79A>G::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+79A>G::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+79A>G::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1738A>G::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180458 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs3122439	0.99446	0.98029,0.99882,1.00000,1.00000,0.99979	75284,	819	843	-0.2180	1.07			/0.0>0.0/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|-48|-13|1|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091270	40091270	A	T	wt	het	wt	off-target	QUAL=2670;DP=152,207,217;AF=0.00,0.51,0.00;MQM=60;SAP=41;ABP=3;SAR=32;SAF=75	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+59T>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+59T>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+59T>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+59T>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670785 [benign DISEASE=not provided];			rs56654546	0.09575	0.08091,0.13875,0.15002,0.09295,0.13138	767,	13007	137323	1.0410	4.78			/3.2>2.7/0.0>0.0	COSV65655895	PPT1|0.00|0.00|0.00|0.00|-33|-15|29|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091361	40091361	A	G	het	wt	het		QUAL=9466;DP=436,344,351;AF=0.44,0.00,0.48;MQM=60;SAP=4;ABP=13;SAR=187;SAF=177	PPT1	missense,intron	PPT1:ENST00000641471.1:missense_variant:MODERATE:exon5/10:c.488T>C:p.Ile163Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000642050.2:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000433473.8:missense_variant:MODERATE:exon4/9:c.398T>C:p.Ile133Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000641319.1:missense_variant:MODERATE:exon4/10:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000439754.6:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	130022 [benign DISEASE=Inborn genetic diseases,not specified,not provided,Neuronal ceroid lipofuscinosis 1];			rs1800205	0.04678	0.00961,0.03510,0.12283,0.04698,0.12687	303,	6509	144973	0.6890	16.02	0.20	0.17	/0.0>0.0/0.0>0.0	COSV65655693	PPT1|0.00|0.01|0.00|0.00|30|38|43|-32	25741868,19054571	25	844	0	0 / 0					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091984	40091984	G	A	hom	het	hom	off-target	QUAL=9465;DP=225,68,60;AF=1.00,0.49,1.00;MQM=60;SAP=618;ABP=3;SAR=9;SAF=309	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron4/9:c.449+61C>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron3/8:c.362+61C>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron3/8:c.359+61C>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron3/9:c.362+61C>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron3/7:c.362+61C>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-2472C>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670733 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs6672053	0.64691	0.49255,0.61435,0.67335,0.71888,0.67157	32542,	33202	53646	0.5120	2.53			/10.0>9.7/0.6>0.0		PPT1|0.00|0.01|0.00|0.00|-27|-3|44|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092584	40092584	C	G	hom	hom	hom	off-target	QUAL=13665;DP=275,68,97;AF=1.00,1.00,1.00;MQM=60;SAP=958;ABP=0;SAR=440;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-77G>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-77G>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-80G>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-77G>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-77G>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3072G>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180459 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];		L1MB5 (LINE/L1)	rs4481840	0.99501	0.98227,0.99889,1.00000,1.00000,0.99979	75368,	739	759	0.2390	3.90			/0.0>0.0/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|-7|-50|31|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092673	40092673	T	A	hom	het	hom	off-target	QUAL=5065;DP=145,14,15;AF=1.00,0.43,1.00;MQM=60;SAP=363;ABP=4;SAR=166;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-166A>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-166A>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-169A>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-166A>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-166A>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3161A>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668040 [benign DISEASE=not provided];		L1MB5 (LINE/L1)	rs4492608	0.64834	0.49299,0.61542,0.67374,0.72111,0.67360	32541,	33193	53305	-1.1650	1.26			/0.0>0.5/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|43|-27|25|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097321	40097321	T	C	hom	hom	hom		QUAL=5693;DP=36,56,97;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0;SAR=116;SAF=73	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297250 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs6600313	0.84405	0.75429,0.83290,0.88447,0.88790,0.87950	54447,	19476	23718	-0.6120	8.80					PPT1|0.00|0.00|0.00|0.00|-48|6|1|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097347	40097347	G	T	het	wt	het		QUAL=1549;DP=30,47,83;AF=0.60,0.02,0.53;MQM=60;SAP=7;ABP=5;SAR=37;SAF=26	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297251 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1];			rs41301070	0.08646	0.17239,0.03880,0.02005,0.04486,0.10443	820,	11518	139030	-0.5190	6.03					PPT1|0.00|0.00|0.01|0.00|27|-20|27|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40257946	40257946	G	A	wt	het	wt	off-target	QUAL=53;DP=32,11,30;AF=0.00,0.55,0.00;MQM=60;SAP=16;ABP=3;SAR=0;SAF=6	ZMPSTE24-DT	non_coding_transcript_exon	ZMPSTE24-DT:ENST00000567508.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.26C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140505 [benign DISEASE=not provided];			rs3765483	0.10338	0.11108,0.13505,0.15324,0.08934,0.15389	900,	13927	136399	-0.1720	5.83			/2.3>1.7/0.0>0.0			19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40270145	40270145	T	G	wt	het	wt	off-target	QUAL=327;DP=100,43,62;AF=0.00,0.40,0.00;MQM=60;SAP=4;ABP=7;SAR=10;SAF=7	ZMPSTE24	splice_region&intron	ZMPSTE24:ENST00000372759.4:splice_region_variant&intron_variant:LOW:intron5/9:c.627+18T>G::	regulatory_region_variant:open_chromatin_region	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.09015	0.06468,0.13546,0.15287,0.08841,0.15329	714,	12290	138452	0.2410	7.05			/3.0>2.8/0.0>0.0	COSV65638901	ZMPSTE24|0.00|0.00|0.00|0.00|-18|-28|-21|-18	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40271844	40271844	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,105,126;AF=1.00,1.00,1.00;MQM=60;SAP=395;ABP=0;SAR=51;SAF=304	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.628-50T>G::		606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140535 [benign DISEASE=not specified,not provided];			rs6677717	0.98748	0.99829,0.99581,1.00000,0.98577,0.98966	74221,	1845	1905	-0.2280	0.98			/5.2>4.1/0.0>0.0		ZMPSTE24|0.00|0.00|0.00|0.00|50|13|49|-48	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	42733051	42733051	C	T	het	n/a	n/a	off-target	QUAL=175;DP=14,0,1;AF=0.64,,1.00;MQM=58;SAP=25;ABP=5;SAR=0;SAF=10	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSg (SINE/Alu)	rs11210707	0.63474	0.64413,0.58886,0.63585,0.63547,0.71202	30220,	34286	54510	-0.5640	1.07							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733077	42733077	-	TC	het	n/a	het	off-target	QUAL=231;DP=25,1,3;AF=0.60,0.00,0.33;MQM=53;SAP=38;ABP=4;SAR=0;SAF=16	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs200763067	0.08225	0.05095,0.07968,0.16516,0.09845,0.05353	400,	10590	127084		0.41							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733353	42733353	C	T	het	wt	het		QUAL=6671;DP=215,253,337;AF=0.51,0.00,0.51;MQM=59;SAP=160;ABP=4;SAR=70;SAF=213	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297316 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement];		AluSx1 (SINE/Alu)	rs112310775	0.12181	0.13245,0.12075,0.20587,0.11529,0.06841	1173,	16174	133518	-0.2000	0.93			/1.2>1.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733444	42733444	A	G	het	wt	het		QUAL=10875;DP=409,354,441;AF=0.49,0.00,0.50;MQM=60;SAP=13;ABP=3;SAR=189;SAF=233	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297318 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement];			rs56345167	0.18935	0.27108,0.17010,0.20687,0.15550,0.12490	3000,	22777	123205	1.0130	6.35			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42734855	42734855	T	C	het	het	het		QUAL=5016;DP=135,127,142;AF=0.49,0.43,0.51;MQM=60;SAP=4;ABP=5;SAR=92;SAF=101	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297335 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement];			rs912075	0.58391	0.53817,0.59805,0.66518,0.59631,0.65795	26092,	36486	63186	-1.7400	0.61			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735184	42735184	G	A	het	het	het		QUAL=7184;DP=120,212,254;AF=0.52,0.54,0.46;MQM=60;SAP=145;ABP=3;SAR=78;SAF=217	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1276324 [benign DISEASE=not provided];			rs74885359	0.09406	0.02482,0.07324,0.00097,0.13796,0.03558	941,	12423	137781	-1.0660	0.27			/8.6>9.8/0.0>0.0		CLDN19|0.01|0.00|0.00|0.00|-50|-11|39|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735545	42735545	A	C	het	het	het		QUAL=10347;DP=186,285,353;AF=0.45,0.49,0.49;MQM=60;SAP=4;ABP=5;SAR=191;SAF=206	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1287286 [benign DISEASE=not provided];		L2b (LINE/L2)	rs12141833	0.53918	0.38634,0.58075,0.66551,0.59431,0.65700	22921,	36055	69995	-1.3840	0.82			/0.0>0.0/0.0>0.1		CLDN19|0.00|0.00|0.00|0.00|43|-29|1|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735863	42735863	G	A	het	wt	het		QUAL=4084;DP=88,176,243;AF=0.45,0.01,0.56;MQM=60;SAP=259;ABP=5;SAR=160;SAF=16	CLDN19	splice_region&intron,missense,3'UTR	CLDN19:ENST00000296387.6:splice_region_variant&intron_variant:LOW:intron4/4:c.626+15C>T::,CLDN19:ENST00000539749.5:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::	regulatory_region_variant:CTCF_binding_site	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297339 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement];			rs4660658	0.18609	0.23673,0.22042,0.23180,0.15555,0.12666	2767,	22749	123703	0.4830	0.26	0.12		/4.3>4.8/0.0>0.0	COSV56418053	CLDN19|0.00|0.00|0.03|0.00|10|15|15|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42746440	42746440	C	T	het	het	het		QUAL=9051;DP=298,180,207;AF=0.49,0.54,0.48;MQM=60;SAP=24;ABP=3;SAR=142;SAF=200	P3H1	3'UTR	P3H1:ENST00000397054.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:ENST00000296388.10:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000236040.8:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	873598 [benign DISEASE=not provided,Osteogenesis Imperfecta, Recessive,Osteogenesis imperfecta type 8];			rs6882	0.64221	0.55619,0.65234,0.70771,0.67544,0.77461	31658,	34354	54414	0.2250	4.65			/1.4>1.1/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-13|-32|-3|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747198	42747198	A	T	het	wt	het		QUAL=2939;DP=109,74,126;AF=0.48,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=56;SAF=59	P3H1	intron,missense	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000236040.8:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674902 [benign DISEASE=not provided];			rs3738496	0.11108	0.07247,0.16547,0.24237,0.11490,0.07057	1062,	14774	135232	0.2420	1.93	0.02		/3.9>2.7/0.0>0.0	COSV52536380	P3H1|0.00|0.03|0.00|0.00|-2|-26|3|9	27335225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747828	42747828	C	T	het	het	het	off-target	QUAL=5993;DP=180,136,220;AF=0.47,0.49,0.48;MQM=60;SAP=138;ABP=5;SAR=191;SAF=65	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674901 [benign DISEASE=not provided,Osteogenesis imperfecta type 8];			rs3738499	0.53424	0.36205,0.57901,0.66479,0.59549,0.68610	22679,	35774	70732	-1.4520	0.26			/0.0>0.0/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-30|6|50|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747939	42747939	T	C	het	het	het	off-target	QUAL=3673;DP=164,53,94;AF=0.52,0.42,0.49;MQM=60;SAP=239;ABP=3;SAR=141;SAF=12	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-141A>G::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667664 [benign DISEASE=not provided];			rs7552138	0.72984	0.75480,0.71358,0.71459,0.71944,0.83894	40572,	29715	41037	-1.0290	0.70			/0.1>1.0/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-44|-15|-24|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42748126	42748126	A	G	het	wt	het	off-target	QUAL=678;DP=49,21,20;AF=0.37,0.00,0.65;MQM=60;SAP=3;ABP=5;SAR=15;SAF=16	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1838+74T>C::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674900 [benign DISEASE=not provided];			rs3738500	0.11111	0.07086,0.16614,0.24614,0.11534,0.07101	1074,	14750	135184	0.5450	4.70			/4.7>4.6/0.0>0.0	COSV52532624	P3H1|0.00|0.00|0.00|0.00|-37|-13|-47|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762196	42762196	G	A	het	het	het	off-target	QUAL=3050;DP=142,43,62;AF=0.51,0.51,0.65;MQM=60;SAP=294;ABP=7;SAR=0;SAF=134	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron2/13:c.618+127C>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667661 [benign DISEASE=not provided];		AluJr4 (SINE/Alu)	rs2760070	0.70066	0.65816,0.70097,0.70854,0.71709,0.83153	37339,	31595	45403	-0.4280	0.92			/0.0>0.0/0.0>0.0	COSV52532167	P3H1|0.00|0.00|0.00|0.00|47|-50|-39|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762518	42762518	T	A	hom	hom	hom	off-target	QUAL=19242;DP=190,217,258;AF=1.00,1.00,1.00;MQM=60;SAP=549;ABP=0;SAR=537;SAF=128	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron1/13:c.466-43A>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674899 [benign DISEASE=not provided];			rs2816593	0.98818	0.99713,0.99509,0.99981,0.98386,0.99212	74272,	1754	1798	-0.1310	2.13			/0.0>0.0/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-43|2|2|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767127	42767127	G	T	wt	het	wt	off-target	QUAL=350;DP=8,27,19;AF=0.00,0.67,0.00;MQM=60;SAP=42;ABP=10;SAR=18;SAF=0	P3H1,C1orf50	upstream_gene	P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	1290909 [benign DISEASE=not provided];			rs11210712	0.19903	0.09248,0.22880,0.01410,0.25283,0.18088	3590,	23057	121687	0.0180	6.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767136	42767136	C	G	het	het	het	off-target	QUAL=604;DP=11,22,18;AF=0.73,0.64,0.56;MQM=60;SAP=72;ABP=10;SAR=32;SAF=0	P3H1,C1orf50	upstream_gene	P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674898 [benign DISEASE=not provided];			rs3738504	0.59989	0.58901,0.61116,0.70456,0.58999,0.75383	27569,	36083	60841	0.7320	10.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42926579	42926579	C	G	wt	het	wt		QUAL=2154;DP=295,227,266;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=19;SAR=47;SAF=48	SLC2A1	3'UTR	SLC2A1:ENST00000426263.10:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::,SLC2A1:ENST00000674765.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*228G>C::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	297374 [benign DISEASE=Dystonia 9,Encephalopathy due to GLUT1 deficiency];			rs4658	0.34109	0.59049,0.36360,0.31296,0.21821,0.26587	10880,	30080	100144	-0.3080	1.42			/0.0>0.4/0.0>0.0		SLC2A1|0.00|0.00|0.00|0.00|-30|31|-49|-31	26358256,28698656,30062472,30545124,29307798,30564000,30531820,26980812,26944167,33522072,36131844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42927574	42927574	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=745;DP=180,100,78;AF=0.00,0.36,0.33;MQM=60;SAP=59;ABP=39;SAR=11;SAF=51	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron8/8:c.1030-718_1030-717insATTTCTCACC::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	1222935 [benign DISEASE=not provided];			rs3831326	0.56978	0.77380,0.59311,0.48272,0.47154,0.60349	25919,	34482	65176		1.66			/4.7>4.7/0.0>0.0		SLC2A1|0.00|0.00|0.00|0.00|-19|39|31|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42929964	42929964	C	T	wt	het	wt		QUAL=1555;DP=120,163,236;AF=0.00,0.42,0.00;MQM=60;SAP=73;ABP=11;SAR=58;SAF=11	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon5/9:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter]		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95414 [benign DISEASE=Inborn genetic diseases,not specified,not provided,Dystonia 9,Encephalopathy due to GLUT1 deficiency,GLUT1 deficiency syndrome 1, autosomal recessive];			rs2229682	0.15681	0.04593,0.21374,0.07542,0.20377,0.17386	2275,	19277	128123	-5.4280	1.82			/4.0>3.2/0.0>0.0	COSV65286860	SLC2A1|0.13|0.07|0.00|0.00|-2|-13|-2|-13	25741868,18414213,23757202,23427181,18212354,21135204,20419766,26980812,33981732,35464866	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42930743	42930743	G	A	wt	het	wt		QUAL=2465;DP=254,155,166;AF=0.00,0.62,0.01;MQM=60;SAP=5;ABP=22;SAR=44;SAF=53	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon4/9:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter]	regulatory_region_variant:CTCF_binding_site	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95411 [benign DISEASE=Inborn genetic diseases,Dystonia 9,not specified,not provided,Encephalopathy due to GLUT1 deficiency,GLUT1 deficiency syndrome 1, autosomal recessive];			rs11537641	0.17037	0.09407,0.22039,0.09907,0.20054,0.18745	2436,	21033	126147	-1.4980	4.27			/5.0>5.3/0.0>0.0	COSV65287469	SLC2A1|0.05|0.00|0.00|0.00|-14|47|11|-26	25741868,18414213,23757202,30353771,21135204	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943295	42943295	G	A	het	het	wt		QUAL=7421;DP=298,350,489;AF=0.44,0.52,0.00;MQM=60;SAP=68;ABP=4;SAR=206;SAF=109	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:,SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon2/9:c.45C>T:p.Ala15=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95413 [benign DISEASE=Inborn genetic diseases,not provided,Hereditary cryohydrocytosis with reduced stomatin,not specified,Dystonia 9,Childhood onset GLUT1 deficiency syndrome 2,Encephalopathy due to GLUT1 deficiency,GLUT1 deficiency syndrome 1, autosomal recessive];			rs1385129	0.21927	0.17686,0.28635,0.29201,0.21640,0.27322	3829,	25667	118655	-1.8290	7.23			/0.0>0.0/0.0>0.0	COSV65287476	SLC2A1|0.00|0.00|0.00|0.00|23|26|46|23	25741868,25512783,18414213,23757202,22707195,29867928,25701507,30353771,18212354,21135204,31222984,25381171,26944167,33522072,34488469,31965635,34708297,36131844,35883738	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943508	42943508	G	T	wt	het	het	off-target	QUAL=1575;DP=89,61,90;AF=0.01,0.51,0.50;MQM=60;SAP=170;ABP=3;SAR=77;SAF=0	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron1/9:c.19-187C>A::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron1/8:c.19-187C>A::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	670109 [benign DISEASE=not provided];			rs12718444	0.15728	0.10870,0.13027,0.16827,0.17786,0.18506	1988,	19927	128079	1.6540	12.75			/0.0>0.0/0.0>0.0		SLC2A1|0.00|0.00|0.00|0.00|-34|24|5|-33	30595370,34641739,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43346404	43346404	G	A	het	wt	het	off-target	QUAL=3913;DP=140,112,148;AF=0.59,0.01,0.53;MQM=60;SAP=230;ABP=12;SAR=16;SAF=146	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron6/11:c.960-41G>A::	regulatory_region_variant:enhancer	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	259760 [benign DISEASE=not specified,not provided];			rs1760670	0.31226	0.22442,0.36658,0.07342,0.37313,0.13770	7921,	31582	104452	0.5750	8.30			/0.1>0.0/0.0>1.2	COSV65245058	MPL|0.00|0.01|0.00|0.00|-27|41|1|-32	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43348662	43348662	G	A	het	n/a	wt	off-target	QUAL=140;DP=13,2,5;AF=0.54,0.50,0.00;MQM=60;SAP=20;ABP=3;SAR=0;SAF=8	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron8/11:c.1309-181G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron8/11:c.1288-181G>A::	regulatory_region_variant:promoter	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]				rs115813067	0.02419	0.07981,0.00942,0.00000,0.00129,0.00125	136,	3406	148352	-0.8140	1.01			/0.0>0.1/0.0>0.0		MPL|0.00|0.00|0.00|0.00|23|-11|-40|17		0	16	0	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43349193	43349193	T	C	het	wt	het	off-target	QUAL=868;DP=53,38,41;AF=0.55,0.00,0.41;MQM=60;SAP=94;ABP=3;SAR=1;SAF=45	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron9/11:c.1469-70T>C::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron9/11:c.1448-70T>C::	regulatory_region_variant:promoter	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	1250463 [benign DISEASE=not provided];			rs839995	0.30095	0.17932,0.36183,0.09845,0.37374,0.14666	7547,	30528	105970	-0.1820	9.21			/0.0>0.0/0.0>0.0		MPL|0.00|0.00|0.00|0.00|-41|48|36|-42	23575445	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43354522	43354522	G	A	wt	het	wt	off-target	QUAL=1542;DP=184,123,119;AF=0.00,0.51,0.01;MQM=60;SAP=57;ABP=3;SAR=52;SAF=12	MPL,CDC20-DT,CDC20	downstream_gene,upstream_gene	MPL:ENST00000372470.9:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998.7:downstream_gene_variant:MODIFIER::::,CDC20-DT:ENST00000424948.2:downstream_gene_variant:MODIFIER::::,CDC20:ENST00000310955.11:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462.1:upstream_gene_variant:MODIFIER::::		159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]&603618_[GENE=CDC20_PHENOS=Oocyte/zygote/embryo maturation arrest 14, 620276 (3), Autosomal recessive]	1287360 [benign DISEASE=not provided];			rs79064184	0.03715	0.00813,0.03341,0.00038,0.04953,0.07688	152,	5349	146519	0.0160	0.45							1	18	0	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), CDC20-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54)
chr1	43792353	43792353	-	GT	het	het	wt	off-target	QUAL=1084;DP=84,48,48;AF=0.45,0.33,0.00;MQM=60;SAP=120;ABP=12;SAR=54;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-22536_164-22535dup::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.211+206_211+207dup::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.211+206_211+207dup::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.166+206_166+207dup::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-22536_119-22535dup::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.166+206_166+207dup::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.166+206_166+207dup::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.211+206_211+207dup::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261624 [benign DISEASE=not provided];			rs34077566	0.37018	0.25039,0.31135,0.59267,0.42840,0.43322	11056,	34073	95591		0.41			/2.1>2.3/0.0>1.0		ST3GAL3|0.00|0.00|0.00|0.00|-48|42|0|42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814709	43814709	A	T	hom	hom	hom	off-target	QUAL=10211;DP=136,99,110;AF=0.99,1.00,1.00;MQM=60;SAP=748;ABP=0;SAR=0;SAF=343	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-182A>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-182A>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-182A>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-182A>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-182A>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-182A>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-182A>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-182A>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-182A>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-182A>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-182A>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-182A>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-182A>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-182A>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-182A>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-182A>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-182A>T::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1241211 [benign DISEASE=not provided];			rs37468	0.90474	0.96745,0.83150,0.91647,0.89632,0.77361	62520,	12636	14496	1.0620	8.64			/5.9>7.3/0.0>0.0		ST3GAL3|0.00|0.00|0.00|0.01|12|11|45|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814753	43814753	T	G	het	het	wt	off-target	QUAL=4844;DP=239,131,162;AF=0.52,0.56,0.00;MQM=60;SAP=422;ABP=6;SAR=1;SAF=196	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-138T>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-138T>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-138T>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-138T>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-138T>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-138T>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-138T>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-138T>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-138T>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-138T>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-138T>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-138T>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-138T>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-138T>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-138T>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-138T>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-138T>G::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1229033 [benign DISEASE=not provided];			rs3791064	0.39557	0.33007,0.32063,0.58900,0.43278,0.43595	12254,	35608	91858	0.0160	4.05			/4.7>2.9/0.0>1.7	COSV53515144	ST3GAL3|0.00|0.00|0.02|0.00|1|43|-33|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43824858	43824858	A	G	het	het	hom		QUAL=7885;DP=268,116,112;AF=0.46,0.41,0.98;MQM=60;SAP=25;ABP=13;SAR=167;SAF=114	ST3GAL3	missense,intron	ST3GAL3:ENST00000372372.7:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000647237.1:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:ENST00000351035.8:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron5/12:c.209+9925A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000262915.8:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000372368.7:missense_variant:MODERATE:exon4/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron2/10:c.161+9925A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	130378 [benign DISEASE=not provided,not specified];		MER5B (DNA/hAT-Charlie)	rs37458	0.31783	0.31622,0.27600,0.14093,0.34711,0.13738	7879,	32554	103692	-0.1460	0.65	0.01		/0.0>0.2/0.0>0.0	COSV53510755	ST3GAL3|0.01|0.00|0.13|0.00|-26|2|34|-1	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899785	43899785	A	G	het	wt	het	off-target	QUAL=3723;DP=141,108,157;AF=0.49,0.00,0.56;MQM=60;SAP=219;ABP=5;SAR=141;SAF=16	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+58A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+58A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+58A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+58A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+58A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1233138 [benign DISEASE=not provided];			rs783304	0.23724	0.41887,0.24273,0.21856,0.14160,0.27999	5422,	25214	115932	-0.0920	1.77			/0.0>5.4/0.0>0.0	COSV53512272	ST3GAL3|0.00|0.04|0.00|0.00|1|24|1|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899857	43899857	G	A	hom	hom	hom	off-target	QUAL=6579;DP=117,44,66;AF=1.00,0.98,1.00;MQM=60;SAP=494;ABP=0;SAR=226;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+130G>A::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+130G>A::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30275G>A::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5380G>A::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+130G>A::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+130G>A::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+130G>A::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+130G>A::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+130G>A::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+130G>A::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+130G>A::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+130G>A::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+130G>A::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+130G>A::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+130G>A::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+130G>A::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5380G>A::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5380G>A::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+594G>A::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+130G>A::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+594G>A::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30275G>A::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+130G>A::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5380G>A::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+568G>A::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1275447 [benign DISEASE=not provided];			rs783303	0.81267	0.64440,0.85113,0.83520,0.89086,0.81504	51136,	21259	28475	0.4930	3.85			/0.0>0.0/0.0>0.0		ST3GAL3|0.00|0.03|0.00|0.00|22|-48|-39|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920633	43920633	C	T	hom	hom	hom	off-target	QUAL=10358;DP=142,86,133;AF=0.99,0.99,0.99;MQM=60;SAP=4;ABP=0;SAR=185;SAF=173	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron10/11:c.1005+83C>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron9/10:c.843+83C>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9499C>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9499C>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron9/10:c.798+83C>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9499C>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron10/12:c.936+83C>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron10/11:c.936+83C>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9499C>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9499C>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron11/12:c.1053+83C>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron11/12:c.891+83C>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron11/12:c.1098+83C>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron11/12:c.984+83C>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+83C>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron8/10:c.843+83C>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9499C>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9499C>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9499C>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron9/10:c.801+83C>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9499C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9499C>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9499C>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9499C>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9499C>T::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1259769 [benign DISEASE=not provided];			rs3120802	0.79626	0.50645,0.85922,0.84142,0.92546,0.87086	50808,	19319	30943	-0.3250	1.44			/1.7>1.3/0.0>0.0	COSV53517032	ST3GAL3|0.00|0.00|0.00|0.00|19|3|-18|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920943	43920943	A	G	hom	hom	hom	off-target	QUAL=11983;DP=76,128,210;AF=0.99,0.98,1.00;MQM=60;SAP=225;ABP=0;SAR=308;SAF=103	ST3GAL3	splice_region&intron,intron	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1083+15A>G::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1038+15A>G::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1131+15A>G::,ST3GAL3:ENST00000645034.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+393A>G::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron9/10:c.990+15A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9189A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262909 [benign DISEASE=Early infantile epileptic encephalopathy with suppression bursts,Intellectual disability, autosomal recessive 12,not specified,Developmental and epileptic encephalopathy, 15];			rs3120803	0.85132	0.69902,0.87584,0.84930,0.92585,0.87209	55812,	17670	22580	-1.2040	2.10			/0.0>0.0/6.2>1.3		ST3GAL3|0.00|0.00|0.00|0.29|-50|-3|-15|-3	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920970	43920970	G	C	het	wt	het	off-target	QUAL=3431;DP=86,95,158;AF=0.50,0.00,0.64;MQM=60;SAP=125;ABP=20;SAR=117;SAF=27	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+42G>C::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+42G>C::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+420G>C::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+42G>C::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9162G>C::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261387 [benign DISEASE=not provided];			rs3764833	0.05532	0.08176,0.04614,0.12997,0.03837,0.04406	288,	7838	143684	1.2920	9.06			/0.0>0.0/0.0>1.5	COSV53519387	ST3GAL3|0.00|0.00|0.00|0.02|23|-30|-42|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43921089	43921089	A	-	het	wt	het	off-target	QUAL=729;DP=27,18,45;AF=0.52,0.00,0.62;MQM=60;SAP=94;ABP=7;SAR=42;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+162del::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+162del::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9042del::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9042del::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+162del::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9042del::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+162del::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+162del::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9042del::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9042del::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+162del::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+162del::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+162del::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+162del::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+540del::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+162del::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9042del::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9042del::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9042del::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+162del::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9042del::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9042del::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9042del::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9042del::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9042del::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs3835022	0.04011	0.02898,0.04178,0.12791,0.03818,0.04234	141,	5815	145899	-0.2410	0.52			/3.8>4.9/0.0>0.0		ST3GAL3|0.03|0.00|0.00|0.00|36|35|-25|-47		9	292	0	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43930114	43930114	C	T	het	hom	het	off-target	QUAL=10349;DP=175,184,258;AF=0.44,1.00,0.47;MQM=60;SAP=104;ABP=11;SAR=124;SAF=257	ST3GAL3	splice_region&intron	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000330208.6:splice_region_variant&intron_variant:LOW:intron4/4:c.255-18C>T::,ST3GAL3:ENST00000335430.10:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000545417.5:splice_region_variant&intron_variant:LOW:intron6/6:c.443-18C>T::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1235-18C>T::,ST3GAL3:ENST00000647237.1:splice_region_variant&intron_variant:LOW:intron10/10:c.907-18C>T::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1280-18C>T::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000353126.8:splice_region_variant&intron_variant:LOW:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000642934.1:splice_region_variant&intron_variant:LOW:intron8/8:c.697-18C>T::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1039-18C>T::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1166-18C>T::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1132-18C>T::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000372368.7:splice_region_variant&intron_variant:LOW:intron10/10:c.1054-18C>T::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1187-18C>T::,ST3GAL3:ENST00000372362.6:splice_region_variant&intron_variant:LOW:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000531451.5:splice_region_variant&intron_variant:LOW:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000372365.5:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372367.5:splice_region_variant&intron_variant:LOW:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000528371.5:splice_region_variant&intron_variant:LOW:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531816.1:splice_region_variant&intron_variant:LOW:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.6:splice_region_variant&intron_variant:LOW:intron6/6:c.604-18C>T::,ST3GAL3:ENST00000361812.9:splice_region_variant&intron_variant:LOW:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372366.6:splice_region_variant&intron_variant:LOW:intron6/6:c.*23-18C>T::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262910 [benign DISEASE=Early infantile epileptic encephalopathy with suppression bursts,not specified,Intellectual disability, autosomal recessive 12,Developmental and epileptic encephalopathy, 15];			rs2108202	0.60004	0.23218,0.62972,0.62196,0.78293,0.61012	31729,	27752	60796	0.2390	12.44	0.03		9.6>10.2/9.6>10.2/0.0>0.0,/9.6>10.2/0.0>0.0	COSV53521961	ST3GAL3|0.01|0.00|0.00|0.00|18|-13|43|-26	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930524	43930524	A	G	het	wt	het		QUAL=3240;DP=153,77,121;AF=0.44,0.00,0.50;MQM=60;SAP=3;ABP=6;SAR=66;SAF=62	ST3GAL3	3'UTR	ST3GAL3:ENST00000372372.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*322A>G::,ST3GAL3:ENST00000361812.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:ENST00000372366.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*415A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs12561948	0.03805	0.02119,0.04145,0.12987,0.03825,0.04363	135,	5519	146343	1.8380	17.29			/4.7>4.1/0.0>0.3		ST3GAL3|0.00|0.00|0.01|0.00|-1|5|-1|-48		0	20	0	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930974	43930974	C	G	het	hom	het		QUAL=13500;DP=228,222,263;AF=0.49,1.00,0.54;MQM=60;SAP=11;ABP=4;SAR=217;SAF=258	ST3GAL3	3'UTR	ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*772C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs6801	0.60027	0.23198,0.62996,0.62249,0.78309,0.61086	31765,	27751	60785	0.1650	2.26			/0.5>0.0/0.0>0.0	COSV53521971	ST3GAL3|0.00|0.00|0.00|0.00|-5|49|16|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44819674	44819674	C	T	hom	n/a	n/a	off-target	QUAL=388;DP=17,2,2;AF=0.94,0.50,0.50;MQM=59;SAP=34;ABP=3;SAR=1;SAF=17	BTBD19,PTCH2,RNU5E-6P	downstream_gene	BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000447098.6:downstream_gene_variant:MODIFIER::::,RNU5E-6P:ENST00000365574.1:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]			AluSx (SINE/Alu)	rs72674049	0.22832	0.39257,0.20643,0.20280,0.16879,0.15664	4432,	22924	107438	-1.3930	3.67							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819746	44819746	C	G	hom	het	het	off-target	QUAL=2503;DP=90,4,5;AF=1.00,0.50,0.40;MQM=60;SAP=199;ABP=3;SAR=1;SAF=93	BTBD19,PTCH2,RNU5E-6P	downstream_gene	BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000447098.6:downstream_gene_variant:MODIFIER::::,RNU5E-6P:ENST00000365574.1:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]			AluSx (SINE/Alu)	rs72674051	0.20313	0.33338,0.18954,0.18963,0.15800,0.14193	4048,	20756	113188	-1.1880	0.88							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819862	44819862	A	C	wt	het	wt		QUAL=164;DP=127,26,28;AF=0.00,0.42,0.00;MQM=60;SAP=19;ABP=4;SAR=1;SAF=10	PTCH2	3'UTR	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]				rs181782534	0.01159	0.00203,0.00798,0.00000,0.01455,0.03415	25,	1714	150446	-0.4220	0.75			/0.0>0.0/1.6>10.1				9	327	0	0 / 0					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819976	44819976	C	T	hom	het	het		QUAL=20068;DP=513,168,176;AF=0.99,0.55,0.49;MQM=60;SAP=681;ABP=4;SAR=112;SAF=575	PTCH2,RNU5E-6P	3'UTR,non_coding_transcript_exon	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::,RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]			U5 (snRNA)	rs41269085	0.22777	0.37240,0.20687,0.20555,0.16929,0.15860	4638,	25366	117448	-0.3300	0.13			/7.1>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44827194	44827194	G	A	hom	het	het		QUAL=9090;DP=169,148,208;AF=0.99,0.51,0.50;MQM=60;SAP=57;ABP=3;SAR=128;SAF=221	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1166504 [benign DISEASE=not provided,Inborn genetic diseases,Gorlin syndrome];			rs2295996	0.14375	0.08306,0.17459,0.20302,0.16728,0.15563	1775,	18316	130248	0.4630	2.03			/0.0>0.0/0.0>0.0	COSV64709782	PTCH2|0.00|0.00|0.00|0.00|-7|-24|2|-27	23826113	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44827846	44827846	A	G	hom	het	het		QUAL=12971;DP=192,271,323;AF=0.99,0.48,0.48;MQM=60;SAP=466;ABP=5;SAR=79;SAF=398	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1166505 [benign DISEASE=Gorlin syndrome,not provided,Inborn genetic diseases];			rs7525308	0.42361	0.58908,0.40787,0.48710,0.34961,0.34458	14614,	35202	87666	1.9440	11.23			/0.0>0.0/1.1>0.0	COSV64709500	PTCH2|0.00|0.00|0.00|0.00|29|-23|-3|2	30591961,23826113,20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44828484	44828484	T	C	hom	het	het	off-target	QUAL=21907;DP=236,520,683;AF=1.00,0.53,0.48;MQM=60;SAP=99;ABP=3;SAR=514;SAF=322	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1327456 [benign DISEASE=Gorlin syndrome];			rs2273940	0.42208	0.58364,0.40713,0.48628,0.34977,0.34549	14452,	35255	87847	-2.2410	0.07			/2.2>0.0/0.0>0.3	COSV64709511	PTCH2|0.01|0.00|0.00|0.00|-41|21|18|21	20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44830239	44830239	-	TA	hom	het	het	off-target	QUAL=1909;DP=69,7,15;AF=0.97,0.57,0.40;MQM=60;SAP=170;ABP=3;SAR=77;SAF=0	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron6/22:c.814-210_814-209insTA::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron6/21:c.814-210_814-209insTA::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1175624 [benign DISEASE=not provided];			rs5773854	0.63087	0.74006,0.69283,0.97333,0.54982,0.67137	31121,	33438	55984		8.90			/0.0>0.0/0.0>0.0		PTCH2|0.02|0.00|0.00|0.00|34|2|-6|-49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44841834	44841834	G	A	hom	het	het	off-target	QUAL=7513;DP=82,183,213;AF=0.98,0.51,0.54;MQM=60;SAP=198;ABP=6;SAR=64;SAF=225	PTCH2	splice_region&intron	PTCH2:ENST00000447098.6:splice_region_variant&intron_variant:LOW:intron2/22:c.265+13C>T::,PTCH2:ENST00000372192.4:splice_region_variant&intron_variant:LOW:intron2/21:c.265+13C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1327457 [benign DISEASE=Gorlin syndrome];			rs3795720	0.34988	0.32648,0.43312,0.43728,0.34741,0.33292	9477,	34201	98769	1.5370	12.41			/0.6>0.3/0.0>0.0	COSV64709520	PTCH2|0.00|0.00|0.00|0.00|-12|13|13|-19	20371205,34990798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44842219	44842219	C	A	wt	wt	het	off-target	QUAL=140;DP=77,34,46;AF=0.00,0.03,0.30;MQM=60;SAP=36;ABP=18;SAR=15;SAF=0	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron1/22:c.73-180G>T::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron1/21:c.73-180G>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]				rs546830330	0.00097	0.00027,0.00046,0.00000,0.00181,0.00000	0,	147	151951	-0.8320	0.53			/0.0>0.0/7.0>2.3		PTCH2|0.00|0.00|0.00|0.06|4|5|-11|5		1	41	0	0 / 0					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44857528	44857528	A	-	het	het	het	off-target;low_conf_region	QUAL=245;DP=64,47,44;AF=0.25,0.09,0.14;MQM=60;SAP=59;ABP=152;SAR=0;SAF=26	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron11/11:c.1306+176del::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1203-6525del::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]			AluSp (SINE/Alu)	rs200709551	0.00130	0.00107,0.00097,0.00250,0.00114,0.00232	0,	175	134703	1.1110	2.63			/2.4>1.5/0.0>0.0		EIF2B3|0.00|0.00|0.00|0.00|-3|-5|-37|-5		1	302	0	0 / 0					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44874610	44874610	C	T	hom	het	het		QUAL=20746;DP=403,252,314;AF=1.00,0.48,0.48;MQM=60;SAP=325;ABP=5;SAR=179;SAF=495	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:ENST00000372183.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	1288223 [benign DISEASE=not provided];		HAL1 (LINE/L1)	rs9988451	0.43082	0.58993,0.46669,0.44524,0.35543,0.34370	14980,	35457	86427	0.3200	4.60			/0.0>0.0/5.2>2.8		EIF2B3|0.00|0.00|0.00|0.00|-2|-31|4|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44875031	44875031	T	C	hom	het	het	off-target	QUAL=2949;DP=90,11,18;AF=1.00,0.55,0.61;MQM=60;SAP=235;ABP=5;SAR=107;SAF=0	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron9/11:c.1054-205A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron9/10:c.1054-205A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron9/9:c.1054-205A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	1232545 [benign DISEASE=not provided];			rs263955	0.67976	0.90400,0.70800,0.97532,0.55274,0.66231	37145,	28944	48634	0.0610	12.79			/1.5>4.1/1.1>1.8		EIF2B3|0.00|0.00|0.00|0.00|0|-25|44|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44879774	44879774	T	A	hom	het	het	off-target	QUAL=4407;DP=102,44,64;AF=1.00,0.57,0.48;MQM=60;SAP=296;ABP=3;SAR=6;SAF=152	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron8/9:c.975+44A>T::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	261223 [benign DISEASE=not specified,not provided];			rs3738248	0.15021	0.11157,0.14888,0.16051,0.17340,0.15504	1830,	19180	129218	0.2800	8.31			/5.4>5.6/0.0>0.0	COSV64517062	EIF2B3|0.00|0.00|0.00|0.00|47|-33|44|32	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897320	44897320	T	C	hom	het	het	off-target	QUAL=6694;DP=143,71,91;AF=1.00,0.52,0.57;MQM=60;SAP=243;ABP=6;SAR=36;SAF=196	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron6/9:c.656+35A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	261222 [benign DISEASE=not specified,not provided];			rs263978	0.67834	0.90371,0.70858,0.97561,0.54965,0.66135	37076,	28990	48908	-1.3970	1.06			/0.0>0.0/0.0>0.0		EIF2B3|0.00|0.00|0.00|0.00|35|23|35|23	25741868,15986317,18854859	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897628	44897628	G	C	hom	het	het	off-target	QUAL=4450;DP=136,11,14;AF=1.00,0.82,0.57;MQM=60;SAP=335;ABP=10;SAR=153;SAF=0	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron5/11:c.567-184C>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron5/10:c.567-184C>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron5/9:c.567-184C>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	1258642 [benign DISEASE=not provided];			rs263979	0.25196	0.44969,0.18884,0.16893,0.18136,0.15878	5955,	26274	113366	-0.0230	3.14			/3.2>2.4/0.0>0.0		EIF2B3|0.00|0.00|0.00|0.00|15|-17|27|-12	31642026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44986555	44986555	G	C	hom	het	het		QUAL=6876;DP=126,109,187;AF=1.00,0.43,0.43;MQM=60;SAP=3;ABP=16;SAR=124;SAF=129	EIF2B3	5'UTR	EIF2B3:ENST00000360403.7:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000620860.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:ENST00000372183.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::	regulatory_region_variant:promoter	606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)]	297453 [benign DISEASE=Vanishing white matter disease];			rs489676	0.47875	0.62934,0.51521,0.43827,0.41512,0.36790	18278,	36169	79181	-3.4960	1.33			/0.0>0.0/0.0>0.4		EIF2B3|0.00|0.00|0.00|0.00|-38|42|48|-9	15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), PPIAP35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45500031	45500031	G	T	wt	wt	het	off-target	QUAL=620;DP=33,29,51;AF=0.03,0.03,0.59;MQM=60;SAP=72;ABP=6;SAR=0;SAF=32	CCDC163	5'UTR	CCDC163:ENST00000629482.3:5_prime_UTR_variant:MODIFIER:exon1/5:c.-422C>A::	regulatory_region_variant:promoter,TF_binding_site_variant	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]	684370 [benign DISEASE=not provided];			rs3748643	0.73754	0.81803,0.79984,0.94249,0.66660,0.75736	41753,	28535	39871	0.6820	13.89			/0.0>0.0/0.0>0.0			19573432,29302025	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDC163 (inh=n/a oe_syn=1.01 oe_mis=0.96 oe_lof=0.19), MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45509417	45509417	T	-	het	het	het		QUAL=688;DP=89,116,124;AF=0.22,0.28,0.10;MQM=60;SAP=19;ABP=270;SAR=43;SAF=21	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+85del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	1208561 [likely benign DISEASE=not provided];		AluSg7 (SINE/Alu)	rs56934185	0.03663	0.01203,0.02345,0.00000,0.04504,0.02422	161,	4351	122889	-2.0820	0.14			/8.6>8.2/0.9>0.9		MMACHC|0.00|0.00|0.00|0.00|43|19|-37|19		46	152	0	0 / 0					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509494	45509494	A	G	wt	wt	het		QUAL=1059;DP=199,130,148;AF=0.01,0.00,0.37;MQM=60;SAP=43;ABP=24;SAR=44;SAF=12	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+147A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297502 [benign DISEASE=Cobalamin C disease,Disorders of Intracellular Cobalamin Metabolism,not provided];		AluSg7 (SINE/Alu)	rs9729395	0.22983	0.21439,0.29355,0.32056,0.22170,0.24660	3982,	26021	113887	0.6060	3.67			/0.0>5.6/0.0>0.0		MMACHC|0.00|0.00|0.00|0.00|-35|-33|-35|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509628	45509628	G	A	wt	het	wt		QUAL=2030;DP=183,135,192;AF=0.01,0.59,0.01;MQM=60;SAP=41;ABP=13;SAR=22;SAF=60	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+281G>A::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297505 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.17855	0.09847,0.13978,0.05698,0.23189,0.15799	2711,	21536	124024	0.5480	2.18			/0.0>0.0/0.3>0.3	COSV53113272	MMACHC|0.00|0.00|0.00|0.00|-27|-29|-4|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510068	45510069	CT	-	wt	wt	het	low_conf_region	QUAL=1773;DP=246,178,191;AF=0.00,0.01,0.49;MQM=58;SAP=21;ABP=3;SAR=33;SAF=61	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-459_*133-458del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs398052965	0.67443	0.60825,0.77590,0.90976,0.66502,0.75121	33011,	31711	47179	0.2820	0.79			/0.0>0.0/1.7>1.7		MMACHC|0.00|0.00|0.00|0.00|38|-6|38|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510077	45510077	A	-	het	het	het	low_conf_region	QUAL=1033;DP=161,108,105;AF=0.19,0.27,0.17;MQM=59;SAP=3;ABP=279;SAR=40;SAF=38	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-437del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]			AluSx4 (SINE/Alu)	rs986671995	0.07223	0.22491,0.03017,0.00116,0.00380,0.00317	574,	6328	96032	0.2270	0.74			/0.0>0.0/0.0>0.0		MMACHC|0.00|0.00|0.00|0.00|29|-15|29|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510475	45510475	G	A	wt	wt	het		QUAL=4630;DP=345,282,403;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=3;SAR=113;SAF=86	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-54G>A::	regulatory_region_variant:enhancer	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803	0.66905	0.59438,0.77343,0.91085,0.66289,0.74845	34371,	32837	50247	-3.1030	0.23			/0.0>0.0/0.0>0.0		MMACHC|0.00|0.00|0.00|0.00|3|-10|6|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510591	45510591	-	T	wt	wt	het		QUAL=3847;DP=317,260,317;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=5;SAR=81;SAF=71	MMACHC	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*195_*196insT::	regulatory_region_variant:enhancer	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.66891	0.59448,0.77323,0.91079,0.66273,0.74803	34342,	32888	50276		0.75			/0.0>0.0/0.0>0.0	COSV53112744	MMACHC|0.00|0.00|0.00|0.00|-46|-41|-47|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510915	45510915	A	G	wt	wt	het		QUAL=2432;DP=267,153,171;AF=0.00,0.00,0.56;MQM=60;SAP=5;ABP=8;SAR=52;SAF=43	MMACHC,PRDX1	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*519A>G::,PRDX1:ENST00000447184.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000424390.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000676549.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717	0.73763	0.81786,0.80018,0.94271,0.66676,0.75694	41804,	28546	39892	-0.7710	1.16			/0.0>0.0/0.0>0.0,/0.0>0.0/7.3>6.9		MMACHC|0.00|0.00|0.00|0.00|-13|39|-36|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45694588	45694588	C	T	hom	het	hom	off-target	QUAL=10274;DP=133,120,145;AF=1.00,0.48,1.00;MQM=60;SAP=281;ABP=4;SAR=271;SAF=64	TMEM69,IPP	downstream_gene	TMEM69:ENST00000372025.5:downstream_gene_variant:MODIFIER::::,IPP:ENST00000396478.4:downstream_gene_variant:MODIFIER::::						rs6658700	0.28331	0.24091,0.30984,0.34563,0.29454,0.36473	6216,	30600	108856	0.2500	9.06						15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45698718	45698727	TTTTTTTTTT	-	hom	n/a	hom		QUAL=737;DP=21,1,5;AF=1.00,1.00,1.00;MQM=60;SAP=62;ABP=0;SAR=0;SAF=27	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::					AluJb (SINE/Alu)	rs78627575	0.31956	0.27599,0.36679,0.37462,0.31894,0.39684	6150,	29519	89047	0.7410	0.78			/0.0>0.0/0.0>0.0		IPP|0.00|0.00|0.00|0.00|35|-1|-1|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45699174	45699174	A	T	hom	het	hom		QUAL=21075;DP=307,179,300;AF=0.99,0.47,1.00;MQM=60;SAP=750;ABP=4;SAR=588;SAF=101	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::						rs10749856	0.28619	0.24088,0.31109,0.36495,0.29750,0.36827	6344,	30799	108463	1.3890	7.00			/1.1>2.4/0.0>0.0		IPP|0.00|0.00|0.00|0.00|-2|-46|49|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45700203	45700203	-	A	hom	het	hom	off-target;low_conf_region	QUAL=9582;DP=144,190,202;AF=0.85,0.41,0.88;MQM=60;SAP=192;ABP=18;SAR=279;SAF=98	IPP	splice_region&intron	IPP:ENST00000396478.4:splice_region_variant&intron_variant:LOW:intron8/8:c.1531-14dup::						rs550999501	0.28483	0.22726,0.31025,0.36714,0.29956,0.37156	6009,	30262	106158		15.65			/11.2>11.2/0.0>0.0		IPP|0.02|0.00|0.00|0.00|-19|-17|-19|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45727474	45727474	-	TCCC	hom	het	hom	off-target;low_conf_region	QUAL=119;DP=7,6,5;AF=0.43,0.17,0.60;MQM=55;SAP=18;ABP=9;SAR=0;SAF=7	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron5/8:c.1048+153_1048+156dup::					(CCTT)n (Simple_repeat)	rs200134370	0.30827	0.38755,0.29450,0.32214,0.27655,0.33826	6628,	30943	99177		0.59			/0.0>0.0/2.6>2.6		IPP|0.00|0.00|0.00|0.00|-34|34|49|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729540	45729542	AAC	-	hom	het	hom	off-target	QUAL=3243;DP=87,18,20;AF=0.94,0.50,1.00;MQM=60;SAP=227;ABP=3;SAR=2;SAF=109	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron4/8:c.880+72_880+74del::	regulatory_region_variant:enhancer					rs139068713	0.28043	0.23472,0.30817,0.32781,0.29399,0.36362	6064,	30457	109271	1.0420	6.62			/1.0>1.4/0.0>0.0		IPP|0.00|0.00|0.00|0.00|45|27|-21|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729703	45729703	T	C	hom	het	hom		QUAL=10569;DP=230,60,65;AF=1.00,0.57,0.97;MQM=60;SAP=139;ABP=5;SAR=235;SAF=92	IPP	missense	IPP:ENST00000396478.4:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	regulatory_region_variant:enhancer					rs28375469	0.28172	0.23524,0.30885,0.34258,0.29483,0.36501	6168,	30492	109198	7.6030	22.40	0.19	0.08	/0.0>0.0/0.0>0.0	COSV63431879	IPP|0.00|0.00|0.00|0.00|6|-38|-46|8	32327693,33777101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740727	45740727	G	A	hom	n/a	n/a	off-target	QUAL=475;DP=15,0,2;AF=1.00,,1.00;MQM=60;SAP=40;ABP=0;SAR=0;SAF=17	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+174C>T::						rs28647556	0.53559	0.56785,0.48817,0.37457,0.53795,0.50935	21827,	37485	70355	0.1770	9.68			/3.9>3.2/0.0>0.0		IPP|0.00|0.00|0.00|0.00|-14|16|-5|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740868	45740868	A	G	hom	het	hom	off-target	QUAL=9799;DP=270,25,37;AF=1.00,0.68,1.00;MQM=60;SAP=704;ABP=10;SAR=0;SAF=323	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+33T>C::						rs28507722	0.28160	0.23495,0.30941,0.34308,0.29464,0.36452	6160,	30508	109258	1.3640	8.30			/1.0>0.9/0.0>0.0	COSV63433613	IPP|0.00|0.00|0.00|0.01|33|29|-29|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46189486	46189486	T	C	hom	hom	hom		QUAL=12819;DP=142,141,131;AF=0.99,1.00,1.00;MQM=60;SAP=157;ABP=0;SAR=121;SAF=292	POMGNT1	missense,missense&splice_region	POMGNT1:ENST00000371984.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000686737.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000685444.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000688608.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000692369.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687683.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687149.1:missense_variant:MODERATE:exon20/21:c.1906A>G:p.Met636Val:	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	167524 [benign DISEASE=Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76,Muscle eye brain disease,not specified];			rs6659553	0.94816	0.81883,0.98220,1.00000,0.99944,0.99917	68933,	6431	7889	5.8290	22.50	0.33	0.04	2.6>0.4/0.0>0.0/2.6>0.4,/0.0>0.0/2.6>0.4		POMGNT1|0.00|0.00|0.01|0.19|1|28|-28|-2	24033266,17878207,25373335,28765568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=AR oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46191979	46191979	T	C	hom	hom	het	off-target	QUAL=13270;DP=246,145,173;AF=0.99,0.99,0.46;MQM=60;SAP=1017;ABP=5;SAR=0;SAF=467	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron17/22:c.1539+119A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron17/20:c.1539+119A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	667975 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs7521880	0.34864	0.34867,0.36175,0.15915,0.35279,0.43336	9397,	34180	98970	-0.1390	5.50			/7.5>8.1/0.0>0.0	COSV64339342	POMGNT1|0.00|0.00|0.00|0.00|24|-39|1|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192656	46192656	A	G	hom	hom	het	off-target	QUAL=27542;DP=425,294,377;AF=0.99,1.00,0.47;MQM=60;SAP=431;ABP=5;SAR=657;SAF=237	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-66T>C::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-66T>C::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671038 [benign DISEASE=not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3];			rs2292484	0.34811	0.34768,0.36149,0.15990,0.35236,0.43304	9309,	34178	98870	0.2780	8.97			/4.3>4.1/0.0>0.0	COSV64341376	POMGNT1|0.00|0.08|0.00|0.00|48|-20|-11|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192671	46192671	G	A	hom	hom	het	off-target	QUAL=26417;DP=439,275,360;AF=0.99,1.00,0.48;MQM=60;SAP=464;ABP=5;SAR=656;SAF=224	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-81C>T::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-81C>T::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671037 [benign DISEASE=not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3];			rs2292485	0.34794	0.34714,0.36176,0.15914,0.35240,0.43216	9291,	34169	98857	0.1270	3.74			/0.0>0.0/0.0>0.0	COSV64341379	POMGNT1|0.00|0.02|0.00|0.00|30|-35|31|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193432	46193432	T	C	hom	hom	het	off-target	QUAL=40803;DP=349,626,797;AF=1.00,1.00,0.49;MQM=60;SAP=17;ABP=4;SAR=728;SAF=635	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron11/20:c.1027-44A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	260869 [benign DISEASE=not specified,Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3];			rs7527668	0.37721	0.44560,0.37310,0.15963,0.35343,0.43431	11081,	35149	94623	-0.3030	4.53			/0.0>0.0/2.3>1.5	COSV64339664	POMGNT1|0.03|0.12|0.00|0.01|-28|10|47|-19	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193691	46193691	T	C	hom	hom	het	off-target	QUAL=23818;DP=299,319,334;AF=0.99,1.00,0.55;MQM=60;SAP=171;ABP=11;SAR=525;SAF=276	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron10/20:c.951-52A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671035 [benign DISEASE=Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,not provided];			rs7527935	0.34870	0.34852,0.36211,0.15959,0.35276,0.43361	9408,	34163	98953	-0.0180	1.62			/0.0>0.0/1.3>2.0	COSV64339668	POMGNT1|0.00|0.00|0.00|0.00|-43|4|4|42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46194623	46194623	T	C	hom	hom	het		QUAL=17601;DP=260,198,303;AF=1.00,0.99,0.45;MQM=60;SAP=113;ABP=11;SAR=382;SAF=209	POMGNT1	synonymous,intron	POMGNT1:ENST00000371984.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000686737.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000692369.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687683.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687149.1:synonymous_variant:LOW:exon8/21:c.681A>G:p.Lys227=:	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	95761 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Congenital Muscular Dystrophy, alpha-dystroglycan related,Retinitis pigmentosa 76,not specified,not provided,Muscle eye brain disease];			rs2292487	0.34916	0.34960,0.36213,0.15928,0.35306,0.43369	9428,	34204	98904	0.3970	10.11	0.05		/0.0>0.0/0.0>0.3	COSV64339346	POMGNT1|0.00|0.04|0.00|0.00|-1|-32|5|29	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47250369	47250370	AA	-	het	het	wt		QUAL=5549;DP=254,174,174;AF=0.52,0.52,0.00;MQM=56;SAP=3;ABP=4;SAR=112;SAF=110	STIL	3'UTR	STIL:ENST00000360380.7:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.8:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:ENST00000337817.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208	0.42489	0.16899,0.43074,0.44751,0.52123,0.54973	15808,	32905	87333	1.6070	3.64			/2.2>2.2/0.0>0.0		STIL|0.00|0.00|0.00|0.00|-28|-2|-28|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47251517	47251517	A	G	het	het	wt		QUAL=8553;DP=443,231,306;AF=0.51,0.40,0.01;MQM=60;SAP=37;ABP=7;SAR=125;SAF=196	STIL	synonymous	STIL:ENST00000360380.7:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.8:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000337817.10:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:ENST00000396221.6:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:ENST00000682977.1:synonymous_variant:LOW:exon18/18:c.3345T>C:p.Pro1115=:,STIL:ENST00000447475.7:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94095 [benign DISEASE=not specified,not provided,Microcephaly 7, primary, autosomal recessive];			rs2758735	0.42587	0.17064,0.43129,0.44732,0.52187,0.54940	15893,	32953	87277	-0.8210	0.85			/3.5>2.5/0.0>0.0		STIL|0.00|0.00|0.00|0.00|17|46|38|-13	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47260415	47260415	T	C	het	het	het		QUAL=6433;DP=211,117,177;AF=0.51,0.47,0.47;MQM=60;SAP=78;ABP=4;SAR=77;SAF=169	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.8:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000337817.10:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:ENST00000396221.6:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:ENST00000682977.1:missense_variant:MODERATE:exon17/18:c.2813A>G:p.His938Arg:,STIL:ENST00000447475.7:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94094 [benign DISEASE=not provided,not specified,Microcephaly 7, primary, autosomal recessive];			rs13376679	0.25279	0.20173,0.21517,0.02537,0.31367,0.20842	5203,	28020	113584	0.0110	1.81	0.03	0.07	/0.0>0.0/0.0>0.0	COSV54551803	STIL|0.00|0.00|0.00|0.00|35|-50|-26|3	25741868,23757202,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47269608	47269608	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	160057 [benign DISEASE=not provided,not specified];			rs2742104	0.42593	0.17048,0.43175,0.44859,0.52187,0.55021	15882,	32941	87211	-0.1460	1.27			/1.1>1.1/0.0>0.0	COSV54550059	STIL|0.00|0.00|0.00|0.03|35|22|35|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47272449	47272449	T	-	hom	hom	het	off-target	QUAL=248;DP=14,3,5;AF=0.86,0.67,0.20;MQM=60;SAP=36;ABP=7;SAR=15;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron13/17:c.2218-208del::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron14/18:c.2077-208del::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron13/17:c.2077-208del::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron14/18:c.2077-208del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1295564 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs60685133	0.52652	0.34461,0.50130,0.46830,0.60580,0.67033	20771,	35204	69016	-0.3060	0.31			/0.0>0.3/0.0>0.0		STIL|0.00|0.00|0.00|0.00|-1|43|39|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281321	47281321	G	A	het	het	het	off-target	QUAL=2697;DP=168,20,44;AF=0.50,0.45,0.41;MQM=60;SAP=244;ABP=4;SAR=111;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-112C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-112C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1246005 [benign DISEASE=not provided];			rs11211505	0.25885	0.22195,0.21751,0.02522,0.31400,0.20828	5410,	28490	112554	-0.5560	1.12			/0.0>0.0/0.0>0.0		STIL|0.00|0.00|0.00|0.00|3|-48|19|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281418	47281418	T	C	het	hom	het	off-target	QUAL=870;DP=64,3,7;AF=0.47,1.00,0.57;MQM=60;SAP=83;ABP=3;SAR=37;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-209A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-209A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1182531 [benign DISEASE=not provided];		L2c (LINE/L2)	rs12145974	0.25887	0.22245,0.21728,0.02540,0.31389,0.20759	5414,	28501	112595	0.3230	9.18			/3.8>3.8/1.4>0.0		STIL|0.00|0.00|0.00|0.00|3|26|35|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47287733	47287733	G	A	het	het	wt	off-target	QUAL=2247;DP=162,54,84;AF=0.40,0.54,0.00;MQM=60;SAP=166;ABP=11;SAR=89;SAF=5	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron10/17:c.1024-73C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron11/18:c.883-73C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron10/17:c.883-73C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron11/18:c.883-73C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	673949 [benign DISEASE=not provided];			rs12125261	0.38281	0.09328,0.40841,0.22424,0.51073,0.45357	13917,	30274	93684	0.7330	14.90			/6.4>6.5/0.0>0.0	COSV54548877	STIL|0.00|0.00|0.00|0.00|-40|-44|15|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47299818	47299818	T	C	het	het	hom	off-target	QUAL=3886;DP=130,45,55;AF=0.45,0.67,1.00;MQM=60;SAP=316;ABP=3;SAR=0;SAF=144	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron7/17:c.701+87A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron8/18:c.560+87A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron7/17:c.560+87A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron8/18:c.560+87A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670465 [benign DISEASE=not provided];			rs9436838	0.58227	0.84011,0.57263,0.58124,0.48575,0.45487	27945,	32618	63498	-0.3510	5.12			/2.3>0.0/0.0>0.3		STIL|0.00|0.00|0.00|0.00|3|-40|5|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47301469	47301469	C	A	het	het	hom	off-target	QUAL=3490;DP=173,26,43;AF=0.49,0.46,1.00;MQM=60;SAP=305;ABP=4;SAR=0;SAF=139	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron6/17:c.453+92G>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron6/18:c.453+92G>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron5/17:c.453+92G>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron6/18:c.453+92G>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670581 [benign DISEASE=not provided];			rs6689687	0.58243	0.84006,0.57213,0.58437,0.48583,0.45536	27928,	32602	63420	0.1760	2.52			/0.0>0.0/0.0>0.0	COSV54552578	STIL|0.00|0.00|0.00|0.00|-3|19|36|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47302242	47302242	G	A	het	het	hom		QUAL=13735;DP=245,185,259;AF=0.51,0.54,0.99;MQM=60;SAP=32;ABP=5;SAR=201;SAF=281	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.8:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000337817.10:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000682977.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000447475.7:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	21354 [benign DISEASE=not specified,not provided,Microcephaly 7, primary, autosomal recessive];			rs3125630	0.57506	0.83169,0.56866,0.55294,0.47908,0.45017	27255,	32820	64532	5.3540	18.91	0.17	0.05	/5.9>5.3/0.0>0.0	COSV54548838	STIL|0.00|0.00|0.00|0.00|-35|0|2|-8	25741868,20301772,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47304769	47304769	A	C	het	het	hom	off-target	QUAL=3955;DP=71,64,77;AF=0.56,0.53,0.99;MQM=60;SAP=329;ABP=6;SAR=0;SAF=150	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron4/17:c.152+120T>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron4/18:c.152+120T>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron3/17:c.152+120T>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron4/18:c.152+120T>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670580 [benign DISEASE=not provided];			rs3122615	0.57492	0.83122,0.56799,0.55156,0.47920,0.45062	27259,	32858	64604	-0.1650	3.20			/10.5>9.0/0.0>0.0		STIL|0.01|0.03|0.00|0.00|-1|2|-1|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47304794	47304794	T	C	wt	wt	het	off-target	QUAL=1416;DP=84,87,124;AF=0.00,0.00,0.49;MQM=60;SAP=96;ABP=3;SAR=5;SAF=56	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron4/17:c.152+95A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron3/16:c.152+95A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron4/18:c.152+95A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron3/16:c.152+95A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron3/17:c.152+95A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron4/18:c.152+95A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	672536 [benign DISEASE=not provided];			rs3122616	0.22052	0.28482,0.31193,0.52682,0.16029,0.23941	4352,	24790	118390	-0.1080	10.61			/0.0>0.0/0.0>0.0	COSV54553648	STIL|0.00|0.01|0.00|0.00|1|-23|1|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305114	47305114	T	A	het	het	wt	off-target	QUAL=2189;DP=142,56,70;AF=0.45,0.55,0.00;MQM=60;SAP=209;ABP=4;SAR=95;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-118A>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-118A>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-118A>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-118A>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670141 [benign DISEASE=not provided];			rs6692734	0.38223	0.09277,0.40914,0.22405,0.50947,0.45215	13916,	30288	93934	-0.4510	0.37			/0.0>0.0/0.0>0.0	COSV54552742	STIL|0.00|0.00|0.00|0.00|-16|7|45|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305134	47305134	T	C	het	het	het	off-target	QUAL=2371;DP=122,22,28;AF=0.55,0.59,0.61;MQM=60;SAP=214;ABP=9;SAR=97;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-138A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-138A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-138A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-138A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1293134 [benign DISEASE=not provided];			rs12129594	0.25509	0.20267,0.21792,0.02544,0.31706,0.20870	5302,	28179	113255	-0.4610	1.20			/0.0>0.0/0.0>0.0	COSV54549757	STIL|0.00|0.00|0.00|0.00|1|-36|1|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	50600416	50600416	T	C	het	het	wt		QUAL=3511;DP=166,136,172;AF=0.43,0.48,0.00;MQM=60;SAP=78;ABP=9;SAR=34;SAF=103	FAF1	intron	FAF1:ENST00000396153.7:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.23256	0.17881,0.23939,0.00328,0.28100,0.24058	4536,	26275	116641	0.3190	4.52			/4.6>4.4/6.0>1.7	COSV65639546	FAF1|0.00|0.00|0.00|0.00|2|50|-1|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	52941734	52941734	-	A	wt	wt	het	off-target;low_conf_region	QUAL=473;DP=94,56,84;AF=0.29,0.13,0.10;MQM=59;SAP=19;ABP=352;SAR=4;SAF=16	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron1/15:c.70-47dup::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron1/14:c.-116-6260dup::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron1/14:c.70-47dup::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron1/14:c.70-47dup::,SCP2:ENST00000371513.9:intron_variant:MODIFIER:intron1/10:c.70-47dup::		184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	1197564 [likely benign DISEASE=not provided];		AluSg (SINE/Alu)	rs143386725	0.01424	0.03317,0.01207,0.02716,0.00345,0.00592	17,	1655	116925		0.81			/0.0>0.0/0.0>0.0		SCP2|0.00|0.00|0.00|0.00|30|27|-23|28		4	536	0	0 / 0					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49), H3P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	52941735	52941735	A	-	het	het	wt	off-target;low_conf_region	QUAL=473;DP=94,56,84;AF=0.07,0.04,0.13;MQM=58;SAP=50;ABP=212;SAR=6;SAF=36	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron1/15:c.70-47del::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron1/14:c.-116-6260del::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron1/14:c.70-47del::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron1/14:c.70-47del::,SCP2:ENST00000371513.9:intron_variant:MODIFIER:intron1/10:c.70-47del::		184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	801491 [benign DISEASE=not provided,Sterol carrier protein 2 deficiency];		AluSg (SINE/Alu)	rs143386725	0.07044	0.11286,0.06007,0.22091,0.03737,0.07539	296,	7764	110264	0.0050	0.25			/0.0>0.0/0.0>0.0		SCP2|0.00|0.00|0.00|0.00|30|27|16|-23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49), H3P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	53047765	53047765	T	C	wt	het	wt	off-target	QUAL=2249;DP=266,163,223;AF=0.00,0.55,0.00;MQM=60;SAP=119;ABP=6;SAR=10;SAF=79	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron14/15:c.1469-93T>C::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron13/14:c.1226-93T>C::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron13/14:c.1337-93T>C::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron13/14:c.1397-93T>C::,SCP2:ENST00000430330.6:intron_variant:MODIFIER:intron3/4:c.248-93T>C::,SCP2:ENST00000408941.7:intron_variant:MODIFIER:intron2/3:c.127-93T>C::,SCP2:ENST00000435345.6:intron_variant:MODIFIER:intron3/4:c.257-93T>C::,SCP2:ENST00000488965.1:intron_variant:MODIFIER:intron2/2:c.127-93T>C::	regulatory_region_variant:enhancer	184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	1290761 [benign DISEASE=not provided];			rs1288362	0.33608	0.10499,0.33910,0.27348,0.44816,0.26088	10336,	30423	100939	-0.6460	2.69			/6.1>6.0/0.0>0.0	COSV65260679	SCP2|0.00|0.00|0.00|0.00|-47|14|-46|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49)
chr1	53196294	53196294	G	A	het	wt	hom	off-target	QUAL=1474;DP=72,32,35;AF=0.40,0.00,0.97;MQM=60;SAP=131;ABP=9;SAR=1;SAF=62	CPT2	upstream_gene	CPT2:ENST00000636867.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636891.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000637252.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636935.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000635862.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000371486.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	1236333 [benign DISEASE=not provided];			rs10888776	0.45494	0.27722,0.44712,0.72293,0.54127,0.27320	17087,	34937	82801	0.1590	9.02							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53197151	53197151	C	A	het	wt	het	off-target	QUAL=1506;DP=12,61,107;AF=0.42,0.00,0.60;MQM=60;SAP=3;ABP=10;SAR=35;SAF=34	CPT2	intron	CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron1/3:c.152+56C>A::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	1177631 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,not provided,Carnitine palmitoyl transferase II deficiency, neonatal form];			rs72673121	0.14500	0.03952,0.14827,0.05079,0.21532,0.09337	2092,	17868	130030	-0.0020	7.72			/3.2>2.3/0.0>0.0		CPT2|0.00|0.00|0.00|0.00|30|28|9|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53209860	53209860	T	C	wt	wt	het	off-target	QUAL=92;DP=116,15,24;AF=0.01,0.00,0.33;MQM=60;SAP=23;ABP=9;SAR=0;SAF=9	CPT2	intron	CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron3/4:c.341-155T>C::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron3/4:c.341-155T>C::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron3/5:c.341-155T>C::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-3404T>C::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron3/5:c.341-155T>C::,CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron3/4:c.341-155T>C::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	680257 [benign DISEASE=not provided,Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form];			rs12737375	0.25530	0.09284,0.23988,0.46068,0.32448,0.16598	6043,	26733	113233	-0.7310	4.22			/7.5>7.2/0.0>0.0	COSV53760513	CPT2|0.00|0.00|0.00|0.00|-47|14|-8|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53210776	53210776	G	A	het	wt	hom		QUAL=11236;DP=290,215,230;AF=0.53,0.00,1.00;MQM=60;SAP=57;ABP=6;SAR=242;SAF=144	CPT2	missense,intron	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000637252.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-2488G>A::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000371486.4:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase]		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	92429 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyltransferase II deficiency,not specified,not provided,Carnitine palmitoyl transferase II deficiency, neonatal form]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, susceptibility to, 4];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.45899	0.28922,0.44935,0.72250,0.54224,0.27294	17289,	35129	82165	-0.0480	0.01	0.23	0.07	/0.0>0.0/0.0>0.0	COSV53758728	CPT2|0.00|0.00|0.00|0.00|-20|-15|-50|21	15986317,23757202,15811315,18306170,20934285,21697855,22809552,26874509,26010953,26460316,33170162,27156515,25361188,34234772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53213557	53213557	A	G	het	wt	het		QUAL=6132;DP=268,177,238;AF=0.48,0.00,0.46;MQM=60;SAP=7;ABP=7;SAR=108;SAF=130	CPT2	missense,3'UTR	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:,CPT2:ENST00000636891.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*192A>G::,CPT2:ENST00000637252.1:missense_variant:MODERATE:exon6/6:c.1975A>G:p.Met659Val:,CPT2:ENST00000636935.1:missense_variant:MODERATE:exon4/4:c.634A>G:p.Met212Val:,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon6/6:c.1906A>G:p.Met636Val:,CPT2:ENST00000371486.4:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	92433 [benign DISEASE=not provided,Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyltransferase II deficiency,not specified];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase II deficiency" GENE=CPT2];		rs1799822	0.15152	0.05125,0.16353,0.08173,0.21677,0.09482	2187,	18683	129113	7.4310	22.80	0.29	0.08	/2.1>3.1/0.0>0.0	COSV53759353	CPT2|0.02|0.00|0.00|0.00|-50|2|33|45	23757202,31201655,15647998,32778093,33170162,27156515,33031748,33414548	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53214206	53214206	T	C	wt	wt	het		QUAL=694;DP=104,48,47;AF=0.00,0.00,0.60;MQM=60;SAP=14;ABP=7;SAR=20;SAF=8	CZIB	3'UTR	CZIB:ENST00000294360.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.25508	0.09270,0.23989,0.46193,0.32415,0.16729	6029,	26732	113280	-0.2760	5.30			/0.0>0.0/0.0>0.0		C1orf123|0.00|0.00|0.00|0.00|-1|15|-44|33	33457407	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	54849678	54849678	T	C	hom	hom	hom		QUAL=17173;DP=249,129,157;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=287;SAF=247	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2555A>G::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.99944	0.99819,0.99967,0.99981,0.99997,1.00000	76006,	85	85	-0.6870	2.33			/0.0>0.0/0.0>0.0		DHCR24|0.00|0.00|0.00|0.00|49|-2|49|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850268	54850268	G	T	het	wt	het		QUAL=10590;DP=448,318,386;AF=0.47,0.00,0.50;MQM=60;SAP=22;ABP=5;SAR=173;SAF=232	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1965C>A::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297621 [benign DISEASE=Desmosterolosis];			rs11555500	0.02389	0.00714,0.01459,0.00038,0.03886,0.00497	75,	3486	148562	0.8670	6.54			/4.0>2.8/0.0>0.0		DHCR24|0.00|0.00|0.00|0.00|32|-20|26|-20		0	14	0	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850409	54850409	A	C	hom	hom	hom		QUAL=25161;DP=319,190,258;AF=1.00,1.00,1.00;MQM=60;SAP=7;ABP=0;SAR=403;SAF=364	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1824T>G::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297623 [benign DISEASE=Desmosterolosis];			rs654561	0.98946	0.96868,0.99693,0.99228,0.99969,0.97021	74529,	1556	1604	-0.2930	3.19			/0.0>0.0/0.0>0.0		DHCR24|0.00|0.00|0.00|0.00|-46|-26|-24|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54854229	54854229	A	G	hom	hom	hom		QUAL=601;DP=7,3,9;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0;SAR=17;SAF=2	DHCR24	synonymous	DHCR24:ENST00000371269.9:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.6:synonymous_variant:LOW:exon8/10:c.1062T>C:p.Ile354=:,DHCR24:ENST00000436604.2:synonymous_variant:LOW:exon7/10:c.1026T>C:p.Ile342=:		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297654 [benign DISEASE=not provided,Desmosterolosis];			rs718265	0.66476	0.61711,0.62113,0.41126,0.69693,0.80344	33896,	33113	50887	1.6670	9.77			/0.0>0.0/0.0>0.0	COSV64875204	DHCR24|0.00|0.00|0.00|0.00|5|-34|-48|2	17510943,21901424,17579359,24489783,34680591	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54871277	54871277	C	G	hom	hom	hom	off-target	QUAL=7887;DP=58,101,112;AF=1.00,1.00,1.00;MQM=60;SAP=591;ABP=0;SAR=0;SAF=271	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron5/8:c.876+73G>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron5/9:c.876+73G>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron5/9:c.876+73G>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1278679 [benign DISEASE=not provided];			rs608458	0.61727	0.53335,0.55477,0.37258,0.67135,0.78631	29724,	34360	58164	-0.2220	1.26			/4.6>5.2/0.0>0.0	COSV64874146	DHCR24|0.00|0.00|0.00|0.00|-18|40|-18|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54876242	54876242	T	G	hom	hom	hom	off-target	QUAL=5314;DP=107,28,43;AF=0.99,1.00,1.00;MQM=60;SAP=387;ABP=0;SAR=177;SAF=0	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron2/8:c.388-195A>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron2/9:c.388-195A>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron2/9:c.388-195A>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1260254 [benign DISEASE=not provided];			rs638944	0.51110	0.35480,0.44879,0.40081,0.58236,0.69834	21053,	35503	74239	-0.2660	0.61			/0.0>0.0/0.0>0.0		DHCR24|0.00|0.00|0.00|0.00|-44|49|49|-33	15986317,17510943,21901424	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54998739	54998739	A	G	hom	hom	het	off-target	QUAL=629;DP=15,7,3;AF=1.00,1.00,0.67;MQM=60;SAP=55;ABP=4;SAR=0;SAF=24	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1224218 [benign DISEASE=not provided];			rs2500338	0.63324	0.38658,0.70282,0.32831,0.77791,0.69897	32761,	30723	55743	0.4130	7.41							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54998838	54998838	C	G	hom	hom	het	off-target	QUAL=4117;DP=75,55,62;AF=0.97,0.96,0.50;MQM=60;SAP=344;ABP=3;SAR=0;SAF=157	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1234155 [benign DISEASE=not provided];			rs2500339	0.62944	0.38551,0.67471,0.31262,0.77778,0.69905	32428,	30808	56320	0.4310	16.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999070	54999070	T	C	hom	hom	het		QUAL=35373;DP=338,531,651;AF=0.99,1.00,0.48;MQM=60;SAP=533;ABP=5;SAR=322;SAF=859	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297673 [benign DISEASE=not provided,Bartter disease type 4A];			rs2500340	0.66966	0.52243,0.68838,0.32824,0.77874,0.70008	35224,	31321	50203	-0.3600	1.25			/0.0>0.0/0.1>0.0	COSV64870665	BSND|0.00|0.00|0.00|0.00|-3|40|34|-3	33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999117	54999117	C	G	hom	hom	het		QUAL=37544;DP=334,572,759;AF=0.99,1.00,0.48;MQM=60;SAP=208;ABP=5;SAR=462;SAF=808	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297674 [benign DISEASE=not provided,Bartter disease type 4A];	CR2045392 [CLASS=DP MUT=ALT PHEN="Joubert syndrome modifier of" GENE=BSND];		rs2500341	0.66986	0.52261,0.68792,0.33605,0.77854,0.70021	35240,	31320	50172	-1.0610	2.96			/5.7>3.7/0.0>0.0	COSV64871304	BSND|0.00|0.00|0.00|0.00|48|10|-13|10	19646679,31879347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55007370	55007370	G	A	het	wt	hom	off-target	QUAL=236;DP=3,3,9;AF=0.67,0.00,1.00;MQM=60;SAP=27;ABP=4;SAR=11;SAF=0	BSND	intron	BSND:ENST00000651561.1:intron_variant:MODIFIER:intron3/3:c.548+98G>A::	regulatory_region_variant:enhancer	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1221679 [benign DISEASE=not provided];			rs6687801	0.48782	0.62157,0.31126,0.21542,0.47068,0.51757	18945,	35909	77483	0.2380	4.89			/0.0>0.0/8.1>4.3	COSV64870849	BSND|0.00|0.00|0.00|0.00|21|48|-44|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008652	55008652	A	C	het	wt	hom		QUAL=18398;DP=297,321,452;AF=0.55,0.01,1.00;MQM=60;SAP=166;ABP=10;SAR=416;SAF=201	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297681 [benign DISEASE=not provided,Bartter disease type 4A];			rs6682884	0.41776	0.49206,0.28497,0.30539,0.42527,0.28782	13661,	36103	88397	0.5590	3.81			/0.6>0.0/0.0>0.0	COSV64871593	BSND|0.00|0.00|0.00|0.00|-5|2|-21|-50	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008803	55008803	C	G	het	wt	hom	off-target	QUAL=5156;DP=167,81,124;AF=0.43,0.00,1.00;MQM=60;SAP=426;ABP=11;SAR=195;SAF=0	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	368877 [benign DISEASE=Bartter syndrome,not provided];			rs4339899	0.45429	0.59060,0.29697,0.30967,0.43034,0.45411	16440,	36094	82854	-1.1140	0.18			/6.9>6.8/0.0>0.0	COSV64871308	BSND|0.00|0.00|0.01|0.00|-44|16|-44|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	56874802	56874802	A	T	wt	wt	het	off-target	QUAL=410;DP=54,26,38;AF=0.00,0.00,0.50;MQM=60;SAP=44;ABP=3;SAR=0;SAF=19	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron2/10:c.172-147A>T::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]			L3 (LINE/CR1)	rs3738563	0.10083	0.02631,0.06425,0.10085,0.15007,0.08040	1000,	13337	136773	-0.8510	0.61			/1.8>2.4/0.0>0.0	COSV63486343	C8A|0.00|0.00|0.00|0.00|18|29|-22|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56875054	56875054	C	A	het	hom	wt		QUAL=5795;DP=136,141,210;AF=0.43,0.99,0.00;MQM=60;SAP=6;ABP=8;SAR=108;SAF=91	C8A	missense	C8A:ENST00000695677.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695678.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695681.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000361249.4:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	17039 [benign DISEASE=not specified,not provided,COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM];			rs652785	0.32555	0.21016,0.24931,0.46051,0.38067,0.50292	8678,	32107	102473	0.0330	6.82	0.10	0.07	/0.0>0.0/2.5>2.0	COSV63484431	C8A|0.00|0.00|0.04|0.00|-7|-2|39|-2	24033266,15986317,7649542,20029952,25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56885772	56885772	G	A	het	wt	het	off-target	QUAL=1456;DP=128,13,20;AF=0.45,0.00,0.50;MQM=56;SAP=148;ABP=6;SAR=0;SAF=67	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron6/10:c.787-155G>A::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron6/10:c.856-155G>A::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]			AluSc5 (SINE/Alu)	rs139789526	0.12227	0.03003,0.14364,0.00097,0.17648,0.06190	1504,	15535	133109	-0.9510	1.15			/0.0>0.0/0.0>0.0		C8A|0.00|0.00|0.00|0.00|26|-38|26|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56906918	56906918	C	T	het	hom	het	off-target	QUAL=3366;DP=154,20,41;AF=0.60,1.00,0.59;MQM=60;SAP=298;ABP=18;SAR=136;SAF=0	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron8/10:c.1153+126C>T::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron8/10:c.1222+126C>T::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs619545	0.78435	0.92581,0.66953,0.99730,0.71418,0.89004	47640,	23957	32783	0.2660	4.91			/0.0>0.0/0.0>0.0		C8A|0.00|0.00|0.00|0.00|30|-36|-38|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56907828	56907830	AGA	-	wt	wt	het	off-target	QUAL=270;DP=85,49,56;AF=0.00,0.02,0.32;MQM=60;SAP=44;ABP=19;SAR=0;SAF=19	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron8/10:c.1227-125_1227-123del::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron8/10:c.1227-125_1227-123del::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron8/10:c.1154-121_1154-119del::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron8/10:c.1223-121_1223-119del::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs10562652	0.22114	0.14731,0.17156,0.06763,0.28908,0.16736	4093,	25413	118339	-0.0990	0.46			/0.0>0.0/0.0>0.0		C8A|0.00|0.01|0.00|0.00|4|-11|12|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56912740	56912740	T	C	hom	hom	hom	off-target	QUAL=5243;DP=97,44,35;AF=1.00,1.00,1.00;MQM=60;SAP=385;ABP=0;SAR=176;SAF=0	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron10/10:c.1552+115T>C::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron10/10:c.1534+115T>C::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs623077	0.88826	0.91403,0.90134,0.93192,0.85949,0.96500	60133,	14831	16995	-0.4330	3.04			/0.0>0.0/0.0>0.0	COSV63483457	C8A|0.00|0.00|0.00|0.00|-17|45|14|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56917685	56917685	C	T	wt	wt	het		QUAL=6232;DP=373,377,467;AF=0.00,0.00,0.53;MQM=60;SAP=4;ABP=6;SAR=118;SAF=130	C8A	missense	C8A:ENST00000695677.1:missense_variant:MODERATE:exon11/11:c.1673C>T:p.Pro558Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000695678.1:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000695681.1:missense_variant:MODERATE:exon11/11:c.1655C>T:p.Pro552Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000361249.4:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain]		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	1166647 [benign DISEASE=not provided];			rs17300936	0.08683	0.03316,0.05621,0.07010,0.12644,0.07066	729,	11748	138882	0.5720	14.20	0.02	0.07	/3.2>3.9/0.0>0.0	COSV63486347	C8A|0.00|0.00|0.00|0.00|3|10|-40|10	25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56929091	56929098	GGCTAGAG	-	hom	hom	hom	off-target	QUAL=3025;DP=26,34,50;AF=1.00,1.00,1.00;MQM=60;SAP=242;ABP=0;SAR=0;SAF=110	C8B	downstream_gene	C8B:ENST00000371237.9:downstream_gene_variant:MODIFIER::::,C8B:ENST00000695842.1:downstream_gene_variant:MODIFIER::::,C8B:ENST00000696164.1:downstream_gene_variant:MODIFIER::::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs3040448	0.82924	0.70538,0.88557,0.94633,0.86384,0.89770	37937,	14460	18602	0.2160	0.91							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929347	56929347	A	G	het	het	wt	low_conf_region	QUAL=14163;DP=541,529,781;AF=0.51,0.49,0.00;MQM=60;SAP=138;ABP=3;SAR=177;SAF=360	C8B	3'UTR	C8B:ENST00000371237.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000695842.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*57T>C::,C8B:ENST00000696164.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs2795	0.31854	0.21884,0.36622,0.51840,0.32570,0.51329	8247,	31928	103590	0.0380	4.66			/0.0>0.0/0.0>0.0		C8B|0.00|0.00|0.00|0.00|44|-11|-39|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929578	56929578	T	C	hom	hom	hom	off-target	QUAL=25449;DP=274,249,294;AF=1.00,1.00,1.00;MQM=60;SAP=1174;ABP=0;SAR=739;SAF=76	C8B	splice_region&intron	C8B:ENST00000371237.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1622-20A>G::,C8B:ENST00000695842.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1493-20A>G::,C8B:ENST00000696164.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1622-20A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1168190 [benign DISEASE=not specified,not provided];			rs605648	0.85061	0.78118,0.89247,0.93494,0.85887,0.96458	55308,	18807	22731	-2.3430	0.13			8.8>8.4/8.8>8.4/0.0>0.0		C8B|0.00|0.00|0.00|0.00|-20|-2|-15|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929748	56929748	C	G	het	het	wt	off-target	QUAL=1347;DP=87,20,25;AF=0.56,0.50,0.00;MQM=60;SAP=131;ABP=5;SAR=59;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-190G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-190G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-190G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs653804	0.31856	0.21888,0.36639,0.51941,0.32571,0.51540	8241,	31889	103471	-0.2680	1.80			/1.0>0.6/0.0>0.0		C8B|0.00|0.00|0.00|0.02|34|0|-27|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929761	56929761	C	G	het	wt	het	off-target	QUAL=795;DP=87,17,14;AF=0.44,0.00,0.21;MQM=60;SAP=92;ABP=11;SAR=41;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-203G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-203G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-203G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs2281598	0.13555	0.05584,0.22455,0.33865,0.13941,0.16466	1751,	17099	131377	-3.3980	0.01			/1.0>0.7/0.0>0.0		C8B|0.00|0.00|0.00|0.00|-13|48|-40|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56931628	56931628	G	A	het	het	wt	off-target	QUAL=2367;DP=202,28,30;AF=0.44,0.50,0.00;MQM=60;SAP=225;ABP=9;SAR=0;SAF=102	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1621+182C>T::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1492+182C>T::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1621+182C>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs683824	0.31876	0.21920,0.36689,0.52016,0.32565,0.51351	8246,	31923	103469	-0.9450	0.21			/0.0>0.0/0.0>0.0		C8B|0.00|0.00|0.00|0.00|-24|-39|2|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56932065	56932065	G	C	het	het	wt	off-target	QUAL=2313;DP=142,54,65;AF=0.48,0.56,0.02;MQM=60;SAP=218;ABP=3;SAR=99;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron10/11:c.1553-187C>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron9/10:c.1424-187C>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron11/12:c.1553-187C>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs612563	0.31873	0.21910,0.36669,0.51941,0.32577,0.51390	8260,	31902	103498	-0.2810	1.38			/1.8>1.1/0.0>0.0	COSV64777108	C8B|0.05|0.00|0.15|0.00|17|-11|-28|28	29875488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56940719	56940719	T	C	het	het	hom	off-target	QUAL=2125;DP=89,28,34;AF=0.45,0.46,1.00;MQM=60;SAP=192;ABP=5;SAR=0;SAF=87	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron9/11:c.1398+130A>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron8/10:c.1269+130A>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron10/12:c.1398+130A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs6669836	0.43413	0.29795,0.46637,0.40795,0.50743,0.34263	14998,	35902	85896	0.0150	3.31			/0.0>0.0/0.0>1.0	COSV64777813	C8B|0.00|0.00|0.00|0.00|0|50|0|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56943656	56943656	A	G	wt	het	wt	off-target	QUAL=2747;DP=185,187,229;AF=0.00,0.58,0.00;MQM=60;SAP=52;ABP=14;SAR=30;SAF=80	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron7/10:c.1105+2165T>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron9/12:c.1234+40T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs72670361	0.03075	0.00900,0.02938,0.00039,0.04798,0.00601	92,	4495	147493	0.1450	1.11			/6.9>7.0/0.0>0.0		C8B|0.00|0.00|0.00|0.00|28|-12|-19|40		43	1464	0	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56956811	56956811	C	T	hom	hom	hom		QUAL=26286;DP=295,250,267;AF=1.00,1.00,1.00;MQM=60;SAP=157;ABP=0;SAR=286;SAF=526	C8B	missense	C8B:ENST00000371237.9:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000695842.1:missense_variant:MODERATE:exon3/11:c.349G>A:p.Gly117Arg:,C8B:ENST00000696164.1:missense_variant:MODERATE:exon4/13:c.349G>A:p.Gly117Arg:		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1169777 [benign DISEASE=not provided];			rs1013579	0.97883	0.99445,0.97275,0.99942,0.96797,0.98902	72908,	3090	3220	0.9500	13.85	0.04	0.04	/0.0>0.0/2.1>0.0		C8B|0.00|0.00|0.00|0.09|-39|7|-3|-42	20438785,25798599,29875488,28240269,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63402460	63402460	A	T	het	wt	wt	off-target	QUAL=104;DP=27,8,19;AF=0.37,0.00,0.05;MQM=49;SAP=27;ABP=7;SAR=11;SAF=0	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron4/14:c.257+117A>T::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]				rs541594476	0.00246	0.00152,0.00505,0.00127,0.00253,0.00363	0,	184	74468	0.0120	5.04			/0.0>0.0/0.0>0.0	COSV54767263	ALG6|0.00|0.00|0.00|0.00|-10|28|-15|-3		7	45	0	0 / 0					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63406210	63406210	A	G	het	het	hom	off-target	QUAL=7688;DP=237,85,105;AF=0.51,0.65,1.00;MQM=60;SAP=577;ABP=8;SAR=4;SAF=276	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron5/14:c.347-107A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180566 [benign DISEASE=ALG6-congenital disorder of glycosylation 1C,not provided];			rs1012872	0.35943	0.36443,0.44509,0.48495,0.33028,0.47054	10037,	34490	97244	0.0500	6.30			/0.0>0.0/1.5>0.0	COSV54765676	ALG6|0.00|0.00|0.00|0.00|1|38|0|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63407200	63407200	A	G	het	het	hom	off-target	QUAL=7178;DP=241,93,101;AF=0.49,0.43,1.00;MQM=60;SAP=337;ABP=5;SAR=230;SAF=30	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron7/14:c.494+74A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180568 [benign DISEASE=not provided,ALG6-congenital disorder of glycosylation 1C];			rs6588028	0.59644	0.79082,0.64936,0.67598,0.48287,0.64227	28520,	33502	61262	-0.5080	0.19			/4.4>3.8/0.0>0.0		ALG6|0.00|0.00|0.00|0.00|-22|24|-34|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63411459	63411459	G	T	het	het	hom	off-target	QUAL=1393;DP=59,12,13;AF=0.61,0.50,1.00;MQM=60;SAP=114;ABP=8;SAR=54;SAF=1	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron8/14:c.680+128G>T::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1230601 [benign DISEASE=not provided];			rs12125868	0.35899	0.36269,0.44538,0.48592,0.33031,0.47120	10005,	34493	97321	-0.1420	1.80			/6.6>7.2/8.3>3.4		ALG6|0.00|0.00|0.00|0.00|-8|-1|-6|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63415679	63415680	TA	-	het	n/a	n/a	off-target	QUAL=73;DP=7,1,0;AF=0.71,0.00,;MQM=60;SAP=14;ABP=6;SAR=0;SAF=5	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron10/14:c.903-183_903-182del::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1254388 [benign DISEASE=not provided];			rs10567757	0.35261	0.33924,0.44343,0.48431,0.33051,0.47148	9554,	34150	97782	0.1750	0.34			/0.9>0.9/1.4>1.4		ALG6|0.00|0.00|0.00|0.00|-32|24|19|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63415881	63415881	C	T	het	het	hom		QUAL=7295;DP=245,64,86;AF=0.56,0.44,1.00;MQM=60;SAP=252;ABP=7;SAR=41;SAF=211	ALG6	missense	ALG6:ENST00000263440.6:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	95531 [benign/likely benign DISEASE=not specified,ALG6-congenital disorder of glycosylation 1C];			rs4630153	0.75731	0.86634,0.76536,0.85866,0.68445,0.86439	44156,	26767	36879	0.6530	21.60	0.19	0.04	/1.0>1.0/0.0>0.0	COSV54765155	ALG6|0.13|0.25|0.00|0.00|13|-8|-8|-24	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63437781	63437781	T	C	het	het	hom		QUAL=2157;DP=96,14,21;AF=0.54,0.57,1.00;MQM=60;SAP=84;ABP=5;SAR=68;SAF=13	ALG6	3'UTR	ALG6:ENST00000263440.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	297858 [benign DISEASE=ALG6-congenital disorder of glycosylation 1C];			rs3009572	0.60551	0.81959,0.65299,0.67470,0.48458,0.64478	29520,	32690	59762	-0.1410	1.12			/6.4>6.1/0.0>0.0		ALG6|0.00|0.00|0.00|0.00|36|-48|-10|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	63438623	63438623	T	C	het	het	hom	off-target	QUAL=2346;DP=80,26,29;AF=0.54,0.46,1.00;MQM=60;SAP=109;ABP=3;SAR=74;SAF=10	ALG6,ITGB3BP	downstream_gene	ALG6:ENST00000263440.6:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000271002.15:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000371092.7:downstream_gene_variant:MODIFIER::::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]				rs3009573	0.76209	0.87360,0.76918,0.85871,0.68971,0.86537	44705,	26417	36159	0.0920	2.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67000108	67000108	G	A	het	wt	wt	low_conf_region	QUAL=287;DP=76,20,26;AF=0.37,0.05,0.00;MQM=60;SAP=66;ABP=14;SAR=29;SAF=0	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs901342235	0.00131	0.00036,0.00122,0.00124,0.00134,0.00000	0,	162	123622	-0.2800	0.83			/5.1>5.0/5.8>4.1		SLC35D1|0.00|0.00|0.00|0.00|-32|-9|15|-2		2	31	0	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000287	67000287	T	-	wt	wt	het		QUAL=220;DP=30,7,8;AF=0.20,0.29,0.00;MQM=60;SAP=4;ABP=42;SAR=2;SAF=4	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu), (T)n (Simple_repeat)	rs377396719	0.00224	0.00027,0.00227,0.00129,0.00172,0.00101	0,	306	136178	1.0070	1.14			/0.0>0.0/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-1|9|4|3		0	61	0	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	-	het	het	wt		QUAL=220;DP=30,7,8;AF=0.20,0.29,0.00;MQM=60;SAP=4;ABP=29;SAR=3;SAF=5	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs397861605	0.01023	0.02174,0.00430,0.00159,0.00632,0.00312	28,	1406	141480	-2.0130	0.09			/1.9>1.9/0.0>0.0	COSV105095829	SLC35D1|0.00|0.00|0.00|0.00|-10|-23|-15|3		6	119	0	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	T	wt	het	wt		QUAL=220;DP=30,7,8;AF=0.20,0.29,0.00;MQM=60;SAP=6;ABP=49;SAR=5;SAF=2	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs7540819	0.64595	0.85795,0.56189,0.51741,0.59742,0.40558	27960,	27809	45893	-2.0130	0.36			/1.9>1.9/0.0>0.0	COSV105095829	SLC35D1|0.00|0.00|0.00|0.00|-10|-24|3|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67009294	67009294	C	T	hom	hom	hom	off-target	QUAL=1170;DP=33,3,5;AF=1.00,1.00,1.00;MQM=60;SAP=92;ABP=0;SAR=41;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron10/11:c.877-127G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246419 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs2755271	0.58280	0.33381,0.70903,0.83802,0.66098,0.76524	27877,	32761	63365	-0.8890	1.34			/0.0>0.0/6.2>0.0		SLC35D1|0.00|0.00|0.02|0.01|-49|9|9|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021436	67021436	C	A	hom	hom	hom	off-target	QUAL=10860;DP=125,102,123;AF=1.00,1.00,1.00;MQM=60;SAP=429;ABP=0;SAR=44;SAF=306	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron9/11:c.797+99G>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1231615 [benign DISEASE=not provided];			rs2065002	0.58065	0.32614,0.70897,0.83675,0.66071,0.77246	27755,	32595	63631	-1.7600	0.18			/0.0>0.0/0.0>0.0	COSV52431286	SLC35D1|0.00|0.01|0.00|0.00|-7|11|12|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021692	67021697	CCAACA	-	het	het	het	off-target;low_conf_region	QUAL=1806;DP=24,29,34;AF=0.79,0.62,0.79;MQM=57;SAP=49;ABP=54;SAR=21;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-95_730-90del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1269364 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs66809311	0.33103	0.15188,0.41671,0.33836,0.40557,0.43731	8684,	27144	89952	0.2540	1.97			/2.0>5.4/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-17|-6|44|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021693	67021693	C	A	het	het	het	off-target;low_conf_region	QUAL=1806;DP=24,29,34;AF=0.79,0.62,0.79;MQM=60;SAP=81;ABP=45;SAR=56;SAF=8	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-91G>T::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1244705 [benign DISEASE=not provided];			rs61780038	0.32087	0.16661,0.41723,0.58605,0.39040,0.48598	2677,	17586	48554	-0.4890	1.68			/2.0>3.4/0.0>0.0	COSV52429637	SLC35D1|0.00|0.00|0.00|0.00|-8|-41|40|46	30595370,32888493,29844566	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021694	67021694	A	G	het	het	het	off-target;low_conf_region	QUAL=1806;DP=24,29,34;AF=0.79,0.62,0.79;MQM=60;SAP=81;ABP=45;SAR=56;SAF=8	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-92T>C::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1276665 [benign DISEASE=not provided];			rs61780039	0.24863	0.11910,0.31673,0.54075,0.31799,0.36664	2683,	17477	69031	0.1890	5.60			/2.0>2.4/0.0>0.0	COSV52429647	SLC35D1|0.00|0.00|0.00|0.00|-17|-9|47|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021706	67021706	G	C	het	het	het	off-target;low_conf_region	QUAL=1288;DP=39,25,30;AF=0.64,0.52,0.63;MQM=54;SAP=73;ABP=12;SAR=50;SAF=7	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-104C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1273225 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11576749	0.13688	0.11705,0.16678,0.38462,0.13675,0.14698	467,	7981	56213	-0.6390	0.96			/2.0>1.5/0.0>0.3	COSV52429658	SLC35D1|0.00|0.00|0.00|0.00|-48|-21|3|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021712	67021712	G	C	hom	hom	hom	off-target;low_conf_region	QUAL=2052;DP=37,31,33;AF=0.73,0.81,0.73;MQM=53;SAP=113;ABP=0;SAR=69;SAF=7	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-110C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(ACACAG)n (Simple_repeat)	rs11576752	0.42325	0.24502,0.50215,0.64656,0.47410,0.54816	7901,	27065	58413	-2.9340	0.27			/2.0>1.7/0.0>0.3		SLC35D1|0.00|0.00|0.00|0.00|48|-27|47|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021718	67021718	G	C	hom	hom	hom	off-target	QUAL=2527;DP=52,27,33;AF=0.88,0.96,1.00;MQM=52;SAP=214;ABP=0;SAR=103;SAF=2	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-116C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234073 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11576753	0.53030	0.28037,0.65748,0.77805,0.61554,0.69609	19411,	29384	60412	-1.0760	0.40			/1.0>0.9/0.0>0.3	COSV52430323	SLC35D1|0.00|0.00|0.00|0.00|-26|-33|41|21	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021724	67021724	G	C	hom	hom	hom	off-target	QUAL=2547;DP=59,26,29;AF=0.90,0.96,1.00;MQM=51;SAP=235;ABP=0;SAR=107;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-122C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246882 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11208992	0.65045	0.47872,0.73433,0.83058,0.68644,0.78698	24453,	28926	41826	0.2770	1.85			/1.0>0.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|48|-39|35|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042051	67042051	T	A	hom	hom	hom	off-target	QUAL=6519;DP=101,45,68;AF=1.00,1.00,1.00;MQM=60;SAP=468;ABP=0;SAR=0;SAF=214	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.729+185A>T::	regulatory_region_variant:open_chromatin_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1233310 [benign DISEASE=not provided];			rs2815375	0.74853	0.66107,0.84071,0.83655,0.77429,0.87785	43001,	27792	38230	-0.2340	1.93			/0.0>0.0/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-27|3|-3|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042398	67042401	CACT	-	het	wt	het	off-target	QUAL=3802;DP=162,217,230;AF=0.49,0.01,0.47;MQM=60;SAP=272;ABP=5;SAR=171;SAF=18	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.637-73_637-70del::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1247932 [benign DISEASE=not provided];		(CA)n (Simple_repeat)	rs10543599	0.31619	0.09436,0.39161,0.50097,0.38780,0.57383	9214,	29539	103737	1.5870	3.57			/3.1>0.0/3.1>0.0		SLC35D1|0.01|0.00|0.00|0.00|-13|42|23|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047220	67047220	G	T	hom	hom	hom	off-target	QUAL=12445;DP=171,106,112;AF=1.00,1.00,1.00;MQM=60;SAP=502;ABP=0;SAR=45;SAF=344	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+45C>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234892 [benign DISEASE=not provided,Schneckenbecken dysplasia];			rs1024229	0.69024	0.76731,0.67512,0.64046,0.66214,0.75228	36445,	31992	47068	-0.7010	3.34			/4.1>2.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|36|45|-22|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047237	67047237	A	C	hom	hom	hom	off-target	QUAL=13922;DP=180,121,140;AF=0.99,1.00,1.00;MQM=60;SAP=471;ABP=0;SAR=66;SAF=374	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+28T>G::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1270736 [benign DISEASE=Schneckenbecken dysplasia,not provided];			rs1024230	0.69019	0.76702,0.67503,0.64049,0.66227,0.75166	36434,	31984	47066	-0.2060	6.35			/0.0>0.3/0.0>7.0		SLC35D1|0.00|0.00|0.01|0.01|28|42|1|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67049626	67049626	C	T	hom	hom	hom	off-target	QUAL=6621;DP=156,24,32;AF=1.00,1.00,1.00;MQM=60;SAP=463;ABP=0;SAR=0;SAF=212	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron6/11:c.533+156G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1287418 [benign DISEASE=not provided];			rs2755257	0.53194	0.34039,0.58133,0.63958,0.60724,0.68061	22716,	35407	71131	-0.9060	0.11			/5.0>3.8/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|18|39|18|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67050633	67050633	T	A	hom	hom	hom	off-target	QUAL=6908;DP=176,20,27;AF=0.99,1.00,1.00;MQM=60;SAP=485;ABP=0;SAR=222;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.393-129A>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1261093 [benign DISEASE=not provided];			rs2815383	0.50032	0.22718,0.56655,0.63467,0.61023,0.67578	21344,	33359	75951	1.1760	4.93			/0.0>0.0/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-14|-12|-14|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67051804	67051804	A	-	het	het	hom	off-target	QUAL=1136;DP=80,5,4;AF=0.55,0.20,1.00;MQM=60;SAP=109;ABP=4;SAR=0;SAF=49	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.392+208del::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1286317 [benign DISEASE=not provided];			rs34503429	0.63128	0.68467,0.58903,0.64291,0.62156,0.74544	30540,	34674	55928	0.4550	5.43			/1.5>1.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|11|17|-28|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67052643	67052643	T	C	wt	wt	het	off-target	QUAL=497;DP=171,53,64;AF=0.00,0.00,0.41;MQM=60;SAP=59;ABP=8;SAR=0;SAF=26	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron3/11:c.324+128A>G::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs183805701	0.00218	0.00075,0.00412,0.00000,0.00331,0.00000	0,	332	151896	-0.6800	3.54			/0.0>0.0/0.6>0.0		SLC35D1|0.00|0.00|0.00|0.00|1|14|-14|-1		0	67	0	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054377	67054378	CA	-	het	het	hom		QUAL=470;DP=23,8,12;AF=0.39,0.50,1.00;MQM=60;SAP=57;ABP=5;SAR=25;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1250615 [benign DISEASE=not provided];			rs3840439	0.62532	0.64670,0.58936,0.63805,0.63193,0.74959	29928,	35044	56862	0.1920	7.06							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054400	67054400	C	T	het	het	wt		QUAL=194;DP=12,6,7;AF=0.75,0.50,0.00;MQM=60;SAP=29;ABP=7;SAR=12;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1243207 [benign DISEASE=not provided];			rs3806321	0.14505	0.08331,0.22716,0.27207,0.15154,0.14552	1881,	18297	130015	-0.6420	3.93							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054457	67054457	T	G	hom	n/a	hom	off-target	QUAL=245;DP=4,2,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=9;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1282317 [benign DISEASE=not provided];			rs2025087	0.76122	0.80618,0.75740,0.86103,0.74117,0.84507	44244,	27186	36284	-1.1250	4.56						34006833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	75724531	75724531	G	A	hom	het	het		QUAL=2091;DP=15,71,100;AF=0.93,0.51,0.43;MQM=60;SAP=96;ABP=5;SAR=15;SAF=78	ACADM	5'UTR	ACADM:ENST00000680964.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::,ACADM:ENST00000541113.6:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000680805.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::	regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298063 [benign/likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs17848068	0.26901	0.26146,0.23307,0.02486,0.28897,0.21660	5738,	29404	111086	-2.2320	1.45			/5.7>4.9/0.0>1.1		ACADM|0.00|0.00|0.00|0.00|18|-4|17|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75724883	75724883	C	T	hom	het	het	off-target	QUAL=354;DP=11,7,8;AF=0.91,0.57,0.38;MQM=60;SAP=40;ABP=3;SAR=17;SAF=0	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-250+66C>T::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron1/12:c.30+66C>T::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+66C>T::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron1/11:c.30+66C>T::	regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1292156 [benign DISEASE=not provided];			rs116034618	0.11514	0.02966,0.12759,0.00058,0.16115,0.09838	1325,	14850	134486	-0.2630	6.37			/1.0>1.6/0.0>0.0		ACADM|0.00|0.00|0.01|0.01|16|-8|-26|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728545	75728545	T	-	hom	hom	hom	off-target	QUAL=16893;DP=177,159,206;AF=1.00,0.99,1.00;MQM=60;SAP=417;ABP=0;SAR=431;SAF=110	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3186del::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3731del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+60del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	226050 [benign DISEASE=not provided,Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs796117827	0.99999	0.99998,1.00000,1.00000,1.00000,1.00000	76091,	1	1	0.0000	0.47			/0.0>0.0/0.0>0.0		ACADM|0.00|0.00|0.00|0.00|-45|-50|-42|-50	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728621	75728621	A	G	hom	hom	hom	off-target	QUAL=11370;DP=178,82,107;AF=1.00,1.00,1.00;MQM=60;SAP=800;ABP=0;SAR=367;SAF=0	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3113A>G::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+133A>G::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3804A>G::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+133A>G::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1261087 [benign DISEASE=not provided];			rs1146572	0.92685	0.97020,0.85831,0.74884,0.93320,0.92250	65572,	9874	11130	-0.1760	2.40			/0.0>0.0/0.4>0.0	COSV63720717	ACADM|0.00|0.00|0.00|0.00|1|-23|30|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75750752	75750752	T	-	het	het	het	off-target	QUAL=88;DP=29,3,5;AF=0.34,0.33,0.20;MQM=58;SAP=29;ABP=13;SAR=12;SAF=0	ACADM	splice_region&intron,intron	ACADM:ENST00000680964.1:splice_region_variant&intron_variant:LOW:intron10/11:c.946-4del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron9/10:c.849+1207del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron9/10:c.804+220del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron10/11:c.687+220del::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron11/12:c.1044+220del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron10/11:c.945+220del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron5/6:c.507+220del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron10/11:c.957+220del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]			MIRb (SINE/MIR), AluSg (SINE/Alu)	rs745487585	0.00700	0.01730,0.00424,0.00209,0.00212,0.00068	5,	966	138356	-1.4820	0.18			/3.7>3.2/0.0>0.0		ACADM|0.01|0.00|0.00|0.00|19|48|13|19		10	132	0	0 / 0					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75761039	75761039	A	C	het	wt	wt	off-target	QUAL=149;DP=38,5,4;AF=0.58,0.00,0.00;MQM=60;SAP=51;ABP=5;SAR=0;SAF=22	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron11/11:c.*39-83A>C::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron9/10:c.850-83A>C::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron9/10:c.805-83A>C::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron10/11:c.688-83A>C::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron11/12:c.1045-83A>C::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron10/11:c.946-83A>C::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron5/6:c.508-83A>C::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron10/11:c.958-83A>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs74090743						-0.5470	0.83			/0.0>0.0/0.0>0.0		ACADM|0.00|0.00|0.00|0.00|49|50|-14|50		0	14	0	0 / 0					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75763641	75763641	T	C	wt	het	het		QUAL=125;DP=31,6,10;AF=0.03,0.17,0.70;MQM=60;SAP=23;ABP=3;SAR=9;SAF=0	ACADM	3'UTR	ACADM:ENST00000681790.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:ENST00000370841.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587	0.65705	0.70710,0.62516,0.72306,0.64389,0.70598	32909,	33993	52097	-1.2740	0.90			/0.0>0.4/0.0>0.0		ACADM|0.00|0.00|0.00|0.00|14|-13|23|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92474854	92474854	C	T	het	wt	het		QUAL=6065;DP=279,119,165;AF=0.53,0.00,0.49;MQM=60;SAP=86;ABP=4;SAR=68;SAF=162	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs41313373	0.09473	0.02309,0.11565,0.01980,0.12749,0.08897	886,	12630	137630	2.7080	15.72			/2.9>1.8/6.4>7.2		GFI1|0.00|0.00|0.00|0.00|36|-15|4|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92475800	92475800	A	G	wt	het	wt		QUAL=3121;DP=451,230,280;AF=0.00,0.52,0.00;MQM=60;SAP=3;ABP=4;SAR=62;SAF=59	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1271213 [benign DISEASE=not provided];			rs4970714	0.71176	0.80377,0.70364,0.94500,0.64577,0.85004	39148,	29839	43791	-2.9480	0.04			/0.0>0.0/0.0>0.0	COSV54042587	GFI1|0.00|0.00|0.00|0.00|44|-22|44|-39	20075157	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478757	92478757	-	AGAGAG	wt	het	wt	low_conf_region	QUAL=5323;DP=62,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=19;ABP=65;SAR=18;SAF=5	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1170883 [benign DISEASE=not provided,Neutropenia, severe congenital, 2, autosomal dominant,not specified,Nonimmune chronic idiopathic neutropenia of adults];			rs35896485	0.32276	0.19991,0.38773,0.55556,0.35381,0.51831	7898,	28691	93347		7.21			/15.4>15.4/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|-4|47|-19|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478759	AG	-	wt	wt	het	low_conf_region	QUAL=5323;DP=62,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=20;ABP=194;SAR=36;SAF=16	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298182 [likely benign(replaced by megSAP based on classifications:3x1,2x3) DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485	0.12340	0.11347,0.10090,0.03015,0.13842,0.04197	1087,	14857	120989	3.1660	7.48			/15.4>7.6/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|47|-4|-19|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478763	AGAGAG	-	hom	het	het	low_conf_region	QUAL=5323;DP=62,99,154;AF=0.00,0.01,0.33;MQM=60;SAP=129;ABP=12;SAR=123;SAF=29	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298185 [benign/likely benign DISEASE=Severe congenital neutropenia,Neutropenia, severe congenital, 2, autosomal dominant,Nonimmune chronic idiopathic neutropenia of adults,not provided];		(AG)n (Simple_repeat)	rs35896485	0.11121	0.06208,0.14562,0.02508,0.13182,0.11071	941,	13479	122769	3.1660	6.76			/15.4>6.5/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|47|-12|-19|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483141	92483141	C	T	het	wt	het	off-target	QUAL=531;DP=28,7,14;AF=0.57,0.00,0.57;MQM=60;SAP=4;ABP=5;SAR=14;SAF=10	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000370332.5:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000427103.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs530464819	0.00918	0.00157,0.00772,0.00000,0.01221,0.00621	13,	1371	150825	-0.0260	8.68			/0.0>0.0/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|-39|-48|23|-13		2	284	0	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483381	92483381	C	T	het	het	wt		QUAL=3383;DP=104,266,323;AF=0.50,0.46,0.00;MQM=60;SAP=118;ABP=6;SAR=39;SAF=135	GFI1	missense	GFI1:ENST00000294702.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	259699 [benign DISEASE=not specified,not provided,Neutropenia, severe congenital, 2, autosomal dominant];			rs34631763	0.04040	0.01027,0.04297,0.00000,0.05922,0.01075	183,	5785	146091	2.4960	16.72	0.06	0.14	/0.0>3.8/0.0>0.0	COSV54042707	GFI1|0.00|0.00|0.01|0.00|-9|18|-8|14	25741868,24033266,20075157,27080012,31013831,31649884,26447191,31508375	80	2302	0	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486100	92486100	-	A	het	het	het	off-target	QUAL=2441;DP=92,67,106;AF=0.47,0.49,0.32;MQM=60;SAP=3;ABP=20;SAR=54;SAF=56	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs112925059	0.12227	0.05072,0.15906,0.02657,0.15634,0.11752	1259,	15392	128570		6.53			/5.6>6.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486661	92486661	A	-	hom	hom	hom	off-target	QUAL=1736;DP=24,20,19;AF=1.00,1.00,1.00;MQM=60;SAP=73;ABP=0;SAR=9;SAF=54	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+65del::	regulatory_region_variant:promoter,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs66635255	0.99999	0.99998,0.99994,1.00000,1.00000,1.00000	76061,	2	2	-0.4670	12.80			/4.7>2.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97078196	97078196	G	A	het	het	het		QUAL=16068;DP=472,323,440;AF=0.48,0.50,0.48;MQM=60;SAP=234;ABP=5;SAR=174;SAF=427	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100064 [benign DISEASE=not provided,Dihydropyrimidine dehydrogenase deficiency];			rs291593	0.28978	0.22780,0.29267,0.60767,0.27549,0.46824	6936,	30116	107810	-1.0340	0.19			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|3|44|24|44	24944790,23960437,28481884,34449663,32235849,34442436	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078208	97078208	C	T	het	het	het		QUAL=15535;DP=404,340,464;AF=0.49,0.50,0.47;MQM=60;SAP=145;ABP=5;SAR=195;SAF=391	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100065 [benign DISEASE=not provided,Dihydropyrimidine dehydrogenase deficiency];			rs291592	0.45200	0.31702,0.57455,0.97059,0.45303,0.61515	16990,	34597	83143	0.1450	2.72			/0.8>1.1/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-9|32|12|38	23960437,28481884,32235849	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078403	97078403	C	T	het	het	wt		QUAL=7016;DP=326,213,285;AF=0.52,0.44,0.00;MQM=60;SAP=214;ABP=3;SAR=212;SAF=52	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100067 [benign DISEASE=not provided,Dihydropyrimidine dehydrogenase deficiency];			rs1042482	0.06250	0.01462,0.04482,0.12962,0.07904,0.17702	400,	8707	142613	0.2650	2.97			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-43|-45|20|1	24944790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97079215	97079215	T	C	hom	hom	hom	off-target	QUAL=27771;DP=233,299,380;AF=0.99,1.00,1.00;MQM=60;SAP=1350;ABP=0;SAR=830;SAF=79	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2908-69A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1222833 [benign DISEASE=not provided];			rs290855	0.80234	0.71049,0.86808,0.98823,0.81333,0.89204	49271,	23382	30036	0.5570	5.41			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-38|-17|-32|32	20587604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97082275	97082275	G	A	hom	hom	hom	off-target	QUAL=15058;DP=185,126,164;AF=1.00,1.00,1.00;MQM=60;SAP=702;ABP=0;SAR=42;SAF=433	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1255090 [benign DISEASE=not provided];			rs290854	0.99998	0.99998,1.00000,1.00000,0.99997,1.00000	76061,	3	3	0.2870	2.09			/7.2>7.4/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-6|39|49|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97306391	97306391	C	A	wt	wt	het	off-target	QUAL=1499;DP=176,106,132;AF=0.00,0.00,0.46;MQM=60;SAP=69;ABP=5;SAR=52;SAF=9	DPYD,DPYD-AS1	intron,intron&non_coding_transcript	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron16/22:c.2059-94G>T::,DPYD-AS1:ENST00000422980.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.249+82C>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1270293 [benign DISEASE=not provided];			rs7556439	0.24219	0.07163,0.39156,0.33327,0.28878,0.31911	5483,	25785	114991	-0.2720	8.84			/6.6>7.1/0.0>0.0,/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-17|-34|-4|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77), DPYD-AS1 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97450068	97450068	A	G	het	wt	het		QUAL=4778;DP=204,150,187;AF=0.45,0.00,0.52;MQM=60;SAP=177;ABP=4;SAR=33;SAF=156	DPYD	synonymous	DPYD:ENST00000370192.8:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100088 [drug response DISEASE=not specified,not provided,fluorouracil response - Toxicity,capecitabine response - Toxicity,Dihydropyrimidine dehydrogenase deficiency];			rs17376848	0.04382	0.02156,0.07288,0.12365,0.04521,0.03913	195,	6276	145466	0.2880	6.57			/1.4>0.7/0.0>0.0	COSV100928729	DPYD|0.00|0.00|0.00|0.00|-15|-5|-9|-5	25741868,16115930,18299612,19104657,19530960,20819423,21498394,24923815,25677447,26099996,26794347,29065426,17697348,21362212,23942539,19473056,30545124,14635116,25782327,14523039,16007086,23588312,27487151,31076604,25915935,28481884,33194059,33228198,33305610,34050721,34064668,34442436,33235483,25614737,33317085,34959317,35582139	12	628	0	0 / 0					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515585	97515585	-	T	wt	wt	het	off-target	QUAL=18;DP=45,6,6;AF=0.00,0.00,0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+140_1740+141insA::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1225056 [benign DISEASE=not provided];			rs56080540	0.08346	0.05293,0.05490,0.01024,0.09917,0.10195	637,	11407	139259		5.12			/4.9>4.7/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|23|-3|-33|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515686	97515686	T	C	hom	het	hom	off-target;low_conf_region	QUAL=8027;DP=188,44,54;AF=1.00,0.45,1.00;MQM=60;SAP=546;ABP=4;SAR=3;SAF=259	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100090 [benign DISEASE=not provided];			rs2811178	0.61775	0.62633,0.65378,0.75233,0.58574,0.62640	29076,	35535	57971	-0.0810	0.88			/5.8>5.3/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|39|40|40|-15	23960437,34959317,35743735	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97516150	97516150	C	T	hom	het	hom	off-target	QUAL=2690;DP=89,3,6;AF=1.00,0.67,1.00;MQM=60;SAP=214;ABP=4;SAR=97;SAF=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron12/22:c.1525-209G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1282683 [benign DISEASE=not provided];			rs1337752	0.61668	0.62078,0.65337,0.75234,0.58652,0.62324	28976,	35525	58105	-0.0740	0.51			/3.7>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-31|-1|-11|1	35743735	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97549850	97549850	A	T	het	het	wt	off-target	QUAL=1564;DP=98,21,28;AF=0.54,0.52,0.00;MQM=60;SAP=142;ABP=4;SAR=64;SAF=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron11/22:c.1340-106T>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100099 [benign DISEASE=not provided];			rs61789183	0.08637	0.02226,0.07681,0.00038,0.12799,0.04801	777,	11588	139014	0.9650	6.49			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|39|-48|45|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77), SEC63P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97679170	97679170	T	C	wt	wt	het		QUAL=586;DP=168,36,55;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:PF07992 [Pyridine nucleotide-disulphide oxidoreductase]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	235464 [likely benign(replaced by megSAP based on classifications:5x1,2x2,1x3) DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided,Inborn genetic diseases,not specified];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.00514	0.00138,0.00360,0.00000,0.00748,0.00497	6,	770	151364	3.8740	22.80	0.61	0.11	/0.0>0.0/4.9>0.7	COSV99058634	DPYD|0.00|0.00|0.00|0.00|12|-43|-5|3	25741868,18299612,24648345,26801900,14635116,24326041,19288105,32707991,33305610,32529295	4	489	1	0 / 0	1	"[3] Stephan Waldmüller 18.11.2015 [n/a] comment imported from detected variant: HGMD: DM für Dihydropyrimidine dehydrogenase deficiency, Literatur nicht überzeugend, VUS3, swal 151118 [1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC"			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97719971	97719971	A	G	hom	hom	hom		QUAL=15798;DP=206,123,150;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0;SAR=262;SAF=217	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs2151562	0.99528	0.98309,0.99921,1.00000,0.99999,1.00000	75151,	713	717	0.4060	5.55			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-11|-29|-28|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97720521	97720521	T	C	hom	hom	hom		QUAL=20031;DP=282,136,192;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0;SAR=184;SAF=426	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs1333718	0.99532	0.98331,0.99914,1.00000,0.99997,1.00000	75164,	707	711	0.7280	16.20			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-12|38|-12|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97883329	97883329	A	G	wt	wt	het		QUAL=2647;DP=218,163,217;AF=0.00,0.00,0.48;MQM=60;SAP=9;ABP=4;SAR=61;SAF=44	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:,DPYD:ENST00000306031.5:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	435 [drug response DISEASE=not specified,not provided,Dihydropyrimidine dehydrogenase deficiency,fluorouracil response - Toxicity,capecitabine response - Toxicity];	CM970421 [CLASS=DFP MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs1801265	0.27323	0.40322,0.24738,0.07215,0.22539,0.24762	6303,	28901	110407	1.6470	18.87		0.04	/0.2>0.0/0.0>0.0		DPYD|0.04|0.00|0.00|0.00|45|-18|23|45	24944790,29334895,31361092,11156223,17121937,18299612,19104657,19530960,20819423,21498394,23988873,24590654,24647007,24923815,25110414,25677447,26216193,26794347,29065426,29193749,25066213,29372689,18381459,26858644,17697348,30356105,19473056,9266349,9439663,20570913,21472143,26785747,28618970,28679691,29681089,23960437,14635116,23328581,23481061,26846104,27249515,27487151,24401318,24297552,26484159,23588107,29273807,28114309,29075194,30915274,31076604,24388031,28481884,29152729,32619063,23781135,30114658,32707991,21521029,33194059,33228198,33305610,34050721,34064668,30551678,20601926,32231042,34442436,33235483,34525956,33491253,34429635,33519226,32347657,33767731,33089968,25614737,34780066,34629888,34798807,33569925,34916829,34959317,34621706,34949935,34944636,29998006,17848752,27752409,24434920,35582139,35582138,35784703,36077453,35886052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97988913	97988913	G	T	wt	wt	het		QUAL=706;DP=246,71,74;AF=0.00,0.00,0.42;MQM=60;SAP=9;ABP=7;SAR=11;SAF=20	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-9598C>A::,MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1726C>A::						rs41285694	0.11714	0.03272,0.09118,0.05864,0.16298,0.14114	1418,	14958	134108	0.4760	1.64			/4.5>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97989572	97989572	A	-	het	het	het		QUAL=945;DP=86,17,28;AF=0.38,0.24,0.25;MQM=60;SAP=16;ABP=34;SAR=14;SAF=30	MIR137HG	intron&non_coding_transcript,splice_region&intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-10257del::,MIR137HG:ENST00000424528.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.1070-3del::	regulatory_region_variant:enhancer				AluSp (SINE/Alu)	rs543197080	0.03147	0.09426,0.01420,0.00814,0.00411,0.00315	149,	3660	121810	-0.9170	0.30			/12.1>2.9/0.0>0.0				3	174	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97990401	97990401	G	A	wt	wt	het		QUAL=1441;DP=174,115,145;AF=0.00,0.00,0.42;MQM=60;SAP=52;ABP=11;SAR=49;SAF=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11086C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-832C>T::					L1PA13 (LINE/L1)	rs61785886	0.11716	0.03285,0.09118,0.05798,0.16289,0.14090	1417,	14967	134141	-1.2530	1.12			/7.1>7.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991087	97991087	G	A	wt	wt	het		QUAL=658;DP=144,45,77;AF=0.00,0.00,0.39;MQM=59;SAP=6;ABP=11;SAR=12;SAF=18	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11772C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1518C>T::					AluY (SINE/Alu)	rs61785887	0.08510	0.02249,0.06504,0.05748,0.12115,0.10707	753,	11400	138750	-0.3250	1.32			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991175	97991175	C	T	wt	wt	het		QUAL=965;DP=216,57,114;AF=0.00,0.00,0.39;MQM=59;SAP=4;ABP=14;SAR=20;SAF=25	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11860G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1606G>A::					AluY (SINE/Alu)	rs61785888	0.11796	0.03364,0.09211,0.05666,0.16399,0.13963	1434,	15039	133899	0.3960	4.45			/0.1>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991351	97991351	C	A	wt	wt	het		QUAL=1314;DP=193,87,96;AF=0.00,0.00,0.53;MQM=60;SAP=18;ABP=4;SAR=16;SAF=35	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12036G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1782G>T::						rs4573558	0.12639	0.06288,0.09442,0.05575,0.16434,0.13984	1503,	16211	132827	-1.2890	0.18			/0.7>1.6/0.0>0.0			34910505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991747	97991747	C	G	wt	wt	het		QUAL=2097;DP=279,106,175;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4;SAR=38;SAF=45	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12432G>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2178G>C::						rs2893376	0.16554	0.19354,0.11284,0.05650,0.16573,0.15112	2247,	20656	126776	-1.0200	0.17			/4.1>1.7/0.0>0.0			27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991967	97991967	A	T	wt	wt	het		QUAL=1559;DP=205,63,126;AF=0.00,0.00,0.48;MQM=60;SAP=29;ABP=3;SAR=44;SAF=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12652T>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2398T>A::						rs2391873	0.15446	0.15579,0.10841,0.05639,0.16535,0.15071	1959,	19563	128541	-0.1440	11.56			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994504	97994504	A	C	het	wt	het		QUAL=2944;DP=159,63,88;AF=0.48,0.00,0.51;MQM=60;SAP=216;ABP=3;SAR=6;SAF=115	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15189T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+412T>G::					AluSx (SINE/Alu)							-0.3580	2.70			/0.0>0.0/0.0>0.0				0	3	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994550	97994550	G	A	hom	hom	het		QUAL=9144;DP=169,86,125;AF=1.00,1.00,0.53;MQM=60;SAP=608;ABP=4;SAR=11;SAF=310	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15235C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+366C>T::					AluSx (SINE/Alu)	rs9440288	0.84005	0.82615,0.88880,0.94173,0.83453,0.84830	53798,	20123	24319	-1.3540	0.19			/0.0>0.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995576	97995576	G	C	hom	hom	het		QUAL=22271;DP=266,282,367;AF=1.00,1.00,0.47;MQM=60;SAP=86;ABP=6;SAR=443;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16261C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-576C>G::					L2a (LINE/L2)	rs9324380	0.91471	0.97695,0.93507,0.94260,0.87865,0.89246	63854,	11459	12977	-4.7770	0.00			/0.0>0.0/0.0>0.0			29942086,29326435,35764056	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995701	97995701	-	TTGT	hom	hom	het		QUAL=16452;DP=233,211,271;AF=0.99,1.00,0.44;MQM=60;SAP=48;ABP=11;SAR=335;SAF=227	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16387_141-16386insACAA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-702_985-701insACAA::						rs10655213	0.87355	0.93720,0.90544,0.94235,0.83591,0.85981	58158,	16198	19182		0.46			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995887	97995887	C	T	het	het	het		QUAL=4939;DP=163,96,103;AF=0.52,0.47,0.52;MQM=60;SAP=43;ABP=3;SAR=121;SAF=63	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16572G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-887G>A::						rs9662365	0.49130	0.49940,0.51920,0.41167,0.49055,0.39170	18442,	37693	77217	-0.0280	14.58			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97996398	97996398	T	C	hom	hom	het		QUAL=5961;DP=151,26,33;AF=0.99,1.00,0.58;MQM=60;SAP=262;ABP=5;SAR=21;SAF=173	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-17083A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-1398A>G::						rs1938570	0.86756	0.93475,0.89933,0.94207,0.82544,0.85889	57259,	17110	20094	-0.5300	0.32			/0.0>0.5/0.0>0.0			23910899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97997365	97997365	C	A	het	wt	het		QUAL=5228;DP=253,155,184;AF=0.50,0.00,0.48;MQM=60;SAP=71;ABP=3;SAR=148;SAF=66	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-18050G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-2365G>T::						rs146033831	0.00650	0.00068,0.02895,0.06317,0.00159,0.00435	27,	934	150944	-0.1480	0.50			/0.0>0.4/1.4>9.1				1	52	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97999972	97999972	G	A	hom	hom	het		QUAL=22747;DP=310,253,336;AF=1.00,1.00,0.50;MQM=60;SAP=335;ABP=3;SAR=198;SAF=532	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20657C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-4972C>T::	regulatory_region_variant:enhancer					rs2154403	0.88192	0.96642,0.90759,0.94240,0.83600,0.85993	59505,	15080	17954	0.9200	3.62			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98000284	98000284	G	A	het	het	wt		QUAL=5776;DP=285,226,308;AF=0.49,0.42,0.00;MQM=60;SAP=21;ABP=11;SAR=139;SAF=95	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20969C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-5284C>T::					L2a (LINE/L2)	rs116319667	0.00946	0.00297,0.00590,0.00000,0.01620,0.00497	13,	1413	150649	-0.3440	0.33			/0.1>0.7/1.3>4.6				8	331	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98001230	98001230	T	C	wt	het	wt		QUAL=1949;DP=338,144,175;AF=0.01,0.51,0.00;MQM=60;SAP=3;ABP=3;SAR=37;SAF=38	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-21915A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-6230A>G::						rs12138817	0.22701	0.07661,0.31353,0.12558,0.30242,0.13655	4793,	24915	117479	-0.8540	0.45			/0.0>0.0/1.1>7.3			32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98002983	98002984	TA	-	hom	hom	het		QUAL=17216;DP=333,146,206;AF=0.98,1.00,0.54;MQM=60;SAP=248;ABP=6;SAR=421;SAF=164	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-23669_141-23668del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-7984_985-7983del::	regulatory_region_variant:enhancer					rs5776390	0.87270	0.93741,0.90695,0.94171,0.83519,0.85430	58049,	16270	19308	0.0270	0.30			/3.1>2.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004131	98004131	A	-	het	wt	het		QUAL=6972;DP=211,246,312;AF=0.50,0.00,0.51;MQM=60;SAP=10;ABP=3;SAR=147;SAF=117	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-24816del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9131del::						rs564190891	0.00219	0.00051,0.01404,0.00000,0.00109,0.00145	7,	319	151759	2.0260	15.18			/7.8>7.6/2.6>0.0				0	22	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004495	98004495	-	AT	hom	hom	het		QUAL=23846;DP=516,128,229;AF=1.00,1.00,0.48;MQM=60;SAP=101;ABP=3;SAR=285;SAF=470	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25181_141-25180insAT::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9496_985-9495insAT::						rs10655252	0.84708	0.84688,0.89423,0.94221,0.83514,0.85493	54611,	19363	23213		0.50			/7.6>7.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98005049	98005049	A	G	hom	hom	het		QUAL=6790;DP=179,20,25;AF=1.00,1.00,0.44;MQM=60;SAP=223;ABP=4;SAR=32;SAF=178	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25734T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-10049T>C::	regulatory_region_variant:enhancer					rs10747495	0.88177	0.96650,0.90881,0.94230,0.83556,0.85507	59481,	15077	17973	0.6310	5.05			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006231	98006231	C	A	wt	het	wt		QUAL=231;DP=278,55,89;AF=0.00,0.33,0.00;MQM=60;SAP=7;ABP=17;SAR=12;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-26916G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11231G>T::					L1ME4a (LINE/L1)	rs55635742	0.01992	0.00486,0.02079,0.00019,0.03150,0.00248	40,	2947	148899	-0.3040	0.54			/0.0>0.0/0.0>0.0				13	550	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006652	98006652	A	G	het	wt	het		QUAL=3000;DP=167,75,97;AF=0.46,0.00,0.41;MQM=60;SAP=54;ABP=11;SAR=32;SAF=84	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-27337T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.01788	0.01410,0.04933,0.17260,0.00224,0.04843	129,	2458	149210	1.1380	5.10			/0.0>0.0/0.0>1.1				5	140	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007323	98007323	C	T	hom	hom	het		QUAL=20998;DP=327,193,254;AF=1.00,1.00,0.56;MQM=60;SAP=16;ABP=11;SAR=362;SAF=299	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28008G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12323G>A::	regulatory_region_variant:open_chromatin_region					rs1938564	0.80482	0.70250,0.88177,0.94226,0.83362,0.84392	49545,	22909	29587	-0.2730	0.96			/0.0>0.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007402	98007402	T	A	hom	hom	het		QUAL=15855;DP=223,171,183;AF=1.00,1.00,0.55;MQM=60;SAP=22;ABP=6;SAR=280;SAF=214	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28087A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12402A>T::	regulatory_region_variant:open_chromatin_region					rs1938563	0.88090	0.96317,0.90861,0.94221,0.83554,0.85471	59197,	15166	18058	0.4550	5.87			/1.2>3.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98008160	98008160	T	A	hom	hom	het		QUAL=18862;DP=396,117,129;AF=1.00,1.00,0.55;MQM=60;SAP=183;ABP=6;SAR=182;SAF=402	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28845A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-13160A>T::						rs1938562	0.88099	0.96331,0.90901,0.94213,0.83547,0.85507	59201,	15155	18041	1.1500	6.07			/0.0>0.8/0.2>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009211	98009211	C	T	hom	hom	het		QUAL=15309;DP=290,116,162;AF=1.00,1.00,0.49;MQM=60;SAP=343;ABP=3;SAR=381;SAF=105	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-29896G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14211G>A::						rs2391902	0.81159	0.72599,0.88372,0.94189,0.83375,0.84343	50263,	22456	28550	0.3390	13.52			/0.0>0.0/7.7>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009966	98009966	T	C	hom	hom	het		QUAL=16460;DP=307,118,172;AF=1.00,1.00,0.52;MQM=60;SAP=170;ABP=4;SAR=158;SAF=357	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-30651A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14966A>G::	regulatory_region_variant:enhancer					rs2154402	0.91446	0.97707,0.93587,0.94249,0.87831,0.88820	63715,	11455	12991	0.7240	8.88			/0.3>0.8/0.0>0.0			34743297	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98010357	98010357	G	A	hom	hom	het		QUAL=14301;DP=297,88,126;AF=1.00,1.00,0.55;MQM=60;SAP=8;ABP=5;SAR=211;SAF=243	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31042C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-15357C>T::						rs9324381	0.84547	0.84443,0.89306,0.94213,0.83422,0.84511	54321,	19540	23428	0.5390	3.20			/0.0>1.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011162	98011162	G	A	hom	hom	het		QUAL=26096;DP=421,219,280;AF=1.00,1.00,0.59;MQM=60;SAP=3;ABP=24;SAR=400;SAF=406	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31847C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16162C>T::						rs1938561	0.88181	0.96652,0.90876,0.94202,0.83555,0.85486	59488,	15084	17968	0.2820	2.41			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011394	98011394	T	C	hom	hom	het		QUAL=25147;DP=341,267,328;AF=1.00,1.00,0.55;MQM=60;SAP=3;ABP=10;SAR=399;SAF=388	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32079A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16394A>G::					L2c (LINE/L2)	rs9440293	0.88050	0.96318,0.90866,0.94143,0.83501,0.85543	59131,	15215	18115	-1.1320	0.90			/2.1>0.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011402	98011402	C	T	hom	hom	het		QUAL=25424;DP=344,268,337;AF=1.00,1.00,0.55;MQM=60;SAP=7;ABP=9;SAR=416;SAF=380	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32087G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16402G>A::					L2c (LINE/L2)	rs9727941	0.84469	0.84377,0.89242,0.94147,0.83359,0.84437	54228,	19603	23545	-0.2230	3.39			/0.0>0.0/2.1>1.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011410	98011410	G	C	hom	hom	het		QUAL=25236;DP=344,266,341;AF=1.00,1.00,0.55;MQM=60;SAP=17;ABP=12;SAR=436;SAF=363	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32095C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16410C>G::					L2c (LINE/L2)	rs9724773	0.84479	0.84406,0.89262,0.94109,0.83355,0.84424	54214,	19606	23524	0.3430	3.96			/0.0>0.0/1.5>2.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012603	98012603	-	AC	het	hom	het		QUAL=11061;DP=253,119,167;AF=0.84,0.91,0.49;MQM=60;SAP=59;ABP=149;SAR=150;SAF=252	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-33290_141-33289dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17605_985-17604dup::					MIRb (SINE/MIR)	rs112555829	0.78354	0.75478,0.84544,0.92680,0.77943,0.80992	45614,	25048	32122		2.93			/5.7>5.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012988	98012988	A	T	hom	hom	het		QUAL=29820;DP=412,333,453;AF=1.00,1.00,0.48;MQM=60;SAP=181;ABP=4;SAR=622;SAF=341	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+33020T>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17988T>A::					L2c (LINE/L2)	rs1938565	0.88182	0.96654,0.90876,0.94273,0.83561,0.85519	59509,	15078	17972	0.1560	12.03			/0.0>0.0/3.2>3.1				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98013425	98013425	C	T	hom	hom	het		QUAL=5322;DP=127,22,28;AF=1.00,1.00,0.43;MQM=60;SAP=13;ABP=4;SAR=94;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+32583G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-18425G>A::						rs1938566	0.81165	0.72586,0.88315,0.94209,0.83387,0.84335	50348,	22491	28587	-1.1710	0.09			/0.0>0.0/0.0>0.0			32203549	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014572	98014572	T	C	hom	hom	het		QUAL=22125;DP=407,194,220;AF=1.00,1.00,0.49;MQM=60;SAP=89;ABP=3;SAR=437;SAF=270	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31436A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567	0.86030	0.89170,0.90273,0.94013,0.83525,0.85470	56278,	17832	21174	-0.9230	1.12			/0.0>0.0/0.0>0.5			25434007	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014656	98014656	C	T	het	het	wt		QUAL=8054;DP=430,147,200;AF=0.54,0.50,0.01;MQM=60;SAP=22;ABP=7;SAR=179;SAF=127	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31352G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.29565	0.14889,0.35000,0.52696,0.33921,0.44701	7354,	29805	106045	-1.1420	0.43			/0.0>0.0/0.0>0.0			34560273,34910505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014760	98014760	A	-	het	het	het	low_conf_region	QUAL=654;DP=104,35,49;AF=0.12,0.17,0.35;MQM=60;SAP=4;ABP=164;SAR=19;SAF=16	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31248del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19760del::					A-rich (Low_complexity)	rs756636800	0.01342	0.00559,0.01110,0.02553,0.01423,0.04422	12,	1422	106314	0.3190	1.28			/4.7>3.0/0.9>0.0				3	318	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98016194	98016194	C	T	het	het	wt		QUAL=6616;DP=335,216,299;AF=0.46,0.47,0.01;MQM=60;SAP=22;ABP=10;SAR=152;SAF=105	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+29814G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-21194G>A::						rs6683447	0.27267	0.12281,0.34917,0.56711,0.31238,0.40463	6595,	28257	110555	-0.8800	0.22			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017024	98017024	G	A	hom	hom	het		QUAL=14233;DP=268,105,171;AF=1.00,1.00,0.50;MQM=60;SAP=369;ABP=3;SAR=90;SAF=368	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28984C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22024C>T::					L1MB1 (LINE/L1)	rs2391903	0.91468	0.97715,0.93762,0.94059,0.87834,0.88847	63844,	11446	12978	0.1620	3.34			/2.7>3.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017137	98017137	A	G	hom	hom	het		QUAL=16886;DP=243,159,245;AF=1.00,1.00,0.54;MQM=60;SAP=3;ABP=6;SAR=268;SAF=266	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28871T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22137T>C::					L1MB1 (LINE/L1)	rs1892549	0.85516	0.87463,0.89841,0.94042,0.83518,0.85614	55762,	18487	22021	-0.2100	2.95			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017272	98017272	A	G	hom	hom	het		QUAL=15804;DP=302,122,139;AF=1.00,1.00,0.44;MQM=60;SAP=53;ABP=8;SAR=295;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28736T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22272T>C::					L1MB1 (LINE/L1)	rs1892550	0.85527	0.87469,0.89862,0.94020,0.83531,0.85599	55794,	18485	22011	-1.3240	0.07			/0.2>0.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017405	98017405	C	T	hom	hom	het		QUAL=14111;DP=279,97,134;AF=1.00,0.99,0.45;MQM=60;SAP=89;ABP=6;SAR=283;SAF=152	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28603G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22405G>A::					L1MB1 (LINE/L1)	rs1892551	0.85541	0.87467,0.89863,0.94089,0.83533,0.85614	55797,	18492	21988	0.8610	9.10			/0.0>4.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017479	98017479	G	A	hom	hom	het		QUAL=9869;DP=216,54,75;AF=1.00,1.00,0.48;MQM=60;SAP=270;ABP=3;SAR=250;SAF=56	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28529C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22479C>T::						rs1892552	0.85538	0.87472,0.89860,0.94066,0.83536,0.85590	55783,	18474	21986	-0.1480	0.56			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017594	98017594	A	G	hom	hom	het		QUAL=6154;DP=147,19,34;AF=1.00,1.00,0.62;MQM=60;SAP=4;ABP=7;SAR=89;SAF=98	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28414T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22594T>C::						rs2391904	0.85518	0.87453,0.89870,0.94017,0.83526,0.85602	55774,	18481	22019	-0.2560	1.50			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017674	98017674	T	A	wt	het	wt		QUAL=148;DP=225,29,54;AF=0.00,0.41,0.00;MQM=60;SAP=6;ABP=5;SAR=4;SAF=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28334A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22674A>T::						rs116414424	0.02650	0.00649,0.02657,0.00019,0.04120,0.00663	68,	3897	148153	-1.0570	1.35			/3.7>4.7/0.0>0.0				1	13	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017766	98017766	T	C	hom	hom	het		QUAL=6594;DP=154,33,49;AF=1.00,1.00,0.31;MQM=60;SAP=10;ABP=19;SAR=114;SAF=88	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28242A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22766A>G::						rs9324382	0.85368	0.87443,0.89718,0.93972,0.83359,0.84475	55543,	18672	22240	0.5980	8.40			/6.6>6.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018596	98018596	T	C	hom	hom	het		QUAL=7937;DP=166,53,91;AF=1.00,1.00,0.35;MQM=60;SAP=3;ABP=20;SAR=126;SAF=125	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27412A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23596A>G::						rs1938571	0.80490	0.70217,0.88350,0.94010,0.83364,0.84431	49686,	22949	29649	-0.1250	1.56			/0.0>0.0/0.0>1.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018735	98018735	G	A	hom	hom	het		QUAL=11189;DP=210,97,108;AF=1.00,1.00,0.36;MQM=60;SAP=11;ABP=21;SAR=191;SAF=155	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27273C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23735C>T::						rs4447033	0.85528	0.87466,0.89855,0.94000,0.83533,0.85625	55776,	18478	22002	0.0700	1.21			/4.8>4.2/0.0>0.0			27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018918	98018918	T	C	hom	hom	het		QUAL=3413;DP=60,40,39;AF=1.00,1.00,0.36;MQM=57;SAP=67;ABP=10;SAR=86;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27090A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23918A>G::					AluSx1 (SINE/Alu)	rs1938572	0.85523	0.87469,0.89838,0.93971,0.83523,0.85599	55611,	18448	21950	-2.1630	0.73			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019061	98019061	C	T	hom	hom	het		QUAL=3195;DP=79,12,27;AF=1.00,1.00,0.41;MQM=60;SAP=4;ABP=5;SAR=54;SAF=48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26947G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24061G>A::					AluSx1 (SINE/Alu)	rs1938573	0.85639	0.87550,0.89970,0.94033,0.83594,0.85756	55598,	18425	21737	-0.0450	0.88			/2.5>6.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019398	98019398	G	T	hom	hom	het		QUAL=19129;DP=335,157,223;AF=1.00,1.00,0.47;MQM=60;SAP=9;ABP=5;SAR=279;SAF=318	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26610C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24398C>A::						rs1938558	0.85527	0.87469,0.89870,0.94046,0.83520,0.85608	55812,	18498	22020	1.1900	8.60			/3.1>2.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019546	98019546	G	A	hom	hom	het		QUAL=13961;DP=250,128,154;AF=1.00,1.00,0.43;MQM=60;SAP=5;ABP=10;SAR=233;SAF=211	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26462C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24546C>T::					MIR (SINE/MIR)	rs1938559	0.85515	0.87456,0.89865,0.94012,0.83517,0.85578	55788,	18497	22033	0.7920	6.77			/0.0>0.3/0.0>0.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019636	98019636	C	T	hom	hom	het		QUAL=22291;DP=509,106,138;AF=1.00,1.00,0.43;MQM=60;SAP=50;ABP=8;SAR=398;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26372G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24636G>A::	regulatory_region_variant:open_chromatin_region				MIR (SINE/MIR)	rs1938560	0.85528	0.87463,0.89882,0.94046,0.83524,0.85623	55808,	18479	22013	0.0020	2.20			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020017	98020017	C	T	hom	hom	het		QUAL=8872;DP=148,88,74;AF=1.00,1.00,0.64;MQM=60;SAP=378;ABP=15;SAR=252;SAF=31	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25991G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25017G>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs9324383	0.85525	0.87463,0.89853,0.94053,0.83527,0.85608	55769,	18481	22005	0.5110	3.42			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TT	het	n/a	n/a		QUAL=233;DP=21,2,2;AF=0.52,1.00,0.00;MQM=58;SAP=5;ABP=20;SAR=1;SAF=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25864_140+25865dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25144_985-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296	0.03505	0.11295,0.01276,0.02149,0.00242,0.00302	315,	4473	140489		2.03			/0.0>0.0/0.0>0.0				2	33	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TTT	het	n/a	n/a		QUAL=233;DP=21,2,2;AF=0.19,0.00,0.00;MQM=58;SAP=17;ABP=3;SAR=11;SAF=2	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25863_140+25865dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25145_985-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296	0.81212	0.75100,0.87889,0.91523,0.82647,0.84974	48238,	21791	27361		1.99			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020371	98020371	T	C	hom	hom	het		QUAL=6998;DP=106,83,108;AF=1.00,0.99,0.44;MQM=58;SAP=356;ABP=6;SAR=20;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25637A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25371A>G::					AluSx1 (SINE/Alu)	rs9725319	0.85517	0.87462,0.89882,0.94038,0.83524,0.85554	55749,	18482	22014	-1.8110	1.46			/0.0>0.0/0.0>1.2				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020435	98020435	C	T	het	wt	het		QUAL=2548;DP=110,136,161;AF=0.37,0.00,0.45;MQM=60;SAP=53;ABP=19;SAR=31;SAF=82	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25573G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.01442	0.01406,0.03135,0.13471,0.00196,0.04589	89,	2014	149854	-1.7430	0.12			/0.0>0.0/0.0>2.8				5	120	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020606	98020606	T	C	hom	hom	het		QUAL=7541;DP=149,66,73;AF=1.00,1.00,0.36;MQM=60;SAP=219;ABP=16;SAR=198;SAF=43	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25402A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25402A>G::						rs4477335	0.85522	0.87468,0.89862,0.94010,0.83530,0.85605	55731,	18468	21996	-0.2530	3.47			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020686	98020686	-	A	hom	hom	het		QUAL=4541;DP=131,19,24;AF=0.94,0.95,0.42;MQM=60;SAP=47;ABP=4;SAR=103;SAF=48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25321dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25321dup::						rs61381274	0.85464	0.87323,0.89796,0.94030,0.83501,0.85581	55581,	18522	22058		0.53			/8.9>9.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020814	98020814	G	A	hom	hom	het		QUAL=4959;DP=101,32,41;AF=1.00,1.00,0.46;MQM=60;SAP=28;ABP=3;SAR=55;SAF=97	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25194C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25194C>T::						rs4480407	0.87380	0.93741,0.90842,0.94040,0.83557,0.85670	58306,	16198	19182	0.4270	3.16			/0.2>0.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021138	98021138	A	C	wt	het	wt		QUAL=1905;DP=497,160,184;AF=0.00,0.50,0.00;MQM=60;SAP=60;ABP=3;SAR=17;SAF=63	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24870T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24870T>G::						rs79792869	0.02655	0.00649,0.02665,0.00019,0.04129,0.00642	69,	3904	148172	0.4270	2.77			/4.6>2.6/0.0>0.0				1	13	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021524	98021524	A	G	wt	het	wt		QUAL=3007;DP=494,177,218;AF=0.00,0.62,0.00;MQM=60;SAP=26;ABP=26;SAR=72;SAF=38	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24484T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24484T>C::						rs77482155	0.03572	0.00801,0.03235,0.00038,0.05315,0.02234	123,	5190	146746	2.9560	15.00			/0.0>0.0/0.0>0.0				1	17	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021777	98021777	A	G	hom	hom	het		QUAL=20794;DP=274,220,282;AF=1.00,1.00,0.57;MQM=60;SAP=13;ABP=17;SAR=355;SAF=301	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24231T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24231T>C::						rs9659624	0.85509	0.87450,0.89860,0.94023,0.83513,0.85593	55733,	18480	22022	0.7530	13.09			/10.1>10.9/0.0>0.0			33686288	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021954	98021954	C	A	hom	hom	het		QUAL=20803;DP=391,162,204;AF=1.00,1.00,0.55;MQM=60;SAP=11;ABP=8;SAR=308;SAF=358	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24054G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24054G>T::						rs5005705	0.85379	0.87344,0.89719,0.94021,0.83422,0.84612	55521,	18653	22211	-1.3150	0.21			/0.0>0.0/0.5>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022010	98022010	C	T	hom	hom	het		QUAL=13876;DP=235,130,144;AF=1.00,0.99,0.53;MQM=60;SAP=49;ABP=5;SAR=269;SAF=172	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23998G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23998G>A::						rs9324384	0.85528	0.87452,0.89856,0.94044,0.83541,0.85626	55747,	18486	21994	-0.6920	0.76			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022207	98022207	G	A	hom	hom	het		QUAL=18188;DP=309,165,182;AF=1.00,0.99,0.50;MQM=60;SAP=43;ABP=3;SAR=230;SAF=332	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23801C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23801C>T::						rs4634961	0.85543	0.87486,0.89870,0.94019,0.83541,0.85581	55740,	18475	21963	-0.2480	1.66			/0.0>0.0/6.2>4.3			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022343	98022343	C	A	hom	hom	het		QUAL=19930;DP=274,232,262;AF=1.00,1.00,0.52;MQM=60;SAP=75;ABP=4;SAR=247;SAF=393	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23665G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23665G>T::						rs9324385	0.85530	0.87478,0.89853,0.94025,0.83526,0.85652	55747,	18483	21989	0.0320	3.16			/4.6>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022403	98022403	G	A	hom	hom	het		QUAL=26136;DP=377,265,327;AF=1.00,1.00,0.51;MQM=60;SAP=11;ABP=3;SAR=376;SAF=431	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23605C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23605C>T::						rs9324386	0.85534	0.87474,0.89854,0.94020,0.83537,0.85632	55772,	18484	21992	-0.1830	0.88			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022474	98022474	G	A	hom	hom	het		QUAL=22630;DP=332,214,332;AF=1.00,1.00,0.50;MQM=60;SAP=105;ABP=3;SAR=447;SAF=264	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23534C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23534C>T::						rs9324387	0.85537	0.87470,0.89858,0.94008,0.83533,0.85667	55778,	18487	21989	-0.0660	1.57			/1.4>2.2/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022599	98022599	G	A	hom	hom	het		QUAL=17798;DP=284,169,197;AF=1.00,1.00,0.46;MQM=60;SAP=3;ABP=5;SAR=267;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23409C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23409C>T::						rs9324388	0.85538	0.87487,0.89852,0.94035,0.83534,0.85643	55784,	18475	21987	0.1320	7.83			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023307	98023307	A	G	hom	hom	het		QUAL=16788;DP=319,127,131;AF=1.00,1.00,0.64;MQM=60;SAP=433;ABP=26;SAR=427;SAF=103	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22701T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22701T>C::						rs9659996	0.85520	0.87464,0.89864,0.93994,0.83523,0.85611	55750,	18484	22008	1.6210	12.03			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023339	98023339	C	T	hom	hom	het		QUAL=10349;DP=169,101,92;AF=1.00,1.00,0.58;MQM=60;SAP=129;ABP=8;SAR=230;SAF=93	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22669G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22669G>A::						rs9658841	0.85521	0.87464,0.89857,0.93992,0.83526,0.85575	55756,	18488	22010	-0.3040	2.64			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023524	98023524	G	A	hom	hom	het		QUAL=7301;DP=173,26,38;AF=1.00,1.00,0.61;MQM=60;SAP=22;ABP=7;SAR=89;SAF=133	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22484C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22484C>T::						rs9661157	0.85533	0.87463,0.89899,0.94105,0.83529,0.85551	55701,	18461	21965	-0.4100	0.16			/0.0>0.0/0.0>1.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023721	98023721	-	TACTT	het	hom	het		QUAL=5495;DP=140,56,90;AF=0.86,0.96,0.36;MQM=60;SAP=5;ABP=55;SAR=109;SAF=97	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22286_140+22287insAAGTA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22286_984+22287insAAGTA::						rs71071680	0.85478	0.87439,0.89818,0.93978,0.83481,0.85554	55491,	18460	21992		12.72			/0.0>0.2/0.0>0.9			34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023774	98023774	C	T	hom	hom	het		QUAL=9454;DP=220,52,81;AF=1.00,1.00,0.31;MQM=60;SAP=136;ABP=29;SAR=81;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22234G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22234G>A::						rs10747496	0.85536	0.87472,0.89878,0.94005,0.83525,0.85637	55648,	18453	21941	0.3660	4.42			/0.9>0.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023922	98023922	A	G	hom	hom	het		QUAL=19534;DP=401,125,163;AF=1.00,1.00,0.42;MQM=60;SAP=5;ABP=11;SAR=287;SAF=308	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22086T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22086T>C::						rs4584446	0.85523	0.87463,0.89845,0.93987,0.83528,0.85611	55703,	18455	21983	-0.0180	2.03			/8.3>8.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024179	98024179	T	C	hom	hom	het		QUAL=14477;DP=325,57,130;AF=1.00,1.00,0.51;MQM=60;SAP=356;ABP=3;SAR=89;SAF=359	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21829A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21829A>G::						rs2391905	0.85525	0.87457,0.89879,0.94005,0.83527,0.85563	55684,	18457	21973	0.2110	6.28			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024456	98024457	TT	-	hom	hom	het		QUAL=11130;DP=314,80,97;AF=0.90,0.93,0.54;MQM=60;SAP=148;ABP=4;SAR=287;SAF=122	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21551_140+21552del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21551_984+21552del::					L2a (LINE/L2)	rs55633609	0.85153	0.86488,0.89687,0.93848,0.83391,0.85491	53784,	18659	22009	0.4400	0.51			/0.0>0.0/0.0>1.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024609	98024609	C	T	hom	hom	het		QUAL=8595;DP=179,46,72;AF=1.00,1.00,0.44;MQM=60;SAP=9;ABP=5;SAR=115;SAF=142	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21399G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21399G>A::						rs4950117	0.87442	0.93928,0.90866,0.94032,0.83557,0.85611	58291,	16090	19054	0.2330	3.05			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024802	98024802	G	T	hom	hom	het		QUAL=16101;DP=259,156,169;AF=1.00,0.99,0.51;MQM=60;SAP=19;ABP=3;SAR=220;SAF=281	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21206C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21206C>A::						rs4950118	0.85494	0.87466,0.89862,0.94008,0.83510,0.85605	55600,	18493	22005	0.5410	16.19			/5.9>5.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025080	98025080	T	C	hom	hom	het		QUAL=18252;DP=373,121,172;AF=0.99,1.00,0.48;MQM=60;SAP=150;ABP=3;SAR=386;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20928A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20928A>G::						rs10783082	0.85512	0.87449,0.89867,0.93998,0.83518,0.85676	55628,	18440	21974	0.1160	14.42			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025214	98025214	-	TTAAGTAT	hom	hom	het		QUAL=13747;DP=235,156,151;AF=0.95,0.99,0.56;MQM=60;SAP=6;ABP=8;SAR=219;SAF=244	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20786_140+20793dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20786_984+20793dup::						rs5776392	0.85468	0.87424,0.89830,0.94002,0.83472,0.85569	55285,	18404	21930		1.86			/0.0>0.0/0.8>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025692	98025692	A	C	hom	hom	het		QUAL=18378;DP=339,140,192;AF=0.99,1.00,0.45;MQM=60;SAP=6;ABP=7;SAR=267;SAF=297	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20316T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20316T>G::					MIR3 (SINE/MIR)	rs4950119	0.84638	0.91527,0.88725,0.93958,0.80547,0.80954	54683,	19001	23299	-0.6610	0.61			/0.0>0.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025826	98025826	G	A	hom	hom	het		QUAL=14582;DP=270,105,175;AF=1.00,1.00,0.44;MQM=60;SAP=55;ABP=8;SAR=278;SAF=174	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20182C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.85528	0.87461,0.89877,0.94046,0.83513,0.85643	55570,	18427	21923	0.1650	3.51			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025917	98025917	A	C	hom	hom	het		QUAL=17800;DP=354,116,173;AF=1.00,0.99,0.50;MQM=60;SAP=104;ABP=3;SAR=197;SAF=358	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20091T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20091T>G::					MIRb (SINE/MIR)	rs4245673	0.85511	0.87455,0.89875,0.93995,0.83518,0.85620	55635,	18444	21978	0.9310	8.22			/0.3>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026176	98026176	T	C	hom	hom	het		QUAL=18400;DP=255,193,286;AF=1.00,1.00,0.49;MQM=60;SAP=127;ABP=3;SAR=385;SAF=202	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19832A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19832A>G::						rs1938568	0.85517	0.87473,0.89867,0.93995,0.83511,0.85608	55670,	18464	21984	0.6240	13.98			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026906	98026906	C	T	hom	hom	het		QUAL=22567;DP=421,185,198;AF=1.00,0.99,0.46;MQM=60;SAP=58;ABP=5;SAR=281;SAF=414	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19102G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19102G>A::						rs9440393	0.85518	0.87481,0.89829,0.94000,0.83522,0.85575	55613,	18446	21960	-0.8030	0.18			/2.9>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027024	98027024	A	G	het	het	het		QUAL=13320;DP=470,262,285;AF=0.49,0.48,0.50;MQM=60;SAP=36;ABP=4;SAR=205;SAF=292	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18984T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18984T>C::						rs9440302	0.48736	0.49956,0.50422,0.37286,0.49057,0.39315	18108,	37578	77622	0.5020	6.00			/3.4>3.3/0.0>0.0			32184616,25217366	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027298	98027298	T	C	hom	hom	het		QUAL=16961;DP=358,95,113;AF=1.00,1.00,0.50;MQM=60;SAP=28;ABP=3;SAR=293;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18710A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18710A>G::						rs9324389	0.85524	0.87479,0.89884,0.94053,0.83520,0.85605	55628,	18428	21950	-2.3170	0.01			/0.7>0.8/0.4>8.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027345	98027345	G	A	wt	het	wt		QUAL=1386;DP=325,92,90;AF=0.00,0.59,0.00;MQM=60;SAP=3;ABP=9;SAR=26;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18663C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18663C>T::						rs74700717	0.01988	0.00483,0.02083,0.00019,0.03145,0.00248	40,	2937	148753	-1.2760	2.31			/6.2>5.8/0.0>0.0				12	553	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027707	98027707	A	G	hom	hom	het		QUAL=13438;DP=217,124,187;AF=1.00,1.00,0.45;MQM=60;SAP=235;ABP=7;SAR=319;SAF=106	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18301T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18301T>C::	regulatory_region_variant:enhancer					rs1938569	0.85494	0.87446,0.89859,0.94012,0.83502,0.85347	55540,	18445	21977	0.7930	5.51			/0.0>0.0/1.5>3.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028229	98028229	G	A	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5;SAR=11;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17779C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17779C>T::						rs2022864	0.85530	0.87447,0.89834,0.94020,0.83486,0.85613	55035,	18261	21711	-0.7290	1.78			/0.0>0.0/0.0>1.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028233	98028233	A	G	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5;SAR=11;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17775T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17775T>C::						rs2022865	0.85505	0.87428,0.89799,0.94016,0.83478,0.85578	55020,	18280	21754	-0.0130	7.71			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028629	98028629	G	A	hom	hom	het		QUAL=12922;DP=217,104,153;AF=0.99,0.99,0.55;MQM=60;SAP=59;ABP=6;SAR=252;SAF=150	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17379C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17379C>T::						rs10875124	0.85494	0.87413,0.89833,0.94015,0.83508,0.85602	55334,	18394	21898	0.8880	5.41			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028644	98028644	A	C	hom	hom	het		QUAL=12390;DP=217,97,141;AF=1.00,0.99,0.53;MQM=60;SAP=76;ABP=4;SAR=251;SAF=137	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17364T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17364T>G::						rs10875125	0.85480	0.87401,0.89832,0.94012,0.83497,0.85566	55305,	18395	21913	0.2010	1.80			/0.0>0.0/0.0>0.0			35710621	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028832	98028832	-	A	hom	hom	het		QUAL=7913;DP=174,48,82;AF=0.98,1.00,0.44;MQM=60;SAP=120;ABP=6;SAR=69;SAF=186	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17175dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17175dup::						rs11404556	0.85521	0.87449,0.89865,0.94070,0.83539,0.85611	55486,	18400	21904		8.59			/3.9>4.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029050	98029050	A	G	hom	hom	het		QUAL=14517;DP=242,132,151;AF=1.00,1.00,0.44;MQM=60;SAP=17;ABP=8;SAR=247;SAF=193	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16958T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16958T>C::						rs1198574	0.85529	0.87458,0.89889,0.93998,0.83545,0.85632	55488,	18376	21886	0.7640	18.63			/0.0>0.0/0.0>0.0			32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029957	98029957	T	C	hom	hom	het		QUAL=10068;DP=153,96,129;AF=1.00,1.00,0.54;MQM=60;SAP=99;ABP=5;SAR=100;SAF=219	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16051A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16051A>G::						rs1198573	0.85516	0.87490,0.89801,0.94044,0.83512,0.85566	55357,	18377	21865	3.3360	16.00			/0.0>0.0/4.7>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98030956	98030956	T	-	het	het	wt		QUAL=4251;DP=222,105,144;AF=0.51,0.60,0.03;MQM=60;SAP=190;ABP=7;SAR=153;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+15052del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+15052del::						rs377025796	0.01041	0.00513,0.00381,0.06096,0.01219,0.00519	25,	1485	145883	0.9970	1.85			/0.0>0.0/1.2>0.0				13	215	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031620	98031620	A	C	hom	hom	het		QUAL=6046;DP=157,16,15;AF=1.00,1.00,0.67;MQM=60;SAP=6;ABP=7;SAR=100;SAF=83	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14388T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14388T>G::						rs1198572	0.82676	0.85251,0.87568,0.93956,0.80432,0.79846	51934,	21206	26208	-0.4610	6.05			/2.6>2.5/0.0>0.0			33686288	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031799	98031799	A	G	het	het	wt		QUAL=773;DP=54,14,10;AF=0.50,0.57,0.00;MQM=59;SAP=30;ABP=3;SAR=28;SAF=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14209T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14209T>C::						rs188465986	0.00819	0.00229,0.00369,0.00000,0.01320,0.00514	7,	1070	131300	0.2980	4.16			/1.1>0.8/0.0>0.0				1	227	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031807	98031807	T	C	het	wt	wt	low_conf_region	QUAL=39;DP=24,9,6;AF=0.00,0.44,0.00;MQM=54;SAP=16;ABP=16;SAR=6;SAF=0	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14201A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14201A>G::					(AC)n (Simple_repeat)	rs796242776	0.00066	0.00040,0.00053,0.00089,0.00090,0.00072	0,	88	133546	-0.6360	2.76			/1.3>1.6/3.3>0.0				4	327	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031808	98031811	ACAC	-	wt	het	wt	low_conf_region	QUAL=39;DP=24,9,6;AF=0.00,0.44,0.00;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14197_140+14200del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14197_984+14200del::					(AC)n (Simple_repeat)	rs34012276	0.04452	0.04874,0.04137,0.00669,0.04717,0.04135	109,	5732	127704	0.3460	1.56			/1.3>0.7/3.3>0.0				4	7	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032116	98032116	A	G	hom	hom	het		QUAL=4984;DP=120,21,35;AF=1.00,1.00,0.37;MQM=60;SAP=89;ABP=8;SAR=38;SAF=116	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13892T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13892T>C::						rs1198571	0.85517	0.87465,0.89849,0.94045,0.83522,0.85596	55539,	18398	21928	0.3560	3.24			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032783	98032783	C	T	wt	het	wt		QUAL=2122;DP=593,197,248;AF=0.00,0.47,0.00;MQM=60;SAP=11;ABP=5;SAR=37;SAF=56	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13225G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13225G>A::						rs17371457	0.18018	0.04780,0.27489,0.08446,0.24452,0.11602	3158,	20985	124223	-0.5830	1.43			/0.0>0.0/0.0>0.7			32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98033342	98033342	C	A	hom	hom	het		QUAL=24017;DP=424,190,268;AF=1.00,1.00,0.47;MQM=60;SAP=214;ABP=5;SAR=504;SAF=236	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+12666G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+12666G>T::						rs1782815	0.85382	0.87447,0.89706,0.94004,0.83391,0.84516	55465,	18600	22176	0.3820	2.66			/0.0>0.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034034	98034034	A	-	het	wt	het	low_conf_region	QUAL=1635;DP=86,30,36;AF=0.58,0.00,0.53;MQM=58;SAP=67;ABP=8;SAR=57;SAF=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11974del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11974del::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs143336786	0.03787	0.08842,0.05261,0.13070,0.00423,0.06692	100,	2216	61386	0.1540	0.40			/4.4>6.2/0.0>0.0				0	8	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034095	98034095	G	A	het	het	het	low_conf_region	QUAL=1393;DP=67,17,14;AF=0.52,0.65,0.50;MQM=54;SAP=6;ABP=4;SAR=31;SAF=22	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11913C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11913C>T::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs1782814	0.22230	0.21205,0.26635,0.28406,0.22247,0.21460	2369,	12402	59964	-0.5910	0.86			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034107	98034107	-	AAAG	hom	hom	het	low_conf_region	QUAL=1400;DP=41,10,7;AF=0.93,0.90,0.29;MQM=59;SAP=3;ABP=6;SAR=26;SAF=23	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11897_140+11900dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11897_984+11900dup::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs780129382	0.31898	0.29562,0.42105,0.30664,0.32017,0.27553	4122,	13390	46188		1.07			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034287	98034287	T	C	hom	hom	het		QUAL=10097;DP=169,94,159;AF=0.99,1.00,0.47;MQM=60;SAP=119;ABP=5;SAR=101;SAF=235	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11721A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11721A>G::	regulatory_region_variant:enhancer					rs1782813	0.86818	0.91827,0.90707,0.93993,0.83522,0.85673	57430,	16896	20006	-0.3410	3.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034489	98034489	G	C	het	het	wt		QUAL=6867;DP=389,133,168;AF=0.50,0.44,0.01;MQM=60;SAP=19;ABP=4;SAR=106;SAF=150	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11519C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11519C>G::	regulatory_region_variant:enhancer				UCON1 (Unknown)	rs7554283	0.27298	0.12113,0.34855,0.56708,0.31312,0.40436	6620,	28203	110375	1.4970	14.87			/0.0>1.0/5.6>4.8			32184616,34560273	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98035455	98035455	T	C	het	het	wt		QUAL=7034;DP=317,202,249;AF=0.48,0.53,0.00;MQM=60;SAP=30;ABP=3;SAR=159;SAF=102	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+10553A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+10553A>G::	regulatory_region_variant:enhancer					rs4950101	0.23845	0.11093,0.23773,0.51152,0.28040,0.35851	5010,	26146	115508	1.6180	9.30			/4.1>2.7/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036428	98036428	T	C	hom	hom	het		QUAL=13812;DP=276,85,106;AF=0.99,0.99,0.59;MQM=60;SAP=4;ABP=11;SAR=205;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9580A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9580A>G::						rs1702294	0.82107	0.83257,0.87390,0.93968,0.80413,0.79946	51425,	21875	27181	-0.0800	1.44			/0.0>4.3/0.0>1.8			26836412,30035013,31995602,31268507,28072415,30518757,28117840,29635364,27072377,30618607,29442441,30038276,31409837,27620842,25056061,31835028,30285260,31522868,32152294,34625583,34159505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036603	98036603	G	C	hom	hom	het		QUAL=29078;DP=322,361,439;AF=1.00,1.00,0.51;MQM=60;SAP=60;ABP=4;SAR=377;SAF=531	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9405C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9405C>G::					Tigger3a (DNA/TcMar-Tigger)	rs1702293	0.91458	0.97716,0.93744,0.94068,0.87821,0.88857	63761,	11438	12978	-2.6840	0.06			/0.0>3.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036784	98036784	G	A	hom	hom	het		QUAL=18821;DP=241,231,244;AF=1.00,1.00,0.48;MQM=60;SAP=16;ABP=4;SAR=323;SAF=264	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9224C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9224C>T::					Tigger3a (DNA/TcMar-Tigger)	rs1782810	0.78304	0.69817,0.86473,0.93958,0.80387,0.79785	46957,	24951	32935	-0.0240	1.79			/2.9>3.1/0.0>0.0			23871474,28540026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036854	98036854	A	C	hom	hom	het		QUAL=21532;DP=276,249,297;AF=1.00,1.00,0.51;MQM=60;SAP=62;ABP=3;SAR=270;SAF=406	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9154T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9154T>G::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.88189	0.96662,0.91029,0.93999,0.83556,0.85634	59450,	15046	17940	-2.7810	0.54			/0.0>3.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037038	98037038	A	C	hom	hom	het		QUAL=18009;DP=241,208,271;AF=1.00,1.00,0.49;MQM=60;SAP=283;ABP=3;SAR=428;SAF=154	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8970T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8970T>G::						rs1628294	0.91463	0.97714,0.93728,0.94086,0.87834,0.88873	63749,	11424	12966	-0.4600	2.03			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037378	98037378	G	T	hom	hom	het		QUAL=10749;DP=212,74,108;AF=1.00,1.00,0.38;MQM=60;SAP=25;ABP=17;SAR=135;SAF=192	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8630C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8630C>A::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.78273	0.69697,0.86473,0.93968,0.80397,0.79913	46893,	24961	32961	-0.3280	0.73			/2.0>1.8/0.0>0.0			27895608,24174267,23637625,28798405,25921703,22910404,21926974,22078159,22850735,22883350,22982201,23459466,23507081,23776546,23786914,23871474,23910899,24132022,24275578,24339136,24361663,24391914,24625753,24718684,24820543,25044277,25154622,25241074,25395183,26123324,26429811,26836412,27028512,27095331,27096222,27481827,28234206,28958479,29042896,29118371,29599094,30026708,30035013,30122962,30610940,31586698,32127940,32184616,29858046,25311363,23637704,26609515,28812221,25250332,22614287,27525637,29657307,27650867,25200985,24468824,25844328,29529357,28117840,24566148,29893792,27396304,26005852,31361772,29635364,27072377,25217366,30566479,30618607,23453885,25941532,24160291,25884492,28217082,29442441,27196537,25387707,31354550,23595788,29665782,31409837,24866554,26925706,24653674,25434007,27244233,24403877,24556472,27733313,27620842,24342994,31522868,33967611,28659691,32406920,23375658,32910167,25084801,32920385,27706734,33708240,32566292,23284144,29033781,22547958,25958205,23805071,34566604,33939221,3234811	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98040554	98040554	A	-	het	het	het		QUAL=841;DP=202,101,137;AF=0.22,0.14,0.17;MQM=60;SAP=4;ABP=384;SAR=37;SAF=44	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+5454del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+5454del::						rs528539462	0.00680	0.00505,0.00841,0.00185,0.00618,0.00000	0,	709	103553	-1.7360	0.04			/3.1>0.3/0.0>0.0				0	140	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCA	het	wt	het		QUAL=2648;DP=82,20,37;AF=0.41,0.40,0.03;MQM=60;SAP=3;ABP=4;SAR=26;SAF=29	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4940_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4940_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4380_4387dup::						rs35835879	0.14840	0.23192,0.14009,0.09162,0.12279,0.05131	1942,	18469	128277		0.13			/0.0>0.0/2.5>2.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCA	het	het	wt		QUAL=2648;DP=82,20,37;AF=0.41,0.40,0.03;MQM=57;SAP=4;ABP=47;SAR=19;SAF=24	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4936_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4936_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4376_4387dup::						rs35835879	0.55720	0.58845,0.53616,0.69232,0.53059,0.60826	23580,	36759	66689		0.12			/0.0>0.0/2.5>2.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCATTCA	wt	het	wt		QUAL=2648;DP=82,20,37;AF=0.41,0.40,0.03;MQM=60;SAP=6;ABP=5;SAR=8;SAF=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4932_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4932_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4372_4387dup::						rs35835879	0.11956	0.05980,0.18514,0.14735,0.13767,0.13204	1300,	15418	132682		0.11			/0.0>0.0/2.5>2.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042140	98042140	A	G	hom	hom	het		QUAL=6052;DP=154,15,35;AF=0.99,1.00,0.43;MQM=60;SAP=3;ABP=5;SAR=90;SAF=93	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3868T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3868T>C::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3308T>C::						rs4292998	0.79434	0.73760,0.86881,0.93950,0.80405,0.79784	48245,	24230	31256	-0.1470	5.88			/0.0>0.0/0.0>0.0			30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042162	98042162	C	A	hom	hom	het		QUAL=7209;DP=184,18,38;AF=0.99,1.00,0.45;MQM=60;SAP=4;ABP=4;SAR=114;SAF=104	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3846G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3846G>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3286G>T::						rs4411173	0.86821	0.91826,0.90694,0.94019,0.83525,0.85572	57565,	16928	20046	0.5130	6.74			/0.0>0.0/0.0>0.0			29500382	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042702	98042702	C	T	hom	hom	het		QUAL=39562;DP=577,412,501;AF=1.00,1.00,0.52;MQM=60;SAP=246;ABP=5;SAR=437;SAF=811	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3306G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3306G>A::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2746G>A::	regulatory_region_variant:enhancer					rs2802535	0.79252	0.73059,0.86857,0.93924,0.80408,0.79975	47936,	24375	31481	-0.7900	0.61			/4.5>2.5/0.0>0.0			24566148,26005852,29635364,29033781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042932	98042932	G	A	het	wt	het		QUAL=8629;DP=419,173,196;AF=0.50,0.00,0.56;MQM=60;SAP=191;ABP=5;SAR=242;SAF=76	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3076C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3076C>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2516C>T::						rs78924727	0.01428	0.01350,0.03130,0.13453,0.00190,0.04689	90,	1992	149938	-0.2050	1.03			/0.0>0.0/0.0>0.0				5	119	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98046571	98046571	G	T	hom	hom	het		QUAL=32967;DP=411,411,498;AF=1.00,1.00,0.47;MQM=60;SAP=11;ABP=6;SAR=497;SAF=560	MIR137HG	non_coding_transcript_exon	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.543C>A::	regulatory_region_variant:promoter					rs2660304	0.82668	0.85208,0.87631,0.93978,0.80413,0.79958	52012,	21293	26273	1.2640	18.18			/0.0>0.0/0.0>0.0			24885463,27004216,28803920,26429811,31059093,24566148,29893792,26005852,27913161,31361772,29635364,30618607,29442441,31409837,25434007,27620842,29483656,26198764,33686288,33479212,31522868,33708240,29033781,33343624,33794697,35581276	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98047588	98047588	T	A	hom	hom	het		QUAL=13200;DP=231,116,132;AF=1.00,1.00,0.53;MQM=60;SAP=11;ABP=4;SAR=228;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.487-961A>T::						rs2660303	0.91372	0.97445,0.93738,0.94068,0.87797,0.88840	63646,	11563	13111	-0.2680	0.48			/0.0>0.0/0.0>0.0			27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CA	wt	wt	het	low_conf_region	QUAL=919;DP=20,18,78;AF=0.00,0.00,0.53;MQM=60;SAP=9;ABP=3;SAR=15;SAF=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1256_486+1257dup::	regulatory_region_variant:promoter					rs1553269771	0.00592	0.00271,0.00375,0.00207,0.00849,0.01355	8,	743	127455		2.81			/1.8>1.8/0.0>0.0				32	127	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CGCA	wt	hom	wt	low_conf_region	QUAL=919;DP=20,18,78;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=31;SAR=1;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1257_486+1258insTGCG::	regulatory_region_variant:promoter					rs150117500	0.02290	0.05090,0.01117,0.00046,0.00834,0.00138	97,	2742	125280		2.72			/1.8>0.9/0.0>0.0				0	2	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CGCACACACACA	het	wt	wt	low_conf_region	QUAL=919;DP=20,18,78;AF=0.10,0.28,0.00;MQM=55;SAP=3;ABP=131;SAR=6;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1257_486+1258insTGTGTGTGTGCG::	regulatory_region_variant:promoter					rs150117500	0.09770	0.10029,0.11669,0.12604,0.09167,0.12660	784,	10936	115478		2.37			/1.8>0.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048156	98048156	-	CACACACACC	wt	hom	wt		QUAL=919;DP=20,18,78;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=31;SAR=1;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1221_486+1222insGGTGTGTGTG::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs750747213	0.03745	0.01112,0.03624,0.00135,0.05517,0.03231	149,	5330	144670		5.84			/0.0>0.0/3.1>3.1				0	1	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048289	98048289	G	A	hom	hom	het		QUAL=13282;DP=149,184,260;AF=1.00,0.99,0.47;MQM=60;SAP=45;ABP=5;SAR=180;SAF=274	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1089C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786696	0.91462	0.97724,0.93727,0.94106,0.87816,0.88887	63862,	11454	12992	0.0740	8.09			/0.6>1.3/0.0>7.4			27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048403	98048403	A	G	hom	hom	het		QUAL=18212;DP=249,209,277;AF=1.00,1.00,0.50;MQM=60;SAP=18;ABP=3;SAR=330;SAF=265	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+975T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786697	0.91466	0.97741,0.93739,0.94052,0.87820,0.88940	63808,	11434	12974	2.6530	20.00			/7.2>7.1/0.0>0.0			27004216,33841080,32152294	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049034	98049034	-	CT	wt	wt	het		QUAL=532;DP=136,92,101;AF=0.12,0.13,0.12;MQM=60;SAP=21;ABP=259;SAR=26;SAF=9	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343dup::	regulatory_region_variant:promoter					rs143725104	0.01285	0.00734,0.00919,0.00472,0.01677,0.01380	20,	1802	141548		13.44			/0.0>0.0/0.0>0.0				9	308	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049035	98049036	CT	-	het	het	wt		QUAL=532;DP=136,92,101;AF=0.02,0.00,0.32;MQM=60;SAP=4;ABP=412;SAR=18;SAF=22	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343del::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104	0.01050	0.03272,0.00352,0.00144,0.00192,0.00156	27,	1445	141235	2.0910	16.18			/0.0>0.0/0.0>0.0				0	101	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	99851033	99851033	A	G	wt	het	wt		QUAL=1816;DP=311,107,144;AF=0.00,0.64,0.01;MQM=60;SAP=3;ABP=23;SAR=35;SAF=36	AGL	5'UTR,splice_acceptor	AGL:ENST00000361915.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000294724.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163.7:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165.7:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G:p.?:	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	195096 [benign DISEASE=not specified,not provided,Glycogen storage disease type III];			rs2307130	0.41880	0.26326,0.43444,0.54519,0.49026,0.54288	14073,	35501	88329	0.3570	15.29			/3.3>0.2/0.0>0.0	COSV54056176	AGL|0.00|0.24|0.00|0.00|-35|2|-46|2	25741868,16400609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99851209	99851209	C	T	het	hom	het	off-target	QUAL=3350;DP=145,41,43;AF=0.46,1.00,0.44;MQM=60;SAP=214;ABP=6;SAR=119;SAF=8	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676091 [benign DISEASE=not provided];			rs663848	0.75860	0.91334,0.71468,0.69804,0.69601,0.76107	44447,	26460	36708	-0.2350	3.85			/6.3>6.2/0.0>0.0		AGL|0.00|0.00|0.00|0.00|48|23|-2|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99852537	99852537	T	-	het	het	het	off-target	QUAL=263;DP=13,6,14;AF=0.38,0.17,0.50;MQM=58;SAP=31;ABP=6;SAR=0;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]			AluJo (SINE/Alu)	rs58176899	0.00062	0.00044,0.00065,0.00025,0.00041,0.00263	1,	72	118726	-0.2510	4.91			/0.0>0.0/0.0>0.0		AGL|0.05|0.00|0.00|0.00|25|1|-24|50		89	662	0	0 / 0					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99861470	99861470	C	T	het	het	het		QUAL=12740;DP=436,201,300;AF=0.53,0.48,0.46;MQM=60;SAP=4;ABP=3;SAR=226;SAF=239	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron1/32:c.35-33C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256750 [benign DISEASE=not specified,Glycogen storage disease type III];			rs2307129	0.23544	0.39011,0.18756,0.11904,0.16979,0.19494	5048,	25665	116131	-1.0140	2.03			/0.0>0.0/3.3>1.9	COSV54053030	AGL|0.00|0.00|0.00|0.00|33|47|46|33	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864333	99864333	G	C	het	hom	het	off-target	QUAL=2588;DP=97,33,51;AF=0.54,1.00,0.39;MQM=60;SAP=222;ABP=3;SAR=1;SAF=104	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron3/32:c.413-53G>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676092 [benign DISEASE=not provided];			rs535461	0.73102	0.86557,0.69428,0.69749,0.67776,0.75716	41149,	28773	40869	-0.0880	2.44			/10.6>8.7/0.0>0.0		AGL|0.01|0.00|0.00|0.00|27|0|27|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864681	99864681	A	G	het	hom	het	off-target	QUAL=4997;DP=145,80,92;AF=0.47,1.00,0.49;MQM=60;SAP=422;ABP=4;SAR=193;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+92A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676094 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs538389	0.75846	0.91281,0.71526,0.69715,0.69616,0.76067	44439,	26442	36726	-0.8040	2.18			/0.0>0.0/0.0>1.4		AGL|0.00|0.00|0.00|0.00|7|4|-24|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864739	99864739	T	C	het	hom	het	off-target	QUAL=2557;DP=122,29,36;AF=0.45,1.00,0.53;MQM=60;SAP=227;ABP=4;SAR=103;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+150T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	677943 [benign DISEASE=not provided];			rs539157	0.75915	0.91516,0.71562,0.69754,0.69616,0.76060	44522,	26361	36613	-1.6830	0.07			/0.0>0.0/0.0>0.0		AGL|0.00|0.00|0.00|0.00|-27|-39|-24|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870232	99870232	A	G	het	het	het	off-target	QUAL=1107;DP=71,12,11;AF=0.56,0.25,0.73;MQM=60;SAP=114;ABP=4;SAR=0;SAF=51	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.617-168A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	679283 [benign DISEASE=not provided];			rs67875069	0.23537	0.39017,0.18705,0.11932,0.16982,0.19428	5054,	25666	116214	0.0710	3.08			/0.0>0.0/0.0>0.6		AGL|0.00|0.00|0.00|0.00|31|10|-1|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870327	99870327	A	G	wt	het	wt	off-target	QUAL=772;DP=144,62,59;AF=0.00,0.58,0.02;MQM=60;SAP=83;ABP=7;SAR=0;SAF=37	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.617-73A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294321 [benign DISEASE=not provided];			rs903126	0.38267	0.19780,0.41049,0.49226,0.46736,0.47111	12142,	33818	93730	2.5420	11.59			/3.1>3.4/0.0>0.0		AGL|0.00|0.00|0.00|0.00|43|25|-23|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870805	99870805	C	T	het	hom	het		QUAL=8603;DP=340,98,117;AF=0.42,1.00,0.51;MQM=60;SAP=24;ABP=14;SAR=124;SAF=178	AGL	synonymous	AGL:ENST00000361915.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000294724.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.6:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	198432 [benign DISEASE=not specified,not provided,Glycogen storage disease type III];			rs2230306	0.75877	0.91289,0.71609,0.69757,0.69628,0.76142	44424,	26407	36643	1.0390	11.31			/2.6>2.2/0.0>0.0		AGL|0.01|0.12|0.00|0.00|20|-47|20|-47	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99874669	99874669	G	A	het	hom	het	off-target	QUAL=11542;DP=218,169,229;AF=0.49,1.00,0.54;MQM=60;SAP=148;ABP=4;SAR=118;SAF=281	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron6/32:c.911-18G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256751 [benign DISEASE=Glycogen storage disease type III,not provided,not specified];			rs634880	0.73413	0.84145,0.68659,0.72058,0.69365,0.73787	41276,	28812	40332	-0.9060	5.56			11.0>11.4/11.0>11.4/8.7>7.2	COSV54049593	AGL|0.02|0.00|0.00|0.00|25|18|18|-6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99876671	99876671	C	T	wt	het	wt	off-target	QUAL=938;DP=82,67,76;AF=0.00,0.57,0.00;MQM=60;SAP=54;ABP=6;SAR=34;SAF=4	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1375+74C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294319 [benign DISEASE=not provided];			rs3736295	0.51569	0.42504,0.56555,0.67381,0.54695,0.59830	20626,	37032	73520	-0.6710	4.51			/6.2>6.1/0.0>0.0	COSV54049212	AGL|0.01|0.00|0.00|0.00|20|1|50|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877517	99877517	T	A	wt	het	wt	off-target	QUAL=38;DP=49,7,11;AF=0.02,0.57,0.00;MQM=60;SAP=14;ABP=3;SAR=0;SAF=5	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-124T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294317 [benign DISEASE=not provided];			rs2291637	0.48959	0.37651,0.54537,0.67508,0.53142,0.59349	18819,	36744	77544	-0.7600	4.83			/0.0>0.0/0.0>0.0	COSV54049668	AGL|0.00|0.00|0.00|0.00|-3|29|-3|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877597	99877597	A	G	wt	het	wt	off-target	QUAL=302;DP=176,22,41;AF=0.00,0.68,0.00;MQM=60;SAP=21;ABP=9;SAR=2;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-44A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256722 [benign DISEASE=not specified,not provided,Glycogen storage disease type III];			rs2291638	0.29689	0.09320,0.32406,0.45989,0.39292,0.30954	8120,	28880	106856	-0.5580	8.44			/0.5>1.0/0.0>0.0	COSV54049682	AGL|0.00|0.00|0.00|0.00|44|50|43|44	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99879853	99879853	C	G	wt	het	wt	off-target	QUAL=815;DP=154,72,106;AF=0.00,0.49,0.00;MQM=60;SAP=36;ABP=3;SAR=6;SAF=29	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron11/32:c.1564-70C>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294318 [benign DISEASE=not provided];		(TTTC)n (Simple_repeat)	rs2392077	0.48976	0.37688,0.54512,0.67490,0.53147,0.59378	18796,	36753	77455	0.7610	5.25			/1.2>0.4/0.0>0.0	COSV54049704	AGL|0.00|0.00|0.00|0.00|-38|47|-9|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99881185	99881185	T	C	wt	het	wt		QUAL=2719;DP=287,209,284;AF=0.00,0.51,0.00;MQM=60;SAP=4;ABP=3;SAR=57;SAF=51	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron14/32:c.1953+8T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296	0.51577	0.42521,0.56458,0.67492,0.54702,0.59934	20631,	37021	73497	2.0820	12.88			/0.0>0.0/0.0>0.0	COSV54049713	AGL|0.00|0.00|0.00|0.00|-7|-47|-8|-20	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99884827	99884827	G	A	wt	het	wt	off-target	QUAL=630;DP=160,80,91;AF=0.00,0.41,0.00;MQM=60;SAP=75;ABP=8;SAR=33;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron19/32:c.2633+124G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1235676 [benign DISEASE=not provided];		MER5A1 (DNA/hAT-Charlie)	rs2234707	0.51580	0.42494,0.56519,0.67546,0.54707,0.59830	20652,	37050	73554	-0.0350	7.68			/0.0>0.0/0.0>0.0	COSV54049748	AGL|0.00|0.00|0.00|0.00|7|1|1|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99888119	99888119	G	A	het	hom	het	off-target	QUAL=12235;DP=175,206,264;AF=0.53,1.00,0.47;MQM=60;SAP=105;ABP=3;SAR=282;SAF=141	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron20/32:c.2764+11G>A::	regulatory_region_variant:open_chromatin_region	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.66224	0.58170,0.69482,0.69969,0.69338,0.74490	33501,	33511	51265	-0.2370	0.59			/0.0>0.0/0.0>0.0	COSV54049809	AGL|0.00|0.00|0.00|0.00|2|34|-7|-20	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891485	99891485	A	G	wt	het	wt	off-target	QUAL=603;DP=192,61,81;AF=0.00,0.43,0.00;MQM=60;SAP=4;ABP=6;SAR=11;SAF=15	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-121A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1269708 [benign DISEASE=not provided];			rs2035960	0.51530	0.42381,0.56508,0.67470,0.54687,0.59842	20593,	37009	73553	-0.5230	0.36			/9.7>9.9/0.0>0.0	COSV54052442	AGL|0.00|0.00|0.00|0.00|40|-2|-1|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891585	99891585	T	A	wt	het	wt	off-target	QUAL=1409;DP=198,121,186;AF=0.00,0.47,0.00;MQM=60;SAP=35;ABP=4;SAR=14;SAF=43	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-21T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256733 [benign DISEASE=not specified,not provided,Glycogen storage disease type III];			rs2035961	0.48931	0.37557,0.54507,0.67452,0.53146,0.59349	18763,	36706	77476	0.0910	5.65			/0.0>0.0/0.0>0.0	COSV54051217	AGL|0.00|0.00|0.00|0.00|39|21|39|20	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892547	99892547	C	T	het	het	het		QUAL=8382;DP=251,182,223;AF=0.49,0.47,0.51;MQM=60;SAP=8;ABP=4;SAR=174;SAF=146	AGL	missense	AGL:ENST00000361915.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000294724.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370163.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.6:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256734 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.13629	0.12021,0.12684,0.02622,0.14643,0.14946	1507,	17690	131210	7.2800	22.20	0.30	0.22	/4.9>6.3/3.2>3.0		AGL|0.11|0.00|0.00|0.00|8|20|-4|-6	25741868,25803781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892644	99892644	G	A	het	hom	het	off-target	QUAL=5719;DP=136,88,117;AF=0.46,1.00,0.49;MQM=60;SAP=296;ABP=5;SAR=187;SAF=20	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256735 [benign DISEASE=not provided,Glycogen storage disease type III,not specified];			rs594249	0.66265	0.58206,0.69504,0.70085,0.69354,0.74855	33579,	33515	51251	-1.8710	0.01			/0.0>1.1/0.0>0.0	COSV54049828	AGL|0.00|0.00|0.00|0.00|50|-42|-37|-41	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900890	99900890	G	T	het	wt	wt	off-target;low_conf_region	QUAL=1592;DP=84,54,54;AF=0.27,0.80,0.46;MQM=58;SAP=68;ABP=114;SAR=30;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+29G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1204532 [likely benign DISEASE=not provided];		(T)n (Simple_repeat)	rs201885902	0.00128	0.00229,0.00169,0.00083,0.00063,0.00022	0,	182	142146	0.6720	2.62			/3.2>3.7/0.0>0.0		AGL|0.00|0.00|0.00|0.02|34|-39|-23|-29		23	842	0	0 / 0	2	"[2] auto-classification 22.09.2017  "			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900891	99900892	TT	-	het	hom	het	off-target;low_conf_region	QUAL=1592;DP=84,54,54;AF=0.27,0.06,0.07;MQM=60;SAP=201;ABP=31;SAR=91;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1220869 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs35956186	0.52536	0.42964,0.50780,0.49917,0.58641,0.47623	19107,	36535	67533	2.0190	1.96			/3.2>2.8/0.0>0.0		AGL|0.00|0.00|0.01|0.00|-23|-29|-29|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910892	99910892	G	A	wt	het	wt	off-target	QUAL=2103;DP=103,176,266;AF=0.00,0.49,0.00;MQM=60;SAP=9;ABP=3;SAR=51;SAF=36	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+45G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256744 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2274570	0.46488	0.37191,0.50900,0.56929,0.50928,0.37651	16702,	36933	80963	-0.2940	0.37			/4.3>2.3/0.0>0.0	COSV54050212	AGL|0.00|0.00|0.00|0.00|-40|-45|-45|-40	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910900	99910900	T	A	wt	het	wt	off-target	QUAL=2114;DP=106,173,261;AF=0.00,0.50,0.00;MQM=60;SAP=14;ABP=3;SAR=54;SAF=33	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+53T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1224847 [benign DISEASE=not provided];			rs1541041	0.46471	0.37194,0.50900,0.56843,0.50913,0.37713	16706,	36943	81041	-0.3640	1.85			/0.0>0.0/0.0>0.0	COSV54050222	AGL|0.00|0.00|0.00|0.00|-48|49|-48|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99912233	99912233	C	T	het	het	het	off-target	QUAL=1026;DP=47,13,25;AF=0.43,0.77,0.60;MQM=60;SAP=101;ABP=4;SAR=0;SAF=45	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3789-172C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	680039 [benign DISEASE=not provided];			rs3818568	0.13621	0.11998,0.12787,0.02637,0.14646,0.13576	1504,	17667	131109	0.0880	1.31			/0.0>0.0/4.3>2.8		AGL|0.00|0.00|0.00|0.00|-1|-42|0|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99915553	99915553	-	T	het	het	het	off-target;low_conf_region	QUAL=986;DP=66,35,37;AF=0.39,0.37,0.41;MQM=60;SAP=74;ABP=17;SAR=48;SAF=6	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron30/32:c.4211+80dup::	regulatory_region_variant:enhancer	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1292307 [benign DISEASE=not provided];			rs11438303	0.43403	0.25058,0.48713,0.57171,0.52120,0.38810	14663,	34203	82841		1.26			/8.0>9.0/0.0>0.0		AGL|0.03|0.00|0.00|0.00|19|30|30|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99916313	99916313	G	A	wt	het	wt	off-target	QUAL=167;DP=120,47,63;AF=0.00,0.28,0.00;MQM=60;SAP=31;ABP=23;SAR=0;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron30/32:c.4212-97G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294320 [benign DISEASE=not provided];			rs2296885	0.39131	0.25528,0.46270,0.55663,0.44920,0.32855	12390,	34596	92362	0.5240	4.82			/0.0>0.0/0.0>0.0	COSV54050263	AGL|0.00|0.00|0.00|0.00|48|-14|-4|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99921923	99921923	G	T	wt	het	wt		QUAL=1097;DP=306,85,96;AF=0.00,0.52,0.00;MQM=60;SAP=4;ABP=3;SAR=25;SAF=20	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291351 [benign DISEASE=not provided,Glycogen storage disease type III];			rs1804808	0.32494	0.12003,0.42501,0.55631,0.40396,0.31562	9469,	30260	102210	0.1500	2.81			/0.0>0.0/0.0>0.0	COSV54050326,COSV54053994	AGL|0.00|0.00|0.00|0.00|30|-19|-43|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922383	99922383	C	T	het	hom	het		QUAL=4274;DP=173,41,53;AF=0.49,1.00,0.45;MQM=60;SAP=14;ABP=4;SAR=61;SAF=88	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600	0.61756	0.53743,0.64315,0.63336,0.65827,0.51686	29017,	35358	57836	0.8200	4.32			/6.3>5.3/0.0>0.0		AGL|0.00|0.00|0.00|0.00|15|2|-3|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922679	99922679	C	T	wt	het	wt		QUAL=258;DP=191,42,62;AF=0.01,0.38,0.00;MQM=60;SAP=6;ABP=8;SAR=6;SAF=11	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.47340	0.39762,0.51229,0.57204,0.51088,0.37744	17318,	37085	79781	0.9610	4.49			/0.0>0.0/0.0>0.0	COSV54050336	AGL|0.00|0.00|0.00|0.00|4|-30|-15|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922947	99922947	A	C	wt	het	wt		QUAL=895;DP=222,61,69;AF=0.00,0.57,0.00;MQM=60;SAP=3;ABP=6;SAR=19;SAF=17	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.37993	0.21674,0.45932,0.55536,0.44880,0.32739	11969,	33724	94108	0.0970	2.97			/0.0>0.0/0.0>0.0	COSV54050348	AGL|0.00|0.00|0.00|0.00|-6|-49|-12|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99923192	99923192	T	C	wt	het	wt		QUAL=1707;DP=267,123,168;AF=0.00,0.54,0.01;MQM=60;SAP=3;ABP=4;SAR=32;SAF=35	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.40472	0.30361,0.46695,0.55635,0.44893,0.32759	12947,	35543	90365	-1.4380	0.29			/0.0>0.0/0.0>0.0	COSV54050357	AGL|0.00|0.00|0.00|0.00|3|7|35|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100187173	100187173	G	A	wt	het	wt		QUAL=311;DP=111,38,41;AF=0.00,0.42,0.02;MQM=60;SAP=32;ABP=5;SAR=1;SAF=16	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291375 [benign DISEASE=not provided,Maple syrup urine disease];			rs72728160	0.11724	0.03168,0.11799,0.00077,0.17598,0.03188	1396,	15030	134192	0.3260	3.52			/3.9>4.4/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-20|6|30|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100187701	100187701	T	-	het	het	het		QUAL=160;DP=18,7,10;AF=0.33,0.29,0.30;MQM=59;SAP=8;ABP=13;SAR=3;SAF=8	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1195364 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs886044938	0.00924	0.00504,0.01166,0.00214,0.01077,0.01194	5,	1136	122938	-1.4950	0.14			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-13|-31|18|36		5	250	0	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	-	het	wt	n/a		QUAL=1059;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3;SAR=3;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291391 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=not provided,Maple syrup urine disease];		AluSz (SINE/Alu)	rs71709231	0.82705	0.71260,0.88330,0.95743,0.85718,0.92380	49179,	20233	24799	0.4640	3.74			/3.5>4.7/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-39|-10|-10|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189353	AA	-	wt	het	n/a		QUAL=1059;DP=42,8,1;AF=0.48,0.00,1.00;MQM=55;SAP=13;ABP=53;SAR=1;SAF=7	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1200821 [likely benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71709231	0.00719	0.00411,0.00704,0.00687,0.00658,0.00262	3,	1024	142166	0.4640	3.95			/3.5>4.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-10|21|-47|-13		2	70	0	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	T	het	het	n/a		QUAL=1059;DP=42,8,1;AF=0.38,0.38,0.00;MQM=59;SAP=4;ABP=9;SAR=8;SAF=11	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291392 [benign DISEASE=not provided,Maple syrup urine disease];		AluSz (SINE/Alu)	rs10783125	0.54686	0.57426,0.52267,0.51316,0.51558,0.51659	1720,	15700	15860	0.4640	7.12			/3.5>3.8/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-2|-11|-48|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189353	100189353	A	T	het	wt	n/a		QUAL=1059;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3;SAR=3;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	875221 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200943386	0.80514	0.68065,0.86775,0.93797,0.83971,0.89086	45023,	22251	27179	0.4640	7.34			/3.5>3.4/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-2|-12|-2|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189354	100189354	A	T	wt	het	n/a		QUAL=1059;DP=42,8,1;AF=0.38,0.38,0.00;MQM=55;SAP=13;ABP=53;SAR=1;SAF=7	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291393 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200062717	0.00744	0.00407,0.00776,0.00700,0.00692,0.00271	3,	1050	140914	0.4640	7.53			/3.5>1.9/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-2|-13|3|-50		20	75	0	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190027	100190027	T	A	hom	hom	hom		QUAL=4322;DP=104,15,13;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0;SAR=80;SAF=52	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291395 [benign DISEASE=not provided,Maple syrup urine disease];		MER3 (DNA/hAT-Charlie)	rs4281338	0.75673	0.47644,0.85423,0.95154,0.84988,0.88328	45899,	23284	36996	-0.7220	0.15			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|17|-2|17|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190140	100190141	AA	-	het	wt	het		QUAL=3494;DP=180,57,89;AF=0.49,0.02,0.65;MQM=60;SAP=194;ABP=8;SAR=17;SAF=131	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291396 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=not provided,Maple syrup urine disease];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711	0.17900	0.04523,0.16322,0.14954,0.24652,0.18621	3079,	21060	124836	0.4950	0.56			/4.5>1.1/0.0>0.0		DBT|0.00|0.00|0.00|0.00|17|-11|33|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190709	100190709	C	T	hom	hom	hom		QUAL=13994;DP=174,105,140;AF=0.99,1.00,1.00;MQM=60;SAP=30;ABP=0;SAR=173;SAF=245	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291404 [benign DISEASE=not provided,Maple syrup urine disease];			rs11166412	0.79162	0.56444,0.87569,0.95220,0.86533,0.89938	49079,	22067	31647	-0.7530	0.12			/4.2>6.5/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-3|-6|-3|-7	17998437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190938	100190938	A	G	wt	het	wt		QUAL=1899;DP=403,187,261;AF=0.00,0.43,0.00;MQM=60;SAP=3;ABP=10;SAR=42;SAF=40	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291406 [benign DISEASE=not provided,Maple syrup urine disease];			rs11166413	0.30555	0.09204,0.37472,0.25897,0.40354,0.31579	8651,	29150	105578	0.6970	8.55			/0.0>0.0/0.0>0.0	COSV64497182	DBT|0.00|0.00|0.00|0.00|7|-28|-39|8	32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191105	100191105	T	C	hom	hom	hom		QUAL=24031;DP=361,156,208;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=434;SAF=289	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291407 [benign DISEASE=not provided,Maple syrup urine disease];			rs6701655	0.75902	0.47895,0.85648,0.95227,0.85185,0.89714	46145,	23087	36631	0.1090	2.52			/1.0>1.2/4.8>0.6		DBT|0.00|0.00|0.00|0.00|40|-4|-4|3	31234531	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191773	ATACACACACACACACACACACACAC	-	het	wt	het		QUAL=1952;DP=33,26,55;AF=0.42,0.88,0.38;MQM=58;SAP=4;ABP=5;SAR=22;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1228726 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs1418854977	0.04292	0.02562,0.03310,0.05591,0.04912,0.05563	241,	5799	140077	0.6740	0.29			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|47|-32|49|-11		4	9	0	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191775	ATACACACACACACACACACACACACAC	-	het	hom	het		QUAL=1952;DP=33,26,55;AF=0.30,0.00,0.55;MQM=58;SAP=7;ABP=11;SAR=34;SAF=24	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1251386 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs140341302	0.68143	0.51548,0.76635,0.83300,0.73008,0.78041	34782,	30103	46595	0.6740	0.28			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|47|-32|49|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100193022	100193022	G	A	hom	hom	hom		QUAL=35099;DP=349,323,479;AF=0.98,1.00,1.00;MQM=60;SAP=5;ABP=0;SAR=588;SAF=556	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291424 [benign DISEASE=not provided,Maple syrup urine disease];			rs2784174	0.75915	0.47928,0.85651,0.95204,0.85188,0.89656	46156,	23090	36612	0.1950	1.26			/0.0>0.0/0.9>0.0		DBT|0.00|0.00|0.00|0.00|-5|34|-5|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100196535	100196536	TG	-	hom	hom	hom	off-target	QUAL=4125;DP=89,26,29;AF=1.00,0.96,1.00;MQM=60;SAP=314;ABP=0;SAR=143;SAF=0	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron10/10:c.1282-114_1282-113del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron11/11:c.1408-114_1408-113del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron11/11:c.739-114_739-113del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]				rs5776501	0.98964	0.96325,0.99750,1.00000,0.99994,0.99979	74248,	1518	1570	0.0000	0.68			/9.4>7.3/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-5|-1|6|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100206073	100206073	A	-	het	hom	het	off-target	QUAL=92;DP=10,3,4;AF=0.40,0.33,0.25;MQM=57;SAP=16;ABP=5;SAR=0;SAF=6	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron10/10:c.1281+157del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron11/11:c.1407+157del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron11/11:c.738+157del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1241624 [benign DISEASE=not provided];		L1PA7 (LINE/L1)	rs35150096	0.40089	0.24774,0.45421,0.28488,0.47357,0.37287	9341,	31345	74763	-0.0320	0.46			/8.2>8.4/0.0>0.0		DBT|0.00|0.01|0.00|0.00|-28|-9|-36|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206310	100206310	T	A	wt	het	wt	low_conf_region	QUAL=295;DP=244,77,112;AF=0.00,0.25,0.00;MQM=60;SAP=3;ABP=46;SAR=9;SAF=11	DBT	splice_region&intron	DBT:ENST00000370132.8:splice_region_variant&intron_variant:LOW:intron9/10:c.1210-9A>T::,DBT:ENST00000681617.1:splice_region_variant&intron_variant:LOW:intron10/11:c.1336-9A>T::,DBT:ENST00000681780.1:splice_region_variant&intron_variant:LOW:intron10/11:c.667-9A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	93987 [benign DISEASE=not specified,Maple syrup urine disease];			rs34229137	0.31337	0.12799,0.38476,0.25357,0.39186,0.33471	7976,	29850	100356	0.7320	1.51			6.0>7.4/6.0>7.4/0.0>0.0	COSV64494912,COSV64495481	DBT|0.02|0.00|0.00|0.00|-9|-2|-15|-9	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206504	100206504	T	C	hom	hom	hom		QUAL=29071;DP=346,245,303;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0;SAR=472;SAF=421	DBT	missense	DBT:ENST00000370132.8:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681617.1:missense_variant:MODERATE:exon10/12:c.1276A>G:p.Ser426Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681780.1:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)]		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	128885 [benign/likely benign DISEASE=Maple syrup urine disease,not provided,not specified];			rs12021720	0.87617	0.76524,0.91698,0.96664,0.91103,0.95309	58703,	15816	18828	1.9390	12.46	0.12	0.04	/0.0>2.4/7.0>2.5		DBT|0.00|0.00|0.00|0.01|-6|15|0|4	30409984,29334895,21827660,9621512,30541556,23112750,22437669,32583022,35657820	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100215037	100215037	-	T	het	het	het	off-target;low_conf_region	QUAL=1325;DP=97,25,27;AF=0.55,0.48,0.48;MQM=60;SAP=132;ABP=4;SAR=73;SAF=5	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron6/11:c.773-55dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron7/11:c.230-55dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291007 [benign DISEASE=not provided];			rs11431894	0.77882	0.58708,0.84842,0.93855,0.84140,0.89126	44764,	23283	32037		0.95			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-1|-45|38|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100218933	100218934	GG	-	hom	hom	hom	off-target	QUAL=1531;DP=49,6,17;AF=0.88,1.00,1.00;MQM=60;SAP=146;ABP=0;SAR=66;SAF=0	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.434-187_434-186del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.434-187_434-186del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-110-187_-110-186del::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.434-187_434-186del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1293954 [benign DISEASE=not provided];			rs55792733	0.80995	0.61053,0.87994,0.95217,0.86824,0.90796	48877,	21101	27889	0.1350	1.00			/6.3>6.1/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-19|49|25|49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100230629	100230629	-	A	hom	hom	het	off-target;low_conf_region	QUAL=878;DP=33,4,12;AF=0.73,0.75,0.58;MQM=59;SAP=77;ABP=4;SAR=0;SAF=34	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.433+103dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.433+103dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-111+103dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.433+103dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291008 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs11394110	0.81603	0.57415,0.88915,0.96148,0.90112,0.94704	48755,	19030	26274		0.70			/8.6>8.6/0.0>0.0		DBT|0.04|0.00|0.00|0.00|-20|-28|-20|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100249898	100249898	G	A	hom	hom	hom	off-target	QUAL=13143;DP=54,196,282;AF=0.98,0.99,1.00;MQM=60;SAP=209;ABP=0;SAR=377;SAF=153	DBT	upstream_gene	DBT:ENST00000370132.8:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681617.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681780.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000370131.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1263587 [benign DISEASE=not provided];			rs3806235	0.72388	0.39063,0.82741,0.94142,0.84473,0.83803	43135,	23715	41953	-1.2050	0.49						29740478	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RTCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	109228441	109228441	T	C	hom	hom	hom		QUAL=21691;DP=237,204,230;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0;SAR=376;SAF=295	SARS1	splice_region&intron	SARS1:ENST00000234677.7:splice_region_variant&intron_variant:LOW:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:splice_region_variant&intron_variant:LOW:intron3/11:c.288+9T>C::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327978 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs683182	0.70306	0.47455,0.78259,0.89392,0.79151,0.66674	39240,	28373	45129	-0.6230	1.81			/1.1>2.1/0.0>0.0	COSV52320213	SARS|0.00|0.00|0.00|0.00|3|19|13|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109229259	109229259	G	T	hom	hom	hom	off-target	QUAL=4799;DP=114,24,26;AF=0.99,1.00,1.00;MQM=60;SAP=357;ABP=0;SAR=0;SAF=163	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron3/10:c.289-155G>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.289-155G>T::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs657511	0.98967	0.96464,0.99457,1.00000,0.99985,0.99979	74557,	1520	1572	1.0760	5.33			/5.2>2.0/0.0>3.6		SARS|0.00|0.00|0.00|0.00|20|33|-2|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109231083	109231083	A	T	n/a	n/a	hom	off-target;low_conf_region	QUAL=116;DP=2,1,4;AF=1.00,0.00,1.00;MQM=60;SAP=16;ABP=0;SAR=6;SAF=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron5/10:c.591+62A>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron5/11:c.591+62A>T::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs66909315	0.00088	0.00266,0.00079,0.00102,0.00008,0.00022	0,	121	137153	0.3750	2.40			/9.3>10.1/0.0>0.0		SARS|0.00|0.00|0.00|0.00|20|2|-13|-50		79	732	0	0 / 0					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235615	109235615	C	T	het	hom	wt	off-target	QUAL=489;DP=41,3,6;AF=0.49,1.00,0.00;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.969+184C>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.969+184C>T::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]			MIR (SINE/MIR)	rs4268379	0.39438	0.14577,0.47568,0.45965,0.49392,0.43342	13728,	32403	91921	0.1580	4.36			/1.9>2.2/0.0>0.0	COSV52320249	SARS|0.00|0.00|0.00|0.00|19|-44|-2|22	26487741	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235955	109235955	T	C	hom	hom	hom	off-target	QUAL=18735;DP=177,160,263;AF=1.00,1.00,1.00;MQM=60;SAP=446;ABP=0;SAR=125;SAF=475	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327979 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs658092	0.70991	0.49828,0.78606,0.89390,0.79161,0.66729	39725,	28416	44078	0.7830	9.53			/1.8>2.3/0.0>0.0	COSV52320257	SARS|0.00|0.00|0.00|0.00|-31|31|35|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110167097	110167097	T	C	het	het	hom		QUAL=19100;DP=264,332,392;AF=0.46,0.00,1.00;MQM=60;SAP=76;ABP=206;SAR=129;SAF=51	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.522A>G::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333111 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome];			rs7527375	0.49575	0.49958,0.39237,0.22297,0.53403,0.35693	18666,	36772	75374	-5.6260	0.64			/0.0>0.0/0.0>0.0,/5.3>5.2/0.0>0.0	COSV58991969	SLC6A17|0.00|0.00|0.00|0.00|-34|5|25|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167098	110167098	G	A	het	wt	hom		QUAL=19100;DP=264,332,392;AF=0.46,0.00,1.00;MQM=60;SAP=231;ABP=7;SAR=372;SAF=140	SLC6A17,SLC6A17-AS1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.521C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333112 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome];			rs12737742	0.33579	0.09663,0.29813,0.22159,0.45979,0.33594	10397,	29608	99698	0.6810	13.12	0.08	0.06	/0.0>0.0/0.0>0.0,/5.3>5.9/0.0>0.0	COSV58993671	SLC6A17|0.00|0.00|0.01|0.00|-35|-39|24|34	29259604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167112	110167112	G	A	wt	het	wt		QUAL=4223;DP=251,314,376;AF=0.00,0.55,0.00;MQM=60;SAP=101;ABP=9;SAR=130;SAF=42	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209 [Sodium neurotransmitter symporter family],SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.507C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41281364	0.05843	0.05370,0.05520,0.00058,0.07204,0.01507	279,	8279	142411	-3.5070	3.74			/1.0>0.0/0.0>0.0,/5.6>4.8/0.0>0.0	COSV58997789	SLC6A17|0.00|0.00|0.01|0.00|-49|12|10|20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173788	110173798	TGAATGGAGCG	-	het	wt	hom	off-target	QUAL=1730;DP=52,55,47;AF=0.50,0.02,1.00;MQM=60;SAP=164;ABP=3;SAR=0;SAF=74	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-171_445-161del::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs67632953	0.38766	0.30121,0.31528,0.22132,0.45276,0.33591	11813,	35161	92859	0.5050	7.02			/3.3>3.3/0.1>0.0		SLC6A17|0.00|0.06|0.00|0.00|-27|0|12|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173889	110173889	C	T	het	wt	hom	off-target	QUAL=7010;DP=103,207,195;AF=0.52,0.00,1.00;MQM=60;SAP=439;ABP=4;SAR=13;SAF=237	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-84C>T::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12747833	0.33397	0.10184,0.31117,0.25878,0.45310,0.33486	10301,	30163	101241	-0.2780	1.72			/0.0>0.0/0.0>0.0	COSV58993259	SLC6A17|0.00|0.00|0.00|0.00|24|-27|-8|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110176467	110176467	A	G	hom	hom	hom	off-target	QUAL=1953;DP=20,23,24;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0;SAR=0;SAF=67	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron5/11:c.754-162A>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs589540	0.94356	0.98076,0.95249,0.98603,0.91573,0.97268	67792,	7942	8586	-2.1500	0.01			/6.4>6.5/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|36|7|-1|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110192415	110192415	T	G	het	hom	het	off-target	QUAL=3975;DP=54,78,76;AF=0.48,1.00,0.53;MQM=60;SAP=90;ABP=3;SAR=34;SAF=110	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron7/11:c.1107-91T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603583	0.63133	0.73181,0.55113,0.34802,0.63166,0.43852	30933,	33981	55971	-1.1330	0.22			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|41|-39|-18|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110195674	110195674	G	A	het	het	het		QUAL=16509;DP=307,385,547;AF=0.50,0.54,0.53;MQM=60;SAP=44;ABP=10;SAR=270;SAF=381	SLC6A17	synonymous	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784140	0.36789	0.10922,0.39192,0.29923,0.49651,0.39751	12538,	30838	96070	-2.0460	6.89			/0.0>1.5/0.0>0.0	COSV58991975,COSV58995492	SLC6A17|0.16|0.03|0.00|0.00|2|-41|2|-16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197242	110197242	A	G	het	het	het	off-target	QUAL=479;DP=14,11,17;AF=0.57,0.45,0.53;MQM=60;SAP=51;ABP=3;SAR=0;SAF=22	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron10/11:c.1653-195A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761442	0.39129	0.17259,0.40533,0.30085,0.50564,0.40576	13318,	32834	92514	0.4440	8.26			/0.0>0.2/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|1|2|-22|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197651	110197651	G	T	het	het	het	off-target	QUAL=4715;DP=246,57,72;AF=0.54,0.40,0.58;MQM=60;SAP=372;ABP=5;SAR=190;SAF=7	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603581	0.39048	0.19083,0.40059,0.29996,0.49542,0.40087	13008,	33323	92627	-0.2150	2.45			/2.1>2.6/0.0>0.0		SLC6A17|0.00|0.01|0.00|0.00|18|34|-41|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197784	110197784	C	T	het	het	het	off-target	QUAL=1176;DP=76,23,26;AF=0.50,0.30,0.38;MQM=60;SAP=24;ABP=7;SAR=39;SAF=16	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+185C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs2761443	0.38166	0.16011,0.39550,0.29985,0.49572,0.40050	12774,	32499	94045	-0.7820	4.50			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|41|-36|-25|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198066	110198066	C	T	het	het	het	off-target	QUAL=8903;DP=181,258,331;AF=0.48,0.50,0.47;MQM=60;SAP=136;ABP=5;SAR=110;SAF=261	SLC6A17	splice_region&intron	SLC6A17:ENST00000331565.5:splice_region_variant&intron_variant:LOW:intron11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761445	0.39725	0.19339,0.40726,0.30151,0.50574,0.40478	13475,	33361	91511	-0.7130	4.71			0.8>0.8/0.8>0.8/0.0>0.0	COSV58993252	SLC6A17|0.01|0.01|0.00|0.00|-1|10|-1|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198459	110198459	C	G	het	het	wt		QUAL=2439;DP=138,119,160;AF=0.50,0.34,0.01;MQM=60;SAP=30;ABP=15;SAR=37;SAF=74	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761446	0.03466	0.00784,0.02087,0.00058,0.05302,0.03062	145,	4985	146903	1.2140	4.22			/3.7>3.1/0.0>0.0	COSV58992447	SLC6A17|0.00|0.00|0.00|0.00|43|-19|-1|-19		79	2023	0	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198464	110198464	C	T	wt	het	wt		QUAL=1787;DP=136,140,207;AF=0.00,0.54,0.00;MQM=60;SAP=4;ABP=5;SAR=34;SAF=41	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41306175	0.08431	0.08248,0.07333,0.00386,0.10303,0.01740	569,	11687	139299	-2.6300	0.06			/3.7>4.2/0.0>0.0	COSV58995363	SLC6A17|0.00|0.00|0.00|0.00|-41|-24|37|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198727	110198727	G	T	het	hom	het		QUAL=17154;DP=366,272,332;AF=0.47,1.00,0.57;MQM=60;SAP=4;ABP=5;SAR=310;SAF=322	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603580	0.63785	0.78617,0.54269,0.34433,0.61914,0.43975	31868,	33260	55072	-0.3460	0.32			/1.8>3.2/0.0>0.9		SLC6A17|0.00|0.00|0.00|0.00|31|0|-22|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198961	110198961	C	G	het	hom	het		QUAL=10090;DP=171,176,215;AF=0.39,1.00,0.53;MQM=60;SAP=4;ABP=7;SAR=171;SAF=185	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784141	0.63811	0.78645,0.54357,0.34514,0.61913,0.44009	31876,	33240	55008	-1.1710	0.26			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|20|21|20|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199463	110199463	T	C	het	hom	het		QUAL=27448;DP=295,503,681;AF=0.43,1.00,0.49;MQM=60;SAP=23;ABP=8;SAR=530;SAF=436	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603579	0.63948	0.78807,0.54639,0.34737,0.62054,0.43949	32025,	33182	54816	0.6570	7.01			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|-30|24|-30|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199880	110199880	A	G	het	het	het	low_conf_region	QUAL=1564;DP=168,84,104;AF=0.32,0.25,0.26;MQM=59;SAP=151;ABP=148;SAR=92;SAF=9	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			(GATG)n (Simple_repeat)	rs2361044	0.40322	0.13903,0.42598,0.34208,0.50994,0.42236	9505,	26810	67814	-0.1920	5.40			/0.0>0.0/1.6>0.0	COSV58997534	SLC6A17|0.00|0.00|0.00|0.00|-19|2|0|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199993	110199993	A	G	het	het	het		QUAL=2565;DP=124,70,109;AF=0.42,0.34,0.44;MQM=60;SAP=207;ABP=25;SAR=8;SAF=116	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			GA-rich (Low_complexity)	rs12133992	0.35580	0.09977,0.37329,0.28347,0.49176,0.36697	11522,	28249	92869	0.3660	3.70			/0.0>0.0/2.3>2.9		SLC6A17|0.00|0.00|0.00|0.00|-40|15|-16|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200370	110200370	T	G	het	het	het		QUAL=7295;DP=175,181,269;AF=0.51,0.52,0.45;MQM=60;SAP=5;ABP=4;SAR=145;SAF=161	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784142	0.38557	0.17041,0.40264,0.30199,0.49655,0.38856	12839,	32618	92898	0.3880	8.85			/2.7>4.2/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|0|-44|-1|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200966	110200966	G	C	het	wt	het		QUAL=8420;DP=164,388,476;AF=0.53,0.00,0.52;MQM=60;SAP=12;ABP=6;SAR=186;SAF=149	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs151008748	0.02010	0.00452,0.02377,0.00000,0.02411,0.00415	61,	2933	148965	-0.6850	6.89			/0.0>0.4/0.3>1.4		SLC6A17|0.00|0.00|0.00|0.00|-40|50|6|-25		1	11	0	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201213	110201213	G	A	wt	het	wt		QUAL=2274;DP=221,164,184;AF=0.00,0.54,0.00;MQM=60;SAP=6;ABP=6;SAR=50;SAF=39	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12138403	0.08409	0.08219,0.07305,0.00367,0.10277,0.01783	565,	11661	139323	0.1650	2.36			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|31|-10|-3|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201559	110201559	C	T	wt	het	wt		QUAL=1082;DP=102,96,124;AF=0.01,0.46,0.00;MQM=60;SAP=3;ABP=4;SAR=24;SAF=21	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs62621393	0.08413	0.08218,0.07322,0.00366,0.10289,0.01781	568,	11661	139309	-4.2660	0.01			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|25|-38|47|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202252	110202252	G	A	wt	wt	het	off-target	QUAL=1733;DP=61,111,162;AF=0.00,0.00,0.46;MQM=60;SAP=20;ABP=6;SAR=49;SAF=25	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs45445195	0.02158	0.00649,0.04123,0.00039,0.03062,0.00435	59,	3166	148896	-0.7690	0.43							0	9	0	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202393	110202393	T	G	het	hom	het	off-target	QUAL=2878;DP=151,31,41;AF=0.44,1.00,0.54;MQM=60;SAP=264;ABP=5;SAR=120;SAF=0	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs545849	0.85234	0.93388,0.86011,0.84200,0.81161,0.89506	55483,	18559	22439	0.2120	3.92							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	114705129	114705129	A	-	wt	het	wt		QUAL=990;DP=203,75,113;AF=0.00,0.59,0.01;MQM=60;SAP=6;ABP=8;SAR=27;SAF=19	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108	0.20283	0.13192,0.13148,0.02277,0.25223,0.23440	3575,	23651	121059	-0.3060	0.07			/7.8>6.4/0.0>0.0		NRAS|0.00|0.00|0.00|0.00|-48|-10|-14|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114707222	114707222	G	A	wt	het	wt		QUAL=1561;DP=407,125,196;AF=0.00,0.51,0.01;MQM=60;SAP=27;ABP=3;SAR=19;SAF=46	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291967 [benign DISEASE=Noonan syndrome 6];			rs14804	0.20282	0.13229,0.13156,0.02252,0.25216,0.23426	3569,	23687	121159	0.3720	8.30			/0.0>0.0/0.0>0.0	COSV65733786	NRAS|0.00|0.00|0.00|0.00|-47|46|-4|-50	33390813,34828284	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114714048	114714048	G	A	het	wt	hom	off-target	QUAL=2286;DP=70,33,52;AF=0.53,0.03,1.00;MQM=60;SAP=198;ABP=4;SAR=90;SAF=0	NRAS	intron	NRAS:ENST00000369535.5:intron_variant:MODIFIER:intron2/6:c.112-70C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	1231751 [benign DISEASE=not provided];			rs969273	0.76306	0.93440,0.82255,0.99827,0.64060,0.83257	45811,	24351	36011	0.3140	2.70			/0.0>0.0/0.0>0.0	COSV99794035	NRAS|0.00|0.00|0.00|0.00|-28|5|2|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	114716780	114716780	C	T	het	wt	het		QUAL=3744;DP=186,111,129;AF=0.60,0.00,0.38;MQM=60;SAP=188;ABP=3;SAR=139;SAF=22	NRAS,CSDE1	upstream_gene,downstream_gene	NRAS:ENST00000369535.5:upstream_gene_variant:MODIFIER::::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689989.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689217.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.7:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000688211.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692719.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689732.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000693467.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686235.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000684913.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686025.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686781.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000687759.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692672.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000529046.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686667.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689885.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000691032.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692044.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000690207.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]										2.4560	21.10					NRAS|0.00|0.00|0.00|0.00|24|-4|25|1		0	2	0	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115029744	115029744	A	G	het	hom	het	off-target	QUAL=8194;DP=163,122,179;AF=0.48,1.00,0.48;MQM=60;SAP=183;ABP=4;SAR=66;SAF=220	TSHB	upstream_gene	TSHB:ENST00000256592.3:upstream_gene_variant:MODIFIER::::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs1321108	0.42245	0.29018,0.40433,0.49787,0.49972,0.38781	14276,	35489	87553	1.2730	14.76						24366283,23344678,26180634,27362444,25506236	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033402	115033402	A	G	hom	hom	hom		QUAL=17955;DP=261,135,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0;SAR=214;SAF=331	TSHB	missense	TSHB:ENST00000256592.3:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	256640 [benign DISEASE=not specified,Congenital hypothyroidism,Isolated thyroid-stimulating hormone deficiency,not provided];			rs10776792	0.97656	0.99401,0.98649,1.00000,0.96625,0.96483	72526,	3454	3564	0.2070	3.81	0.05	0.05	/2.8>2.9/0.0>0.0		TSHB|0.04|0.00|0.00|0.00|-40|2|37|3	25741868,28515030,31242667	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033790	115033790	T	A	het	wt	het	off-target	QUAL=1532;DP=105,8,11;AF=0.55,0.00,0.36;MQM=60;SAP=27;ABP=4;SAR=18;SAF=44	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-183T>A::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs17477369	0.04838	0.01870,0.05279,0.01310,0.06599,0.04992	204,	6947	144675	-0.0780	1.74			/10.8>9.9/0.0>0.0		TSHB|0.00|0.00|0.00|0.00|-9|20|35|-2		36	357	0	0 / 0					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033861	115033861	C	G	het	hom	het	off-target	QUAL=2884;DP=217,25,30;AF=0.37,1.00,0.53;MQM=60;SAP=240;ABP=30;SAR=3;SAF=118	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-112C>G::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	1268415 [benign DISEASE=not provided];			rs28566771	0.46466	0.43631,0.41917,0.49884,0.50038,0.38859	16620,	37266	81232	-0.5090	2.36			/2.1>2.4/0.0>0.0	COSV56655935	TSHB|0.00|0.00|0.00|0.00|4|5|28|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115286692	115286692	G	A	hom	het	hom		QUAL=20271;DP=186,277,390;AF=0.99,0.51,0.99;MQM=60;SAP=139;ABP=3;SAR=251;SAF=462	NGF-AS1,NGF	intron&non_coding_transcript,missense,5'UTR	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:ENST00000676038.2:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000369512.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680116.1:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000681124.1:5_prime_UTR_variant:MODIFIER:exon3/3:c.-368C>T::,NGF:ENST00000675637.2:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:ENST00000679806.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680540.1:missense_variant:MODERATE:exon1/1:c.104C>T:p.Ala35Val:,NGF:ENST00000680752.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:		162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	291993 [benign DISEASE=not specified,not provided,Congenital sensory neuropathy with selective loss of small myelinated fibers];			rs6330	0.35571	0.19164,0.35780,0.16196,0.45538,0.22121	10904,	32263	97937	1.7880	22.80	0.10	0.07	/0.0>0.0/0.0>0.0,/1.2>1.0/0.0>0.0	COSV65687373	NGF|0.00|0.00|0.00|0.00|18|-46|2|-46	21294249,21358750,19063739,17192954,17212826,18520591,18763222,22330829,23195334,23772677,23964269,25162994,26989097,27486327,28413930,29499660,30214536,30981636,28507530,30283335,28751869,26215504,30983028,26675984,22832952,23388219,23565345,27196537,29453651,19038326,18179783,26579581,31996124,33170162,32599917,32894097,31577263,22301435,35040003,35088019	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	115338434	115338434	G	A	hom	het	hom	off-target	QUAL=2524;DP=23,38,51;AF=1.00,0.50,1.00;MQM=60;SAP=205;ABP=3;SAR=93;SAF=0	NGF-AS1,NGF	intron&non_coding_transcript,intron,5'UTR	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.208-27236G>A::,NGF:ENST00000679806.1:intron_variant:MODIFIER:intron1/2:c.-137+174C>T::,NGF:ENST00000680752.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-206C>T::	regulatory_region_variant:promoter	162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	667672 [benign DISEASE=not provided];			rs11102930	0.54501	0.35504,0.52123,0.42735,0.64873,0.51268	23887,	34981	69087	0.2770	7.60			/0.0>0.0/0.0>0.0,/2.3>3.3/0.0>0.0			19063739,27486327,21178826,22468730,30418350,19038326,31996124,33066277,35280258	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119421632	119421632	T	C	het	wt	het	off-target	QUAL=1716;DP=100,56,57;AF=0.45,0.00,0.56;MQM=60;SAP=170;ABP=3;SAR=0;SAF=77	HSD3B2	intron	HSD3B2:ENST00000543831.5:intron_variant:MODIFIER:intron3/3:c.308-177T>C::,HSD3B2:ENST00000369416.4:intron_variant:MODIFIER:intron3/3:c.308-177T>C::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	1243214 [benign DISEASE=not provided];			rs58154933	0.24598	0.52240,0.21050,0.25166,0.11242,0.25577	6948,	23225	113787	-1.0750	0.54			/4.2>3.5/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|-30|36|1|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422896	119422896	C	T	het	wt	het		QUAL=10751;DP=464,297,355;AF=0.54,0.00,0.41;MQM=60;SAP=11;ABP=5;SAR=216;SAF=179	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292274 [benign DISEASE=not provided,3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1819698	0.24302	0.50976,0.20974,0.25347,0.11230,0.25715	6732,	23476	115062	0.6820	4.06			/3.6>3.5/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|30|-33|-7|10	21708280,28652652,19197249,20660004,22638611,25114582,23284679,19168589,25600087,27814623,23593537,19230916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422941	119422941	C	G	het	wt	het		QUAL=10568;DP=435,291,356;AF=0.54,0.00,0.42;MQM=60;SAP=5;ABP=4;SAR=203;SAF=182	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1361530	0.19188	0.34100,0.18869,0.25173,0.10716,0.25486	3633,	21932	122972	-0.6320	0.57			/0.0>0.0/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|-15|14|0|-35	21708280,28652652,23284679,19168589	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	146017351	146017351	A	G	wt	wt	het	off-target	QUAL=1691;DP=194,129,135;AF=0.00,0.00,0.53;MQM=60;SAP=159;ABP=4;SAR=0;SAF=72	HJV	downstream_gene	HJV:ENST00000475797.1:downstream_gene_variant:MODIFIER::::,HJV:ENST00000497365.5:downstream_gene_variant:MODIFIER::::,HJV:ENST00000336751.11:downstream_gene_variant:MODIFIER::::,HJV:ENST00000357836.5:downstream_gene_variant:MODIFIER::::,HJV:ENST00000636675.1:downstream_gene_variant:MODIFIER::::,HJV:ENST00000634927.1:downstream_gene_variant:MODIFIER::::		608374_[GENE=HJV_PHENOS=Hemochromatosis, type 2A, 602390 (3), Autosomal recessive]			L2d (LINE/L2)	rs7551245	0.14762	0.34691,0.16855,0.17856,0.04109,0.12940	3023,	16406	129638	0.0910	1.41							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HJV (inh=AR oe_syn=0.94 oe_mis=1.03 oe_lof=0.44)
chr1	147756396	147756396	G	A	wt	het	wt		QUAL=1649;DP=351,145,217;AF=0.00,0.46,0.00;MQM=60;SAP=15;ABP=5;SAR=24;SAF=43	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1404290876	0.00004	0.00000,0.00000,0.00000,0.00009,0.00000	0,	6	152120	0.5250	3.18			/0.0>0.0/0.0>0.0		GJA5|0.00|0.00|0.00|0.00|24|-39|-9|-2		0	4	0	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147756741	147756741	C	T	het	het	wt		QUAL=6299;DP=267,195,301;AF=0.51,0.55,0.00;MQM=60;SAP=5;ABP=6;SAR=130;SAF=114	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11240121	0.31400	0.47722,0.36845,0.47067,0.20823,0.39154	8585,	30492	104126	-0.2490	1.23			/0.0>0.0/0.0>0.0		GJA5|0.00|0.00|0.00|0.00|39|-25|-24|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757166	147757166	A	G	wt	wt	het		QUAL=2006;DP=218,134,162;AF=0.00,0.00,0.50;MQM=60;SAP=54;ABP=3;SAR=19;SAF=63	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043806	0.19136	0.17086,0.15756,0.08989,0.22609,0.06797	2906,	23275	122917	1.5780	10.62			/3.6>3.4/0.0>0.0			21076161,23134779,17412882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757430	147757430	G	A	het	het	wt		QUAL=7624;DP=355,318,384;AF=0.43,0.48,0.00;MQM=60;SAP=43;ABP=14;SAR=116;SAF=191	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043802	0.25786	0.36336,0.30531,0.25543,0.19305,0.36026	5551,	28073	112747	0.3330	4.57			/0.0>0.0/0.0>0.0		GJA5|0.00|0.00|0.00|0.00|17|30|9|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757496	147757520	GGGCATTTGCCAGAGGTACATACCA	-	het	het	het	low_conf_region	QUAL=10459;DP=265,338,412;AF=0.54,0.51,0.44;MQM=60;SAP=3;ABP=3;SAR=251;SAF=250	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11267274	0.48753	0.58413,0.52799,0.59875,0.43183,0.45130	18185,	37258	77394	0.2250	2.62			/0.0>0.0/8.1>8.1				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757554	147757554	G	A	wt	wt	het		QUAL=5574;DP=432,380,483;AF=0.00,0.00,0.45;MQM=60;SAP=3;ABP=15;SAR=107;SAF=111	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.14310	0.03859,0.12989,0.00078,0.21685,0.03303	2113,	17493	130061	0.6610	6.97			/0.0>0.0/0.0>0.0		GJA5|0.00|0.00|0.00|0.00|-47|45|-40|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147758109	147758109	C	T	wt	wt	het		QUAL=2632;DP=319,191,231;AF=0.00,0.01,0.45;MQM=60;SAP=37;ABP=7;SAR=33;SAF=74	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1692141	0.17735	0.12165,0.15333,0.09033,0.22593,0.06776	2590,	21775	125029	-0.5590	4.27			/0.0>0.0/1.9>0.0			23134779,22713807,17412882,25893100	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760380	147760380	A	G	het	het	wt	off-target	QUAL=2364;DP=147,79,130;AF=0.50,0.38,0.00;MQM=60;SAP=220;ABP=6;SAR=1;SAF=103	GJA5	intron	GJA5:ENST00000579774.3:intron_variant:MODIFIER:intron1/1:c.-34+119T>C::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1109T>C::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs12136839	0.03344	0.01112,0.02311,0.00019,0.05662,0.00734	127,	4801	146105	-1.2540	0.27			/0.0>0.0/5.5>0.0		GJA5|0.00|0.00|0.00|0.00|31|-15|23|38	25893100	0	0	0	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760538	147760538	G	A	wt	het	wt		QUAL=3094;DP=307,251,365;AF=0.00,0.52,0.00;MQM=60;SAP=5;ABP=4;SAR=71;SAF=60	GJA5	5'UTR,intron	GJA5:ENST00000579774.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs191717313	0.00208	0.00060,0.00190,0.00000,0.00357,0.00104	0,	316	151834	-0.0050	7.22			/0.0>0.0/0.0>7.1		GJA5|0.00|0.00|0.12|0.01|25|-18|2|-39		0	80	0	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760632	147760632	T	C	het	het	het	off-target	QUAL=8409;DP=197,169,238;AF=0.49,0.56,0.59;MQM=60;SAP=261;ABP=14;SAR=264;SAF=66	GJA5	intron	GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]		CR112614 [CLASS=DFP MUT=ALT PHEN="Atrial fibrillation association with" GENE=GJA5];	L2c (LINE/L2)	rs10465885	0.45675	0.38670,0.53572,0.54938,0.47742,0.46184	15874,	37633	82519	-0.3630	1.03			/2.8>2.7/0.0>0.0			21076161,23134779,23040431,27826129,31270966,22690879,28496873,24065925,26516624,29915175,28775688,30061737,29504899,25893100,33350184,25200600,35453689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150799227	150799227	T	C	hom	hom	hom		QUAL=34927;DP=351,341,363;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0;SAR=488;SAF=567	CTSK	synonymous,intron	CTSK:ENST00000678337.1:synonymous_variant:LOW:exon6/7:c.867A>G:p.Ala289=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676716.1:synonymous_variant:LOW:exon5/6:c.708A>G:p.Ala236=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676966.1:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000443913.2:synonymous_variant:LOW:exon7/8:c.1008A>G:p.Ala336=:PF00112 [Papain family cysteine protease],CTSK:ENST00000271651.8:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron6/6:c.784+317A>G::,CTSK:ENST00000676970.1:synonymous_variant:LOW:exon7/8:c.843A>G:p.Ala281=:PF00112 [Papain family cysteine protease],CTSK:ENST00000677887.1:synonymous_variant:LOW:exon8/9:c.873A>G:p.Ala291=:PF00112 [Papain family cysteine protease],CTSK:ENST00000679260.1:synonymous_variant:LOW:exon6/7:c.612A>G:p.Ala204=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676824.1:synonymous_variant:LOW:exon8/9:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease]		601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]	1166561 [benign DISEASE=not provided,Pyknodysostosis];			rs10788796	0.97615	0.92459,0.98645,0.99114,0.99888,0.97658	72569,	3402	3630	-7.3880	1.90			/1.0>2.4/0.0>0.0		CTSK|0.05|0.05|0.00|0.00|46|-2|-11|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	150807005	150807005	T	C	het	wt	wt	off-target	QUAL=166;DP=94,16,11;AF=0.26,0.00,0.00;MQM=46;SAP=55;ABP=52;SAR=24;SAF=0	CTSK	5'UTR,intron	CTSK:ENST00000678337.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-164A>G::,CTSK:ENST00000676966.1:intron_variant:MODIFIER:intron1/7:c.-2+125A>G::,CTSK:ENST00000443913.2:intron_variant:MODIFIER:intron1/7:c.177-199A>G::,CTSK:ENST00000271651.8:intron_variant:MODIFIER:intron1/7:c.-1-199A>G::,CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron1/6:c.-1-199A>G::,CTSK:ENST00000676970.1:intron_variant:MODIFIER:intron1/7:c.-1-199A>G::,CTSK:ENST00000677887.1:intron_variant:MODIFIER:intron2/8:c.42-199A>G::,CTSK:ENST00000679260.1:intron_variant:MODIFIER:intron1/6:c.-1-199A>G::,CTSK:ENST00000676824.1:intron_variant:MODIFIER:intron2/8:c.-1-199A>G::	regulatory_region_variant:promoter	601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]			(TC)n (Simple_repeat)	rs10648774	0.00254	0.00030,0.00037,0.00042,0.00209,0.00048	2,	349	138529	-2.2240	3.16			/0.0>0.0/0.0>0.0		CTSK|0.00|0.00|0.00|0.00|11|41|-48|41		13	1099	0	0 / 0					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), ARNT (inh=n/a oe_syn=0.95 oe_mis=0.70 oe_lof=0.15)
chr1	150808106	150808106	T	C	het	het	wt	off-target	QUAL=1550;DP=102,33,43;AF=0.46,0.61,0.00;MQM=60;SAP=148;ABP=3;SAR=0;SAF=67	CTSK	intron	CTSK:ENST00000271651.8:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676970.1:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000677887.1:intron_variant:MODIFIER:intron1/8:c.-53+108A>G::,CTSK:ENST00000679260.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676824.1:intron_variant:MODIFIER:intron2/8:c.-2+108A>G::	regulatory_region_variant:promoter	601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]				rs4379678	0.07392	0.01409,0.06622,0.18283,0.09372,0.10311	582,	10086	140942	-0.7520	8.02			/3.0>3.4/0.0>5.1		CTSK|0.00|0.00|0.00|0.00|9|-25|1|-24	18366646,32117071,22844403,20628624,22674224	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), ARNT (inh=n/a oe_syn=0.95 oe_mis=0.70 oe_lof=0.15), RNU6-1309P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151341298	151341298	A	G	het	hom	wt		QUAL=6590;DP=285,90,138;AF=0.49,1.00,0.01;MQM=60;SAP=37;ABP=3;SAR=145;SAF=85	RFX5	3'UTR	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292600 [benign DISEASE=MHC class II deficiency];			rs7552906	0.62917	0.62286,0.60618,0.64360,0.65143,0.62334	30201,	35155	56321	0.2160	5.21			/0.0>0.0/0.0>0.0		RFX5|0.00|0.00|0.00|0.00|26|-3|-20|2	31922974	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151341903	151341903	T	C	het	hom	het		QUAL=8320;DP=199,114,158;AF=0.56,1.00,0.47;MQM=60;SAP=420;ABP=4;SAR=270;SAF=30	RFX5	3'UTR	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.6:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:enhancer	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292605 [benign DISEASE=MHC class II deficiency];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.78363	0.83908,0.77422,0.69806,0.77755,0.72220	46919,	25212	32872	-1.7860	1.28			/1.9>1.5/0.0>0.0	COSV51841510	RFX5|0.00|0.00|0.00|0.00|27|-35|27|-5	31922974	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151342811	151342811	G	C	het	het	wt		QUAL=3178;DP=119,138,186;AF=0.49,0.51,0.00;MQM=60;SAP=14;ABP=3;SAR=77;SAF=51	RFX5	missense	RFX5:ENST00000290524.8:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.7:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.6:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain]		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292612 [benign DISEASE=not provided,not specified,MHC class II deficiency];			rs2233854	0.11332	0.03040,0.11279,0.00135,0.17070,0.08668	1332,	14570	134848	1.7820	20.80	0.03	0.08	/0.0>0.0/0.0>0.0	COSV51839208	RFX5|0.00|0.00|0.01|0.00|1|-45|-22|30	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151343685	151343685	G	A	hom	hom	hom		QUAL=13288;DP=189,94,132;AF=1.00,1.00,1.00;MQM=60;SAP=36;ABP=0;SAR=168;SAF=247	RFX5	synonymous	RFX5:ENST00000290524.8:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452671.7:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.6:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	403373 [benign DISEASE=MHC class II deficiency,not specified];			rs1752386	0.97876	0.92515,0.99391,1.00000,0.99982,0.99959	72963,	2965	3231	0.0830	6.86			/0.0>0.0/0.0>0.0		RFX5|0.00|0.00|0.03|0.01|-32|11|21|-4	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152302209	152302209	T	A	hom	hom	hom		QUAL=8567;DP=95,63,107;AF=1.00,1.00,1.00;MQM=60;SAP=180;ABP=0;SAR=59;SAF=206	CCDST,FLG	intron&non_coding_transcript,3'UTR	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-30374T>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-30374T>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG:ENST00000368799.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs1933061	0.99800	0.99937,0.99902,1.00000,0.99628,0.99938	75809,	304	304	-2.4350	0.05			/1.5>0.8/0.0>0.0,/0.2>1.7/5.3>4.4		FLG|0.00|0.00|0.00|0.00|-4|-2|36|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303673	152303673	C	T	het	het	het		QUAL=43767;DP=482,1288,1879;AF=0.48,0.50,0.51;MQM=59;SAP=58;ABP=3;SAR=807;SAF=1023	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28910C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28910C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs77422831	0.15706	0.03423,0.32622,0.56781,0.13546,0.37677	3119,	17606	127972	-2.0090	0.41	0.02	0.08	/0.0>0.0/0.0>0.4,/0.1>0.0/0.0>0.0	COSV64245538	FLG|0.00|0.00|0.00|0.00|-11|23|7|-47	27678121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303901	152303901	C	G	wt	het	het		QUAL=10119;DP=503,1478,2046;AF=0.05,0.19,0.31;MQM=28;SAP=456;ABP=1792;SAR=247;SAF=689	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28682C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28682C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2068C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206244 [benign/likely benign DISEASE=Ichthyosis vulgaris,Dermatitis, atopic, 2,not specified,not provided];			rs75235053	0.02245	0.00303,0.05494,0.10040,0.01971,0.08295	0,	2960	128916	-0.4810	14.34	0.03	0.13	/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>1.5	COSV64238890	FLG|0.00|0.00|0.00|0.00|-30|-1|4|35	29281699,34484176	0	4994	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303983	152303983	C	T	wt	het	het		QUAL=17463;DP=426,1555,2204;AF=0.10,0.22,0.39;MQM=31;SAP=496;ABP=1098;SAR=881;SAF=352	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28600C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28600C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246453 [benign DISEASE=not provided];			rs75448155	0.03555	0.00504,0.08682,0.15385,0.03212,0.11854	0,	4627	125523	1.6980	22.20	0.10	0.16	/0.0>0.0/0.0>0.0	COSV64238118	FLG|0.00|0.00|0.00|0.00|9|-1|-47|42	34484176	0	1590	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304107	152304107	C	G	het	het	het	low_conf_region	QUAL=11137;DP=354,900,632;AF=0.15,0.19,0.69;MQM=33;SAP=49;ABP=367;SAR=390;SAF=272	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28476C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28476C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2274C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274774 [benign DISEASE=not provided];			rs12083389	0.18261	0.35649,0.20083,0.37528,0.08260,0.21790	2272,	17836	100178	0.0220	0.24	0.04	0.06	/2.5>1.9/0.0>0.0,/2.8>3.2/0.0>0.0	COSV64240501	FLG|0.00|0.00|0.00|0.00|-32|-9|-16|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304122	152304122	G	A	wt	het	hom	low_conf_region	QUAL=11633;DP=389,811,430;AF=0.07,0.21,0.98;MQM=31;SAP=145;ABP=602;SAR=410;SAF=209	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28461G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28461G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2289G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274484 [benign DISEASE=not provided];			rs12742178	0.08898	0.06821,0.15583,0.36751,0.07374,0.19772	712,	9196	108730	-2.4390	0.12			/0.0>0.0/0.0>0.0,/2.8>2.8/0.0>0.0	COSV64237396	FLG|0.00|0.00|0.00|0.00|-14|-32|5|-31	34484176	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304150	152304150	G	C	het	het	hom	low_conf_region	QUAL=6392;DP=446,760,318;AF=0.13,0.16,0.98;MQM=33;SAP=254;ABP=1329;SAR=361;SAF=124	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28433G>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28433G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2317G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1225072 [benign DISEASE=not provided];			rs3126075	0.22068	0.50798,0.22382,0.40766,0.07490,0.20917	5466,	15324	92720	-4.9740	0.00	0.01	0.07	/0.0>0.0/2.2>0.0,/0.9>0.0/0.0>0.0	COSV64238703	FLG|0.00|0.00|0.00|0.00|-1|25|0|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304195	152304195	C	T	wt	het	het	low_conf_region	QUAL=1721;DP=612,884,490;AF=0.10,0.13,0.26;MQM=45;SAP=279;ABP=1255;SAR=53;SAF=249	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28388C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28388C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2362C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263753 [benign DISEASE=not provided];			rs7518080	0.05889	0.11967,0.08477,0.22758,0.02510,0.08841	1,	6288	100524	-0.4320	0.21	0.01	0.06	/1.6>1.8/0.0>0.0,/3.3>3.0/0.0>0.0	COSV64235950	FLG|0.00|0.00|0.00|0.00|-14|8|30|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304223	152304223	A	G	het	het	het	low_conf_region	QUAL=7749;DP=523,900,554;AF=0.25,0.14,0.55;MQM=36;SAP=814;ABP=813;SAR=508;SAF=51	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28360A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28360A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2390A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265104 [benign DISEASE=not provided];			rs12728605	0.13766	0.28785,0.16858,0.33098,0.05325,0.18259	24,	16253	102113	-0.2880	1.06	0.01	0.14	/0.0>0.0/0.0>0.0,/7.0>7.4/0.0>0.0	COSV64235956	FLG|0.00|0.00|0.00|0.00|-20|-48|-7|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304296	152304296	C	A	het	het	het	low_conf_region	QUAL=32034;DP=414,1143,673;AF=0.45,0.44,0.86;MQM=57;SAP=56;ABP=100;SAR=548;SAF=725	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28287C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28287C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1237029 [benign DISEASE=not provided];			rs72697000	0.14584	0.03304,0.30022,0.50658,0.13061,0.34889	2021,	17794	127888	-1.4330	6.17	0.06	0.23	/0.6>0.0/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64247197	FLG|0.00|0.00|0.00|0.00|2|0|2|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304395	152304395	A	G	het	het	hom	low_conf_region	QUAL=38504;DP=536,1130,643;AF=0.41,0.47,0.99;MQM=59;SAP=8;ABP=38;SAR=667;SAF=721	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28188A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28188A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1231010 [benign DISEASE=not provided];			rs3126066	0.28608	0.47263,0.37715,0.60666,0.13912,0.40725	8359,	26244	107212	-1.9970	0.22			/0.0>0.0/0.0>0.0	COSV64245547,COSV64251897	FLG|0.00|0.00|0.00|0.00|49|-35|-8|23	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304413	152304413	A	G	het	het	hom	low_conf_region	QUAL=37825;DP=535,1142,635;AF=0.40,0.46,0.99;MQM=59;SAP=12;ABP=50;SAR=648;SAF=723	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28170A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28170A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1272130 [benign DISEASE=not provided];			rs3126067	0.35374	0.69947,0.40740,0.61200,0.14146,0.40927	14148,	24670	96764	-2.0410	0.23			/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>0.2	COSV64247205	FLG|0.00|0.00|0.00|0.00|31|-14|-26|5	29281699,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304579	152304579	C	G	het	het	het	low_conf_region	QUAL=26822;DP=485,855,547;AF=0.38,0.46,0.89;MQM=54;SAP=35;ABP=67;SAR=593;SAF=468	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28004C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28004C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065955	0.34603	0.69227,0.40077,0.59836,0.13859,0.39046	13368,	24748	97300	-0.7110	11.40	0.03	0.10	/0.0>0.0/0.0>4.1,/0.0>0.0/0.0>0.0	COSV64245550	FLG|0.00|0.00|0.00|0.00|30|13|19|-27	29281699,29774148,27535066	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304692	152304692	A	G	het	het	hom		QUAL=45485;DP=534,1063,913;AF=0.46,0.45,0.99;MQM=51;SAP=247;ABP=29;SAR=604;SAF=1033	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27891A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27891A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs3091276	0.30264	0.50959,0.38899,0.61627,0.14491,0.42142	9175,	26245	102759	-1.2340	0.95			/4.7>0.0/0.0>0.0,/1.7>1.2/0.0>0.0	COSV64246356	FLG|0.00|0.00|0.00|0.00|26|-18|26|27	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304833	152304833	G	A	wt	wt	het		QUAL=25937;DP=621,1366,2027;AF=0.00,0.00,0.51;MQM=54;SAP=3;ABP=6;SAR=524;SAF=515	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27750G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27750G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3000G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs34687484	0.00355	0.00097,0.00288,0.00019,0.00543,0.00585	3,	534	151388	-4.7750	0.07			/0.4>0.0/1.9>0.0,/0.0>0.0/0.0>0.0		FLG|0.00|0.00|0.00|0.00|24|-28|36|-5		5	323	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304869	152304869	C	T	het	het	het	low_conf_region	QUAL=47312;DP=577,1340,1989;AF=0.45,0.48,0.48;MQM=59;SAP=4;ABP=25;SAR=914;SAF=940	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27714C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27714C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065956	0.15658	0.03398,0.32622,0.56660,0.13544,0.37841	3146,	17459	127937	-0.3080	0.30			/0.0>0.0/0.0>0.0,/0.0>0.0/1.2>0.0	COSV64237848	FLG|0.00|0.00|0.00|0.00|-12|3|-10|0	29281699,21163515,19733298,24831437,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304920	152304920	T	C	het	het	hom	low_conf_region	QUAL=80837;DP=525,1284,1871;AF=0.45,0.49,0.99;MQM=59;SAP=47;ABP=10;SAR=1478;SAF=1244	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27663T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27663T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302748 [benign DISEASE=not provided];			rs6681433	0.20085	0.12831,0.35757,0.59095,0.15938,0.44005	4067,	22282	121018	-1.1510	0.19			/0.0>0.0/0.0>0.0,/2.2>3.5/0.0>0.0	COSV64251428	FLG|0.00|0.00|0.00|0.00|-1|44|-22|-43	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305078	152305078	G	A	wt	wt	het		QUAL=19211;DP=504,1195,1543;AF=0.00,0.00,0.49;MQM=60;SAP=28;ABP=5;SAR=423;SAF=330	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27505G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27505G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3245G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs35621145	0.01787	0.00421,0.01963,0.02484,0.02327,0.05921	54,	2603	149035	-0.2850	16.54	0.11	0.12	/0.2>3.3/0.9>0.0,/3.7>3.1/0.0>0.0	COSV64237541	FLG|0.00|0.00|0.00|0.00|-16|2|44|-15		32	1235	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305241	152305241	C	A	het	het	hom	low_conf_region	QUAL=41783;DP=297,901,1124;AF=0.35,0.35,1.00;MQM=48;SAP=294;ABP=233;SAR=997;SAF=543	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27342C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27342C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246798 [benign DISEASE=not provided];			rs9436066	0.29942	0.47173,0.38747,0.65088,0.15965,0.43982	8533,	27741	104837	-4.7800	0.06			/0.0>0.0/0.0>0.0,/0.0>0.0/3.7>0.0	COSV64238716	FLG|0.00|0.00|0.00|0.00|-32|-45|19|3	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305346	152305346	T	C	het	wt	hom	low_conf_region	QUAL=8016;DP=324,659,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=293;SAR=390;SAF=0	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27237T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27237T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3513T>C::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174667 [benign DISEASE=not specified,not provided];			rs3126069	0.15763	0.07669,0.30102,0.53663,0.13358,0.35657	2574,	16557	115991	-4.2200	0.79			/0.0>0.0/0.0>0.0,/1.1>1.9/0.0>0.0	COSV64242448,COSV64251192	FLG|0.00|0.00|0.00|0.00|25|-39|44|-1	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305350	152305350	A	C	het	wt	hom	low_conf_region	QUAL=8016;DP=324,659,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=293;SAR=390;SAF=0	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27233A>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27233A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175078 [benign DISEASE=not provided,not specified];			rs2065957	0.26521	0.44829,0.34226,0.57493,0.13514,0.36570	6657,	23041	100727	-1.7610	0.25	0.03	0.04	/0.0>0.0/0.1>1.1,/1.1>0.0/0.0>0.0	COSV64246955	FLG|0.00|0.00|0.00|0.00|-43|-18|9|2	29281699,34833463	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305958	152305958	T	G	het	het	wt	low_conf_region	QUAL=2706;DP=444,490,552;AF=0.23,0.24,0.00;MQM=39;SAP=489;ABP=557;SAR=0;SAF=224	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26625T>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26625T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4125T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175150 [benign DISEASE=not provided,not specified];			rs61816760	0.37261	0.38784,0.33157,0.12050,0.39091,0.31165	607,	39412	68406	-1.9480	0.04	0.02	0.13	/3.0>2.3/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64235961	FLG|0.00|0.00|0.00|0.00|-22|20|21|20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306008	152306008	C	T	wt	wt	het		QUAL=3358;DP=439,705,878;AF=0.00,0.00,0.25;MQM=39;SAP=485;ABP=469;SAR=0;SAF=222	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26575C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26575C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4175C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205931 [benign DISEASE=not specified,not provided];			rs61690342	0.03479	0.09988,0.02271,0.01878,0.01850,0.04476	4,	4620	128396	-2.2770	0.24	0.04	0.09	/1.1>0.3/0.0>0.0,/2.5>0.9/0.0>0.0		FLG|0.00|0.00|0.00|0.00|-2|-9|27|-29		1	1253	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306079	152306079	T	C	het	het	het		QUAL=26875;DP=447,1314,1616;AF=0.25,0.25,0.50;MQM=46;SAP=841;ABP=484;SAR=280;SAF=976	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26504T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26504T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1242222 [benign DISEASE=not provided];			rs80221306	0.15860	0.10189,0.26921,0.41259,0.12912,0.31143	5,	21103	112011	-0.3070	7.29	0.02	0.13	/0.0>0.0/0.0>0.0	COSV64237772	FLG|0.00|0.00|0.00|0.00|-45|46|1|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306213	152306213	C	A	het	het	hom		QUAL=149892;DP=695,2569,3391;AF=0.56,0.56,1.00;MQM=50;SAP=62;ABP=90;SAR=2411;SAF=2786	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26370C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26370C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222401 [benign DISEASE=not provided];			rs57672167	0.23104	0.22993,0.37410,0.60229,0.15931,0.43654	5985,	20434	107850	-4.9140	0.19			/0.0>0.0/0.0>0.0,/0.0>0.0/3.7>0.0	COSV64247949	FLG|0.00|0.00|0.00|0.00|-3|-45|19|3	34833463	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306338	152306338	C	T	wt	het	het	low_conf_region	QUAL=21614;DP=1104,3001,4224;AF=0.09,0.18,0.25;MQM=39;SAP=184;ABP=4882;SAR=662;SAF=1038	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26245C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26245C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4505C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1260709 [benign DISEASE=not provided];			rs2184952	0.03219	0.02973,0.06738,0.19142,0.01725,0.09553	0,	3563	107117	-0.3030	1.83	0.02	0.06	/0.0>0.0/0.0>0.0	COSV64238707	FLG|0.00|0.00|0.00|0.00|-2|50|24|-16		1	1053	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306380	152306380	T	G	het	het	het		QUAL=16092;DP=869,2700,3963;AF=0.22,0.21,0.18;MQM=51;SAP=3;ABP=6162;SAR=733;SAF=722	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26203T>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26203T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246169 [benign DISEASE=not provided];			rs11582087	0.11924	0.03455,0.23792,0.39848,0.10014,0.26370	0,	15921	117599	-0.6650	13.19	0.03	0.52	/2.2>2.4/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64235994	FLG|0.00|0.00|0.00|0.00|8|39|-18|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306543	152306543	G	A	het	het	het		QUAL=8459;DP=1007,2440,4118;AF=0.16,0.19,0.17;MQM=35;SAP=11;ABP=7085;SAR=684;SAF=615	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26040G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26040G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4710G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178454 [benign DISEASE=not provided];			rs57670307	0.09675	0.02465,0.21253,0.37861,0.08299,0.23818	0,	12963	121019	-3.2420	0.77			/0.0>0.0/0.0>0.0,/0.0>0.0/4.6>2.9	COSV64241227,COSV64246502	FLG|0.00|0.00|0.00|0.00|1|-1|36|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307253	152307253	C	T	het	het	hom		QUAL=71392;DP=592,1195,1548;AF=0.47,0.53,0.99;MQM=59;SAP=3;ABP=4;SAR=1215;SAF=1229	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25330C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25330C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302747 [benign DISEASE=not provided];			rs3126072	0.30947	0.51548,0.39568,0.62366,0.16031,0.44398	9449,	27134	102714	-1.6190	1.64	0.02	0.07	/0.0>0.0/0.0>0.0,/3.9>0.0/0.0>0.0	COSV64248815	FLG|0.00|0.00|0.00|0.00|-2|4|41|-11	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307365	152307365	G	C	het	het	hom		QUAL=72706;DP=479,1198,1582;AF=0.49,0.51,1.00;MQM=59;SAP=29;ABP=4;SAR=1130;SAF=1300	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25218G>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25218G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302746 [benign DISEASE=not provided];			rs3126074	0.30109	0.47546,0.39208,0.62110,0.16036,0.44407	8618,	28172	105402	-5.2830	0.00	0.02	0.09	/0.0>0.0/0.6>0.0,/5.6>5.7/0.0>0.0	COSV100910597	FLG|0.00|0.00|0.00|0.00|-1|-5|22|-5	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307444	152307444	A	G	het	het	hom		QUAL=75505;DP=464,1215,1670;AF=0.49,0.53,1.00;MQM=59;SAP=23;ABP=7;SAR=1189;SAF=1343	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25139A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25139A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302745 [benign DISEASE=not provided];			rs55650366	0.20283	0.13382,0.35870,0.59620,0.15938,0.43734	4056,	22438	120068	-1.1930	0.03	0.01	0.05	/3.5>3.5/0.0>0.0,/0.0>0.0/0.6>3.2	COSV64245556	FLG|0.00|0.00|0.00|0.00|-1|-37|-1|24	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307488	152307488	C	T	wt	wt	het		QUAL=22737;DP=631,1226,1675;AF=0.00,0.00,0.52;MQM=60;SAP=23;ABP=10;SAR=394;SAF=483	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25095C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25095C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5655C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265210 [benign DISEASE=not provided];			rs71625199	0.01763	0.00364,0.01955,0.02372,0.02327,0.05791	47,	2576	148776	-9.3410	0.11			/0.4>1.4/0.0>0.0,/0.0>1.3/0.0>0.0	COSV64236421	FLG|0.00|0.00|0.00|0.00|-2|-50|-45|26	29281699,32325630	22	1244	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307556	152307556	T	C	het	het	hom		QUAL=82521;DP=553,1332,1842;AF=0.48,0.51,1.00;MQM=58;SAP=89;ABP=3;SAR=1223;SAF=1554	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25027T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25027T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222131 [benign DISEASE=not provided];			rs71625200	0.20279	0.13396,0.35841,0.59674,0.15934,0.43627	4069,	22510	120486	-1.0410	1.36	0.03	0.06	/0.0>0.0/0.0>0.0	COSV64248823	FLG|0.00|0.00|0.00|0.00|-42|-3|-42|-5	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307694	152307694	C	G	het	het	hom		QUAL=56692;DP=467,1167,1440;AF=0.45,0.44,0.97;MQM=47;SAP=536;ABP=55;SAR=1417;SAF=697	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24889C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24889C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239802 [benign DISEASE=not provided];			rs71625201	0.17945	0.12423,0.30471,0.47990,0.14898,0.36745	1665,	23326	121884	-1.6180	0.20	0.02	0.15	/0.0>0.0/0.0>0.0	COSV64237400	FLG|0.00|0.00|0.00|0.00|-43|12|-16|50	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307789	152307789	C	G	het	het	het		QUAL=34986;DP=503,1103,1086;AF=0.38,0.31,0.86;MQM=38;SAP=534;ABP=54;SAR=1036;SAF=436	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24794C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24794C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265666 [benign DISEASE=not provided];			rs71625202	0.14751	0.03629,0.28050,0.43654,0.14422,0.33326	414,	21156	127046	-0.1640	14.30	0.09	0.13	/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>1.5	COSV64236000	FLG|0.00|0.00|0.00|0.00|-30|-1|4|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307871	152307871	C	T	het	het	het	low_conf_region	QUAL=29908;DP=489,1151,1017;AF=0.35,0.29,0.79;MQM=37;SAP=262;ABP=5;SAR=456;SAF=851	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24712C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24712C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs139476473	0.15172	0.03639,0.29528,0.46147,0.14574,0.35043	1049,	20538	126556	1.6960	22.80	0.14	0.17	/0.0>0.0/0.0>0.0	COSV64236201	FLG|0.00|0.00|0.00|0.00|9|-1|8|-18	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307896	152307896	G	A	het	het	hom		QUAL=41059;DP=516,1117,1043;AF=0.48,0.34,0.99;MQM=36;SAP=1198;ABP=182;SAR=355;SAF=1313	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24687G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24687G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179883 [benign DISEASE=not provided];			rs6664985	0.30010	0.47903,0.38767,0.61707,0.15913,0.43774	8554,	27935	105053	-5.0360	0.07			/4.1>3.4/0.0>0.0,/2.0>2.1/0.0>0.0	COSV64242880	FLG|0.00|0.00|0.00|0.00|-16|47|27|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307995	152307995	C	G	het	het	het	low_conf_region	QUAL=9778;DP=671,1353,1878;AF=0.23,0.14,0.29;MQM=37;SAP=139;ABP=2467;SAR=568;SAF=331	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24588C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24588C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6162C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1286180 [benign DISEASE=not provided];			rs78179835	0.12239	0.14057,0.20764,0.36515,0.07455,0.25633	102,	14442	105024	-1.2630	0.00	0.03	0.05	/2.5>1.9/0.0>0.0,/2.8>3.2/0.0>0.0	COSV64236496	FLG|0.00|0.00|0.00|0.00|1|-1|-16|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308209	152308209	C	A	wt	wt	het	low_conf_region	QUAL=1930;DP=409,1246,1789;AF=0.03,0.06,0.15;MQM=55;SAP=125;ABP=1890;SAR=110;SAF=253	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24374C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24374C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6376C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs544807449	0.00179	0.00856,0.00049,0.00117,0.00006,0.00123	0,	173	96461	-0.0090	9.62	0.17	0.16	/4.7>2.7/0.0>0.0,/1.8>3.0/4.8>0.0	COSV64242592,COSV64251050	FLG|0.00|0.00|0.00|0.00|20|-49|-33|5		0	462	1314	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308211	152308211	C	T	wt	wt	het	low_conf_region	QUAL=1930;DP=409,1246,1789;AF=0.03,0.06,0.15;MQM=55;SAP=125;ABP=1890;SAR=110;SAF=253	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24372C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24372C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6378C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244717 [benign DISEASE=not provided];			rs564482396	0.00206	0.01008,0.00063,0.00130,0.00009,0.00128	0,	194	93928	-0.8000	0.36			/4.7>5.0/0.0>0.0,/1.8>0.8/4.8>7.0	COSV64243287,COSV64244530	FLG|0.00|0.00|0.00|0.00|-2|18|3|18		0	464	1313	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308212	152308212	A	G	wt	wt	het	low_conf_region	QUAL=1930;DP=409,1246,1789;AF=0.03,0.06,0.15;MQM=55;SAP=125;ABP=1890;SAR=110;SAF=253	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24371A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24371A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6379A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1255099 [benign DISEASE=not provided];			rs116918835	0.00212	0.01057,0.00064,0.00135,0.00008,0.00132	0,	197	92835	-1.7780	0.36	0.04	0.06	/4.7>5.1/0.0>0.0,/1.8>2.1/4.8>0.0	COSV64243288	FLG|0.00|0.00|0.00|0.00|17|2|-36|2		0	466	1315	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308215	152308215	A	T	wt	wt	het	low_conf_region	QUAL=1930;DP=409,1246,1789;AF=0.03,0.06,0.15;MQM=55;SAP=125;ABP=1890;SAR=110;SAF=253	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24368A>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24368A>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6382A>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235186 [benign DISEASE=not provided];			rs117945779	0.00710	0.03600,0.00293,0.00144,0.00029,0.00139	0,	648	90562	-1.5680	1.12	0.03	0.04	/4.7>0.0/8.3>7.2,/1.8>0.0/4.8>8.1	COSV64235963	FLG|0.00|0.00|0.00|0.00|-2|14|-1|21		0	482	1316	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308260	152308260	T	C	het	het	het		QUAL=23788;DP=796,1509,2395;AF=0.31,0.18,0.33;MQM=55;SAP=71;ABP=2017;SAR=552;SAF=754	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24323T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24323T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6427T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1287967 [benign DISEASE=not provided];			rs66977240	0.18427	0.30670,0.24821,0.39738,0.09677,0.28366	0,	23242	102886	-1.7600	0.00	0.01	0.07	/0.0>0.0/0.0>0.0,/1.0>0.7/0.0>0.0	COSV64235967	FLG|0.00|0.00|0.00|0.00|6|-31|-46|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308283	152308283	A	G	het	het	het		QUAL=36231;DP=868,1567,2678;AF=0.34,0.23,0.40;MQM=54;SAP=97;ABP=1169;SAR=727;SAF=1001	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24300A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24300A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6450A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1182765 [benign DISEASE=not provided];			rs2338554	0.24199	0.41811,0.28640,0.41733,0.12503,0.31371	2529,	29172	107224	-1.1410	0.51			/0.0>0.0/0.0>0.0	COSV64236535	FLG|0.00|0.00|0.00|0.00|49|-35|-17|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308306	152308306	A	G	het	het	hom		QUAL=131931;DP=896,1658,2793;AF=0.65,0.63,1.00;MQM=57;SAP=49;ABP=415;SAR=2052;SAF=2359	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24277A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24277A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244740 [benign DISEASE=not provided];			rs2184953	0.36960	0.70129,0.42198,0.63265,0.16264,0.45292	14547,	26803	95339	-5.5540	0.14	0.01	0.09	/0.7>1.4/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64235971	FLG|0.00|0.00|0.00|0.00|30|-19|-8|2	29281699,28487959,18434257,27206134,24831437,29774148,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308312	152308312	T	G	het	het	het		QUAL=71710;DP=894,1663,2831;AF=0.31,0.27,0.73;MQM=55;SAP=110;ABP=18;SAR=1210;SAF=1580	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24271T>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24271T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6479T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239242 [benign DISEASE=not provided];			rs66954353	0.23448	0.35279,0.30288,0.42518,0.14128,0.33363	51,	34160	111858	-0.3510	0.66	0.02	0.07	/2.7>2.0/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64236338	FLG|0.00|0.00|0.00|0.00|-38|24|47|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308388	152308388	A	G	het	het	hom		QUAL=112146;DP=517,1519,2571;AF=0.61,0.66,1.00;MQM=55;SAP=3;ABP=377;SAR=1936;SAF=1942	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24195A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24195A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1223320 [benign DISEASE=not provided];			rs2184954	0.30444	0.48063,0.39359,0.63124,0.16105,0.45070	8796,	28321	104897	-3.3990	0.94			/0.0>0.0/0.0>0.0,/2.9>2.3/0.0>0.0	COSV100910603	FLG|0.00|0.00|0.00|0.00|22|-25|27|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308424	152308424	T	G	het	het	het		QUAL=32374;DP=706,1474,2394;AF=0.31,0.30,0.36;MQM=51;SAP=7;ABP=1065;SAR=743;SAF=796	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24159T>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24159T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174419 [benign DISEASE=not provided];			rs74129452	0.22677	0.35327,0.29575,0.42186,0.12690,0.31810	0,	32860	112046	-4.1840	0.01	0.11	0.09	/0.5>0.0/0.9>0.4,/0.0>0.0/0.0>0.0	COSV64235975	FLG|0.00|0.00|0.00|0.00|-9|-32|-9|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308531	152308531	A	G	het	het	het		QUAL=32684;DP=837,1599,2400;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1481;SAR=661;SAF=850	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24052A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24052A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1221916 [benign DISEASE=not provided];			rs7512553	0.22875	0.35878,0.29897,0.42225,0.12606,0.30977	0,	34101	114975	-0.1890	2.22	0.04	0.06	/0.0>0.0/0.0>0.0,/1.3>1.7/0.0>0.0	COSV64247222	FLG|0.00|0.00|0.00|0.00|36|-9|-45|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308532	152308532	A	G	het	het	het		QUAL=32684;DP=837,1599,2400;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1481;SAR=661;SAF=850	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24051A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24051A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179898 [benign DISEASE=not provided];			rs7512554	0.22856	0.35844,0.29841,0.42257,0.12585,0.30874	0,	34116	115152	-2.6100	0.38			/0.0>4.8/0.0>0.0,/1.3>1.3/0.0>0.0	COSV64247223	FLG|0.00|0.00|0.00|0.00|35|-10|-46|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308563	152308563	G	A	het	het	het		QUAL=33614;DP=951,1652,2401;AF=0.30,0.33,0.31;MQM=60;SAP=25;ABP=1479;SAR=727;SAF=853	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24020G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24020G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179724 [benign DISEASE=not provided];			rs7522925	0.22818	0.35916,0.29808,0.42170,0.12533,0.30458	0,	34194	115662	-3.2620	0.04	0.07	0.09	/1.9>0.3/0.0>0.0,/0.0>0.5/0.0>0.0	COSV64245563	FLG|0.00|0.00|0.00|0.00|-41|43|44|-40	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308752	152308752	C	G	het	het	het		QUAL=38193;DP=739,1968,2613;AF=0.25,0.35,0.33;MQM=53;SAP=25;ABP=1397;SAR=801;SAF=935	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23831C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23831C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6154C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266034 [benign DISEASE=not provided];			rs7546186	0.22326	0.34608,0.29529,0.41806,0.12410,0.30350	0,	33363	116073	1.0670	15.34	0.09	0.08	/0.1>5.6/0.0>0.4,/0.0>0.0/1.2>0.0	COSV64238126	FLG|0.00|0.00|0.00|0.00|-7|21|-5|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308814	152308814	A	G	het	het	het		QUAL=35340;DP=671,1996,2598;AF=0.21,0.34,0.33;MQM=51;SAP=15;ABP=1512;SAR=886;SAF=790	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23769A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23769A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6092A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263645 [benign DISEASE=not provided];			rs80353812	0.22510	0.35526,0.29591,0.41890,0.12330,0.30304	0,	33452	115158	-6.8100	0.14			/0.0>0.0/0.0>0.0,/2.2>2.2/0.0>0.0	COSV64245566	FLG|0.00|0.00|0.00|0.00|41|10|-41|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308828	152308828	A	C	het	het	het		QUAL=36822;DP=675,1970,2613;AF=0.25,0.34,0.34;MQM=51;SAP=32;ABP=1395;SAR=931;SAF=780	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23755A>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23755A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266162 [benign DISEASE=not provided];			rs7512857	0.21891	0.33319,0.29380,0.42025,0.12332,0.30255	0,	32559	116177	0.0140	10.79	0.03	0.11	/0.0>0.0/0.0>0.0	COSV64245569	FLG|0.00|0.00|0.00|0.00|27|-22|-3|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308841	152308841	G	T	wt	wt	het		QUAL=21002;DP=798,2034,2648;AF=0.00,0.00,0.34;MQM=60;SAP=20;ABP=598;SAR=492;SAF=408	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23742G>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23742G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6065G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1251416 [benign DISEASE=not provided];			rs71626704	0.01760	0.00371,0.01919,0.02429,0.02320,0.05821	47,	2584	149470	-0.1350	2.51	0.05	0.25	/0.0>0.0/0.0>0.0		FLG|0.00|0.00|0.00|0.00|14|40|-45|-16	29281699,32325630	21	1244	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309003	152309003	G	T	het	het	hom		QUAL=106410;DP=892,1623,1999;AF=0.60,0.68,1.00;MQM=56;SAP=149;ABP=487;SAR=2058;SAF=1565	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23580G>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23580G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278608 [benign DISEASE=not provided];			rs3126079	0.36843	0.70039,0.42088,0.63065,0.16218,0.44707	14548,	26818	95850	-7.0030	0.00	0.02	0.10	/2.5>3.1/0.0>0.0,/1.4>0.0/0.0>0.0	COSV64242281	FLG|0.00|0.00|0.00|0.00|35|-5|-49|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309047	152309047	A	C	het	het	het		QUAL=20209;DP=830,1557,1839;AF=0.19,0.30,0.30;MQM=49;SAP=190;ABP=1835;SAR=743;SAF=426	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23536A>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23536A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5859A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1270895 [benign DISEASE=not provided,not specified];			rs80059102	0.21599	0.34254,0.28853,0.41790,0.11874,0.29711	0,	31205	113269	-1.9190	2.79	0.01	0.07	/4.5>5.5/0.0>0.0,/0.3>0.0/0.0>0.4	COSV100912331,COSV64235980	FLG|0.00|0.00|0.00|0.00|19|-9|19|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309058	152309058	A	T	het	het	het		QUAL=17130;DP=764,1516,1783;AF=0.18,0.28,0.28;MQM=48;SAP=241;ABP=2046;SAR=697;SAF=357	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23525A>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23525A>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5848A>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205946 [benign/likely benign DISEASE=not specified,not provided];			rs113544881	0.20016	0.30045,0.27984,0.41426,0.11481,0.29118	1,	28162	112544	-2.1680	0.06	0.05	0.04	/0.0>1.8/0.0>0.0,/0.3>0.0/0.0>0.0	COSV64235983	FLG|0.00|0.00|0.00|0.00|8|-20|6|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309214	152309214	C	T	het	het	het		QUAL=41100;DP=550,1171,1371;AF=0.47,0.51,0.53;MQM=59;SAP=4;ABP=6;SAR=777;SAF=803	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23369C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23369C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1247656 [benign DISEASE=not provided];			rs12407748	0.15659	0.03410,0.32651,0.56627,0.13556,0.37437	3092,	17513	127639	-2.7720	0.01	0.05	0.07	/0.0>0.0/0.0>0.0,/6.0>2.3/0.0>0.0	COSV64235683	FLG|0.00|0.00|0.00|0.00|-2|-10|-25|-27	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309215	152309215	G	A	wt	wt	het		QUAL=16231;DP=560,1173,1373;AF=0.00,0.00,0.47;MQM=60;SAP=7;ABP=16;SAR=307;SAF=340	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23368G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23368G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5691G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs36006086	0.01792	0.00427,0.01967,0.02506,0.02332,0.05882	48,	2620	148856	-1.2590	18.13	0.04	0.14	/0.0>0.0/0.0>0.0,/6.0>5.9/0.0>0.0	COSV64237885,COSV64241834	FLG|0.00|0.00|0.00|0.00|-11|-26|26|-26		22	1248	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309269	152309269	G	T	wt	wt	het		QUAL=16369;DP=635,1190,1422;AF=0.00,0.00,0.45;MQM=60;SAP=10;ABP=33;SAR=300;SAF=345	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23314G>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23314G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5637G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235678 [benign DISEASE=not provided];			rs62623409	0.01791	0.00424,0.01955,0.02550,0.02330,0.05933	50,	2619	149073	2.7110	11.52	0.04	0.12	/0.6>1.2/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64237889	FLG|0.00|0.00|0.00|0.00|19|42|12|-28	29281699,32325630	23	1241	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309472	152309472	G	A	het	het	het		QUAL=37661;DP=464,1121,1946;AF=0.48,0.51,0.39;MQM=58;SAP=12;ABP=108;SAR=820;SAF=739	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23111G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23111G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1248526 [benign DISEASE=not provided];			rs12405241	0.15677	0.03421,0.32593,0.56768,0.13545,0.37463	3081,	17510	127330	-5.8650	0.15	0.10	0.14	/0.0>0.0/3.2>0.1,/0.0>0.0/0.0>0.0	COSV64247244	FLG|0.00|0.00|0.00|0.00|25|-11|2|-11	33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309616	152309616	T	C	wt	wt	het		QUAL=2587;DP=551,1251,1987;AF=0.01,0.00,0.17;MQM=52;SAP=3;ABP=1910;SAR=172;SAF=165	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22967T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22967T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5290T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs778942937	0.00384	0.00063,0.00443,0.00584,0.00485,0.01473	0,	569	147627	0.5620	15.12	0.03	0.17	/0.0>0.1/0.0>0.0,/0.0>0.0/0.0>0.4	COSV64244851	FLG|0.00|0.00|0.00|0.00|3|-35|-34|-3		0	103	57	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309791	152309791	G	A	het	het	het		QUAL=36543;DP=428,1233,1525;AF=0.47,0.48,0.49;MQM=60;SAP=15;ABP=14;SAR=811;SAF=719	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22792G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22792G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12405278	0.15701	0.03411,0.32618,0.57019,0.13550,0.37657	3128,	17559	127861	-0.0710	19.54	0.05	0.22	/6.5>6.5/0.0>0.0,/0.6>0.2/0.0>0.0	COSV64245576	FLG|0.00|0.00|0.00|0.00|2|-22|2|9	22209813	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309835	152309835	C	T	het	het	het		QUAL=39386;DP=522,1240,1512;AF=0.47,0.48,0.51;MQM=60;SAP=23;ABP=5;SAR=866;SAF=743	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22748C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22748C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407807	0.16648	0.06673,0.32891,0.57023,0.13569,0.37578	3222,	18836	126568	-4.5020	2.50	0.07	0.10	/0.0>0.0/0.0>0.4,/1.8>2.1/0.0>0.0	COSV64247251	FLG|0.00|0.00|0.00|0.00|-8|40|30|-35	33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310046	152310046	C	T	wt	het	wt		QUAL=11284;DP=556,1021,1250;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=6;SAR=229;SAF=264	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22537C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22537C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4860C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]										-1.3830	3.62	0.03	0.14	/0.4>0.0/0.0>0.3,/2.3>1.9/0.0>0.0	COSV64246735	FLG|0.00|0.00|0.00|0.00|-8|3|-8|5		0	1	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310318	152310318	G	A	wt	wt	het		QUAL=16970;DP=443,1156,1468;AF=0.00,0.00,0.48;MQM=60;SAP=3;ABP=6;SAR=351;SAF=359	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22265G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22265G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4588G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1293919 [benign DISEASE=not provided];			rs12750081	0.01785	0.00418,0.01966,0.02463,0.02329,0.05886	50,	2612	149214	-0.5980	7.59	0.01	0.15	/0.0>0.0/0.7>5.8,/0.5>1.6/0.0>0.0	COSV64247535	FLG|0.00|0.00|0.00|0.00|-8|21|36|-47		24	1241	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310434	152310434	G	C	wt	wt	het		QUAL=18595;DP=493,1078,1495;AF=0.00,0.00,0.49;MQM=60;SAP=10;ABP=4;SAR=345;SAF=393	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22149G>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22149G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4472G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278160 [benign DISEASE=not provided];			rs71626706	0.01778	0.00376,0.01973,0.02482,0.02334,0.05893	50,	2593	148765	-4.7510	0.00	0.05	0.10	/0.0>0.4/0.0>0.0,/0.0>0.0/4.6>2.6	COSV64250380	FLG|0.00|0.00|0.00|0.00|-1|-7|36|-1	29281699	24	1248	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310441	152310441	G	T	het	het	het		QUAL=38135;DP=485,1076,1525;AF=0.49,0.50,0.50;MQM=59;SAP=11;ABP=3;SAR=807;SAF=730	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22142G>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22142G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1277512 [benign DISEASE=not provided];			rs11204978	0.15633	0.03399,0.32565,0.56680,0.13528,0.37279	3082,	17505	127733	0.0040	12.42	0.06	0.19	/0.0>0.0/0.0>5.9,/0.0>0.0/0.0>0.0	COSV64247255	FLG|0.00|0.00|0.00|0.00|-14|3|-36|29	29281699,29774148,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310476	152310476	A	G	wt	wt	het		QUAL=19719;DP=552,1144,1572;AF=0.00,0.00,0.49;MQM=60;SAP=15;ABP=5;SAR=352;SAF=417	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22107A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22107A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4430A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1241427 [benign DISEASE=not provided];			rs12732920	0.01781	0.00376,0.01963,0.02540,0.02328,0.06018	48,	2603	148881	-7.1290	0.15			/0.0>0.0/0.0>0.0,/1.2>0.1/0.0>0.0		FLG|0.00|0.00|0.00|0.00|38|-32|-43|2		24	1242	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310577	152310577	G	A	wt	wt	het		QUAL=20720;DP=589,1201,1688;AF=0.00,0.00,0.49;MQM=60;SAP=3;ABP=5;SAR=416;SAF=412	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22006G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22006G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4329G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	916211 [likely benign DISEASE=not provided];			rs12750571	0.00477	0.00118,0.00609,0.00019,0.00701,0.00644	4,	717	151249	0.4170	22.40	0.04	0.13	/0.1>0.9/0.0>0.0,/0.8>2.4/0.0>0.0	COSV105827350	FLG|0.00|0.00|0.00|0.00|-24|-42|-7|-23		5	505	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310760	152310760	T	C	het	het	hom		QUAL=76329;DP=534,1306,1686;AF=0.49,0.49,0.99;MQM=55;SAP=6;ABP=6;SAR=1317;SAF=1255	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21823T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21823T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178727 [benign DISEASE=not provided];			rs11581433	0.20233	0.13281,0.35773,0.59648,0.15922,0.43656	4077,	22549	121045	-3.1550	0.00	0.01	0.05	/0.0>0.0/0.0>0.0,/1.4>2.2/0.0>0.0	COSV64246547	FLG|0.00|0.00|0.00|0.00|-7|-19|5|12	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310807	152310807	C	T	het	het	het		QUAL=40233;DP=527,1248,1664;AF=0.49,0.50,0.49;MQM=54;SAP=12;ABP=4;SAR=890;SAF=807	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21776C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21776C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1253040 [benign DISEASE=not provided];			rs11586631	0.15725	0.03455,0.32571,0.56987,0.13547,0.37599	3117,	17592	127692	-3.9920	0.02	0.02	0.08	/0.0>0.0/0.0>0.4,/1.8>2.1/0.0>0.0	COSV64245581	FLG|0.00|0.00|0.00|0.00|-11|34|35|-9	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311386	152311386	G	C	het	het	hom		QUAL=65118;DP=547,1108,1466;AF=0.48,0.50,1.00;MQM=54;SAP=4;ABP=3;SAR=1156;SAF=1123	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21197G>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21197G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1298018 [benign DISEASE=not provided];			rs58001094	0.36545	0.69777,0.41794,0.62361,0.16167,0.44372	14267,	26645	95809	-2.4700	0.03	0.05	0.05	/0.0>0.0/4.1>0.0,/0.0>0.0/0.0>0.0	COSV64238211	FLG|0.00|0.00|0.00|0.00|-47|19|-27|19	29281699,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311499	152311499	A	G	het	het	hom		QUAL=75713;DP=597,1211,1701;AF=0.51,0.50,1.00;MQM=52;SAP=15;ABP=4;SAR=1244;SAF=1365	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21084A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21084A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1245184 [benign DISEASE=not provided];			rs66831674	0.30112	0.47542,0.39117,0.62096,0.16025,0.44340	8653,	28269	105779	-2.6140	0.53			/4.7>0.0/0.0>0.0,/1.7>1.2/0.0>0.0	COSV64248837	FLG|0.00|0.00|0.00|0.00|26|-18|26|27	29281699,34224231	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311901	152311901	G	A	het	wt	het		QUAL=30538;DP=619,1317,1585;AF=0.53,0.02,0.54;MQM=56;SAP=3;ABP=32;SAR=612;SAF=602	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20682G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20682G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs373872833	0.00010	0.00007,0.00081,0.00000,0.00000,0.00000	0,	15	149535	-1.2540	0.12			/0.0>0.0/0.0>0.0,/3.2>3.2/0.0>0.0	COSV64236179	FLG|0.00|0.00|0.00|0.00|-14|-47|5|28		0	4	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311948	152311948	G	C	wt	wt	het		QUAL=21820;DP=734,1325,1653;AF=0.02,0.04,0.51;MQM=55;SAP=85;ABP=5;SAR=363;SAF=549	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20635G>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20635G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2958G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	402869 [benign DISEASE=not specified,not provided];			rs12756586	0.02505	0.02614,0.02305,0.02876,0.02402,0.07093	52,	3345	134223	-3.1850	0.00	0.02	0.04	/0.0>0.0/0.0>0.0	COSV64236115	FLG|0.00|0.00|0.00|0.00|34|-11|34|12	24033266,29281699	24	1315	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312002	152312002	A	G	wt	wt	het	low_conf_region	QUAL=516;DP=548,1322,1821;AF=0.01,0.07,0.13;MQM=39;SAP=114;ABP=2154;SAR=101;SAF=231	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20581A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20581A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2904A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1200762 [likely benign DISEASE=not specified,not provided];			rs199888588	0.02219	0.08026,0.01554,0.01835,0.00304,0.02795	0,	2695	118737	-1.9140	0.11	0.02	0.12	/0.0>0.0/0.0>0.0,/7.0>7.4/0.0>0.0	COSV64239582	FLG|0.00|0.00|0.00|0.00|-20|-42|49|-20		0	450	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312021	152312021	A	G	wt	wt	het	low_conf_region	QUAL=2113;DP=520,1345,1949;AF=0.02,0.07,0.16;MQM=40;SAP=13;ABP=2013;SAR=181;SAF=225	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20562A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20562A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2885A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs144437056	0.03247	0.12050,0.02149,0.02799,0.00428,0.02973	0,	3836	114286	-5.4140	0.18			/0.0>0.0/0.0>0.0	COSV64248679	FLG|0.00|0.00|0.00|0.00|-39|-5|-39|-17		0	238	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312029	152312029	C	G	wt	wt	het		QUAL=2702;DP=547,1378,2013;AF=0.02,0.07,0.16;MQM=41;SAP=5;ABP=2001;SAR=209;SAF=227	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20554C>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20554C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2877C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206179 [benign DISEASE=not specified,not provided];			rs201137357	0.04679	0.17200,0.02951,0.02567,0.00464,0.03102	55,	5530	114898	-0.1500	12.90	0.06	0.09	/0.0>0.0/0.0>0.0,/0.0>0.0/3.4>0.1	COSV64235720	FLG|0.00|0.00|0.00|0.00|-47|22|38|-47		0	264	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312065	152312065	G	A	wt	wt	het		QUAL=6;DP=531,1439,2155;AF=0.00,0.00,0.13;MQM=45;SAP=8;ABP=2612;SAR=149;SAF=125	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20518G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20518G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2841G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs138002269	0.00142	0.00029,0.00120,0.00039,0.00192,0.00612	0,	212	149164	-0.4950	18.67	0.05	0.19	/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>3.8	COSV64245372,COSV64246254	FLG|0.00|0.00|0.00|0.00|39|7|2|-14		0	793	21	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312100	152312100	C	A	wt	wt	het		QUAL=1864;DP=587,1432,2121;AF=0.03,0.05,0.15;MQM=43;SAP=110;ABP=2310;SAR=269;SAF=129	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20483C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20483C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2806C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206107 [likely benign DISEASE=not provided];			rs143382793	0.01408	0.06004,0.00655,0.00467,0.00143,0.00863	0,	1725	120833	-0.6740	15.32	0.03	0.10	/0.6>2.2/0.0>0.0,/0.0>0.0/2.1>0.0	COSV64242745	FLG|0.00|0.00|0.00|0.00|14|5|-33|5		0	1071	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312121	152312121	A	C	wt	wt	het		QUAL=198;DP=527,1428,2115;AF=0.02,0.04,0.12;MQM=43;SAP=117;ABP=2595;SAR=232;SAF=100	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20462A>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20462A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2785A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	2345585 [likely benign DISEASE=Inborn genetic diseases];			rs201928359	0.00877	0.03829,0.00334,0.00173,0.00082,0.00453	0,	1088	122926	-1.6050	2.17	0.02	0.09	/0.0>0.3/0.0>0.0,/4.7>7.4/0.0>0.0	COSV64236204	FLG|0.00|0.00|0.00|0.00|-1|-7|-1|-16		0	409	139	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312378	152312378	A	G	het	het	hom		QUAL=57616;DP=489,879,1251;AF=0.48,0.51,0.99;MQM=59;SAP=23;ABP=3;SAR=1030;SAF=898	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20205A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20205A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1230019 [benign DISEASE=not provided];			rs3120653	0.31046	0.50756,0.39750,0.62168,0.16108,0.44147	9079,	28150	102852	-2.3270	0.35			/0.0>0.0/0.0>0.0,/0.0>0.0/2.9>4.6	COSV104425295,COSV64244277	FLG|0.00|0.00|0.00|0.00|35|36|-1|36	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312623	152312623	C	T	het	het	hom		QUAL=86336;DP=494,1422,1885;AF=0.51,0.50,1.00;MQM=60;SAP=24;ABP=3;SAR=1337;SAF=1504	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19960C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19960C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.48C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	377878 [benign DISEASE=not specified];			rs74129461	0.18570	0.07725,0.34957,0.58872,0.15900,0.43326	3756,	20635	123423	-0.4630	12.23	0.03	0.12	/0.0>0.0/0.0>0.0	COSV64248843	FLG|0.00|0.00|0.00|0.00|-4|-1|15|-16	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312705	152312705	G	T	wt	wt	het		QUAL=22887;DP=478,1379,1844;AF=0.00,0.00,0.48;MQM=60;SAP=32;ABP=7;SAR=502;SAF=393	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19878G>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19878G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2201G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516 [Filaggrin],CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.130G>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs7512779	0.01788	0.00423,0.01964,0.02482,0.02331,0.05902	51,	2615	149239	-4.9160	0.00	0.01	0.18	/5.7>4.5/0.0>0.0,/2.2>0.9/0.0>1.3		FLG|0.00|0.00|0.00|0.00|10|-20|4|-49		24	1242	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313454	152313454	G	A	het	het	hom		QUAL=70555;DP=533,1179,1572;AF=0.51,0.50,0.99;MQM=60;SAP=9;ABP=3;SAR=1170;SAF=1251	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19129G>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19129G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.879G>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666623 [benign DISEASE=not specified,not provided];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.20336	0.13809,0.35760,0.59212,0.15901,0.43531	4065,	22639	120535	-1.8060	0.00	0.04	0.04	/0.0>0.0/0.0>0.0	COSV64239594	FLG|0.00|0.00|0.00|0.00|-32|18|19|35	29281699,28866311,18193244,29774148,24521637,32325630	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313526	152313526	T	C	het	het	hom		QUAL=68650;DP=466,1154,1580;AF=0.48,0.49,0.99;MQM=60;SAP=6;ABP=6;SAR=1148;SAF=1207	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19057T>C::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19057T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.951T>C::,CCDST:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666624 [benign DISEASE=not specified,not provided];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.30250	0.47837,0.39363,0.62406,0.16023,0.44412	8757,	28312	105664	-1.3090	0.74	0.08	0.06	/0.0>0.0/0.2>3.9,/1.0>1.7/0.0>0.0	COSV64245598	FLG|0.00|0.00|0.00|0.00|-37|-11|5|-10	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313556	152313556	C	T	het	het	het		QUAL=40843;DP=568,1213,1564;AF=0.48,0.50,0.46;MQM=60;SAP=5;ABP=17;SAR=816;SAF=782	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19027C>T::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19027C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.981C>T::,CCDST:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1249558 [benign DISEASE=not provided];			rs11588170	0.15667	0.03399,0.32614,0.56684,0.13549,0.37573	3090,	17551	127743	-0.3500	14.31	0.04	0.15	/4.1>3.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64247273	FLG|0.00|0.00|0.00|0.00|-2|20|4|-40	29281699,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313650	152313650	A	G	het	het	wt		QUAL=20702;DP=469,1206,1523;AF=0.50,0.50,0.00;MQM=60;SAP=4;ABP=3;SAR=426;SAF=409	CCDST,FLG	intron&non_coding_transcript,synonymous,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18933A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18933A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1075A>G::,CCDST:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1259919 [benign DISEASE=not specified,not provided];			rs11582620	0.09138	0.02137,0.07856,0.10036,0.12352,0.19836	914,	12006	137552	-4.6310	0.81			/5.5>5.9/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64236548	FLG|0.00|0.00|0.00|0.00|-18|2|-19|28	29281699,21163515,27206134,19733298,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313891	152313891	C	A	het	het	hom		QUAL=59587;DP=573,911,1283;AF=0.51,0.50,1.00;MQM=60;SAP=142;ABP=3;SAR=1195;SAF=834	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18692C>A::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18692C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1316C>A::,CCDST:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs41267154	0.20087	0.12847,0.35645,0.59330,0.15901,0.43529	4024,	22448	121326	-0.4760	14.12	0.02	0.19	/0.0>0.0/0.0>0.0	COSV64246426	FLG|0.00|0.00|0.00|0.00|-7|38|2|38	29281699,34224231,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152314866	152314866	T	-	het	het	hom	off-target;low_conf_region	QUAL=1886;DP=96,17,39;AF=0.46,0.47,0.92;MQM=60;SAP=194;ABP=5;SAR=88;SAF=0	CCDST,FLG	intron&non_coding_transcript,intron,non_coding_transcript_exon	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-17706del::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-17706del::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-29del::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron2/2:c.139-119del::,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.1717del::,CCDST:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.834del::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1288712 [benign DISEASE=not provided];			rs34224823	0.19533	0.04474,0.36278,0.60726,0.18422,0.44437	4020,	20513	117623	-0.2050	0.57			/6.1>6.2/0.0>0.0,/0.0>0.0/0.0>0.0		FLG|0.00|0.00|0.00|0.00|-28|-29|-28|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152325041	152325041	A	G	het	het	hom	off-target	QUAL=3603;DP=143,26,47;AF=0.51,0.62,1.00;MQM=60;SAP=298;ABP=4;SAR=0;SAF=136	CCDST,FLG	intron&non_coding_transcript,intron	CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-7542A>G::,CCDST:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-7542A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.515-7542A>G::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron1/2:c.-22+148T>C::,CCDST:ENST00000665223.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.1798-7542A>G::,CCDST:ENST00000392688.7:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.915-7542A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407553	0.20224	0.13283,0.35746,0.59605,0.15901,0.43548	4061,	22559	121027	0.1790	5.10			/8.0>8.2/0.0>0.0,/3.1>3.0/0.0>0.0		FLG|0.00|0.00|0.00|0.00|29|-5|50|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154156196	154156196	G	A	wt	het	wt		QUAL=803;DP=183,87,125;AF=0.01,0.46,0.00;MQM=60;SAP=6;ABP=4;SAR=17;SAF=25	TPM3	3'UTR	TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs4540651	0.61155	0.74120,0.66689,0.89437,0.50739,0.66390	29444,	34008	59006	0.0330	1.28			/0.0>0.0/0.1>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154156789	154156789	A	G	wt	het	wt		QUAL=131;DP=106,11,19;AF=0.00,0.73,0.00;MQM=60;SAP=7;ABP=8;SAR=6;SAF=2	TPM3	3'UTR	TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000330188.13:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]				rs1051370	0.30584	0.14125,0.45307,0.44068,0.34073,0.37231	8025,	30453	105547	-0.3650	9.61			/1.6>1.4/0.0>0.0			18957677,20022891,23196875,24388127,26981122,27805284,18957674,33173933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154162081	154162081	A	C	wt	het	wt		QUAL=1944;DP=464,218,366;AF=0.00,0.44,0.00;MQM=60;SAP=22;ABP=11;SAR=63;SAF=34	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	292625 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs3196889	0.30235	0.13936,0.45254,0.44039,0.33646,0.37095	7823,	30283	105979	0.3690	5.62			/5.2>5.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165752	154165752	G	A	wt	het	wt		QUAL=640;DP=198,37,58;AF=0.01,0.76,0.00;MQM=60;SAP=36;ABP=24;SAR=4;SAF=25	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	292666 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs10908723	0.31959	0.15101,0.48469,0.44984,0.34318,0.38059	7583,	29370	94818	-0.0240	2.22			/0.6>0.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165790	154165790	A	-	het	het	het		QUAL=1014;DP=147,29,44;AF=0.20,0.21,0.27;MQM=59;SAP=68;ABP=155;SAR=5;SAF=43	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	292667 [likely benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs68185418	0.23840	0.33772,0.16524,0.41911,0.18218,0.20544	1418,	16735	62523	-0.4990	0.20			/4.0>4.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166689	154166689	-	T	wt	het	wt		QUAL=118;DP=183,36,38;AF=0.12,0.00,0.08;MQM=60;SAP=8;ABP=350;SAR=11;SAF=5	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	292677 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs72189266	0.43143	0.43827,0.56270,0.51065,0.39260,0.52804	13897,	35940	83994		6.06			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166690	154166690	T	-	het	wt	wt		QUAL=118;DP=183,36,38;AF=0.03,0.31,0.00;MQM=60;SAP=23;ABP=232;SAR=20;SAF=5	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs72189266	0.00039	0.00005,0.00054,0.00000,0.00042,0.00021	0,	57	147745	0.8190	5.50			/0.0>0.0/0.0>0.0				0	14	0	0 / 0					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166905	154166905	A	C	wt	het	wt		QUAL=547;DP=151,62,71;AF=0.01,0.44,0.01;MQM=60;SAP=16;ABP=5;SAR=8;SAF=21	TPM3	intron,3'UTR	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	292682 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSx1 (SINE/Alu)	rs6673171	0.30350	0.14225,0.45321,0.44038,0.33649,0.37324	7855,	30375	105761	0.7390	4.45			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154169432	154169432	A	G	wt	het	wt	off-target	QUAL=3050;DP=183,250,303;AF=0.00,0.50,0.00;MQM=60;SAP=50;ABP=3;SAR=88;SAF=36	TPM3	intron	TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:ENST00000611659.5:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000651641.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:ENST00000368530.7:intron_variant:MODIFIER:intron8/9:c.776-49T>C::		191030_[GENE=TPM3_PHENOS=Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive]	262627 [benign DISEASE=not provided,not specified,Congenital myopathy 4B, autosomal recessive,Congenital myopathy with fiber type disproportion];			rs4845364	0.62745	0.80446,0.67927,0.88088,0.50334,0.66584	31338,	32644	56596	1.1000	18.83			/0.9>1.1/0.0>0.0		TPM3|0.00|0.01|0.00|0.00|-7|-49|-49|-47	25741868,32317632	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154272666	154272666	T	G	wt	wt	het		QUAL=2989;DP=383,167,244;AF=0.00,0.02,0.50;MQM=60;SAP=3;ABP=3;SAR=66;SAF=61	HAX1	5'UTR	HAX1:ENST00000696932.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-58T>G::,HAX1:ENST00000457918.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000696938.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000696941.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-113T>G::,HAX1:ENST00000328703.12:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000697830.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-63T>G::,HAX1:ENST00000697592.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-142T>G::	regulatory_region_variant:promoter	605998_[GENE=HAX1_PHENOS=Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive]	292700 [benign DISEASE=Kostmann syndrome,not provided];			rs11265425	0.21718	0.05240,0.16182,0.44324,0.28522,0.17894	4607,	23808	119030	-2.1040	2.40			/0.0>0.0/0.0>0.0	COSV55171217	HAX1|0.00|0.00|0.01|0.00|-13|-3|37|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBAP2L (inh=n/a oe_syn=1.01 oe_mis=0.62 oe_lof=0.03), HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154576245	154576245	T	C	hom	hom	het		QUAL=8997;DP=115,126,109;AF=0.98,1.00,0.51;MQM=60;SAP=12;ABP=3;SAR=165;SAF=130	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072660	0.70608	0.56294,0.75874,0.73544,0.76773,0.80141	38418,	30466	44666	-2.5390	0.27			/0.0>0.0/1.3>2.4		CHRNB2|0.00|0.00|0.00|0.00|-50|15|2|-5	21467728,17373692,18593715,15154117,17503330,18534558,18571741,19259974,19760673,20854418,25036316,21606948,16314871,20736995,22180580,23691092,24667010,25640319,25778907,23350800,24486638,26301171,24057800,24569419,25774163,25259584,23264444,28054193,19698703,19665479,19854014,33217458,35213538	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576404	154576404	G	A	wt	wt	het		QUAL=1186;DP=77,62,106;AF=0.01,0.02,0.48;MQM=60;SAP=3;ABP=3;SAR=25;SAF=28	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072661	0.25335	0.28048,0.23365,0.28102,0.23781,0.19971	4804,	28896	113476	0.5620	5.30			/0.0>0.0/0.4>5.8		CHRNB2|0.00|0.00|0.00|0.00|27|-37|-3|-37	22992668,21808284,25819021,18593715,18165968,15154117,17503330,18534558,19859904,20854418,25036316,21606948,20736995,22180580,23691092,24667010,25778907,19238175,19482438,19755656,20981002,22103610,22290489,23249876,23943838,29196725,18618000,24065931,23350800,24486638,26301171,22002450,24569419,24428733,23824835,34413872	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576994	154576994	T	C	wt	wt	het		QUAL=3420;DP=302,241,299;AF=0.00,0.00,0.45;MQM=60;SAP=17;ABP=10;SAR=53;SAF=82	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs12130403	0.29788	0.28584,0.27869,0.29098,0.30732,0.23074	6706,	31846	106678	-0.0680	6.02			/7.8>7.7/0.0>0.0		CHRNB2|0.00|0.05|0.00|0.00|-43|12|18|12	31832568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154578468	154578469	AG	-	wt	wt	het		QUAL=3333;DP=272,213,268;AF=0.00,0.00,0.49;MQM=60;SAP=23;ABP=4;SAR=83;SAF=48	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	regulatory_region_variant:enhancer	118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs3841062	0.26994	0.27781,0.21650,0.29189,0.27057,0.21420	5508,	29993	110911	0.4920	1.36			/0.0>0.0/0.0>0.0		CHRNB2|0.00|0.00|0.00|0.00|41|-34|35|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154579534	154579534	C	G	het	het	wt		QUAL=8453;DP=297,338,413;AF=0.56,0.48,0.00;MQM=60;SAP=3;ABP=4;SAR=162;SAF=165	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs1049998302	0.00001	0.00000,0.00000,0.00000,0.00003,0.00000	0,	2	152176	-0.4080	1.19			/9.1>8.7/0.0>0.0		CHRNB2|0.00|0.00|0.00|0.00|-29|17|22|-31		0	4	0	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155234893	155234893	A	G	wt	het	wt		QUAL=74;DP=52,18,27;AF=0.00,0.56,0.00;MQM=27;SAP=25;ABP=3;SAR=0;SAF=10	GBA1	3'UTR	GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs368275143	0.01941	0.06527,0.01527,0.00203,0.00718,0.01408	14,	235	13287	1.0560	6.97			/0.0>0.0/3.7>4.1		GBA|0.00|0.00|0.00|0.00|-16|6|-16|0		14	199	0	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155234903	155234903	C	T	wt	het	wt		QUAL=122;DP=51,24,31;AF=0.00,0.58,0.00;MQM=28;SAP=33;ABP=4;SAR=0;SAF=14	GBA1	3'UTR	GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	1809693 [likely benign DISEASE=Gaucher disease perinatal lethal,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Gaucher disease type II,Lewy body dementia,Parkinson disease, late-onset,Gaucher disease type III,Gaucher disease type I];			rs708606	0.00705	0.00468,0.00970,0.00347,0.00822,0.01458	1,	127	18171	0.5230	6.12			/0.0>0.0/0.0>0.0	COSV59168994	GBA|0.00|0.00|0.00|0.00|-4|-26|-26|-50	31077260	14	146	0	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155235878	155235878	G	T	hom	hom	hom	off-target;low_conf_region	QUAL=21552;DP=149,253,338;AF=0.98,1.00,1.00;MQM=56;SAP=760;ABP=0;SAR=622;SAF=115	GBA1	intron	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::	regulatory_region_variant:enhancer	606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	256871 [benign DISEASE=not specified,not provided,Gaucher disease,Gaucher disease perinatal lethal,Gaucher disease type I];			rs3115534	0.95312	0.84067,0.98277,0.99961,0.99804,0.99854	68942,	5961	7075	0.1160	1.83			/0.0>0.0/0.0>0.0		GBA|0.01|0.04|0.00|0.00|-34|5|42|40	25741868,23418865	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155237596	155237596	A	T	het	het	wt	off-target	QUAL=4087;DP=193,140,175;AF=0.52,0.54,0.00;MQM=54;SAP=335;ABP=5;SAR=170;SAF=6	GBA1	splice_region&intron	GBA1:ENST00000368373.8:splice_region_variant&intron_variant:LOW:intron6/10:c.762-18T>A::,GBA1:ENST00000327247.9:splice_region_variant&intron_variant:LOW:intron7/11:c.762-18T>A::,GBA1:ENST00000427500.7:splice_region_variant&intron_variant:LOW:intron5/9:c.615-18T>A::,GBA1:ENST00000428024.3:splice_region_variant&intron_variant:LOW:intron5/9:c.501-18T>A::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	198756 [benign/likely benign DISEASE=Inborn genetic diseases,not specified,not provided,Gaucher disease type I,Gaucher disease type II,Gaucher disease type III,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Lewy body dementia,Gaucher disease perinatal lethal,Parkinson disease, late-onset];			rs140335079	0.00862	0.00270,0.01223,0.00019,0.01329,0.00249	6,	1300	150916	0.7750	7.07			10.8>7.9/10.8>7.9/0.0>0.0		GBA|0.01|0.03|0.00|0.00|-2|-18|-17|-35	25741868,32714263,34380910	5	759	0	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155238856	155238856	T	C	hom	hom	hom	off-target	QUAL=3492;DP=46,35,46;AF=1.00,1.00,1.00;MQM=51;SAP=270;ABP=0;SAR=126;SAF=1	GBA1	intron	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron4/10:c.455-206A>G::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron5/11:c.455-206A>G::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron3/9:c.308-206A>G::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron3/9:c.194-206A>G::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs7416991	0.56930	0.30382,0.63379,0.29572,0.70261,0.64185	27027,	32389	65397	0.3340	4.30			/0.0>0.0/0.0>0.0		GBA|0.02|0.00|0.00|0.00|5|-27|5|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155752715	155752715	C	G	hom	hom	het	off-target	QUAL=890;DP=31,3,3;AF=1.00,1.00,0.67;MQM=48;SAP=81;ABP=4;SAR=36;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::					AluJr (SINE/Alu)	rs12134456	0.25698	0.05941,0.22098,0.00406,0.37734,0.20377	6621,	25799	112881	-0.3730	0.77			/0.0>0.0/2.4>0.0		GON4L|0.00|0.00|0.00|0.01|-16|-32|-43|5	31152163,31578528,32888493,31676860,35810165	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155754524	155754524	G	T	het	het	wt	off-target;low_conf_region	QUAL=204;DP=61,48,86;AF=0.39,0.10,0.03;MQM=50;SAP=72;ABP=55;SAR=32;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::					AluSg (SINE/Alu)	rs200722936	0.00043	0.00016,0.00055,0.00060,0.00050,0.00115	0,	43	98949	0.1270	1.70			/0.0>0.0/0.0>0.0	COSV55185833	GON4L|0.00|0.00|0.00|0.00|-11|-39|-40|-36		2	251	0	0 / 0					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767594	155767594	C	T	hom	hom	hom	off-target	QUAL=8275;DP=39,118,156;AF=1.00,1.00,1.00;MQM=45;SAP=153;ABP=0;SAR=230;SAF=83	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::						rs849712	0.93651	0.77802,0.97609,1.00000,0.99952,0.99896	67305,	7491	9633	-0.1340	3.66			/0.0>0.0/0.0>0.0		GON4L|0.12|0.00|0.00|0.00|8|0|-22|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767635	155767638	ACAC	-	hom	hom	hom	off-target	QUAL=5155;DP=49,79,107;AF=0.86,0.86,0.90;MQM=52;SAP=450;ABP=0;SAR=206;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::					(AC)n (Simple_repeat)	rs3831996	0.51896	0.28110,0.58138,0.29106,0.63950,0.58751	21767,	34052	71918	0.5100	1.23			/2.9>1.2/0.0>0.0		GON4L|0.01|0.00|0.00|0.00|-32|-8|13|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155776550	155776550	T	-	hom	hom	hom	off-target;low_conf_region	QUAL=6512;DP=131,58,107;AF=0.82,0.95,0.87;MQM=60;SAP=278;ABP=0;SAR=218;SAF=38	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron15/20:c.2092-69del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron15/20:c.2092-69del::					AluJr (SINE/Alu)	rs60525991	0.86155	0.64352,0.93230,0.99862,0.94851,0.96018	56485,	15099	20581	0.4820	1.56			/0.0>0.0/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|47|15|-30|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155783885	155783885	A	G	hom	hom	hom	off-target	QUAL=10385;DP=159,76,107;AF=1.00,1.00,1.00;MQM=59;SAP=720;ABP=0;SAR=3;SAF=339	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::						rs822019	0.83518	0.54511,0.92336,0.99904,0.95107,0.93794	55500,	16000	25064	-0.8600	1.94			/3.3>2.8/0.0>0.0		GON4L|0.00|0.01|0.00|0.00|-39|1|44|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785306	155785306	G	A	hom	hom	hom	off-target	QUAL=25714;DP=235,250,306;AF=1.00,1.00,1.00;MQM=60;SAP=190;ABP=0;SAR=265;SAF=526	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::						rs822021	0.93630	0.77760,0.97607,1.00000,0.99952,0.99896	67377,	7548	9682	-1.0920	5.37			/0.0>0.0/0.0>0.0		GON4L|0.00|0.00|0.00|0.03|28|-10|2|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785448	155785448	T	C	hom	hom	hom	off-target	QUAL=20685;DP=154,230,266;AF=1.00,1.00,1.00;MQM=60;SAP=292;ABP=0;SAR=472;SAF=178	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::					L3b (LINE/CR1)	rs822022	0.86355	0.64151,0.93485,0.99923,0.95125,0.96132	58205,	14934	20754	-0.4910	8.87			/0.0>0.0/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|-49|-2|5|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155804783	155804783	-	A	het	wt	wt	off-target;low_conf_region	QUAL=6;DP=29,5,6;AF=0.14,0.00,0.00;MQM=60;SAP=12;ABP=36;SAR=0;SAF=4	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron11/20:c.1645+165dup::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron11/20:c.1645+165dup::					AluJr (SINE/Alu)	rs780720104	0.00482	0.01206,0.00190,0.00128,0.00156,0.00098	2,	630	130816		2.31			/3.4>3.4/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|-10|-6|-41|-10		5	63	0	0 / 0					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155804808	155804808	T	C	hom	hom	hom	off-target	QUAL=3049;DP=50,30,32;AF=1.00,1.00,1.00;MQM=60;SAP=246;ABP=0;SAR=0;SAF=112	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::						rs822016	0.86958	0.66101,0.93702,0.99981,0.95152,0.96216	58681,	14569	19787	0.4160	6.38			/1.0>2.5/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|-35|-2|-35|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155813972	155813972	C	T	hom	hom	hom	off-target	QUAL=2701;DP=64,14,10;AF=0.98,1.00,1.00;MQM=60;SAP=151;ABP=0;SAR=82;SAF=5	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::						rs822012	0.83596	0.54814,0.92368,0.99904,0.95091,0.93835	55575,	16021	24955	-0.1590	6.85			/0.0>0.0/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|-44|-1|-49|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155814581	155814581	G	A	hom	hom	hom	off-target	QUAL=9032;DP=153,76,97;AF=1.00,1.00,1.00;MQM=60;SAP=711;ABP=0;SAR=326;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::					AluSx (SINE/Alu)	rs822013	0.93642	0.77788,0.97590,1.00000,0.99953,0.99896	67335,	7541	9655	-1.4210	0.68			/6.0>5.2/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|40|0|40|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815788	155815791	AACT	-	hom	hom	hom	off-target	QUAL=22181;DP=251,211,270;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0;SAR=233;SAF=499	GON4L	splice_region&intron	GON4L:ENST00000368331.6:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000615926.4:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.5:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000271883.9:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.9:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000622608.2:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::						rs148569012	0.86342	0.64059,0.93515,0.99942,0.95119,0.96125	57983,	14913	20703	-0.2520	6.23			/4.5>6.3/4.2>0.0		GON4L|0.00|0.00|0.19|0.13|0|37|0|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815986	155815986	A	-	het	wt	het	off-target	QUAL=101;DP=258,80,105;AF=0.12,0.08,0.10;MQM=60;SAP=83;ABP=469;SAR=45;SAF=3	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron7/20:c.1066-86del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron7/20:c.1066-86del::						rs913306261	0.00194	0.00378,0.00258,0.00107,0.00091,0.00113	0,	264	135698	0.3180	7.39			/0.0>0.0/0.0>0.0		GON4L|0.00|0.00|0.00|0.00|-22|14|14|32		0	129	0	0 / 0					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853180	155853180	C	T	hom	hom	hom	off-target	QUAL=1645;DP=31,10,16;AF=1.00,1.00,1.00;MQM=60;SAP=127;ABP=0;SAR=0;SAF=57	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+96G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+96G>A::	regulatory_region_variant:enhancer					rs822490	0.53324	0.28173,0.59100,0.29478,0.66328,0.59698	23771,	33509	70945	-1.2110	0.42			/0.0>0.0/0.0>0.8	COSV55201923	GON4L|0.00|0.00|0.00|0.00|19|-8|-11|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853211	155853211	T	C	hom	hom	hom	off-target	QUAL=3157;DP=62,26,21;AF=1.00,1.00,1.00;MQM=60;SAP=240;ABP=0;SAR=0;SAF=109	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+65A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+65A>G::						rs822491	0.99971	0.99916,0.99954,1.00000,1.00000,1.00000	76070,	44	44	-0.0960	4.46			/5.7>6.1/0.0>1.5		GON4L|0.00|0.00|0.00|0.00|-29|-12|1|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156054582	156054582	A	G	hom	n/a	n/a	off-target	QUAL=103;DP=3,0,2;AF=1.00,,0.50;MQM=60;SAP=12;ABP=3;SAR=0;SAF=4	UBQLN4,LAMTOR2	upstream_gene	UBQLN4:ENST00000368309.4:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368305.9:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368304.9:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368302.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1233192 [benign DISEASE=not provided];			rs3754293	0.44292	0.18288,0.55547,0.15949,0.56207,0.56424	17366,	32586	84670	1.6360	17.34						31709530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156055305	156055305	C	T	wt	het	wt		QUAL=1260;DP=86,108,167;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3;SAR=20;SAF=35	LAMTOR2	synonymous	LAMTOR2:ENST00000368305.9:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368304.9:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368302.3:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain]	regulatory_region_variant:promoter	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1165734 [benign DISEASE=not provided];			rs7541	0.11796	0.05225,0.12060,0.00135,0.16029,0.07489	1270,	15402	134156	-0.9160	8.58			/0.0>0.0/0.0>0.0	COSV64145997	LAMTOR2|0.00|0.00|0.00|0.00|35|-42|-5|37	23341997	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156130443	156130443	-	G	wt	het	wt	off-target	QUAL=9;DP=22,13,21;AF=0.00,0.31,0.00;MQM=60;SAP=12;ABP=7;SAR=0;SAF=4	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron4/12:c.357-171dup::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron3/12:c.357-171dup::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron2/11:c.357-171dup::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron2/11:c.357-171dup::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron1/9:c.357-171dup::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron1/11:c.357-171dup::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron1/11:c.357-171dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron1/12:c.21-171dup::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron2/10:c.114-171dup::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron2/12:c.60-171dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1243267 [benign DISEASE=not provided];			rs113265975	0.08201	0.17418,0.05671,0.00058,0.04791,0.05173	806,	10794	138874		17.46			/0.0>0.0/4.3>4.4		LMNA|0.00|0.00|0.00|0.00|-42|49|44|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156130948	156130948	T	C	wt	het	wt	off-target	QUAL=110;DP=46,16,18;AF=0.02,0.44,0.00;MQM=60;SAP=20;ABP=4;SAR=8;SAF=0	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron5/12:c.513+175T>C::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron4/12:c.513+175T>C::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron3/11:c.513+175T>C::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron3/11:c.513+175T>C::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron2/9:c.513+175T>C::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron2/11:c.513+175T>C::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron2/11:c.513+175T>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron2/12:c.177+175T>C::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron3/10:c.270+175T>C::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron3/12:c.216+175T>C::	regulatory_region_variant:CTCF_binding_site	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672782 [benign DISEASE=not provided];			rs577492	0.21139	0.56642,0.10394,0.02273,0.07115,0.13008	7090,	17954	119878	-0.7020	1.45			/0.0>0.0/0.0>0.0		LMNA|0.00|0.00|0.00|0.00|-42|40|-24|-2	17327437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156134206	156134206	A	C	wt	het	wt	off-target	QUAL=537;DP=53,48,47;AF=0.02,0.54,0.00;MQM=60;SAP=62;ABP=4;SAR=0;SAF=27	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron5/12:c.514-197A>C::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron4/12:c.514-197A>C::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron3/11:c.514-197A>C::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron3/11:c.514-197A>C::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron2/9:c.514-197A>C::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron2/11:c.514-197A>C::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron2/11:c.514-197A>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron2/12:c.178-197A>C::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron3/10:c.271-197A>C::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron3/12:c.217-197A>C::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672783 [benign DISEASE=not provided];			rs569025	0.22945	0.62875,0.10954,0.02267,0.07151,0.13112	8673,	17486	116976	-0.9490	1.93			/7.3>7.2/0.0>0.0		LMNA|0.01|0.00|0.01|0.00|14|2|34|-47	34107879	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156135237	156135237	T	C	wt	het	wt		QUAL=340;DP=94,36,54;AF=0.01,0.47,0.00;MQM=60;SAP=20;ABP=3;SAR=15;SAF=3	LMNA	synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon7/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000361308.9:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038 [Intermediate filament protein],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038 [Intermediate filament protein]	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48088 [benign DISEASE=Charcot-Marie-Tooth disease,not specified,not provided,Emery-Dreifuss muscular dystrophy,Cardiomyopathy,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,Charcot-Marie-Tooth disease type 2,Dilated cardiomyopathy 1A,Familial partial lipodystrophy, Dunnigan type,Cardiovascular phenotype,Primary dilated cardiomyopathy,Congenital muscular dystrophy due to LMNA mutation,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Charcot-Marie-Tooth disease type 2B1,Lethal tight skin contracture syndrome];	CM217020 [CLASS=DM? MUT=ALT PHEN="Cardiomyopathy dilated modifier of" GENE=LMNA];		rs538089	0.17604	0.44210,0.09297,0.02269,0.07088,0.12914	4475,	17838	125380	-7.5680	5.54			/0.0>0.0/0.0>0.0		LMNA|0.00|0.00|0.00|0.00|-50|42|-9|-36	25741868,24033266,15637659,20127487,28785654,18344805,23861362,23757202,29104234,27896052,22419169,32698886	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156135818	156135818	G	T	wt	het	wt	off-target	QUAL=913;DP=42,72,77;AF=0.00,0.61,0.00;MQM=60;SAP=99;ABP=11;SAR=0;SAF=44	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron8/12:c.937-83G>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron7/12:c.937-83G>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron6/11:c.937-83G>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron6/11:c.937-83G>T::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron5/9:c.937-83G>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron5/11:c.937-83G>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron5/11:c.937-83G>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron5/12:c.601-83G>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron6/10:c.694-83G>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron6/12:c.640-83G>T::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]				rs646840	0.17557	0.44171,0.09325,0.02278,0.07071,0.12822	4431,	17801	125207	0.2890	6.13			/0.0>0.0/2.7>0.0		LMNA|0.00|0.01|0.00|0.01|21|43|-2|-1	28785654	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136137	156136137	G	A	wt	het	wt	off-target	QUAL=3073;DP=91,261,311;AF=0.01,0.49,0.00;MQM=60;SAP=14;ABP=3;SAR=77;SAF=52	LMNA	splice_region&intron	LMNA:ENST00000368301.6:splice_region_variant&intron_variant:LOW:intron9/12:c.1157+16G>A::,LMNA:ENST00000676385.2:splice_region_variant&intron_variant:LOW:intron8/12:c.1157+16G>A::,LMNA:ENST00000675939.1:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000675667.1:splice_region_variant&intron_variant:LOW:intron7/11:c.1157+16G>A::,LMNA:ENST00000683032.1:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000682650.1:splice_region_variant&intron_variant:LOW:intron7/11:c.1157+16G>A::,LMNA:ENST00000361308.9:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000677389.1:splice_region_variant&intron_variant:LOW:intron6/9:c.1157+16G>A::,LMNA:ENST00000368300.9:splice_region_variant&intron_variant:LOW:intron6/11:c.1157+16G>A::,LMNA:ENST00000368299.7:splice_region_variant&intron_variant:LOW:intron6/11:c.1157+16G>A::,LMNA:ENST00000448611.6:splice_region_variant&intron_variant:LOW:intron6/12:c.821+16G>A::,LMNA:ENST00000368297.5:splice_region_variant&intron_variant:LOW:intron7/10:c.914+16G>A::,LMNA:ENST00000473598.6:splice_region_variant&intron_variant:LOW:intron7/12:c.860+16G>A::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	36474 [benign/likely benign DISEASE=Charcot-Marie-Tooth disease,not specified,not provided,Charcot-Marie-Tooth disease type 2,Primary dilated cardiomyopathy];			rs534807	0.17567	0.44342,0.09325,0.02254,0.07012,0.12381	4477,	17759	125349	0.5750	3.25			/0.0>0.0/0.0>0.0		LMNA|0.00|0.00|0.00|0.00|50|-16|-29|-44	25741868,24033266,28785654,18344805,23757202,27896052,22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136394	156136394	T	C	wt	het	wt		QUAL=1107;DP=47,108,140;AF=0.00,0.46,0.00;MQM=60;SAP=14;ABP=4;SAR=33;SAF=17	LMNA	synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon9/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000361308.9:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932 [Lamin Tail Domain]	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48037 [benign DISEASE=Charcot-Marie-Tooth disease,not specified,Emery-Dreifuss muscular dystrophy,Cardiomyopathy,not provided,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,Charcot-Marie-Tooth disease type 2,Familial partial lipodystrophy, Dunnigan type,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Dilated cardiomyopathy 1A,Primary dilated cardiomyopathy,Cardiovascular phenotype,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease type 2B1,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome];			rs505058	0.22677	0.61941,0.10918,0.02279,0.07093,0.13516	8429,	17626	117582	-0.5110	5.62			/0.0>0.0/1.5>0.8	COSV61542738	LMNA|0.00|0.00|0.00|0.00|-41|47|42|-6	25741868,24033266,17327460,17994215,20127487,28785654,18344805,23861362,23757202,18780302,18830724,18848371,20574532,20594621,21537449,21903150,23164068,29596498,21132329,30781626,29104234,30595370,27896052,22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136578	156136578	G	A	wt	het	wt	off-target	QUAL=104;DP=41,18,26;AF=0.00,0.39,0.04;MQM=60;SAP=13;ABP=5;SAR=7;SAF=1	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron10/12:c.1380+142G>A::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron9/12:c.1380+142G>A::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron8/11:c.1380+142G>A::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron8/11:c.1380+142G>A::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron7/9:c.1380+142G>A::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron7/11:c.1380+142G>A::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron7/11:c.1380+142G>A::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron7/12:c.1044+142G>A::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron8/10:c.1137+142G>A::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron8/12:c.1083+142G>A::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672784 [benign DISEASE=not provided];		MIRc (SINE/MIR)	rs476000	0.22414	0.61278,0.10812,0.02273,0.07024,0.12925	8237,	17599	117941	-2.8530	0.15			/8.7>5.4/0.0>0.0		LMNA|0.05|0.01|0.00|0.02|2|8|-29|47	22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137072	156137072	C	T	wt	het	wt	off-target	QUAL=2825;DP=185,240,371;AF=0.00,0.53,0.00;MQM=60;SAP=31;ABP=5;SAR=85;SAF=44	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron10/12:c.1489-41C>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron9/12:c.1192-41C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66834 [benign DISEASE=not provided,not specified];			rs553016	0.16722	0.41260,0.09044,0.02276,0.07026,0.12722	3896,	17618	126548	0.3860	6.84			/0.0>0.0/0.0>0.0	COSV61542554	LMNA|0.01|0.00|0.00|0.00|21|38|-44|15	25741868,15637659,16262891,18344805,27896052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137743	156137743	C	T	het	wt	het		QUAL=6957;DP=149,263,356;AF=0.61,0.00,0.55;MQM=60;SAP=24;ABP=22;SAR=117;SAF=169	LMNA	synonymous,intron,splice_region&synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron11/12:c.1608+511C>T::,LMNA:ENST00000675939.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000675667.1:splice_region_variant&synonymous_variant:LOW:exon11/12:c.1698C>T:p.His566=:,LMNA:ENST00000683032.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron10/11:c.1608+511C>T::,LMNA:ENST00000361308.9:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000677389.1:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000368300.9:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368299.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000448611.6:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000368297.5:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000473598.6:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48048 [benign DISEASE=Charcot-Marie-Tooth disease,Cardiomyopathy,Emery-Dreifuss muscular dystrophy,not specified,not provided,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Limb-Girdle Muscular Dystrophy, Recessive,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Cardiovascular phenotype,Charcot-Marie-Tooth disease type 2,Familial partial lipodystrophy, Dunnigan type,Dilated cardiomyopathy 1A,Primary dilated cardiomyopathy,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease type 2B1,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.21275	0.09341,0.28232,0.25251,0.26111,0.30381	4003,	24349	119727	-1.6030	8.23			9.3>7.8/0.3>0.0/9.3>7.8,/0.3>0.0/9.3>7.8	COSV61541921	LMNA|0.00|0.00|0.00|0.00|-29|0|0|7	25741868,24033266,15637659,16262891,17327437,17327460,17327461,17994215,19841875,20127487,20501691,21108632,22303384,22340368,24244950,26365620,26379929,26602028,27182706,28785654,25649378,21980471,27409638,25151201,23090008,24019745,27896052,23800289,26634508,24831476,32698886,33953703,34021172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139185	156139185	G	C	wt	het	wt		QUAL=36;DP=68,7,15;AF=0.00,0.57,0.00;MQM=60;SAP=5;ABP=3;SAR=1;SAF=3	LMNA	3'UTR,intron	LMNA:ENST00000675939.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000675667.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*206G>C::,LMNA:ENST00000683032.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000682650.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000361308.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:ENST00000473598.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66756 [benign DISEASE=not specified,not provided];			rs7339	0.16966	0.42137,0.09052,0.02266,0.07044,0.12671	4048,	17640	125952	-0.0620	2.75			/1.2>0.0/0.0>0.0	COSV61542559	LMNA|0.00|0.00|0.00|0.00|-45|30|41|-5	16262891,28785654,18344805	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139303	156139303	-	A	wt	het	wt		QUAL=51;DP=57,33,52;AF=0.02,0.24,0.06;MQM=60;SAP=6;ABP=22;SAR=4;SAF=8	LMNA	3'UTR,intron	LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+215dup::		150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1267964 [benign DISEASE=not provided];			rs200317083	0.13375	0.30071,0.08611,0.00333,0.07038,0.06142	1718,	13777	111481		13.27			/0.0>0.0/0.0>0.0		LMNA|0.00|0.00|0.00|0.00|-41|-46|-42|-46	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156815564	156815564	T	C	hom	hom	hom	off-target	QUAL=4482;DP=72,45,39;AF=1.00,1.00,1.00;MQM=60;SAP=342;ABP=0;SAR=0;SAF=156	SH2D2A	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.70-343A>G::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.124-343A>G::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.124-343A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667736 [benign DISEASE=not provided];			rs2150906	0.85514	0.67813,0.86248,0.93629,0.94168,0.89631	56484,	16957	22009	-1.7110	0.21			/0.0>0.0/0.0>0.0	COSV63885495,COSV63885550	SH2D2A|0.06|0.01|0.00|0.00|13|-22|13|42	30738251	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815825	156815825	G	A	hom	hom	hom		QUAL=22421;DP=198,210,299;AF=1.00,1.00,1.00;MQM=60;SAP=56;ABP=0;SAR=419;SAF=288	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000674537.2:5_prime_UTR_variant:MODIFIER:exon1/18:c.-217G>A::,NTRK1:ENST00000392302.7:5_prime_UTR_variant:MODIFIER:exon1/17:c.-77G>A::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	380853 [benign DISEASE=not specified,Hereditary insensitivity to pain with anhidrosis];			rs1800601	0.63521	0.50530,0.69521,0.81931,0.67662,0.64629	31197,	34046	55384	-1.8390	0.22			/0.0>0.0/0.0>2.2,/0.0>0.0/0.0>0.0	COSV63884607	SH2D2A|0.04|0.00|0.00|0.00|-33|39|-2|18	20219210,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815971	156815971	G	-	hom	hom	hom	off-target	QUAL=7360;DP=95,81,99;AF=1.00,1.00,1.00;MQM=60;SAP=600;ABP=0;SAR=275;SAF=0	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+35del::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+35del::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+35del::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+133del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+133del::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1225268 [benign DISEASE=not provided];			rs11325907	0.56435	0.33654,0.64600,0.81834,0.64240,0.64588	25680,	34062	65942	0.2390	2.35			/0.0>0.0/0.0>0.0		SH2D2A|0.00|0.00|0.00|0.00|-41|-32|8|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815979	156815979	A	G	hom	hom	hom	off-target	QUAL=7532;DP=85,78,102;AF=1.00,1.00,1.00;MQM=60;SAP=578;ABP=0;SAR=265;SAF=0	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+27T>C::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+141A>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+141A>G::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667767 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis];			rs7546838	0.59832	0.45517,0.65845,0.81765,0.64253,0.64671	27774,	34990	60782	-1.3060	1.14			/0.0>0.0/0.0>0.0,/4.6>5.3/0.0>0.0	COSV63884348	SH2D2A|0.00|0.00|0.00|0.00|2|-50|27|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815987	156815987	G	A	hom	hom	hom	off-target	QUAL=6031;DP=88,74,88;AF=0.97,1.00,1.00;MQM=60;SAP=539;ABP=0;SAR=247;SAF=0	SH2D2A,NTRK1	splice_region&intron,intron	SH2D2A:ENST00000368198.7:splice_region_variant&intron_variant:LOW:intron2/8:c.69+19C>T::,SH2D2A:ENST00000368199.8:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,SH2D2A:ENST00000392306.2:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+149G>A::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+149G>A::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667768 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis];			rs1800600	0.65464	0.57452,0.69982,0.81800,0.67656,0.65340	32670,	33714	52256	-0.7970	0.37			/0.0>0.0/0.0>0.0,/4.6>3.9/0.0>0.0		SH2D2A|0.00|0.00|0.00|0.00|-49|46|19|-9	18554728	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156868349	156868349	T	C	hom	hom	hom	off-target	QUAL=3475;DP=59,32,29;AF=1.00,1.00,1.00;MQM=60;SAP=222;ABP=0;SAR=115;SAF=5	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron7/17:c.412+100T>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron6/16:c.412+100T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron5/15:c.574+100T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron5/16:c.574+100T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron5/15:c.574+100T>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667738 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis];			rs1800879	0.62957	0.63821,0.64599,0.94987,0.60356,0.73279	30567,	34534	56290	-4.5820	0.02			/0.0>0.0/0.0>0.0		NTRK1|0.00|0.00|0.00|0.00|-10|15|34|-11	18077166,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156871467	156871467	A	C	hom	hom	hom	off-target	QUAL=4942;DP=75,42,53;AF=1.00,1.00,1.00;MQM=60;SAP=372;ABP=0;SAR=0;SAF=170	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron8/17:c.556-156A>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron7/16:c.556-156A>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron6/15:c.718-156A>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron6/16:c.718-156A>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron6/15:c.718-156A>C::	regulatory_region_variant:enhancer	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667741 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis];			rs2644614	0.97979	0.93001,0.99261,1.00000,0.99950,0.99959	73129,	2838	3076	-0.5680	1.42			/0.0>0.0/0.0>0.0		NTRK1|0.00|0.00|0.00|0.00|-6|48|-49|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GT	wt	wt	het	off-target;low_conf_region	QUAL=944;DP=17,39,45;AF=0.06,0.56,0.00;MQM=60;SAP=15;ABP=84;SAR=12;SAF=3	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291502 [benign DISEASE=not provided];			rs56185968	0.09601	0.25134,0.05459,0.03897,0.03224,0.05094	1280,	11098	128600		1.16			/0.0>0.0/2.4>2.4		NTRK1|0.00|0.00|0.00|0.01|-41|-5|-36|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GTGT	wt	wt	het	off-target;low_conf_region	QUAL=944;DP=17,39,45;AF=0.06,0.56,0.00;MQM=60;SAP=26;ABP=3;SAR=20;SAF=4	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron13/17:c.1321+67_1321+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+67_1321+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1236121 [benign DISEASE=not provided];			rs56185968	0.50377	0.31193,0.52848,0.06083,0.62801,0.31897	19739,	32345	70749		1.11			/0.0>0.0/2.4>2.4		NTRK1|0.00|0.00|0.01|0.01|-5|-47|-34|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875701	156875702	GT	-	wt	het	wt	off-target;low_conf_region	QUAL=944;DP=17,39,45;AF=0.06,0.03,0.29;MQM=60;SAP=24;ABP=4;SAR=19;SAF=4	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70del::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291500 [benign DISEASE=not provided];		(GT)n (Simple_repeat)	rs56185968	0.14227	0.16445,0.15811,0.36934,0.10821,0.17750	1561,	17177	122379	0.3490	0.83			/0.0>0.0/2.4>2.4		NTRK1|0.00|0.00|0.01|0.00|-41|-5|-34|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156876441	156876441	G	A	het	hom	wt		QUAL=6457;DP=149,149,146;AF=0.50,1.00,0.00;MQM=60;SAP=48;ABP=3;SAR=78;SAF=146	NTRK1	synonymous	NTRK1:ENST00000674537.2:synonymous_variant:LOW:exon15/18:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon14/17:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine and serine/threonine kinase]	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	292889 [benign DISEASE=not specified,not provided,Hereditary insensitivity to pain with anhidrosis];			rs6334	0.20091	0.13858,0.22620,0.34620,0.21785,0.23986	3221,	24110	121520	0.2210	8.92			/0.0>0.0/3.2>5.3	COSV62323674	NTRK1|0.00|0.00|0.00|0.00|-32|-8|1|42	23195334,21178826,29054434,30283335,20003389,29453651,16373086,33004033,31577263	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879002	156879002	C	T	het	wt	hom	off-target	QUAL=664;DP=25,15,19;AF=0.44,0.00,0.95;MQM=60;SAP=66;ABP=4;SAR=0;SAF=29	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron15/17:c.1626-120C>T::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-120C>T::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-120C>T::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-120C>T::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-120C>T::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667763 [benign DISEASE=not provided];			rs2768756	0.52132	0.17419,0.55508,0.04906,0.72378,0.37094	25601,	28014	72738	-0.1740	3.70			/9.4>9.9/0.0>0.0	COSV62329334	NTRK1|0.01|0.00|0.00|0.00|13|7|13|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879016	156879016	T	C	het	het	hom	off-target	QUAL=933;DP=27,17,22;AF=0.41,0.41,1.00;MQM=60;SAP=90;ABP=6;SAR=0;SAF=40	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron15/17:c.1626-106T>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-106T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-106T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-106T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-106T>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667764 [benign DISEASE=not provided];			rs2768757	0.79561	0.68028,0.79050,0.38936,0.89146,0.55602	49400,	22092	31056	-1.5260	0.13			/9.4>8.4/0.3>0.0	COSV62328512	NTRK1|0.00|0.00|0.00|0.00|25|-1|5|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879203	156879203	C	T	het	wt	hom		QUAL=3876;DP=49,104,128;AF=0.33,0.01,0.97;MQM=60;SAP=11;ABP=16;SAR=59;SAF=82	NTRK1	synonymous	NTRK1:ENST00000674537.2:synonymous_variant:LOW:exon16/18:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon15/17:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine and serine/threonine kinase]		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	138564 [benign DISEASE=not specified,Hereditary insensitivity to pain with anhidrosis];			rs6337	0.53311	0.21425,0.55860,0.05025,0.72396,0.37074	25959,	29030	70892	-3.9860	1.64			/0.8>1.5/0.0>0.0	COSV62325231	NTRK1|0.00|0.00|0.00|0.04|13|40|-50|12	26384852,20003389,16373086,33986442	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880312	156880312	G	C	het	het	hom	off-target	QUAL=1424;DP=19,25,29;AF=0.58,0.56,1.00;MQM=60;SAP=120;ABP=5;SAR=54;SAF=0	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2025+155G>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+155G>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+155G>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+155G>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+155G>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667765 [benign DISEASE=not provided];			rs2274499	0.82797	0.67191,0.83823,0.47404,0.93265,0.68583	53395,	18751	26085	0.0000	2.51			/1.2>1.5/0.0>0.0		NTRK1|0.00|0.00|0.00|0.00|-29|29|-15|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880320	156880320	T	G	het	het	hom	off-target	QUAL=1482;DP=19,26,31;AF=0.63,0.54,1.00;MQM=60;SAP=127;ABP=5;SAR=57;SAF=0	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2025+163T>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+163T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+163T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+163T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+163T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667766 [benign DISEASE=not provided];			rs2274500	0.82815	0.67189,0.83845,0.47314,0.93317,0.68576	53434,	18723	26061	-3.5770	0.10			/0.0>0.0/0.0>0.0		NTRK1|0.00|0.04|0.00|0.00|-37|46|-1|-9	29029385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156881249	156881249	T	G	hom	n/a	n/a	off-target	QUAL=244;DP=6,1,2;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=0;SAF=9	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2026-208T>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2026-208T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2188-208T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2206-208T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2197-208T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	670556 [benign DISEASE=not provided];			rs2768758	0.97972	0.92869,0.99359,1.00000,0.99987,0.99979	73136,	2823	3087	-0.4380	3.40			/0.0>0.0/0.0>0.0		NTRK1|0.00|0.00|0.00|0.00|31|3|31|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160039331	160039331	A	C	het	het	wt		QUAL=3050;DP=173,68,80;AF=0.50,0.46,0.00;MQM=60;SAP=7;ABP=3;SAR=52;SAF=66	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1171T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2715T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293090 [benign DISEASE=not provided,EAST syndrome,Autosomal recessive nonsyndromic hearing loss 4];			rs1053074	0.45632	0.61346,0.44332,0.33450,0.39838,0.46915	16600,	35475	81821	1.6730	8.27			/0.0>0.0/0.0>0.0	COSV63635370	KCNJ10|0.00|0.00|0.00|0.00|-50|-6|-11|-5	16451705,25874548,32021205,19864112,17660461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039353	160039353	G	C	hom	hom	hom		QUAL=8558;DP=145,59,69;AF=1.00,0.97,1.00;MQM=60;SAP=26;ABP=0;SAR=109;SAF=162	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1149C>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2693C>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293091 [benign DISEASE=EAST syndrome,Autosomal recessive nonsyndromic hearing loss 4,not provided];			rs2486254	0.99765	0.99204,0.99881,1.00000,0.99993,1.00000	74911,	350	354	0.1670	3.99			/2.4>1.2/0.0>2.7		KCNJ10|0.00|0.00|0.00|0.00|1|-5|1|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039375	AC	-	wt	wt	het		QUAL=1027;DP=16,37,41;AF=0.31,0.46,0.07;MQM=60;SAP=7;ABP=14;SAR=13;SAF=7	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1127_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2671_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293094 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.12021	0.08458,0.11757,0.05720,0.14364,0.10387	987,	14167	118131	0.6770	0.96			/0.9>0.0/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|49|-25|41|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039377	ACAC	-	wt	het	wt		QUAL=1027;DP=16,37,41;AF=0.31,0.46,0.07;MQM=60;SAP=6;ABP=39;SAR=8;SAF=13	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1125_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2669_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293095 [benign/likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.16683	0.17680,0.23796,0.17740,0.14889,0.10905	1898,	18601	111851	0.6770	5.44			/0.9>0.3/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|48|-25|39|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039379	ACACAC	-	het	het	wt		QUAL=1027;DP=16,37,41;AF=0.31,0.46,0.07;MQM=60;SAP=5;ABP=48;SAR=15;SAF=10	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1123_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2667_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293097 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.08981	0.12773,0.06324,0.06346,0.08074,0.07245	549,	10978	122382	0.6770	5.31			/0.9>1.0/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|-47|-25|41|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039629	160039629	A	C	hom	hom	hom		QUAL=31990;DP=369,263,345;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0;SAR=426;SAF=550	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+873T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2417T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293102 [benign DISEASE=not provided,EAST syndrome,Autosomal recessive nonsyndromic hearing loss 4];			rs2486253	0.81887	0.81786,0.82626,0.96086,0.80532,0.82303	51070,	22339	27535	0.2820	7.94			/0.0>0.0/0.0>0.0	COSV105294526	KCNJ10|0.00|0.00|0.00|0.00|37|9|-38|38	25008907,32021205,33187755	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160040361	160040361	C	T	wt	het	wt		QUAL=2287;DP=334,197,282;AF=0.00,0.50,0.00;MQM=60;SAP=5;ABP=3;SAR=54;SAF=45	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+141G>A::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+1685G>A::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	874513 [benign/likely benign DISEASE=Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome];			rs17375748	0.04470	0.01163,0.03564,0.00058,0.06828,0.02317	208,	6388	145408	0.2860	1.55			/0.2>0.0/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|-24|39|-5|-42	28520217,33096746,33462668	14	206	0	0 / 0					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160042703	160042703	G	A	wt	het	het	off-target	QUAL=1668;DP=88,65,94;AF=0.00,0.42,0.54;MQM=60;SAP=172;ABP=3;SAR=78;SAF=0	KCNJ10	intron	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron1/3:c.1-171C>T::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron1/2:c.1-171C>T::,KCNJ10:ENST00000644903.1:intron_variant:MODIFIER:intron1/1:c.1-171C>T::,KCNJ10:ENST00000638728.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::,KCNJ10:ENST00000638868.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	682044 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs3120973	0.23824	0.06225,0.23907,0.32401,0.31548,0.23018	5339,	25536	115794	-1.1120	0.25			/5.5>5.0/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.02|-14|40|37|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160069869	160069869	G	A	wt	het	wt	off-target	QUAL=161;DP=17,27,39;AF=0.00,0.37,0.00;MQM=60;SAP=25;ABP=7;SAR=0;SAF=10	KCNJ10	intron	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron1/3:c.-1+153C>T::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron1/2:c.-1+153C>T::,KCNJ10:ENST00000644903.1:intron_variant:MODIFIER:intron1/1:c.-1+153C>T::,KCNJ10:ENST00000638728.1:intron_variant:MODIFIER:intron1/2:c.-67+153C>T::	regulatory_region_variant:promoter	602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	1253634 [benign DISEASE=not provided];			rs2820585	0.21851	0.05629,0.21566,0.22562,0.29656,0.19449	4528,	24172	118842	-0.1510	4.76			/7.6>6.3/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|2|38|2|-48	32021205,19864112,33096746	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160276695	160276695	C	T	het	het	n/a	off-target	QUAL=236;DP=30,4,0;AF=0.40,0.25,;MQM=60;SAP=31;ABP=7;SAR=0;SAF=13	PEX19	downstream_gene	PEX19:ENST00000368072.10:downstream_gene_variant:MODIFIER::::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]				rs1557524	0.45503	0.35013,0.47598,0.34460,0.50396,0.60964	16108,	36875	82747	0.2290	2.95					RP11-574F21.3|0.00|0.00|0.00|0.00|-13|46|-3|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277200	160277200	T	-	het	het	het		QUAL=1365;DP=292,136,193;AF=0.18,0.22,0.17;MQM=60;SAP=3;ABP=538;SAR=57;SAF=58	PEX19	3'UTR	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]			Charlie10 (DNA/hAT-Charlie)	rs751979135	0.00113	0.00060,0.00062,0.00040,0.00094,0.00044	0,	164	144762	-0.5870	0.23			/0.8>0.5/1.1>0.0		PEX19|0.01|0.00|0.00|0.00|20|-1|-20|0,RP11-574F21.3|0.00|0.00|0.00|0.00|20|33|17|0		1	215	29	0 / 0					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277395	160277395	G	C	het	wt	hom		QUAL=10199;DP=282,165,218;AF=0.44,0.01,1.00;MQM=60;SAP=13;ABP=13;SAR=191;SAF=152	PEX19	3'UTR	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A (Zellweger)];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.45526	0.35034,0.47668,0.34578,0.50400,0.61031	16142,	36891	82771	0.4650	3.34			/7.1>5.3/0.0>0.0	COSV63619513	PEX19|0.00|0.18|0.00|0.00|32|-8|-7|-43,RP11-574F21.3|0.00|0.07|0.00|0.00|32|-8|-7|-39	20819849,16451705,19001172,25284319	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160282002	160282002	A	G	het	wt	hom	off-target	QUAL=6881;DP=210,91,149;AF=0.44,0.00,1.00;MQM=60;SAP=300;ABP=9;SAR=30;SAF=212	PEX19	intron	PEX19:ENST00000368072.10:intron_variant:MODIFIER:intron5/7:c.594+37T>C::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	1227462 [benign DISEASE=Peroxisome biogenesis disorder 12A (Zellweger),not provided];			rs2795067	0.64345	0.86274,0.57599,0.46583,0.55637,0.70547	32988,	31799	54179	-1.4240	0.16			/2.5>1.4/0.0>0.0	COSV63619299	PEX19|0.00|0.00|0.00|0.00|-41|-50|35|37,RP11-574F21.3|0.00|0.00|0.00|0.00|-41|-50|35|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161167557	161167557	C	T	het	wt	wt	off-target;low_conf_region	QUAL=270;DP=45,37,51;AF=0.51,0.03,0.08;MQM=47;SAP=64;ABP=3;SAR=28;SAF=0	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron4/12:c.338+71C>T::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron4/12:c.338+71C>T::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.222+323C>T::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.87+623C>T::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.87+623C>T::	regulatory_region_variant:promoter	600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]			AluSx4 (SINE/Alu)	rs141054760	0.00448	0.00478,0.00479,0.00289,0.00456,0.00525	0,	331	73585	-0.5660	1.01			/0.0>0.0/0.0>0.0	COSV57087179	PPOX|0.00|0.02|0.00|0.00|37|31|-8|31		58	255	0	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170329	161170329	A	C	het	het	het	off-target;low_conf_region	QUAL=833;DP=30,43,74;AF=0.33,0.70,0.66;MQM=54;SAP=196;ABP=17;SAR=0;SAF=89	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron9/12:c.988-80A>C::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron9/12:c.988-80A>C::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-291A>C::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-291A>C::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-291A>C::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]				rs944809134	0.24719	0.22184,0.13006,0.20070,0.32732,0.22383	0,	10692	32562	-5.2820	0.18			/0.5>2.7/0.0>0.0		PPOX|0.00|0.00|0.00|0.00|22|-32|-12|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170337	161170337	A	C	wt	het	het	off-target	QUAL=198;DP=24,38,58;AF=0.17,0.26,0.28;MQM=57;SAP=68;ABP=47;SAR=0;SAF=30	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron9/12:c.988-72A>C::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron9/12:c.988-72A>C::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-283A>C::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-283A>C::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-283A>C::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]				rs1174445197	0.02025	0.02922,0.00817,0.01176,0.02430,0.00667	0,	100	4838	-2.4180	0.17			/0.5>0.0/0.0>0.0		PPOX|0.00|0.00|0.00|0.00|14|-28|-36|-28		1	99	0	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170488	161170488	A	-	het	wt	het		QUAL=6458;DP=230,326,379;AF=0.46,0.00,0.46;MQM=60;SAP=84;ABP=12;SAR=89;SAF=191	PPOX	frameshift,intron	PPOX:ENST00000352210.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-132del::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-132del::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]										7.2260				/6.0>0.0/0.0>0.0		PPOX|0.00|0.00|0.12|0.04|32|3|-26|32		0	2	0	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161206347	161206347	A	G	wt	wt	het	off-target	QUAL=1224;DP=116,71,91;AF=0.00,0.00,0.58;MQM=60;SAP=110;ABP=8;SAR=1;SAF=52	NDUFS2	intron	NDUFS2:ENST00000677550.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000676600.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000678507.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677579.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677231.1:intron_variant:MODIFIER:intron3/12:c.203-60A>G::,NDUFS2:ENST00000678911.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000677846.1:intron_variant:MODIFIER:intron3/15:c.203-60A>G::,NDUFS2:ENST00000679176.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000367993.7:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000392179.5:intron_variant:MODIFIER:intron2/12:c.203-60A>G::,NDUFS2:ENST00000678511.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677453.1:intron_variant:MODIFIER:intron2/14:c.203-60A>G::,NDUFS2:ENST00000678783.1:intron_variant:MODIFIER:intron2/12:c.203-60A>G::,NDUFS2:ENST00000676972.1:intron_variant:MODIFIER:intron2/13:c.203-60A>G::		602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1229436 [benign DISEASE=not provided];			rs4656993	0.60972	0.60953,0.67586,0.89126,0.57021,0.74648	28598,	35460	59308	0.2820	5.74			/1.0>1.4/0.0>0.0		NDUFS2|0.00|0.00|0.00|0.00|-31|20|-20|-41	23637325,26053550,20406964	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34)
chr1	161212171	161212171	A	-	wt	het	wt	off-target	QUAL=39;DP=24,13,23;AF=0.04,0.31,0.04;MQM=60;SAP=16;ABP=7;SAR=0;SAF=6	NDUFS2	intron	NDUFS2:ENST00000677550.1:intron_variant:MODIFIER:intron10/13:c.987-168del::,NDUFS2:ENST00000676600.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000678507.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677579.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677231.1:intron_variant:MODIFIER:intron9/12:c.909-168del::,NDUFS2:ENST00000678911.1:intron_variant:MODIFIER:intron9/13:c.909-168del::,NDUFS2:ENST00000677846.1:intron_variant:MODIFIER:intron10/15:c.987-168del::,NDUFS2:ENST00000679176.1:intron_variant:MODIFIER:intron10/13:c.987-168del::,NDUFS2:ENST00000367993.7:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000392179.5:intron_variant:MODIFIER:intron9/12:c.987-168del::,NDUFS2:ENST00000678511.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677453.1:intron_variant:MODIFIER:intron9/14:c.987-168del::,NDUFS2:ENST00000678783.1:intron_variant:MODIFIER:intron8/12:c.912-168del::,NDUFS2:ENST00000676972.1:intron_variant:MODIFIER:intron9/13:c.987-168del::		602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]				rs79986323	0.00112	0.00053,0.00081,0.00214,0.00107,0.00000	0,	154	136776	0.9320	5.78			/5.7>5.7/0.0>0.0		NDUFS2|0.00|0.00|0.00|0.00|2|1|22|-24		1	279	0	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TG	wt	wt	het		QUAL=1679;DP=234,163,213;AF=0.19,0.09,0.13;MQM=60;SAP=69;ABP=750;SAR=62;SAF=14	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293284 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Mitochondrial complex I deficiency,not provided];			rs10629771	0.28073	0.37930,0.27353,0.46728,0.22021,0.31988	5962,	29248	105488		1.48			/0.0>0.0/0.3>0.3		NDUFS2|0.00|0.00|0.00|0.00|1|7|1|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TGTG	wt	het	wt		QUAL=1679;DP=234,163,213;AF=0.19,0.09,0.13;MQM=60;SAP=44;ABP=456;SAR=39;SAF=9	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*104_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1253405 [benign DISEASE=not provided];			rs10629771	0.12915	0.08359,0.12657,0.03054,0.15640,0.10608	1280,	16401	127849		1.43			/0.0>0.0/0.3>0.3		NDUFS2|0.00|0.00|0.00|0.00|0|7|0|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214270	161214271	TG	-	het	wt	wt		QUAL=1679;DP=234,163,213;AF=0.02,0.08,0.27;MQM=60;SAP=102;ABP=680;SAR=75;SAF=12	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107del::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293286 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771	0.00132	0.00129,0.00034,0.00041,0.00091,0.00874	0,	194	146494	0.3460	2.26			/0.0>0.0/0.3>0.3		NDUFS2|0.00|0.00|0.00|0.00|9|3|11|3		1	161	3	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214307	161214307	A	G	wt	wt	het		QUAL=2149;DP=363,186,252;AF=0.00,0.00,0.39;MQM=60;SAP=112;ABP=30;SAR=84;SAF=14	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*114A>G::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293289 [benign DISEASE=Mitochondrial complex I deficiency, nuclear type 1,not provided];			rs1136224	0.14182	0.04430,0.19236,0.30135,0.15555,0.29523	1776,	16859	123515	-0.8360	1.40			/3.8>3.7/0.0>0.0		NDUFS2|0.00|0.00|0.00|0.00|47|19|-5|-9	18682780,22545919,30782949,26053550,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161304858	161304858	G	C	wt	het	het		QUAL=67;DP=35,28,34;AF=0.00,0.29,0.29;MQM=60;SAP=42;ABP=27;SAR=0;SAF=18	MPZ	3'UTR	MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::,MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]				rs185093979	0.28218	0.21217,0.17742,0.24159,0.37510,0.27469	1,	20069	51057	-0.5840	0.46			/0.0>0.0/0.0>0.0		MPZ|0.00|0.00|0.00|0.00|25|-10|49|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161305115	161305115	T	C	wt	het	wt		QUAL=172;DP=68,29,18;AF=0.00,0.38,0.00;MQM=60;SAP=3;ABP=7;SAR=6;SAF=5	MPZ	3'UTR	MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::,MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	293304 [benign DISEASE=Roussy-Levy syndrome,Neuropathy, congenital hypomyelinating, 2,not provided,Charcot-Marie-Tooth disease type 4E,Charcot-Marie-Tooth disease type 1B,Charcot-Marie-Tooth disease dominant intermediate D];			rs16832786	0.12919	0.22065,0.08420,0.04125,0.10417,0.14830	1547,	16520	132212	-1.1360	2.00			/0.2>7.4/0.0>0.0		MPZ|0.00|0.00|0.00|0.00|-1|27|-1|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161306644	161306644	A	G	hom	hom	hom	off-target	QUAL=12517;DP=181,88,126;AF=1.00,1.00,1.00;MQM=60;SAP=31;ABP=0;SAR=162;SAF=233	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000491222.5:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000672287.2:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron3/5:c.367+145T>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	683189 [benign DISEASE=not provided];			rs6674383	1.00000	1.00000,1.00000,1.00000,1.00000,1.00000	76078,	0	0	-1.2910	0.63			/0.0>0.0/1.0>5.3		MPZ|0.00|0.00|0.00|0.00|-35|-48|40|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161307006	161307006	G	A	het	wt	wt	off-target	QUAL=73;DP=77,15,15;AF=0.31,0.00,0.07;MQM=51;SAP=57;ABP=27;SAR=25;SAF=0	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron2/5:c.235-85C>T::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron2/5:c.235-85C>T::,MPZ:ENST00000491222.5:intron_variant:MODIFIER:intron1/4:c.-354-85C>T::,MPZ:ENST00000672287.2:intron_variant:MODIFIER:intron1/4:c.-354-85C>T::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron2/5:c.235-85C>T::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs76800398	0.01474	0.01067,0.01269,0.01020,0.01798,0.00292	0,	115	7685	0.8930	2.50			/2.2>2.1/0.0>0.0		MPZ|0.00|0.00|0.00|0.00|-13|33|11|46		0	20	0	0 / 0					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161309728	161309728	T	C	wt	het	n/a	off-target	QUAL=41;DP=8,4,1;AF=0.00,0.75,0.00;MQM=60;SAP=10;ABP=5;SAR=0;SAF=3	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron1/5:c.67+111A>G::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron1/5:c.67+111A>G::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron1/5:c.67+111A>G::		159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]&602413_[GENE=SDHC_PHENOS=Paragangliomas 3, 605373 (3), Autosomal dominant; Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3), Isolated cases, Autosomal dominant]	667646 [benign DISEASE=not provided];			rs11579939	0.07918	0.05163,0.06693,0.00330,0.10658,0.09996	560,	10867	139401	0.0980	13.94			/0.0>0.0/2.1>2.0		MPZ|0.00|0.00|0.00|0.00|17|-2|5|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25), SDHC (inh=AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.67)
chr1	167430497	167430497	A	C	het	het	wt	off-target	QUAL=1875;DP=121,40,51;AF=0.51,0.48,0.00;MQM=60;SAP=179;ABP=3;SAR=0;SAF=81	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2527T>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870875	0.36814	0.30084,0.46944,0.43004,0.36056,0.45483	10608,	34779	96107	-0.7870	0.38			/0.0>0.0/0.0>0.0			25569266,23936387	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430524	167430524	T	G	hom	hom	hom	off-target	QUAL=6811;DP=115,54,65;AF=1.00,1.00,1.00;MQM=60;SAP=511;ABP=0;SAR=0;SAF=234	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2500A>C::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870876	0.86049	0.79641,0.88770,0.76618,0.88526,0.90745	56559,	17813	21227	-1.5450	1.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430631	167430631	-	AG	hom	hom	hom		QUAL=15224;DP=190,147,177;AF=0.99,0.99,0.99;MQM=60;SAP=783;ABP=0;SAR=41;SAF=469	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2391_429+2392dup::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs5778549	0.98770	0.95827,0.99268,0.99981,0.99977,0.99938	74289,	1791	1873		0.42			/1.1>1.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430725	167430725	T	C	hom	hom	hom		QUAL=39603;DP=383,381,465;AF=1.00,1.00,1.00;MQM=60;SAP=331;ABP=0;SAR=399;SAF=830	CD247	intron,3'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2299A>G::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*956A>G::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*956A>G::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs947480	0.98773	0.95835,0.99274,1.00000,0.99977,0.99938	74309,	1788	1868	-1.3400	1.51			/1.4>1.2/0.0>0.0		CD247|0.00|0.00|0.00|0.00|30|-46|-2|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430837	167430837	T	A	hom	hom	hom		QUAL=44599;DP=405,434,558;AF=1.00,1.00,1.00;MQM=60;SAP=15;ABP=0;SAR=742;SAF=654	CD247	intron,3'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2187A>T::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*844A>T::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*844A>T::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs1052231	0.81878	0.75908,0.86003,0.76455,0.83642,0.86853	51196,	22197	27575	-0.1800	2.97			/0.0>0.0/0.0>0.0		CD247|0.00|0.00|0.00|0.00|22|48|41|-1	25569266,18178846,30064597,19422667,23861880,34233083,33902375	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167434267	167434267	A	G	hom	hom	hom	off-target	QUAL=3736;DP=89,20,22;AF=1.00,1.00,1.00;MQM=60;SAP=287;ABP=0;SAR=131;SAF=0	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron5/7:c.334-191T>C::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron3/4:c.52-191T>C::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron3/5:c.49-191T>C::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron4/6:c.49-191T>C::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron4/6:c.178-191T>C::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron5/7:c.49-191T>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron6/8:c.361-191T>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron5/6:c.337-191T>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.253-191T>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron6/8:c.358-191T>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron5/6:c.334-191T>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron6/8:c.52-191T>C::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron3/5:c.52-191T>C::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1259945 [benign DISEASE=not provided];			rs952962	0.86286	0.80317,0.89010,0.76683,0.88583,0.90862	56763,	17673	20853	-1.3100	0.26			/0.0>0.0/0.0>0.0		CD247|0.00|0.00|0.00|0.00|49|-19|-7|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438449	167438449	T	C	hom	hom	hom	off-target	QUAL=11109;DP=161,104,111;AF=1.00,1.00,1.00;MQM=60;SAP=819;ABP=0;SAR=0;SAF=376	CD247	intron,missense	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron2/4:c.15+121A>G::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron3/6:c.15+121A>G::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron3/6:c.144+121A>G::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron4/7:c.15+121A>G::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.252+169A>G::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700161.1:missense_variant:MODERATE:exon2/2:c.136A>G:p.Arg46Gly:,CD247:ENST00000700142.1:missense_variant:MODERATE:exon4/4:c.421A>G:p.Arg141Gly:		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1192703 [benign DISEASE=not provided,Immunodeficiency 25];			rs2462553	0.86554	0.80761,0.89130,0.77434,0.88807,0.90824	57110,	17375	20443	-2.3710	0.12			/4.9>0.0/0.0>0.0		CD247|0.00|0.04|0.00|0.00|-8|-2|11|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438836	167438836	C	A	hom	hom	hom	off-target	QUAL=6350;DP=118,39,56;AF=1.00,1.00,1.00;MQM=60;SAP=415;ABP=0;SAR=207;SAF=6	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron1/4:c.-66-186G>T::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron2/6:c.-66-186G>T::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron2/6:c.64-186G>T::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron3/7:c.-66-186G>T::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700161.1:intron_variant:MODIFIER:intron1/1:c.-66-186G>T::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron3/3:c.220-186G>T::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1258083 [benign DISEASE=not provided];			rs2258497	0.86005	0.82264,0.87899,0.77549,0.87313,0.89145	56310,	18103	21271	-1.1210	0.32			/3.7>0.0/0.8>0.0	COSV62979487	CD247|0.00|0.00|0.00|0.00|-15|48|36|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167439433	167439433	C	T	het	het	hom	off-target	QUAL=11590;DP=77,224,288;AF=0.53,0.50,0.99;MQM=60;SAP=173;ABP=3;SAR=311;SAF=126	CD247	intron,5'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700155.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-156G>A::,CD247:ENST00000470379.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron1/6:c.-123-33G>A::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron1/6:c.7-33G>A::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron2/7:c.-123-33G>A::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000476733.6:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700161.1:5_prime_UTR_variant:MODIFIER:exon1/2:c.-156G>A::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron2/3:c.163-33G>A::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1179252 [benign DISEASE=not provided];			rs840016	0.28272	0.08787,0.30624,0.10479,0.40320,0.29189	7499,	28012	109122	0.5350	10.89			/1.7>1.6/0.0>0.0	COSV62980812	CD247|0.00|0.00|0.00|0.00|-38|-41|-4|46	20453842,20933377,22294642,22355377,26119816,33344378	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167440943	167440943	C	T	wt	wt	het	off-target	QUAL=1166;DP=115,78,111;AF=0.00,0.00,0.51;MQM=60;SAP=127;ABP=3;SAR=57;SAF=0	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron1/7:c.-227-176G>A::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron2/8:c.83-176G>A::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron2/8:c.83-176G>A::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron1/3:c.59-176G>A::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1706749 [likely benign DISEASE=not provided];			rs75534980	0.01319	0.00249,0.01413,0.00000,0.01964,0.00290	33,	1942	150194	0.2630	3.51			/0.0>0.0/0.0>0.0		CD247|0.00|0.00|0.01|0.02|37|-11|10|-11		9	475	0	0 / 0					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167518349	167518349	C	G	het	het	wt	off-target	QUAL=1448;DP=49,67,87;AF=0.53,0.55,0.00;MQM=60;SAP=115;ABP=5;SAR=3;SAF=60	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron1/8:c.-327+59G>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron1/3:c.58+59G>C::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1237879 [benign DISEASE=not provided];		(CCACTC)n (Simple_repeat)	rs35864197	0.14286	0.07561,0.12948,0.01793,0.18840,0.23942	1771,	18179	130325	0.8050	6.53			/6.0>6.5/1.2>1.3		CD247|0.00|0.00|0.00|0.02|-3|-16|-7|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	173825449	173825449	C	T	wt	wt	het	off-target	QUAL=200;DP=37,23,34;AF=0.00,0.04,0.41;MQM=60;SAP=36;ABP=5;SAR=15;SAF=0	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron1/13:c.127+93C>T::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron1/15:c.127+93C>T::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron1/14:c.127+93C>T::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron1/16:c.127+93C>T::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron1/15:c.127+93C>T::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron1/13:c.127+93C>T::	regulatory_region_variant:promoter	610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs146050880	0.03089	0.01349,0.02635,0.00468,0.04142,0.03458	83,	4260	138840	-1.6540	2.12			/1.5>1.7/0.0>0.0	COSV53408650	DARS2|0.00|0.00|0.00|0.00|33|41|-2|2		11	181	0	0 / 0					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173826666	173826666	T	-	het	het	het	off-target;low_conf_region	QUAL=777;DP=119,22,47;AF=0.22,0.32,0.21;MQM=60;SAP=96;ABP=123;SAR=0;SAF=43	DARS2	splice_region&intron	DARS2:ENST00000648960.1:splice_region_variant&intron_variant:LOW:intron1/13:c.128-5del::,DARS2:ENST00000648807.1:splice_region_variant&intron_variant:LOW:intron1/15:c.128-5del::,DARS2:ENST00000649067.1:splice_region_variant&intron_variant:LOW:intron1/14:c.128-5del::,DARS2:ENST00000649689.2:splice_region_variant&intron_variant:LOW:intron1/16:c.128-5del::,DARS2:ENST00000647645.1:splice_region_variant&intron_variant:LOW:intron1/15:c.128-5del::,DARS2:ENST00000648458.1:splice_region_variant&intron_variant:LOW:intron1/13:c.128-5del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs746151025	0.01136	0.00552,0.01243,0.02142,0.01313,0.00781	4,	1456	127406	0.0210	1.78			/2.6>2.5/0.0>0.0		DARS2|0.04|0.00|0.00|0.00|-3|9|19|22		4	1621	0	0 / 0					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173838019	173838019	C	T	wt	wt	het	off-target	QUAL=644;DP=86,49,57;AF=0.00,0.00,0.51;MQM=60;SAP=66;ABP=3;SAR=0;SAF=29	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron8/13:c.771-171C>T::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron8/15:c.771-171C>T::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron8/14:c.771-171C>T::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron8/16:c.771-171C>T::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron8/15:c.771-171C>T::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron8/13:c.771-171C>T::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	683703 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs3791021	0.18751	0.39525,0.12269,0.31875,0.09214,0.10439	4119,	20262	123490	-1.5910	0.42			/3.4>3.7/0.0>0.0		DARS2|0.00|0.00|0.01|0.00|-33|7|31|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173845120	173845120	T	C	wt	wt	het	off-target	QUAL=408;DP=120,33,41;AF=0.00,0.00,0.49;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron11/13:c.1129-109T>C::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron11/15:c.1129-109T>C::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron11/14:c.1129-109T>C::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron11/16:c.1129-109T>C::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1128+4147T>C::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron11/13:c.1129-109T>C::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	671620 [benign DISEASE=not provided];			rs77124001	0.08235	0.03939,0.07547,0.31520,0.08885,0.10041	744,	11037	139569	-0.1400	2.41			/3.4>2.7/0.0>0.0	COSV53406344	DARS2|0.00|0.00|0.00|0.00|6|14|6|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850284	173850284	A	-	het	het	het	off-target;low_conf_region	QUAL=443;DP=81,19,29;AF=0.19,0.26,0.24;MQM=60;SAP=62;ABP=98;SAR=0;SAF=27	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5007del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-3051del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron12/16:c.1192-29del::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1129-29del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron12/13:c.1192-29del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs199872112	0.00132	0.00120,0.00083,0.00095,0.00137,0.00165	0,	153	115811	-2.2710	0.11			/0.0>0.0/0.0>0.0		DARS2|0.00|0.00|0.00|0.00|26|40|16|44		6	832	0	0 / 0					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850606	173850606	T	-	het	het	het	off-target	QUAL=208;DP=49,18,25;AF=0.29,0.28,0.16;MQM=59;SAP=53;ABP=53;SAR=23;SAF=0	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5330del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-2728del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-2728del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron13/16:c.1344+142del::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron12/15:c.1281+142del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron13/13:c.1344+142del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	1201456 [likely benign DISEASE=not provided];		AluSx (SINE/Alu)	rs66665709	0.00408	0.00063,0.00410,0.00228,0.00359,0.00204	0,	578	141250	2.0850	5.40			/8.7>8.6/0.0>0.0		DARS2|0.00|0.00|0.00|0.00|-19|20|-50|45		3	474	0	0 / 0					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179550354	179550354	G	A	hom	hom	hom	off-target	QUAL=694;DP=16,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	AXDND1	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4158G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4158G>A::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs3767840	0.61418	0.60373,0.63863,0.46928,0.62513,0.59138	28791,	35662	58576	0.0230	5.93			/0.0>0.0/1.5>0.0		AXDND1|0.00|0.00|0.00|0.00|44|-7|44|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550503	179550506	TTTC	-	wt	wt	het	off-target	QUAL=485;DP=124,52,58;AF=0.00,0.00,0.41;MQM=60;SAP=55;ABP=7;SAR=0;SAF=24	AXDND1	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4006_*1207-4003del::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs147171656	0.20230	0.06925,0.20275,0.04925,0.27226,0.19259	3759,	23206	121150	0.8130	9.71			/3.8>3.5/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|19|35|32|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550745	179550745	T	C	hom	hom	hom		QUAL=27916;DP=268,273,330;AF=1.00,1.00,1.00;MQM=60;SAP=208;ABP=0;SAR=579;SAF=292	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3767T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224486 [benign DISEASE=Nephrotic syndrome, type 2];			rs1060775	0.90449	0.84193,0.93581,0.96387,0.92966,0.87765	62357,	12792	14520	0.2640	3.71			/1.6>1.9/0.0>0.0,/6.6>6.7/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|40|41|40|-31,NPHS2|0.00|0.00|0.00|0.00|-1|-4|-13|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550915	179550915	T	C	het	hom	wt		QUAL=7954;DP=330,121,177;AF=0.45,1.00,0.00;MQM=60;SAP=42;ABP=10;SAR=100;SAF=170	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3597T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224485 [benign DISEASE=not provided,Nephrotic syndrome, type 2];			rs2274622	0.24181	0.12728,0.30247,0.35590,0.28105,0.35068	4892,	26967	115233	0.2590	6.33			/2.7>2.3/0.0>0.0,/0.0>0.0/0.7>1.2		AXDND1|0.00|0.00|0.00|0.00|-2|50|50|5,NPHS2|0.00|0.00|0.00|0.00|29|23|-22|-19	17942957	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551016	179551016	C	T	hom	hom	hom		QUAL=24195;DP=286,194,263;AF=1.00,1.00,0.99;MQM=60;SAP=28;ABP=0;SAR=324;SAF=417	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3496C>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224483 [benign DISEASE=not provided,Nephrotic syndrome, type 2];			rs1410590	0.90723	0.85160,0.93656,0.96364,0.92970,0.87795	62758,	12506	14114	-1.5440	0.37			/0.5>1.6/0.0>0.0,/0.0>0.0/2.8>0.0		AXDND1|0.00|0.00|0.00|0.00|6|22|-2|15,NPHS2|0.00|0.00|0.00|0.00|-2|26|-26|0	23269701,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551119	179551119	C	G	hom	hom	hom		QUAL=22310;DP=393,131,175;AF=0.99,0.99,0.99;MQM=60;SAP=192;ABP=0;SAR=470;SAF=224	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3393C>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	293845 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs1410591	0.61471	0.60392,0.63834,0.46811,0.62645,0.59112	28851,	35685	58533	0.9520	5.38			/1.4>2.1/3.0>2.9,/0.0>0.0/0.0>0.0	COSV62634863	AXDND1|0.00|0.00|0.00|0.00|16|-2|-3|-2,NPHS2|0.00|0.00|0.00|0.00|-7|-32|-48|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551371	179551371	G	A	hom	hom	hom		QUAL=20887;DP=350,128,184;AF=0.99,0.99,1.00;MQM=60;SAP=26;ABP=0;SAR=287;SAF=371	AXDND1,NPHS2	intron,synonymous	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3141G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260432 [benign DISEASE=not provided,Nephrotic syndrome, type 2,Steroid-resistant nephrotic syndrome,not specified];			rs1410592	0.61404	0.60388,0.63820,0.46766,0.62517,0.59119	28786,	35685	58617	-0.5620	2.36			/0.0>0.0/0.0>0.0,/3.8>3.6/0.0>0.0	COSV62634578	AXDND1|0.00|0.00|0.00|0.00|21|-33|21|-16,NPHS2|0.00|0.00|0.00|0.00|-44|13|-29|19	25741868,20947785,31754646,24070238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552549	179552549	T	C	het	wt	het	off-target	QUAL=3052;DP=149,83,125;AF=0.45,0.00,0.47;MQM=60;SAP=162;ABP=7;SAR=15;SAF=111	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1963T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1227202 [benign DISEASE=not provided];			rs11808359	0.04676	0.01156,0.03282,0.00000,0.06996,0.02640	265,	6582	144998	-0.1000	4.38			/3.5>3.2/0.0>0.0,/0.0>0.0/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|34|11|-10|-26,NPHS2|0.00|0.00|0.00|0.00|-5|-40|5|-4		102	2376	0	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552596	179552596	T	C	wt	het	wt		QUAL=1107;DP=140,114,198;AF=0.01,0.45,0.00;MQM=60;SAP=21;ABP=6;SAR=16;SAF=37	AXDND1,NPHS2	intron,splice_region&intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1916T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,NPHS2:ENST00000367615.9:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,NPHS2:ENST00000367616.4:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260430 [benign/likely benign DISEASE=Focal segmental glomerulosclerosis,Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs115778946	0.02974	0.00725,0.03430,0.00039,0.04782,0.00872	97,	4326	147484	-0.3160	1.92			/0.0>0.0/0.0>0.0,/5.3>6.0/0.0>0.0		AXDND1|0.00|0.06|0.00|0.00|-36|36|-24|47,NPHS2|0.00|0.00|0.00|0.06|7|11|13|7	25741868	91	2617	0	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552797	179552797	G	T	hom	hom	het	off-target	QUAL=8404;DP=158,84,103;AF=1.00,1.00,0.46;MQM=60;SAP=515;ABP=5;SAR=275;SAF=14	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1715G>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1715G>T::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron6/7:c.795-116C>A::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron5/6:c.591-116C>A::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1289362 [benign DISEASE=not provided];			rs2274626	0.41652	0.55253,0.43680,0.43180,0.35212,0.39760	13856,	35588	88674	-0.3310	2.27			/0.0>0.0/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|8|1|8|39,NPHS2|0.00|0.00|0.00|0.00|5|24|5|-30	17903305,17942957,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559782	179559782	G	A	wt	wt	het	off-target	QUAL=2053;DP=168,135,157;AF=0.00,0.00,0.53;MQM=60;SAP=12;ABP=4;SAR=51;SAF=32	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-21C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180466 [benign DISEASE=not provided,Nephrotic syndrome, type 2];			rs12401708	0.20229	0.06962,0.20254,0.04840,0.27185,0.19349	3794,	23157	121243	0.0840	2.16			/0.0>0.0/0.0>0.0		NPHS2|0.00|0.00|0.00|0.00|-21|-1|2|-20	20947785,26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559807	179559807	G	A	wt	wt	het	off-target	QUAL=1843;DP=146,116,139;AF=0.00,0.00,0.55;MQM=60;SAP=22;ABP=6;SAR=51;SAF=25	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-46C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180467 [benign DISEASE=not provided,Nephrotic syndrome, type 2];			rs12401711	0.20245	0.06976,0.20244,0.04882,0.27206,0.19358	3795,	23177	121203	-0.3660	1.72			/0.0>0.7/0.0>0.0	COSV62635112	NPHS2|0.00|0.00|0.00|0.00|-11|20|48|43	26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559905	179559905	G	A	het	wt	het	off-target	QUAL=1366;DP=75,39,52;AF=0.48,0.00,0.46;MQM=60;SAP=133;ABP=4;SAR=60;SAF=0	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-144C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-144C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1232335 [benign DISEASE=not provided];		MER94 (DNA/hAT-Blackjack)	rs41267604	0.05185	0.03087,0.03433,0.00000,0.06959,0.02637	272,	7339	144165	-0.0400	3.52			/11.3>11.9/0.0>0.0		NPHS2|0.00|0.00|0.00|0.00|-11|-5|-10|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179575763	179575763	T	C	n/a	hom	hom		QUAL=442;DP=1,3,13;AF=1.00,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=7;SAF=10	NPHS2	synonymous	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260424 [benign DISEASE=not provided,Steroid-resistant nephrotic syndrome,not specified,Nephrotic syndrome, type 2];			rs1079292	0.94744	0.84392,0.97546,0.97752,0.99278,0.94058	68551,	6873	7987	-0.4120	2.12			/0.0>0.0/0.0>0.0	COSV62634486	NPHS2|0.00|0.00|0.00|0.00|-16|48|18|-1	25741868,20947785,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575915	179575915	C	A	n/a	wt	het		QUAL=196;DP=1,9,18;AF=0.00,0.00,0.61;MQM=60;SAP=3;ABP=5;SAR=6;SAF=5	NPHS2	5'UTR	NPHS2:ENST00000367615.9:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	225144 [benign DISEASE=Focal segmental glomerulosclerosis,not specified,not provided,Nephrotic syndrome, type 2]; 225143 [pathogenic DISEASE=Nephrotic syndrome, type 2];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.23671	0.15988,0.26848,0.11330,0.27251,0.20790	4502,	26994	116076	-1.1430	4.19			/9.0>9.3/0.0>0.0	COSV62635817	NPHS2|0.00|0.00|0.00|0.00|-10|13|-10|13	20947785,16900088,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575980	179575980	G	A	n/a	hom	wt	off-target	QUAL=67;DP=1,4,7;AF=1.00,1.00,0.00;MQM=60;SAP=14;ABP=0;SAR=5;SAF=0	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615.9:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1165811 [benign DISEASE=not provided,Nephrotic syndrome, type 2,Steroid-resistant nephrotic syndrome];	CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.23313	0.09573,0.29779,0.36444,0.28133,0.35845	4745,	25907	116435	-4.5670	0.94							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180230249	180230249	-	AG	het	hom	wt	off-target	QUAL=208;DP=31,9,9;AF=0.39,1.00,0.00;MQM=60;SAP=49;ABP=6;SAR=0;SAF=21	LHX4	upstream_gene	LHX4:ENST00000263726.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]			G-rich (Low_complexity)	rs138033992	0.41420	0.45466,0.33692,0.17075,0.43426,0.38362	13157,	35628	87604		18.33							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180248115	180248115	C	T	het	hom	wt	off-target	QUAL=2249;DP=100,38,50;AF=0.50,1.00,0.00;MQM=60;SAP=194;ABP=3;SAR=0;SAF=88	LHX4	intron	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron1/5:c.77-170C>T::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1269459 [benign DISEASE=not provided];		MER91A (DNA/hAT-Tip100)	rs4652490	0.18337	0.20192,0.13441,0.15877,0.19669,0.08213	2695,	22499	124203	-0.3180	0.75			/0.4>0.4/6.8>3.4		LHX4|0.00|0.00|0.01|0.02|46|0|-34|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180248656	180248656	C	T	het	hom	wt	off-target	QUAL=716;DP=54,12,24;AF=0.46,0.92,0.00;MQM=60;SAP=81;ABP=4;SAR=36;SAF=0	LHX4	intron	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron2/5:c.248+200C>T::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1285896 [benign DISEASE=not provided];			rs3911334	0.18329	0.20192,0.13410,0.15799,0.19672,0.08213	2690,	22503	124243	-3.2990	0.11			/0.0>0.0/0.0>0.0		LHX4|0.00|0.00|0.00|0.00|-43|37|34|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180266593	180266593	C	T	het	wt	het		QUAL=1863;DP=74,91,107;AF=0.51,0.00,0.42;MQM=60;SAP=88;ABP=6;SAR=70;SAF=13	LHX4	splice_region&synonymous	LHX4:ENST00000263726.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262223 [benign DISEASE=not provided,not specified,Short stature-pituitary and cerebellar defects-small sella turcica syndrome];			rs16855642	0.03891	0.10319,0.01825,0.01464,0.01120,0.01781	261,	5396	146194	-0.7690	8.34			9.9>9.3/0.0>0.0/9.9>9.3		LHX4|0.00|0.00|0.00|0.00|37|-47|-2|1	25741868	15	808	0	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271375	180271375	T	C	het	het	wt		QUAL=1647;DP=67,77,115;AF=0.52,0.47,0.00;MQM=60;SAP=76;ABP=3;SAR=11;SAF=60	LHX4,ACBD6	splice_region&intron,3'UTR	LHX4:ENST00000263726.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1850A>G::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	293866 [benign DISEASE=not provided,Short stature-pituitary and cerebellar defects-small sella turcica syndrome];			rs2764449	0.05754	0.01489,0.04538,0.01813,0.07856,0.07167	357,	8038	143352	1.0550	8.63			10.0>9.2/10.0>9.2/0.0>0.0,/0.0>0.0/0.2>0.0	COSV55378051	LHX4|0.00|0.00|0.00|0.00|-11|5|14|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271617	180271617	C	T	het	het	het	off-target	QUAL=2226;DP=69,45,63;AF=0.55,0.49,0.51;MQM=60;SAP=67;ABP=4;SAR=72;SAF=20	LHX4,ACBD6	intron,3'UTR	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron4/5:c.606+83C>T::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1608G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1266198 [benign DISEASE=not provided];			rs3845397	0.39988	0.16870,0.33108,0.56347,0.49926,0.59144	14049,	32521	90973	-3.5160	0.05			/4.2>3.8/0.0>0.0,/1.9>2.2/3.6>0.0	COSV55372623	LHX4|0.00|0.00|0.00|0.00|17|2|-24|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180274389	180274389	A	G	het	het	het		QUAL=7713;DP=212,155,204;AF=0.48,0.48,0.57;MQM=60;SAP=6;ABP=4;SAR=156;SAF=137	LHX4,ACBD6	missense,intron	LHX4:ENST00000263726.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron10/13:c.*936+262T>C::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262225 [benign DISEASE=not specified,not provided,Short stature-pituitary and cerebellar defects-small sella turcica syndrome];			rs7536561	0.41969	0.18799,0.34459,0.59311,0.51844,0.60763	15297,	33139	88125	2.5250	13.78	0.26	0.06	/0.6>5.7/0.0>0.0,/0.0>0.0/0.0>0.0	COSV55374116	LHX4|0.00|0.00|0.00|0.00|1|25|23|-35	25741868,25938945,23199197,29998616,34868058	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180288557	180288557	A	C	hom	hom	hom	off-target	QUAL=19104;DP=251,156,203;AF=1.00,1.00,1.00;MQM=60;SAP=835;ABP=0;SAR=546;SAF=63	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.695-40T>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::	regulatory_region_variant:enhancer					rs2254465	0.94985	0.96076,0.94288,0.98844,0.94442,0.91158	68664,	7144	7628	-3.9170	0.01			/0.3>0.0/3.2>3.0		ACBD6|0.00|0.00|0.00|0.00|41|-40|-48|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180314524	180314524	T	C	hom	hom	hom	off-target	QUAL=4532;DP=84,32,36;AF=1.00,1.00,1.00;MQM=58;SAP=333;ABP=0;SAR=0;SAF=152	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.694+168A>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.694+168A>G::					AluSx1 (SINE/Alu)	rs2764433	0.95642	0.98299,0.94604,0.98827,0.94469,0.91169	69688,	6202	6634	-2.3750	0.19			/0.0>0.1/0.0>0.0		ACBD6|0.00|0.00|0.00|0.00|34|32|-48|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180397348	180397348	G	C	het	het	hom	off-target	QUAL=1636;DP=60,17,27;AF=0.52,0.35,1.00;MQM=60;SAP=133;ABP=3;SAR=1;SAF=63	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron6/13:c.663+168C>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron6/7:c.663+168C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant				L1MB5 (LINE/L1)	rs10798759	0.54992	0.39800,0.51627,0.56510,0.62356,0.66777	23793,	35916	68342	-0.2870	0.48			/0.0>0.0/0.0>0.0		ACBD6|0.00|0.00|0.00|0.00|-31|20|47|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180413647	180413647	T	A	het	het	hom	off-target	QUAL=940;DP=76,7,7;AF=0.39,0.57,1.00;MQM=60;SAP=92;ABP=9;SAR=41;SAF=0	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron4/13:c.468-176A>T::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron4/7:c.468-176A>T::						rs4421553	0.48668	0.18711,0.48668,0.56347,0.62030,0.65970	20797,	32315	77955	-0.5460	0.49			/0.6>8.3/0.0>0.0		ACBD6|0.01|0.00|0.00|0.00|-11|-2|24|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180501931	180501931	C	T	het	n/a	n/a	off-target	QUAL=55;DP=7,1,0;AF=0.71,1.00,;MQM=60;SAP=16;ABP=6;SAR=0;SAF=6	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron1/13:c.222+114G>A::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron1/7:c.222+114G>A::	regulatory_region_variant:promoter				(A)n (Simple_repeat)	rs61811621	0.02082	0.00545,0.01590,0.00000,0.02579,0.00591	55,	3020	147242	-1.3100	2.37			/0.0>0.0/0.0>0.0		ACBD6|0.00|0.00|0.00|0.00|-46|-4|7|40		19	154	0	0 / 0					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183186093	183186093	C	A	wt	het	wt		QUAL=2647;DP=175,250,307;AF=0.00,0.49,0.01;MQM=60;SAP=61;ABP=3;SAR=34;SAF=92	LAMC2	upstream_gene	LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293975 [benign DISEASE=not provided,Junctional epidermolysis bullosa];			rs2276544	0.13949	0.06493,0.19187,0.31515,0.15977,0.19619	1751,	17696	130766	0.1400	13.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186170	183186170	G	A	het	wt	hom		QUAL=19363;DP=269,354,500;AF=0.55,0.00,1.00;MQM=60;SAP=65;ABP=8;SAR=255;SAF=391	LAMC2	upstream_gene	LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293977 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276543	0.27316	0.19574,0.31483,0.38094,0.27890,0.33789	5955,	29601	110453	3.4730	21.50						29875488,30072576,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186264	183186264	A	G	wt	het	wt		QUAL=3315;DP=377,283,400;AF=0.01,0.48,0.00;MQM=60;SAP=4;ABP=4;SAR=73;SAF=67	LAMC2	5'UTR	LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::,LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293979 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided,Junctional epidermolysis bullosa];			rs2276542	0.18113	0.21584,0.20414,0.33056,0.15814,0.19979	2655,	22236	124534	1.7150	17.56			/0.0>0.0/0.3>0.0	COSV51459231			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186347	183186347	C	A	wt	wt	het		QUAL=799;DP=26,68,91;AF=0.00,0.00,0.47;MQM=60;SAP=25;ABP=4;SAR=11;SAF=32	LAMC2	5'UTR	LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::,LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293983 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided,Junctional epidermolysis bullosa];			rs684527	0.25651	0.10120,0.29455,0.42763,0.29493,0.34348	5789,	27397	112971	0.4330	18.61			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|2|45|-3|-50	30048462,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186565	183186565	C	A	het	wt	hom	off-target	QUAL=859;DP=68,16,13;AF=0.44,0.00,1.00;MQM=60;SAP=96;ABP=5;SAR=43;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+134C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+134C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1250223 [benign DISEASE=not provided];			rs6678888	0.31671	0.24141,0.33498,0.46349,0.31671,0.38066	7112,	31062	97704	0.9110	8.75			/3.8>1.8/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|-44|21|35|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186581	183186581	T	-	het	het	hom	off-target	QUAL=720;DP=61,13,7;AF=0.44,0.46,1.00;MQM=60;SAP=90;ABP=5;SAR=40;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+150del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+150del::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1178172 [benign DISEASE=not provided];			rs60707856	0.55949	0.68878,0.56843,0.72620,0.47512,0.56019	24518,	35809	66801	0.6650	6.26			/4.9>6.0/0.0>0.0	COSV51452174,COSV51455144	LAMC2|0.00|0.00|0.00|0.00|-30|6|-48|-36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186582	183186582	C	A	het	het	hom	off-target	QUAL=720;DP=61,13,7;AF=0.44,0.46,1.00;MQM=60;SAP=90;ABP=5;SAR=40;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+151C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+151C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1253775 [benign DISEASE=not provided];			rs61418038	0.55951	0.68880,0.56843,0.72611,0.47512,0.56061	24521,	35812	66804	0.0720	7.80			/4.9>5.1/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|4|6|-50|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	T	het	het	het	off-target;low_conf_region	QUAL=1126;DP=59,54,46;AF=0.12,0.39,0.28;MQM=60;SAP=84;ABP=84;SAR=1;SAF=40	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-31dup::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1224645 [benign DISEASE=not provided];			rs10668798	0.17473	0.19717,0.16584,0.25324,0.15821,0.22682	2244,	19899	115183		7.18			/0.8>2.0/1.5>1.5	COSV51458071	LAMC2|0.02|0.00|0.00|0.00|46|33|-3|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	TT	wt	wt	het	off-target;low_conf_region	QUAL=1126;DP=59,54,46;AF=0.10,0.06,0.39;MQM=60;SAP=62;ABP=154;SAR=0;SAF=27	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1229395 [benign DISEASE=not provided];			rs10668798	0.34065	0.29795,0.36821,0.37829,0.34953,0.27783	8267,	30995	91997		6.90			/0.8>1.8/1.5>1.5	COSV51458071	LAMC2|0.00|0.00|0.00|0.00|20|46|46|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208083	183208083	A	G	het	wt	hom	off-target	QUAL=9050;DP=136,214,242;AF=0.47,0.00,1.00;MQM=60;SAP=220;ABP=4;SAR=241;SAF=66	LAMC2	splice_region&intron	LAMC2:ENST00000493293.5:splice_region_variant&intron_variant:LOW:intron2/21:c.268+14A>G::,LAMC2:ENST00000264144.5:splice_region_variant&intron_variant:LOW:intron2/22:c.268+14A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259785 [benign DISEASE=Junctional epidermolysis bullosa,not specified,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];		GA-rich (Low_complexity)	rs647347	0.45849	0.46730,0.48023,0.55168,0.42879,0.50832	16114,	37313	82133	-1.3710	0.14			/0.0>0.0/2.5>1.4	COSV51456075,COSV51458451	LAMC2|0.00|0.00|0.07|0.00|48|-13|-14|-26	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208147	183208147	G	C	wt	het	wt	off-target	QUAL=1691;DP=163,125,131;AF=0.00,0.56,0.00;MQM=60;SAP=155;ABP=7;SAR=70;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.268+78G>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.268+78G>C::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			GA-rich (Low_complexity)							-0.5790	0.17			/0.0>0.0/0.1>0.0		LAMC2|0.00|0.00|0.00|0.00|7|1|-37|45		0	0	0	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215293	183215293	C	T	wt	het	wt	off-target	QUAL=871;DP=98,60,84;AF=0.00,0.62,0.01;MQM=60;SAP=86;ABP=10;SAR=0;SAF=38	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.269-160C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.269-160C>T::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1287887 [benign DISEASE=not provided];			rs2274982	0.10393	0.03549,0.12847,0.18699,0.12856,0.08413	956,	13898	136314	0.2380	1.86			/2.3>3.3/2.7>0.8		LAMC2|0.00|0.00|0.00|0.00|13|-30|1|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215389	183215389	C	T	wt	het	wt	off-target	QUAL=1451;DP=312,134,220;AF=0.00,0.48,0.00;MQM=60;SAP=90;ABP=4;SAR=7;SAF=58	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.269-64C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.269-64C>T::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1245200 [benign DISEASE=not provided];			rs2274981	0.25644	0.38707,0.28928,0.35164,0.17763,0.31061	5767,	27420	112948	0.1440	4.48			/0.0>0.0/0.0>0.0	COSV51453590	LAMC2|0.00|0.00|0.00|0.00|13|-15|-15|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215481	183215481	C	T	wt	het	wt		QUAL=2930;DP=271,244,345;AF=0.00,0.48,0.01;MQM=60;SAP=3;ABP=4;SAR=57;SAF=62	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain]	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259787 [benign DISEASE=not specified,Junctional epidermolysis bullosa,not provided,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz];			rs2274980	0.25623	0.38663,0.28945,0.35054,0.17752,0.30996	5744,	27419	112937	-0.4250	9.04			/1.8>2.5/0.0>0.0	COSV51453066	LAMC2|0.00|0.00|0.00|0.00|12|-28|-18|22	25741868,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215713	183215713	T	G	wt	het	wt	off-target	QUAL=541;DP=175,48,88;AF=0.00,0.56,0.01;MQM=60;SAP=64;ABP=5;SAR=28;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.404+125T>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.404+125T>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1227354 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs875794	0.29843	0.52996,0.30858,0.35243,0.17861,0.31201	8629,	28099	106627	-1.3930	0.24			/0.0>0.0/0.0>0.7	COSV51459573	LAMC2|0.00|0.00|0.00|0.00|-8|13|38|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218359	183218359	T	C	wt	het	wt	off-target	QUAL=3565;DP=343,296,466;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=4;SAR=63;SAF=81	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.405-31T>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.405-31T>C::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1180478 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,not provided,Junctional epidermolysis bullosa, non-Herlitz type];			rs10911285	0.25626	0.38649,0.28947,0.35043,0.17752,0.31069	5750,	27447	113033	-1.1210	6.51			/0.0>0.0/0.0>0.0	COSV51453509	LAMC2|0.00|0.00|0.00|0.00|41|31|41|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218468	183218468	C	T	wt	het	wt		QUAL=3070;DP=196,250,324;AF=0.00,0.50,0.00;MQM=60;SAP=28;ABP=3;SAR=82;SAF=44	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain]	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259789 [benign DISEASE=Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not specified,not provided];			rs1129723	0.25632	0.38665,0.28949,0.34944,0.17764,0.31064	5756,	27447	113035	0.7460	12.32			/0.0>0.0/0.0>0.0	COSV51453519	LAMC2|0.00|0.00|0.00|0.00|-40|-4|20|22	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183222009	183222009	C	T	wt	het	wt	off-target	QUAL=1103;DP=138,108,153;AF=0.00,0.45,0.00;MQM=60;SAP=78;ABP=5;SAR=4;SAF=45	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron5/21:c.641-80C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron5/22:c.641-80C>T::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1180479 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,not provided,Junctional epidermolysis bullosa, non-Herlitz type];			rs2296307	0.25750	0.39011,0.28994,0.35338,0.17780,0.31019	5817,	27473	112765	-0.0870	1.74			/0.0>0.0/2.1>1.0	COSV51453597	LAMC2|0.00|0.00|0.00|0.00|34|-7|1|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223169	183223169	T	G	wt	het	wt		QUAL=2774;DP=231,208,281;AF=0.00,0.53,0.00;MQM=60;SAP=14;ABP=5;SAR=44;SAF=68	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)]		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259790 [benign DISEASE=Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type,not specified,not provided,Junctional epidermolysis bullosa gravis of Herlitz];			rs1047980	0.29310	0.51116,0.30808,0.35205,0.17871,0.31196	8160,	28216	107412	-0.3900	10.35			/0.0>0.0/0.0>0.0	COSV51453536	LAMC2|0.02|0.00|0.00|0.00|-11|33|-34|-12	25741868,31151762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223361	183223361	A	G	wt	het	wt	off-target	QUAL=2028;DP=216,137,173;AF=0.00,0.59,0.00;MQM=60;SAP=123;ABP=13;SAR=74;SAF=7	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.953+37A>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.953+37A>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1268335 [benign DISEASE=not provided];			rs3738824	0.12694	0.11467,0.13768,0.18777,0.12909,0.08523	1242,	16826	132814	0.4220	5.28			/0.0>0.0/0.0>0.0	COSV51456347	LAMC2|0.00|0.00|0.00|0.00|-37|-36|18|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183225484	183225484	A	G	wt	het	wt	off-target	QUAL=483;DP=111,53,62;AF=0.01,0.45,0.00;MQM=60;SAP=57;ABP=4;SAR=0;SAF=25	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.954-124A>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.954-124A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1277223 [benign DISEASE=not provided];			rs2021956	0.25709	0.38907,0.28975,0.35233,0.17763,0.31090	5797,	27467	112877	-0.2240	1.15			/6.3>7.4/0.0>0.0	COSV51455315	LAMC2|0.00|0.00|0.00|0.02|18|36|-40|-16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183232835	183232835	G	C	wt	het	wt		QUAL=907;DP=128,109,163;AF=0.00,0.39,0.00;MQM=60;SAP=28;ABP=15;SAR=32;SAF=10	LAMC2	missense	LAMC2:ENST00000493293.5:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000264144.5:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259784 [benign DISEASE=not specified,Junctional epidermolysis bullosa,not provided,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz];			rs2296303	0.16086	0.23137,0.15304,0.18984,0.12956,0.08564	2136,	20179	127555	1.3040	13.16	0.07	0.10	/0.0>0.0/0.9>0.0	COSV51456358	LAMC2|0.00|0.00|0.02|0.04|-22|-1|26|-1	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236345	183236345	C	T	wt	het	wt	off-target	QUAL=534;DP=71,47,82;AF=0.00,0.55,0.01;MQM=57;SAP=62;ABP=4;SAR=0;SAF=27	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-115C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-115C>T::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1278594 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs3738823	0.15930	0.22953,0.15321,0.18937,0.12919,0.08237	2054,	19568	124954	-1.7180	0.15			/0.9>1.8/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|16|28|-15|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236389	A	-	het	het	wt	off-target;low_conf_region	QUAL=2510;DP=66,29,64;AF=0.47,0.45,0.50;MQM=59;SAP=6;ABP=171;SAR=9;SAF=15	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1235485 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs34154823	0.29727	0.49632,0.30602,0.49080,0.19223,0.35959	6215,	24421	87113	-0.0480	0.73			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|31|18|46|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236390	AA	-	het	het	het	off-target;low_conf_region	QUAL=2510;DP=66,29,64;AF=0.12,0.31,0.11;MQM=59;SAP=93;ABP=4;SAR=10;SAF=66	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-55_2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-55_2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1278088 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs34154823	0.39432	0.26065,0.38972,0.43061,0.44343,0.33388	9358,	30181	75107	0.3020	1.50			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|20|31|47|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236391	AAA	-	wt	wt	het	off-target;low_conf_region	QUAL=2510;DP=66,29,64;AF=0.06,0.03,0.31;MQM=60;SAP=28;ABP=165;SAR=4;SAF=21	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-56_2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-56_2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs34154823	0.00139	0.00037,0.00181,0.00046,0.00114,0.00000	0,	173	123955	0.3020	1.88			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|-27|20|46|-15		25	567	0	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183237438	183237438	G	A	wt	het	wt		QUAL=3682;DP=364,276,405;AF=0.00,0.51,0.00;MQM=60;SAP=27;ABP=3;SAR=91;SAF=51	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:,LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259786 [benign DISEASE=Junctional epidermolysis bullosa,not specified,Junctional epidermolysis bullosa, non-Herlitz type,not provided,Junctional epidermolysis bullosa gravis of Herlitz];			rs1047981	0.29222	0.50820,0.30640,0.35152,0.17880,0.31165	8099,	28220	107584	-0.3600	0.17			/0.0>0.0/0.0>0.0	COSV51453550	LAMC2|0.00|0.00|0.01|0.00|-36|-27|-36|17	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183238468	183238468	T	C	wt	het	wt	off-target	QUAL=1090;DP=197,82,112;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6;SAR=38;SAF=8	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]				rs1925043	0.29889	0.53113,0.30850,0.35220,0.17901,0.31216	8644,	28132	106542	-1.2890	0.62			/0.0>0.0/0.0>0.0	COSV51453562	LAMC2|0.00|0.00|0.00|0.00|-47|41|46|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183239707	183239707	T	G	wt	het	wt	off-target	QUAL=124;DP=89,11,26;AF=0.00,0.73,0.00;MQM=60;SAP=20;ABP=8;SAR=8;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron20/21:c.3069+144T>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron20/22:c.3069+144T>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1183236 [benign DISEASE=not provided];			rs648809	0.14129	0.18392,0.14588,0.19830,0.12049,0.08848	1586,	18315	130589	-0.9030	0.30			/0.0>0.0/0.5>0.6	COSV51455053	LAMC2|0.00|0.00|0.00|0.00|1|-47|1|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183239951	183239951	C	A	wt	het	wt	off-target	QUAL=726;DP=206,76,104;AF=0.00,0.49,0.00;MQM=60;SAP=83;ABP=3;SAR=0;SAF=37	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron20/21:c.3070-89C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron20/22:c.3070-89C>A::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1179728 [benign DISEASE=not provided];			rs2477436	0.27671	0.48147,0.29645,0.35192,0.16784,0.31639	7311,	27405	109857	0.1650	6.94			/1.5>1.4/0.0>0.0	COSV51453621	LAMC2|0.00|0.00|0.00|0.00|2|-11|3|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183241246	183241246	A	-	het	het	wt	low_conf_region	QUAL=143;DP=18,10,5;AF=0.28,0.60,0.20;MQM=60;SAP=6;ABP=6;SAR=8;SAF=4	LAMC2	3'UTR,intron	LAMC2:ENST00000493293.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3328+870del::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs11318188	0.19259	0.15716,0.26485,0.35829,0.18507,0.23112	1395,	17578	85392	0.4720	0.78			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|-25|32|22|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243036	183243036	C	A	wt	het	wt	off-target	QUAL=657;DP=129,61,55;AF=0.01,0.52,0.00;MQM=60;SAP=75;ABP=3;SAR=0;SAF=33	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3329-111C>A::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1276996 [benign DISEASE=not provided];			rs3768594	0.24189	0.35735,0.28191,0.37510,0.16730,0.31107	5090,	26558	115144	0.8030	4.28			/6.3>5.3/0.0>0.0	COSV51457662	LAMC2|0.00|0.00|0.00|0.00|39|6|-49|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243413	183243413	T	G	wt	het	wt		QUAL=2493;DP=214,175,247;AF=0.00,0.56,0.00;MQM=60;SAP=8;ABP=8;SAR=42;SAF=57	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294025 [benign DISEASE=Junctional epidermolysis bullosa,Junctional epidermolysis bullosa gravis of Herlitz];			rs3768593	0.24213	0.35790,0.28225,0.37524,0.16757,0.31032	5110,	26584	115198	0.2590	7.28			/0.0>0.0/0.0>0.0	COSV51452226	LAMC2|0.00|0.00|0.00|0.00|-47|-3|14|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244275	183244275	G	T	wt	het	wt		QUAL=2295;DP=275,178,200;AF=0.00,0.49,0.01;MQM=60;SAP=3;ABP=3;SAR=44;SAF=46	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294036 [benign DISEASE=Junctional epidermolysis bullosa];			rs10797863	0.09876	0.03764,0.12646,0.19626,0.11949,0.08547	861,	13288	136976	-0.1160	0.43			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|22|-23|28|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244798	183244798	C	T	wt	wt	het		QUAL=4919;DP=472,284,395;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=6;SAR=94;SAF=92	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294053 [uncertain significance DISEASE=Junctional epidermolysis bullosa];			rs564740740	0.00229	0.00068,0.00079,0.00000,0.00366,0.00207	0,	349	151837	0.4890	4.86			/0.0>0.0/0.0>0.0	COSV51452086	LAMC2|0.00|0.00|0.00|0.00|28|-43|33|49		0	89	0	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183555720	183555720	C	A	hom	hom	hom		QUAL=43774;DP=458,381,545;AF=1.00,0.99,0.99;MQM=60;SAP=108;ABP=0;SAR=560;SAF=818	NCF2	3'UTR	NCF2:ENST00000367535.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:ENST00000413720.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:ENST00000367536.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000697351.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000697330.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	294066 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2];			rs796860	0.90164	0.93754,0.89456,0.99808,0.87731,0.94753	61925,	13237	14955	-2.0460	1.14			/0.0>0.0/0.0>0.0		NCF2|0.00|0.00|0.00|0.00|-18|-1|-40|1	24163247,30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183556317	183556317	T	G	hom	hom	hom	off-target	QUAL=17388;DP=260,135,168;AF=1.00,1.00,0.99;MQM=60;SAP=772;ABP=0;SAR=504;SAF=58	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron14/14:c.1469-87A>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron13/13:c.1334-87A>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron12/12:c.1226-87A>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron13/13:c.1361-87A>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1226524 [benign DISEASE=not provided];			rs699244	0.89363	0.90676,0.89322,0.99807,0.87861,0.94755	60816,	14276	16178	0.3840	3.06			/0.0>0.0/0.7>2.3	COSV61633935	NCF2|0.00|0.00|0.00|0.00|-49|-2|16|-33	17897462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183565800	183565800	C	T	hom	hom	het	off-target	QUAL=13728;DP=149,193,253;AF=1.00,1.00,0.51;MQM=60;SAP=59;ABP=3;SAR=290;SAF=180	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron8/13:c.817-21G>A::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1235081 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2,not provided];			rs2296164	0.45515	0.36046,0.55968,0.61451,0.47392,0.46992	16095,	36866	82666	-2.9130	0.01			/0.0>0.0/0.0>0.0	COSV62315476	NCF2|0.00|0.00|0.00|0.00|-21|9|-29|-21	25416100,24163247,30567305,24239855	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183573252	183573252	T	C	hom	hom	het		QUAL=18376;DP=258,192,266;AF=0.98,1.00,0.55;MQM=60;SAP=6;ABP=8;SAR=282;SAF=309	NCF2	missense,intron	NCF2:ENST00000367535.8:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.5:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:ENST00000367536.5:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron4/13:c.501+1235A>G::,NCF2:ENST00000697330.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:	regulatory_region_variant:enhancer	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	256116 [benign DISEASE=not specified,not provided,Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2];			rs2274064	0.45737	0.36490,0.56048,0.61943,0.47298,0.51266	16259,	36951	82419	0.6150	16.25	0.08	0.06	/0.0>4.8/1.1>0.0	COSV62314890	NCF2|0.00|0.00|0.00|0.00|-1|40|37|4	25741868,24033266,16608528,23821607,25416100,24163247,24239855,28926565,24159917	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183587156	183587156	A	G	het	wt	het	off-target	QUAL=829;DP=75,24,26;AF=0.39,0.00,0.42;MQM=60;SAP=90;ABP=12;SAR=40;SAF=0	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron1/14:c.175-179T>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron1/12:c.175-179T>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron2/15:c.175-179T>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron2/15:c.175-179T>C::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1287540 [benign DISEASE=not provided];			rs789192	0.49332	0.67500,0.47360,0.16699,0.43866,0.32264	19723,	35515	76991	0.2970	3.84			/0.0>0.0/0.0>0.0	COSV62315307	NCF2|0.00|0.00|0.00|0.00|9|50|-29|-6	30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196651787	196651787	C	T	het	wt	het	off-target	QUAL=4154;DP=303,48,61;AF=0.49,0.04,0.52;MQM=60;SAP=396;ABP=3;SAR=0;SAF=181	CFH	5'UTR	CFH:ENST00000359637.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-331C>T::	regulatory_region_variant:promoter	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1249325 [benign DISEASE=not provided];	CR033844 [CLASS=DP MUT=ALT PHEN="Haemolytic uraemic syndrome association with" GENE=CFH];		rs3753394	0.22795	0.07464,0.27715,0.52749,0.28677,0.27746	5008,	24617	117303	-0.3120	4.41			/0.0>0.0/0.0>0.0			18483746,19861685,26559391,31118930,27805046,22253485,30696427,22035603,26152901,17167412,19026761,18421087,20161815,15870199,18316707,18515590,19187823,20132989,21784901,22509112,23687431,23919682,24365176,24558588,25205864,26296146,27252648,29844195,30225264,30300269,31815877,31925659,21067572,21111031,31525397,19162324,23966370,26852301,30073298,31883521,22622361,22223611,23431077,20595690,22153652,27500215,19373492,19878229,25735482,23441108,24722444,23028341,31428128,30046676,22246034,29929468,24904082,24272913,23747994,17517971,18371543,15163532,19854291,20850857,20304497,33976403,33387109,34150810,33920896,32923941,34502390,33224962,33643312,24201651,32954088,33456587,20523265,35052395,35682771,35925583	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196672844	196672845	GA	-	het	het	het	off-target	QUAL=18;DP=83,15,14;AF=0.11,0.20,0.36;MQM=60;SAP=32;ABP=121;SAR=1;SAF=16	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron1/8:c.59-114_59-113del::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron1/7:c.59-114_59-113del::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron1/16:c.59-114_59-113del::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron1/20:c.59-114_59-113del::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron1/20:c.59-114_59-113del::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron2/22:c.-131-114_-131-113del::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron1/10:c.59-114_59-113del::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron1/22:c.59-114_59-113del::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron1/9:c.-131-114_-131-113del::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]			(GA)n (Simple_repeat)	rs55759441	0.01316	0.04466,0.00672,0.00019,0.00036,0.00000	43,	1890	148130	0.5060	0.73			/0.0>0.0/0.0>0.0		CFH|0.00|0.00|0.00|0.00|-11|18|37|-29		1	52	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196672942	196672942	C	T	wt	het	wt	off-target	QUAL=324;DP=121,48,75;AF=0.00,0.38,0.00;MQM=60;SAP=15;ABP=10;SAR=4;SAF=14	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron1/8:c.59-36C>T::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron1/7:c.59-36C>T::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron1/16:c.59-36C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron1/20:c.59-36C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron1/20:c.59-36C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron2/22:c.-131-36C>T::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron1/10:c.59-36C>T::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron1/22:c.59-36C>T::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron1/9:c.-131-36C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1209735 [benign DISEASE=not provided,Age related macular degeneration 4,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Basal laminar drusen];			rs551397	0.39765	0.71753,0.38876,0.42425,0.23387,0.32704	15215,	29929	91431	-0.1450	1.01			/4.1>4.8/0.0>0.0	COSV62776788	CFH|0.00|0.00|0.00|0.00|36|8|27|36	17314151,24453474,22618592,24692129,18421087,20161815,23289807,30179527,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673103	196673103	G	A	wt	het	wt		QUAL=924;DP=232,83,139;AF=0.00,0.48,0.00;MQM=60;SAP=5;ABP=3;SAR=23;SAF=17	CFH	missense,5'UTR	CFH:ENST00000359637.3:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:missense_variant:MODERATE:exon2/8:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:missense_variant:MODERATE:exon2/17:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:missense_variant:MODERATE:exon2/21:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon2/21:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:5_prime_UTR_variant:MODIFIER:exon3/23:c.-6G>A::,CFH:ENST00000695978.1:missense_variant:MODERATE:exon2/11:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon2/23:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696030.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:5_prime_UTR_variant:MODIFIER:exon2/10:c.-6G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	16550 [benign DISEASE=Hemolytic uremic syndrome, atypical, susceptibility to, 1,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Factor H deficiency,not provided,Focal segmental glomerulosclerosis,Age related macular degeneration 4,Basal laminar drusen];			rs800292	0.39684	0.71585,0.38818,0.42308,0.23384,0.32586	15151,	29949	91577	1.6040	7.64	0.14	0.06	/2.7>2.6/0.0>0.0	COSV62776782	CFH|0.00|0.00|0.08|0.02|2|-13|8|-1	18162041,25537509,19961953,18541031,29700787,27730450,19861685,20203157,26559391,31118930,16080115,17314151,30696427,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,23873044,25132797,29312345,17167412,19026761,19958499,20181037,20961462,22618592,25276841,25883802,22936692,23577725,19825847,20157618,23620142,24069533,18787502,24692129,18421087,20161815,23289807,17591627,20157352,8072530,15870199,16299065,17022693,17877809,17947292,17962488,18316707,18515590,19187823,19259132,19823576,19933189,20132989,20538655,20581873,20678803,20689796,21394116,21397333,21555552,21609242,21784901,21811649,21850184,21856016,21896867,21899915,21909106,22019782,22046503,22065918,22065928,22174912,22509112,22534080,22536038,22558131,22666427,22714898,22876110,23103884,23111182,23233260,23289808,23687431,23864767,23919682,24120328,24365176,24393350,24403817,24520367,24558588,24675670,24860613,24865190,24865191,24906858,25205864,25277308,25388911,25558172,25612476,25732348,25771815,25792034,26171855,26217379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673839	196673839	-	TT	wt	het	wt	off-target	QUAL=947;DP=98,110,131;AF=0.00,0.39,0.00;MQM=60;SAP=5;ABP=14;SAR=18;SAF=25	CFH	splice_region&intron,intron	CFH:ENST00000359637.3:splice_region_variant&intron_variant:LOW:intron2/8:c.245-10_245-9dup::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron2/7:c.244+684_244+685dup::,CFH:ENST00000695969.1:splice_region_variant&intron_variant:LOW:intron2/16:c.245-10_245-9dup::,CFH:ENST00000695970.1:splice_region_variant&intron_variant:LOW:intron2/20:c.245-10_245-9dup::,CFH:ENST00000695971.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000695974.1:splice_region_variant&intron_variant:LOW:intron2/20:c.245-10_245-9dup::,CFH:ENST00000695976.1:splice_region_variant&intron_variant:LOW:intron3/22:c.56-10_56-9dup::,CFH:ENST00000695978.1:splice_region_variant&intron_variant:LOW:intron2/10:c.245-10_245-9dup::,CFH:ENST00000695979.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000695981.1:splice_region_variant&intron_variant:LOW:intron2/22:c.245-10_245-9dup::,CFH:ENST00000696023.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000696027.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000696028.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000696029.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+684_244+685dup::,CFH:ENST00000696030.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000630130.2:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000695987.1:splice_region_variant&intron_variant:LOW:intron2/9:c.56-10_56-9dup::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1166414 [benign DISEASE=Age related macular degeneration 4,Basal laminar drusen,Factor H deficiency,Hemolytic uremic syndrome, atypical, susceptibility to, 1,not specified,not provided,Atypical hemolytic-uremic syndrome];	CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs35507625	0.24262	0.18742,0.31338,0.49610,0.22774,0.32797	4684,	27266	114360		1.21			/10.0>11.6/0.0>0.0		CFH|0.01|0.02|0.00|0.00|18|22|41|50	19796758,27239600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196685194	196685194	A	C	het	het	het		QUAL=9403;DP=284,209,267;AF=0.49,0.48,0.48;MQM=60;SAP=61;ABP=6;SAR=232;SAF=133	CFH	synonymous,intron	CFH:ENST00000359637.3:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:synonymous_variant:LOW:exon5/8:c.738A>C:p.Ala246=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:synonymous_variant:LOW:exon7/17:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon8/23:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:synonymous_variant:LOW:exon7/11:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:synonymous_variant:LOW:exon7/23:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+12031A>C::,CFH:ENST00000696030.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:synonymous_variant:LOW:exon7/10:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294488 [benign DISEASE=Atypical hemolytic-uremic syndrome,Basal laminar drusen,Factor H deficiency,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1,not provided,Age related macular degeneration 4];			rs1061147	0.62972	0.57835,0.72925,0.94744,0.61759,0.72017	30581,	34356	56166	-0.1750	6.10			/0.0>0.0/0.0>0.0	COSV62778986	CFH|0.00|0.00|0.00|0.00|-1|10|37|10	17314151,18043728,19796758,27239600,24453474,21637784,24586071,17167412,19026761,16936733,15870199,16299065,22558131,28011711,20339564,27068115,31031394,28729648,29854987,25756647,29706360,27239594,23326517,29606303,28293111,15163532,30571950,33102952,31919107,33920896,24634144,33564431,30389424,32179765,36161202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689367	196689367	G	T	het	het	het	off-target;low_conf_region	QUAL=1495;DP=93,15,17;AF=0.55,0.53,0.18;MQM=60;SAP=138;ABP=3;SAR=0;SAF=62	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron5/7:c.782-53G>T::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron7/16:c.965-53G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron7/21:c.965-74G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron8/22:c.776-53G>T::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron7/10:c.965-53G>T::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron7/9:c.965-74G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron7/22:c.965-53G>T::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16204G>T::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron7/9:c.965-128G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron7/9:c.776-53G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1276326 [benign DISEASE=not provided];			rs482934	0.69160	0.78569,0.75935,0.94795,0.61942,0.72045	37045,	30974	46850	-0.1410	1.48			/1.6>4.3/0.0>0.0	COSV62776949	CFH|0.00|0.00|0.00|0.00|13|29|47|-1	19796758,24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689775	196689775	G	A	het	het	het	off-target	QUAL=1071;DP=72,17,13;AF=0.49,0.29,0.54;MQM=60;SAP=105;ABP=4;SAR=47;SAF=0	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron7/8:c.967+161G>A::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron6/7:c.976+161G>A::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron8/16:c.1159+161G>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron8/21:c.1138+161G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron9/22:c.970+161G>A::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron8/10:c.1159+161G>A::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron8/9:c.1138+161G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron8/22:c.1159+161G>A::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16612G>A::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron8/9:c.1084+161G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron8/9:c.970+161G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1289573 [benign DISEASE=not provided];			rs12029785	0.64509	0.62918,0.73724,0.94832,0.61839,0.72022	32007,	33854	53844	-0.2900	0.27			/0.0>0.0/0.0>0.0		CFH|0.00|0.00|0.00|0.00|21|0|31|-1	24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196690107	196690107	C	T	het	het	het		QUAL=5483;DP=190,104,108;AF=0.57,0.41,0.49;MQM=57;SAP=134;ABP=3;SAR=47;SAF=158	CFH	missense,intron	CFH:ENST00000359637.3:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:missense_variant:MODERATE:exon7/8:c.1021C>T:p.His341Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:missense_variant:MODERATE:exon9/17:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:missense_variant:MODERATE:exon9/22:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon10/23:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:missense_variant:MODERATE:exon9/11:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:missense_variant:MODERATE:exon9/10:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon9/23:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16944C>T::,CFH:ENST00000696030.1:missense_variant:MODERATE:exon9/10:c.1129C>T:p.His377Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:missense_variant:MODERATE:exon9/10:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294490 [benign(replaced by megSAP based on classifications:11x1,1x3) DISEASE=Basal laminar drusen,Factor H deficiency,Hemolytic uremic syndrome, atypical, susceptibility to, 1,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided,Age related macular degeneration 4,Atypical hemolytic-uremic syndrome];			rs1061170	0.64457	0.62903,0.73735,0.94835,0.61778,0.71923	31967,	33902	53948	-8.3310	0.00	0.09	0.08	/0.0>0.0/0.0>0.0	COSV62776341	CFH|0.01|0.01|0.00|0.00|12|-44|12|21	18248681,16519819,16723442,17697822,18162041,19076828,19692124,18541031,29334895,29700787,23820649,19861685,20203157,23251215,26559391,31118930,27306948,16080115,17314151,22022419,22253485,30696427,24498017,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,22969267,23873044,25132797,24586071,25786237,15761122,17167412,17917691,19026761,19958499,20961462,21072178,22259222,22618592,24526414,25276841,25883802,22936692,26681391,16936733,21807600,23523162,23577725,19825847,26493033,20157618,22694956,23620142,20378180,24692129,23289807,32034129,32100327,20385826,22155603,29579787,26490493,17591627,20157352,23112570,15870199,16299065,17022693,17877809,17962488,18316707,18515590,19187823,19259132,19823576,20132989,20581873,20678803,20689796,21394116,21555552,21609242,21784901,21811649,21850184,21856016,22019782,22046503,22174912,22509112,22536038,22558131,22666427,23103884,23111182,23289808,23687431,23919682,24120328,24403817,24558588,24675670,24860613,25205864,25558172,25612476,25792034,2617185	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701627	196701627	C	T	het	het	het	off-target	QUAL=3757;DP=161,62,88;AF=0.52,0.45,0.56;MQM=58;SAP=353;ABP=4;SAR=161;SAF=0	CFH	intron,3'UTR	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11388C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11388C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11388C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11388C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26719C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*296C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]			LTR26 (LTR/ERV1)	rs4658046	0.64752	0.64022,0.73942,0.94729,0.61717,0.71874	32287,	33754	53526	-1.8450	0.44			/0.0>0.0/2.4>2.1		CFH|0.00|0.00|0.00|0.00|19|-20|-46|0	24453474,16936733,32843070,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701709	196701709	A	G	het	het	het	off-target	QUAL=1475;DP=90,14,18;AF=0.51,0.57,0.50;MQM=60;SAP=140;ABP=3;SAR=63;SAF=0	CFH	intron,3'UTR	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11470A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11470A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11470A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11470A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26637A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*378A>G::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]				rs10754199	0.64760	0.64003,0.73967,0.94765,0.61733,0.71858	32284,	33729	53489	-0.5760	3.62			/7.0>7.5/0.0>0.0		CFH|0.00|0.00|0.00|0.00|1|-18|-1|-38	16936733,20385819,29875488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196713817	196713817	G	A	het	het	het		QUAL=8591;DP=262,192,257;AF=0.42,0.49,0.48;MQM=60;SAP=100;ABP=13;SAR=103;SAF=224	CFH	synonymous,intron	CFH:ENST00000695969.1:synonymous_variant:LOW:exon10/17:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon10/22:c.1398G>A:p.Ala466=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon11/23:c.1230G>A:p.Ala410=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:synonymous_variant:LOW:exon10/23:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-14529G>A::,CFH:ENST00000367429.9:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294491 [benign DISEASE=Atypical hemolytic-uremic syndrome,Basal laminar drusen,Factor H deficiency,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1,not provided,Age related macular degeneration 4];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.43936	0.46501,0.48454,0.44356,0.40797,0.55848	14776,	37072	85016	0.4850	1.75			/2.7>3.0/0.0>0.0	COSV66406791	CFH|0.00|0.01|0.00|0.00|20|-26|20|37	29700787,22022419,18043728,19796758,22035603,27239600,24453474,21637784,23873044,26838040,17917691,22618592,22936692,26681391,16936733,21807600,23523162,19825847,24692129,18421087,20161815,30179527,15870199,16299065,17962488,20132989,20678803,22046503,22558131,23687431,24860613,25612476,25771815,27778189,27832277,30225264,22905135,20339564,16612335,17327825,18081690,20843825,21402993,22324898,22699975,22848687,24289920,28358029,26852301,19692168,27625572,31819893,29875488,29376001,29142592,23441108,19025119,29854987,29033536,29263899,24391822,26634245,15163532,18596911,21882633,23582991,33564431,34502390,32578437,32610483,32328755,32179765,20523265,35136347,35625740	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715438	196715438	C	T	het	wt	het	off-target	QUAL=1364;DP=96,16,18;AF=0.57,0.00,0.22;MQM=60;SAP=131;ABP=3;SAR=0;SAF=59	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-155C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-155C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-155C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-155C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12908C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]				rs535465835	0.00007	0.00010,0.00000,0.00000,0.00009,0.00000	0,	11	151981	-2.4820	0.01			/2.1>3.5/0.0>0.0		CFH|0.00|0.00|0.00|0.00|20|39|-38|39		0	0	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715444	196715444	C	T	het	wt	het	off-target	QUAL=1426;DP=100,18,22;AF=0.54,0.00,0.27;MQM=60;SAP=133;ABP=3;SAR=0;SAF=60	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-149C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-149C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-149C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-149C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12902C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1265873 [benign DISEASE=not provided];			rs6664877	0.19723	0.26832,0.15296,0.05515,0.17503,0.31959	3298,	23357	121919	-1.1770	0.32			/2.1>2.4/0.0>0.0		CFH|0.00|0.00|0.00|0.00|14|33|-2|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715445	196715445	A	G	het	wt	het	off-target	QUAL=1426;DP=100,18,22;AF=0.54,0.00,0.27;MQM=60;SAP=133;ABP=3;SAR=0;SAF=60	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-148A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-148A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-148A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-148A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12901A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1290753 [benign DISEASE=not provided];			rs6677460	0.23197	0.35079,0.16761,0.05500,0.19530,0.32637	4767,	25716	116710	0.0970	2.16			/2.1>2.3/0.0>0.0		CFH|0.00|0.00|0.00|0.00|32|2|32|-37	32321835	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715495	196715495	G	T	het	het	het	off-target	QUAL=2530;DP=137,44,62;AF=0.43,0.55,0.42;MQM=60;SAP=240;ABP=9;SAR=0;SAF=109	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-98G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-98G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-98G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-98G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12851G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1258057 [benign DISEASE=not provided];			rs203674	0.65549	0.73554,0.74103,0.94744,0.57904,0.71192	33388,	32783	52327	-0.9460	0.29			/2.7>2.3/0.0>0.0		CFH|0.00|0.00|0.00|0.00|30|1|-18|1	18541031,21197116,18043728,19796758,22035603,22059990,26152901,27239600,15870199,30073298,28729648,19878229,25735482,24272913	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196736796	196736796	C	A	het	het	het	off-target;low_conf_region	QUAL=139;DP=16,4,13;AF=0.25,0.50,0.38;MQM=60;SAP=19;ABP=11;SAR=1;SAF=10	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron15/16:c.2414-28C>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron15/20:c.2414-28C>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron15/21:c.2393-28C>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron14/20:c.2237-28C>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron16/22:c.2225-28C>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron15/22:c.2414-28C>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron15/21:c.2408-28C>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron3/9:c.422-28C>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1274202 [benign DISEASE=not provided];		(TTAATT)n (Simple_repeat)	rs375046	0.67302	0.79645,0.74728,0.94253,0.57783,0.72006	35062,	31009	49135	-1.3850	0.85			/0.2>0.4/0.0>0.0		CFH|0.00|0.05|0.00|0.00|31|28|31|40	24453474,22834933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196740686	196740686	G	T	het	wt	het		QUAL=7000;DP=283,187,217;AF=0.53,0.00,0.52;MQM=60;SAP=39;ABP=6;SAR=98;SAF=164	CFH	intron,missense	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-1189G>T::,CFH:ENST00000695971.1:missense_variant:MODERATE:exon18/22:c.2829G>T:p.Gln943His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon17/21:c.2673G>T:p.Gln891His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon19/23:c.2661G>T:p.Gln887His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon18/23:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon18/22:c.2844G>T:p.Gln948His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:missense_variant:MODERATE:exon6/10:c.858G>T:p.Gln286His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294510 [likely benign(replaced by megSAP based on classifications:2x1,6x2,1x3) DISEASE=Basal laminar drusen,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Age related macular degeneration 4,Hemolytic uremic syndrome, atypical, susceptibility to, 1,not specified,not provided,Atypical hemolytic-uremic syndrome];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.00399	0.00114,0.00387,0.00000,0.00610,0.00021	0,	607	151421	-0.6000	16.35	0.32	0.18	/0.0>0.0/1.0>0.0	COSV99054698	CFH|0.00|0.00|0.00|0.00|-41|-22|-16|12	14583443,27007659,28056875,25814826,30377230,29148534,28752844,32641076,35877417	1	276	0	0 / 0	2	"[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196741786	196741786	T	C	het	wt	het	off-target	QUAL=2999;DP=123,70,87;AF=0.59,0.01,0.55;MQM=60;SAP=268;ABP=14;SAR=0;SAF=122	CFH	intron	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-89T>C::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron18/21:c.2936-89T>C::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron17/20:c.2780-89T>C::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron19/22:c.2768-89T>C::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron18/22:c.2957-89T>C::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron18/21:c.2951-89T>C::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron18/21:c.2885-89T>C::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron18/21:c.2957-95T>C::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron6/9:c.965-89T>C::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron18/21:c.2957-89T>C::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1228859 [benign DISEASE=not provided];			rs16840522	0.22628	0.33142,0.16822,0.05457,0.19484,0.32437	4491,	25437	117689	0.6700	7.56			/7.6>7.7/0.0>0.0	COSV66408666	CFH|0.00|0.00|0.00|0.00|1|16|32|-22	17314151,24453474,23873044,32321835,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743447	196743447	T	C	wt	het	wt		QUAL=305;DP=179,132,120;AF=0.00,0.23,0.00;MQM=45;SAP=70;ABP=84;SAR=0;SAF=31	CFH	splice_region&intron	CFH:ENST00000695970.1:splice_region_variant&intron_variant:LOW:intron18/20:c.2960-5T>C::,CFH:ENST00000695971.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3113-5T>C::,CFH:ENST00000695974.1:splice_region_variant&intron_variant:LOW:intron18/20:c.2957-5T>C::,CFH:ENST00000695976.1:splice_region_variant&intron_variant:LOW:intron20/22:c.2945-5T>C::,CFH:ENST00000695981.1:splice_region_variant&intron_variant:LOW:intron19/22:c.3134-5T>C::,CFH:ENST00000696027.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3128-5T>C::,CFH:ENST00000696028.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3062-5T>C::,CFH:ENST00000696029.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3128-5T>C::,CFH:ENST00000695984.1:splice_region_variant&intron_variant:LOW:intron7/9:c.1142-5T>C::,CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	875337 [uncertain significance(replaced by megSAP based on classifications:1x1,4x3) DISEASE=not provided,not specified,Atypical hemolytic-uremic syndrome,Age related macular degeneration 4,Basal laminar drusen,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1];			rs513699	0.02923	0.02967,0.04823,0.04755,0.02510,0.02492	0,	3010	99962	3.0890	9.48			9.3>8.6/9.3>8.6/0.0>0.0	COSV66406795	CFH|0.01|0.04|0.00|0.00|-24|5|5|30	26559391,29148534	0	7625	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743456	196743456	C	T	wt	het	wt		QUAL=512;DP=192,149,135;AF=0.00,0.26,0.00;MQM=47;SAP=57;ABP=76;SAR=4;SAF=35	CFH	synonymous	CFH:ENST00000695970.1:synonymous_variant:LOW:exon19/21:c.2964C>T:p.Thr988=:,CFH:ENST00000695971.1:synonymous_variant:LOW:exon20/22:c.3117C>T:p.Thr1039=:,CFH:ENST00000695974.1:synonymous_variant:LOW:exon19/21:c.2961C>T:p.Thr987=:,CFH:ENST00000695976.1:synonymous_variant:LOW:exon21/23:c.2949C>T:p.Thr983=:,CFH:ENST00000695981.1:synonymous_variant:LOW:exon20/23:c.3138C>T:p.Thr1046=:,CFH:ENST00000696027.1:synonymous_variant:LOW:exon20/22:c.3132C>T:p.Thr1044=:,CFH:ENST00000696028.1:synonymous_variant:LOW:exon20/22:c.3066C>T:p.Thr1022=:,CFH:ENST00000696029.1:synonymous_variant:LOW:exon20/22:c.3132C>T:p.Thr1044=:,CFH:ENST00000695984.1:synonymous_variant:LOW:exon8/10:c.1146C>T:p.Thr382=:,CFH:ENST00000367429.9:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294519 [benign DISEASE=Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Kidney disorder,Basal laminar drusen,not specified];			rs61822181	0.05524	0.05249,0.08447,0.09508,0.05060,0.04642	0,	5432	92896	-0.2980	2.55			/0.0>0.0/0.0>0.0	COSV66406800	CFH|0.00|0.00|0.00|0.00|23|-4|-4|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196746205	196746205	G	A	het	wt	het	off-target	QUAL=1062;DP=72,10,12;AF=0.58,0.00,0.50;MQM=51;SAP=107;ABP=7;SAR=48;SAF=0	CFH	intron	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron20/20:c.3319+206G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron21/21:c.3472+206G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron20/20:c.3316+206G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron22/22:c.3304+206G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron21/22:c.3493+206G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron21/21:c.3421+206G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron9/9:c.1501+206G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron21/21:c.3493+206G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]			AluY (SINE/Alu)	rs34231058	0.03636	0.00730,0.02921,0.04303,0.04654,0.10224	170,	5187	146489	0.5070	2.17			/0.0>0.0/0.0>0.0		CFH|0.03|0.00|0.00|0.00|-41|4|25|-18		24	387	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197084011	197084011	T	C	het	het	het	off-target	QUAL=1224;DP=89,7,9;AF=0.51,0.43,0.44;MQM=60;SAP=116;ABP=3;SAR=0;SAF=52	ASPM	downstream_gene	ASPM:ENST00000367409.9:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680265.1:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000294732.11:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680710.1:downstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1252618 [benign DISEASE=not provided];			rs1332660	0.17619	0.04441,0.33307,0.69408,0.16193,0.30921	3852,	19080	125230	-0.1650	6.94							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084243	197084243	G	A	hom	hom	hom		QUAL=19016;DP=240,138,198;AF=1.00,1.00,1.00;MQM=60;SAP=67;ABP=0;SAR=223;SAF=353	ASPM	3'UTR	ASPM:ENST00000367409.9:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::,ASPM:ENST00000680265.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*81C>T::,ASPM:ENST00000294732.11:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	294591 [benign DISEASE=not provided,Microcephaly 5, primary, autosomal recessive];			rs12677	0.78443	0.45184,0.87126,0.99923,0.91020,0.89813	49972,	19223	32749	3.0170	4.41			/1.1>0.7/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|21|-1|25|-46	18541031	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084432	197084432	A	-	het	het	het	low_conf_region	QUAL=421;DP=97,26,42;AF=0.21,0.12,0.29;MQM=59;SAP=48;ABP=122;SAR=31;SAF=4	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10554-6del::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10308-6del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1204775 [likely benign DISEASE=not provided];			rs200839523	0.00350	0.00477,0.00343,0.00142,0.00180,0.00089	2,	496	142552	-0.4390	0.01			/10.7>11.2/0.0>0.0		ASPM|0.01|0.00|0.00|0.00|17|-5|-6|-5		0	307	305	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086652	197086652	T	C	hom	hom	hom	off-target	QUAL=4305;DP=80,28,32;AF=1.00,1.00,1.00;MQM=60;SAP=307;ABP=0;SAR=0;SAF=140	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron27/27:c.10331+151A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron28/28:c.10553+151A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron26/26:c.5576+151A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron27/27:c.10307+151A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678055 [benign DISEASE=not provided];			rs10733087	0.78396	0.45067,0.87120,0.99923,0.91027,0.89801	49998,	19231	32857	-0.6590	1.16			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-1|50|0|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086795	197086795	T	C	hom	hom	hom		QUAL=13641;DP=169,108,137;AF=1.00,1.00,1.00;MQM=60;SAP=200;ABP=0;SAR=110;SAF=304	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10553+8A>G::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10307+8A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157775 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs10754213	0.78413	0.45106,0.87136,0.99923,0.91037,0.89772	49988,	19226	32816	-0.0560	1.86			/0.0>0.0/0.0>0.3		ASPM|0.00|0.00|0.00|0.00|31|38|31|8	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090748	197090748	G	A	hom	hom	hom	off-target	QUAL=5534;DP=96,41,53;AF=0.99,1.00,1.00;MQM=60;SAP=413;ABP=0;SAR=0;SAF=189	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+102C>T::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+102C>T::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+102C>T::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+102C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673924 [benign DISEASE=not provided];			rs4915315	0.77028	0.40593,0.86516,0.97871,0.90994,0.89797	48974,	19084	34902	-2.4770	0.03			/0.0>0.0/1.9>0.7		ASPM|0.00|0.00|0.00|0.00|-28|20|22|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090762	197090762	A	G	hom	hom	hom	off-target	QUAL=6279;DP=100,47,66;AF=1.00,1.00,1.00;MQM=60;SAP=466;ABP=0;SAR=0;SAF=213	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+88T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+88T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+88T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+88T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673923 [benign DISEASE=not provided];			rs10754214	0.76272	0.37951,0.86330,0.97872,0.90982,0.89735	48486,	18913	36051	0.7910	5.73			/0.6>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|6|-10|-24|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090798	197090798	A	G	hom	hom	hom	off-target	QUAL=8873;DP=104,80,101;AF=1.00,1.00,1.00;MQM=60;SAP=483;ABP=0;SAR=17;SAF=268	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+52T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+52T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673922 [benign DISEASE=not provided,Microcephaly 5, primary, autosomal recessive];			rs4915316	0.76249	0.37889,0.86323,0.97872,0.90977,0.89752	48460,	18909	36079	1.5570	5.16			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-30|45|48|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197091229	197091230	TG	-	hom	n/a	n/a	off-target	QUAL=1304;DP=66,2,1;AF=0.82,0.50,1.00;MQM=60;SAP=125;ABP=0;SAR=56;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron22/27:c.9445-189_9445-188del::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron23/28:c.9667-189_9667-188del::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron21/26:c.4690-189_4690-188del::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron22/27:c.9421-189_9421-188del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1274698 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs35277950	0.78318	0.45296,0.87033,0.99902,0.90824,0.89699	49331,	19335	32667	0.3770	0.60			/0.8>0.7/0.9>0.0		ASPM|0.00|0.00|0.00|0.00|-1|3|-22|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101391	197101391	C	G	wt	het	wt		QUAL=1188;DP=301,97,129;AF=0.00,0.49,0.00;MQM=60;SAP=12;ABP=3;SAR=17;SAF=31	ASPM	missense,intron	ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7860G>C:p.Gln2620His:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21609 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs12138336	0.04868	0.01402,0.04475,0.00078,0.07318,0.02883	237,	6911	144317	-0.9070	2.86	0.08	0.17	/0.2>1.6/0.0>0.0	COSV54130527	ASPM|0.00|0.00|0.00|0.00|-7|-1|33|-43	25741868,18414213,20301772,16631353	26	879	0	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101646	197101646	C	T	het	het	het		QUAL=8723;DP=227,190,246;AF=0.55,0.46,0.49;MQM=60;SAP=12;ABP=3;SAR=185;SAF=147	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21603 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs10922162	0.17550	0.04198,0.33360,0.69547,0.16197,0.30518	3827,	18942	124952	0.1710	1.00			/6.3>4.0/0.0>0.0	COSV54139486	ASPM|0.00|0.00|0.00|0.00|-2|-10|3|0	25741868,18414213,20301772,21297427,15355437,23381943,35330488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101685	197101685	T	C	hom	hom	hom		QUAL=19698;DP=237,155,197;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0;SAR=341;SAF=248	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7566A>G:p.Leu2522=:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21602 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs1412640	0.81194	0.54696,0.88349,0.99922,0.91054,0.89822	52003,	19083	28509	-0.3560	1.00			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|32|-21|-39|11	25741868,20301772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101771	197101771	A	G	hom	hom	hom		QUAL=23198;DP=319,168,205;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0;SAR=313;SAF=379	ASPM	missense,intron	ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21599 [benign DISEASE=not provided,not specified,Microcephaly 5, primary, autosomal recessive];			rs964201	0.99666	0.99923,0.99789,0.99981,0.99418,0.99772	75383,	507	507	3.0690	15.59	0.19	0.05	/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|15|-24|-7|2	25741868,18414213,20301772,25480035,16141009	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197122407	197122407	A	T	hom	hom	hom		QUAL=24438;DP=311,203,251;AF=1.00,1.00,1.00;MQM=60;SAP=142;ABP=0;SAR=272;SAF=493	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon14/29:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000294732.11:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain]		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21578 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs4915337	0.78398	0.45097,0.87139,0.99884,0.91011,0.89785	49965,	19236	32836	-0.2950	7.32			/4.5>2.7/0.0>0.0		ASPM|0.00|0.00|0.01|0.00|-25|-8|-19|48	25741868,18541031,20301772,16631353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197123968	197123968	A	T	hom	hom	n/a	off-target	QUAL=3002;DP=89,5,2;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0;SAR=0;SAF=96	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron13/28:c.3390+142T>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron13/26:c.3390+142T>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	670423 [benign DISEASE=not provided];			rs6685259	0.89076	0.81920,0.91658,0.99923,0.91161,0.89988	60497,	14464	16612	-2.2250	0.02			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|41|-10|3|33	34260948	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124702	197124702	T	C	hom	n/a	hom	off-target	QUAL=598;DP=17,0,3;AF=1.00,,1.00;MQM=59;SAP=46;ABP=0;SAR=0;SAF=20	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron12/28:c.3168+168A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron12/26:c.3168+168A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1227779 [benign DISEASE=not provided];		(AT)n (Simple_repeat)	rs4915338	0.76001	0.37781,0.86094,0.97930,0.90513,0.89514	47870,	19040	36244	0.9350	5.43			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-44|43|5|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124900	197124900	C	T	het	het	het		QUAL=9395;DP=392,152,184;AF=0.50,0.48,0.48;MQM=60;SAP=300;ABP=4;SAR=68;SAF=289	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon12/29:c.3138G>A:p.Arg1046=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21573 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs6676084	0.25675	0.15902,0.25319,0.12635,0.31056,0.29693	5398,	28171	112803	-1.3250	0.48			/0.0>0.0/0.0>0.0	COSV54127589,COSV54135932	ASPM|0.00|0.00|0.03|0.02|35|1|-30|1	25741868,18414213,20301772,21297427	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197128343	197128343	-	A	het	het	het	off-target	QUAL=803;DP=62,8,5;AF=0.40,0.75,0.60;MQM=59;SAP=77;ABP=4;SAR=0;SAF=34	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron10/27:c.2936+146dup::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron10/28:c.2936+146dup::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron10/26:c.2936+146dup::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron10/27:c.2936+146dup::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1242265 [benign DISEASE=not provided];			rs200280533	0.68630	0.38698,0.79548,0.95140,0.77048,0.82128	34339,	25961	43259		1.23			/10.7>12.0/3.2>3.2		ASPM|0.05|0.00|0.00|0.00|-3|33|-3|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197129013	197129013	G	C	hom	hom	hom	off-target	QUAL=5988;DP=143,18,31;AF=1.00,1.00,1.00;MQM=60;SAP=420;ABP=0;SAR=0;SAF=192	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron9/28:c.2760+174C>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron9/26:c.2760+174C>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678053 [benign DISEASE=not provided];			rs6695300	0.86509	0.73234,0.90067,0.99923,0.91106,0.89992	57378,	16691	20499	-1.2280	0.31			/2.7>1.3/0.0>0.0		ASPM|0.00|0.00|0.00|0.03|0|32|0|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197132491	197132491	T	C	hom	hom	hom	off-target	QUAL=4757;DP=72,41,42;AF=0.99,1.00,1.00;MQM=60;SAP=337;ABP=0;SAR=154;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron6/28:c.2420-139A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron6/26:c.2420-139A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678052 [benign DISEASE=not provided];			rs3737111	0.45705	0.28429,0.59471,0.82253,0.47359,0.60741	17213,	34940	82404	-0.8560	1.42			/0.0>0.0/0.4>8.6		ASPM|0.00|0.00|0.02|0.00|-43|-34|1|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133615	197133615	A	G	het	het	het	off-target	QUAL=3220;DP=142,70,73;AF=0.49,0.40,0.45;MQM=60;SAP=228;ABP=8;SAR=123;SAF=7	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron5/28:c.2174-20T>C::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron5/26:c.2174-20T>C::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95887 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs4915344	0.17639	0.04436,0.33338,0.69479,0.16194,0.31020	3862,	19095	125223	0.8830	16.16			6.9>6.5/6.9>6.5/0.0>0.0	COSV54132578	ASPM|0.00|0.18|0.00|0.00|34|-20|-20|-50	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133709	197133709	A	C	hom	hom	hom	off-target	QUAL=4106;DP=98,16,22;AF=1.00,1.00,1.00;MQM=60;SAP=298;ABP=0;SAR=136;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2174-114T>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2174-114T>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678051 [benign DISEASE=not provided];			rs4915345	0.81227	0.54754,0.88347,0.99923,0.91026,0.89830	52118,	19146	28516	-0.7650	0.63			/0.0>0.0/6.7>5.5		ASPM|0.00|0.00|0.00|0.00|0|-2|13|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197135020	197135020	A	-	hom	hom	hom	off-target	QUAL=4884;DP=98,25,39;AF=0.99,0.96,0.97;MQM=60;SAP=314;ABP=0;SAR=4;SAF=155	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2173+76del::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2173+76del::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2173+76del::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2173+76del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673908 [benign DISEASE=not provided];			rs35659894	0.76248	0.37908,0.86287,0.97865,0.90971,0.89735	48507,	18935	36119	0.2300	0.79			/3.7>4.3/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|4|-12|40|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139563	197139563	C	T	hom	n/a	hom	off-target	QUAL=1668;DP=45,0,10;AF=0.98,,1.00;MQM=60;SAP=120;ABP=0;SAR=0;SAF=54	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron4/28:c.2026+204G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron4/26:c.2026+204G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678050 [benign DISEASE=not provided];		L1MA4 (LINE/L1)	rs10737687	0.76251	0.37888,0.86302,0.97879,0.90971,0.89748	48512,	18935	36117	0.3670	4.02			/0.0>0.0/0.0>0.3		ASPM|0.00|0.00|0.00|0.00|-34|-10|-8|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139816	197139816	A	G	het	het	wt		QUAL=4128;DP=256,109,143;AF=0.42,0.44,0.00;MQM=60;SAP=27;ABP=21;SAR=57;SAF=98	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon4/29:c.1977T>C:p.Ile659=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21561 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs17550662	0.04098	0.00902,0.03103,0.00000,0.06363,0.01098	178,	5880	145940	2.0950	6.35			/3.5>3.0/0.0>0.0		ASPM|0.01|0.00|0.20|0.00|39|-16|-49|47	18414213,20301772,21297427	103	2989	0	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139912	197139912	C	T	hom	hom	hom	off-target	QUAL=12561;DP=234,65,88;AF=1.00,1.00,1.00;MQM=60;SAP=452;ABP=0;SAR=335;SAF=52	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron3/28:c.1922-41G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157788 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs1332663	0.78417	0.45127,0.87148,0.99923,0.91006,0.89806	50010,	19234	32822	-0.9920	5.70			/4.9>4.8/0.0>0.0	COSV54136485	ASPM|0.01|0.02|0.00|0.00|-18|-41|-18|-49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143403	197143403	G	A	hom	hom	hom		QUAL=7466;DP=113,61,52;AF=1.00,0.98,1.00;MQM=60;SAP=10;ABP=0;SAR=126;SAF=99	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon3/29:c.849C>T:p.Ser283=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95890 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs6677082	0.76269	0.37934,0.86321,0.97882,0.90973,0.89739	48487,	18925	36061	0.2230	2.02			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|45|25|24|0	25741868,18541031,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143943	197143943	G	A	hom	hom	hom	off-target	QUAL=4412;DP=107,14,21;AF=1.00,1.00,1.00;MQM=60;SAP=311;ABP=0;SAR=142;SAF=0	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron2/28:c.441+14C>T::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron2/26:c.441+14C>T::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95888 [benign/likely benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive];			rs1571964	0.76280	0.37946,0.86321,0.97900,0.90964,0.89777	48485,	18932	36040	0.1980	4.14			/1.1>0.8/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|42|14|14|9	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	198638824	198638824	T	A	wt	wt	het	off-target	QUAL=80;DP=29,11,22;AF=0.00,0.00,0.32;MQM=60;SAP=18;ABP=9;SAR=0;SAF=7	PTPRC	upstream_gene	PTPRC:ENST00000348564.11:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000442510.8:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697631.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697632.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000367364.5:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000413409.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs2274364	0.03700	0.00858,0.08363,0.13610,0.03168,0.09490	186,	5247	146253	1.0410	7.16							0	1	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198638868	198638868	G	A	wt	wt	het	off-target	QUAL=447;DP=54,42,68;AF=0.00,0.00,0.37;MQM=60;SAP=57;ABP=13;SAR=0;SAF=25	PTPRC	upstream_gene	PTPRC:ENST00000348564.11:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000442510.8:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697631.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697632.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000367364.5:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000413409.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs2274365	0.06962	0.11935,0.09905,0.13603,0.03264,0.09494	537,	9506	141384	-0.5080	0.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198692539	198692539	G	A	het	het	wt		QUAL=808;DP=56,7,5;AF=0.46,0.86,0.00;MQM=60;SAP=10;ABP=3;SAR=11;SAF=21	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron3/30:c.100+166G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+166G>A::,PTPRC:ENST00000367364.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000413409.6:intron_variant:MODIFIER:intron3/3:c.100+166G>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs115067628	0.00984	0.00232,0.00473,0.00019,0.01551,0.00829	17,	1459	150195	-0.7680	0.15			/5.4>5.7/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|7|-42|2|-44		4	297	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696566	198696568	ATG	-	wt	wt	het	off-target	QUAL=611;DP=93,47,56;AF=0.00,0.00,0.52;MQM=60;SAP=66;ABP=3;SAR=0;SAF=29	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4193_100+4195del::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.101-146_101-144del::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron3/30:c.101-146_101-144del::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4193_-456+4195del::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]			(TA)n (Simple_repeat)	rs1050669320	0.00002	0.00005,0.00007,0.00000,0.00000,0.00000	0,	3	152191	0.0580	0.56			/0.0>0.0/0.9>0.0		PTPRC|0.00|0.00|0.00|0.00|30|-18|7|2		0	1	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696788	198696788	C	G	wt	het	wt		QUAL=3200;DP=451,206,293;AF=0.00,0.58,0.00;MQM=60;SAP=8;ABP=15;SAR=69;SAF=52	PTPRC	intron,synonymous	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:ENST00000442510.8:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:,PTPRC:ENST00000697631.1:synonymous_variant:LOW:exon4/31:c.177C>G:p.Pro59=:,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4415C>G::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	378444 [benign/likely benign DISEASE=not specified,Immunodeficiency 105,PTPRC POLYMORPHISM,Immunodeficiency 104];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.00833	0.00258,0.00727,0.00019,0.01377,0.00705	8,	1252	150872	0.5270	3.33			/1.4>0.0/0.0>1.0	COSV100723197	PTPRC|0.00|0.00|0.00|0.00|-36|6|0|-38	25147926,16400609,19898481,20158892,18634151,19879912,22095823,22524693,28759630,30332657,31572362,21067564,19111528,32888494,31824477,21507955,15372250,7621884,11528386,11548742,11841494,11101853,12373647,16505159	3	702	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198697103	198697103	A	G	wt	wt	het	off-target	QUAL=19;DP=52,5,4;AF=0.00,0.00,0.75;MQM=60;SAP=10;ABP=5;SAR=3;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4730A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron4/32:c.298+194A>G::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron4/30:c.298+194A>G::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4730A>G::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1250478 [benign DISEASE=not provided];			rs2296618	0.20226	0.36060,0.18560,0.12331,0.13874,0.16957	3981,	22769	121207	1.2130	9.34			/2.6>2.2/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|46|-2|-24|-2	31361310,31959851,27863252,30595370,31015401,32888494,34103634,34469753,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198708291	198708291	T	A	wt	wt	het	off-target	QUAL=521;DP=105,37,45;AF=0.00,0.00,0.51;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron8/30:c.748+30T>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron6/28:c.-6+30T>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1271164 [benign DISEASE=not provided];			rs2274368	0.05373	0.07260,0.09134,0.14223,0.03139,0.09106	282,	7606	143898	-0.3250	0.39			/0.0>0.0/0.0>0.0		PTPRC|0.00|0.00|0.01|0.00|-33|-40|-30|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198709964	198709964	G	A	het	wt	het	off-target	QUAL=1021;DP=73,8,13;AF=0.47,0.00,0.54;MQM=60;SAP=92;ABP=3;SAR=41;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron8/29:c.688+140G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron11/32:c.1171+140G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron9/30:c.886+140G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron7/28:c.133+140G>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1288182 [benign DISEASE=not provided];		L1M4 (LINE/L1)	rs10753834	0.08432	0.02307,0.09421,0.00039,0.12330,0.00932	754,	11300	139090	-0.2870	2.51			/4.4>3.8/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|39|-25|-45|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198709964	198709964	G	T	wt	wt	het	off-target	QUAL=1021;DP=73,8,13;AF=0.00,0.00,0.46;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron8/29:c.688+140G>T::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron11/32:c.1171+140G>T::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron9/30:c.886+140G>T::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron7/28:c.133+140G>T::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1232658 [benign DISEASE=not provided];		L1M4 (LINE/L1)	rs10753834	0.40520	0.59156,0.43658,0.39032,0.30797,0.38221	13680,	34174	90326	-0.2870	2.04			/4.4>4.7/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|-1|-25|38|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198732160	198732160	T	C	hom	hom	het	off-target	QUAL=2962;DP=73,17,19;AF=1.00,1.00,0.63;MQM=60;SAP=225;ABP=6;SAR=0;SAF=102	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron15/29:c.1492-140T>C::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron18/32:c.1975-140T>C::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron16/30:c.1690-140T>C::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron14/28:c.937-140T>C::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1280542 [benign DISEASE=not provided];			rs1932433	0.60662	0.65457,0.55563,0.35200,0.62751,0.42674	28229,	35409	59573	-0.9970	0.40			/1.9>1.0/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|50|36|-46|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198748089	198748089	-	T	het	het	het	off-target;low_conf_region	QUAL=714;DP=52,17,36;AF=0.29,0.53,0.25;MQM=60;SAP=38;ABP=34;SAR=5;SAF=28	PTPRC	splice_region&intron	PTPRC:ENST00000348564.11:splice_region_variant&intron_variant:LOW:intron23/29:c.2365-4dup::,PTPRC:ENST00000442510.8:splice_region_variant&intron_variant:LOW:intron26/32:c.2848-4dup::,PTPRC:ENST00000697631.1:splice_region_variant&intron_variant:LOW:intron24/30:c.2563-4dup::,PTPRC:ENST00000697632.1:splice_region_variant&intron_variant:LOW:intron22/28:c.1810-4dup::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs57296163	0.25904	0.09300,0.22713,0.11829,0.36877,0.16077	5361,	24396	100450		0.22			/11.0>11.8/0.0>0.0		PTPRC|0.02|0.00|0.00|0.00|22|-10|22|20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198749603	198749603	A	G	het	wt	het	off-target	QUAL=3828;DP=213,81,109;AF=0.47,0.00,0.50;MQM=60;SAP=298;ABP=4;SAR=150;SAF=5	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron26/30:c.2787+54A>G::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron24/28:c.2034+54A>G::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs549239314	0.00099	0.00048,0.00033,0.00000,0.00171,0.00000	0,	150	151734	-0.6400	0.07			/5.5>6.0/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|-49|10|-49|-50		0	55	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198754594	198754594	-	TAAG	hom	n/a	het	off-target	QUAL=1813;DP=67,2,6;AF=0.94,1.00,0.33;MQM=60;SAP=148;ABP=4;SAR=67;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron29/29:c.3162+192_3162+195dup::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron32/32:c.3645+192_3645+195dup::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron30/30:c.3360+192_3360+195dup::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron28/28:c.2607+192_2607+195dup::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1286830 [benign DISEASE=not provided];			rs34412391	0.25074	0.10635,0.22012,0.09110,0.35345,0.13992	5669,	26544	113202		1.41			/0.6>0.0/0.4>8.1		PTPRC|0.01|0.00|0.01|0.00|-38|48|0|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201039454	201039454	-	G	hom	het	het	off-target	QUAL=2007;DP=47,29,54;AF=0.91,0.52,0.50;MQM=60;SAP=188;ABP=3;SAR=0;SAF=85	CACNA1S	downstream_gene	CACNA1S:ENST00000362061.4:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000681874.1:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000367338.7:downstream_gene_variant:MODIFIER::::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs35360610	0.55011	0.78563,0.43093,0.41747,0.47912,0.32539	24814,	33943	68347		0.94							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040158	201040158	C	T	wt	wt	het	off-target	QUAL=331;DP=105,32,33;AF=0.00,0.00,0.48;MQM=60;SAP=23;ABP=3;SAR=2;SAF=14	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron43/43:c.5370+73G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron42/42:c.5310+73G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron42/42:c.5313+73G>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs1034542271	0.00001	0.00000,0.00000,0.00000,0.00001,0.00000	0,	1	152209	-0.1020	2.36			/0.0>0.0/5.8>0.0		CACNA1S|0.00|0.00|0.00|0.00|-20|-42|-15|0		0	1	0	0 / 0					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040428	201040428	A	G	hom	het	het	off-target	QUAL=5971;DP=132,63,83;AF=0.99,0.52,0.48;MQM=60;SAP=127;ABP=3;SAR=156;SAF=48	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron41/42:c.5167-54T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678243 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs1546416	0.35808	0.41526,0.29372,0.29780,0.35331,0.26098	9989,	34460	97588	-0.3470	0.78			/3.4>2.9/3.0>4.8	COSV62945146	CACNA1S|0.00|0.03|0.00|0.00|20|-14|-2|37	19825159,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040769	201040769	T	C	hom	hom	hom	off-target	QUAL=3854;DP=55,30,46;AF=1.00,1.00,1.00;MQM=60;SAP=123;ABP=0;SAR=108;SAF=23	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron40/42:c.5075-56A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678241 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1];			rs6427875	0.99330	0.99754,0.99123,1.00000,0.98962,0.99483	75086,	1002	1020	-4.2510	0.00			/3.8>4.9/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|37|-24|37|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201041734	201041734	T	C	hom	het	het	off-target	QUAL=3698;DP=62,92,107;AF=1.00,0.49,0.44;MQM=60;SAP=337;ABP=5;SAR=154;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron40/43:c.5049-145A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron39/42:c.4989-145A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron39/42:c.4992-145A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678239 [benign DISEASE=not provided];			rs6675915	0.55265	0.79339,0.43141,0.42637,0.47923,0.32747	25121,	33779	68011	-0.0780	3.75			/0.0>0.0/0.0>0.4	COSV62945328	CACNA1S|0.00|0.00|0.00|0.00|-50|31|29|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201043469	201043469	G	A	hom	wt	hom		QUAL=365;DP=10,3,4;AF=1.00,0.00,1.00;MQM=60;SAP=25;ABP=0;SAR=13;SAF=1	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon39/43:c.4800C>T:p.Pro1600=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254841 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified];			rs41267497	0.10454	0.02962,0.09013,0.00039,0.16194,0.02177	1167,	13549	136047	-1.2030	0.12			/3.6>4.3/0.0>0.0		CACNA1S|0.01|0.00|0.00|0.00|-16|38|39|-36	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201044208	201044208	T	C	hom	het	het	off-target	QUAL=6216;DP=76,130,190;AF=0.99,0.52,0.57;MQM=60;SAP=548;ABP=10;SAR=0;SAF=251	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron39/43:c.4797+120A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron38/42:c.4737+120A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron38/42:c.4740+120A>G::	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678237 [benign DISEASE=not provided];			rs2297906	0.55143	0.78815,0.43137,0.42523,0.47957,0.32695	24889,	33867	68043	-0.2290	2.61			/1.1>2.1/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|37|-43|8|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047168	201047168	G	A	wt	wt	het		QUAL=3275;DP=345,183,245;AF=0.00,0.00,0.52;MQM=60;SAP=14;ABP=4;SAR=51;SAF=76	CACNA1S	missense	CACNA1S:ENST00000362061.4:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:ENST00000681874.1:missense_variant:MODERATE:exon37/43:c.4555C>T:p.Arg1519Cys:,CACNA1S:ENST00000367338.7:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	197021 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified,not provided];			rs3850625	0.09054	0.02150,0.08087,0.03602,0.12041,0.19295	823,	12123	138313	7.7080	26.80	0.28	0.25	/0.0>0.0/0.0>0.0	COSV62938023	CACNA1S|0.00|0.01|0.00|0.00|-9|24|-41|-10	25741868,23139751,19825159,26831199,24029420,28452372,30604766,31440704,31152163,31511532,31015462,33097823,30595370,33547301,25658027,31851124,33790942,34429635,34272381,34798807,34949935,34594039,35773277,35710981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201050977	201050977	A	G	wt	het	het		QUAL=6115;DP=133,211,276;AF=0.01,0.53,0.49;MQM=60;SAP=98;ABP=3;SAR=72;SAF=176	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron32/42:c.4053+7T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	199680 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified,not provided];			rs6702590	0.77857	0.92879,0.80187,0.99400,0.66576,0.87573	47206,	23958	33666	-0.1500	3.11			/1.4>0.2/0.0>0.9		CACNA1S|0.00|0.00|0.00|0.00|31|45|7|2	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201051232	201051232	G	A	hom	het	het	off-target	QUAL=6100;DP=121,114,140;AF=0.97,0.40,0.52;MQM=60;SAP=515;ABP=5;SAR=236;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron32/43:c.3954-89C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron31/42:c.3894-89C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron31/42:c.3897-89C>T::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	680202 [benign DISEASE=not provided];			rs12138260	0.10510	0.02907,0.08982,0.00039,0.16306,0.02172	1186,	13615	136121	-1.2270	1.53			/1.1>0.7/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-32|15|11|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054308	201054308	C	T	wt	het	het	off-target	QUAL=362;DP=55,23,29;AF=0.00,0.48,0.38;MQM=60;SAP=51;ABP=6;SAR=0;SAF=22	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron29/43:c.3666+197G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron28/42:c.3606+197G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-721G>A::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1238693 [benign DISEASE=not provided];			rs3818873	0.53222	0.37651,0.64502,0.85603,0.53842,0.81343	22798,	35279	71083	-0.0660	3.98			/0.3>2.3/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-13|-1|16|-28	32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054723	201054723	C	G	wt	het	het	off-target;low_conf_region	QUAL=62;DP=12,8,11;AF=0.00,0.50,0.64;MQM=58;SAP=27;ABP=4;SAR=11;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-162G>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-162G>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1136G>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs529174581	0.10142	0.14298,0.08382,0.04380,0.09514,0.12162	0,	571	5059	-1.5300	0.26			/5.3>5.3/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-32|37|22|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054728	201054728	T	G	wt	het	het	off-target	QUAL=66;DP=12,5,6;AF=0.00,0.80,0.83;MQM=58;SAP=23;ABP=13;SAR=9;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-167A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-167A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1141A>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	680271 [likely benign DISEASE=not provided];			rs988057279	0.08160	0.08898,0.07623,0.06707,0.08348,0.09690	0,	889	10005	-2.7920	0.06			/5.3>5.6/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-20|32|44|-23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054732	201054732	T	G	wt	het	het	off-target	QUAL=66;DP=12,5,6;AF=0.00,0.80,0.83;MQM=58;SAP=23;ABP=13;SAR=9;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-171A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-171A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1145A>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs913779535	0.12271	0.12280,0.08354,0.12054,0.14044,0.12723	0,	2195	15693	-2.0630	2.81			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-41|28|30|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201062179	201062179	A	C	wt	het	het	off-target	QUAL=3317;DP=79,121,170;AF=0.00,0.40,0.53;MQM=60;SAP=193;ABP=5;SAR=124;SAF=14	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron23/43:c.2907-89T>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron22/42:c.2847-89T>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron23/42:c.2907-89T>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1192645 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1];			rs2297903	0.51667	0.48225,0.60496,0.76057,0.49059,0.70058	20657,	37057	73315	-1.5020	7.75			/8.1>7.6/0.0>0.0		CACNA1S|0.00|0.21|0.00|0.00|42|-17|1|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201069559	201069559	A	G	het	wt	het		QUAL=8039;DP=215,343,428;AF=0.47,0.00,0.51;MQM=60;SAP=20;ABP=3;SAR=185;SAF=135	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein]	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254814 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified,not provided];			rs7415038	0.42108	0.52593,0.33639,0.00155,0.44829,0.16998	14602,	34746	87922	4.8560	12.17			/0.0>0.0/0.0>0.0	COSV62939654	CACNA1S|0.00|0.01|0.00|0.00|42|-36|4|42	25741868,19825159,20681998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073349	201073351	CTG	-	het	wt	hom	off-target	QUAL=1317;DP=69,25,20;AF=0.65,0.00,1.00;MQM=60;SAP=144;ABP=17;SAR=0;SAF=65	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+198_2157+200del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678223 [benign DISEASE=not provided];			rs71138316	0.70588	0.49886,0.72685,0.96006,0.77533,0.89793	39104,	28732	44558	0.2530	4.38			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.04|0.00|0.00|-36|27|27|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073490	201073490	G	A	het	wt	hom	off-target	QUAL=4976;DP=82,101,140;AF=0.49,0.00,1.00;MQM=60;SAP=129;ABP=3;SAR=39;SAF=141	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678298 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs9333652	0.43961	0.34525,0.47614,0.95907,0.40163,0.76358	16095,	34542	85068	0.1200	1.76			/7.7>7.9/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-15|-44|46|0	19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201074718	201074719	CT	-	het	wt	het	off-target	QUAL=2515;DP=99,57,85;AF=0.49,0.00,0.88;MQM=60;SAP=272;ABP=51;SAR=124;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron13/43:c.1949-99_1949-98del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678222 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs66932448	0.71996	0.54721,0.73247,0.96006,0.77592,0.89801	40291,	28681	42499	-0.2410	0.99			/0.0>0.0/0.5>0.5		CACNA1S|0.00|0.04|0.00|0.00|-30|-50|42|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201075620	201075620	A	G	het	wt	hom		QUAL=10519;DP=152,259,278;AF=0.51,0.00,1.00;MQM=60;SAP=25;ABP=3;SAR=208;SAF=148	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254804 [benign/likely benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not provided,Thyrotoxic periodic paralysis, susceptibility to, 1,not specified];			rs1998721	0.72079	0.54970,0.73288,0.96069,0.77604,0.89809	40463,	28673	42455	-0.5120	0.14			11.3>10.7/11.3>10.7/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-15|-5|-5|-4	25741868,27182706,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201076897	201076897	G	T	het	wt	het	off-target	QUAL=4312;DP=82,275,337;AF=0.48,0.01,0.53;MQM=60;SAP=326;ABP=4;SAR=19;SAF=199	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1293266 [benign DISEASE=not provided];		L2c (LINE/L2)	rs7549030	0.06791	0.07838,0.04895,0.00019,0.07045,0.02526	411,	9510	141812	-0.1210	1.74			/2.5>1.1/0.0>0.0		CACNA1S|0.00|0.00|0.01|0.00|32|-44|-49|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077251	201077251	T	G	het	wt	hom	off-target	QUAL=5680;DP=70,129,172;AF=0.41,0.00,1.00;MQM=60;SAP=439;ABP=7;SAR=201;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-124A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678221 [benign DISEASE=not provided];			rs925060	0.71380	0.56856,0.67472,0.81571,0.78150,0.86838	39318,	29650	43418	0.2580	4.14			/1.1>0.0/2.2>3.1		CACNA1S|0.00|0.00|0.00|0.00|45|-34|0|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077260	201077260	A	G	het	wt	hom	off-target	QUAL=5157;DP=80,110,152;AF=0.44,0.00,1.00;MQM=60;SAP=409;ABP=6;SAR=187;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-133T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678220 [benign DISEASE=not provided];			rs6672094	0.80431	0.79472,0.77663,0.95944,0.79801,0.90907	49206,	23618	29690	-4.3810	0.04			/1.1>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|36|2|-9|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077934	201077934	G	A	hom	hom	het		QUAL=15041;DP=143,260,267;AF=0.99,1.00,0.48;MQM=60;SAP=128;ABP=4;SAR=177;SAF=351	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254801 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.22499	0.25929,0.24840,0.04016,0.22096,0.10054	4045,	26128	117868	4.9060	9.80			/0.0>0.0/0.0>0.0	COSV62944479	CACNA1S|0.00|0.00|0.00|0.00|46|-6|15|45	25741868,26648445,11940049	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077947	201077947	A	G	hom	hom	het		QUAL=17376;DP=185,267,286;AF=0.99,1.00,0.50;MQM=60;SAP=118;ABP=3;SAR=208;SAF=385	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254800 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not provided,not specified];			rs4915477	0.68475	0.89317,0.65172,0.23425,0.65065,0.29523	37747,	28592	47920	-1.1500	3.40			/0.0>0.0/0.0>0.0	COSV62938741	CACNA1S|0.00|0.00|0.00|0.00|33|42|-45|42	25741868,26648445,18325191	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083071	201083071	T	C	hom	hom	het	off-target	QUAL=14792;DP=203,181,258;AF=1.00,0.99,0.50;MQM=60;SAP=1023;ABP=3;SAR=10;SAF=499	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron10/43:c.1393+91A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678296 [benign DISEASE=not provided];			rs3767511	0.22257	0.26072,0.22698,0.03350,0.22069,0.10534	3960,	25918	118192	-0.0180	6.45			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-42|10|1|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083512	201083512	G	A	het	het	hom	off-target	QUAL=3415;DP=91,48,65;AF=0.44,0.58,1.00;MQM=60;SAP=292;ABP=3;SAR=133;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron9/43:c.1233-190C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678219 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs4915478	0.63299	0.73228,0.68839,0.99750,0.51723,0.82110	31630,	32918	55764	-1.0690	0.09			/4.5>4.5/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-16|14|15|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201085069	201085069	G	T	wt	het	wt	off-target	QUAL=923;DP=82,88,114;AF=0.00,0.50,0.00;MQM=60;SAP=19;ABP=3;SAR=13;SAF=31	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678295 [benign DISEASE=not provided];			rs41267505	0.15648	0.14242,0.22069,0.03369,0.16329,0.07625	2027,	19736	128238	-0.0120	0.41			/0.0>0.0/0.0>0.0	COSV62945385	CACNA1S|0.00|0.00|0.00|0.00|25|-38|21|49	32572223	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201089564	201089564	T	C	hom	het	hom	off-target	QUAL=10824;DP=157,143,166;AF=0.99,0.50,1.00;MQM=60;SAP=848;ABP=3;SAR=392;SAF=1	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron5/43:c.695-101A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron5/42:c.695-101A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron5/42:c.695-101A>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678218 [benign DISEASE=not provided];			rs2296384	0.58387	0.59071,0.51501,0.38442,0.62389,0.51388	26217,	36302	63242	-0.0040	2.45			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|0|14|1|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201091737	201091737	G	A	wt	wt	het		QUAL=2468;DP=165,158,185;AF=0.01,0.00,0.54;MQM=60;SAP=6;ABP=5;SAR=56;SAF=44	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254852 [benign DISEASE=Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified,not provided];			rs2296383	0.32824	0.10912,0.34886,0.36588,0.43286,0.43675	9768,	30358	102112	-0.7110	8.08			/3.5>3.1/0.0>0.0	COSV62936330	CACNA1S|0.00|0.01|0.00|0.00|2|47|48|47	25741868,19825159,32765863,32825595	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201110404	201110404	C	T	het	wt	het	off-target	QUAL=3268;DP=126,134,188;AF=0.47,0.00,0.50;MQM=60;SAP=335;ABP=3;SAR=153;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron1/43:c.153-135G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron1/42:c.153-135G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron1/42:c.153-135G>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1298108 [benign DISEASE=not provided];			rs111530734	0.02051	0.00557,0.01649,0.00000,0.02478,0.00290	60,	3001	149071	-0.8410	0.45			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.01|0.00|0.00|7|20|32|1	31211845	1	165	0	0 / 0					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39), ASCL5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209614868	209614868	T	C	hom	het	het		QUAL=5677;DP=152,41,72;AF=0.99,0.59,0.46;MQM=60;SAP=455;ABP=3;SAR=0;SAF=208	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.9:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	368859 [benign DISEASE=Junctional epidermolysis bullosa];			rs926387	0.74804	0.92175,0.75697,0.75580,0.65901,0.70091	43642,	26417	38297	-1.4470	0.23							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209615169	209615169	G	A	het	wt	het		QUAL=5466;DP=185,240,262;AF=0.53,0.00,0.46;MQM=60;SAP=108;ABP=3;SAR=161;SAF=58	LAMB3	3'UTR	LAMB3:ENST00000356082.9:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:ENST00000367030.7:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	295059 [benign DISEASE=not provided,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa gravis of Herlitz];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.27396	0.24754,0.35100,0.34620,0.27353,0.27028	5818,	30008	110364	1.1420	8.92			/0.0>0.0/0.0>0.0	COSV50521190	LAMB3|0.00|0.00|0.00|0.00|-8|40|2|-29	20163849,21627860,21692980,23554684,23614619,28584635,31882771,23320911,29963045,25337271,25132800,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618217	209618217	C	T	het	wt	het	off-target	QUAL=3188;DP=184,66,63;AF=0.59,0.02,0.37;MQM=60;SAP=188;ABP=5;SAR=119;SAF=13	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2910-169G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1286389 [benign DISEASE=not provided];			rs2076220	0.29073	0.30637,0.35625,0.34492,0.27366,0.27101	6516,	31162	107816	-0.0670	1.13			/0.0>0.0/0.0>0.0		LAMB3|0.00|0.00|0.00|0.01|-8|31|16|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618270	209618270	G	A	het	wt	het	off-target	QUAL=2528;DP=172,37,45;AF=0.48,0.00,0.40;MQM=60;SAP=16;ABP=5;SAR=63;SAF=38	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2909+182C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1276454 [benign DISEASE=not provided];			rs2076221	0.34700	0.50027,0.37839,0.34295,0.27452,0.27188	9927,	32871	99219	-0.2600	0.19			/1.3>1.2/0.0>0.0	COSV50524219	LAMB3|0.00|0.00|0.00|0.00|-19|30|31|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618670	209618670	-	C	hom	hom	hom	off-target	QUAL=12696;DP=164,133,183;AF=0.95,0.94,0.98;MQM=60;SAP=714;ABP=0;SAR=424;SAF=36	LAMB3	splice_region&intron	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron17/21:c.2702-12dup::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255590 [benign DISEASE=not specified,Junctional epidermolysis bullosa, non-Herlitz type,not provided,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa gravis of Herlitz];			rs397807887	0.95653	0.98772,0.97495,0.99981,0.93176,0.98986	69717,	6171	6617		12.76			/8.9>8.3/0.0>0.0		LAMB3|0.01|0.00|0.00|0.00|-40|-11|30|-42	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209622922	209622922	G	A	het	wt	het	off-target	QUAL=777;DP=57,12,14;AF=0.54,0.00,0.36;MQM=60;SAP=7;ABP=3;SAR=14;SAF=22	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron16/21:c.2556+60C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180485 [benign DISEASE=Amelogenesis imperfecta type 1A,not provided,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type];			rs3737913	0.27458	0.24678,0.35290,0.35128,0.27441,0.26867	5840,	30027	110185	-4.6550	0.00			/0.0>0.0/3.0>2.5	COSV61915383	LAMB3|0.00|0.00|0.00|0.00|-14|-38|30|-2	25368101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209625908	209625908	A	G	het	hom	het		QUAL=21489;DP=303,382,547;AF=0.41,1.00,0.50;MQM=60;SAP=290;ABP=11;SAR=550;SAF=229	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain]	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255587 [benign DISEASE=not specified,Junctional epidermolysis bullosa, non-Herlitz type,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa,not provided,Junctional epidermolysis bullosa gravis of Herlitz];			rs2179402	0.74876	0.77111,0.75137,0.82350,0.72700,0.74027	42675,	28549	38217	-0.9660	1.56			/0.0>0.0/0.0>0.0	COSV61918520	LAMB3|0.00|0.02|0.00|0.00|17|-43|-12|2	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209627765	209627765	C	T	het	hom	het	off-target	QUAL=3475;DP=202,24,24;AF=0.53,1.00,0.54;MQM=60;SAP=188;ABP=5;SAR=128;SAF=17	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron10/21:c.1289-186G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180469 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,Amelogenesis imperfecta type 1A,not provided,Junctional epidermolysis bullosa, non-Herlitz type];			rs61822212	0.17206	0.04289,0.12670,0.01639,0.24850,0.14022	3048,	20078	125944	-1.1520	0.35			/0.0>0.0/0.0>1.3		LAMB3|0.00|0.00|0.00|0.01|41|21|31|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209630750	209630750	G	A	hom	hom	hom	off-target	QUAL=12100;DP=114,124,158;AF=1.00,1.00,1.00;MQM=60;SAP=158;ABP=0;SAR=282;SAF=114	LAMB3	splice_region&intron	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron7/21:c.823-15C>T::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255598 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa,not specified,not provided];			rs4844863	0.84139	0.82879,0.82945,0.82732,0.84566,0.80042	53847,	20115	24093	-1.8920	1.56			8.4>7.7/8.4>7.7/0.0>0.0	COSV61919103	LAMB3|0.00|0.01|0.00|0.00|-15|-39|46|-14	25741868,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209634627	209634627	G	A	hom	hom	hom		QUAL=5430;DP=37,58,91;AF=1.00,1.00,1.00;MQM=60;SAP=85;ABP=0;SAR=135;SAF=51	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255596 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa,not specified,not provided,Junctional epidermolysis bullosa gravis of Herlitz];			rs1130667	0.31007	0.13952,0.26628,0.24098,0.39702,0.32476	8286,	30464	104660	-4.0090	0.33			/0.0>0.0/0.0>0.0	COSV61916410	LAMB3|0.00|0.00|0.00|0.02|-19|11|11|-34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638541	209638541	T	G	hom	hom	hom		QUAL=19103;DP=260,137,210;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0;SAR=236;SAF=371	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255592 [benign DISEASE=not provided,not specified,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type];			rs2076356	0.55965	0.41975,0.50275,0.27596,0.65040,0.48215	25022,	34984	66904	-0.8890	5.33			/2.8>3.2/0.0>0.0	COSV61915034	LAMB3|0.00|0.00|0.00|0.00|2|-4|-7|-4	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638718	209638718	T	C	hom	hom	hom	off-target	QUAL=8289;DP=107,68,103;AF=1.00,1.00,1.00;MQM=60;SAP=547;ABP=0;SAR=271;SAF=7	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron3/22:c.184-70A>G::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron2/21:c.184-70A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron3/22:c.184-70A>G::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180480 [benign DISEASE=not provided,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type,Amelogenesis imperfecta type 1A];			rs2076357	0.58622	0.38631,0.61579,0.63433,0.67779,0.67553	27353,	34303	62827	-0.6750	4.59			/0.6>2.0/0.0>0.0	COSV61915925	LAMB3|0.00|0.00|0.00|0.00|-30|42|48|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209651362	209651362	A	T	hom	hom	hom	off-target	QUAL=9401;DP=175,81,84;AF=0.99,1.00,1.00;MQM=60;SAP=739;ABP=0;SAR=339;SAF=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1252656 [benign DISEASE=not provided];			rs10779510	0.87723	0.79994,0.90637,0.99923,0.89135,0.94830	58763,	15921	18677	-0.3030	3.32			/4.3>7.6/0.0>0.0		LAMB3|0.00|0.00|0.00|0.00|-2|-44|3|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652041	209652041	T	C	hom	hom	hom	off-target	QUAL=4100;DP=73,32,35;AF=1.00,1.00,1.00;MQM=60;SAP=307;ABP=0;SAR=0;SAF=140	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-38+328A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-38+208A>G::	regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1285919 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs10863778	0.84451	0.80461,0.85997,0.69825,0.86652,0.78957	54282,	19721	23619	0.3640	5.56			/2.5>1.9/0.0>0.0		LAMB3|0.00|0.00|0.00|0.00|2|-20|34|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652603	209652603	C	G	hom	hom	hom	off-target	QUAL=2543;DP=46,17,25;AF=0.98,1.00,1.00;MQM=60;SAP=192;ABP=0;SAR=87;SAF=0	LAMB3	upstream_gene	LAMB3:ENST00000356082.9:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1242415 [benign DISEASE=not provided];			rs7519942	0.92537	0.92136,0.92750,0.99923,0.91621,0.95571	65137,	10516	11354	-0.5090	0.81							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209786269	209786269	G	T	het	wt	het		QUAL=6865;DP=339,126,185;AF=0.53,0.00,0.50;MQM=58;SAP=11;ABP=5;SAR=152;SAF=120	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295175 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs1044516	0.22881	0.26639,0.32781,0.55017,0.17288,0.31134	4638,	25498	117204	-0.3060	0.98			/0.0>0.0/0.0>0.0		IRF6|0.02|0.00|0.00|0.00|-34|3|20|-34	20652317,31495697,30410503,31122291,25663376,27033726,33195260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786527	209786527	G	A	hom	hom	hom		QUAL=19090;DP=313,125,150;AF=1.00,0.99,0.99;MQM=57;SAP=4;ABP=0;SAR=285;SAF=300	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295178 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs680331	0.80874	0.84728,0.82665,0.80599,0.79173,0.77988	49753,	23355	29055	-0.0200	1.32			/1.4>1.0/0.0>0.0		IRF6|0.00|0.00|0.00|0.00|-41|45|46|-31	21319277,23248214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786742	209786742	A	-	wt	wt	het		QUAL=1633;DP=254,130,118;AF=0.00,0.00,0.53;MQM=60;SAP=3;ABP=4;SAR=32;SAF=31	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295181 [benign DISEASE=Cleft Lip +/- Cleft Palate, Autosomal Dominant,Van der Woude syndrome 1];			rs141112353	0.19268	0.19587,0.18875,0.09084,0.19812,0.12008	2876,	23547	122761	0.4050	0.86			/3.6>1.6/0.0>0.0		IRF6|0.00|0.00|0.00|0.00|18|-2|46|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786807	209786807	T	A	wt	wt	het		QUAL=1229;DP=263,102,105;AF=0.00,0.00,0.49;MQM=60;SAP=8;ABP=3;SAR=20;SAF=31	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs1195550606						-0.6430	0.75			/0.1>2.2/0.0>0.0		IRF6|0.00|0.00|0.00|0.00|-48|-2|24|-48		0	1	0	0 / 0					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787091	209787091	G	A	het	wt	het		QUAL=6313;DP=254,202,249;AF=0.46,0.00,0.51;MQM=60;SAP=56;ABP=4;SAR=83;SAF=160	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295184 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];		AluJo (SINE/Alu)	rs2235372	0.22580	0.26952,0.32778,0.47232,0.17247,0.30975	4426,	25436	117562	-1.0050	1.31			/0.0>0.0/0.0>0.0	COSV50551228	IRF6|0.00|0.00|0.00|0.00|1|-43|3|-49	23121717	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787577	209787577	A	C	het	hom	wt		QUAL=2823;DP=125,45,125;AF=0.46,1.00,0.00;MQM=60;SAP=14;ABP=4;SAR=63;SAF=40	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295189 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs599021	0.36293	0.26111,0.30156,0.24100,0.43260,0.35322	10686,	33703	96675	0.2660	4.92			/0.0>0.0/0.7>0.0		IRF6|0.00|0.00|0.00|0.00|-30|-50|25|2	18278815,17438386,20652317,19388848	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787580	209787580	T	C	het	wt	het		QUAL=3153;DP=129,44,123;AF=0.54,0.00,0.45;MQM=60;SAP=35;ABP=3;SAR=84;SAF=41	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295190 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs742214	0.22464	0.26646,0.32671,0.47240,0.17241,0.30900	4383,	25341	117721	-0.9660	0.99			/0.0>1.8/0.7>0.0		IRF6|0.00|0.00|0.00|0.00|-9|-2|22|-1	30410503	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787678	209787678	T	A	het	wt	het		QUAL=2224;DP=98,51,81;AF=0.50,0.02,0.49;MQM=60;SAP=19;ABP=3;SAR=32;SAF=58	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295193 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs742215	0.23055	0.28625,0.32887,0.47404,0.17254,0.31023	4595,	25625	116195	0.9740	10.13			/0.0>0.0/0.0>0.0	COSV54213600	IRF6|0.00|0.00|0.00|0.00|0|-4|2|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787969	209787969	T	C	het	wt	het		QUAL=6608;DP=269,188,239;AF=0.51,0.01,0.47;MQM=60;SAP=3;ABP=3;SAR=128;SAF=122	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295199 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs17317411	0.10738	0.02999,0.11446,0.04032,0.15157,0.18683	1158,	13998	135614	0.3090	13.74			/0.0>1.1/0.0>0.0	COSV54213602	IRF6|0.00|0.00|0.00|0.00|30|-26|-8|8	20652317,28593555,23121717,30689861	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209788009	209788009	G	A	wt	wt	het		QUAL=2559;DP=333,163,208;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=5;SAR=52;SAF=46	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295200 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];		MIR3 (SINE/MIR)	rs187379424	0.00472	0.00089,0.00065,0.00000,0.00637,0.00062	4,	710	151342	1.8520	10.32			/3.0>4.4/0.0>0.0		IRF6|0.00|0.00|0.00|0.00|-10|30|-2|-48		1	111	0	0 / 0					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209790458	209790458	G	A	het	wt	het	off-target	QUAL=3830;DP=194,88,127;AF=0.52,0.00,0.52;MQM=60;SAP=363;ABP=4;SAR=0;SAF=166	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291060 [benign DISEASE=not provided];			rs2235373	0.21563	0.23474,0.32306,0.47131,0.17236,0.30809	4031,	24733	119293	-0.8660	0.88			/0.0>0.0/0.0>0.0	COSV65418889	IRF6|0.00|0.00|0.00|0.00|-11|20|37|-9	18278815,17438386,20652317,19388848,25592222,19444471,28593555,33137956,35865051	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209792242	209792242	G	C	het	wt	hom	off-target	QUAL=10463;DP=196,215,261;AF=0.46,0.00,1.00;MQM=60;SAP=256;ABP=6;SAR=74;SAF=276	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259926 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not specified,not provided];			rs2235375	0.36744	0.28812,0.49365,0.56561,0.37025,0.43168	10636,	34569	96133	0.0730	2.36			/2.6>2.7/0.0>0.0	COSV65418892	IRF6|0.00|0.00|0.00|0.00|2|-22|23|27	25741868,17318851,18278815,17438386,20215007,15558496,25853057,23940636,19734457,28712851,20631690,33195260,25489771,32533457,35633982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795339	209795339	C	A	het	wt	hom		QUAL=18560;DP=341,326,460;AF=0.45,0.00,1.00;MQM=60;SAP=7;ABP=11;SAR=290;SAF=323	IRF6	synonymous	IRF6:ENST00000367021.8:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.5:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259925 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not provided,Van der Woude syndrome,Popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not specified];			rs2013162	0.36519	0.27990,0.49450,0.56658,0.37017,0.42993	10523,	34453	96473	-1.7160	0.79			/0.0>0.0/0.0>0.0	COSV65418898	IRF6|0.01|0.00|0.00|0.00|-22|47|-22|-49	25741868,20403199,29065370,18278815,20436469,18978678,27511269,17438386,20652317,19521098,19937600,21319277,23029012,31448957,18209213,29211286,21859832,21204206,15558496,25853057,23940636,16096995,19734457,22440537,31156544,17616516,28593555,25663376,29291710,18452891,33195260,27706679,33406080,25489771,35075162,35633982,36158961	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795573	209795573	G	A	het	wt	het	off-target	QUAL=2861;DP=162,67,80;AF=0.51,0.00,0.53;MQM=60;SAP=272;ABP=3;SAR=124;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron4/8:c.380-155C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron2/6:c.95-155C>T::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291056 [benign DISEASE=not provided];			rs17015224	0.17010	0.22510,0.14219,0.06474,0.15904,0.21417	2375,	21099	126119	-0.1270	1.23			/0.0>0.0/0.0>0.0	COSV65418901	IRF6|0.01|0.00|0.00|0.00|-22|40|-35|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796557	209796557	G	C	het	wt	hom		QUAL=4839;DP=210,51,86;AF=0.47,0.02,0.99;MQM=60;SAP=346;ABP=4;SAR=178;SAF=7	IRF6	splice_region&intron	IRF6:ENST00000367021.8:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.5:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259923 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not specified,not provided,Van der Woude syndrome,Popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1];			rs7552506	0.31992	0.27177,0.31343,0.15580,0.35688,0.33403	7901,	32663	103027	1.3340	13.91			9.7>6.9/9.7>6.9/0.0>0.0,/9.7>6.9/0.0>0.0	COSV65419346	IRF6|0.00|0.02|0.00|0.00|-18|-5|-5|-23	25741868,20652317,19937600,18209213,17551329,28593555,33195260,32108996,25489771	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796634	209796634	A	C	het	n/a	het	off-target;low_conf_region	QUAL=63;DP=10,1,9;AF=0.40,0.00,0.11;MQM=48;SAP=14;ABP=12;SAR=5;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-82T>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-82T>G::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]			(AC)n (Simple_repeat)	rs113569623	0.00006	0.00008,0.00014,0.00000,0.00005,0.00000	0,	8	136804	0.1100	2.89			/1.3>0.8/0.0>0.0	COSV65418639	IRF6|0.00|0.00|0.00|0.00|-23|-17|3|46		35	1709	0	0 / 0					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796635	209796636	AC	-	wt	n/a	het	off-target;low_conf_region	QUAL=63;DP=10,1,9;AF=0.40,0.00,0.11;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-84_175-83del::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-84_-111-83del::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1179706 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs3028134	0.14563	0.10129,0.13623,0.09591,0.16860,0.13040	1406,	17083	116723	1.6150	8.22			/1.3>0.5/0.0>0.0		IRF6|0.00|0.00|0.00|0.00|44|-17|-17|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796751	209796751	C	G	het	n/a	n/a	off-target	QUAL=449;DP=48,2,1;AF=0.52,0.00,0.00;MQM=60;SAP=57;ABP=3;SAR=25;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-199G>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-199G>C::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1285878 [benign DISEASE=not provided];			rs17015226	0.17001	0.22505,0.14216,0.06448,0.15896,0.21438	2373,	21058	125976	0.0710	3.88			/6.8>8.4/0.0>0.0	COSV65418904	IRF6|0.00|0.00|0.00|0.00|15|-29|-33|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209802041	209802041	A	G	het	hom	wt		QUAL=11948;DP=286,263,351;AF=0.49,1.00,0.00;MQM=60;SAP=59;ABP=3;SAR=253;SAF=151	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.8:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295214 [benign DISEASE=Orofacial cleft 6, susceptibility to,not provided,Van der Woude syndrome 1,not specified];			rs861019	0.43289	0.50528,0.33006,0.24063,0.43312,0.35000	14686,	36369	86125	-0.2070	2.01			/10.8>11.0/0.0>0.0	COSV65419778	IRF6|0.00|0.00|0.00|0.00|2|-16|-1|44	17318851,18278815,17438386,20652317,19388848,23029012,31495697,16160700,18209213,19561605,21834040,29211286,28593555,18452891,33195260,33406080	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806173	209806173	T	A	wt	wt	het		QUAL=1273;DP=34,96,127;AF=0.00,0.00,0.54;MQM=60;SAP=73;ABP=5;SAR=58;SAF=11	IRF6	5'UTR	IRF6:ENST00000542854.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-338A>T::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295219 [benign DISEASE=Van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.15877	0.04435,0.17751,0.09158,0.21308,0.13024	2392,	19356	127908	-0.0070	6.99			/0.0>0.0/0.0>0.0	COSV65419508		28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806184	209806184	A	T	wt	wt	het		QUAL=1222;DP=27,83,120;AF=0.00,0.00,0.54;MQM=60;SAP=97;ABP=5;SAR=59;SAF=6	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	368864 [benign DISEASE=Cleft Lip +/- Cleft Palate, Autosomal Dominant,Van der Woude syndrome 1,Popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Van der Woude syndrome];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.15894	0.04440,0.17756,0.09135,0.21322,0.13072	2397,	19353	127779	0.0190	16.03						27369588,28593555,28361103,33195260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806268	209806268	C	G	het	wt	hom	off-target	QUAL=1913;DP=37,43,53;AF=0.59,0.00,1.00;MQM=60;SAP=166;ABP=6;SAR=75;SAF=0	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545538	0.40304	0.28615,0.51460,0.56765,0.42792,0.47435	12826,	35626	90762	0.9250	9.94						25592222	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806290	209806290	C	T	het	wt	hom	off-target	QUAL=1631;DP=41,32,39;AF=0.66,0.00,1.00;MQM=60;SAP=146;ABP=12;SAR=66;SAF=0	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545542	0.37478	0.28014,0.50059,0.56690,0.38528,0.43998	11103,	34779	95065	0.5000	8.22						33817668	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215622731	215622732	AA	-	hom	n/a	n/a	off-target	QUAL=509;DP=18,0,2;AF=0.94,,1.00;MQM=60;SAP=44;ABP=0;SAR=0;SAF=19	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs34483623	0.98318	0.94366,0.99304,0.99807,0.99912,0.99834	73341,	2505	2553	-1.3290	0.06							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215622854	215622854	-	TTATT	het	het	wt	off-target	QUAL=649;DP=95,18,34;AF=0.35,0.22,0.00;MQM=60;SAP=83;ABP=32;SAR=0;SAF=37	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs75551431	0.23602	0.09998,0.24608,0.43488,0.27874,0.51351	4938,	25925	115885		1.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215623008	215623008	T	G	het	wt	hom		QUAL=13554;DP=354,178,266;AF=0.52,0.00,1.00;MQM=60;SAP=226;ABP=5;SAR=118;SAF=333	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs6667509	0.10450	0.11536,0.09730,0.05708,0.10242,0.12816	856,	14176	136146	2.2060	5.40			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-40|25|-40|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215624672	215624672	G	A	hom	hom	hom		QUAL=33458;DP=445,226,327;AF=1.00,1.00,1.00;MQM=60;SAP=39;ABP=0;SAR=435;SAF=563	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs2797255	0.99076	0.96808,0.99672,1.00000,0.99984,1.00000	74692,	1339	1405	-0.3060	0.14			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-21|44|35|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215634665	215634665	G	A	het	het	wt		QUAL=3674;DP=175,136,196;AF=0.48,0.50,0.00;MQM=60;SAP=189;ABP=3;SAR=133;SAF=19	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48455 [benign/likely benign DISEASE=Retinitis pigmentosa 39,Usher syndrome type 2A,not provided,not specified];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.01334	0.00316,0.00334,0.00000,0.01742,0.00975	24,	1982	150118	3.1780	16.64	0.09	0.08	/0.0>0.0/0.0>0.0	COSV99048303	USH2A|0.00|0.01|0.00|0.00|-43|38|38|-34	24033266,21569298,18273898,26927203	11	842	0	0 / 0	1	"[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215640844	215640844	C	A	het	wt	het	off-target	QUAL=97;DP=28,15,13;AF=0.25,0.13,0.15;MQM=56;SAP=27;ABP=48;SAR=11;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron67/71:c.14792-110G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron67/72:c.14792-110G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]			(AACAA)n (Simple_repeat)	rs78797010	0.00180	0.00128,0.00121,0.00113,0.00221,0.00131	0,	186	102880	-3.5250	0.02			/2.8>5.2/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-5|-48|-5|29		6	117	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215640845	215640845	A	-	het	het	wt	off-target	QUAL=97;DP=28,15,13;AF=0.25,0.40,0.15;MQM=60;SAP=36;ABP=29;SAR=15;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron67/71:c.14792-111del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron67/72:c.14792-111del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1231816 [benign DISEASE=not provided];		(AACAA)n (Simple_repeat)	rs56212994	0.75597	0.57875,0.83768,0.83954,0.81823,0.81049	28548,	21050	25226	-0.0150	0.47			/2.8>3.8/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-48|-6|-14|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215674720	215674720	C	T	het	het	wt		QUAL=8187;DP=381,246,314;AF=0.51,0.50,0.01;MQM=60;SAP=27;ABP=3;SAR=189;SAF=130	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48413 [benign DISEASE=not provided,Usher syndrome type 2A,not specified];			rs2009923	0.15867	0.05606,0.16269,0.35074,0.18485,0.29087	2361,	19397	127887	0.2990	0.97			/2.5>3.2/0.0>0.0	COSV56336645	USH2A|0.00|0.00|0.00|0.00|-16|-46|21|-46	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675245	215675245	T	C	wt	het	wt		QUAL=3267;DP=276,245,319;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3;SAR=74;SAF=51	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48403 [benign DISEASE=not provided,not specified,Usher syndrome type 2A];			rs2797234	0.33895	0.21962,0.41624,0.30518,0.39068,0.29909	9406,	32729	100521	-0.4260	0.69			/4.2>4.1/0.0>0.0	COSV56342646	USH2A|0.00|0.00|0.00|0.00|22|-20|-19|-5	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675299	215675299	T	C	het	het	hom		QUAL=20696;DP=388,280,377;AF=0.47,0.50,0.99;MQM=60;SAP=41;ABP=5;SAR=293;SAF=403	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	177993 [benign DISEASE=not specified,not provided,Usher syndrome type 2A];			rs2797235	0.74796	0.63481,0.79882,0.64520,0.81313,0.67965	43036,	27640	38318	0.1010	0.59			/0.0>0.0/0.0>0.0	COSV56342874	USH2A|0.00|0.00|0.00|0.00|43|-7|-21|45	24033266,21686329,20145675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675702	215675702	C	G	het	het	wt	off-target	QUAL=5318;DP=282,151,199;AF=0.48,0.50,0.01;MQM=60;SAP=360;ABP=3;SAR=200;SAF=13	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12295-86G>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12295-86G>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1290576 [benign DISEASE=not provided];			rs4443864	0.19632	0.12174,0.19024,0.35656,0.21222,0.33610	3263,	23318	122174	-1.2320	0.46			/0.0>0.0/0.0>0.0	COSV56377492	USH2A|0.00|0.00|0.00|0.00|21|-40|21|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680015	215680015	G	A	het	wt	het	off-target	QUAL=975;DP=76,5,15;AF=0.47,0.00,0.47;MQM=60;SAP=96;ABP=4;SAR=0;SAF=43	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12294+134C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12294+134C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1236125 [benign DISEASE=not provided];			rs10864183	0.20494	0.12710,0.25003,0.38966,0.21493,0.51119	3718,	23734	120922	1.0170	15.75			/0.8>2.0/0.4>8.2	COSV56344121	USH2A|0.00|0.00|0.00|0.00|1|10|2|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680407	215680407	T	-	het	het	het	off-target	QUAL=3627;DP=151,53,70;AF=0.52,0.62,0.86;MQM=60;SAP=326;ABP=42;SAR=166;SAF=6	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-31del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1225305 [benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa 39,not provided];			rs5780842	0.89329	0.76216,0.94335,0.99405,0.94267,0.92042	58941,	13199	15659	1.7360	0.52			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-30|-32|-39|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680493	215680493	A	G	het	wt	het	off-target	QUAL=2010;DP=117,24,34;AF=0.55,0.00,0.59;MQM=60;SAP=185;ABP=7;SAR=84;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-117T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-117T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1247988 [benign DISEASE=not provided];			rs12140451	0.19250	0.12423,0.19416,0.29207,0.21174,0.48583	3158,	22856	122374	-0.4630	0.43			/2.4>3.5/0.0>0.0	COSV56344126	USH2A|0.00|0.00|0.00|0.00|-37|0|-37|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680558	215680558	G	C	het	wt	het	off-target	QUAL=1144;DP=81,5,9;AF=0.54,0.00,0.67;MQM=60;SAP=112;ABP=5;SAR=50;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-182C>G::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-182C>G::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1174446 [benign DISEASE=not provided];			rs4375237	0.26019	0.31436,0.26988,0.39076,0.21610,0.52285	5539,	28356	112122	-0.3540	0.45			/0.0>3.4/0.0>0.0	COSV56344135	USH2A|0.00|0.00|0.00|0.00|-1|13|13|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215728150	215728150	C	T	hom	het	hom		QUAL=39547;DP=411,543,642;AF=0.99,0.42,0.99;MQM=60;SAP=122;ABP=33;SAR=504;SAF=768	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48387 [benign DISEASE=not specified,Usher syndrome type 2A,not provided];			rs2820718	0.16836	0.16875,0.11262,0.00386,0.18563,0.13582	2287,	21016	126404	0.7290	4.65			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|4|-16|17|6	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215741409	215741409	G	T	het	het	wt		QUAL=5401;DP=208,192,253;AF=0.53,0.52,0.00;MQM=60;SAP=63;ABP=5;SAR=67;SAF=143	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48380 [benign/likely benign DISEASE=not specified,not provided,Usher syndrome type 2A];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.01286	0.00336,0.00334,0.00019,0.01950,0.01266	19,	1916	150028	6.1100	24.80	0.34	0.17	/0.0>0.0/0.0>0.0	COSV99048391	USH2A|0.00|0.01|0.00|0.00|-2|48|41|-34	24033266,25133751,20507924,21569298,22004887,18273898,17405132,20145675,29216386,25999674,26927203	16	942	0	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign; gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215743079	215743079	C	T	hom	het	hom	off-target	QUAL=4799;DP=95,38,51;AF=1.00,0.45,1.00;MQM=60;SAP=357;ABP=4;SAR=0;SAF=163	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron59/71:c.11548+98G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron59/72:c.11548+98G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1290577 [benign DISEASE=not provided];			rs2797223	0.14998	0.12308,0.10855,0.00503,0.17217,0.11222	1866,	19029	128999	1.8500	13.46			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-27|-1|-6|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215758586	215758586	T	A	wt	wt	het		QUAL=2193;DP=223,176,196;AF=0.00,0.00,0.46;MQM=60;SAP=42;ABP=6;SAR=25;SAF=65	USH2A	splice_region&intron	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron58/71:c.11389+9A>T::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron58/72:c.11389+9A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48372 [benign DISEASE=not provided,Usher syndrome type 2A,not specified];			rs12095085	0.12321	0.13515,0.09899,0.00096,0.13137,0.04515	1271,	16185	133265	0.4490	5.50			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.02|9|23|-8|9	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759461	215759461	C	T	hom	n/a	n/a	off-target	QUAL=1652;DP=56,2,2;AF=1.00,0.50,0.50;MQM=60;SAP=129;ABP=3;SAR=0;SAF=58	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+199G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+199G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1259820 [benign DISEASE=not provided];			rs55908750	0.04155	0.04744,0.02033,0.00540,0.04255,0.06418	147,	6008	145380	-1.6560	0.13			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-42|-21|8|-21		17	120	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759615	215759615	G	A	wt	het	wt	off-target	QUAL=1056;DP=203,82,122;AF=0.00,0.55,0.00;MQM=60;SAP=76;ABP=5;SAR=3;SAF=42	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+45C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177014 [benign/likely benign DISEASE=Usher syndrome type 2A,not provided];			rs17025373	0.07031	0.01465,0.14134,0.35521,0.06522,0.09760	739,	9213	141369	-1.3310	0.20			/0.0>0.4/0.0>0.0	COSV56338606	USH2A|0.00|0.00|0.00|0.00|50|11|45|42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782390	215782390	-	AA	hom	het	het	off-target	QUAL=1546;DP=51,6,9;AF=0.98,0.50,0.67;MQM=60;SAP=131;ABP=4;SAR=59;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10586-196_10586-195dup::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10586-196_10586-195dup::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1222339 [benign DISEASE=not provided];			rs35071811	0.36215	0.45126,0.32756,0.28148,0.32801,0.34405	10266,	34407	96765		2.16			/1.7>1.9/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-15|46|46|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782595	215782595	T	G	hom	het	het	off-target	QUAL=991;DP=27,10,11;AF=0.96,0.40,0.55;MQM=60;SAP=65;ABP=3;SAR=2;SAF=34	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10585+143A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10585+143A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	678884 [benign DISEASE=not provided,Usher syndrome type 2A];			rs6665799	0.36269	0.45245,0.32785,0.28373,0.32819,0.34437	10326,	34462	96844	-0.6860	0.38			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|32|37|24|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782962	215782962	A	G	hom	hom	hom	off-target	QUAL=3935;DP=81,22,27;AF=0.99,1.00,1.00;MQM=60;SAP=266;ABP=0;SAR=127;SAF=2	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177015 [benign DISEASE=not provided,Usher syndrome type 2A];			rs7518466	0.59062	0.72116,0.58305,0.63346,0.52490,0.49191	27103,	35480	62166	-0.8160	0.04			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|4|-27|-27|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786811	215786811	A	C	het	wt	wt		QUAL=143;DP=237,234,280;AF=0.36,0.01,0.02;MQM=60;SAP=199;ABP=42;SAR=93;SAF=1	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10246T>G:p.Cys3416Gly:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10246T>G:p.Cys3416Gly:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	143168 [benign DISEASE=not provided,Usher syndrome type 2A];	CM135012 [CLASS=DM? MUT=ALT PHEN="Usher syndrome" GENE=USH2A];		rs527236140	0.00166	0.00041,0.00105,0.00039,0.00293,0.00000	0,	252	151328	5.2650	25.60	0.28	0.25	/3.9>1.5/5.3>1.1	COSV56321520	USH2A|0.00|0.00|0.00|0.00|-43|2|0|2	29343940	0	31	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786825	215786825	T	G	hom	hom	hom		QUAL=26980;DP=223,287,368;AF=1.00,1.00,1.00;MQM=60;SAP=221;ABP=0;SAR=587;SAF=290	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48344 [benign DISEASE=not provided,Usher syndrome type 2A,not specified];			rs10864198	0.57980	0.68343,0.57934,0.63333,0.52486,0.49275	25934,	36153	63793	2.9590	11.04	0.09	0.04	/0.8>1.6/0.0>0.0	COSV56336661	USH2A|0.00|0.02|0.00|0.00|-3|49|-14|-12	25741868,24033266,23757202,21686329,20145675,18665195,29986705,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215790032	215790032	G	A	wt	wt	het	off-target	QUAL=1532;DP=129,110,128;AF=0.00,0.00,0.50;MQM=60;SAP=109;ABP=3;SAR=4;SAF=60	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron51/72:c.10182+27C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1290575 [benign DISEASE=not provided];			rs11120629	0.12792	0.15020,0.10203,0.00078,0.13122,0.04660	1381,	16574	131822	0.0070	3.33			/0.0>0.0/0.0>2.6	COSV56371467	USH2A|0.00|0.00|0.00|0.02|27|50|2|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215813880	215813880	T	C	wt	wt	het		QUAL=3234;DP=271,169,280;AF=0.00,0.00,0.46;MQM=60;SAP=22;ABP=6;SAR=82;SAF=48	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48631 [benign DISEASE=not specified,not provided,Usher syndrome type 2A];			rs4129843	0.05565	0.07847,0.06193,0.15171,0.04210,0.07667	299,	7864	143596	0.1950	0.54	0.04	0.06	/0.0>0.0/0.0>0.0	COSV56343447	USH2A|0.00|0.00|0.00|0.00|24|-9|-34|3	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215838019	215838019	T	C	wt	wt	het		QUAL=3248;DP=341,238,263;AF=0.00,0.00,0.49;MQM=60;SAP=5;ABP=3;SAR=58;SAF=70	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48623 [benign DISEASE=not specified,not provided,Usher syndrome type 2A];			rs56032526	0.03609	0.01013,0.05402,0.15216,0.04207,0.07692	169,	5154	146686	0.0680	0.79	0.14	0.07	/0.0>0.0/0.0>0.0	COSV56343459	USH2A|0.00|0.00|0.00|0.00|-1|-29|-28|-42	25741868,24033266,18273898	34	1000	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215846085	215846085	A	-	wt	wt	het	off-target	QUAL=404;DP=124,42,44;AF=0.02,0.00,0.50;MQM=60;SAP=55;ABP=3;SAR=24;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron44/71:c.8846-52del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron44/72:c.8846-52del::	regulatory_region_variant:enhancer	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1256903 [benign DISEASE=not provided];			rs77889398	0.03683	0.01032,0.05488,0.15388,0.04280,0.07739	173,	5152	143776	0.0850	0.15			/6.6>6.2/0.0>0.0	COSV56391224	USH2A|0.05|0.09|0.00|0.00|26|-10|-10|-3		13	325	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877638	215877638	C	T	wt	wt	het	off-target	QUAL=809;DP=109,49,56;AF=0.00,0.00,0.63;MQM=60;SAP=79;ABP=11;SAR=0;SAF=35	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron43/71:c.8681+120G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron43/72:c.8681+120G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	761707 [benign DISEASE=not provided];			rs56301415	0.04951	0.05883,0.06316,0.14029,0.04114,0.07566	220,	7088	144532	0.4900	15.31			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-40|-33|-4|33		12	289	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877783	215877783	G	A	wt	wt	het		QUAL=2915;DP=195,198,216;AF=0.00,0.00,0.52;MQM=60;SAP=11;ABP=4;SAR=46;SAF=67	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48607 [benign/likely benign DISEASE=Retinitis pigmentosa 39,Usher syndrome type 2A,not provided,not specified];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.04955	0.05879,0.06323,0.14220,0.04107,0.07584	222,	7088	144464	6.8370	18.56	0.14	0.04	/0.0>0.1/0.0>0.0	COSV56343477	USH2A|0.00|0.00|0.00|0.01|-25|11|32|-25	25741868,24033266,18273898,17085681	21	615	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877945	215877945	A	G	wt	het	het	off-target	QUAL=3326;DP=231,136,138;AF=0.00,0.45,0.54;MQM=60;SAP=167;ABP=3;SAR=118;SAF=17	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron42/71:c.8559-65T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron42/72:c.8559-65T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177604 [benign DISEASE=not provided,Usher syndrome type 2A];			rs7518358	0.24332	0.33954,0.21245,0.43743,0.19452,0.37184	4941,	27092	114980	0.8390	16.11			/0.0>0.0/0.0>0.0	COSV56431732	USH2A|0.00|0.00|0.00|0.00|7|-25|25|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215878039	215878039	G	T	wt	wt	het	off-target	QUAL=530;DP=91,32,39;AF=0.00,0.00,0.64;MQM=60;SAP=57;ABP=10;SAR=25;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron42/71:c.8559-159C>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron42/72:c.8559-159C>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs79952600	0.03987	0.02502,0.05862,0.14155,0.04108,0.07613	163,	5650	143908	-0.1970	0.06			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-2|-39|0|-21		12	232	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215879207	215879207	A	G	wt	het	het	off-target	QUAL=1417;DP=187,80,71;AF=0.00,0.50,0.39;MQM=60;SAP=151;ABP=6;SAR=68;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron41/71:c.8224-109T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron41/72:c.8224-109T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1180911 [benign DISEASE=not provided];			rs6669557	0.17545	0.18888,0.17501,0.33011,0.16916,0.22631	2404,	21866	125362	0.6750	7.35			/0.0>0.0/0.0>0.0	COSV56388299	USH2A|0.00|0.00|0.00|0.00|27|-41|-9|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215993112	215993112	T	G	het	het	wt		QUAL=2820;DP=128,94,98;AF=0.48,0.57,0.00;MQM=60;SAP=10;ABP=4;SAR=67;SAF=48	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48568 [benign/likely benign DISEASE=not provided,Retinitis pigmentosa 39,Usher syndrome type 2A,not specified];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.01924	0.00567,0.01362,0.00039,0.02722,0.01305	47,	2833	149243	4.8150	25.00	0.27	0.15	/0.0>1.9/0.0>0.0	COSV56370381	USH2A|0.00|0.00|0.00|0.00|-15|30|43|45	24033266,18273898,17085681,29343940	33	1288	0	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215998787	215998787	T	-	het	wt	het	off-target	QUAL=13;DP=85,74,86;AF=0.08,0.03,0.14;MQM=60;SAP=49;ABP=228;SAR=0;SAF=21	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron34/71:c.6657+100del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron34/72:c.6657+100del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1235862 [benign DISEASE=not provided];			rs140899702	0.04086	0.13699,0.01409,0.00021,0.00171,0.00202	336,	5100	135496	0.3260	0.83			/0.0>0.0/0.0>0.0	COSV56388325	USH2A|0.00|0.00|0.00|0.00|-1|1|2|1		3	117	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999038	215999038	A	G	hom	hom	hom		QUAL=19006;DP=180,188,229;AF=0.99,1.00,1.00;MQM=60;SAP=434;ABP=0;SAR=470;SAF=126	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48562 [benign DISEASE=not provided,Usher syndrome type 2A,not specified];			rs10864219	0.50965	0.42974,0.55764,0.84223,0.50175,0.61199	20294,	36736	74396	2.3650	17.40	0.11	0.11	/0.0>0.0/1.5>0.6	COSV56370398	USH2A|0.04|0.00|0.00|0.00|20|2|-2|2	25741868,24033266,21686329,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999243	215999243	G	A	hom	hom	hom	off-target	QUAL=2233;DP=62,5,6;AF=1.00,1.00,1.00;MQM=60;SAP=162;ABP=0;SAR=73;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron33/71:c.6486-185C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron33/72:c.6486-185C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1267088 [benign DISEASE=not provided];			rs1436780	0.94594	0.94311,0.94195,0.99981,0.94296,0.95443	68102,	7725	8225	0.3710	6.83			/10.2>10.2/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-16|47|-16|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216046439	216046439	A	G	het	het	hom		QUAL=8819;DP=201,125,147;AF=0.49,0.50,1.00;MQM=60;SAP=328;ABP=3;SAR=47;SAF=262	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	167815 [benign DISEASE=not provided,not specified,Usher syndrome type 2A];			rs6657250	0.66735	0.76518,0.50617,0.44466,0.67566,0.50062	34516,	32185	50453	1.2600	9.86	0.13	0.05	/0.0>0.0/0.0>0.0	COSV56342913	USH2A|0.00|0.00|0.05|0.00|18|-8|-8|16	24033266,21686329,18665195,31817543,29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216048379	216048379	C	T	hom	hom	het	off-target	QUAL=8821;DP=150,78,141;AF=1.00,1.00,0.53;MQM=60;SAP=661;ABP=4;SAR=0;SAF=303	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron31/71:c.6163+155G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron31/72:c.6163+155G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1297779 [benign DISEASE=not provided];			rs10864227	0.37010	0.17937,0.29686,0.48798,0.46004,0.37287	11713,	32753	95615	3.5030	18.59			/0.9>1.3/1.6>5.5	COSV56436962	USH2A|0.00|0.00|0.00|0.00|36|2|-1|38	29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216072799	216072799	G	C	wt	het	wt	off-target	QUAL=1538;DP=235,152,194;AF=0.00,0.43,0.00;MQM=60;SAP=85;ABP=9;SAR=8;SAF=58	USH2A,USH2A-AS2	intron,intron&non_coding_transcript,non_coding_transcript_exon	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron29/71:c.5857+90C>G::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron29/72:c.5857+90C>G::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+199G>C::,USH2A-AS2:ENST00000430890.5:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.71G>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs183556728	0.00227	0.00046,0.00347,0.00000,0.00369,0.00021	2,	341	151797	-1.0490	0.12			/0.0>0.0/0.0>0.0,/4.6>5.9/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|0|-17|-38|0		0	223	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216073334	216073334	G	-	het	het	het	off-target	QUAL=5118;DP=174,99,132;AF=0.51,0.53,0.55;MQM=60;SAP=423;ABP=5;SAR=208;SAF=5	USH2A,USH2A-AS2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron27/72:c.5573-34del::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1243806 [benign DISEASE=not provided,Usher syndrome type 2A,Retinitis pigmentosa 39];			rs35944387	0.72287	0.74394,0.76176,0.94272,0.69278,0.78333	39926,	29804	42040	0.8790	13.09			/0.0>0.0/0.0>0.0		USH2A|0.01|0.00|0.00|0.00|-33|-39|-28|21	21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216084852	216084852	G	T	het	het	het		QUAL=6006;DP=156,133,177;AF=0.49,0.51,0.51;MQM=60;SAP=171;ABP=3;SAR=185;SAF=50	USH2A,USH2A-AS2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,USH2A-AS2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48527 [benign DISEASE=not specified,not provided,Usher syndrome type 2A];			rs56110889	0.16239	0.19383,0.13519,0.00058,0.17993,0.05836	2189,	20293	127253	0.1710	8.24			/5.1>3.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV56425186	USH2A|0.01|0.00|0.00|0.00|25|-17|25|1	25741868,24033266,23757202,17085681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216174110	216174110	C	A	het	het	wt		QUAL=3558;DP=219,108,121;AF=0.42,0.45,0.00;MQM=60;SAP=3;ABP=18;SAR=69;SAF=71	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	295405 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A];			rs401269	0.20344	0.16360,0.20380,0.21844,0.23454,0.22102	3220,	24450	120948	-0.1820	4.30			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|36|13|36|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216174214	216174214	A	G	het	het	wt		QUAL=3712;DP=224,56,55;AF=0.48,0.54,0.00;MQM=60;SAP=78;ABP=3;SAR=103;SAF=34	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A];			rs439940	0.20424	0.16626,0.20395,0.22016,0.23457,0.22144	3243,	24564	120978	0.8240	7.15			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|4|42|-2|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216175422	216175422	C	T	het	het	hom		QUAL=29642;DP=481,457,509;AF=0.53,0.49,1.00;MQM=60;SAP=152;ABP=4;SAR=624;SAF=364	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	177992 [benign DISEASE=not specified,not provided,Usher syndrome type 2A];			rs1805049	0.62905	0.57703,0.66129,0.76242,0.62257,0.70875	30303,	34966	56360	-1.5240	6.63	0.02	0.08	/3.0>3.1/0.0>1.9	COSV56346078	USH2A|0.01|0.29|0.00|0.00|27|-1|27|0	24033266,21686329,20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216190498	216190498	-	T	het	het	het	off-target	QUAL=165;DP=52,16,18;AF=0.27,0.19,0.11;MQM=60;SAP=44;ABP=61;SAR=19;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron19/71:c.4252-132dup::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron19/72:c.4252-132dup::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron19/20:c.4252-132dup::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs746805392	0.01999	0.00902,0.02704,0.17052,0.01263,0.01506	91,	2595	136171		0.05			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-13|24|1|-16		4	299	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216196766	216196766	C	T	het	het	wt	off-target	QUAL=3479;DP=188,93,127;AF=0.51,0.51,0.00;MQM=60;SAP=278;ABP=3;SAR=138;SAF=4	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177619 [benign DISEASE=Usher syndrome type 2A,not provided];			rs447102	0.17756	0.07148,0.19706,0.22019,0.23479,0.21984	2763,	21449	124947	-1.2300	0.01			/0.0>0.0/0.0>0.0	COSV56445389	USH2A|0.00|0.00|0.00|0.00|-44|-47|30|-48	18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216196788	216196788	T	G	hom	hom	hom	off-target	QUAL=10430;DP=172,71,95;AF=0.99,1.00,1.00;MQM=60;SAP=709;ABP=0;SAR=334;SAF=3	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-66A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-66A>C::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-66A>C::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+863T>G::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177620 [benign DISEASE=not provided,Usher syndrome type 2A];			rs386851	0.90531	0.97500,0.90003,0.98182,0.86651,0.93292	62565,	12564	14402	0.0510	2.24			/3.1>3.1/0.0>0.0,/3.2>3.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-18|38|-39|38	18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216198592	216198592	A	C	het	het	wt		QUAL=4100;DP=223,82,90;AF=0.54,0.55,0.00;MQM=60;SAP=336;ABP=7;SAR=162;SAF=3	USH2A,USH2A-AS1	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48508 [benign DISEASE=not specified,not provided,Retinitis pigmentosa,Usher syndrome type 2A];			rs646094	0.20457	0.16350,0.20882,0.22022,0.23567,0.22119	3257,	24576	120886	2.6310	8.66			9.7>8.9/9.7>8.9/0.0>0.0,/0.0>0.0/0.0>0.0		USH2A|0.00|0.14|0.00|0.00|42|-8|44|-8	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216217352	216217352	C	T	het	het	hom	off-target	QUAL=7342;DP=179,110,125;AF=0.48,0.52,1.00;MQM=60;SAP=360;ABP=3;SAR=29;SAF=239	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177621 [benign DISEASE=not provided,Usher syndrome type 2A];		L3b (LINE/CR1)	rs1324330	0.55911	0.34232,0.63192,0.76025,0.61941,0.69196	25206,	34456	66924	0.1690	2.32			/0.8>3.9/0.0>0.0	COSV56329695	USH2A|0.02|0.00|0.03|0.00|-49|39|35|-49	20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216232288	216232288	T	A	het	het	wt	off-target	QUAL=1162;DP=88,7,11;AF=0.53,0.43,0.00;MQM=60;SAP=112;ABP=4;SAR=50;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron13/71:c.2810-152A>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron13/72:c.2810-152A>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron13/20:c.2810-152A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs533694105	0.00183	0.00060,0.00111,0.00000,0.00307,0.00062	0,	278	151966	-0.2400	0.75			/0.2>1.4/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-15|-10|34|-1		1	75	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216289580	216289580	C	A	het	wt	het	off-target	QUAL=1412;DP=93,35,34;AF=0.44,0.00,0.53;MQM=60;SAP=131;ABP=4;SAR=59;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron10/71:c.1841-170G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron10/72:c.1841-170G>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron10/20:c.1841-170G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1216713 [likely benign DISEASE=not provided];			rs114284380	0.01330	0.00212,0.00819,0.00000,0.01828,0.00290	21,	1981	150121	3.4400	18.53			/0.1>0.8/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-32|7|8|-31		7	377	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216418661	216418661	T	C	hom	hom	hom		QUAL=18997;DP=160,190,255;AF=1.00,0.99,1.00;MQM=60;SAP=132;ABP=0;SAR=396;SAF=207	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48528 [benign DISEASE=not provided,not specified,Retinitis pigmentosa,Usher syndrome type 2A];			rs4253963	0.61732	0.50141,0.65662,0.83255,0.65078,0.62314	29431,	34781	58049	-0.5650	0.35			/0.0>0.0/0.0>5.2		USH2A|0.03|0.00|0.00|0.00|18|7|19|18	25741868,24033266,22876132,21686329,18665195,31817543,29283788,32313182	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216421964	216421964	C	T	hom	hom	hom		QUAL=33085;DP=295,279,446;AF=0.99,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=503;SAF=515	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48507 [benign DISEASE=not provided,not specified,Retinitis pigmentosa,Usher syndrome type 2A];			rs10779261	0.73228	0.75552,0.72253,0.83250,0.70831,0.76036	40838,	29559	40667	0.3580	4.92	0.08	0.06	/0.0>0.0/0.2>0.0		USH2A|0.00|0.00|0.00|0.00|-27|7|5|1	25741868,24033266,21686329,20145675,18665195,30419932,31817543,29283788,32313182,33829662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220150107	220150107	T	-	het	het	het		QUAL=1414;DP=144,39,48;AF=0.27,0.36,0.27;MQM=60;SAP=11;ABP=95;SAR=25;SAF=41	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295627 [uncertain significance DISEASE=Martsolf syndrome,Warburg micro syndrome];		FLAM_C (SINE/Alu)	rs11316594	0.47075	0.62119,0.48039,0.68907,0.38631,0.44688	14619,	33260	70264	-2.8380	0.07			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-7|13|20|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150452	T	-	het	het	het		QUAL=709;DP=60,14,21;AF=0.27,0.43,0.29;MQM=60;SAP=41;ABP=38;SAR=3;SAF=25	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.16474	0.31699,0.13142,0.24534,0.09033,0.11008	2069,	16481	104543	-0.1300	3.64			/0.0>0.0/1.3>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-1|34|23|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150453	TT	-	het	wt	wt		QUAL=709;DP=60,14,21;AF=0.23,0.21,0.14;MQM=60;SAP=10;ABP=72;SAR=6;SAF=14	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.00150	0.00284,0.00155,0.00067,0.00089,0.00129	0,	188	124964	-0.1300	3.62			/0.0>0.0/1.3>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-24|12|44|0		0	66	0	0 / 0					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150847	220150847	A	G	het	wt	het		QUAL=9844;DP=415,218,267;AF=0.54,0.00,0.53;MQM=60;SAP=283;ABP=12;SAR=293;SAF=75	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000685664.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*708T>C::,RAB3GAP2:ENST00000690824.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295635 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome];			rs1059140	0.07165	0.01718,0.06016,0.06228,0.09832,0.14283	520,	9860	141232	0.2210	6.90			/0.6>2.0/0.0>0.0		RAB3GAP2|0.01|0.00|0.00|0.00|10|-46|17|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157330	220157330	C	T	het	wt	het		QUAL=9505;DP=419,211,288;AF=0.55,0.00,0.48;MQM=60;SAP=268;ABP=5;SAR=78;SAF=290	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.7:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:synonymous_variant:LOW:exon31/35:c.3507G>A:p.Leu1169=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:synonymous_variant:LOW:exon30/34:c.3393G>A:p.Leu1131=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:synonymous_variant:LOW:exon30/34:c.3396G>A:p.Leu1132=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:synonymous_variant:LOW:exon32/36:c.3570G>A:p.Leu1190=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:synonymous_variant:LOW:exon31/35:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:synonymous_variant:LOW:exon30/34:c.3459G>A:p.Leu1153=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:synonymous_variant:LOW:exon31/34:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130080 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs11547779	0.07103	0.01715,0.05955,0.06269,0.09788,0.12863	510,	9769	141097	-0.5860	5.52			/5.2>5.2/0.8>0.0	COSV62784001	RAB3GAP2|0.00|0.00|0.00|0.00|-8|50|33|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157863	220157863	C	G	het	wt	het		QUAL=6490;DP=291,182,248;AF=0.45,0.00,0.46;MQM=60;SAP=3;ABP=11;SAR=124;SAF=123	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.7:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:missense_variant:MODERATE:exon30/35:c.3287G>C:p.Ser1096Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:missense_variant:MODERATE:exon29/34:c.3173G>C:p.Ser1058Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:missense_variant:MODERATE:exon29/34:c.3176G>C:p.Ser1059Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:missense_variant:MODERATE:exon31/36:c.3350G>C:p.Ser1117Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:missense_variant:MODERATE:exon30/35:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:missense_variant:MODERATE:exon29/34:c.3239G>C:p.Ser1080Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:missense_variant:MODERATE:exon30/34:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130079 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs2289189	0.07080	0.01716,0.05860,0.06175,0.09774,0.12878	507,	9756	141356	7.3560	25.70	0.18	0.26	/0.0>0.0/0.0>0.0	COSV62784008	RAB3GAP2|0.00|0.00|0.00|0.00|43|-50|-32|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157956	220157956	C	G	het	wt	het	off-target	QUAL=4154;DP=168,143,161;AF=0.46,0.00,0.53;MQM=60;SAP=173;ABP=3;SAR=138;SAF=25	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3274-80G>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3160-80G>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3163-80G>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3337-80G>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2998-80G>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-80G>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3262-80G>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293227 [benign DISEASE=not provided];			rs3767655	0.07083	0.01718,0.05857,0.06197,0.09782,0.12836	509,	9760	141380	-1.0190	0.21			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|28|-50|21|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157977	220157977	T	G	wt	het	wt	off-target	QUAL=1552;DP=134,108,133;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6;SAR=47;SAF=13	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3262-101A>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3274-101A>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3160-101A>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3163-101A>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3337-101A>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2998-101A>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2998-101A>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2998-101A>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-101A>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3262-101A>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3262-101A>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1228713 [benign DISEASE=not provided];			rs3767654	0.14841	0.03727,0.22226,0.13473,0.19065,0.16087	2143,	18288	129536	0.2030	3.17			/0.0>0.0/2.2>1.4	COSV62782794,COSV62783440	RAB3GAP2|0.01|0.00|0.00|0.00|7|-2|-15|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159210	220159210	C	T	het	het	het	off-target	QUAL=2775;DP=115,53,64;AF=0.51,0.43,0.55;MQM=60;SAP=257;ABP=3;SAR=0;SAF=117	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3273+176G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3159+176G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3162+176G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3336+176G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2997+176G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1334G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3261+176G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1257064 [benign DISEASE=not provided];			rs2789792	0.48240	0.67870,0.48485,0.71004,0.37330,0.44913	19270,	34682	78566	-5.6310	0.04			/9.8>9.8/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-20|-1|18|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159534	220159534	G	A	het	het	het	off-target	QUAL=2079;DP=106,25,38;AF=0.53,0.52,0.42;MQM=60;SAP=171;ABP=3;SAR=83;SAF=2	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron28/34:c.3238-113C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron27/33:c.3124-113C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron27/33:c.3127-113C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron29/35:c.3301-113C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron28/34:c.2962-113C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1658C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron28/33:c.3226-113C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1258027 [benign DISEASE=not provided];			rs2808026	0.48231	0.67822,0.48526,0.70980,0.37332,0.44824	19273,	34716	78636	0.3150	5.54			/6.5>6.5/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-7|34|39|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220162088	220162088	A	G	wt	het	wt	off-target	QUAL=580;DP=135,60,61;AF=0.00,0.45,0.00;MQM=60;SAP=46;ABP=4;SAR=2;SAF=25	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron28/34:c.3225+110T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron28/34:c.3237+110T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron27/33:c.3123+110T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron27/33:c.3126+110T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron29/35:c.3300+110T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron28/34:c.2961+110T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron29/35:c.2961+110T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron29/35:c.2961+110T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3225+110T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron28/33:c.3225+110T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron28/34:c.3225+110T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	668611 [benign DISEASE=not provided];			rs2164790	0.27848	0.35115,0.31319,0.40386,0.22903,0.23707	6234,	29849	109641	-1.5740	0.14			/4.6>4.6/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-4|-17|-26|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220162424	220162428	ATTTC	-	wt	wt	het	off-target	QUAL=181;DP=51,22,27;AF=0.00,0.00,0.41;MQM=60;SAP=27;ABP=5;SAR=11;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron27/34:c.3155-160_3155-156del::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron27/34:c.3167-160_3167-156del::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron26/33:c.3053-160_3053-156del::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron26/33:c.3056-160_3056-156del::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron28/35:c.3230-160_3230-156del::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron27/34:c.2891-160_2891-156del::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron28/35:c.2891-160_2891-156del::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron28/35:c.2891-160_2891-156del::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron27/33:c.3155-160_3155-156del::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron27/33:c.3155-160_3155-156del::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron27/34:c.3155-160_3155-156del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]				rs779116294	0.00072	0.00000,0.00000,0.00000,0.00096,0.00000	0,	110	152078	0.0260	0.35			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-5|40|37|-43		0	37	0	0 / 0					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172230	220172230	A	C	het	wt	het	off-target	QUAL=1258;DP=102,17,15;AF=0.47,0.00,0.47;MQM=60;SAP=122;ABP=4;SAR=55;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2429-181T>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2315-181T>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2318-181T>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2492-181T>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2153-181T>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1263789 [benign DISEASE=not provided];			rs73098558	0.12963	0.12973,0.10367,0.09927,0.13532,0.18986	1373,	16973	132405	-1.8110	0.14			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|36|19|-5|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172536	220172536	A	G	het	wt	het	off-target	QUAL=3647;DP=159,64,112;AF=0.54,0.00,0.56;MQM=60;SAP=285;ABP=9;SAR=5;SAF=144	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2428+101T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2314+101T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2317+101T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2491+101T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2152+101T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1178138 [benign DISEASE=not provided];			rs41303055	0.07139	0.01720,0.05927,0.06260,0.09766,0.14558	527,	9806	141258	-0.2050	2.52			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-17|0|-17|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220182092	220182092	T	-	het	het	het	off-target	QUAL=382;DP=38,5,7;AF=0.39,0.20,0.43;MQM=60;SAP=44;ABP=9;SAR=0;SAF=19	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron21/34:c.2310+165del::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron21/34:c.2322+165del::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron20/33:c.2208+165del::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron20/33:c.2211+165del::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron22/35:c.2385+165del::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron21/34:c.2046+165del::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron21/34:c.2310+165del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1231942 [benign DISEASE=not provided];			rs11343960	0.48039	0.67848,0.48188,0.70947,0.37212,0.42018	19006,	34587	78525	0.3420	0.42			/3.3>3.3/0.4>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|2|39|2|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220193155	220193155	T	A	het	wt	het	off-target	QUAL=1862;DP=115,64,60;AF=0.45,0.00,0.45;MQM=60;SAP=166;ABP=7;SAR=1;SAF=78	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron13/34:c.1282+85A>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron12/33:c.1168+85A>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron12/33:c.1171+85A>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron14/35:c.1345+85A>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron13/34:c.1006+85A>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293232 [benign DISEASE=not provided];			rs78010602	0.06926	0.01674,0.05622,0.06406,0.09655,0.10095	480,	9579	141631	0.1860	5.30			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|2|31|2|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220196404	220196404	A	-	wt	het	wt		QUAL=829;DP=166,91,94;AF=0.05,0.48,0.01;MQM=60;SAP=88;ABP=3;SAR=50;SAF=4	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951.7:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::,RAB3GAP2:ENST00000691661.1:splice_region_variant&intron_variant:LOW:intron9/34:c.824-6del::,RAB3GAP2:ENST00000691862.1:splice_region_variant&intron_variant:LOW:intron8/33:c.710-6del::,RAB3GAP2:ENST00000690315.1:splice_region_variant&intron_variant:LOW:intron8/33:c.713-6del::,RAB3GAP2:ENST00000692972.1:splice_region_variant&intron_variant:LOW:intron10/35:c.887-6del::,RAB3GAP2:ENST00000687647.1:splice_region_variant&intron_variant:LOW:intron9/34:c.548-6del::,RAB3GAP2:ENST00000686381.1:splice_region_variant&intron_variant:LOW:intron10/35:c.548-6del::,RAB3GAP2:ENST00000687065.1:splice_region_variant&intron_variant:LOW:intron10/35:c.548-6del::,RAB3GAP2:ENST00000692813.1:splice_region_variant&intron_variant:LOW:intron9/33:c.812-6del::,RAB3GAP2:ENST00000685664.1:splice_region_variant&intron_variant:LOW:intron9/33:c.812-6del::,RAB3GAP2:ENST00000690824.1:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295665 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not provided,Warburg micro syndrome];			rs35396665	0.26469	0.25720,0.32171,0.39014,0.24847,0.24385	5003,	28498	106966	-0.0030	1.96			/9.6>11.7/0.0>0.0		RAB3GAP2|0.00|0.01|0.00|0.00|-40|-5|-5|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), MIR664A (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SNORA36B (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	220206161	220206161	G	C	het	het	het	off-target	QUAL=1028;DP=72,13,14;AF=0.50,0.46,0.29;MQM=60;SAP=103;ABP=4;SAR=46;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron7/34:c.625-155C>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron6/33:c.511-155C>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron7/35:c.613-155C>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron7/34:c.349-155C>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron7/9:c.613-155C>G::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1243694 [benign DISEASE=not provided];			rs4142940	0.45715	0.68472,0.45102,0.45277,0.35239,0.37293	17608,	34207	82439	-1.4300	3.15			/0.0>0.0/0.0>0.0	COSV52966966	RAB3GAP2|0.00|0.00|0.00|0.00|30|46|45|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), SNX2P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	220213730	220213730	-	T	hom	n/a	het	off-target;low_conf_region	QUAL=467;DP=23,1,6;AF=0.83,0.00,0.67;MQM=60;SAP=53;ABP=4;SAR=0;SAF=23	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+125dup::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+125dup::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+125dup::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+125dup::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			G-rich (Low_complexity)	rs370682557	0.11361	0.03478,0.08244,0.09765,0.13801,0.19911	701,	6185	59193		0.27			/2.1>2.7/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-1|48|-32|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220213735	220213735	G	A	het	wt	het	off-target;low_conf_region	QUAL=438;DP=25,3,6;AF=0.88,0.00,0.67;MQM=60;SAP=59;ABP=34;SAR=0;SAF=26	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+121C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+121C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+121C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+121C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+121C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+121C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+121C>T::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+121C>T::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1251110 [benign DISEASE=not provided];		G-rich (Low_complexity)	rs138212227	0.07567	0.01848,0.05288,0.02519,0.10492,0.14335	667,	6932	100972	0.0340	0.90			/2.1>2.7/0.0>0.0	COSV52967437	RAB3GAP2|0.00|0.00|0.00|0.00|-5|-40|6|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220213741	220213741	G	A	het	wt	het	off-target;low_conf_region	QUAL=678;DP=37,4,9;AF=0.86,0.00,0.78;MQM=60;SAP=88;ABP=51;SAR=0;SAF=39	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+115C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+115C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+115C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+115C>T::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1248119 [benign DISEASE=not provided];		G-rich (Low_complexity)	rs147804604	0.08434	0.02412,0.05693,0.08265,0.10809,0.16286	641,	7621	96653	-1.4020	0.19			/2.1>2.9/0.0>0.0	COSV52967451	RAB3GAP2|0.00|0.00|0.00|0.00|49|-46|49|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220232949	220232949	A	G	het	het	het	off-target	QUAL=4351;DP=138,94,130;AF=0.45,0.51,0.52;MQM=60;SAP=207;ABP=3;SAR=153;SAF=24	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.116-86T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-149-86T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.116-86T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	673980 [benign DISEASE=not provided];		X10b_DNA (DNA/TcMar-Tigger)	rs10863538	0.45806	0.70876,0.45039,0.44967,0.34120,0.38230	18000,	33553	82289	0.5120	3.15			/1.5>1.7/0.3>0.1	COSV52966274	RAB3GAP2|0.00|0.00|0.00|0.00|14|-44|14|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220272146	220272146	C	T	het	wt	het	off-target	QUAL=679;DP=24,34,70;AF=0.50,0.00,0.51;MQM=60;SAP=107;ABP=3;SAR=0;SAF=48	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.115+77G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-150+210G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.115+77G>A::	regulatory_region_variant:promoter	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293230 [benign DISEASE=not provided];			rs2292418	0.06858	0.01677,0.05455,0.07160,0.09466,0.12024	471,	9427	140827	-2.0140	5.33			/0.0>0.0/0.0>0.0	COSV52967126	RAB3GAP2|0.00|0.00|0.00|0.00|-37|1|18|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), AURKAP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222928597	222928597	A	C	het	het	het	off-target	QUAL=5401;DP=179,136,156;AF=0.42,0.47,0.50;MQM=60;SAP=264;ABP=9;SAR=190;SAF=28	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.31809	0.30700,0.23267,0.05387,0.35810,0.24917	8061,	32228	103652	-0.0850	5.90			/0.0>0.0/0.0>0.0		DISP1|0.00|0.00|0.00|0.00|13|-46|-27|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222942767	222942767	C	T	het	het	het	off-target	QUAL=3240;DP=102,91,104;AF=0.48,0.51,0.48;MQM=60;SAP=318;ABP=3;SAR=0;SAF=145	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::			1247665 [benign DISEASE=not provided];			rs75109669	0.17712	0.19566,0.13305,0.00193,0.19622,0.07499	2527,	21846	124978	-0.0570	8.58			/0.0>0.0/0.0>0.0		DISP1|0.00|0.00|0.00|0.00|40|36|-42|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222982872	222982872	C	T	hom	hom	hom	off-target	QUAL=2098;DP=40,10,18;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0;SAR=0;SAF=68	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-208C>T::			1182516 [benign DISEASE=not provided];			rs2926160	0.97805	0.92698,0.98880,1.00000,0.99922,0.99938	72794,	3107	3337	-3.2720	0.03			/2.6>3.4/0.0>0.0		DISP1|0.00|0.00|0.00|0.02|50|-49|-24|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222982938	222982938	-	TT	wt	wt	het	off-target	QUAL=183;DP=105,32,41;AF=0.00,0.00,0.29;MQM=60;SAP=29;ABP=18;SAR=0;SAF=12	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-132_510-131dup::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-132_510-131dup::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-132_510-131dup::			1242292 [benign DISEASE=not provided];			rs10626845	0.28267	0.25219,0.30896,0.21213,0.28438,0.33952	5839,	30101	106023		0.27			/2.2>2.7/0.0>0.0		DISP1|0.00|0.00|0.00|0.00|24|-5|44|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983040	222983040	C	T	hom	hom	hom	off-target	QUAL=17389;DP=272,113,154;AF=1.00,1.00,1.00;MQM=60;SAP=477;ABP=0;SAR=98;SAF=441	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-40C>T::			1250961 [benign DISEASE=not provided];			rs2926159	0.99974	0.99910,0.99993,1.00000,0.99999,1.00000	75769,	39	39	1.0190	10.88			/1.5>1.2/0.0>0.0		DISP1|0.00|0.00|0.00|0.00|49|40|39|49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983311	222983311	C	T	het	het	het	off-target	QUAL=2016;DP=125,28,33;AF=0.49,0.43,0.55;MQM=60;SAP=201;ABP=3;SAR=91;SAF=0	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron3/7:c.539+202C>T::			1238426 [benign DISEASE=not provided];			rs4388710	0.34150	0.18981,0.39213,0.42868,0.40634,0.32545	9528,	32761	99915	-0.5440	0.47			/0.0>0.0/0.0>0.0	COSV52666631	DISP1|0.03|0.00|0.01|0.00|25|9|-14|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222994871	222994871	T	C	wt	wt	het	off-target	QUAL=1100;DP=182,56,93;AF=0.00,0.00,0.48;MQM=60;SAP=7;ABP=3;SAR=18;SAF=27	DISP1	splice_region&intron	DISP1:ENST00000675850.1:splice_region_variant&intron_variant:LOW:intron7/8:c.890-14T>C::,DISP1:ENST00000675961.1:splice_region_variant&intron_variant:LOW:intron7/8:c.890-14T>C::,DISP1:ENST00000284476.7:splice_region_variant&intron_variant:LOW:intron6/7:c.890-14T>C::	regulatory_region_variant:enhancer		262132 [benign DISEASE=not specified,not provided];			rs2609359	0.35097	0.43575,0.33734,0.29584,0.29917,0.44752	9713,	33854	98528	0.0770	8.15			10.9>9.8/10.9>9.8/0.0>0.0	COSV52656379	DISP1|0.00|0.01|0.00|0.00|13|14|13|30	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223002278	223002278	G	A	het	wt	het	off-target	QUAL=4160;DP=193,118,138;AF=0.52,0.00,0.52;MQM=60;SAP=379;ABP=4;SAR=0;SAF=173	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron7/7:c.988-107G>A::	regulatory_region_variant:enhancer					rs190562655	0.00273	0.00099,0.00275,0.00000,0.00379,0.00124	1,	414	151690	-0.9070	0.18			/0.0>0.0/0.5>0.0		DISP1|0.00|0.00|0.00|0.00|2|22|-3|-1		1	72	0	0 / 0					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223004232	223004232	A	G	wt	wt	het		QUAL=5301;DP=508,263,407;AF=0.00,0.00,0.50;MQM=60;SAP=28;ABP=3;SAR=78;SAF=127	DISP1	synonymous	DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:			262128 [benign DISEASE=not provided,not specified];			rs2609355	0.26562	0.18396,0.28191,0.22367,0.29793,0.29875	5579,	29190	111554	-0.5890	3.67			/0.0>0.0/0.0>0.0	COSV52659190	DISP1|0.00|0.00|0.00|0.00|1|2|0|3	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223005219	223005219	A	C	hom	hom	het		QUAL=20487;DP=191,288,372;AF=1.00,1.00,0.53;MQM=60;SAP=3;ABP=6;SAR=336;SAF=341	DISP1	synonymous	DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:			262131 [benign DISEASE=not specified,not provided];			rs9441941	0.53471	0.45085,0.54946,0.49419,0.58162,0.47120	21985,	37268	70692	-0.9000	1.93			/0.0>0.0/0.0>0.0	COSV52656581	DISP1|0.00|0.00|0.00|0.00|46|-14|-48|-42	25741868,22952568,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225401771	225401771	C	T	het	wt	het		QUAL=8397;DP=322,266,352;AF=0.50,0.00,0.44;MQM=60;SAP=9;ABP=8;SAR=173;SAF=144	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.25269	0.51203,0.14318,0.04234,0.15933,0.30539	6962,	24479	113573	0.7850	9.24			/2.5>1.6/0.4>0.0		LBR|0.00|0.00|0.00|0.00|-43|-47|3|-43	25079360,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225403048	225403048	G	C	het	wt	het		QUAL=4479;DP=310,46,56;AF=0.47,0.00,0.50;MQM=60;SAP=150;ABP=5;SAR=33;SAF=142	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295928 [benign DISEASE=not provided,Greenberg dysplasia];			rs11551874	0.09174	0.03581,0.07026,0.04099,0.12022,0.25840	844,	12258	138074	0.6960	2.76			/1.4>0.8/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-19|-16|44|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410144	225410144	A	G	het	hom	het	off-target	QUAL=6229;DP=179,78,95;AF=0.58,1.00,0.62;MQM=60;SAP=526;ABP=24;SAR=0;SAF=241	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1225790 [benign DISEASE=not provided];			rs1011319	0.74192	0.46925,0.85581,0.95735,0.84048,0.69813	44131,	24500	39224	-5.9380	0.02			/2.0>0.9/0.0>0.0		LBR|0.00|0.00|0.01|0.00|-25|31|-25|2	26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410607	225410607	A	C	het	hom	het	off-target	QUAL=2971;DP=102,32,64;AF=0.54,1.00,0.52;MQM=60;SAP=264;ABP=4;SAR=120;SAF=0	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1224301 [benign DISEASE=not provided];		L1MC4a (LINE/L1)	rs1538930	0.58542	0.33274,0.71548,0.85208,0.66869,0.49317	27999,	32922	62972	0.0910	2.94			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|50|-21|-43|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225411153	225411153	G	A	het	wt	het	off-target	QUAL=844;DP=63,11,10;AF=0.54,0.00,0.40;MQM=60;SAP=86;ABP=3;SAR=0;SAF=38	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1239470 [benign DISEASE=not provided];			rs17557867	0.08757	0.02231,0.06852,0.04083,0.11998,0.25363	812,	11694	138758	-2.5190	0.02			/5.4>5.4/2.4>0.0		LBR|0.00|0.00|0.00|0.00|-21|20|36|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225412650	225412650	A	-	het	het	het	low_conf_region	QUAL=185;DP=89,28,37;AF=0.20,0.11,0.16;MQM=59;SAP=62;ABP=144;SAR=27;SAF=0	LBR	splice_region&intron	LBR:ENST00000272163.9:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:ENST00000338179.6:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	439855 [benign/likely benign DISEASE=not specified,not provided];			rs78306811	0.00913	0.01850,0.00496,0.00193,0.00443,0.00977	5,	1209	132231	-0.0670	2.55			/10.7>11.7/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-34|-4|-34|3		1	1042	233	0 / 0					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225415401	225415401	C	T	het	hom	het	off-target;low_conf_region	QUAL=7194;DP=219,104,142;AF=0.42,1.00,0.46;MQM=60;SAP=183;ABP=16;SAR=204;SAF=57	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron6/13:c.838-69G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron6/13:c.838-69G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1263342 [benign DISEASE=not provided];		(AT)n (Simple_repeat)	rs6702433	0.72953	0.42728,0.84964,0.95732,0.84000,0.69354	43234,	24391	41101	-0.1800	0.07			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-2|-41|22|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225419442	225419442	C	T	het	hom	het		QUAL=1842;DP=75,20,47;AF=0.40,1.00,0.45;MQM=60;SAP=45;ABP=10;SAR=54;SAF=17	LBR	missense	LBR:ENST00000272163.9:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.6:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258619 [benign DISEASE=not provided,not specified,Reynolds syndrome,Pelger-Huet anomaly,Greenberg dysplasia];			rs2230419	0.72959	0.42769,0.84942,0.95666,0.83978,0.69843	43266,	24388	41110	-0.1670	0.00	0.17	0.06	/0.0>0.0/0.0>0.0	COSV55291160	LBR|0.00|0.01|0.00|0.00|10|-1|-12|-33	25741868,24033266,26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225422182	225422182	A	G	het	hom	het		QUAL=2368;DP=126,16,18;AF=0.57,1.00,0.61;MQM=60;SAP=7;ABP=10;SAR=43;SAF=56	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.6:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258617 [benign DISEASE=not specified,not provided,Reynolds syndrome,Pelger-Huet anomaly,Greenberg dysplasia];			rs1056608	0.68405	0.39363,0.81800,0.89238,0.79150,0.64971	38101,	27720	48000	-0.7860	2.29			/0.0>0.2/0.0>0.0		LBR|0.00|0.01|0.00|0.00|-49|39|-16|19	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225423959	225423959	C	T	het	het	hom		QUAL=17180;DP=366,211,283;AF=0.53,0.49,1.00;MQM=60;SAP=12;ABP=5;SAR=266;SAF=316	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.6:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258616 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056607	0.71152	0.63857,0.77420,0.76022,0.73712,0.50787	38809,	30508	43838	-3.1000	1.22			/0.0>0.0/0.0>0.0	COSV55289527	LBR|0.00|0.00|0.00|0.00|-35|21|3|-48	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225424143	225424143	C	T	wt	het	het	off-target;low_conf_region	QUAL=2277;DP=183,83,111;AF=0.00,0.43,0.52;MQM=60;SAP=116;ABP=3;SAR=82;SAF=12	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	810884 [benign DISEASE=not specified,not provided];			rs1340867	0.62019	0.59227,0.71220,0.76051,0.62258,0.38458	29478,	35252	57694	-1.5450	0.31			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-18|-45|35|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225427864	225427864	G	C	het	het	hom	off-target	QUAL=252;DP=5,4,7;AF=0.60,0.50,1.00;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-15+90C>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+842C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1247977 [benign DISEASE=not provided];			rs4653636	0.74188	0.64243,0.80165,0.78157,0.78231,0.56056	42220,	28146	39172	-0.2910	6.29			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-1|-34|11|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225428676	225428676	G	C	het	het	wt	off-target	QUAL=4190;DP=197,179,251;AF=0.55,0.50,0.00;MQM=60;SAP=305;ABP=5;SAR=16;SAF=182	LBR	intron	LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]				rs75691342	0.07764	0.05161,0.06107,0.03977,0.09156,0.22946	565,	10677	140267	-0.4380	4.82			/4.6>4.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226360483	226360483	A	-	het	het	het	off-target	QUAL=221;DP=46,15,13;AF=0.15,0.40,0.31;MQM=60;SAP=40;ABP=50;SAR=0;SAF=17	PARP1	downstream_gene	PARP1:ENST00000366794.10:downstream_gene_variant:MODIFIER::::,PARP1:ENST00000677203.1:downstream_gene_variant:MODIFIER::::						rs111264055	0.00127	0.00182,0.00134,0.00181,0.00088,0.00044	0,	181	142641	-0.1470	0.15							0	3	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226360853	226360853	A	G	wt	het	wt		QUAL=860;DP=168,77,97;AF=0.01,0.49,0.00;MQM=60;SAP=38;ABP=3;SAR=32;SAF=7	PARP1	3'UTR	PARP1:ENST00000366794.10:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::,PARP1:ENST00000677203.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.16587	0.06100,0.17895,0.05947,0.22799,0.24803	2639,	19952	126876	-0.5110	1.46			/0.0>0.0/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|3|11|-26|2	31637880,23614619,21976407,25114582,21767974,22166496,25003827,27746584,29048575,31413734,29937070,26630397,28646528,29156695,28537887,26261599,25139788,22964086,24616890,17560163,34530710,33391423,33791158,32780923,33112558,33147530,36006023	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226361797	226361797	G	A	wt	het	wt	off-target	QUAL=725;DP=145,58,93;AF=0.00,0.57,0.00;MQM=60;SAP=58;ABP=5;SAR=2;SAF=31	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron22/22:c.2963+172C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron21/21:c.2834+172C>T::						rs2271347	0.16471	0.06091,0.17726,0.05957,0.22626,0.24617	2600,	19833	126951	-0.6350	0.62			/1.2>0.6/0.0>0.0		PARP1|0.00|0.02|0.00|0.00|-50|9|-50|-3	27746584,19925161,27099827,29683114,23370117,30260276,29799308,35005347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226362185	226362185	T	-	het	het	het	off-target	QUAL=62;DP=100,60,82;AF=0.13,0.23,0.22;MQM=60;SAP=101;ABP=210;SAR=45;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron21/22:c.2849-102del::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron20/21:c.2720-102del::					AluSx (SINE/Alu)	rs368063214	0.00236	0.00208,0.00171,0.00101,0.00213,0.00114	0,	333	140645	0.9620	1.53			/0.0>0.0/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|35|7|2|1		1	187	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363223	226363223	G	C	het	hom	het	off-target	QUAL=5158;DP=103,71,107;AF=0.43,1.00,0.62;MQM=60;SAP=162;ABP=4;SAR=148;SAF=33	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2787-63C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2658-63C>G::						rs747657	0.57760	0.45667,0.54351,0.19433,0.67092,0.62557	26426,	34916	64186	-0.6160	0.35			/0.0>0.0/0.0>0.0	COSV64690496	PARP1|0.00|0.02|0.00|0.00|-25|-18|50|24	20981448,17560163,32341527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363759	226363759	T	C	het	hom	het	off-target	QUAL=1813;DP=69,25,22;AF=0.58,1.00,0.36;MQM=60;SAP=162;ABP=4;SAR=0;SAF=73	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+184A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+184A>G::	regulatory_region_variant:enhancer				MLT1O (LTR/ERVL-MaLR)	rs752309	0.80996	0.84627,0.68839,0.53206,0.84042,0.80353	50367,	22409	28893	-0.2500	3.31			/0.0>0.0/0.0>0.0	COSV64689687	PARP1|0.00|0.01|0.00|0.00|-1|41|47|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363828	226363828	C	G	het	hom	het	off-target	QUAL=4015;DP=143,51,75;AF=0.52,1.00,0.44;MQM=60;SAP=340;ABP=3;SAR=1;SAF=158	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+115G>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+115G>C::	regulatory_region_variant:enhancer					rs752307	0.82106	0.86975,0.69188,0.57044,0.84054,0.88716	51758,	21336	27210	-0.7920	0.61			/2.2>4.5/0.0>0.0	COSV64689696,COSV64692544	PARP1|0.00|0.00|0.00|0.00|-28|-31|-11|-22	19249341,20522537,17560163,29403010,33284833,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365341	226365341	C	T	wt	wt	het	off-target	QUAL=306;DP=85,35,35;AF=0.00,0.00,0.46;MQM=60;SAP=38;ABP=4;SAR=16;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2506-187G>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2377-187G>A::	regulatory_region_variant:enhancer					rs3219140	0.03629	0.02859,0.02407,0.00000,0.04525,0.00620	107,	5309	146675	-0.2990	0.77			/1.9>1.6/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|-2|-12|27|-36		15	296	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365784	226365784	A	C	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+170T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+170T>G::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs118165556	0.80139	0.83027,0.68186,0.53191,0.83370,0.81810	47274,	22814	29086	-0.7340	1.00			/1.5>1.5/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|-1|19|1|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365785	226365785	C	A	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+169G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+169G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs146042055	0.81548	0.84975,0.68904,0.57101,0.84089,0.88743	49527,	21534	27286	-0.8190	0.36			/1.5>1.9/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|18|-46|9|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365789	226365789	C	A	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+165G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+165G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs34917861	0.81294	0.84897,0.68633,0.57002,0.83782,0.88664	48928,	21774	27528	-0.8680	0.29			/1.5>2.1/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|14|-50|-10|5	32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365793	226365793	-	A	het	n/a	het	off-target;low_conf_region	QUAL=101;DP=20,2,8;AF=0.40,0.00,0.13;MQM=60;SAP=23;ABP=11;SAR=0;SAF=9	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+160dup::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+160dup::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs11378196	0.81762	0.86943,0.68855,0.57007,0.83505,0.88488	49403,	21300	26792		0.43			/1.5>1.5/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|10|13|15|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226366233	226366233	A	C	het	hom	het	off-target	QUAL=1712;DP=69,20,38;AF=0.46,1.00,0.53;MQM=60;SAP=159;ABP=3;SAR=72;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron17/22:c.2407-181T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron16/21:c.2278-181T>G::	regulatory_region_variant:open_chromatin_region				MIR3 (SINE/MIR)	rs2271349	0.81664	0.86928,0.69102,0.53178,0.84050,0.80345	51215,	21672	27864	-1.2250	0.39			/0.0>0.0/9.7>2.0		PARP1|0.00|0.00|0.00|0.25|-32|30|14|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367601	226367601	A	G	het	wt	het		QUAL=5929;DP=197,220,302;AF=0.49,0.00,0.47;MQM=60;SAP=66;ABP=5;SAR=161;SAF=78	PARP1	missense	PARP1:ENST00000366794.10:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain],PARP1:ENST00000677203.1:missense_variant:MODERATE:exon16/22:c.2156T>C:p.Val719Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]			1261945 [benign DISEASE=not provided];	CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.15728	0.05391,0.30202,0.42888,0.15932,0.11215	2589,	18737	128135	8.9420	27.40	0.18	0.41	/0.0>0.0/0.9>0.0	COSV64689246	PARP1|0.00|0.00|0.00|0.00|34|33|-31|2	21976407,21767974,31413734,30337837,25111588,23139751,19249341,26648684,18191955,17267408,21989229,31288058,32103589,21606320,16465622,16857995,17203305,17220334,18701435,19109789,19124499,19318434,19822020,20150366,20211558,20353610,20486200,20559012,21037106,21129811,21385363,21420246,21700777,21810555,22127734,22687647,22740911,22792228,22850545,22969958,23608917,23633189,23644255,23720673,24172093,24203816,24340057,24500421,25106941,25179837,25231222,25493225,25911198,26921778,27055523,27099827,27285066,27323894,27415837,27588484,27840165,27866211,28765340,28956850,29399184,29484706,29662639,30183716,31489712,31584889,31609976,31762827,31983162,28206966,22430443,25178586,31374908,28749454,29937070,29577582,31415677,22868256,25837821,29156789,31171785,27105872,26316174,27959887,25356504,24392019,27209488,27052028,28423490,26261599,25374063,26388025,22591901,29184509,23755158,27081507,27324896,31921313,28599464,24853559,25139788,26019482,27895737,23857046,23537197,24489833,20725763,17214964,17560163,2011383	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367647	226367647	G	A	wt	het	wt	off-target	QUAL=2128;DP=205,175,243;AF=0.00,0.49,0.00;MQM=60;SAP=37;ABP=3;SAR=62;SAF=25	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron15/21:c.2149-39C>T::						rs3219123	0.04028	0.00965,0.04069,0.00019,0.05951,0.04621	198,	5733	146027	0.4890	3.05			/0.0>0.0/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|-39|-13|20|42	31134135,21767974,20158304,21537398,17560163	89	2609	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226368393	226368393	T	C	hom	hom	hom	off-target	QUAL=2783;DP=24,20,46;AF=1.00,1.00,1.00;MQM=60;SAP=128;ABP=0;SAR=81;SAF=9	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron15/22:c.2155-72A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron14/21:c.2026-72A>G::						rs1805400	0.98496	0.94718,0.99509,1.00000,0.99993,0.99979	73894,	2135	2289	-0.5630	6.12			/0.0>0.3/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|-41|-10|49|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226374060	226374060	G	C	het	hom	het	off-target	QUAL=2780;DP=112,33,46;AF=0.51,1.00,0.43;MQM=60;SAP=242;ABP=3;SAR=0;SAF=110	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron14/22:c.2070+166C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+3048C>G::						rs2377312	0.80375	0.82409,0.68748,0.53277,0.84031,0.80320	49568,	23045	29833	0.0570	2.36			/0.0>0.0/0.0>0.0	COSV64690890	PARP1|0.00|0.00|0.00|0.00|46|9|17|15	33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226376990	226376990	T	C	het	hom	het	off-target	QUAL=2955;DP=133,38,36;AF=0.50,1.00,0.33;MQM=60;SAP=255;ABP=5;SAR=0;SAF=116	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron13/22:c.1941+118A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+118A>G::					L1M4 (LINE/L1)	rs3219090	0.57635	0.45188,0.54285,0.19348,0.67128,0.62656	26306,	34875	64309	1.3350	10.08			/0.0>0.0/0.0>0.0	COSV64689321	PARP1|0.00|0.01|0.00|0.00|-1|-42|6|35	21976407,21983785,19925161,27099827,30824778,25077817,24535833,23393188,24906573,26998216,27221533,28759004,29641532,24642353,24980573,25837821,28667740,29753029,25307738,27993549,25380778,26342156,29890168,23580930,23537197,32341527,32856602,30190865,29799308,31568773,32226509,33383480,27644669,35045882,35005347,34898573	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379025	226379025	A	C	het	hom	het	off-target	QUAL=6544;DP=155,104,131;AF=0.54,0.99,0.47;MQM=60;SAP=544;ABP=3;SAR=0;SAF=249	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron12/22:c.1745+117T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron12/21:c.1745+117T>G::						rs907190	0.80380	0.82421,0.68743,0.53295,0.84034,0.80299	49546,	23028	29808	-1.0680	3.41			/0.0>0.0/0.0>0.0	COSV64689201	PARP1|0.01|0.00|0.00|0.00|24|-44|24|30	33284833,35585065	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379471	226379471	A	C	het	het	wt	off-target	QUAL=4413;DP=229,147,213;AF=0.49,0.46,0.00;MQM=60;SAP=30;ABP=5;SAR=66;SAF=113	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron11/22:c.1612+102T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron11/21:c.1612+102T>G::						rs2271345	0.13210	0.09622,0.11134,0.03132,0.15551,0.20489	1456,	17172	131952	-1.7420	0.12			/0.0>0.0/0.0>0.0	COSV64689740	PARP1|0.00|0.00|0.00|0.00|-39|16|-39|2	17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226380964	226380964	T	C	het	het	wt	off-target	QUAL=3187;DP=144,157,190;AF=0.48,0.45,0.01;MQM=60;SAP=290;ABP=7;SAR=2;SAF=138	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron9/22:c.1300+104A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron9/21:c.1300+104A>G::						rs1805410	0.13227	0.09617,0.11138,0.03159,0.15575,0.20657	1465,	17183	131945	-0.1450	3.59			/0.0>0.0/0.0>0.0	COSV64689744	PARP1|0.00|0.00|0.00|0.00|1|-36|40|-22	21976407,21767974,21668397,20574454,22701660,23921907,27758874,23872737,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226383139	226383139	T	C	het	hom	het		QUAL=4872;DP=93,72,92;AF=0.57,1.00,0.51;MQM=60;SAP=35;ABP=6;SAR=111;SAF=61	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:,PARP1:ENST00000677203.1:synonymous_variant:LOW:exon8/22:c.1056A>G:p.Lys352=:						rs1805415	0.82763	0.89256,0.69321,0.57099,0.84080,0.88831	52662,	20600	26226	-0.1010	8.59			/0.0>0.0/0.0>0.0	COSV64689254	PARP1|0.00|0.03|0.00|0.00|17|-23|1|9	19249341,17267408,27153553,17560163,20113831,33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226385663	226385663	A	G	het	wt	het		QUAL=4737;DP=158,208,248;AF=0.54,0.00,0.45;MQM=60;SAP=154;ABP=4;SAR=157;SAF=40	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon7/22:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain]				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.42431	0.54248,0.45818,0.80630,0.33150,0.38061	14726,	35019	87471	-2.5750	0.42			/0.0>0.0/0.0>0.0	COSV64689261	PARP1|0.00|0.00|0.00|0.00|17|-37|-46|1	18805967,21767974,27746584,29662639,30183716,31609976,31762827,19604089,21695249,17560163,20113831,33284833,23803078,32352035	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226388569	226388569	A	G	het	wt	het	off-target	QUAL=3417;DP=171,83,101;AF=0.59,0.00,0.47;MQM=60;SAP=316;ABP=8;SAR=1;SAF=147	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron5/22:c.717+87T>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron5/21:c.717+87T>C::						rs2255403	0.18954	0.15269,0.31010,0.46763,0.15962,0.19677	3228,	22379	123293	2.3010	9.54			/3.2>2.3/0.0>0.0	COSV64687805	PARP1|0.00|0.00|0.00|0.00|-47|-36|-8|7	20522537,17560163,34477880	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390346	226390346	G	T	het	wt	het	off-target;low_conf_region	QUAL=1259;DP=70,66,94;AF=0.30,0.00,0.48;MQM=60;SAP=114;ABP=17;SAR=4;SAF=62	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron4/22:c.617+64C>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron4/21:c.617+64C>A::						rs1805411	0.17209	0.10657,0.30655,0.42835,0.15911,0.11261	2801,	20554	125836	-0.1320	1.52			/0.0>0.0/0.0>0.0	COSV64688261	PARP1|0.00|0.00|0.00|0.00|-8|-48|-46|-8	21487324,33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390398	226390398	T	C	hom	het	hom	off-target	QUAL=8991;DP=91,122,162;AF=1.00,0.54,0.99;MQM=60;SAP=437;ABP=5;SAR=33;SAF=285	PARP1	splice_region&intron	PARP1:ENST00000366794.10:splice_region_variant&intron_variant:LOW:intron4/22:c.617+12A>G::,PARP1:ENST00000677203.1:splice_region_variant&intron_variant:LOW:intron4/21:c.617+12A>G::						rs1805403	0.83402	0.93826,0.82268,0.94013,0.77251,0.75290	53408,	19974	25232	-5.7450	0.01			/0.0>0.0/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|12|34|19|12	27746584,19657367	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226392088	226392102	ACGTTGAGCTAGCAC	-	het	wt	het	off-target	QUAL=1405;DP=102,44,52;AF=0.43,0.00,0.54;MQM=60;SAP=159;ABP=4;SAR=0;SAF=72	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron3/22:c.402+97_402+111del::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron3/21:c.402+97_402+111del::						rs201956818	0.01480	0.00270,0.01014,0.00019,0.01880,0.00103	31,	2191	149987	3.0680	6.55			/0.0>0.0/10.7>0.0		PARP1|0.00|0.00|0.00|0.00|41|3|-16|3		4	428	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402008	226402008	C	T	het	wt	het	off-target	QUAL=1636;DP=134,17,31;AF=0.44,0.00,0.48;MQM=60;SAP=164;ABP=7;SAR=0;SAF=74	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron2/22:c.286+206G>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron2/21:c.286+206G>A::						rs2666428	0.44223	0.61245,0.46193,0.80605,0.32932,0.37712	16327,	34516	84720	-0.5930	6.43			/9.9>9.1/4.8>0.0	COSV104680319	PARP1|0.00|0.00|0.00|0.00|18|0|18|1	21976407,31413734,29937070,33391423,33791158,32780923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402257	226402257	G	A	het	wt	het		QUAL=9340;DP=301,299,471;AF=0.47,0.00,0.48;MQM=60;SAP=6;ABP=6;SAR=173;SAF=196	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon2/22:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]						rs1805404	0.17900	0.13050,0.30897,0.42926,0.15932,0.11274	2944,	21335	124861	3.1620	11.98			/0.0>0.0/0.0>0.0	COSV64687027	PARP1|0.00|0.00|0.00|0.00|-4|-11|33|-43	17267408,20486200,30183716,31609976,27462201,31415677,20113831,32888493,33284833,23576132	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226407946	226407946	C	G	het	wt	het		QUAL=2211;DP=42,139,146;AF=0.52,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=47;SAF=48	PARP1	5'UTR	PARP1:ENST00000366794.10:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::,PARP1:ENST00000677203.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-17G>C::	regulatory_region_variant:promoter,TF_binding_site_variant					rs907187	0.16135	0.05392,0.30361,0.43007,0.16312,0.11351	2724,	19075	127461	0.9510	12.41			/0.4>2.7/0.0>0.0	COSV64687065	PARP1|0.00|0.00|0.00|0.00|28|5|29|-46	21767974,17267408,21989229,31288058,32103589,26261599,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226961502	226961502	G	A	wt	het	wt		QUAL=307;DP=72,32,36;AF=0.00,0.50,0.00;MQM=60;SAP=4;ABP=3;SAR=9;SAF=7	COQ8A	splice_region&intron,synonymous	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron1/14:c.-34-6G>A::,COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128273 [benign DISEASE=Autosomal recessive cerebellar ataxia,not specified,not provided,Autosomal recessive ataxia due to ubiquinone deficiency];			rs11549708	0.16049	0.05139,0.12361,0.00096,0.24143,0.07530	2570,	19281	127743	-3.5600	3.92			/0.0>0.0/0.0>0.0	COSV64658484	ADCK3|0.00|0.00|0.00|0.00|2|-32|2|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226964961	226964961	C	T	wt	het	wt	off-target	QUAL=926;DP=83,67,86;AF=0.01,0.63,0.00;MQM=60;SAP=80;ABP=12;SAR=2;SAF=41	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron2/14:c.22-39C>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron2/14:c.178-39C>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759581953	0.00001	0.00000,0.00000,0.00000,0.00001,0.00000	0,	2	152224	-1.1540	0.06			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|39|2|45|39		0	3	0	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977534	226977534	C	T	het	wt	het	off-target	QUAL=439;DP=18,31,25;AF=0.50,0.00,0.52;MQM=60;SAP=3;ABP=3;SAR=11;SAF=11	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron5/14:c.574+11C>T::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron5/14:c.730+11C>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759489004	0.00001	0.00000,0.00000,0.00000,0.00000,0.00000	0,	1	152147	0.7940	6.46			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|-10|-49|-2|-9		0	3	0	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977661	226977661	C	G	wt	wt	het	off-target	QUAL=106;DP=14,16,13;AF=0.00,0.00,0.46;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron5/14:c.574+138C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron5/14:c.730+138C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs544460523	0.00296	0.00087,0.00105,0.00000,0.00501,0.00186	2,	446	151700	-0.2140	1.21			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|-40|26|-14|4		1	99	0	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982597	226982597	A	G	het	hom	wt	off-target	QUAL=4732;DP=58,139,190;AF=0.60,0.99,0.00;MQM=60;SAP=158;ABP=8;SAR=31;SAF=142	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron6/14:c.698-81A>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron6/14:c.854-81A>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671530 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs2297412	0.44092	0.47148,0.39641,0.20846,0.46707,0.23229	15029,	36788	84760	-2.7470	0.16			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|50|23|-26|50	27863252,33356394	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982842	226982842	C	G	het	het	wt	off-target	QUAL=3789;DP=115,177,294;AF=0.61,0.47,0.01;MQM=60;SAP=88;ABP=4;SAR=117;SAF=39	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron7/14:c.940-52C>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671531 [benign DISEASE=not provided,Autosomal recessive ataxia due to ubiquinone deficiency];			rs2297413	0.20283	0.13099,0.23390,0.31274,0.23043,0.15447	3383,	24082	121244	0.6420	2.96			/2.3>1.1/0.0>0.0	COSV64657732	ADCK3|0.00|0.01|0.00|0.00|28|11|-29|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983509	226983509	G	A	het	wt	hom	off-target	QUAL=5894;DP=84,144,175;AF=0.49,0.00,0.99;MQM=60;SAP=204;ABP=3;SAR=37;SAF=178	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671619 [benign DISEASE=not provided];			rs12739480	0.10603	0.03593,0.06164,0.05056,0.14295,0.20721	1139,	13844	135926	-0.4310	0.57			/0.0>0.0/0.0>0.0	COSV64659018	ADCK3|0.00|0.00|0.00|0.00|43|-13|41|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983884	226983884	T	-	het	hom	wt	off-target	QUAL=1957;DP=104,41,77;AF=0.44,1.00,0.00;MQM=60;SAP=68;ABP=6;SAR=69;SAF=18	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1100+32del::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1256+32del::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1183738 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs3215919	0.36929	0.29283,0.32602,0.13814,0.44296,0.19967	10965,	34216	95890	-0.8150	0.16			/8.1>7.2/0.0>0.0		ADCK3|0.00|0.00|0.03|0.00|-35|11|40|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984035	226984035	-	T	wt	het	wt	off-target	QUAL=2158;DP=66,57,41;AF=0.62,0.53,0.00;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-59_1101-58insT::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1294314 [benign DISEASE=not provided];			rs149374145	0.16142	0.05303,0.12363,0.00062,0.23971,0.07102	2411,	18625	121807		3.95			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.01|0.00|0.00|-39|34|-17|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984036	226984036	G	T	het	het	wt	off-target	QUAL=2158;DP=66,57,41;AF=0.62,0.53,0.00;MQM=60;SAP=54;ABP=9;SAR=15;SAF=56	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1291028 [benign DISEASE=not provided];			rs1574184	0.24686	0.26920,0.23416,0.24092,0.24303,0.16338	4060,	26254	104872	1.7960	4.23			/0.0>0.0/0.0>0.0	COSV64656763	ADCK3|0.00|0.01|0.00|0.00|-40|33|-6|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984037	226984037	G	T	wt	het	wt	off-target	QUAL=2158;DP=66,57,41;AF=0.62,0.53,0.00;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-57G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1262417 [benign DISEASE=not provided];			rs377335668	0.15541	0.04991,0.12083,0.00340,0.23566,0.06953	2351,	18470	125934	0.2130	0.99			/0.0>0.0/0.0>0.4		ADCK3|0.00|0.01|0.00|0.00|-41|32|-11|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984038	226984038	G	T	het	het	wt	off-target	QUAL=2158;DP=66,57,41;AF=0.62,0.53,0.00;MQM=60;SAP=54;ABP=9;SAR=15;SAF=56	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1188901 [benign DISEASE=not provided,Autosomal recessive ataxia due to ubiquinone deficiency];			rs1574185	0.23480	0.24011,0.21940,0.23537,0.24090,0.15988	3739,	25551	107637	-0.1650	0.81			/0.0>0.0/0.0>0.8		ADCK3|0.00|0.00|0.00|0.00|3|31|-42|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984257	226984257	G	C	wt	het	wt	off-target	QUAL=1013;DP=114,75,107;AF=0.00,0.53,0.00;MQM=60;SAP=4;ABP=4;SAR=22;SAF=18	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron11/14:c.1242+22G>C::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1247645 [benign DISEASE=not provided];			rs7530213	0.25051	0.15909,0.24018,0.09604,0.32024,0.12821	5196,	27711	113999	0.7580	6.30			/0.0>0.0/6.9>0.0	COSV64657987	ADCK3|0.00|0.00|0.07|0.32|48|0|48|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984589	226984589	C	T	het	hom	wt		QUAL=15688;DP=333,380,506;AF=0.47,0.98,0.00;MQM=60;SAP=6;ABP=5;SAR=252;SAF=279	COQ8A	synonymous	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:PF03109 [ABC1 atypical kinase-like domain],COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:PF03109 [ABC1 atypical kinase-like domain]	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128274 [benign DISEASE=Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not specified,not provided,Autosomal recessive ataxia due to ubiquinone deficiency];			rs12593	0.35011	0.20320,0.31925,0.17298,0.45393,0.19855	10345,	32521	98771	-0.2170	4.88			/0.0>0.0/0.0>0.0	COSV64656797	ADCK3|0.00|0.00|0.00|0.00|23|-41|-24|-4	31816047,34127677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226985202	226985202	G	A	het	hom	wt	off-target	QUAL=8142;DP=103,230,303;AF=0.60,0.98,0.00;MQM=60;SAP=96;ABP=12;SAR=88;SAF=199	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	676090 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs2297415	0.37804	0.28871,0.33408,0.16680,0.46063,0.19971	11508,	34414	94486	-2.2820	1.16			/0.0>1.2/0.0>0.0	COSV62011699,COSV62017351	ADCK3|0.00|0.00|0.00|0.00|2|10|27|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226985234	226985234	C	G	het	hom	wt	off-target	QUAL=9730;DP=115,267,344;AF=0.62,1.00,0.00;MQM=60;SAP=18;ABP=17;SAR=145;SAF=193	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron13/14:c.1417-20C>G::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron13/14:c.1573-20C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	518313 [benign/likely benign DISEASE=not provided,not specified,Autosomal recessive ataxia due to ubiquinone deficiency];			rs2297416	0.37372	0.27253,0.33425,0.16686,0.46078,0.19988	11314,	34149	95149	0.0300	3.50			12.3>10.9/12.3>10.9/0.0>3.0	COSV62011473	ADCK3|0.02|0.00|0.00|0.00|28|20|-5|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986421	226986421	C	G	wt	het	wt	off-target	QUAL=940;DP=88,73,139;AF=0.00,0.56,0.00;MQM=60;SAP=6;ABP=5;SAR=17;SAF=24	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-32C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671534 [benign DISEASE=not provided];			rs41303131	0.19785	0.09351,0.14505,0.00483,0.28443,0.11439	3668,	22710	121816	-1.9210	0.17			/0.0>0.0/0.0>0.0	COSV62005838	ADCK3|0.00|0.00|0.00|0.00|42|-6|47|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986444	226986444	T	C	het	hom	wt		QUAL=4058;DP=105,89,169;AF=0.52,1.00,0.00;MQM=60;SAP=50;ABP=4;SAR=44;SAF=100	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron14/14:c.1504-9T>C::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron14/14:c.1660-9T>C::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296024 [benign DISEASE=not specified,Autosomal recessive ataxia due to ubiquinone deficiency,not provided,Autosomal recessive cerebellar ataxia];			rs7552783	0.44300	0.41625,0.37220,0.21337,0.50334,0.26373	15302,	36558	84446	-3.6360	5.40			11.5>10.7/11.5>10.7/0.0>0.0	COSV62011703,COSV62011928	ADCK3|0.00|0.00|0.00|0.00|-36|19|8|-30	26503814,32439900	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986509	226986509	T	C	het	hom	wt		QUAL=5379;DP=163,119,185;AF=0.45,1.00,0.00;MQM=60;SAP=3;ABP=7;SAR=99;SAF=93	COQ8A	synonymous	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128275 [benign DISEASE=Autosomal recessive cerebellar ataxia,not specified,not provided,Autosomal recessive ataxia due to ubiquinone deficiency];			rs3738725	0.41335	0.31514,0.35568,0.21743,0.50329,0.26222	13639,	35310	88830	-5.5320	0.04			/0.0>0.0/0.0>0.5	COSV62011476	ADCK3|0.00|0.18|0.00|0.00|2|28|1|28	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987122	226987122	-	T	het	hom	wt		QUAL=13789;DP=251,375,475;AF=0.46,1.00,0.00;MQM=60;SAP=79;ABP=6;SAR=180;SAF=311	COQ8A	3'UTR	COQ8A:ENST00000366778.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366777.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839	0.40346	0.29409,0.35125,0.16956,0.50044,0.24159	13225,	34851	90637		1.76			/2.3>3.5/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|21|20|26|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987544	226987544	-	T	het	hom	wt		QUAL=7959;DP=164,221,329;AF=0.45,0.96,0.00;MQM=60;SAP=26;ABP=6;SAR=171;SAF=116	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296050 [benign DISEASE=not provided,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,Autosomal recessive cerebellar ataxia,Autosomal recessive ataxia due to ubiquinone deficiency];			rs3215920	0.37262	0.18621,0.34034,0.16808,0.50118,0.24078	12089,	32416	95286		1.93			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|-21|-2|-4|-34	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987552	226987552	C	T	het	hom	wt		QUAL=8643;DP=165,214,325;AF=0.48,1.00,0.00;MQM=60;SAP=45;ABP=4;SAR=184;SAF=109	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	368867 [benign DISEASE=Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,Autosomal recessive cerebellar ataxia,not provided];			rs10495274	0.52572	0.38037,0.48316,0.34374,0.63490,0.39462	22087,	35663	72025	-0.9260	0.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987666	226987666	G	T	het	hom	wt	off-target	QUAL=3399;DP=119,75,136;AF=0.49,1.00,0.00;MQM=60;SAP=292;ABP=3;SAR=133;SAF=0	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1250369 [benign DISEASE=not provided];			rs6426558	0.40313	0.28342,0.35059,0.21619,0.50187,0.26180	13205,	34872	90734	-0.4880	0.39						27863252,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228159235	228159235	G	A	het	wt	het		QUAL=2189;DP=43,92,130;AF=0.53,0.00,0.54;MQM=60;SAP=25;ABP=5;SAR=62;SAF=31	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]	1265470 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Hereditary spastic paraplegia,not provided];			rs45491398	0.05762	0.01601,0.04061,0.00077,0.09061,0.02233	366,	8039	143449	-1.8580	0.34			/0.0>0.0/0.0>0.0		GJC2|0.00|0.00|0.00|0.00|2|-48|21|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228159651	228159651	A	G	hom	hom	hom		QUAL=1512;DP=31,8,13;AF=1.00,1.00,1.00;MQM=60;SAP=107;ABP=0;SAR=1;SAF=51	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]				rs6668719	0.84797	0.64532,0.88619,0.76069,0.94723,0.92458	55985,	16902	23106	0.0710	4.20			/0.0>0.0/0.0>0.0		GJC2|0.00|0.00|0.00|0.00|-15|22|4|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228424743	228424743	A	G	het	het	hom	off-target	QUAL=3092;DP=104,51,46;AF=0.47,0.55,1.00;MQM=60;SAP=270;ABP=3;SAR=0;SAF=123	H3-4	downstream_gene	H3-4:ENST00000366696.2:downstream_gene_variant:MODIFIER::::						rs1188473	0.89815	0.94558,0.94583,0.67446,0.89199,0.85380	61589,	13421	15491	-0.2750	0.95							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425137	228425137	G	T	het	het	hom		QUAL=18693;DP=292,285,384;AF=0.51,0.46,1.00;MQM=60;SAP=424;ABP=4;SAR=512;SAF=153	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]						rs2230656	0.73719	0.40731,0.86552,0.66287,0.88636,0.84692	44714,	22742	39988	2.0500	8.50			/4.6>4.0/2.5>1.5	COSV64210568	HIST3H3|0.06|0.00|0.03|0.00|-19|-7|-1|6	30066433,29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425191	228425191	G	A	wt	wt	het		QUAL=2235;DP=186,213,260;AF=0.00,0.00,0.47;MQM=60;SAP=158;ABP=6;SAR=107;SAF=14	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:PF00125 [Core histone H2A/H2B/H3/H4]						rs56336130	0.06309	0.01621,0.05853,0.02059,0.09193,0.09367	417,	8772	142644	0.1770	6.19			/0.0>0.0/2.0>9.8	COSV64210887	HIST3H3|0.00|0.00|0.67|0.00|2|-34|2|-3	29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425351	228425351	T	C	het	het	hom	off-target	QUAL=1630;DP=58,34,31;AF=0.40,0.41,1.00;MQM=60;SAP=151;ABP=11;SAR=68;SAF=0	H3-4	5'UTR	H3-4:ENST00000366696.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::						rs1188474	0.89231	0.92638,0.94045,0.67418,0.89197,0.85431	60765,	14215	16383	-2.8600	0.35			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229432484	229432484	T	G	hom	hom	hom	off-target	QUAL=2169;DP=8,34,46;AF=1.00,1.00,1.00;MQM=60;SAP=194;ABP=0;SAR=88;SAF=0	ACTA1	intron	ACTA1:ENST00000684723.1:intron_variant:MODIFIER:intron2/5:c.320-53A>C::,ACTA1:ENST00000366684.7:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000366683.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:enhancer	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	676564 [benign DISEASE=Progressive scapulohumeroperoneal distal myopathy,not provided,Congenital myopathy with fiber type disproportion,Actin accumulation myopathy];			rs527621	0.99844	0.99972,0.99891,1.00000,0.99899,0.99661	72810,	228	228	-1.3790	3.26			/0.0>0.0/0.0>0.0		ACTA1|0.00|0.03|0.00|0.00|-7|-25|-48|-25	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434056	229434056	A	G	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5;SAR=89;SAF=43	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-59T>C::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	296060 [benign DISEASE=Familial restrictive cardiomyopathy,not provided,Congenital myopathy with fiber type disproportion,Actin accumulation myopathy];			rs605430	0.63240	0.75827,0.65643,0.45743,0.58014,0.65515	30966,	33954	55736	0.5810	19.39			/3.9>4.3/0.0>0.0	COSV64203106	ACTA1|0.00|0.00|0.00|0.00|-14|31|19|-36	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434057	229434057	G	A	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5;SAR=89;SAF=43	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-60C>T::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	296062 [benign DISEASE=Familial restrictive cardiomyopathy,not provided,Congenital myopathy with fiber type disproportion,Actin accumulation myopathy];			rs605428	0.63220	0.75802,0.65643,0.45672,0.57998,0.65480	30962,	33957	55781	0.2370	17.21			/3.9>4.7/0.0>0.0	COSV64204088	ACTA1|0.00|0.00|0.00|0.00|-15|30|-28|18	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231241335	231241335	C	T	hom	hom	het		QUAL=19014;DP=314,251,317;AF=0.96,0.99,0.55;MQM=60;SAP=206;ABP=10;SAR=232;SAF=492	GNPAT	5'UTR	GNPAT:ENST00000366647.9:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	296108 [benign DISEASE=not specified,Rhizomelic chondrodysplasia punctata type 2];			rs518686	0.54876	0.56879,0.59235,0.61637,0.53352,0.62428	23065,	37246	68560	0.1320	10.49			/0.0>0.0/0.0>0.0	COSV59641814	GNPAT|0.00|0.00|0.00|0.00|5|-14|-2|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231250866	231250866	T	A	hom	hom	het	off-target	QUAL=9501;DP=206,74,92;AF=0.99,1.00,0.48;MQM=60;SAP=702;ABP=3;SAR=0;SAF=322	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron1/15:c.79-95T>A::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244833 [benign DISEASE=not provided];			rs508908	0.59101	0.69081,0.61032,0.62108,0.54490,0.62801	26965,	35831	62117	-0.4300	0.93			/0.9>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|-32|-5|-32|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231260370	231260370	-	TA	hom	hom	het	off-target	QUAL=3025;DP=86,19,37;AF=0.92,0.95,0.41;MQM=60;SAP=246;ABP=6;SAR=0;SAF=112	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron2/15:c.262-136_262-135insAT::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1274329 [benign DISEASE=not provided];			rs3215759	0.59062	0.68986,0.60992,0.61964,0.54481,0.62941	26919,	35831	62153		3.09			/0.0>0.0/2.8>2.8		GNPAT|0.00|0.00|0.00|0.00|29|-32|-2|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231260888	231260888	T	C	hom	n/a	n/a	off-target	QUAL=1779;DP=57,0,0;AF=1.00,,;MQM=60;SAP=127;ABP=0;SAR=57;SAF=0	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron3/15:c.438+205T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671164 [benign DISEASE=not provided];			rs531592	0.50107	0.46289,0.56437,0.55143,0.51411,0.57791	19246,	37617	75785	-0.1680	2.06			/2.2>1.8/0.0>0.0	COSV64153471	GNPAT|0.00|0.00|0.00|0.00|22|30|50|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265159	231265159	A	G	hom	hom	het	off-target	QUAL=2516;DP=66,17,15;AF=1.00,1.00,0.67;MQM=60;SAP=205;ABP=7;SAR=0;SAF=93	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron4/15:c.569-134A>G::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671168 [benign DISEASE=not provided];		FLAM_C (SINE/Alu)	rs849714	0.57935	0.64972,0.60789,0.62139,0.54517,0.61997	25840,	36367	63929	-0.7750	1.40			/0.6>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|1|6|23|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265458	231265458	T	C	hom	het	het	off-target	QUAL=12327;DP=212,178,233;AF=1.00,0.48,0.52;MQM=60;SAP=116;ABP=3;SAR=282;SAF=135	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron5/15:c.696+38T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1256935 [benign DISEASE=not provided];			rs6702011	0.26762	0.28042,0.32661,0.23612,0.25385,0.26284	5526,	29624	111314	-0.6780	7.53			/0.0>0.0/0.0>0.0	COSV64154015	GNPAT|0.00|0.00|0.00|0.00|-44|47|-49|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265850	231265850	T	C	hom	het	het	off-target	QUAL=14384;DP=274,163,252;AF=1.00,0.48,0.48;MQM=60;SAP=139;ABP=5;SAR=322;SAF=150	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron6/15:c.772+63T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244648 [benign DISEASE=not provided];			rs532226	0.54391	0.56174,0.59043,0.61776,0.52929,0.60971	22658,	37337	69307	0.0210	5.84			/1.9>2.1/0.0>0.0	COSV64153524	GNPAT|0.00|0.00|0.00|0.00|34|-2|19|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231266156	231266156	G	A	hom	het	het		QUAL=17593;DP=348,202,258;AF=1.00,0.49,0.50;MQM=60;SAP=91;ABP=3;SAR=364;SAF=211	GNPAT	synonymous	GNPAT:ENST00000366647.9:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:PF19277 [Glycerol-3-phosphate acyltransferase C-terminal region]		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	260363 [benign DISEASE=not provided,Rhizomelic chondrodysplasia punctata type 2,not specified];			rs574553	0.58828	0.68955,0.60788,0.62042,0.54117,0.62085	26756,	35868	62554	1.6320	5.21			/0.0>0.0/0.0>0.0	COSV64153484	GNPAT|0.00|0.00|0.04|0.00|-19|-34|13|-34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231267519	231267519	T	C	hom	hom	het	off-target	QUAL=4211;DP=110,22,17;AF=1.00,1.00,0.53;MQM=60;SAP=309;ABP=3;SAR=0;SAF=141	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron8/15:c.1056-161T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671169 [benign DISEASE=not provided];			rs474297	0.54641	0.56260,0.59244,0.61671,0.53316,0.60929	22823,	37304	68860	-0.4310	1.01			/0.0>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|-47|11|-7|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231268084	231268084	C	T	hom	hom	het	off-target	QUAL=2629;DP=85,7,14;AF=1.00,1.00,0.43;MQM=43;SAP=207;ABP=4;SAR=97;SAF=1	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1279+181C>T::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671188 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs579924	0.54624	0.56250,0.59207,0.61549,0.53305,0.61017	22822,	37287	68891	-0.9420	0.72			/0.0>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|-13|-8|-13|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231270549	231270549	T	C	hom	het	n/a	off-target	QUAL=2058;DP=67,11,2;AF=1.00,0.36,0.50;MQM=60;SAP=159;ABP=5;SAR=0;SAF=72	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1280-209T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671190 [benign DISEASE=not provided];			rs3767758	0.54388	0.56170,0.59044,0.61685,0.52933,0.60987	22649,	37334	69298	2.2510	8.55			/5.0>4.6/0.0>0.0		GNPAT|0.00|0.00|0.00|0.04|0|-41|35|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231364607	231364607	-	T	hom	het	hom		QUAL=17904;DP=351,163,186;AF=0.97,0.44,0.97;MQM=60;SAP=15;ABP=8;SAR=325;SAF=268	EGLN1	3'UTR	EGLN1:ENST00000366641.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]				rs541569859	0.57423	0.40957,0.55301,0.56012,0.65354,0.57805	25902,	35393	64653		7.84			/0.0>0.0/0.0>0.0		EGLN1|0.00|0.00|0.00|0.00|-29|-20|-46|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	-	het	wt	het	off-target;low_conf_region	QUAL=9754;DP=159,169,201;AF=0.65,0.31,0.68;MQM=60;SAP=52;ABP=593;SAR=58;SAF=17	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24del::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1243379 [benign DISEASE=not provided];			rs371204614	0.00093	0.00027,0.00106,0.00136,0.00071,0.00021	0,	140	149942	-0.5900	2.38			/0.4>0.0/0.0>0.0	COSV64150067	EGLN1|0.00|0.00|0.00|0.00|14|1|-31|-22		0	579	494	0 / 0					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	A	het	het	het	off-target;low_conf_region	QUAL=9754;DP=159,169,201;AF=0.65,0.31,0.68;MQM=60;SAP=213;ABP=15;SAR=230;SAF=62	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1292828 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome];			rs1435167	0.57195	0.41950,0.54709,0.55757,0.64863,0.57675	25166,	35803	64463	-0.5900	5.73			/0.4>0.6/0.0>0.0	COSV64150067	EGLN1|0.00|0.00|0.00|0.00|-24|-33|-32|-23	35710628	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366564	231366564	T	C	hom	het	hom	off-target	QUAL=11803;DP=213,113,126;AF=1.00,0.42,1.00;MQM=60;SAP=671;ABP=9;SAR=366;SAF=21	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-89A>G::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1257712 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs1435166	0.52359	0.26160,0.53075,0.55379,0.64162,0.56530	22835,	33868	72370	-0.6810	0.82			/5.7>6.6/0.0>0.0	COSV64149252	EGLN1|0.00|0.00|0.00|0.00|-10|-31|5|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231370811	231370811	G	A	hom	het	hom	off-target	QUAL=9230;DP=189,58,98;AF=1.00,0.36,1.00;MQM=60;SAP=672;ABP=13;SAR=308;SAF=0	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron2/4:c.1012-113C>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1265678 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs2256908	0.54651	0.31732,0.54173,0.55995,0.65161,0.57581	24289,	34472	68914	1.5660	6.51			/0.0>0.0/2.1>0.0	COSV64149687	EGLN1|0.00|0.00|0.00|0.00|1|23|2|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231421509	231421509	C	G	het	hom	wt		QUAL=206;DP=3,9,3;AF=0.67,1.00,0.00;MQM=60;SAP=27;ABP=4;SAR=11;SAF=0	EGLN1	missense	EGLN1:ENST00000366641.4:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	242640 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided,Erythrocytosis, familial, 3]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.15577	0.30655,0.13464,0.44271,0.06023,0.23187	2912,	17741	127717	1.2680	12.82	0.21	0.06	/0.0>0.0/0.0>0.9	COSV64149723	EGLN1|0.00|0.00|0.00|0.00|-23|1|-2|47	31712437,29625625,25129147,28116332,30719713,31824328,24711448,28096303,24030663,30188897,28036300,27325755,28819001,33282179,32414920,33282944,32377332,25319824,33370224,35132109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231423480	231423480	A	G	het	hom	wt		QUAL=5114;DP=197,71,82;AF=0.51,1.00,0.02;MQM=60;SAP=19;ABP=3;SAR=105;SAF=69	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296223 [benign DISEASE=Erythrocytosis, familial, 3];			rs12406290	0.19278	0.21274,0.21094,0.48094,0.15450,0.34754	3232,	22855	122765	2.9670	10.08					EGLN1|0.00|0.00|0.00|0.00|-8|16|-8|39	32185192,25431923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231424474	231424474	A	G	het	hom	wt		QUAL=15143;DP=598,209,205;AF=0.52,1.00,0.00;MQM=60;SAP=357;ABP=5;SAR=114;SAF=405	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296240 [benign DISEASE=Erythrocytosis, familial, 3];			rs2153364	0.19345	0.21260,0.21147,0.48229,0.15510,0.35782	3262,	22902	122686	0.2220	4.11					EGLN1|0.00|0.00|0.00|0.00|-23|-14|-42|20	32185192,25431923,32478477,32718338	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235379947	235379947	-	A	wt	het	wt	off-target	QUAL=921;DP=59,43,63;AF=0.22,0.12,0.37;MQM=56;SAP=64;ABP=159;SAR=0;SAF=28	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34469dup::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron4/19:c.-31-55dup::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron3/18:c.-31-55dup::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron3/18:c.-31-55dup::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron4/19:c.-31-55dup::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron1/15:c.-341-55dup::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron1/15:c.-31-55dup::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron1/15:c.-31-55dup::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron1/17:c.-31-55dup::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron1/14:c.-31-55dup::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1174300 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs36068852	0.72123	0.86053,0.69282,0.64786,0.66884,0.58819	34104,	27457	36977		1.86			/0.0>0.0/0.0>0.0		TBCE|0.00|0.00|0.00|0.00|42|48|-15|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235379948	235379948	A	-	het	wt	het	off-target	QUAL=921;DP=59,43,63;AF=0.17,0.35,0.05;MQM=58;SAP=92;ABP=94;SAR=0;SAF=41	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34469del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron4/19:c.-31-55del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron3/18:c.-31-55del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron3/18:c.-31-55del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron4/19:c.-31-55del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron1/15:c.-341-55del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron1/15:c.-31-55del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron1/15:c.-31-55del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron1/17:c.-31-55del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron1/14:c.-31-55del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs36068852	0.00094	0.00033,0.00086,0.00066,0.00080,0.00025	0,	125	132581	0.5660	1.58			/0.0>0.0/0.0>0.0		TBCE|0.00|0.00|0.00|0.00|42|29|-7|-13		4	540	0	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380165	TGTG	-	wt	wt	het	off-target;low_conf_region	QUAL=1657;DP=26,96,31;AF=0.04,0.36,0.00;MQM=60;SAP=4;ABP=11;SAR=6;SAF=4	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34222_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+62_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+62_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1601254 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.05841	0.04927,0.04676,0.08077,0.05838,0.07396	275,	7596	131308	0.5040	1.36			/0.0>0.0/0.5>0.5		TBCE|0.00|0.00|0.00|0.00|-44|-46|-46|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380175	TGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1657;DP=26,96,31;AF=0.04,0.36,0.00;MQM=60;SAP=9;ABP=48;SAR=23;SAF=13	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34232_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+52_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+52_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245486 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.28172	0.15146,0.25475,0.11742,0.37238,0.12145	6200,	26941	100307	0.6670	1.46			/0.0>0.0/0.5>0.5		TBCE|0.00|0.00|0.01|0.00|-29|-11|-46|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380177	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target;low_conf_region	QUAL=1657;DP=26,96,31;AF=0.04,0.36,0.00;MQM=59;SAP=41;ABP=81;SAR=25;SAF=3	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34234_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+50_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+50_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1232644 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.04552	0.07557,0.03259,0.08953,0.02810,0.04207	199,	5961	133353	0.6670	1.54			/0.0>0.0/0.5>0.5		TBCE|0.00|0.00|0.02|0.00|-46|-44|-46|-12		55	372	0	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380179	TGTGTGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1657;DP=26,96,31;AF=0.04,0.36,0.00;MQM=60;SAP=7;ABP=12;SAR=23;SAF=15	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34236_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+48_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+48_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	403520 [benign/likely benign DISEASE=not provided,not specified];		(TG)n (Simple_repeat)	rs10524346	0.14071	0.15724,0.22962,0.43077,0.08650,0.27251	1830,	16003	120077	0.6670	1.55			/0.0>0.0/0.5>0.5		TBCE|0.00|0.00|0.01|0.00|-12|-11|-46|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235430867	235430867	A	G	het	hom	wt	off-target	QUAL=5133;DP=158,98,90;AF=0.51,1.00,0.00;MQM=60;SAP=179;ABP=3;SAR=149;SAF=29	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron5/14:c.321+63A>G::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron10/19:c.660+63A>G::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron9/18:c.660+63A>G::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron9/18:c.660+63A>G::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron10/19:c.660+63A>G::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+63A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+63A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+63A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+63A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+63A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+63A>G::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1229298 [benign DISEASE=not provided];			rs2291687	0.72452	0.90967,0.72184,0.66107,0.64010,0.58630	41061,	28028	41882	-0.2960	0.94			/3.9>5.6/0.0>0.0	COSV64005596	TBCE|0.00|0.00|0.00|0.00|0|16|-41|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235430935	235430935	A	G	het	hom	wt	off-target	QUAL=2970;DP=115,45,37;AF=0.59,1.00,0.00;MQM=60;SAP=248;ABP=11;SAR=113;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron5/14:c.321+131A>G::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron10/19:c.660+131A>G::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron9/18:c.660+131A>G::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron9/18:c.660+131A>G::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron10/19:c.660+131A>G::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+131A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+131A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+131A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+131A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+131A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+131A>G::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245648 [benign DISEASE=not provided];			rs2291688	0.48774	0.40126,0.57149,0.64335,0.49977,0.46623	18475,	37139	77815	-0.3340	1.46			/3.5>5.0/0.0>6.2	COSV64005600	TBCE|0.00|0.00|0.00|0.00|0|19|-1|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235435658	235435658	C	T	het	hom	wt	off-target	QUAL=3963;DP=156,79,111;AF=0.44,1.00,0.00;MQM=60;SAP=179;ABP=9;SAR=19;SAF=128	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron6/14:c.399-87C>T::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron11/19:c.738-87C>T::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron10/18:c.738-87C>T::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron10/18:c.738-87C>T::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron11/19:c.738-87C>T::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron7/15:c.399-87C>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron8/15:c.738-87C>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron7/15:c.552-87C>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron9/17:c.891-87C>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron6/14:c.549-87C>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron7/15:c.738-87C>T::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1265656 [benign DISEASE=not provided];			rs2055127	0.49729	0.39827,0.57847,0.65131,0.51590,0.47158	19251,	37033	76357	-0.4370	0.32			/3.8>3.1/0.0>0.0	COSV64005614	TBCE|0.00|0.00|0.00|0.00|14|-8|-37|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235436814	235436814	T	C	het	hom	wt	off-target	QUAL=2197;DP=155,14,9;AF=0.53,1.00,0.00;MQM=60;SAP=211;ABP=4;SAR=96;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron9/14:c.624+206T>C::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron14/19:c.963+206T>C::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron13/18:c.963+206T>C::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron13/18:c.963+206T>C::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron14/19:c.963+206T>C::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron10/15:c.624+206T>C::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron11/15:c.963+206T>C::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron10/15:c.777+206T>C::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron12/17:c.1116+206T>C::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron9/14:c.774+206T>C::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron10/15:c.963+206T>C::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1251326 [benign DISEASE=not provided];			rs6429082	0.54963	0.54479,0.60251,0.65222,0.53320,0.48280	23129,	37213	68397	-4.3450	0.09			/0.0>0.0/0.0>0.0		TBCE|0.00|0.00|0.00|0.00|6|14|14|-36	21976109,19557161,30595370,31844048,34855049	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235438643	235438643	G	T	het	hom	wt	off-target	QUAL=2236;DP=70,46,64;AF=0.53,1.00,0.00;MQM=60;SAP=183;ABP=4;SAR=0;SAF=83	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron10/14:c.778-126G>T::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron15/19:c.1117-126G>T::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron14/18:c.1117-126G>T::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron14/18:c.1117-126G>T::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron15/19:c.1117-126G>T::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron11/15:c.778-126G>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron12/15:c.1117-126G>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron11/15:c.931-126G>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron13/17:c.1270-126G>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron10/14:c.928-126G>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron11/15:c.1117-126G>T::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1285897 [benign DISEASE=not provided];			rs3819974	0.71755	0.88754,0.71714,0.66879,0.63834,0.58306	40116,	28791	42915	-3.3610	0.02			/0.0>0.0/0.0>0.0	COSV64005625	TBCE|0.00|0.00|0.00|0.00|46|1|-11|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235439089	235439089	G	A	het	hom	wt	off-target	QUAL=1578;DP=83,28,32;AF=0.42,1.00,0.00;MQM=60;SAP=131;ABP=7;SAR=62;SAF=1	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron11/14:c.931+167G>A::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron16/19:c.1270+167G>A::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron15/18:c.1270+167G>A::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron15/18:c.1270+167G>A::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron16/19:c.1270+167G>A::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron12/15:c.931+167G>A::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron13/15:c.1270+167G>A::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron12/15:c.1150+101G>A::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron14/17:c.1423+167G>A::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron11/14:c.1081+167G>A::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron12/15:c.1336+101G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1262727 [benign DISEASE=not provided];			rs2270538	0.68405	0.79365,0.69340,0.66951,0.63210,0.56840	35997,	31871	47973	-1.5350	0.07			/0.0>0.0/0.0>0.0	COSV64005629	TBCE|0.00|0.00|0.00|0.00|-21|5|14|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235442009	235442009	T	-	het	het	het	off-target	QUAL=453;DP=72,22,37;AF=0.28,0.23,0.35;MQM=58;SAP=86;ABP=53;SAR=38;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron12/14:c.1000+143del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron17/19:c.1339+143del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron16/18:c.1339+143del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron16/18:c.1339+143del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron17/19:c.1339+143del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron13/15:c.1000+143del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron14/15:c.1339+143del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron13/15:c.1219+143del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron15/17:c.1492+143del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron12/14:c.1150+143del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron13/15:c.1405+143del::	regulatory_region_variant:enhancer	604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs376999568	0.00382	0.00606,0.00299,0.00081,0.00233,0.00067	1,	542	141846	-5.0460	0.01			/2.3>1.5/0.0>0.0		TBCE|0.00|0.00|0.00|0.00|25|21|-27|45		21	447	0	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235449005	235449005	C	T	het	hom	wt	off-target	QUAL=4408;DP=135,84,91;AF=0.55,0.99,0.00;MQM=60;SAP=270;ABP=6;SAR=148;SAF=9	TBCE,B3GALNT2	3'UTR	TBCE:ENST00000406207.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:ENST00000642610.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:ENST00000366600.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]&610194_[GENE=B3GALNT2_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11, 615181 (3), Autosomal recessive]				rs704705	0.73725	0.92368,0.72773,0.66885,0.65284,0.61054	42460,	27164	39946	0.6550	9.48			/9.4>8.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64003592			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235660889	235660889	-	A	wt	n/a	het	off-target;low_conf_region	QUAL=158;DP=19,2,6;AF=0.32,0.00,0.17;MQM=56;SAP=14;ABP=23;SAR=0;SAF=5	LYST	downstream_gene	LYST:ENST00000389793.7:downstream_gene_variant:MODIFIER::::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]			AluSc8 (SINE/Alu)	rs11430102	0.51495	0.46534,0.41961,0.07467,0.58554,0.18571	11868,	25142	46040		0.48							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235660890	235660890	A	-	het	n/a	het	off-target;low_conf_region	QUAL=158;DP=19,2,6;AF=0.11,0.00,0.50;MQM=54;SAP=18;ABP=14;SAR=0;SAF=7	LYST	downstream_gene	LYST:ENST00000389793.7:downstream_gene_variant:MODIFIER::::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]			AluSc8 (SINE/Alu)	rs11430102	0.00175	0.00092,0.00078,0.03110,0.00079,0.00042	0,	167	95089	-0.7480	0.13							4	16	0	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235662343	235662343	G	A	het	het	wt		QUAL=2795;DP=207,30,66;AF=0.47,0.33,0.00;MQM=60;SAP=20;ABP=8;SAR=39;SAF=68	LYST	3'UTR	LYST:ENST00000389793.7:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs1400168809	0.00002	0.00000,0.00000,0.00000,0.00004,0.00000	0,	3	152139	1.0680	4.70			/3.6>4.8/0.0>3.9		LYST|0.00|0.00|0.00|0.00|-41|1|2|-25		0	2	0	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663083	235663083	A	-	hom	het	hom		QUAL=15591;DP=243,196,277;AF=0.90,0.51,0.91;MQM=60;SAP=142;ABP=3;SAR=380;SAF=189	LYST	splice_region&intron	LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,Autoinflammatory syndrome,not specified,not provided];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994	0.55332	0.77305,0.39030,0.04955,0.52591,0.17675	24831,	32904	66654	-0.6940	1.92			/8.6>4.7/0.0>0.0		LYST|0.05|0.01|0.00|0.00|-42|-4|-4|2	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663283	235663283	G	A	wt	het	wt	off-target	QUAL=219;DP=121,23,31;AF=0.00,0.52,0.00;MQM=60;SAP=29;ABP=3;SAR=12;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron52/52:c.11268-205C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1283354 [benign DISEASE=not provided];			rs3754230	0.12182	0.10524,0.17123,0.12428,0.11959,0.19561	1157,	16199	133455	0.2250	1.62			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|39|-31|39|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664143	235664143	T	C	hom	het	hom	off-target	QUAL=8892;DP=167,68,91;AF=0.99,0.54,1.00;MQM=60;SAP=465;ABP=4;SAR=272;SAF=22	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11196-88A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1276755 [benign DISEASE=not provided];			rs3819013	0.40461	0.26637,0.33381,0.04586,0.52273,0.15679	14015,	33446	90464	-0.2940	2.92			/3.1>2.8/0.0>1.1	COSV67704793	LYST|0.00|0.00|0.00|0.00|-40|-28|1|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664341	235664341	C	T	hom	het	hom	off-target	QUAL=3714;DP=85,14,25;AF=1.00,0.50,1.00;MQM=60;SAP=86;ABP=3;SAR=25;SAF=92	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11195+124G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684368 [benign DISEASE=not provided];			rs12092604	0.53750	0.72455,0.38821,0.04561,0.52444,0.17574	23817,	34001	70243	-0.5320	0.87			/3.5>3.0/2.2>4.9	COSV67704799	LYST|0.00|0.00|0.00|0.00|43|1|-1|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693238	235693238	-	C	hom	hom	hom	off-target	QUAL=3847;DP=67,34,48;AF=0.87,1.00,1.00;MQM=56;SAP=307;ABP=0;SAR=0;SAF=140	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron47/52:c.10701+111dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684366 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs5781839	0.95047	0.98796,0.94465,0.99038,0.92702,0.98305	68790,	7081	7539		0.30			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|-32|-23|-40|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693601	235693601	G	A	hom	het	hom	off-target	QUAL=9698;DP=200,85,85;AF=1.00,0.49,1.00;MQM=60;SAP=711;ABP=3;SAR=326;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10565-115C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1249412 [benign DISEASE=not provided];			rs3754232	0.40398	0.25729,0.35623,0.04495,0.52153,0.16122	13985,	33392	90530	0.4190	2.65			/0.0>0.0/0.0>0.0	COSV67704843	LYST|0.00|0.00|0.00|0.00|-49|19|7|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235697040	235697040	C	T	hom	het	hom	off-target	QUAL=3255;DP=69,29,23;AF=1.00,0.59,1.00;MQM=60;SAP=190;ABP=5;SAR=6;SAF=103	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254908 [benign DISEASE=not specified,not provided];			rs7541057	0.53210	0.72146,0.38137,0.04507,0.51692,0.17199	23439,	34003	71123	-1.8750	0.01			/0.0>0.0/2.3>0.0		LYST|0.00|0.00|0.02|0.00|43|21|43|31	25741868,34469753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235709365	235709365	T	C	hom	het	hom	off-target;low_conf_region	QUAL=7693;DP=179,47,56;AF=0.99,0.51,1.00;MQM=60;SAP=563;ABP=3;SAR=258;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684363 [benign DISEASE=not provided];			rs2275856	0.49991	0.82209,0.36295,0.06933,0.40958,0.19739	22426,	31098	75976	-0.7320	1.43			/2.4>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|43|-2|43|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235715131	235715131	-	GTT	wt	het	wt	off-target	QUAL=1089;DP=136,117,141;AF=0.01,0.44,0.00;MQM=60;SAP=94;ABP=6;SAR=3;SAF=50	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron42/52:c.9784+67_9784+69dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1221305 [benign DISEASE=not provided];			rs3831362	0.10714	0.02598,0.17813,0.16097,0.12882,0.20329	1091,	14061	135357		2.15			/1.1>1.1/0.0>0.0		LYST|0.00|0.00|0.00|0.00|-45|42|0|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235723976	235723976	G	T	hom	het	hom	off-target	QUAL=9236;DP=134,99,116;AF=0.99,0.52,1.00;MQM=60;SAP=399;ABP=3;SAR=33;SAF=267	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684361 [benign DISEASE=not provided];			rs6667717	0.49777	0.82088,0.36126,0.06315,0.40660,0.19561	22275,	31050	76278	-2.6600	0.00			/0.0>0.0/3.6>5.9	COSV67704991	LYST|0.00|0.00|0.00|0.00|-31|13|-1|-30	18485661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235733426	235733426	C	T	hom	het	hom	off-target	QUAL=6725;DP=119,63,84;AF=0.99,0.51,1.00;MQM=60;SAP=511;ABP=3;SAR=0;SAF=234	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron34/52:c.8801+77G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684360 [benign DISEASE=not provided];			rs6429275	0.49953	0.82123,0.36287,0.06219,0.40934,0.19717	22358,	31095	75953	-0.6810	4.46			/2.3>5.0/0.0>0.0	COSV67705001	LYST|0.00|0.00|0.00|0.00|-2|-9|-2|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24), LDHAP2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235746185	235746185	T	C	het	wt	het	off-target	QUAL=1939;DP=145,15,21;AF=0.47,0.07,0.57;MQM=60;SAP=179;ABP=3;SAR=0;SAF=81	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron29/52:c.7972+151A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1268311 [benign DISEASE=not provided];			rs10926565	0.27266	0.33637,0.21160,0.01905,0.26972,0.16079	5978,	29473	110515	-0.0390	4.07			/0.0>0.0/2.5>10.6		LYST|0.00|0.00|0.01|0.00|42|-44|1|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235752840	235752840	C	T	hom	n/a	n/a	off-target	QUAL=368;DP=14,1,0;AF=1.00,0.00,;MQM=60;SAP=33;ABP=0;SAR=0;SAF=14	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron26/52:c.7460+204G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1226819 [benign DISEASE=not provided];			rs2273585	0.40772	0.49443,0.32753,0.06226,0.41299,0.19701	13283,	35219	89753	-0.1980	5.01			/0.0>0.0/1.0>0.0	COSV67705022	LYST|0.00|0.00|0.00|0.00|-2|46|20|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235755389	235755393	AAAAG	-	hom	hom	hom	off-target	QUAL=2856;DP=28,35,41;AF=1.00,0.97,0.98;MQM=60;SAP=225;ABP=0;SAR=0;SAF=102	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron25/52:c.7229+85_7229+89del::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	801635 [benign DISEASE=not provided,Chediak-Higashi syndrome];		AluSx3 (SINE/Alu), (AAAAG)n (Simple_repeat)	rs71174459	0.35612	0.31474,0.30622,0.07368,0.40508,0.20793	9221,	31674	90614	0.1310	0.76			/3.8>4.0/0.0>0.0		LYST|0.01|0.00|0.00|0.00|-3|4|-3|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235758928	235758928	T	C	het	wt	het	off-target	QUAL=2279;DP=141,28,43;AF=0.56,0.04,0.44;MQM=60;SAP=218;ABP=5;SAR=0;SAF=99	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254935 [benign DISEASE=not specified,not provided];			rs3738519	0.29689	0.41669,0.22399,0.01927,0.27078,0.16272	7328,	30461	106847	-3.8310	0.03			/3.8>5.4/0.0>0.0		LYST|0.00|0.00|0.00|0.00|43|44|44|38	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235765937	235765937	A	G	hom	het	hom	off-target	QUAL=4256;DP=98,22,35;AF=0.99,0.55,1.00;MQM=60;SAP=316;ABP=3;SAR=0;SAF=144	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron21/52:c.6121+142T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1287899 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs12565325	0.40649	0.49520,0.33217,0.06267,0.40899,0.19602	13233,	35210	90052	-0.1930	1.14			/0.0>0.0/0.0>0.0	COSV67705039	LYST|0.02|0.00|0.00|0.00|12|-13|12|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235770048	235770048	-	A	het	het	het	off-target	QUAL=387;DP=33,6,4;AF=0.45,0.50,0.50;MQM=59;SAP=46;ABP=3;SAR=0;SAF=20	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron20/52:c.5922+111dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1286384 [benign DISEASE=not provided];			rs11443965	0.16119	0.24494,0.13149,0.04524,0.14250,0.03584	2034,	19213	121155		3.89			/10.4>10.4/0.0>0.0	COSV67714644	LYST|0.06|0.00|0.00|0.00|-15|2|-15|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235777150	235777150	C	T	hom	het	hom		QUAL=17707;DP=241,203,237;AF=1.00,0.43,1.00;MQM=60;SAP=223;ABP=12;SAR=162;SAF=401	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254927 [benign DISEASE=not specified,not provided,Chediak-Higashi syndrome];			rs2273584	0.40418	0.49289,0.32685,0.06264,0.40745,0.18900	13083,	35163	90409	0.6210	6.01			/1.0>0.0/0.0>0.0	COSV67705051	LYST|0.00|0.00|0.00|0.00|-35|45|36|-34	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781886	235781886	G	A	het	het	het	off-target	QUAL=4565;DP=135,93,153;AF=0.44,0.54,0.51;MQM=60;SAP=169;ABP=3;SAR=34;SAF=154	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254924 [benign DISEASE=not specified,not provided];		AluJo (SINE/Alu)	rs72763416	0.10697	0.07068,0.10593,0.04334,0.13743,0.03318	971,	14312	135698	-0.9540	0.38			/0.0>0.0/0.0>0.0	COSV67705060	LYST|0.00|0.00|0.00|0.01|6|-6|41|-6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781994	235781994	T	C	hom	het	hom		QUAL=15483;DP=184,150,232;AF=0.99,0.51,1.00;MQM=60;SAP=5;ABP=3;SAR=255;SAF=235	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254923 [benign DISEASE=not specified,Chediak-Higashi syndrome,not provided];			rs6696123	0.40498	0.49434,0.32643,0.06308,0.40782,0.19578	13154,	35190	90358	-0.3850	2.91			/2.8>4.4/0.0>0.0	COSV67705068	LYST|0.00|0.00|0.00|0.00|-11|48|50|3	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235782202	235782202	A	G	hom	het	hom	off-target	QUAL=1979;DP=58,8,8;AF=1.00,0.50,1.00;MQM=57;SAP=155;ABP=3;SAR=70;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron14/52:c.4863-115T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684345 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs2011390	0.80307	0.89827,0.76412,0.84170,0.75685,0.77207	48436,	23204	29446	-1.8820	0.53			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|10|-23|-33|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235791850	235791850	G	A	wt	wt	het		QUAL=6557;DP=590,414,524;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4;SAR=115;SAF=138	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254921 [benign/likely benign DISEASE=not provided,not specified,Chediak-Higashi syndrome];			rs11583387	0.09077	0.06418,0.09211,0.04325,0.11283,0.03144	711,	12387	138325	3.0790	8.58			/2.1>2.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|-22|31|7|-22	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235800154	235800154	C	A	het	het	het	off-target	QUAL=1056;DP=63,11,23;AF=0.52,0.45,0.39;MQM=60;SAP=105;ABP=3;SAR=0;SAF=47	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron10/52:c.4006+166G>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1251917 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs72763422	0.10679	0.06981,0.10536,0.04329,0.13756,0.03316	956,	14146	134316	-0.4020	1.64			/0.0>0.6/0.0>0.0	COSV67705088	LYST|0.00|0.00|0.00|0.00|-35|-26|-38|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235800584	235800584	C	T	hom	n/a	n/a	off-target	QUAL=1358;DP=43,2,0;AF=1.00,0.50,;MQM=60;SAP=67;ABP=3;SAR=40;SAF=4	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron9/52:c.3940-198G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1265120 [benign DISEASE=not provided];			rs7552221	0.40508	0.49416,0.32701,0.06257,0.40783,0.19576	13127,	35201	90257	-1.1150	0.24			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|-2|-22|-2|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235806982	235806982	A	G	het	het	het	off-target	QUAL=1330;DP=116,4,6;AF=0.47,0.25,0.83;MQM=60;SAP=133;ABP=4;SAR=60;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron5/52:c.2364-210T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1222779 [benign DISEASE=not provided];			rs41315862	0.10863	0.07544,0.10721,0.04360,0.13801,0.03337	997,	14529	135575	1.0580	5.78			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|25|0|-20|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235808463	235808463	A	G	het	het	het		QUAL=8440;DP=201,197,270;AF=0.53,0.51,0.51;MQM=60;SAP=53;ABP=5;SAR=128;SAF=217	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254915 [benign/likely benign DISEASE=not specified,not provided,Chediak-Higashi syndrome];			rs3768066	0.10733	0.07099,0.10576,0.04352,0.13808,0.03378	975,	14305	135199	-0.0390	6.68			/6.0>6.5/0.0>0.0		LYST|0.00|0.00|0.07|0.01|41|-9|-8|24	25741868,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809135	235809135	T	C	hom	het	hom		QUAL=27853;DP=482,198,287;AF=0.99,0.52,1.00;MQM=60;SAP=24;ABP=3;SAR=388;SAF=480	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254912 [benign DISEASE=not provided,not specified,Chediak-Higashi syndrome];			rs3820553	0.40516	0.49451,0.32785,0.06264,0.40809,0.19481	13166,	35199	90337	-0.4290	0.53			/4.1>4.9/0.0>0.0	COSV67705097	LYST|0.00|0.00|0.00|0.00|28|-4|46|28	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809567	235809567	T	C	hom	het	hom		QUAL=27986;DP=456,190,307;AF=1.00,0.56,0.99;MQM=60;SAP=22;ABP=10;SAR=476;SAF=390	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs1063128	0.40538	0.49467,0.32787,0.06231,0.40820,0.19585	13165,	35203	90257	-0.0510	4.14			/6.9>8.3/0.0>0.0	COSV67705101	LYST|0.00|0.00|0.00|0.00|-1|-8|-1|-8	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235866977	235866977	C	G	n/a	n/a	het	off-target	QUAL=30;DP=0,1,6;AF=,0.00,0.50;MQM=60;SAP=4;ABP=3;SAR=2;SAF=1	LYST	intron	LYST:ENST00000697181.1:intron_variant:MODIFIER:intron1/3:c.-98+16210G>C::,LYST:ENST00000697182.1:intron_variant:MODIFIER:intron1/2:c.-98+16210G>C::,LYST:ENST00000468107.5:intron_variant:MODIFIER:intron1/3:c.-98+16210G>C::	regulatory_region_variant:promoter	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs3820556	0.08758	0.02531,0.09674,0.04523,0.12465,0.03373	745,	11817	138639	0.7070	16.17			/0.0>0.0/0.2>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236394471	236394471	G	A	hom	hom	hom		QUAL=24570;DP=251,225,289;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0;SAR=477;SAF=288	EDARADD	intron,missense	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14745G>A::,EDARADD:ENST00000334232.9:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,not specified,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs966365	0.76643	0.55150,0.85786,0.91898,0.84079,0.91698	46074,	24391	35515	-0.0690	9.15	0.13	0.19	/0.0>0.0/0.0>1.3	COSV62061862	EDARADD|0.00|0.00|0.00|0.07|34|-16|38|34	25741868,18466582,31452656	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236394628	236394628	G	A	hom	hom	hom	off-target	QUAL=5071;DP=94,33,41;AF=1.00,1.00,1.00;MQM=60;SAP=368;ABP=0;SAR=168;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14588G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.61+123G>A::	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	439637 [benign DISEASE=not specified,not provided];			rs966364	0.76225	0.53694,0.85625,0.91923,0.84085,0.91653	45725,	24443	36147	0.3730	4.73			/1.8>1.1/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|31|-4|-26|-30	17160898	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409069	236409069	A	-	het	het	het	off-target	QUAL=715;DP=56,19,13;AF=0.23,0.42,0.31;MQM=60;SAP=49;ABP=39;SAR=1;SAF=24	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-129del::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-129del::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-129del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs772223735	0.00430	0.00270,0.00367,0.00227,0.00248,0.02515	1,	553	128541	0.3360	0.47			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|21|20|22|27		107	967	0	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409089	236409089	G	A	hom	hom	hom	off-target	QUAL=715;DP=56,19,13;AF=0.23,0.42,0.31;MQM=60;SAP=42;ABP=70;SAR=0;SAF=18	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-127G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-127G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-127G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295882 [benign DISEASE=not provided];			rs659901	0.67690	0.67001,0.67894,0.37324,0.69968,0.67294	34655,	32057	48385	-0.9900	0.10			/0.0>0.0/4.3>6.4	COSV62066165	EDARADD|0.00|0.00|0.02|0.00|1|-1|1|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409175	236409175	A	G	het	hom	het	off-target	QUAL=10270;DP=180,172,161;AF=0.50,1.00,0.55;MQM=60;SAP=69;ABP=5;SAR=124;SAF=227	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-41A>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-41A>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255368 [benign DISEASE=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,not provided];			rs669710	0.53312	0.47961,0.48758,0.26322,0.58979,0.49274	22044,	36820	70854	0.2780	4.54			/3.7>3.9/0.0>0.4	COSV62061755	EDARADD|0.00|0.00|0.00|0.00|1|41|0|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414461	236414461	T	C	het	hom	het	off-target	QUAL=1817;DP=44,13,14;AF=0.45,1.00,0.36;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+162T>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+162T>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+162T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295767 [benign DISEASE=not provided];			rs625444	0.66205	0.50155,0.64454,0.56030,0.70563,0.66356	17402,	32819	34519	0.2880	3.93			/8.1>7.9/0.0>0.0	COSV105889711	EDARADD|0.00|0.00|0.00|0.00|35|14|-5|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414462	236414462	-	T	het	wt	het	off-target	QUAL=1817;DP=44,13,14;AF=0.45,1.00,0.36;MQM=60;SAP=72;ABP=4;SAR=32;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+169dup::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+169dup::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+169dup::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1278018 [benign DISEASE=not provided];			rs61021118	0.54800	0.78969,0.54935,0.77187,0.41297,0.51043	24949,	33342	68658		0.85			/8.1>8.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|13|-25|11|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414462	236414462	C	T	het	hom	het	off-target	QUAL=1817;DP=44,13,14;AF=0.52,0.00,0.64;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+163C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+163C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+163C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1290224 [benign DISEASE=not provided];			rs625443	0.44575	0.18845,0.44860,0.22803,0.58692,0.48896	17454,	32822	84216	-0.4690	0.64			/8.1>8.3/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|13|-14|4|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414500	236414500	G	A	het	hom	het	off-target	QUAL=562;DP=43,6,6;AF=0.40,1.00,0.33;MQM=60;SAP=57;ABP=8;SAR=25;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+201G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+201G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+201G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295803 [benign DISEASE=not provided];			rs665150	0.43668	0.15618,0.44576,0.22810,0.58685,0.48860	17193,	31951	85575	0.4660	3.32			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|46|-25|-27|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427197	236427197	C	G	het	hom	het	off-target	QUAL=1029;DP=54,13,33;AF=0.43,1.00,0.36;MQM=60;SAP=107;ABP=10;SAR=0;SAF=48	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-195C>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-195C>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-195C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1224591 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs1759388	0.47912	0.29986,0.46129,0.22964,0.58817,0.47077	18766,	35218	79090	-2.2650	0.07			/0.7>2.5/0.5>0.7	COSV62063292	EDARADD|0.00|0.00|0.00|0.00|0|3|-21|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427263	236427263	C	T	het	hom	het	off-target	QUAL=2662;DP=96,33,77;AF=0.44,1.00,0.44;MQM=60;SAP=240;ABP=9;SAR=0;SAF=109	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-129C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-129C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-129C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295875 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs1778861	0.44958	0.19657,0.45215,0.22950,0.58773,0.47055	17640,	33011	83609	1.0310	6.49			/7.4>7.3/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|17|-6|31|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427329	236427329	C	T	het	hom	het	off-target	QUAL=5893;DP=122,77,140;AF=0.52,1.00,0.51;MQM=60;SAP=136;ABP=4;SAR=49;SAF=163	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-63C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-63C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-63C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1237172 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs636378	0.44932	0.19624,0.45205,0.22991,0.58770,0.47091	17602,	32936	83510	-0.1690	1.79			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|5|-11|-35|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427359	236427359	G	C	het	hom	het	off-target	QUAL=6544;DP=150,90,154;AF=0.51,0.99,0.51;MQM=60;SAP=85;ABP=3;SAR=74;SAF=170	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-33G>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-33G>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255369 [benign DISEASE=Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not provided];		(T)n (Simple_repeat)	rs636048	0.44890	0.19688,0.45232,0.23050,0.58691,0.46640	17437,	32889	83191	0.8960	5.45			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|39|-41|33|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427516	236427516	T	G	het	hom	het	off-target	QUAL=3800;DP=118,42,74;AF=0.50,1.00,0.55;MQM=60;SAP=168;ABP=4;SAR=123;SAF=19	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron4/5:c.153+66T>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron4/5:c.219+66T>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron4/5:c.189+66T>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1222286 [benign DISEASE=not provided];			rs635487	0.47875	0.29927,0.46134,0.22909,0.58801,0.47098	18735,	35244	79170	0.7230	7.04			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|-32|7|-32|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236482115	236482115	A	-	het	het	wt	off-target	QUAL=180;DP=31,16,12;AF=0.13,0.25,0.00;MQM=60;SAP=20;ABP=47;SAR=0;SAF=8	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron5/5:c.200-136del::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron5/5:c.266-136del::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron5/5:c.236-136del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluYk3 (SINE/Alu)	rs374553103	0.04018	0.10796,0.02348,0.06992,0.00652,0.00532	69,	2806	70332	2.3530	1.95			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|-27|3|17|6		54	249	0	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236482140	236482140	C	T	wt	wt	hom	off-target	QUAL=180;DP=31,16,12;AF=0.13,0.25,0.00;MQM=60;SAP=27;ABP=60;SAR=0;SAF=11	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron5/5:c.200-127C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron5/5:c.266-127C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron5/5:c.236-127C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1247629 [benign DISEASE=not provided];			rs603158	0.66244	0.66776,0.59765,0.41735,0.68522,0.66917	33216,	33195	50767	-0.1690	0.25			/0.0>0.1/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|46|-7|-2|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236482370	236482370	C	T	wt	wt	het		QUAL=5227;DP=211,357,481;AF=0.00,0.01,0.44;MQM=60;SAP=4;ABP=18;SAR=113;SAF=104	EDARADD	synonymous	EDARADD:ENST00000637660.1:synonymous_variant:LOW:exon6/6:c.303C>T:p.Asp101=:,EDARADD:ENST00000334232.9:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362.6:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262602 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,not provided,Hypohidrotic Ectodermal Dysplasia, Recessive,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not specified];			rs604070	0.18475	0.07564,0.15288,0.09203,0.25035,0.14132	3128,	21811	123855	0.1980	4.39			/0.0>0.0/0.0>0.0	COSV62061161	EDARADD|0.00|0.00|0.00|0.00|-1|-11|0|36	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484211	236484211	T	C	het	het	hom		QUAL=13061;DP=277,142,225;AF=0.53,0.49,1.00;MQM=60;SAP=16;ABP=4;SAR=247;SAF=195	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296476 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,not provided,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs7513402	0.31399	0.23060,0.32944,0.10772,0.36789,0.33872	8022,	31665	104237	-1.7820	3.08			/2.5>1.6/0.0>0.0	COSV62064204			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484250	236484250	C	G	het	het	hom		QUAL=13852;DP=329,127,225;AF=0.54,0.53,1.00;MQM=60;SAP=3;ABP=9;SAR=236;SAF=234	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296479 [benign/likely benign DISEASE=not provided,Hypohidrotic Ectodermal Dysplasia, Recessive,Hypohidrotic ectodermal dysplasia];			rs3916983	0.23261	0.15335,0.26865,0.10420,0.27789,0.27314	4538,	26285	116657	0.7020	3.23			/0.0>0.0/0.0>0.0	COSV62063742			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484436	236484436	C	T	het	het	hom		QUAL=7203;DP=155,73,129;AF=0.55,0.53,0.99;MQM=60;SAP=3;ABP=7;SAR=125;SAF=127	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296481 [benign/likely benign DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive,Hypohidrotic ectodermal dysplasia,not provided];			rs6428955	0.17863	0.06242,0.20172,0.05191,0.24127,0.22712	2989,	21142	124706	-0.0630	0.74			/0.0>0.0/0.4>0.0	COSV62066249			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484708	236484708	G	-	het	het	wt	low_conf_region	QUAL=141;DP=14,13,19;AF=0.21,0.15,0.42;MQM=59;SAP=25;ABP=7;SAR=10;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296489 [uncertain significance DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];		AluSc (SINE/Alu)	rs886046200	0.00009	0.00004,0.00000,0.00000,0.00013,0.00000	0,	9	99393	-4.5470	0.09			/0.0>0.0/0.0>0.0				1	5	0	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484709	A	-	wt	wt	het		QUAL=141;DP=14,13,19;AF=0.21,0.15,0.42;MQM=60;SAP=27;ABP=30;SAR=11;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1270976 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs11358746	0.46145	0.28749,0.43525,0.15242,0.56708,0.45082	12220,	30321	63911	-2.6210	0.09			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484710	AA	-	het	wt	het		QUAL=141;DP=14,13,19;AF=0.29,0.46,0.00;MQM=60;SAP=31;ABP=22;SAR=13;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluSc (SINE/Alu)	rs11358746	0.00086	0.00029,0.00135,0.00000,0.00080,0.00056	0,	102	118614	-2.3440	0.11			/0.0>0.0/0.0>0.0				4	42	0	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236795232	236795232	G	T	het	het	hom	off-target	QUAL=1134;DP=15,23,29;AF=0.47,0.48,1.00;MQM=60;SAP=105;ABP=3;SAR=0;SAF=47	MTR	upstream_gene	MTR:ENST00000366577.10:upstream_gene_variant:MODIFIER::::,MTR:ENST00000674797.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.6:upstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1249677 [benign DISEASE=not provided];	CR1417888 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];		rs28372871	0.46331	0.53464,0.47307,0.48589,0.42603,0.41294	16574,	37249	81547	-0.5370	2.91						27808252,32819312,35334827	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236808886	236808886	A	G	het	het	wt	off-target	QUAL=4795;DP=204,168,220;AF=0.50,0.54,0.01;MQM=60;SAP=344;ABP=4;SAR=185;SAF=10	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron4/32:c.409+113A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron3/31:c.61+113A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron4/30:c.409+113A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron4/29:c.409+113A>G::	regulatory_region_variant:enhancer	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1232929 [benign DISEASE=not provided];			rs12759827	0.18278	0.05293,0.19962,0.00115,0.26972,0.06255	3384,	21022	124254	-0.5500	0.83			/0.0>0.0/0.0>0.3		MTR|0.00|0.00|0.00|0.00|-34|31|22|-6	18381459,21274745,23940529,22941668,29763473,33499176	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236815692	236815692	-	TCTG	het	het	het	off-target;low_conf_region	QUAL=7165;DP=161,111,173;AF=0.46,0.49,0.90;MQM=60;SAP=79;ABP=77;SAR=192;SAF=92	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.321+32_321+33insGTCT::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.669+32_669+33insGTCT::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.669+32_669+33insGTCT::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1263040 [benign DISEASE=not provided];			rs5781924	0.72240	0.91466,0.67722,0.81553,0.62967,0.73732	40879,	27766	42088		2.49			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.03|0.00|-29|-23|-29|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236816297	236816297	A	G	het	het	hom	off-target	QUAL=1494;DP=60,13,19;AF=0.55,0.54,1.00;MQM=60;SAP=131;ABP=4;SAR=0;SAF=59	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.670-152A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.322-152A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.670-152A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.670-152A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1241010 [benign DISEASE=not provided];			rs3795708	0.35007	0.20754,0.40839,0.40409,0.40952,0.30257	10062,	33041	98707	-2.4980	0.01			/7.9>8.2/0.0>0.0	COSV63969853	MTR|0.00|0.00|0.00|0.00|48|-26|48|-14	25598430	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236825293	236825293	-	T	het	het	hom	off-target	QUAL=3955;DP=138,36,48;AF=0.57,0.67,1.00;MQM=60;SAP=211;ABP=14;SAR=15;SAF=135	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron8/31:c.518-40dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron9/30:c.866-40dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron9/29:c.866-40dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1236260 [benign DISEASE=not provided];			rs5781926	0.34680	0.20767,0.40235,0.40089,0.40900,0.29300	9854,	32834	98962		0.79			/3.0>4.5/0.0>0.0		MTR|0.00|0.00|0.00|0.00|9|45|45|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236826841	236826841	G	A	wt	het	wt		QUAL=1793;DP=296,153,221;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=4;SAR=38;SAF=35	MTR	missense	MTR:ENST00000366577.10:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000674797.2:missense_variant:MODERATE:exon10/32:c.592G>A:p.Asp198Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000535889.6:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000679842.1:missense_variant:MODERATE:exon11/31:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681102.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681177.1:missense_variant:MODERATE:exon11/30:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296556 [benign DISEASE=not specified,Methylcobalamin deficiency type cblG,not provided,Disorders of Intracellular Cobalamin Metabolism];			rs2229274	0.01815	0.00927,0.01932,0.00000,0.02349,0.00393	30,	2702	149382	4.1030	22.50	0.12	0.15	/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|19|-12|-12|30	19112534	23	1279	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838626	236838626	A	G	het	het	hom	off-target	QUAL=12894;DP=177,180,256;AF=0.51,0.51,1.00;MQM=60;SAP=492;ABP=3;SAR=376;SAF=62	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+27A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+27A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+27A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278171 [benign DISEASE=not provided];			rs3820568	0.35585	0.21177,0.41334,0.43257,0.41379,0.29561	10400,	33289	97911	-0.9150	0.09			/7.0>8.1/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-26|-27|13|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838732	236838732	A	C	het	het	hom	off-target	QUAL=6702;DP=305,56,85;AF=0.47,0.64,1.00;MQM=60;SAP=574;ABP=3;SAR=263;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+133A>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+133A>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+133A>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+133A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1178281 [benign DISEASE=not provided];		(ATATAC)n (Simple_repeat)	rs55748381	0.35584	0.21190,0.41291,0.43484,0.41384,0.29569	10387,	33292	97872	0.5030	2.62			/0.0>0.0/0.0>3.1	COSV63964088	MTR|0.00|0.00|0.00|0.00|26|2|-35|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236850615	236850617	TGA	-	het	het	hom	off-target	QUAL=2676;DP=54,42,56;AF=0.57,0.48,0.98;MQM=60;SAP=233;ABP=4;SAR=106;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1695+95_1695+97del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1347+95_1347+97del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1695+95_1695+97del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1695+95_1695+97del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-1903_1516-1901del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-9215_1516-9213del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1229225 [benign DISEASE=not provided];			rs35913043	0.46964	0.52910,0.47505,0.66037,0.43289,0.40593	17048,	36977	80261	0.6900	2.72			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|28|3|22|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236852328	236852328	C	T	het	het	hom	off-target	QUAL=767;DP=60,3,4;AF=0.45,0.33,1.00;MQM=60;SAP=72;ABP=5;SAR=0;SAF=32	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1696-193C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1348-193C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1696-193C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1696-193C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-193C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-7505C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1262193 [benign DISEASE=not provided];			rs2275568	0.42561	0.40503,0.45559,0.45795,0.43204,0.38322	13917,	36667	87047	0.0500	1.34			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|36|-32|-18|30	19834535,29445423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860033	236860033	T	C	het	het	hom	off-target	QUAL=4795;DP=67,77,98;AF=0.57,0.60,1.00;MQM=60;SAP=279;ABP=12;SAR=167;SAF=15	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+111T>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+111T>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+111T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+111T>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+111T>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+111T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1183329 [benign DISEASE=not provided];			rs10925254	0.65360	0.68809,0.65824,0.63086,0.63448,0.72950	28858,	29054	45988	1.0330	7.87			/0.0>0.0/0.0>0.0	COSV63965200	MTR|0.00|0.00|0.00|0.00|13|34|-1|12	32492698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860070	236860077	CCCCCCCC	-	n/a	hom	hom	off-target;low_conf_region	QUAL=60;DP=0,6,7;AF=,0.50,0.71;MQM=60;SAP=20;ABP=0;SAR=8;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+161_2043+168del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+161_1695+168del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+161_2043+168del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+161_2043+168del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+161_1863+168del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+161_1605+168del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			(C)n (Simple_repeat)	rs59525673	0.27527	0.24198,0.29951,0.25740,0.28276,0.47010	341,	11263	31449	0.0960	0.44			/9.5>9.5/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-25|41|-41|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860094	236860094	A	G	n/a	hom	hom	off-target	QUAL=60;DP=0,6,7;AF=,0.50,0.71;MQM=60;SAP=20;ABP=0;SAR=8;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+172A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+172A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+172A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+172A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+172A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+172A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1290727 [benign DISEASE=not provided];		MER20 (DNA/hAT-Charlie)	rs45534439	0.44689	0.25715,0.50845,0.57151,0.50996,0.33142	4834,	17727	33907	-0.9390	0.74			/8.2>8.6/0.0>0.0	COSV63966199	MTR|0.00|0.00|0.00|0.00|16|4|-49|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874528	236874528	G	A	het	n/a	hom	off-target	QUAL=536;DP=32,0,3;AF=0.63,,1.00;MQM=48;SAP=53;ABP=7;SAR=0;SAF=23	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-198G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-198G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-198G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6227G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-198G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-198G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1286676 [benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs4659737	0.64527	0.67511,0.64223,0.61325,0.62947,0.70809	31530,	33954	53332	-1.7780	0.41			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|16|-5|27|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874553	236874553	C	A	hom	n/a	hom	off-target	QUAL=1476;DP=43,0,7;AF=1.00,,1.00;MQM=53;SAP=112;ABP=0;SAR=0;SAF=50	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-173C>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-173C>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-173C>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6202C>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-173C>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-173C>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1246495 [benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs2712831	0.99942	0.99807,0.99967,1.00000,0.99996,1.00000	75354,	88	88	-0.6200	1.26			/0.0>0.6/0.0>0.0		MTR|0.00|0.00|0.00|0.00|2|8|2|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874571	236874571	A	-	het	n/a	wt	off-target	QUAL=44;DP=32,2,9;AF=0.16,0.00,0.00;MQM=60;SAP=14;ABP=36;SAR=0;SAF=5	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-141del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-141del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-141del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6170del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-141del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-141del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs763802762	0.00328	0.00416,0.00354,0.00098,0.00190,0.00051	3,	385	118907	0.3080	0.46			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|17|37|42|37		2	122	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874699	236874699	T	-	het	het	hom	off-target;low_conf_region	QUAL=1458;DP=47,25,46;AF=0.30,0.48,0.74;MQM=60;SAP=12;ABP=15;SAR=22;SAF=38	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18del::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18del::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047del::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18del::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1220586 [benign DISEASE=Methylcobalamin deficiency type cblG,not provided];			rs150727404	0.64176	0.74696,0.63421,0.79688,0.58184,0.70165	30382,	32905	52287	0.3150	0.07			/2.2>1.9/0.0>0.0		MTR|0.00|0.00|0.00|0.00|20|46|28|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874708	236874708	T	A	het	het	hom	off-target;low_conf_region	QUAL=1458;DP=47,25,46;AF=0.30,0.48,0.74;MQM=60;SAP=12;ABP=15;SAR=22;SAF=38	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18T>A::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18T>A::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047T>A::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18T>A::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	378884 [benign DISEASE=not specified,Methylcobalamin deficiency type cblG];			rs10925256	0.45591	0.53414,0.46432,0.49792,0.41722,0.38880	12428,	35521	72055	-0.6490	1.12			0.0>0.0/2.2>1.9/0.0>0.0,/2.2>1.9/0.0>0.0	COSV63966075	MTR|0.00|0.03|0.00|0.00|36|18|18|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874861	236874861	T	C	het	het	wt	off-target	QUAL=2567;DP=81,127,168;AF=0.47,0.51,0.00;MQM=60;SAP=38;ABP=3;SAR=72;SAF=31	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron24/32:c.2594+15T>C::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron23/31:c.2246+15T>C::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron23/31:c.2441+15T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-5894T>C::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron23/31:c.2414+15T>C::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron21/29:c.2156+15T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138288 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,Methylcobalamin deficiency type cblG];			rs1770449	0.27562	0.08174,0.32305,0.18719,0.36856,0.27267	7111,	27690	110150	-0.1570	3.53			/0.0>0.0/0.0>0.0	COSV63964725	MTR|0.00|0.00|0.00|0.00|-30|-15|-15|-10	25741868,19493349,21254359,22496743,20180013,21743092,30911047,35802641,35495149	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236885262	236885262	G	A	het	het	hom	off-target	QUAL=11129;DP=332,114,149;AF=0.55,0.49,1.00;MQM=60;SAP=438;ABP=9;SAR=334;SAF=55	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2427+43G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2586+43G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2595+43G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2337+43G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1258762 [benign DISEASE=not provided];			rs2275566	0.71611	0.89393,0.67206,0.81424,0.63065,0.72620	40112,	28586	43136	-1.2850	0.29			/5.7>4.7/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-43|-42|-39|-43	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236886153	236886153	C	T	het	wt	het	off-target	QUAL=2037;DP=106,64,91;AF=0.47,0.00,0.56;MQM=60;SAP=222;ABP=3;SAR=0;SAF=101	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2776-139C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2428-139C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2623-139C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2587-139C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2596-139C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2338-139C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1187579 [likely benign DISEASE=not provided];			rs41295948	0.01555	0.00437,0.02356,0.00000,0.02352,0.00228	21,	2324	149818	-0.6570	1.24			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|30|-11|-16|24		19	572	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236889492	236889492	T	A	het	het	hom	off-target	QUAL=2707;DP=96,26,43;AF=0.51,0.46,1.00;MQM=60;SAP=229;ABP=3;SAR=104;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron28/32:c.3007+156T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron27/31:c.2659+156T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron27/31:c.2854+156T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron26/30:c.2818+156T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron27/31:c.2827+156T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron25/29:c.2569+156T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278175 [benign DISEASE=not provided];			rs3768150	0.69165	0.81075,0.66269,0.81554,0.62936,0.72480	37027,	31054	46860	-1.5090	0.04			/5.5>4.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|36|8|11|36	21274745,22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891269	236891269	A	G	het	het	hom		QUAL=7205;DP=100,101,145;AF=0.54,0.50,1.00;MQM=60;SAP=20;ABP=4;SAR=147;SAF=103	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon28/32:c.2796A>G:p.Ala932=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon27/31:c.2955A>G:p.Ala985=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon28/32:c.2964A>G:p.Ala988=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon26/30:c.2706A>G:p.Ala902=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138290 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,Methylcobalamin deficiency type cblG];			rs2229276	0.34730	0.19564,0.40134,0.44084,0.40664,0.30270	9993,	32777	99159	-1.1170	0.76			/4.4>3.2/0.0>0.0	COSV63966508	MTR|0.00|0.00|0.00|0.01|-29|2|48|-7	19493349,22496743,19683694,21960995,20718043,18842806,21597034,35334827	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891499	236891499	A	G	het	het	hom	off-target	QUAL=891;DP=44,11,17;AF=0.41,0.36,1.00;MQM=60;SAP=88;ABP=8;SAR=39;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3204+170A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2856+170A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3051+170A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3015+170A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3024+170A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2766+170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1235800 [benign DISEASE=not provided];			rs2282369	0.67835	0.82456,0.63762,0.75968,0.60954,0.63958	35812,	31445	48871	-1.8070	0.09			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|49|-44|-10|50	22941668,29763473,25950259	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236894308	236894308	G	A	het	het	hom	off-target	QUAL=7987;DP=97,140,175;AF=0.51,0.50,1.00;MQM=60;SAP=510;ABP=3;SAR=16;SAF=278	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2857-49G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3016-49G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3025-49G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2767-49G>A::	regulatory_region_variant:open_chromatin_region	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1270532 [benign DISEASE=not provided];			rs2297965	0.55966	0.45808,0.58460,0.55616,0.60219,0.60908	24176,	36537	66791	-0.5020	2.45			/0.0>0.0/0.0>0.0	COSV63966743	MTR|0.00|0.00|0.00|0.00|25|49|49|-16	22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895444	236895444	C	A	het	het	hom		QUAL=14627;DP=216,223,310;AF=0.50,0.46,1.00;MQM=60;SAP=11;ABP=4;SAR=282;SAF=239	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3144C>A:p.Arg1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3303C>A:p.Arg1101=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3312C>A:p.Arg1104=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3054C>A:p.Arg1018=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138283 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,Methylcobalamin deficiency type cblG];			rs12070777	0.34894	0.20214,0.40411,0.43210,0.40688,0.29664	10032,	32959	98933	0.0910	2.36			/0.0>0.0/0.0>0.0	COSV63966512	MTR|0.00|0.00|0.00|0.00|-27|45|8|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895528	236895528	C	T	wt	het	het		QUAL=4192;DP=136,168,182;AF=0.00,0.43,0.53;MQM=60;SAP=117;ABP=4;SAR=131;SAF=37	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3228C>T:p.Leu1076=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3387C>T:p.Leu1129=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3396C>T:p.Leu1132=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3138C>T:p.Leu1046=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138284 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,Methylcobalamin deficiency type cblG];			rs1131449	0.54438	0.45652,0.56027,0.55163,0.57843,0.60594	22891,	36890	69192	-3.3670	0.04			/0.0>0.0/0.0>0.0	COSV63964165	MTR|0.00|0.00|0.00|0.00|5|-39|5|22	19683694,20615890,21274745,21960995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895696	236895696	-	TATT	het	het	hom	off-target	QUAL=799;DP=87,12,8;AF=0.31,0.58,1.00;MQM=60;SAP=94;ABP=24;SAR=42;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron31/32:c.3598+147_3598+150dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron30/31:c.3250+147_3250+150dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron30/31:c.3445+147_3445+150dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron29/30:c.3409+147_3409+150dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron30/31:c.3418+147_3418+150dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron28/29:c.3160+147_3160+150dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1239035 [benign DISEASE=not provided];			rs75739277	0.71825	0.90953,0.66817,0.81499,0.62603,0.72699	40435,	28167	42773		1.97			/9.1>9.1/0.0>0.0		MTR|0.00|0.00|0.00|0.00|34|0|45|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897133	236897133	G	T	het	het	hom	off-target	QUAL=12444;DP=205,200,245;AF=0.42,0.50,0.99;MQM=60;SAP=228;ABP=9;SAR=320;SAF=109	MTR	splice_region&intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron32/32:c.3711+15G>T::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron31/31:c.3363+15G>T::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron31/31:c.3558+15G>T::,MTR:ENST00000679842.1:splice_region_variant&intron_variant:LOW:intron30/30:c.3522+15G>T::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron31/31:c.3531+15G>T::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron29/29:c.3273+15G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138285 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,Methylcobalamin deficiency type cblG];			rs3820571	0.70785	0.87720,0.66193,0.81359,0.62524,0.72582	39138,	29282	44392	-0.2020	0.40			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.08|0.00|-29|-15|-15|-4	19493349,23430981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897310	236897310	G	A	het	het	het	off-target;low_conf_region	QUAL=158;DP=47,11,11;AF=0.13,0.18,0.73;MQM=52;SAP=8;ABP=46;SAR=5;SAF=11	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron32/32:c.3711+192G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron31/31:c.3363+192G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron31/31:c.3558+192G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron30/30:c.3522+192G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron31/31:c.3531+192G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron29/29:c.3273+192G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			(CA)n (Simple_repeat)	rs12120433	0.00024	0.00033,0.00015,0.00000,0.00024,0.00055	0,	31	128579	0.0750	1.32			/0.0>0.0/0.0>0.0	COSV63964742	MTR|0.00|0.00|0.00|0.00|40|-46|-30|-46		750	5245	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897646	236897646	T	-	het	het	het	low_conf_region	QUAL=503;DP=154,73,119;AF=0.18,0.19,0.11;MQM=60;SAP=8;ABP=353;SAR=33;SAF=22	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296586 [likely benign(replaced by megSAP based on classifications:2x1,1x3) DISEASE=Disorders of Intracellular Cobalamin Metabolism,Methylcobalamin deficiency type cblG,not provided];		(T)n (Simple_repeat)	rs67705775	0.17985	0.19599,0.13667,0.08262,0.18673,0.19726	1955,	21471	115741	1.2650	10.14			/0.3>0.3/0.0>0.0		MTR|0.00|0.02|0.00|0.02|-5|44|-17|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897756	236897756	A	C	het	het	hom		QUAL=10730;DP=309,80,153;AF=0.54,0.53,1.00;MQM=60;SAP=18;ABP=8;SAR=156;SAF=206	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not provided];			rs2853522	0.56193	0.46401,0.58485,0.55728,0.60274,0.61514	24345,	36486	66402	-1.1490	3.07			/0.5>0.7/0.0>0.0		MTR|0.00|0.00|0.00|0.00|21|43|10|-22	22856873,30884202,33033524	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898405	236898405	T	-	het	het	hom		QUAL=2240;DP=102,29,38;AF=0.53,0.59,0.82;MQM=59;SAP=96;ABP=5;SAR=84;SAF=18	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs796166778	0.68107	0.84091,0.63771,0.80289,0.60299,0.70349	32753,	30219	44825	0.1060	0.92			/3.0>2.9/0.0>0.0		MTR|0.00|0.00|0.00|0.00|21|17|-32|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898549	236898549	G	A	het	het	wt		QUAL=1307;DP=82,34,66;AF=0.44,0.59,0.00;MQM=51;SAP=71;ABP=3;SAR=7;SAF=49	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];	CR1417889 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];	AluY (SINE/Alu)	rs1131450	0.28436	0.13441,0.32107,0.18726,0.35880,0.25199	6957,	29081	108207	0.1710	1.57			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-7|36|-7|46	27808252,32819312,35201488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898898	236898898	A	C	het	het	hom		QUAL=16908;DP=265,243,297;AF=0.55,0.47,1.00;MQM=60;SAP=15;ABP=4;SAR=250;SAF=306	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523	0.71919	0.91101,0.66922,0.81267,0.62663,0.72761	40590,	28101	42669	-0.2280	4.71			/2.3>2.1/0.0>0.0		MTR|0.08|0.03|0.00|0.00|31|-45|31|-45	21146954,22856873,18381459,23940529,20871623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236899005	236899005	A	G	het	het	hom		QUAL=22013;DP=414,295,370;AF=0.53,0.52,0.99;MQM=60;SAP=5;ABP=7;SAR=359;SAF=382	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993	0.71933	0.91099,0.66927,0.81315,0.62675,0.72756	40616,	28105	42661	-0.4520	1.96			/0.0>0.0/8.9>6.3		MTR|0.00|0.00|0.00|0.00|1|27|46|-4	19493349,21254359,22496743,18381459,19064578,20180013,21743092,30911047,23430981,35802641,35495149	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900035	236900035	G	C	het	het	hom		QUAL=12882;DP=227,207,221;AF=0.49,0.53,1.00;MQM=60;SAP=134;ABP=3;SAR=302;SAF=139	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996	0.68863	0.80835,0.65641,0.81669,0.62533,0.72648	36703,	31250	47322	-0.1630	3.37			/3.4>3.9/0.0>0.0		MTR|0.00|0.00|0.00|0.00|15|-18|-32|27	22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900204	236900204	A	G	het	het	hom		QUAL=11976;DP=379,107,148;AF=0.50,0.54,1.00;MQM=60;SAP=7;ABP=3;SAR=184;SAF=212	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.34592	0.20205,0.40211,0.43774,0.40438,0.29564	9841,	32861	99349	-1.1570	0.18			/0.7>0.6/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-26|27|-43|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900409	236900409	-	A	het	het	hom		QUAL=13780;DP=188,138,185;AF=0.41,0.42,0.94;MQM=60;SAP=3;ABP=22;SAR=155;SAF=155	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098	0.72608	0.74140,0.72316,0.63047,0.72161,0.75994	32750,	33321	37281		0.29			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|42|13|-6|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900418	236900419	AG	-	het	het	wt		QUAL=13780;DP=188,138,185;AF=0.41,0.42,0.94;MQM=60;SAP=11;ABP=4;SAR=97;SAF=72	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1553332314	0.27963	0.08706,0.33011,0.18397,0.37270,0.27218	7193,	27959	109089	0.5750	1.01			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|6|47|5|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236901326	236901326	T	G	het	het	hom		QUAL=33917;DP=421,513,671;AF=0.50,0.48,0.99;MQM=60;SAP=22;ABP=4;SAR=611;SAF=512	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866	0.56281	0.46859,0.58528,0.55523,0.60243,0.60975	24374,	36540	66252	1.5210	7.27			/2.0>0.4/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-36|-20|25|-20	21146954,19493349,18381459,21274745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902026	236902026	C	T	het	het	hom		QUAL=8157;DP=170,113,159;AF=0.55,0.47,1.00;MQM=60;SAP=137;ABP=4;SAR=84;SAF=221	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746	0.56841	0.48295,0.59102,0.55693,0.60338,0.60943	24904,	36500	65534	-0.6270	0.80			/0.0>0.0/3.4>0.3		MTR|0.00|0.00|0.00|0.00|24|-5|-45|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902283	236902283	G	T	het	het	hom		QUAL=13225;DP=220,175,256;AF=0.51,0.57,1.00;MQM=60;SAP=9;ABP=8;SAR=217;SAF=252	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264	0.71903	0.91075,0.66894,0.81352,0.62651,0.72686	40491,	28061	42611	-0.3300	0.95			/1.3>6.8/0.0>0.0		MTR|0.00|0.00|0.00|0.00|5|1|4|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902510	236902510	T	G	het	wt	het		QUAL=4893;DP=181,179,171;AF=0.53,0.00,0.55;MQM=60;SAP=146;ABP=8;SAR=151;SAF=39	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.01557	0.00439,0.02343,0.00000,0.02358,0.00228	21,	2328	149800	-0.3180	2.04			/2.0>1.5/0.0>1.1		MTR|0.00|0.00|0.00|0.00|-15|17|0|-3		9	425	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902814	236902814	A	G	het	het	wt		QUAL=3173;DP=157,85,113;AF=0.50,0.59,0.00;MQM=60;SAP=101;ABP=5;SAR=26;SAF=102	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.01969	0.00609,0.02134,0.00000,0.02730,0.00083	53,	2888	149098	0.5290	2.80			/3.3>0.1/0.0>3.9		MTR|0.00|0.00|0.00|0.00|1|-50|-5|-10		5	384	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240775321	240775321	G	A	het	n/a	n/a	off-target	QUAL=199;DP=17,0,0;AF=0.53,,;MQM=60;SAP=23;ABP=3;SAR=0;SAF=9	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7043C>T::						rs6700378	0.17204	0.33030,0.09776,0.13017,0.12003,0.10295	3022,	20106	125852	-2.3970	0.01			/4.3>4.0/0.0>0.0			20627871	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775804	240775804	G	A	het	hom	wt		QUAL=9113;DP=345,146,165;AF=0.48,0.99,0.00;MQM=60;SAP=178;ABP=4;SAR=76;SAF=234	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7526C>T::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*416C>T::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*359C>T::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::						rs35557904	0.17228	0.33079,0.09791,0.13007,0.12022,0.10290	3026,	20113	125711	0.6560	19.19			/0.0>0.0/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|11|48|22|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775852	240775852	A	G	het	hom	wt		QUAL=9499;DP=320,181,209;AF=0.44,0.99,0.00;MQM=60;SAP=88;ABP=13;SAR=104;SAF=216	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7574T>C::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*368T>C::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*311T>C::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::						rs16840577	0.17206	0.33042,0.09793,0.13017,0.12011,0.10278	3026,	20106	125870	2.4410	16.55			/0.0>0.1/0.0>0.0		RGS7|0.01|0.00|0.00|0.00|6|-46|6|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776091	240776091	C	T	het	het	wt		QUAL=12747;DP=505,550,687;AF=0.46,0.47,0.00;MQM=60;SAP=22;ABP=16;SAR=277;SAF=211	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7813G>A::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*129G>A::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*72G>A::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::						rs12757054	0.06099	0.03901,0.04584,0.02414,0.08228,0.08440	353,	8570	142814	1.5850	10.68			/0.0>1.4/0.0>0.0	COSV58544216	RGS7|0.00|0.00|0.00|0.00|-3|44|-48|-23	21698121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776374	240776374	T	C	het	hom	wt	off-target	QUAL=1259;DP=85,32,64;AF=0.38,0.97,0.00;MQM=60;SAP=140;ABP=14;SAR=63;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-8096A>G::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron14/14:c.*7-161A>G::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron16/16:c.1360-161A>G::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron15/15:c.*7-161A>G::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron13/13:c.*7-161A>G::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron19/19:c.1282-161A>G::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron15/15:c.1309-161A>G::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron16/16:c.1432-161A>G::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron15/15:c.1156-161A>G::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron15/15:c.1357-161A>G::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron15/15:c.1240-161A>G::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::					(CCTC)n (Simple_repeat)	rs3795681	0.16285	0.31450,0.09053,0.11883,0.11736,0.09469	2664,	18833	124203	0.4360	8.87			/0.0>0.0/2.5>1.9	COSV58530577	RGS7|0.00|0.00|0.00|0.00|-43|-6|-43|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240805960	240805960	A	-	wt	het	wt	off-target	QUAL=20;DP=14,6,7;AF=0.00,0.50,0.00;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron15/16:c.1269+180del::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron15/18:c.1269+180del::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron12/14:c.1110+180del::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron15/16:c.1269+180del::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron13/15:c.1110+180del::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron17/19:c.1191+180del::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron16/18:c.1191+180del::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron11/13:c.993+180del::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron17/19:c.1191+180del::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron18/19:c.1191+180del::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron14/15:c.1218+180del::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron15/16:c.1341+180del::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron13/16:c.1110+180del::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron14/16:c.1158+180del::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron14/15:c.1065+180del::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron14/15:c.1266+180del::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron14/15:c.1149+180del::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron16/17:c.1323+180del::						rs142377602	0.09261	0.22772,0.04710,0.10451,0.03680,0.02700	1197,	11684	137932	0.3760	0.30			/0.0>0.0/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|37|-23|37|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240811913	240811913	T	C	het	wt	hom		QUAL=11018;DP=255,201,238;AF=0.54,0.00,1.00;MQM=60;SAP=133;ABP=7;SAR=113;SAF=263	RGS7	splice_region&intron,intron	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:ENST00000348120.6:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000693043.1:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron10/13:c.806+5A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron17/19:c.1004+5A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1031+5A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1154+5A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron12/16:c.923+5A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron13/16:c.971+5A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1705A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1079+5A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron13/15:c.962+5A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::						rs2275742	0.47003	0.26012,0.42957,0.46276,0.57950,0.43005	18434,	34505	80475	0.2170	8.97			8.4>10.6/0.0>0.0/8.4>10.6,/0.0>0.0/8.4>10.6	COSV58534718	RGS7|0.00|0.00|0.02|0.00|32|5|5|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240812135	240812135	C	T	het	wt	hom	off-target	QUAL=4760;DP=172,66,94;AF=0.47,0.02,1.00;MQM=60;SAP=383;ABP=5;SAR=175;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron13/18:c.957-92G>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron10/14:c.798-92G>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron11/15:c.798-92G>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron14/18:c.879-92G>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron9/13:c.681-92G>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron16/19:c.879-92G>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron12/15:c.906-92G>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron13/16:c.1029-92G>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron11/16:c.798-92G>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.846-92G>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1483G>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron12/15:c.954-92G>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron12/15:c.837-92G>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::						rs2275744	0.47005	0.26002,0.42978,0.46328,0.57962,0.43109	18446,	34493	80481	0.1520	7.28			/0.0>0.0/0.0>0.0	COSV58543544	RGS7|0.00|0.00|0.00|0.00|18|22|-2|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814664	240814664	G	T	hom	het	hom	off-target	QUAL=9579;DP=169,64,108;AF=0.99,0.44,1.00;MQM=60;SAP=300;ABP=5;SAR=50;SAF=254	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron8/13:c.569+52C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron15/19:c.767+52C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron11/15:c.794+52C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron12/16:c.917+52C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron10/16:c.686+52C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron12/15:c.767+52C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron11/15:c.842+52C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron11/15:c.725+52C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::						rs12744536	0.61049	0.40591,0.58565,0.47900,0.72896,0.58351	29908,	32951	59187	-1.0950	0.01			/0.0>0.0/0.0>0.0	COSV58534726	RGS7|0.00|0.00|0.00|0.00|-48|-20|48|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814977	240814977	T	-	wt	het	wt	off-target	QUAL=54;DP=78,11,16;AF=0.00,0.55,0.00;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron11/18:c.784-200del::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron8/14:c.625-200del::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron9/15:c.625-200del::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron13/19:c.706-200del::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron12/18:c.706-200del::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron7/13:c.508-200del::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron13/19:c.706-200del::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron14/19:c.706-200del::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron10/15:c.733-200del::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron11/16:c.856-200del::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron9/16:c.625-200del::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron11/15:c.706-200del::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron10/15:c.781-200del::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-221del::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron11/17:c.784-200del::						rs199649548	0.04411	0.04341,0.02677,0.10204,0.04497,0.02711	148,	6416	145470	0.0080	0.14			/2.8>2.8/0.0>0.0	COSV58541930	RGS7|0.00|0.00|0.00|0.00|-48|38|40|5		13	218	0	0 / 0					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816503	240816503	G	A	hom	hom	hom	off-target	QUAL=8679;DP=180,39,56;AF=1.00,1.00,1.00;MQM=60;SAP=525;ABP=0;SAR=266;SAF=9	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-88C>T::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-88C>T::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-88C>T::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-88C>T::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-88C>T::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-88C>T::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-88C>T::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-88C>T::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-88C>T::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-88C>T::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-88C>T::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1747C>T::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::						rs3738068	0.75691	0.79788,0.65596,0.58894,0.77593,0.63691	43877,	27329	36961	-2.2010	0.00			/4.2>3.8/0.0>0.0	COSV58537200	RGS7|0.00|0.00|0.00|0.00|-28|-15|21|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816570	240816570	A	T	het	hom	wt	off-target	QUAL=792;DP=54,11,14;AF=0.44,1.00,0.00;MQM=60;SAP=79;ABP=4;SAR=35;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-155T>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-155T>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-155T>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-155T>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-155T>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-155T>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-155T>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-155T>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-155T>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-155T>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-155T>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1814T>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::						rs3738069	0.21100	0.27692,0.19802,0.11985,0.19579,0.17832	3597,	24892	119984	0.9480	5.37			/5.0>4.4/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|-35|-11|-38|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240870308	240870308	C	T	wt	wt	het	off-target	QUAL=34;DP=68,7,12;AF=0.00,0.00,0.42;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron6/18:c.386-189G>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.227-189G>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.227-189G>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron8/19:c.308-189G>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron7/18:c.308-189G>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron5/13:c.334-43136G>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron8/19:c.308-189G>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron9/19:c.308-189G>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron5/15:c.335-189G>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.227-189G>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron6/15:c.308-189G>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron6/15:c.386-189G>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron6/15:c.386-189G>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron6/17:c.386-189G>A::						rs261800	0.35754	0.50827,0.23598,0.18709,0.31507,0.28108	10511,	33207	97445	-0.6470	0.34			/5.2>5.5/2.3>0.0		RGS7|0.00|0.00|0.00|0.00|-32|1|28|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240936822	240936822	G	T	hom	het	hom	off-target	QUAL=1546;DP=39,8,10;AF=0.97,0.75,1.00;MQM=60;SAP=112;ABP=7;SAR=53;SAF=1	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.227-116C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+46257C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+46257C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.149-116C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.227-116C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.149-116C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-116C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+46257C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.149-116C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::					LTR10B1 (LTR/ERV1)	rs261857	0.39381	0.28224,0.45907,0.25609,0.43530,0.37573	12295,	35262	92132	-1.4410	7.91			/0.0>0.0/0.0>0.0	COSV58539328	RGS7|0.00|0.00|0.00|0.00|0|-33|3|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240983022	240983022	A	G	het	wt	het	off-target	QUAL=4096;DP=215,57,82;AF=0.52,0.00,0.54;MQM=60;SAP=217;ABP=5;SAR=16;SAF=140	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.226+57T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.148+57T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-46316T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.148+57T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::						rs7520707	0.37099	0.31939,0.40793,0.28946,0.39690,0.39437	10701,	34971	95579	0.7580	3.57			/4.3>3.2/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|15|-35|49|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241355798	241355798	T	A	hom	hom	hom		QUAL=35477;DP=442,288,422;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=484;SAF=667	RGS7	5'UTR	RGS7:ENST00000690539.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000440928.6:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:ENST00000366563.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.5:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000693043.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000691979.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000685936.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-288A>T::,RGS7:ENST00000688703.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-218A>T::,RGS7:ENST00000689640.1:5_prime_UTR_variant:MODIFIER:exon2/14:c.-22A>T::,RGS7:ENST00000690614.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-562A>T::,RGS7:ENST00000687448.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-393A>T::,RGS7:ENST00000689602.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-216A>T::,RGS7:ENST00000691485.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-444A>T::,RGS7:ENST00000692410.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:ENST00000690019.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688633.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000689115.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000691989.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000686465.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-100A>T::,RGS7:ENST00000686908.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688737.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688863.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::						rs4659599	0.95555	0.87499,0.98042,0.99672,0.98743,0.98797	69621,	6092	6760	1.4650	12.93			/0.0>0.0/0.0>0.4		RGS7|0.00|0.00|0.00|0.00|47|-2|2|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356017	241356017	A	G	het	het	hom	off-target	QUAL=3313;DP=132,28,57;AF=0.47,0.39,1.00;MQM=60;SAP=285;ABP=6;SAR=130;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron1/18:c.-50-191T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron1/17:c.-160-81T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron1/19:c.-316-191T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron1/18:c.-246-191T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron1/13:c.-50-191T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron1/19:c.-590-191T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron1/19:c.-421-191T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron1/17:c.-244-191T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron1/17:c.-472-191T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron1/17:c.-232-191T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron1/15:c.-128-191T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::	regulatory_region_variant:promoter					rs6677041	0.84380	0.76535,0.82118,0.93599,0.88714,0.77769	54438,	19452	23756	0.9460	6.41			/0.0>0.0/0.0>0.0		RGS7|0.00|0.00|0.02|0.00|-27|-22|-27|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356888	241356888	T	C	n/a	hom	hom	off-target	QUAL=980;DP=0,17,16;AF=,1.00,1.00;MQM=60;SAP=14;ABP=0;SAR=10;SAF=23	RGS7	splice_region&intron	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron1/18:c.-51+11A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-161+11A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-317+11A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron1/18:c.-247+11A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron1/13:c.-51+11A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-591+11A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-422+11A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-245+11A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-473+11A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-233+11A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000686465.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-129+11A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::	regulatory_region_variant:promoter					rs1891130	0.95576	0.87587,0.98057,0.99682,0.98745,0.98798	69329,	6040	6698	-0.1090	15.45			/0.0>0.0/1.7>0.0		RGS7|0.00|0.00|0.00|0.00|41|-3|11|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241500602	241500602	-	GAGA	wt	het	het	off-target;low_conf_region	QUAL=1205;DP=4,60,95;AF=0.00,0.18,0.28;MQM=60;SAP=36;ABP=90;SAR=31;SAF=7	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-16_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-16_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296866 [likely benign(replaced by megSAP based on classifications:1x1,2x2,4x3) DISEASE=not provided,Hereditary cancer-predisposing syndrome,not specified,Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency];			rs144131869	0.25511	0.15233,0.31682,0.16956,0.29315,0.36780	4472,	25141	99523		0.08			/6.2>6.2/0.0>0.0		FH|0.04|0.00|0.00|0.00|-34|-12|45|-34	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGA	wt	het	wt	off-target;low_conf_region	QUAL=1205;DP=4,60,95;AF=0.00,0.00,0.25;MQM=60;SAP=22;ABP=195;SAR=16;SAF=3	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-18_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-18_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296867 [uncertain significance(replaced by megSAP based on classifications:1x1,4x3) DISEASE=not specified,not provided,Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency];			rs144131869	0.20220	0.17519,0.18843,0.17167,0.22584,0.21273	2678,	21638	106508		0.07			/6.2>6.2/0.0>0.0		FH|0.02|0.00|0.00|0.00|-38|-12|-6|-15	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGAGAGA	wt	wt	het	off-target;low_conf_region	QUAL=1205;DP=4,60,95;AF=0.00,0.20,0.07;MQM=60;SAP=16;ABP=54;SAR=18;SAF=6	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-22_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-22_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296869 [likely benign(replaced by megSAP based on classifications:2x1,3x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.04007	0.05730,0.02961,0.03495,0.03418,0.06235	146,	5058	128174		0.07			/6.2>6.2/0.0>0.0		FH|0.08|0.01|0.00|0.00|-34|-12|0|-34	24033266	57	521	0	0 / 0					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241503933	241503933	C	T	het	hom	het	off-target	QUAL=6089;DP=119,114,141;AF=0.49,1.00,0.49;MQM=60;SAP=526;ABP=3;SAR=0;SAF=241	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+109G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+109G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1270362 [benign DISEASE=not provided];			rs4660099	0.27389	0.10167,0.24967,0.20967,0.37203,0.23166	6754,	28155	110453	-1.7330	0.18			/0.0>0.3/0.0>0.0	COSV63818865	FH|0.00|0.01|0.00|0.00|-5|19|-36|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241503944	241503944	G	T	het	hom	het	off-target	QUAL=6480;DP=116,119,158;AF=0.48,1.00,0.48;MQM=60;SAP=548;ABP=4;SAR=0;SAF=251	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+98C>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+98C>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1264123 [benign DISEASE=not provided];			rs4659607	0.73728	0.78230,0.68884,0.56489,0.72480,0.84762	41503,	29159	39969	-0.6400	0.55			/4.6>0.4/0.0>0.0	COSV63818713	FH|0.01|0.01|0.00|0.00|8|-3|8|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241511819	241511819	G	C	het	hom	het	off-target	QUAL=1419;DP=84,14,14;AF=0.46,1.00,0.36;MQM=60;SAP=129;ABP=5;SAR=0;SAF=58	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron4/9:c.555+148C>G::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron4/8:c.555+148C>G::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1291013 [benign DISEASE=not provided];			rs6673988	0.33562	0.31375,0.26812,0.21103,0.37421,0.23340	8693,	33574	100880	0.4080	7.27			/0.0>0.0/0.0>1.6	COSV63819132	FH|0.00|0.00|0.00|0.00|31|4|1|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241513458	241513458	C	T	het	hom	het	off-target	QUAL=5564;DP=173,66,91;AF=0.60,1.00,0.46;MQM=60;SAP=463;ABP=9;SAR=0;SAF=212	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron3/9:c.378+145G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron3/8:c.378+145G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1181498 [benign DISEASE=not provided];			rs10926500	0.39951	0.43692,0.33025,0.35190,0.40027,0.32752	12181,	36278	91146	-0.0780	6.00			/0.0>0.0/0.0>0.0		FH|0.00|0.00|0.00|0.00|27|36|22|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247417907	247417907	T	C	het	het	het	off-target	QUAL=2995;DP=135,68,53;AF=0.50,0.46,0.51;MQM=60;SAP=277;ABP=3;SAR=0;SAF=126	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron1/10:c.-106-322T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron1/8:c.-748-146T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron1/9:c.-748-146T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs12137901	0.25810	0.33545,0.26481,0.29769,0.21749,0.20311	5328,	28580	112780	-0.9840	2.33			/1.0>0.6/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|-10|25|-10|-45	26722603,33922655,26662437,33015616,35428826	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418258	247418258	A	T	het	wt	het		QUAL=12727;DP=507,358,472;AF=0.51,0.00,0.52;MQM=60;SAP=54;ABP=4;SAR=306;SAF=197	NLRP3	5'UTR	NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-543A>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543A>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77A>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness];			rs116502550	0.00685	0.00068,0.00138,0.00000,0.00847,0.00084	13,	1009	149955	0.2370	6.13			/0.0>0.0/0.0>0.0		NLRP3|0.01|0.00|0.00|0.00|-29|-5|32|-29		2	222	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418390	247418390	T	C	hom	hom	hom		QUAL=17879;DP=269,161,169;AF=1.00,1.00,1.00;MQM=59;SAP=754;ABP=0;SAR=527;SAF=72	NLRP3	intron,5'UTR	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-411T>C::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-411T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-45+100T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296931 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness];		AluSx1 (SINE/Alu)	rs7523422	0.99784	0.99251,0.99908,1.00000,0.99996,1.00000	75709,	319	329	-2.9180	2.76			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|-7|7|-43|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418570	247418570	G	A	het	het	het		QUAL=5099;DP=217,68,85;AF=0.54,0.56,0.44;MQM=59;SAP=22;ABP=5;SAR=76;SAF=117	NLRP3	intron,5'UTR	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-231G>A::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-231G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-44-187G>A::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296932 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness];		AluSx1 (SINE/Alu)	rs138900557	0.03470	0.00714,0.01727,0.00135,0.05137,0.02173	139,	5002	146888	0.3990	4.10			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|21|-37|-33|21		2	47	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418761	247418761	G	T	het	het	het		QUAL=9849;DP=332,231,287;AF=0.48,0.41,0.50;MQM=60;SAP=29;ABP=11;SAR=164;SAF=233	NLRP3	5'UTR	NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-40G>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-40G>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000474792.2:5_prime_UTR_variant:MODIFIER:exon1/3:c.-40G>T::,NLRP3:ENST00000643234.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296937 [benign DISEASE=Autoinflammatory syndrome,Familial cold autoinflammatory syndrome 1,not provided,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs73136263	0.04367	0.03794,0.02146,0.00173,0.05153,0.02173	166,	6310	145470	-0.3700	2.48			/0.0>0.0/0.0>0.0		NLRP3|0.01|0.00|0.00|0.00|-4|-42|-6|42	33015616	59	1785	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424175	247424175	G	A	het	het	het		QUAL=6269;DP=163,152,191;AF=0.48,0.41,0.58;MQM=60;SAP=66;ABP=3;SAR=168;SAF=83	NLRP3	synonymous	NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	138528 [benign DISEASE=Keratitis fugax hereditaria,Cryopyrin associated periodic syndrome,not specified,not provided,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Familial cold autoinflammatory syndrome 1];			rs3806268	0.42053	0.11556,0.41037,0.54455,0.56093,0.55144	16379,	31050	87926	-2.2250	1.72			/0.0>0.0/0.0>0.0	COSV60221462	NLRP3|0.00|0.00|0.00|0.00|45|20|40|23	25741868,24033266,30131971,30123371,28116820,31467293,28847925,26722603,20940146,22318840,33922655,34354741,32313131,32576967,32499599,32871918,34390315,34791504,34830358,35313392,35428826,36105941,36057006,36051474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424229	247424229	A	G	hom	hom	hom		QUAL=14095;DP=154,118,163;AF=1.00,1.00,1.00;MQM=60;SAP=48;ABP=0;SAR=265;SAF=170	NLRP3	synonymous	NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	403243 [benign DISEASE=Keratitis fugax hereditaria,Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,not provided];			rs4925543	0.92851	0.85521,0.95219,0.99748,0.95839,0.88990	65724,	9700	10868	-0.0360	6.58			/0.0>0.4/0.0>1.4		NLRP3|0.00|0.00|0.00|0.00|4|2|-31|3	24033266,28847925,33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247425793	247425793	-	A	het	het	het	off-target	QUAL=1617;DP=89,54,61;AF=0.36,0.39,0.51;MQM=60;SAP=185;ABP=17;SAR=84;SAF=0	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron5/10:c.2150+204dup::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2150+204dup::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2150+204dup::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron3/7:c.2150+204dup::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron3/8:c.2150+204dup::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs369266215	0.03724	0.00792,0.01994,0.06435,0.05283,0.02617	148,	5270	143886		1.91			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.06|-18|-23|-28|-23		11	292	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433906	247433906	T	G	het	hom	n/a	off-target;low_conf_region	QUAL=1077;DP=95,15,0;AF=0.44,0.93,;MQM=43;SAP=125;ABP=6;SAR=0;SAF=56	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-197T>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-197T>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-197T>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-197T>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-197T>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-197T>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-257T>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs113966299	0.04302	0.08419,0.02892,0.03226,0.00864,0.01070	0,	930	20690	-2.6030	0.52			/2.3>0.9/0.0>0.0	COSV60223933	NLRP3|0.00|0.01|0.00|0.00|-23|31|30|-17		226	943	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433909	247433909	T	C	het	hom	n/a	off-target;low_conf_region	QUAL=1077;DP=95,15,0;AF=0.44,0.93,;MQM=43;SAP=125;ABP=6;SAR=0;SAF=56	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-194T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-194T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-194T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-194T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-194T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-194T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-254T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs112695411	0.04551	0.08789,0.03034,0.03361,0.00927,0.00974	0,	927	19441	-1.0810	1.70			/2.3>1.9/0.0>0.0	COSV60223939	NLRP3|0.00|0.00|0.02|0.00|-26|28|27|-20		223	940	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433921	247433921	G	A	het	hom	n/a	off-target;low_conf_region	QUAL=719;DP=101,14,1;AF=0.41,1.00,0.00;MQM=43;SAP=122;ABP=11;SAR=0;SAF=55	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-182G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-182G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-182G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-182G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-182G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-182G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-242G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs111632834	0.00107	0.00083,0.00000,0.00000,0.00191,0.00000	0,	10	9340	-0.7870	1.99			/4.3>10.3/0.0>0.0	COSV60221409	NLRP3|0.27|0.01|0.00|0.01|2|16|2|15		404	2844	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433937	247433937	G	A	het	het	n/a	off-target;low_conf_region	QUAL=935;DP=79,16,2;AF=0.46,0.88,1.00;MQM=45;SAP=116;ABP=4;SAR=0;SAF=52	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-166G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-166G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-166G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-166G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-166G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-166G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-226G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs78648901	0.03160	0.00665,0.02303,0.00000,0.04543,0.01595	11,	1256	39162	-3.5040	0.76			/4.3>3.3/7.0>4.0	COSV60223954	NLRP3|0.00|0.01|0.00|0.01|-12|0|-6|-1		130	946	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433956	247433956	G	C	het	het	het	off-target;low_conf_region	QUAL=1058;DP=69,20,5;AF=0.62,0.15,0.20;MQM=55;SAP=105;ABP=3;SAR=0;SAF=47	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-147G>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-147G>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-147G>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-147G>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-147G>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-147G>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-207G>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10802498	0.66280	0.44503,0.66320,0.82181,0.71675,0.73919	22494,	24305	35253	-2.7440	0.41			/0.9>2.3/0.0>0.0	COSV60231833	NLRP3|0.00|0.00|0.00|0.00|23|-19|-20|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433974	247433974	A	G	het	wt	wt	off-target;low_conf_region	QUAL=124;DP=95,8,8;AF=0.19,0.00,0.00;MQM=60;SAP=42;ABP=83;SAR=0;SAF=18	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-129A>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-129A>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-129A>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-129A>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-129A>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-129A>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-189A>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs77795397	0.17840	0.12178,0.23433,0.41561,0.17118,0.19977	3305,	10060	76772	-2.8280	1.76			/3.5>3.3/0.0>4.0	COSV60228530	NLRP3|0.00|0.01|0.00|0.01|42|47|-1|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433990	247433990	T	G	het	wt	wt	off-target;low_conf_region	QUAL=873;DP=125,12,8;AF=0.42,0.00,0.00;MQM=57;SAP=118;ABP=9;SAR=0;SAF=53	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-113T>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-113T>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-113T>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-113T>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-113T>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-113T>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-173T>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs1335841375	0.00175	0.00152,0.00242,0.00520,0.00149,0.00464	1,	107	62073	-3.8310	0.74			/2.3>0.9/0.0>0.0		NLRP3|0.00|0.01|0.03|0.00|-23|31|30|19		44	961	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433993	247433993	T	C	het	wt	wt	off-target;low_conf_region	QUAL=873;DP=125,12,8;AF=0.42,0.00,0.00;MQM=57;SAP=118;ABP=9;SAR=0;SAF=53	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-110T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-110T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-110T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-110T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-110T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-110T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-170T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs1380076253	0.00157	0.00155,0.00182,0.00515,0.00124,0.00346	1,	107	69411	0.3540	4.90			/2.3>1.9/0.0>0.0		NLRP3|0.00|0.01|0.09|0.00|-14|28|27|-47		44	964	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434027	247434027	C	T	hom	hom	hom	off-target;low_conf_region	QUAL=1189;DP=39,8,10;AF=0.00,0.88,1.00;MQM=60;SAP=68;ABP=0;SAR=0;SAF=30	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-76C>T::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-76C>T::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-76C>T::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-76C>T::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-136C>T::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs12124866	0.91732	0.83204,0.94622,0.98901,0.94904,0.88107	60305,	10413	11809	-2.1460	1.86			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.01|0.05|0.00|36|-6|-7|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434047	247434047	-	GAGCTCTCTGGTCAGATGTGTTCTGAGGCCTTCTCTATTCCA	wt	hom	hom	off-target;low_conf_region	QUAL=1189;DP=39,8,10;AF=0.00,0.88,1.00;MQM=56;SAP=40;ABP=0;SAR=0;SAF=17	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-101_2322-100insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs566064212	0.00002	0.00000,0.00000,0.00000,0.00006,0.00000	0,	1	44853		0.35			/4.1>8.4/0.0>4.0		NLRP3|0.03|0.01|0.01|0.00|2|-26|15|-27		7773	4201	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434063	247434063	G	A	hom	hom	hom	off-target	QUAL=9048;DP=137,70,115;AF=0.99,1.00,1.00;MQM=57;SAP=590;ABP=0;SAR=13;SAF=307	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-40G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-40G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-100G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10925022	0.30913	0.43156,0.25488,0.35766,0.25878,0.18689	10045,	21862	93756	-1.8440	0.36			/4.1>3.1/7.0>4.0		NLRP3|0.03|0.01|0.00|0.01|40|0|-43|-1	33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434355	247434355	G	-	hom	hom	hom	off-target	QUAL=7442;DP=78,86,101;AF=1.00,1.00,1.00;MQM=60;SAP=578;ABP=0;SAR=265;SAF=0	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2492+85del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2321+85del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+85del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+85del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2432+85del::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs3835304	0.53315	0.31424,0.48134,0.51855,0.64599,0.59163	23243,	34549	70957	-1.0870	0.10			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|33|-7|-7|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435768	247435768	T	C	hom	hom	hom	off-target	QUAL=2514;DP=49,19,18;AF=1.00,1.00,1.00;MQM=60;SAP=190;ABP=0;SAR=0;SAF=86	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-202T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-202T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1495T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1495T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-202T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1169053 [benign DISEASE=Cryopyrin associated periodic syndrome];			rs4612666	0.64897	0.45685,0.65609,0.54796,0.74896,0.65547	33319,	31965	53335	0.4010	3.12			/0.0>0.0/0.0>0.0	COSV60223405	NLRP3|0.00|0.00|0.00|0.00|-23|-9|9|-18	27417569,22110538,22112657,24901306,27446957,29214547,24971461,28503575,20650817,30208882,18576390,21258359,29102545,29430721,28116820,19767079,23973727,24967817,26444566,26854620,27455015,29573224,29850543,29888470,30811631,31978095,26440629,32152480,31751447,30447690,26722603,29026154,25101079,28366820,24003382,28607508,29734345,34596590,33922655,26118952,34354741,34210954,21083527,34199122,33424869,33533549,33849530,34367252,34172780,32499599,32733479,32871918,32922288,34504564,34501201,33951966,33855388,34769275,35095918,34830358,35528000,35313259,36105941,35862251,35238332,35695647,35833125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435930	247435930	G	A	het	het	het	off-target	QUAL=1387;DP=47,39,64;AF=0.49,0.41,0.52;MQM=60;SAP=34;ABP=4;SAR=20;SAF=52	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1657G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1657G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-40G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1259697 [benign DISEASE=not provided];			rs10754557	0.51606	0.24462,0.50223,0.67378,0.62373,0.60370	22556,	33186	73424	-0.6010	1.37			/0.0>0.0/6.0>8.2		NLRP3|0.00|0.09|0.00|0.00|41|40|39|-34	29850521,32104685,22318840,33922655,34345180,33925158	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247448358	247448359	AG	-	het	het	wt	off-target	QUAL=2101;DP=182,39,77;AF=0.45,0.54,0.00;MQM=60;SAP=199;ABP=6;SAR=3;SAF=99	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron6/6:c.2664-45_2664-44del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron7/7:c.2835-45_2835-44del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron8/8:c.2946-45_2946-44del::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs201053423	0.04080	0.01065,0.03929,0.03254,0.05509,0.10473	185,	5688	142412	-0.3360	1.81			/0.0>0.8/0.0>0.0		NLRP3|0.01|0.00|0.00|0.00|27|3|-46|47	33462484	56	1910	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247448734	247448734	G	C	hom	hom	hom		QUAL=50373;DP=704,384,504;AF=1.00,1.00,1.00;MQM=60;SAP=999;ABP=0;SAR=1222;SAF=368	NLRP3	3'UTR	NLRP3:ENST00000391828.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:ENST00000391827.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000336119.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000348069.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000697350.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296956 [benign DISEASE=Cryopyrin associated periodic syndrome,Atypical hemolytic-uremic syndrome,Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome 1,Autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome];			rs10754558	0.63561	0.74350,0.71042,0.58526,0.58440,0.61139	31418,	33787	55393	0.2860	7.16			/4.4>6.3/0.0>0.0	COSV59510002	NLRP3|0.00|0.00|0.00|0.00|-42|36|-42|46	27810495,22110538,22112657,23110140,24901306,27446957,29214547,30728751,24144834,26833430,28503575,29385859,26698117,30208882,18576390,21258359,29102545,29430721,28116820,31405022,19767079,23973727,26444566,27455015,29850543,29888470,25297810,26440629,28139755,16642435,20370570,20502346,21245836,22227487,23031505,26236392,26689701,26945813,27060062,27110561,27942564,28456882,28764843,29230505,29732382,31448710,32020248,26273672,26462562,30783474,28702029,31751447,29507526,30447690,26722603,25788762,29171506,28337127,29026154,23658628,30182779,28740569,27021275,31276515,30618791,21163704,30873162,30214462,34596590,34161370,32973739,33922655,33193317,32689633,21083527,34177937,34345180,33613533,34595244,33424869,33533549,33849530,34367252,34367183,33434563,34064909,34172780,32903730,32499599,32733479,33868225,33143375,34471376,32871918,32033104,30264444,34571825,34504564,33202693,33951966,32784383,34390315,34467240,34769275,35000611,35022530,34956329,35095918,34636069,34881085,34830358,34834553,34705319,3492546	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247449133	247449133	A	T	hom	hom	n/a	off-target	QUAL=1339;DP=38,3,1;AF=1.00,1.00,1.00;MQM=60;SAP=78;ABP=0;SAR=40;SAF=2	OR2B11	3'UTR	OR2B11:ENST00000641527.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1896T>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs4925547	0.36349	0.24415,0.47307,0.54449,0.39585,0.46186	10790,	33662	96736	0.5200	7.58			/5.0>4.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	hom	wt		QUAL=255376;DP=4362,3908,4222;AF=0.99,0.99,0.00;MQM=58;SAP=1407;ABP=0;SAR=5262;SAF=2957	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879158303	0.02502					-0.0730								860	37	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	wt	hom		QUAL=122492;DP=4322,3948,4305;AF=0.01,0.00,1.00;MQM=55;SAP=282;ABP=0;SAR=2541;SAF=1795	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs869183622	0.71574					-1.2370							34002094,35453788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	wt	hom		QUAL=129638;DP=4152,3299,4005;AF=0.00,0.00,0.99;MQM=60;SAP=902;ABP=0;SAR=2630;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs62581312	0.16628					-3.9110							33728047,29774306,24040623,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	wt	hom		QUAL=129638;DP=4152,3299,4005;AF=0.00,0.00,0.99;MQM=60;SAP=902;ABP=0;SAR=2630;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs117135796	0.31733					-1.7640							33062421	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	wt	hom		QUAL=109620;DP=3721,2443,3387;AF=0.00,0.00,1.00;MQM=60;SAP=975;ABP=0;SAR=2314;SAF=1081	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs2857291	0.27606					0.2630							22723804,27217714,31380278,26550561,33062421,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	wt	hom		QUAL=101854;DP=3348,2043,3152;AF=0.00,0.00,0.99;MQM=60;SAP=1015;ABP=0;SAR=2173;SAF=964	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879219259	0.00821					0.8940								319	42	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=199389;DP=2691,1163,2355;AF=1.00,1.00,1.00;MQM=60;SAP=2915;ABP=0;SAR=4541;SAF=1658	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515	0.99070					0.1780							22723804,33062421,29695379,35453788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	wt	hom		QUAL=58342;DP=2190,784,1911;AF=0.00,0.00,0.99;MQM=60;SAP=795;ABP=0;SAR=1368;SAF=535	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs41528348	0.05604					-2.8920							31380278,35328073	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	het	wt		QUAL=52691;DP=798,317,1342;AF=0.06,0.06,0.00;MQM=60;SAP=1775;ABP=163;SAR=816;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::							0.00000													820	3173	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	het	wt		QUAL=52691;DP=798,317,1342;AF=0.73,0.74,0.00;MQM=58;SAP=162;ABP=414;SAR=73;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::							0.00000													55	726	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	hom	wt		QUAL=52691;DP=798,317,1342;AF=0.05,0.02,0.00;MQM=59;SAP=46;ABP=640;SAR=20;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs369786048	0.62551													n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	wt	hom		QUAL=52691;DP=798,317,1342;AF=0.06,0.06,0.00;MQM=60;SAP=478;ABP=674;SAR=913;SAF=381	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1556422422	0.00427													224	13	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	wt	hom		QUAL=51007;DP=2010,476,1675;AF=0.00,0.00,0.99;MQM=60;SAP=341;ABP=0;SAR=1087;SAF=578	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879055956	0.00671					-0.2030								302	5	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	wt	hom		QUAL=55553;DP=2925,1270,1864;AF=0.00,0.00,0.99;MQM=60;SAP=545;ABP=0;SAR=588;SAF=1269	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1603218409	0.00019					-1.1600								12	1	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	wt	hom		QUAL=66890;DP=3076,1861,2281;AF=0.00,0.00,0.99;MQM=60;SAP=363;ABP=0;SAR=828;SAF=1441	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs28625645	0.10935					-1.4590							26116242,31380278,24040623,34976016,35453788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	wt	hom		QUAL=66975;DP=3214,1875,2306;AF=0.00,0.00,0.99;MQM=60;SAP=67;ABP=0;SAR=1017;SAF=1277	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::						rs879162984	0.01117					-2.2930							34976016	376	43	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=292729;DP=3363,2672,3133;AF=1.00,1.00,1.00;MQM=59;SAP=172;ABP=0;SAR=5004;SAF=4159	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::			441148 [not provided DISEASE=not provided];			rs2853518	0.98341					6.9050				/0.0>0.0/0.0>0.0			31380278,35328073,35453788,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=710654;DP=8324,6312,7287;AF=1.00,1.00,1.00;MQM=56;SAP=541;ABP=0;SAR=12117;SAF=9788	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::			42220 [benign DISEASE=not specified,not provided];			rs2001030	0.95610					0.2380				/0.0>0.0/0.0>0.0			24033266,9519725,18830133,31380278,33728047,29695379,35453788,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	wt	hom		QUAL=121831;DP=5777,3336,3827;AF=0.00,0.00,0.99;MQM=60;SAP=11;ABP=0;SAR=1839;SAF=1959	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::						rs878878913	0.00445					2.0490				/0.2>0.0/0.0>0.0				224	16	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2487	2487	A	C	wt	het	het		QUAL=704;DP=3345,1230,1401;AF=0.01,0.22,0.22;MQM=57;SAP=1321;ABP=1794;SAR=607;SAF=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.817A>C::						rs1603218760	0.00000					1.7730				/0.0>0.0/0.0>0.0				0	0	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=182540;DP=3123,1283,1476;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0;SAR=3311;SAF=2557	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::					LSU-rRNA_Hsa (rRNA)	rs2854128	0.73949					-0.0780				/0.0>0.0/0.0>0.0			30242290,31380278,32387288,29695379,34002094,34980117,35453788,35499074	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	wt	hom		QUAL=105736;DP=3607,3080,3473;AF=0.00,0.00,0.99;MQM=45;SAP=248;ABP=0;SAR=2044;SAF=1419	MT-ND1	missense	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase]			9724 [benign DISEASE=not provided,Leber optic atrophy,Leigh syndrome];			rs1599988	0.11756					0.2170			0.13	/0.0>0.0/0.2>0.0	COSV62293824		1732158,1900003,7635294,20301353,22723804,29370225,1417830,31380278,30684245,27594409,33475980,34478492,35328073,35130313,35682771,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	hom	wt		QUAL=101481;DP=2319,1597,1793;AF=0.99,0.99,0.00;MQM=33;SAP=33;ABP=0;SAR=2056;SAF=1824	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter]						rs28357975	0.02425					-3.5290				/4.1>3.3/0.0>0.0				631	12	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=166155;DP=2022,1858,2037;AF=1.00,1.00,1.00;MQM=36;SAP=1995;ABP=0;SAR=1790;SAF=4118	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter]			441150 [benign DISEASE=Mitochondrial disease,not provided];			rs3021086	0.98387					-20.0000				/1.3>0.2/0.0>0.0			31380278,35453788,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT; NGSD: >13000 other homo samples; gnomAD 3.1: >98% are also homo"			MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=309114;DP=3034,3457,3975;AF=0.99,1.00,1.00;MQM=43;SAP=347;ABP=0;SAR=4578;SAF=5864	MT-CO1	synonymous	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I]			1676315 [benign DISEASE=Mitochondrial disease];			rs2015062	0.74940					-9.1980				/2.7>2.9/0.0>0.0			24917144,31380278,24148579,29695379,35453788,35130313,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	wt	hom		QUAL=46944;DP=3920,1385,1606;AF=0.00,0.00,0.99;MQM=43;SAP=208;ABP=0;SAR=603;SAF=991	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::			42228 [benign DISEASE=not specified,Mitochondrial disease,Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];		tRNA-Ser-TCA(m) (tRNA)	rs201950015	0.01102					-0.8360				/0.0>0.0/0.0>0.0			24033266,15286157,18790089,8155739,8728705,9384601,19371214,21621438,31965079,35328073,35130313	406	16	0	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	wt	hom		QUAL=150780;DP=7553,5686,5190;AF=0.00,0.00,0.98;MQM=58;SAP=3789;ABP=0;SAR=1064;SAF=4050	MT-CO2	synonymous	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain]			376897 [benign DISEASE=not provided];			rs386829014	0.01099					-9.8780				/6.2>5.0/0.0>0.0			25741868,31380278	390	51	0	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=170859;DP=1658,2090,2272;AF=0.99,1.00,1.00;MQM=35;SAP=19;ABP=0;SAR=3112;SAF=2899	MT-ATP6	missense	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain]			693004 [benign DISEASE=Leigh syndrome];			rs2001031	0.99381					0.2660			0.11	/0.0>0.0/0.0>0.0			33728047,35453788,36066780	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT variant; MitoMap: in >99% of gnomAD 3.1 sequences homo; NGSD: almost existing in each sample homo"			MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	wt	hom		QUAL=120304;DP=4721,3116,3738;AF=0.00,0.00,0.99;MQM=60;SAP=202;ABP=0;SAR=1575;SAF=2160	MT-ND3	missense	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:			9713 [benign DISEASE=Parkinson disease, resistance to,Leigh syndrome];			rs2853826	0.41848					-0.3380			0.06	/1.3>0.6/0.0>0.0			24437375,23133645,30713765,6343397,17066297,26116242,26336829,31380278,28826375,23944767,25580814,30275759,32396277,33585966,34120353,33062421,30531304,33116761,34976016,35453788,35130313,35163579,35885965,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	wt	hom		QUAL=122882;DP=4629,3083,3758;AF=0.00,0.00,0.99;MQM=60;SAP=7;ABP=0;SAR=1913;SAF=1832	MT-ND4L	synonymous	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L]			376866 [benign DISEASE=not provided];			rs1057520074	0.00742					-1.0050				/1.7>0.0/0.0>0.0			25741868	292	22	0	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	wt	hom		QUAL=179482;DP=6536,4787,5638;AF=0.00,0.00,0.99;MQM=60;SAP=78;ABP=0;SAR=2586;SAF=3026	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter]						rs869096886	0.11009					-6.9950				/0.0>0.0/0.0>0.0	COSV62293827		29370225,33895935,32635923,35082309,35328073,35885965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	wt	hom		QUAL=146058;DP=6187,4080,4568;AF=0.00,0.00,0.99;MQM=60;SAP=415;ABP=0;SAR=2734;SAF=1806	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter]						rs193302938	0.01361					1.9500				/0.0>0.0/0.3>0.0				457	76	0	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	wt	hom		QUAL=166539;DP=6980,4200,5349;AF=0.00,0.01,1.00;MQM=57;SAP=14;ABP=0;SAR=2778;SAF=2610	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter]						rs2853495	0.71104					-12.2800				/0.0>0.0/0.0>0.0	COSV104668829		27716073,31380278,27877219,24148579,33895935,29695379,34002094,35453788,35885965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	wt	hom		QUAL=165169;DP=7668,4375,5156;AF=0.00,0.00,0.99;MQM=60;SAP=168;ABP=0;SAR=2253;SAF=2877	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus]						rs28359172	0.05775					-3.2010				/7.0>0.0/0.0>0.0			31380278,29695379,34002094,35328073	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	wt	hom		QUAL=52676;DP=4615,1558,1719;AF=0.00,0.00,0.99;MQM=60;SAP=5;ABP=0;SAR=830;SAF=872	MT-ND5	missense	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			9696 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs28359178	0.07564					0.6330			0.13	/3.6>3.8/0.0>0.0			24917144,19387457,29594131,1732158,1900003,7635294,20301353,1417830,1764087,31380278,24148579,25925750,33585966,33475980,29695379,33491309,34002094,35328073,35130313,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	wt	hom		QUAL=55453;DP=4703,1674,1813;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0;SAR=825;SAF=968	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			377244 [benign DISEASE=not provided];			rs386829190	0.00757					-7.6180				/0.0>0.0/0.0>0.0			25741868	293	21	2	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	wt	hom		QUAL=97341;DP=3925,2802,3085;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0;SAR=1635;SAF=1445	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			377029 [benign DISEASE=not provided];			rs879100848	0.00794					-7.4090				/0.0>0.0/0.0>0.0			25741868	298	30	0	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	hom	wt		QUAL=193562;DP=3989,2182,2366;AF=0.99,0.99,0.00;MQM=60;SAP=50;ABP=0;SAR=3245;SAF=2880	MT-ND6	synonymous	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6]						rs1603224697	0.00067					-11.2190				/0.0>0.0/0.0>0.0				30	1	0	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	wt	hom		QUAL=71944;DP=3302,2106,2296;AF=0.00,0.01,1.00;MQM=60;SAP=258;ABP=0;SAR=895;SAF=1416	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:			140587 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs193302980	0.70679					0.1160			0.14	/0.0>0.0/0.0>0.0			32943110,34069212,34002094,35453788,35130313,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	wt	hom		QUAL=122790;DP=4513,3618,3836;AF=0.00,0.00,0.99;MQM=60;SAP=24;ABP=0;SAR=1810;SAF=2001	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF00033 [Cytochrome b/b6/petB]			9674 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs41518645	0.01274					6.1030			0.12	/0.0>0.0/0.0>0.0	COSV62378578		1732158,7635294,20301353,1764087,7901141,8240104,8321540,8755941,28993255,35118571,34002094,35328073,35130313,35885965	483	66	0	0 / 0					MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=371534;DP=4477,3495,3661;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0;SAR=6341;SAF=5281	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF00033 [Cytochrome b/b6/petB]			140592 [benign DISEASE=Leigh syndrome,Familial cancer of breast,Mitochondrial disease];			rs2853508	0.99342					-5.3890			0.06	/0.0>0.0/0.0>0.0			31267007,34069212,35118571,35453788,35130313,35885965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	wt	hom		QUAL=108182;DP=6695,3241,3403;AF=0.00,0.00,0.99;MQM=60;SAP=15;ABP=0;SAR=1624;SAF=1758	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:			143925 [benign DISEASE=Leigh syndrome,Neoplasm of ovary];			rs193302994	0.11031					-2.5920			0.09	/2.6>1.4/0.0>0.0			29594131,29370225,31380278,30684245,32635923,35260714,35328073,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	hom	wt		QUAL=302564;DP=6006,3326,3779;AF=0.99,0.99,0.00;MQM=60;SAP=24;ABP=0;SAR=4776;SAF=4475	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::			690224 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];			rs35788393	0.02238					-0.9230				/0.0>0.0/0.0>0.0			31965079,32943110,34976016	698	19	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	wt	hom		QUAL=119589;DP=5788,3614,3749;AF=0.00,0.00,0.99;MQM=60;SAP=21;ABP=0;SAR=1776;SAF=1950	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147903261	0.05621					-2.0290							31380278,28813576	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	wt	hom		QUAL=124476;DP=5750,4040,3926;AF=0.00,0.00,0.99;MQM=60;SAP=167;ABP=0;SAR=1683;SAF=2226	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147029798	0.14321					-0.6180							31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	wt	hom		QUAL=125022;DP=5694,4067,3951;AF=0.00,0.00,0.99;MQM=60;SAP=147;ABP=0;SAR=1705;SAF=2214	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs41419246	0.02836					-1.2640							31380278,35328073	872	112	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	wt	hom		QUAL=150306;DP=6732,4472,4808;AF=0.00,0.00,0.99;MQM=60;SAP=112;ABP=0;SAR=2133;SAF=2621	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::					(CAACTAT)n (Simple_repeat)	rs386829286	0.00778					-0.3440								300	36	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	wt	hom		QUAL=150550;DP=7169,4292,4802;AF=0.00,0.00,0.99;MQM=60;SAP=27;ABP=0;SAR=2259;SAF=2486	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs138126107	0.03654					-1.3990							31380278	1030	141	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	hom	wt		QUAL=333186;DP=6122,4222,4825;AF=0.99,0.99,0.00;MQM=60;SAP=110;ABP=0;SAR=5464;SAF=4756	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs148377232	0.04984					-0.9170								1179	147	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	hom	wt		QUAL=374779;DP=6867,4675,4961;AF=1.00,1.00,0.02;MQM=59;SAP=4;ABP=0;SAR=5836;SAF=5768	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs3937033	0.65725					-0.2250							22723804,26550561,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)		"hohe Frequenz [1] ahbecks1 15.09.2021 [n/a] ahbecks1 15.09.2021"			MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
